FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Wilhelm, B
   Waddell, L
   Greig, J
   Young, I
AF Wilhelm, Barbara
   Waddell, Lisa
   Greig, Judy
   Young, Ian
TI Systematic review and meta-analysis of the seroprevalence of hepatitis E
   virus in the general population across non-endemic countries
SO PLOS ONE
LA English
DT Review
ID ALANINE AMINOTRANSFERASE LEVEL; LINKED-IMMUNOSORBENT-ASSAY; JAPANESE
   BLOOD-DONORS; ANTI-HEV; HIGH PREVALENCE; UNITED-STATES; NATIONWIDE
   SURVEY; E ANTIBODIES; IGM ANTIBODIES; RISK-FACTORS
AB Background
   Hepatitis E virus (HEV) has commonly been associated with large waterborne outbreaks of human jaundice in endemic areas but it has been increasingly recognised as a cause of sporadic human cases of jaundice in non-endemic areas, in individuals with no history of travel. Zoonotic exposure is widely hypothesized to be an important potential transmission route in these sporadic human cases. Serosurveys conducted to determine the frequency of HEV human exposure report wide ranges in prevalence across studies and locations. Our study objective was to compute meta-analysis summary estimates of human seroprevalence of HEV IgG within countries considered HEV non-endemic, where possible, and to determine whether this varied significantly across these countries, as well as investigating the role of potential HEV seroprevalence predictors such as population age structure.
   Materials and methods
   A broad literature search was conducted in six electronic databases. Citations were appraised, and relevant data extracted using forms designed and pre-tested a priori. Meta-analysis and meta-regression were conducted in R, with HEV IgG seroprevalence in blood donors or the general population being the outcome of interest, and country, assay, population age and sex structure, and chronological time investigated as predictors of the outcome.
   Results
   From 4163 unique citations initially captured, data were extracted from 135 studies investigating HEV serology in blood donors or the general population, of 31 countries among those categorised as 'very high human development' by the United Nations. Country of sampling and assay employed were consistently significant predictors of HEV IgG seroprevalence with chronological time being a non-significant predictor in the dataset of captured studies.
   Conclusions
   While country of sampling and assay employed were significant predictors of HEV seroprevalence, comparison of HEV seroprevalence across non-endemic countries is hampered by the lack of a gold standard assay and uncertainty regarding residual bias across studies, as well as regional differences within some countries.
C1 [Wilhelm, Barbara] Big Sky Hlth Analyt, Vermilion, AB, Canada.
   [Waddell, Lisa; Greig, Judy] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada.
   [Young, Ian] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON, Canada.
RP Wilhelm, B (reprint author), Big Sky Hlth Analyt, Vermilion, AB, Canada.
EM barbwilhelm16@gmail.com
CR Abdelaal M, 1998, IRISH J MED SCI, V167, P94, DOI 10.1007/BF02937946
   Abravanel F, 2013, MED MALADIES INFECT, V43, P263, DOI 10.1016/j.medmal.2013.03.005
   Adlhoch C, 2016, J CLIN VIROL, V82, P9, DOI 10.1016/j.jcv.2016.06.010
   Ahn JM, 2005, J CLIN MICROBIOL, V43, P3042, DOI 10.1128/JCM.43.7.3042-3048.2005
   Andenaes S, 2000, AVIAT SPACE ENVIR MD, V71, P1178
   ARIF M, 1994, ANN TROP MED PARASIT, V88, P163, DOI 10.1080/00034983.1994.11812854
   Atiq M, 2009, EMERG INFECT DIS, V15, P479, DOI 10.3201/eid1503.080740
   Ayoola EA, 2002, J MED VIROL, V66, P329, DOI 10.1002/jmv.2149
   BALAYAN MS, 1990, J MED VIROL, V32, P58, DOI 10.1002/jmv.1890320110
   Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104
   Baylis SA, 2010, VOX SANG, V98, P479, DOI 10.1111/j.1423-0410.2009.01258.x
   Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656
   Borenstein M, 2009, INTRO METAANALYSIS, P289, DOI [10.1002/jmv.21056, DOI 10.1002/JMV.21056]
   Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07
   Bouwknegt M, 2008, EPIDEMIOL INFECT, V136, P567, DOI 10.1017/S0950268807008941
   Bukowska A, 2016, VOX SANG, V111, P200
   BUTI M, 1995, J VIROL METHODS, V55, P49, DOI 10.1016/0166-0934(95)00044-U
   Buti M, 2006, CLIN VACCINE IMMUNOL, V13, P1328, DOI 10.1128/CVI.00255-06
   Capai L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060285
   Carpentier A, 2012, J CLIN MICROBIOL, V50, P2888, DOI 10.1128/JCM.00989-12
   Caruso C, 2017, TRANSBOUND EMERG DIS, V64, P1443, DOI 10.1111/tbed.12533
   Caspari G, 2000, VOX SANG, V78, P198
   Chaussade H, 2013, J CLIN VIROL, V58, P504, DOI 10.1016/j.jcv.2013.08.030
   Choi IS, 2003, J CLIN MICROBIOL, V41, P3602, DOI 10.1128/JCM.41.8.3602-3608.2003
   Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970
   Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056
   COURSAGET P, 1994, RES VIROLOGY, V145, P51, DOI 10.1016/S0923-2516(07)80007-0
   Dalekos GN, 1998, TRANSFUSION, V38, P589, DOI 10.1046/j.1537-2995.1998.38698326339.x
   Dalton H, 2010, GUT, V59, pA43, DOI [10.1136/gut.2010.223362.105, DOI 10.1136/GUT.2010.223362.105]
   Dalton HR, 2008, EUR J CLIN MICROBIOL, V27, P579, DOI 10.1007/s10096-008-0480-z
   Dalton HR, 2007, J GASTROEN HEPATOL, V22, P1236, DOI 10.1111/j.1440-1746.2007.04894.x
   Dalton HR, 2016, TRANSFUS APHER SCI, V55, P271, DOI 10.1016/j.transci.2016.10.016
   Dalton HR, 2011, EUR J GASTROEN HEPAT, V23, P1200, DOI 10.1097/MEG.0b013e32834ca4da
   DAWSON GJ, 1992, J VIROL METHODS, V38, P175, DOI 10.1016/0166-0934(92)90180-L
   de Vries A, 2015, R DUMMIES
   Debes JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160082
   Ding X, 2003, HEPATOL RES, V27, P169, DOI 10.1016/S1386-6346(03)00233-X
   Ditah I, 2014, HEPATOLOGY, V60, P815, DOI 10.1002/hep.27219
   Dohoo I, 2009, VET EPIDEMIOLOGIC RE
   Dong C, 2011, J CLIN MICROBIOL, V49, P4164, DOI 10.1128/JCM.05481-11
   Dremsek P, 2012, MED MICROBIOL IMMUN, V201, P189, DOI 10.1007/s00430-011-0221-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elsheikh A. A., 2012, The Journal of American Science, V8, P674
   Engle RE, 2002, J CLIN MICROBIOL, V40, P4576, DOI 10.1128/JCM.40.12.4576-4580.2002
   European Centre for Disease Prevention and Control, 2017, HEP E EU EAA 2005 20
   Faber MS, 2012, EMERG INFECT DIS, V18, P1654, DOI 10.3201/eid1810.111756
   Fearon MA, 2017, TRANSFUSION, V57, P1420, DOI 10.1111/trf.14089
   Fischer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119576
   Fogeda M, 2012, J MED VIROL, V84, P71, DOI 10.1002/jmv.22270
   FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756
   Fukae J, 2016, NEUROL SCI, V37, P1849, DOI 10.1007/s10072-016-2644-4
   Fukuda S, 2007, ARCH VIROL, V152, P1623, DOI 10.1007/s00705-007-0996-z
   Fukuda S, 2004, J MED VIROL, V73, P554, DOI 10.1002/jmv.20125
   Gallian P, 2014, EMERG INFECT DIS, V20, P1914, DOI 10.3201/eid2011.140516
   Gessoni G, 1996, J VIRAL HEPATITIS, V3, P197, DOI 10.1111/j.1365-2893.1996.tb00095.x
   Gotanda Y, 2007, J MED VIROL, V79, P734, DOI 10.1002/jmv.20834
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011
   Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06
   Herremans M, 2007, J VIRAL HEPATITIS, V14, P140, DOI 10.1111/j.1365-2893.2006.00786.x
   Hickey C, 2016, Ir Med J, V109, P451
   Higgins J, 2011, COCHRANE COLLAB, V5, P1, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hogema BM, 2014, TRANSFUSION, V54, P3092, DOI 10.1111/trf.12733
   Holm DK, 2015, TRANSFUSION, V55, P1662, DOI 10.1111/trf.13028
   Hornik K, 2018, R FAQ
   Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005
   Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410
   Izopet J, 2015, J CLIN VIROL, V70, P39, DOI 10.1016/j.jcv.2015.06.103
   Johargy AK, 2013, J PAK MED ASSOC, V63, P185
   Juhl D, 2014, TRANSFUSION, V54, P49, DOI 10.1111/trf.12121
   Karetnyi YV, 1999, J CLIN VIROL, V14, P51, DOI 10.1016/S1386-6532(99)00037-2
   Karetnyi YV, 1996, CLIN DIAGN VIROL, V6, P73, DOI 10.1016/0928-0197(96)00204-8
   Khudyakov Y, 2011, VIRUS RES, V161, P84, DOI 10.1016/j.virusres.2011.06.006
   Krumbholz A, 2014, MED MICROBIOL IMMUN, V203, P273, DOI 10.1007/s00430-014-0336-3
   Krumbholz A, 2012, MED MICROBIOL IMMUN, V201, P239, DOI 10.1007/s00430-011-0210-5
   Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319
   Lagler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087669
   Lange H, 2017, EPIDEMIOL INFECT, V145, P181, DOI 10.1017/S0950268816002144
   LAVANCHY D, 1994, LANCET, V344, P747, DOI 10.1016/S0140-6736(94)92235-7
   Li TC, 2000, J MED VIROL, V62, P327, DOI 10.1002/1096-9071(200011)62:3<327::AID-JMV4>3.0.CO;2-1
   LOK ASF, 1992, LANCET, V340, P1205, DOI 10.1016/0140-6736(92)92901-Q
   Love A, 2018, SCAND J GASTROENTERO, V53, P293, DOI 10.1080/00365521.2017.1420218
   Lucarelli C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.30.30299
   Mansuy JM, 2015, EUROSURVEILLANCE, V20, P27, DOI 10.2807/1560-7917.ES2015.20.19.21127
   Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056
   Mansuy JM, 2016, HEPATOLOGY, V63, P1145, DOI 10.1002/hep.28436
   Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371
   Masia G, 2009, J Prev Med Hyg, V50, P227
   Mast EE, 1997, J INFECT DIS, V176, P34, DOI 10.1086/514037
   Mateos ML, 1999, VOX SANG, V76, P78
   Mauceri C, 2018, J INFECT PUBLIC HEAL, V11, P1, DOI 10.1016/j.jiph.2017.08.004
   MEDRANO FJ, 1995, LANCET, V345, P127
   Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002
   Meng XJ, 2003, CURR TOP MICROBIOL, V278, P185
   Mesquita JR, 2014, J MED VIROL, V86, P954, DOI 10.1002/jmv.23927
   Miletic Lovric M, 2016, VOX SANG, V111, P199
   Mitsui T, 2005, J MED VIROL, V76, P526, DOI 10.1002/jmv.20393
   MOAVEN L, 1995, J MED VIROL, V45, P326, DOI 10.1002/jmv.1890450316
   MOHER D, 2009, PLOS MED, V6
   Mor O, 2015, EMERG INFECT DIS, V21, P692, DOI 10.3201/eid2104.140245
   Munn Z, 2015, INT J EVID-BASED HEA, V13, P147, DOI 10.1097/XEB.0000000000000054
   Munne MS, 2014, ANN HEPATOL, V13, P496, DOI 10.1016/S1665-2681(19)31248-7
   Nasrallah G, 2016, VOX SANG, V111, P9
   Nemecek V, 2015, J CLIN VIROL, V70, pS116, DOI 10.1016/j.jcv.2015.07.270
   Niederhauser C, 2016, VOX SANG, V111, P175
   Norder H, 2016, J CLIN MICROBIOL, V54, P549, DOI 10.1128/JCM.02343-15
   O'Riordan J, 2016, TRANSFUSION, V56, P2868, DOI 10.1111/trf.13757
   Obriadina A, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS360, DOI 10.1046/j.1440-1746.17.s3.28.x
   Olsen BR, 2006, SCAND J INFECT DIS, V38, P55, DOI 10.1080/00365540500321470
   Ooi WW, 1999, AM J TROP MED HYG, V61, P822, DOI 10.4269/ajtmh.1999.61.822
   Park HK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-142
   PAUL DA, 1994, J INFECT DIS, V169, P801, DOI 10.1093/infdis/169.4.801
   Pavia M, 1998, INFECTION, V26, P36, DOI 10.1007/BF02768749
   Pereira SS, 2016, J HEPATOL, V64, pS206, DOI 10.1016/S0168-8278(16)01724-4
   Pischke S, 2014, TRANSPL INFECT DIS, V16, P333, DOI 10.1111/tid.12183
   Pischke S, 2011, Z GASTROENTEROL, V49, P1255, DOI 10.1055/s-0031-1273394
   Pischke S, 2010, J HEPATOL, V52, pS135, DOI 10.1016/S0168-8278(10)60324-8
   Pischke S, 2016, CLIN INFECT DIS, V63, P569, DOI 10.1093/cid/ciw309
   Pittaras T, 2014, VOX SANG, V106, P387, DOI 10.1111/vox.12122
   Psichogiou M, 1996, SCAND J INFECT DIS, V28, P443, DOI 10.3109/00365549609037936
   Purcell RH, 2000, LANCET, V355, P578, DOI 10.1016/S0140-6736(05)73231-1
   PURDY MA, 2010, PLOS ONE, V5
   Puttini Camilla, 2015, Infez Med, V23, P253
   Rapicetta M, 2013, INFECTION, V41, P69, DOI 10.1007/s15010-012-0385-8
   Reinheimer C, 2012, MED MICROBIOL IMMUN, V201, P171, DOI 10.1007/s00430-011-0218-x
   Rey, 1997, J Travel Med, V4, P100, DOI 10.1111/j.1708-8305.1997.tb00788.x
   Ricco G, 2016, DIGEST LIVER DIS, V48, P536, DOI 10.1016/j.dld.2016.01.007
   Riveiro-Barciela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103028
   Sadik S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2007-z
   Sakata H, 2008, TRANSFUSION, V48, P2568, DOI 10.1111/j.1537-2995.2008.01910.x
   Sargento C, 2016, VOX SANG, V111, P198
   Sargento C, 2014, VOX SANG, V107, P165
   Sauleda S, 2015, TRANSFUSION, V55, P972, DOI 10.1111/trf.12929
   Schnegg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062980
   Schwarzer G, 2018, PACKAGE META
   Schwarzer G., 2007, R NEWS, V7, P40, DOI DOI 10.3389/FPSYG.2014.01521
   Scotto G, 2014, EPIDEMIOL INFECT, V142, P287, DOI 10.1017/S0950268813001167
   Shaz BH, 2011, J NATL MED ASSOC, V103, P351, DOI 10.1016/S0027-9684(15)30316-3
   Shrestha AC, 2014, EMERG INFECT DIS, V20, P1940, DOI 10.3201/eid2011.140412
   Slot E, 2013, EUROSURVEILLANCE, V18, P23, DOI 10.2807/1560-7917.ES2013.18.31.20550
   Strakova P, 2014, EPIDEMIOL MIKROBI IM, V63, P92
   Stramer SL, 2016, TRANSFUSION, V56, P481, DOI 10.1111/trf.13355
   Sulkowska E, 2016, VOX SANG S1, V111, P198
   Sylvan SPE, 1998, J MED VIROL, V54, P38, DOI 10.1002/(SICI)1096-9071(199801)54:1<38::AID-JMV6>3.0.CO;2-Q
   Takahashi M, 2005, J CLIN MICROBIOL, V43, P49, DOI 10.1128/JCM.43.1.49-56.2005
   Takahashi M, 2010, J MED VIROL, V82, P271, DOI 10.1002/jmv.21678
   Takeda H, 2010, VOX SANG, V99, P307, DOI 10.1111/j.1423-0410.2010.01362.x
   Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147
   Teixeira J, 2017, MED MICROBIOL IMMUN, V206, P77, DOI 10.1007/s00430-016-0484-8
   Teshale EH, 2015, J INFECT DIS, V211, P366, DOI 10.1093/infdis/jiu466
   Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006
   Toyoda K, 2008, J GASTROEN HEPATOL, V23, P1885, DOI 10.1111/j.1440-1746.2008.05568.x
   United Nations Development Programme, 2016, HUM DEV REP 2016 HUM
   Unzueta A, 2016, ANN HEPATOL, V15, P33, DOI 10.5604/16652681.1184202
   van den Berg B, 2014, NEUROLOGY, V82, P491, DOI 10.1212/WNL.0000000000000111
   Verhoef L, 2012, EPIDEMIOL INFECT, V140, P1838, DOI 10.1017/S0950268811002913
   Victor D, 2018, NY TIMES
   Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261
   Viechtbauer W, 2011, METHODS DATA
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Vilibic-Cavlek T, 2016, ZOONOSES PUBLIC HLTH, V63, P494, DOI 10.1111/zph.12254
   Vollmer T, 2012, J CLIN MICROBIOL, V50, P2708, DOI 10.1128/JCM.01119-12
   Wenzel JJ, 2014, HEPATOLOGY, V60, P1180, DOI 10.1002/hep.27244
   Wenzel JJ, 2013, J INFECT DIS, V207, P497, DOI 10.1093/infdis/jis688
   Wong KH, 2004, J MED VIROL, V72, P538, DOI 10.1002/jmv.2003
   Xu CY, 2013, TRANSFUSION, V53, P2505, DOI 10.1111/trf.12326
   Yoo D, 2001, CLIN DIAGN LAB IMMUN, V8, P1213, DOI 10.1128/CDLI.8.6.1213-1219.2001
   Yoon Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-517
   Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507
   Zaaijer HL, 2015, HEPATOLOGY, V62, P654, DOI 10.1002/hep.27611
   ZAAIJER HL, 1995, J MED VIROL, V46, P244, DOI 10.1002/jmv.1890460313
   ZAAIJER HL, 1992, LANCET, V340, P681, DOI 10.1016/0140-6736(92)92224-4
   ZANETTI AR, 1994, J MED VIROL, V42, P318, DOI 10.1002/jmv.1890420321
   Zervou EZ, 2015, VOX SANG, V109, P242
   2016, VOX SANG, V110, P93
NR 178
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 7
PY 2019
VL 14
IS 6
AR e0216826
DI 10.1371/journal.pone.0216826
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC0OB
UT WOS:000470658500006
PM 31173594
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU del-Pino-Casado, R
   Cardosa, MR
   Lopez-Martinez, C
   Orgeta, V
AF del-Pino-Casado, Rafael
   Rodriguez Cardosa, Marta
   Lopez-Martinez, Catalina
   Orgeta, Vasiliki
TI The association between subjective caregiver burden and depressive
   symptoms in carers of older relatives: A systematic review and
   meta-analysis
SO PLOS ONE
LA English
DT Review
ID QUALITY-OF-LIFE; INFORMAL CAREGIVERS; DEMENTIA CAREGIVERS; FAMILY
   CAREGIVERS; ALZHEIMER-DISEASE; SELF-EFFICACY; PSYCHOLOGICAL SYMPTOMS;
   PERCEIVED BURDEN; MENTAL-HEALTH; ANXIETY
AB Background
   Family carers are an important source of care for older people. Although several studies have reported that subjective caregiver burden is related to depressive symptoms there are no systematic reviews quantifying this association.
   Objective
   To establish the extent to which subjective caregiver burden is associated with depressive symptoms and whether this association would vary by study or care characteristics.
   Methods
   We searched major databases such as PubMed, CINAHL, PsycINFO, Scopus and ISI Proceedings up to March 2018, and conducted a meta-analysis of included studies. Summary estimates of the association were obtained using a random-effects model to improve generalisation of findings.
   Results
   After screening of 4,688 articles, 55 studies were included providing a total of 56 independent comparisons with a total of 9,847 carers from data across 20 countries. There was a large, positive association between subjective caregiver burden and depressive symptoms ((r) over bar = 0.514; 95% CI = 0.486, 0.541), with very low heterogeneity amongst individual studies (I-2 = 8.6%). Sensitivity analyses showed no differences between cross-sectional or repeated measures ((r) over bar = 0.521; 95% CI = 0.491, 0.550; 51 samples) and longitudinal studies ((r) over bar = 0.454; 95% CI = 0.398, 0.508; 6 samples). We found a higher effect size for those caring for people living with dementia compared to those caring for frail older people, and stroke survivors. Carer sex, age and kinship did not change the estimate of the effect.
   Conclusions
   Subjective caregiver burden is a significant risk factor for depressive symptoms in carers of older people and may precipitate clinical depression. Those caring for people with dementia experience greater burden. There is a need for longitudinal evaluations examining the effects of potential mediators of the association of subjective burden and depressive symptoms. Future interventions should test whether minimizing subjective burden may modify the risk of developing depression in carers of older relatives.
C1 [del-Pino-Casado, Rafael; Rodriguez Cardosa, Marta; Lopez-Martinez, Catalina] Univ Jaen, Sch Hlth Sci, Dept Nursing, Jaen, Spain.
   [Orgeta, Vasiliki] UCL, Fac Brain Sci, Div Psychiat, London, England.
RP del-Pino-Casado, R (reprint author), Univ Jaen, Sch Hlth Sci, Dept Nursing, Jaen, Spain.
EM rdelpino@ujaen.es
RI del-Pino-Casado, Rafael/L-3733-2018
OI del-Pino-Casado, Rafael/0000-0003-2263-2415
CR Adams K. B., 2008, DEMENTIA-LONDON, V7, P301, DOI DOI 10.1177/1471301208093286
   Alspaugh MEL, 1999, PSYCHOL AGING, V14, P34, DOI 10.1037/0882-7974.14.1.34
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Aneshensel CS, 1995, PROFILES CAREGIVING
   Ar Y, 2017, THESIS
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   Bachner YG, 2016, J AM PSYCHIAT NURSES, V22, P27, DOI 10.1177/1078390316629959
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bianchi M, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.1379.2835
   Bin Sallim A, 2015, J AM MED DIR ASSOC, V16, P1034, DOI 10.1016/j.jamda.2015.09.007
   Borenstein M., 2009, INTRO METAANALYSIS, P45, DOI [DOI 10.1002/9780470743386.CH7, 10.1002/9780470743386.ch7]
   Boyle M. H., 1998, EVID BASED MENT HLTH, V1, P37, DOI DOI 10.1136/EBMH.1.2.37
   Brandao D, 2017, SCAND J CARING SCI, V31, P984, DOI 10.1111/scs.12423
   Byun E, 2013, THESIS
   Carter JH, 2008, MOVEMENT DISORD, V23, P1211, DOI 10.1002/mds.21686
   Cheng ST, 2013, AM J GERIAT PSYCHIAT, V21, P1029, DOI 10.1016/j.jagp.2013.01.041
   Chow EOW, 2012, AGING MENT HEALTH, V16, P1016, DOI 10.1080/13607863.2012.692769
   Clark MC, 2013, BIOL RES NURS, V15, P112, DOI 10.1177/1099800411414872
   Clyburn LD, 2000, J GERONTOL B-PSYCHOL, V55, pS2
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Cooper C, 2008, INT PSYCHOGERIATR, V20, P494, DOI 10.1017/S104161020700645X
   Cooper H, 2009, HDB RES SYNTHESIS ME
   Corazza Danilla I, 2014, Rev Esp Geriatr Gerontol, V49, P173, DOI 10.1016/j.regg.2014.03.007
   D'Aoust RF, 2015, INT J OLDER PEOPLE N, V10, P14, DOI 10.1111/opn.12043
   del-Pino-Casado R, 2019, J AFFECT DISORDERS, V242, P14, DOI 10.1016/j.jad.2018.08.002
   del-Pino-Casado R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189874
   del-Pino-Casado R, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0667-1
   Del-Pino-Casado R, 2015, RES NURS HEALTH, V38, P384, DOI 10.1002/nur.21671
   del-Pino-Casado R, 2011, J ADV NURS, V67, P2311, DOI 10.1111/j.1365-2648.2011.05725.x
   Diehl-Schmid J, 2013, J GERIATR PSYCH NEUR, V26, P221, DOI 10.1177/0891988713498467
   Domingues NS, 2018, AM J ALZHEIMERS DIS, V33, P401, DOI 10.1177/1533317518788151
   dos Santos GD, 2017, PSYCHOGERIATRICS, V17, P317, DOI 10.1111/psyg.12241
   DRINKA TJK, 1987, J AM GERIATR SOC, V35, P522, DOI 10.1111/j.1532-5415.1987.tb01398.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Edelstein OE, 2018, AGING MENT HEALTH, V22, P639, DOI 10.1080/13607863.2017.1289363
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Feast A, 2016, INT PSYCHOGERIATR, V28, P1761, DOI 10.1017/S1041610216000922
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   Gallagher D, 2011, AGING MENT HEALTH, V15, P663, DOI 10.1080/13607863.2011.562179
   Geng HM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011863
   GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897
   Gonzalez-Abraldes I, 2013, ARCH GERONTOL GERIAT, V56, P91, DOI 10.1016/j.archger.2012.07.011
   Graf R, 2017, TOP STROKE REHABIL, V24, P488, DOI 10.1080/10749357.2017.1338371
   Grano C, 2017, INT PSYCHOGERIATR, V29, P1095, DOI 10.1017/S1041610217000059
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011
   Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203
   Heo GJ, 2013, J APPL GERONTOL, V32, P582, DOI 10.1177/0733464811433484
   Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674
   Hirschman KB, 2004, J AM GERIATR SOC, V52, P1724, DOI 10.1111/j.1532-5415.2004.52468.x
   Jaracz K, 2012, NEUROL NEUROCHIR POL, V46, P224, DOI 10.5114/ninp.2012.29130
   Jones SBW, 2015, J PSYCHOSOC ONCOL, V33, P178, DOI 10.1080/07347332.2014.1002657
   Karabekiroglu A, 2018, SINGAP MED J, V59, P572, DOI 10.11622/smedj.2018066
   Khalaila R, 2011, AGING MENT HEALTH, V15, P679, DOI 10.1080/13607863.2011.569479
   Kim SK, 2017, INT PSYCHOGERIATR, V29, P227, DOI 10.1017/S1041610216001770
   Kowalska J, 2017, AM J ALZHEIMERS DIS, V32, P509, DOI 10.1177/1533317517734350
   Kruithof WJ, 2016, PATIENT EDUC COUNS, V99, P1632, DOI 10.1016/j.pec.2016.04.007
   Lacey Rebecca E, 2019, Psychol Med, V49, P1652, DOI 10.1017/S0033291718002222
   Lai DWL, 2009, SOC WORK HEALTH CARE, V48, P432, DOI 10.1080/00981380802591759
   LAWTON MP, 1991, J GERONTOL, V46, pP181, DOI 10.1093/geronj/46.4.P181
   Lazarus RS, 1984, STRESS APPRAISAL COP
   Li CY, 2013, AGING MENT HEALTH, V17, P924, DOI 10.1080/13607863.2013.814098
   Liu HY, 2017, J ADV NURS, V73, P2962, DOI 10.1111/jan.13379
   Liu J, 2012, ARCH GERONTOL GERIAT, V55, P560, DOI 10.1016/j.archger.2012.05.014
   Loh AZ, 2017, J AM MED DIR ASSOC, V18, P111, DOI 10.1016/j.jamda.2016.08.014
   Lopez-Martinez C, 2019, GAC SANIT, V33, P185, DOI 10.1016/j.gaceta.2017.09.005
   Luther K, 2014, THESIS
   Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3
   Mausbach BT, 2012, AGING MENT HEALTH, V16, P27, DOI 10.1080/13607863.2011.615738
   McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53
   Meader N, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-82
   Medrano Martin, 2014, Dement. neuropsychol., V8, P384, DOI 10.1590/S1980-57642014DN84000013
   Mohamed S, 2010, AM J GERIAT PSYCHIAT, V18, P917, DOI 10.1097/JGP.0b013e3181d5745d
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Morlett Paredes A, 2014, THESIS
   OECD, 2017, HLTH GLANC 2017 OECD
   Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737
   Parker LD, 2007, THESIS
   Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112
   Powers SM, 2014, THESIS
   Raveis VH, 1998, CANCER, V83, P1652, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1652::AID-CNCR22>3.3.CO;2-H
   Robinson Shurgot GS, 2005, J MENTAL HLTH AGING, V3, P37
   Roche L, 2015, J GERIATR PSYCH NEUR, V28, P218, DOI 10.1177/0891988715588830
   Roe B, 2007, REVIEWING RESEARCH EVIDENCE FOR NURSING PRACTICE: SYSTEMATIC REVIEWS, P9, DOI 10.1002/9780470692127.ch2
   Romero-Moreno R, 2011, AGING MENT HEALTH, V15, P221, DOI 10.1080/13607863.2010.505231
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Schoenmakers B, 2010, MATURITAS, V66, P191, DOI 10.1016/j.maturitas.2010.02.009
   Sherwood PR, 2005, J AGING HEALTH, V17, P125, DOI 10.1177/0898264304274179
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sutter M, 2016, J TRANSCULT NURS, V27, P376, DOI 10.1177/1043659615573081
   van der Lee J, 2014, AGEING RES REV, V15, P76, DOI 10.1016/j.arr.2014.03.003
   Viswanathan M, 2013, ASSESSING RISK BIAS
   VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392
   Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1
   Wang W., 2017, J TEXTURE STUD, V10, P1111
   Watson B, 2018, GERONTOLOGIST
   Williams Francesca, 2018, Aging Ment Health, P1, DOI 10.1080/13607863.2018.1515886
   Yates ME, 1999, J GERONTOL B-PSYCHOL, V54, pP12, DOI 10.1093/geronb/54B.1.P12
   ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649
   Zhu W, 2018, J STROKE CEREBROVASC, V27, P3636, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.037
NR 99
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2019
VL 14
IS 5
AR e0217648
DI 10.1371/journal.pone.0217648
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA1LO
UT WOS:000469323000073
PM 31141556
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU White, CA
   Uttl, B
   Holder, MD
AF White, Carmela A.
   Uttl, Bob
   Holder, Mark D.
TI Meta-analyses of positive psychology interventions: The effects are much
   smaller than previously reported
SO PLOS ONE
LA English
DT Article
ID WELL-BEING THERAPY; RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT
   ABILITY; QUALITY-OF-LIFE; COUNTING BLESSINGS; FORGIVENESS THERAPY;
   HEALTH-BENEFITS; GOAL ATTAINMENT; HAPPINESS; GRATITUDE
AB For at least four decades, researchers have studied the effectiveness of interventions designed to increase well-being. These interventions have become known as positive psychology interventions (PPIs). Two highly cited meta-analyses examined the effectiveness of PPIs on well-being and depression: Sin and Lyubomirsky (2009) and Bolier et al. (2013). Sin and Lyubomirsky reported larger effects of PPIs on well-being (r =.29) and depression (r =.31) than Bolier et al. reported for subjective well-being (r =.17), psychological wellbeing (r =.10), and depression (r =.11). A detailed examination of the two meta-analyses reveals that the authors employed different approaches, used different inclusion and exclusion criteria, analyzed different sets of studies, described their methods with insufficient detail to compare them clearly, and did not report or properly account for significant small sample size bias. The first objective of the current study was to reanalyze the studies selected in each of the published meta-analyses, while taking into account small sample size bias. The second objective was to replicate each meta-analysis by extracting relevant effect sizes directly from the primary studies included in the meta-analyses. The present study revealed three key findings: (1) many of the primary studies used a small sample size; (2) small sample size bias was pronounced in many of the analyses; and (3) when small sample size bias was taken into account, the effect of PPIs on well-being were small but significant (approximately r =.10), whereas the effect of PPIs on depression were variable, dependent on outliers, and generally not statistically significant. Future PPI research needs to focus on increasing sample sizes. A future meta-analyses of this research needs to assess cumulative effects from a comprehensive collection of primary studies while being mindful of issues such as small sample size bias.
C1 [White, Carmela A.; Holder, Mark D.] Univ British Columbia, Kelowna, BC, Canada.
   [Uttl, Bob] Mt Royal Univ, Calgary, AB, Canada.
RP White, CA (reprint author), Univ British Columbia, Kelowna, BC, Canada.
EM whitecarmela@gmail.com
CR Abbott J-A, 2009, ELECT J APPL PSYCHOL, V5, P89, DOI DOI 10.7790/EJAP.V5I1.145
   Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489
   Boehm JK, 2011, COGNITION EMOTION, V25, P1263, DOI 10.1080/02699931.2010.541227
   Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119
   Borenstein M., 2009, INTRO METAANALYSIS
   Buchanan KE, 2010, J SOC PSYCHOL, V150, P235, DOI 10.1080/00224540903365554
   Burton CM, 2004, J RES PERS, V38, P150, DOI 10.1016/S0092-6566(03)00058-8
   Capaldi C. A., 2015, INT J WELLBEING, V5, DOI [10.5502/ijw.v5i4.449, DOI 10.5502/IJW.V5I4.1]
   Cheavens JS, 2006, SOC INDIC RES, V77, P61, DOI 10.1007/s11205-005-5553-0
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   Cook E A, 1998, Health Care Women Int, V19, P109, DOI 10.1080/073993398246449
   Cooper H, 1993, HDB RES SYNTHESIS
   Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839
   Csikszentmihalyi M., 2014, FLOW FDN POSITIVE PS
   Davis Marsha Courville, 2004, Issues Ment Health Nurs, V25, P503, DOI 10.1080/01612840490443455
   Della Porta MD, 2009, SEARCHING PLACEBO EF
   Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34
   DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542
   Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377
   Fava GA, 2005, PSYCHOTHER PSYCHOSOM, V74, P26, DOI 10.1159/000082023
   Fava GA, 2003, J BEHAV THER EXP PSY, V34, P45, DOI 10.1016/S0005-7916(03)00019-3
   Fava GA, 1998, PSYCHOL MED, V28, P475, DOI 10.1017/S0033291797006363
   Feldman DB, 2012, J HAPPINESS STUD, V13, P745, DOI 10.1007/s10902-011-9292-4
   FORDYCE MW, 1983, J COUNS PSYCHOL, V30, P483, DOI 10.1037/0022-0167.30.4.483
   FORDYCE MW, 1977, J COUNS PSYCHOL, V24, P511, DOI 10.1037/0022-0167.24.6.511
   Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262
   Freedman SR, 1996, J CONSULT CLIN PSYCH, V64, P983, DOI 10.1037/0022-006X.64.5.983
   Frieswijk N, 2006, PATIENT EDUC COUNS, V61, P219, DOI 10.1016/j.pec.2005.03.011
   Froh JJ, 2008, J SCHOOL PSYCHOL, V46, P213, DOI 10.1016/j.jsp.2007.03.005
   Gander F, 2013, J HAPPINESS STUD, V14, P1241, DOI 10.1007/s10902-012-9380-0
   Goldstein ED, 2007, J CLIN PSYCHOL, V63, P1001, DOI 10.1002/jclp.20402
   Grant A. M., 2012, J SYST THER, V31, P21, DOI [10.1521/jsyt.2012.31.2.21, DOI 10.1521/JSYT.2012.31.2.21]
   Grant AM, 2009, J POSIT PSYCHOL, V4, P396, DOI 10.1080/17439760902992456
   Green L. S., 2006, J POSIT PSYCHOL, V1, P142, DOI DOI 10.1080/17439760600619849
   Grossman P, 2007, PSYCHOTHER PSYCHOSOM, V76, P226, DOI 10.1159/000101501
   Hedges LV, 1989, CONTRIBUTIONS PROBAB, P447, DOI 10.1007/978-1-4612-3678-8_31
   Hempel S, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-107
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Howell AJ, 2016, J HAPPINESS STUD, V17, P2347, DOI 10.1007/s10902-015-9697-6
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   Hurley DB, 2012, J HAPPINESS STUD, V13, P579, DOI 10.1007/s10902-011-9280-8
   Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007
   Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539
   King LA, 2000, PERS SOC PSYCHOL B, V26, P220, DOI 10.1177/0146167200264008
   King LA, 2001, PERS SOC PSYCHOL B, V27, P798, DOI 10.1177/0146167201277003
   Kremers IP, 2006, AGING MENT HEALTH, V10, P476, DOI 10.1080/13607860600841206
   Kushlev K, 2017, CONTEMP CLIN TRIALS, V52, P62, DOI 10.1016/j.cct.2016.11.003
   Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863
   Layous K, 2013, J HAPPINESS STUD, V14, P635, DOI 10.1007/s10902-012-9346-2
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   LICHTER S, 1980, NEW ZEAL PSYCHOL, V9, P57
   Lin WF, 2004, J CONSULT CLIN PSYCH, V72, P1114, DOI 10.1037/0022-006X.72.6.1114
   Low CA, 2006, HEALTH PSYCHOL, V25, P181, DOI 10.1037/0278-6133.25.2.181
   Martinez-Marti ML, 2010, SPAN J PSYCHOL, V13, P886, DOI 10.1017/S1138741600002535
   Luthans F, 2008, ACAD MANAG LEARN EDU, V7, P209, DOI 10.5465/AMLE.2008.32712618
   Luthans F, 2010, HUM RESOUR DEV Q, V21, P41, DOI 10.1002/hrdq.20034
   Lyubomirsky S, 2006, J PERS SOC PSYCHOL, V90, P692, DOI 10.1037/0022-3514.90.4.692
   Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111
   Lyubomirsky S, 2011, EMOTION, V11, P391, DOI 10.1037/a0022575
   MacLeod AK, 2008, J HAPPINESS STUD, V9, P185, DOI 10.1007/s10902-007-9057-2
   McMahan EA, 2015, J POSIT PSYCHOL, V10, P507, DOI 10.1080/17439760.2014.994224
   Mitchell J, 2009, COMPUT HUM BEHAV, V25, P749, DOI 10.1016/j.chb.2009.02.003
   Mongrain M, 2012, J CLIN PSYCHOL, V68, DOI 10.1002/jclp.21839
   Mongrain M, 2011, J HAPPINESS STUD, V12, P963, DOI 10.1007/s10902-010-9239-1
   Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059
   Niemiec R. M., 2012, J MENTAL HLTH COUNSE, V34, P240, DOI DOI 10.17744/MEHC.34.3.34P6328X2V204V21
   Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z
   Page KM, 2013, J HAPPINESS STUD, V14, P1007, DOI 10.1007/s10902-012-9366-y
   Parks AC, 2013, POSITIVE INTERVENTIO
   Passmore B, 2016, 2016 IEEE 4TH WORKSHOP ON WIDE BANDGAP POWER DEVICES AND APPLICATIONS (WIPDA), P1, DOI 10.1109/WiPDA.2016.7799900
   Peters ML, 2010, J POSIT PSYCHOL, V5, P204, DOI 10.1080/17439761003790963
   Peterson C, 2005, J HAPPINESS STUD, V6, P25, DOI DOI 10.1007/S10902-004-1278-Z
   Pretorius C, 2008, J PSYCHOL AFR, V18, P301
   Quoidbach J, 2009, J POSIT PSYCHOL, V4, P349, DOI 10.1080/17439760902992365
   R Core Team, 2015, R LANG EN STAT COMP
   Rashid T, 2008, HDB DEPRESSION CHILD, P250
   Reed GL, 2006, J CONSULT CLIN PSYCH, V74, P920, DOI 10.1037/0022-006X.74.5.920
   Rucker G, 2011, BIOMETRICAL J, V53, P351, DOI 10.1002/bimj.201000151
   Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046
   Ruini C, 2006, PSYCHOTHER PSYCHOSOM, V75, P331, DOI 10.1159/000095438
   Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141
   RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719, DOI 10.1037/0022-3514.69.4.719
   Schmidt F. L., 2014, METHODS METAANALYSIS
   Schueller S, 2014, INT J WELLBEING, P4
   Schueller SM, 2012, J MED INTERNET RES, V14, P4, DOI 10.2196/jmir.1850
   Seligman M. E. P., 2011, FLOURISH VISIONARY N
   Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774
   Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410
   Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5
   Sergeant S, 2011, J POSIT PSYCHOL, V6, P260, DOI 10.1080/17439760.2011.577089
   Shapira LB, 2010, J POSIT PSYCHOL, V5, P377, DOI 10.1080/17439760.2010.516763
   Sheldon K.M., 2006, J POSIT PSYCHOL, V1, P73, DOI DOI 10.1080/17439760500510676
   Sheldon KM, 2002, J PERS, V70, P5, DOI 10.1111/1467-6494.00176
   Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593
   SMITH WP, 1995, J CLIN PSYCHOL, V51, P269
   Spence G. B., 2007, J POSIT PSYCHOL, V2, P185, DOI DOI 10.1080/17439760701228896
   Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095
   Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101
   Surawy C, 2005, BEHAV COGN PSYCHOTH, V33, P103, DOI 10.1017/S135246580400181X
   Tkach C, 2006, J HAPPINESS STUD, V7, P183, DOI [10.1007/s10902-005-4754-1, DOI 10.1007/S10902-005-4754-1]
   Tkach CT, 2005, UNLOCKING TREASURY H
   Viechtbauer W, 2010, RES SYNTH METHODS, V1, P112, DOI 10.1002/jrsm.11
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Wampold BE, 1997, PSYCHOL BULL, V122, P203, DOI 10.1037/0033-2909.122.3.203
   Watkins PC, 2003, SOC BEHAV PERSONAL, V31, P431, DOI 10.2224/sbp.2003.31.5.431
   Wing JF, 2006, J CLIN PSYCHOL, V62, P1291, DOI 10.1002/jclp.20292
   Zautra AJ, 2008, J CONSULT CLIN PSYCH, V76, P408, DOI 10.1037/0022-006X.76.3.408
NR 109
TC 0
Z9 0
U1 6
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2019
VL 14
IS 5
AR e0216588
DI 10.1371/journal.pone.0216588
PG 48
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA1LO
UT WOS:000469323000016
PM 31141537
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU Batteux, E
   Ferguson, E
   Tunney, RJ
AF Batteux, Eleonore
   Ferguson, Eamonn
   Tunney, Richard J.
TI Do our risk preferences change when we make decisions for others? A
   meta-analysis of self-other differences in decisions involving risk
SO PLOS ONE
LA English
DT Article
ID PSYCHOLOGICAL DISTANCE; LEVEL; WOULD; REAL
AB Background
   Are we more risk-averse or risk-seeking when we make decisions on behalf of other people as opposed to ourselves? So far, findings have not been able to provide a clear and consistent answer.
   Method
   We propose a meta-analysis to assess whether self-other differences vary according to particular features of the decision. We reviewed 78 effect sizes from 49 studies (7,576 participants).
   Results
   There was no overall self-other difference, but there were moderating effects of domain and frame. Decisions in the interpersonal domain were more risk-averse for self than for other. Decisions in the medical domain were more risk-seeking for self than for other. There were no overall self-other differences in the financial domain, however there was a moderating effect of frame: decisions in a gain frame were more risk-averse for self than other whereas decisions in a loss frame were more risk-seeking for self than other. This effect of frame was slightly different overall and in the medical domain, where self-other differences occurred in a loss frame but not in a gain frame.
   Conclusion
   Future work should continue to investigate how the specific content and context of the decision impacts self-other differences in order to understand the effects of domain and frame we report.
C1 [Batteux, Eleonore; Ferguson, Eamonn] Univ Nottingham, Nottingham, England.
   [Tunney, Richard J.] Aston Univ, Birmingham, W Midlands, England.
RP Batteux, E (reprint author), Univ Nottingham, Nottingham, England.
EM eleonore.batteux@nottingham.ac.uk
OI Tunney, Richard/0000-0003-4673-757X; Batteux,
   Eleonore/0000-0002-5494-7385
FU Economic and Social Research Council [ES/J500100/1]
FX This work was supported by the Economic and Social Research Council
   [grant number ES/J500100/1], an ESRC post-graduate studentship to
   Eleonore Batteux. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andersson O, 2014, MANAGE SCI, V2461
   Andersson O, 2013, RISKING OTHER PEOPLE, P1
   Atanasov P., 2015, RISK PREFERENCES CHO
   Barreda-Tarrazona I, 2014, SPAN J FINANC ACCOUN, V40, P613
   Batteux E, 2017, EXP PSYCHOL, V64, P290, DOI 10.1027/1618-3169/a000371
   Beisswanger AH, 2003, BASIC APPL SOC PSYCH, V25, P121, DOI 10.1207/S15324834BASP2502_3
   Benjamin AM, 2007, PERS INDIV DIFFER, V43, P221, DOI 10.1016/j.paid.2006.11.026
   Borenstein M., 2009, INTRO METAANALYSIS, P21, DOI DOI 10.1002/9780470743386.CH6
   Carroll AE, 2017, J HLTH PSYCHOL
   Chakravarty S, 2011, SOUTH ECON J, V77, P901, DOI 10.4284/0038-4038-77.4.901
   Charness G, 2012, J ECON BEHAV ORGAN, V81, P1, DOI 10.1016/j.jebo.2011.08.009
   Cohen J., 1988, STAT POWER ANAL BEHA, P283
   Cook S., 2002, WORK LEARNING RES, P1
   Cooper H., 1999, SYNTHESIZING RES GUI, V3rd, pXII
   Cumming G., 2012, UNDERSTANDING NEW ST, Vxiv, P519
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533
   Eriksen KW, 2017, RISK TAKING BEHALF O
   Fairley K, 2012, SOCIAL RISK AMBIGUIT
   Fernandez-Duque D, 2007, JUDGM DECIS MAK, V2, P1
   Fullbrunn S, 2015, AM I MY PEERS KEEPER
   Garcia-Retamero R, 2012, J EXP PSYCHOL-APPL, V18, P38, DOI 10.1037/a0026018
   GREENWALD AG, 1976, PSYCHOL BULL, V83, P314, DOI 10.1037/0033-2909.83.2.314
   Hermann D, 2017, 2017332 CEGE
   Hershfield HE, EXAMINING EFFECT SOC
   Hinvest NS, 2010, Q J EXP PSYCHOL, V63, P1072, DOI 10.1080/17470210903276350
   Jastrebski SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181900
   Kogan Teger, 1971, P 79 ANN CONV AM PSY, V6
   Kray L, 1999, J BEHAV DECIS MAKING, V12, P207, DOI 10.1002/(SICI)1099-0771(199909)12:3<207::AID-BDM322>3.0.CO;2-P
   Lakens D., 2013, FRONT PSYCHOL, V4, P1, DOI DOI 10.3389/FPSYG.2013.00863
   Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043
   Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   Losecaat Vermeer AB, 2017, RISKY DECISIONS CONT
   Madsen DO, 2015, PROCD SOC BEHV, V187, P113, DOI 10.1016/j.sbspro.2015.03.022
   Maglio SJ, 2013, J EXP PSYCHOL GEN, V142, P644, DOI 10.1037/a0030258
   Matusiewicz AK, 2013, BEHAV PROCESS, V100, P116, DOI 10.1016/j.beproc.2013.07.019
   Mengel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094099
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Pachur T., 2014, DECISION, V1, P64, DOI [10.1037/dec0000006, DOI 10.1037/DEC0000006]
   Polanin JR, 2016, REV EDUC RES, V86, P207, DOI 10.3102/0034654315582067
   Pollmann MMH, 2014, ECON LETT, V123, P387, DOI 10.1016/j.econlet.2014.04.004
   Polman E, 2012, ORGAN BEHAV HUM DEC, V119, P141, DOI 10.1016/j.obhdp.2012.06.005
   Polman E, 2011, PERS SOC PSYCHOL B, V37, P492, DOI 10.1177/0146167211398362
   Pronin E, 2008, PERS SOC PSYCHOL B, V34, P224, DOI 10.1177/0146167207310023
   Rigoli F, 2018, COGN AFFECT BEHAV NE, V18, P331, DOI 10.3758/s13415-018-0572-x
   Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493
   Slovic P, 1967, RES B, V7
   Stone ER, 2002, J APPL SOC PSYCHOL, V32, P1797, DOI 10.1111/j.1559-1816.2002.tb00260.x
   Stone ER, 2008, BASIC APPL SOC PSYCH, V30, P114, DOI 10.1080/01973530802208832
   Stone ER, 2013, JUDGM DECIS MAK, V8, P250
   Sun QZ, 2017, J SOC PSYCHOL, V157, P502, DOI 10.1080/00224545.2016.1242471
   Tang MY, 2016, J HEALTH PSYCHOL, V21, P781, DOI 10.1177/1359105314539527
   Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963
   Tunney RJ, 2015, PERSPECT PSYCHOL SCI, V10, P880, DOI 10.1177/1745691615598508
   TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Vieider FM, 2016, ECON INQ, V54, P879, DOI 10.1111/ecin.12290
   Vlaev I, 2012, J ECON PSYCHOL, V33, P963, DOI 10.1016/j.joep.2012.05.005
   Whittaker A, 2017, J SOC WORK PRACT, V31, P375, DOI 10.1080/02650533.2017.1397612
   Wray LD, 2005, J BEHAV DECIS MAKING, V18, P125, DOI 10.1002/bdm.490
   Xu SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29520
   ZALESKA M, 1971, SOCIOMETRY, V34, P198, DOI 10.2307/2786410
   Zhang X, 2017, FRONT PLANT SCI, V8, P1
   Ziegler Fenja V, 2015, BMC Psychol, V3, P9, DOI 10.1186/s40359-015-0067-2
   Ziegler FV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049479
   Zikmund-Fisher BJ, 2006, J GEN INTERN MED, V21, P618, DOI 10.1111/j.1525-1497.2006.00410.x
   Zou X, 2016, PERS SOC PSYCHOL B, V42, P275, DOI 10.1177/0146167215626706
   2010, REV FINANC, V14, P521
NR 69
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 8
PY 2019
VL 14
IS 5
AR e0216566
DI 10.1371/journal.pone.0216566
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HX4MT
UT WOS:000467373000050
PM 31067283
OA DOAJ Gold
DA 2019-07-16
ER

PT J
AU van Aert, RCM
   Wicherts, JM
   van Assen, MALM
AF van Aert, Robbie C. M.
   Wicherts, Jelte M.
   van Assen, Marcel A. L. M.
TI Publication bias examined in meta-analyses from psychology and medicine:
   A meta-meta-analysis
SO PLOS ONE
LA English
DT Article
ID BETWEEN-STUDY HETEROGENEITY; ESTIMATING EFFECT SIZE;
   PREDICTIVE-DISTRIBUTIONS; CONDUCTING METAANALYSES; STATISTICAL TESTS;
   JUDGMENT CALLS; FUNNEL-PLOT; FILL METHOD; PREVALENCE; SCIENCE
AB Publication bias is a substantial problem for the credibility of research in general and of meta-analyses in particular, as it yields overestimated effects and may suggest the existence of non-existing effects. Although there is consensus that publication bias exists, how strongly it affects different scientific literatures is currently less well-known. We examined evidence of publication bias in a large-scale data set of primary studies that were included in 83 meta-analyses published in Psychological Bulletin (representing meta-analyses from psychology) and 499 systematic reviews from the Cochrane Database of Systematic Reviews (CDSR; representing meta-analyses from medicine). Publication bias was assessed on all homogeneous subsets (3.8% of all subsets of meta-analyses published in Psychological Bulletin) of primary studies included in meta-analyses, because publication bias methods do not have good statistical properties if the true effect size is heterogeneous. Publication bias tests did not reveal evidence for bias in the homogeneous subsets. Overestimation was minimal but statistically significant, providing evidence of publication bias that appeared to be similar in both fields. However, a Monte-Carlo simulation study revealed that the creation of homogeneous subsets resulted in challenging conditions for publication bias methods since the number of effect sizes in a subset was rather small (median number of effect sizes equaled 6). Our findings are in line with, in its most extreme case, publication bias ranging from no bias until only 5% statistically nonsignificant effect sizes being published. These and other findings, in combination with the small percentages of statistically significant primary effect sizes (28.9% and 18.9% for subsets published in Psychological Bulletin and CDSR), led to the conclusion that evidence for publication bias in the studied homogeneous subsets is weak, but suggestive of mild publication bias in both psychology and medicine.
C1 [van Aert, Robbie C. M.; Wicherts, Jelte M.; van Assen, Marcel A. L. M.] Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands.
   [van Assen, Marcel A. L. M.] Univ Utrecht, Dept Sociol, Utrecht, Netherlands.
RP van Aert, RCM (reprint author), Tilburg Univ, Dept Methodol & Stat, Tilburg, Netherlands.
EM R.C.M.vanAert@tilburguniversity.edu
RI Wicherts, Jelte/A-2664-2008
OI Wicherts, Jelte/0000-0003-2415-2933
FU Netherlands Organization for Scientific Research (NWO) [406-13-050];
   Berkeley Initiative for Transparency in the Social Sciences; Laura and
   John Arnold Foundation; European Research Council [726361]
FX RvA received Grant number: 406-13-050 from The Netherlands Organization
   for Scientific Research (NWO), URL funder website: www.nwo.nl. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. RvA also received
   funding from Berkeley Initiative for Transparency in the Social Sciences
   and the Laura and John Arnold Foundation, URL funder website:
   www.bitss.org. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. JW
   received Grant number: 726361 (IMPROVE) from The European Research
   Council, URL funder website: www.erc.europa.eu. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716
   Aguinis H, 2011, J MANAGE, V37, P5, DOI 10.1177/0149206310377113
   Alinaghi N, 2018, RES SYNTH METHODS, V9, P285, DOI 10.1002/jrsm.1298
   Anderson SF, 2017, PSYCHOL SCI, V28, P1547, DOI 10.1177/0956797617723724
   Augusteijn HEM, PSYCHOL METHODS
   Auspurg K, 2014, KOLNER Z SOZIOL SOZ, V66, P549, DOI 10.1007/s11577-014-0284-3
   Aytug ZG, 2012, ORGAN RES METHODS, V15, P103, DOI 10.1177/1094428111403495
   Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060
   Banks GC, 2012, EDUC EVAL POLICY AN, V34, P259, DOI 10.3102/0162373712446144
   Banks GC, 2012, INT J SELECT ASSESS, V20, P182, DOI 10.1111/j.1468-2389.2012.00591.x
   Becker BJ, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P111
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Borenstein M., 2009, HDB RES SYNTHESIS ME, P221
   Borenstein M., 2009, INTRO METAANALYSIS
   Bouter Lex M, 2016, Res Integr Peer Rev, V1, P17, DOI 10.1186/s41073-016-0024-5
   Brodeur A, 2016, AM ECON J-APPL ECON, V8, P1, DOI 10.1257/app.20150044
   Carter E, 2018, CORRECTING BIAS PSYC
   Citkowicz M, 2017, PSYCHOL METHODS, V22, P28, DOI 10.1037/met0000119
   Coburn KM, 2015, PSYCHOL METHODS, V20, P310, DOI 10.1037/met0000046
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cooper H, 1997, PSYCHOL METHODS, V2, P447
   Copas J, 1999, J R STAT SOC A STAT, V162, P95, DOI 10.1111/1467-985X.00123
   COURSOL A, 1986, PROF PSYCHOL-RES PR, V17, P136, DOI 10.1037/0735-7028.17.2.136
   Dear KB, 1992, STAT SCI, V7, P237, DOI DOI 10.1214/SS/1177011363
   DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3
   Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33
   Fanelli D, 2017, P NATL ACAD SCI USA, V114, P3714, DOI 10.1073/pnas.1618569114
   Fanelli D, 2013, P NATL ACAD SCI USA, V110, P15031, DOI 10.1073/pnas.1302997110
   Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7
   Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068
   Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445
   Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733
   Fleiss J. L, 2009, HDB RES SYNTHESIS ME, P237
   Francis G, 2013, J MATH PSYCHOL, V57, P153, DOI 10.1016/j.jmp.2013.02.003
   Franco A, 2016, SOC PSYCHOL PERS SCI, V7, P8, DOI 10.1177/1948550615598377
   Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484
   Glass G.V., 1976, EDUC RES, V5, P3, DOI [DOI 10.3102/0013189X005010003, 10.3102/0013189X005010003, 10.3102/0013189x005010003]
   Guan M, 2016, PSYCHON B REV, V23, P74, DOI 10.3758/s13423-015-0868-6
   Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D
   Hartgerink CHJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3068
   Hartgerink CHJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1935
   Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106
   Hedges L. V., 1984, J EDUC STATIST, V9, P61, DOI DOI 10.3102/10769986009001061
   Hedges LV, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P145
   HEDGES LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204
   Hopewell S, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P49, DOI 10.1002/0470870168.ch4
   Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441
   Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410
   Ioannidis JPA, 2006, J CLIN EPIDEMIOL, V59, P1023, DOI 10.1016/j.jclinepi.2006.02.013
   Iyengar S., 1988, STAT SCI, V3, P133, DOI [10.1214/ss/1177013019, DOI 10.1214/SS/1177013019]
   Iyengar Shanto, 1988, STAT SCI, V3, P109, DOI DOI 10.1214/SS/1177013012
   Jackson D, 2006, STAT MED, V25, P2911, DOI 10.1002/sim.2293
   Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453
   Jager LR, 2014, BIOSTATISTICS, V15, P1, DOI 10.1093/biostatistics/kxt007
   Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104
   Jurgens G, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004022.pub2CD004022, DOI 10.1002/14651858.CD004022.PUB2CD004022]
   Kepes S, 2012, ORGAN RES METHODS, V15, P624, DOI 10.1177/1094428112452760
   Kirkham JJ, 2010, BMJ-BRIT MED J, V340, pc365, DOI DOI 10.1136/BMJ.C365
   Klein R. A., 2018, ADV METHODS PRACT PS, V1, P443, DOI [10.1177/2515245918810225, DOI 10.1177/2515245918810225]
   Koenker R, 2005, QUANTILE REGRESSION
   Krawczyk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127872
   LANE DM, 1978, BRIT J MATH STAT PSY, V31, P107, DOI 10.1111/j.2044-8317.1978.tb00578.x
   Langan D, 2017, RES SYNTH METHODS, V8, P181, DOI 10.1002/jrsm.1198
   Light RJ, 1984, SUMMING SCI REV RES
   LOEVINGER J, 1948, PSYCHOL BULL, V45, P507, DOI 10.1037/h0055827
   Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698
   McShane BB, 2016, PERSPECT PSYCHOL SCI, V11, P730, DOI 10.1177/1745691616662243
   Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2
   Nuijten MB, 2015, REV GEN PSYCHOL, V19, P172, DOI 10.1037/gpr0000034
   Olsson-Collentine A, 2019, LTD EVIDENCE W UNPUB
   PAULE RC, 1982, J RES NAT BUR STAND, V87, P377, DOI 10.6028/jres.087.022
   Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889
   R Core Team, 2018, R LANG ENV STAT COMP
   Raudenbush SW, 2009, HDB RES SYNTHESIS ME, V2, P295
   Reed WR, 2015, ECONOMICS-KIEL, V9, DOI 10.5018/economics-ejournal.ja.2015-30
   Rhodes KM, 2015, J CLIN EPIDEMIOL, V68, P52, DOI 10.1016/j.jclinepi.2014.08.012
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1
   Rothstein HR, 2012, PSYCHOL METHODS, V17, P129, DOI 10.1037/a0027128
   Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79
   Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988
   Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080
   Springate DA, 2014, COCHRANE SCRAPER TOO
   Stanley TD, 2017, SOC PSYCHOL PERS SCI, V8, P581, DOI 10.1177/1948550617693062
   Stanley TD, 2017, STAT MED, V36, P1580, DOI 10.1002/sim.7228
   Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095
   Stanley TD, 2010, AM STAT, V64, P70, DOI 10.1198/tast.2009.08205
   STERLING TD, 1995, AM STAT, V49, P108, DOI 10.2307/2684823
   Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Sutton AJ, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P175
   Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006
   Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461
   Turner RM, 2015, STAT MED, V34, P984, DOI 10.1002/sim.6381
   van Aert RCM, 2018, PUNIFORM METAANALYSI
   van Aert RCM, CORRECTING PUB UNPUB
   van Aert RCM, 2018, BEHAV RES METHODS, V50, P1515, DOI 10.3758/s13428-017-0967-6
   van Aert RCM, 2016, PERSPECT PSYCHOL SCI, V11, P713, DOI 10.1177/1745691616650874
   van Assen MALM, 2015, PSYCHOL METHODS, V20, P293, DOI 10.1037/met0000025
   Veroniki AA, 2016, RES SYNTH METHODS, V7, P55, DOI 10.1002/jrsm.1164
   Vevea JL, 2005, PSYCHOL METHODS, V10, P428, DOI 10.1037/1082-989X.10.4.428
   VEVEA JL, 1995, PSYCHOMETRIKA, V60, P419, DOI 10.1007/BF02294384
   Viechtbauer W, 2007, BRIT J MATH STAT PSY, V60, P29, DOI 10.1348/000711005X64042
   Viechtbauer W, 2007, J EDUC BEHAV STAT, V32, P39, DOI 10.3102/1076998606298034
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   von Hippel PT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0024-z
NR 117
TC 1
Z9 1
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 12
PY 2019
VL 14
IS 4
AR e0215052
DI 10.1371/journal.pone.0215052
PG 32
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HT1UC
UT WOS:000464349000032
PM 30978228
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bosu, WK
   Reilly, ST
   Aheto, JMK
   Zucchelli, E
AF Bosu, William Kofi
   Reilly, Siobhan Theresa
   Aheto, Justice Moses Kwaku
   Zucchelli, Eugenio
TI Hypertension in older adults in Africa: A systematic review and
   meta-analysis
SO PLOS ONE
LA English
DT Review
ID SUB-SAHARAN AFRICA; RISK-FACTORS; BLOOD-PRESSURE; PREVALENCE; AWARENESS;
   HEALTH; DEMENTIA; PEOPLE; URBAN; BIAS
AB Background
   Hypertension is the leading driver of cardiovascular disease deaths in Africa. Its prevalence is highest in older populations. Yet, this group has received little attention in many African countries. We conducted a systematic review and meta-analysis (PROSPERO registration: CRD42017056474) to estimate the prevalence of hypertension in older adults living in Africa.
   Methods
   We searched grey literature and major electronic databases including PubMed and Embase for population-based studies and published between 1 January 1980 to 28 May 2018 reporting the prevalence of hypertension for adults aged >= 50 years living in Africa. We employed a random effects model to estimate the pooled prevalence across included studies.
   Findings
   We screened 10,719 articles and retrieved 103 full-text articles to evaluate for inclusion in the review. Thirty-four unique studies providing 37 data points on 43,025 individuals in 15 African countries were analyzed. The prevalence of hypertension ranged from 22.3% to 90.0% from the individual studies while the overall pooled prevalence was 57.0% (95% CI 52%-61%). The prevalence was not statistically significantly different by sex, residence, or African sub-region. In individual studies, older age and overweight/obesity were independently associated with hypertension. Twenty-nine (78%) data points were deemed to be of low-or moderate-risk of bias. Eliminating high-risk bias studies made little difference to the pooled estimate of hypertension. Sensitivity analyses, omitting one study at a time, identified three studies with significant but relatively small impact on the pooled estimate. We observed substantial heterogeneity (I-2 = 98.9%) across the studies which was further explored by meta-regression analyses. Overall, the GRADE assessment suggested moderate quality evidence in the results.
   Conclusion
   The persistent high prevalence of hypertension among older adults in Africa, even in rural populations warrants more attention to the cardiovascular health of this group by public health authorities.
C1 [Bosu, William Kofi] West African Hlth Org, Dept Publ Hlth & Res, Bobo Dioulasso, Burkina Faso.
   [Bosu, William Kofi; Reilly, Siobhan Theresa; Zucchelli, Eugenio] Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Lancaster, England.
   [Aheto, Justice Moses Kwaku] Univ Ghana, Sch Publ Hlth, Dept Biostat, Legon, Accra, Ghana.
RP Bosu, WK (reprint author), West African Hlth Org, Dept Publ Hlth & Res, Bobo Dioulasso, Burkina Faso.; Bosu, WK (reprint author), Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Lancaster, England.
EM billybosu@gmail.com
RI Aheto, Justice Moses K./H-8890-2019
OI Aheto, Justice Moses K./0000-0003-1384-2461; Zucchelli,
   Eugenio/0000-0003-3883-5006
CR Abegunde KA, 2013, ANN AFR MED, V12, P90, DOI [10.4103/1596-3519.112398, 10.4103/596-3519.112398]
   Aboderin I, 2010, PUBLIC HEALTH REV, V32, P357, DOI 10.1007/BF03391607
   Aboyade OM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1378-4
   Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336
   Addo J, 2006, ETHNIC DIS, V16, P894
   Adeloye D, 2015, J HYPERTENS, V33, P230, DOI 10.1097/HJH.0000000000000413
   Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300
   Akinyemi RO, 2019, BRAIN RES BULL, V145, P97, DOI 10.1016/j.brainresbull.2018.05.018
   Amugsi DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26991-4
   Amugsi DA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017344
   [Anonymous], 2018, COV SYST REV SOFTW
   [Anonymous], 2015, STAT STAT SOFTW REL
   Apt NA, 2012, AGEING INT, V37, P93, DOI 10.1007/s12126-011-9138-8
   Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394
   Awuah RB, 2014, J HYPERTENS, V32, P1203, DOI 10.1097/HJH.0000000000000165
   Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374
   Boateng GO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186947
   Bosu WK, 2017, SYST REV, V6, DOI 10.1186/s13643-017-0585-5
   Bosu WK, 2016, INT J HYPERTENS, DOI 10.1155/2016/3192149
   Bosu WK, 2015, P NUTR SOC, V74, P466, DOI 10.1017/S0029665114001669
   Bosu WK, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26227
   Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34
   Callender T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001699
   Chami MA, 2015, MED MALADIES METABOL, V9, P210, DOI [10.1016/S1957-2557%2815%2930046-8, DOI 10.1016/S1957-2557%2815%2930046-8]
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   Debpuur C, 2010, GLOBAL HEALTH ACTION, V3, P54, DOI 10.3402/gha.v3i0.2151
   Dewhurst MJ, 2013, J HUM HYPERTENS, V27, P374, DOI 10.1038/jhh.2012.59
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X
   Duboz P, 2015, Bull Soc Pathol Exot, V108, P25, DOI 10.1007/s13149-014-0397-y
   Duda RB, 2011, J CROSS-CULT GERONTO, V26, P299, DOI 10.1007/s10823-011-9148-8
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   El Tallawy HN, 2012, NEUROEPIDEMIOLOGY, V38, P130, DOI 10.1159/000335655
   El-Tallawy HN, 2013, CLIN NEUROL NEUROSUR, V115, P1792, DOI 10.1016/j.clineuro.2013.04.014
   Etyang AnthonyO, 2013, Glob Health Action, V6, P19090, DOI 10.3402/gha.v6i0.19090
   Ezejimofor M, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010420
   Fajemilehin BR, 2005, AFR J NURS MIDWIFERY, V7, P17
   Gray WK, 2016, ARCH GERONTOL GERIAT, V62, P36, DOI 10.1016/j.archger.2015.10.008
   Guerchet M, 2012, J ALZHEIMERS DIS, V29, P15, DOI 10.3233/JAD-2011-111364
   Hammami S, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-65
   Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403
   Hien H, 2014, TROP MED INT HEALTH, V19, P1328, DOI 10.1111/tmi.12377
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014
   Ice GH, 2008, J CROSS-CULT GERONTO, V23, P111, DOI 10.1007/s10823-008-9063-9
   Iorio A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h870
   Iribhogbe I, 2013, INT J COMMUNITY RES, V2, P22
   Ivy A, 2015, J CLIN HYPERTENS, V17, P389, DOI 10.1111/jch.12501
   Kamoun M, 2006, REV GERIATR, V31, P477
   Kaze Arnaud D, 2017, J Hypertens, V35, P1345, DOI 10.1097/HJH.0000000000001345
   Kinyanda E, 2016, AIDS CARE, V28, P1516, DOI 10.1080/09540121.2016.1191601
   Koopman JJE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046855
   Laouani Kechrid Chadia, 2004, Tunis Med, V82, P1001
   Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P510, DOI 10.1016/j.otohns.2010.06.817
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6
   Lloyd-Sherlock P, 2017, EUR J DEV RES, V29, P827, DOI 10.1057/s41287-016-0063-2
   Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215
   Macia E, 2012, CARDIOVASC J AFR, V23, P265, DOI 10.5830/CVJA-2011-039
   Macia E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161544
   Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569
   MDS Project Team, 2002, PROP WORK DEF OLD PE
   Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292
   Mkhize XN, 2011, SITUATION ANAL FREE
   Mkhize X, 2013, HEALTH SA GESONDHEID, V18, DOI 10.4102/hsag.v18i1.656
   Mugisha JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078394
   Ndabarora E, 2018, KIBOGORA POLYTECHNIC, V1, P11
   Nuertey BD, 2017, BMC OBES, V4, P1, DOI [10.1186/s40608-016-0139-8, DOI 10.1186/S40608-016-0139-8]
   Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39
   O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2
   Ochayi B, 2006, AGING MENT HEALTH, V10, P616, DOI 10.1080/13607860600736182
   Ogunniyi A, 2011, ACTA NEUROL SCAND, V124, P396, DOI 10.1111/j.1600-0404.2011.01491.x
   Okeahialam B N, 2012, West Afr J Med, V31, P14
   Okpechi IG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073403
   Osman A, 2017, THESIS
   Paddick SM, 2015, AM J GERIAT PSYCHIAT, V23, P950, DOI 10.1016/j.jagp.2014.12.005
   Peltzer K, 2013, CARDIOVASC J AFR, V24, P66, DOI 10.5830/CVJA-2013-002
   Phaswana-Mafuya N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20680
   Pilleron S, 2017, J AM SOC HYPERTENS, V11, P449, DOI 10.1016/j.jash.2017.04.013
   Putnam HWI, 2018, J CLIN HYPERTENS, V20, P217, DOI 10.1111/jch.13187
   Raji Yemi Raheem, 2017, Pan Afr Med J, V27, P190, DOI 10.11604/pamj.2017.27.190.11682
   Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959
   Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886
   Schutte AE, 2017, J HUM HYPERTENS, V31, P491, DOI 10.1038/jhh.2017.18
   Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647
   Tianyi Frank L, 2018, Health Sci Rep, V1, pe44, DOI 10.1002/hsr2.44
   Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d
   Tyrovolas S, 2015, ATHEROSCLEROSIS, V238, P240, DOI 10.1016/j.atherosclerosis.2014.11.029
   Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003
   Villareal DT, 2006, AM J CLIN NUTR, V84, P1317
   WHO, 2016, GLOB STRAT ACT PLAN
   WHO, 2002, ACT AG POL FRAM
   WHO, 2016, WHO STEPS SURV MANUA
   Yerly P, 2013, CARDIOVASC J AFR, V24, P17, DOI 10.5830/CVJA-2012-070
   Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5
NR 96
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 5
PY 2019
VL 14
IS 4
AR e0214934
DI 10.1371/journal.pone.0214934
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HR9NM
UT WOS:000463487500021
PM 30951534
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, JJW
   Ein, N
   Gervasio, J
   Vickers, K
AF Liu, Jenny J. W.
   Ein, Natalie
   Gervasio, Julia
   Vickers, Kristin
TI The efficacy of stress reappraisal interventions on stress responsivity:
   A meta-analysis and systematic review of existing evidence
SO PLOS ONE
LA English
DT Review
ID EMOTION REGULATION; PHYSIOLOGICAL-RESPONSES; BIOPSYCHOSOCIAL MODEL;
   SOCIAL ANXIETY; PERFORMANCE; THREAT; CHALLENGE; AROUSAL; STRATEGIES;
   REACTIVITY
AB Background
   The beliefs we hold about stress play an important role in coping with stressors. Various theoretical frameworks of stress point to the efficacy of reframing stress-related information through brief reappraisal interventions in order to promote adaptive coping.
   Purpose
   The goal of the current meta-analysis and systematic review is to substantiate the efficacy of reappraisal interventions on stress responsivity compared to control conditions. Differences in experimental methodologies (e.g., type of stressor used, timing of reappraisal intervention, and content of intervention instructions) will be examined to further delineate their effects on intervention outcomes.
   Methods
   The literature searches were conducted on May 16, 2018 using PsycINFO, ProQuest Dissertations and Theses, and PILOTS databases with no date restriction. The search terms included stress, reframing, reappraisal, mindset and reconceptualising. A total of 14 articles with 36 independent samples were included in the meta-analysis, while 22 articles with 46 independent samples were included in the systematic review. Random-effects model was used to test the null hypothesis using two-tailed significance testing. Fisher's Z value was reported for each corresponding test. Heterogeneity tests are reported via Cochran's Q-statistics.
   Results
   Findings from both the meta-analysis and systematic review revealed that overall, reappraisal interventions are effective in attenuating subjective responsivity to stress. Standard differences in means across groups are 0.429 (SE = 0.185, 95% CI = 0.067 to 0.791; z = 2.320, p = .020). However, reappraisal intervention groups did not outperform control groups on measures of physiological stress, with standard differences of -0.084 (SE = 0.135, 95% CI = -0.349 to 0.180; z = -0.627, p = .531). Moderator analysis revealed heterogeneous effects suggesting large variability in findings.
   Conclusions
   On one hand, findings may suggest a promising avenue for the effective management of self-reported stress and optimization of stress responses. However, more research is needed to better elucidate the effects, if any, of reappraisal interventions on stress physiology. Implications for the use of reappraisal interventions on stress optimization are discussed in the context of theoretical frameworks and considerations for future studies.
C1 [Liu, Jenny J. W.; Ein, Natalie; Gervasio, Julia; Vickers, Kristin] Ryerson Univ, Dept Psychol, Toronto, ON, Canada.
   [Liu, Jenny J. W.; Ein, Natalie; Vickers, Kristin] Ryerson Univ, Inst Stress & Wellbeing Res, Toronto, ON, Canada.
RP Vickers, K (reprint author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.; Vickers, K (reprint author), Ryerson Univ, Inst Stress & Wellbeing Res, Toronto, ON, Canada.
EM kvickers@psych.ryerson.ca
CR Akinola M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167977
   Beltzer ML, 2014, EMOTION, V14, P761, DOI 10.1037/a0036326
   Bijur PE, 2003, ACAD EMERG MED, V10, P390, DOI 10.1111/j.1553-2712.2003.tb01355.x
   Blascovich J, 2003, PERS SOC PSYCHOL REV, V7, P234, DOI 10.1207/S15327957PSPR0703_03
   Borenstein M, 2014, COMPREHENSIVE METAAN
   Borenstein M, 2007, METAANALYSIS FIXED E
   Bowlin S., THESIS, P2026
   Brooks AW, 2014, J EXP PSYCHOL GEN, V143, P1144, DOI 10.1037/a0035325
   Caci H, 2003, EUR PSYCHIAT, V18, P394, DOI 10.1016/j.eurpsy.2003.05.003
   Cohen N, 2018, CLIN PSYCHOL SCI, V6, P155, DOI 10.1177/2167702617731379
   Crum A, 2014, WILEY BLACKWELL HDB
   Crum AJ, 2017, ANXIETY STRESS COPIN, V30, P379, DOI 10.1080/10615806.2016.1275585
   Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201
   Cutuli D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00175
   Denson TF, 2014, PSYCHONEUROENDOCRINO, V49, P69, DOI 10.1016/j.psyneuen.2014.07.003
   Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Dweck CS, 2008, CURR DIR PSYCHOL SCI, V17, P391, DOI 10.1111/j.1467-8721.2008.00612.x
   Ein N, INT J OBESITY
   Ein N, 2018, STRESS HEALTH, V34, P477, DOI 10.1002/smi.2812
   EKEBERG O, 1990, SCAND J CLIN LAB INV, V50, P671, DOI 10.3109/00365519009089186
   Erazo E., 2017, THESIS
   Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2
   Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8
   Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3
   Germain CL, 2015, BEHAV CHANGE, V32, P35, DOI 10.1017/bec.2014.28
   Gong L, 2016, ANXIETY STRESS COPIN, V29, P305, DOI 10.1080/10615806.2015.1042462
   Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224
   Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016
   Hobfoll SE, 2004, STRESS CULTURE COMMU
   Jackson B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169972
   Jamieson JP, 2018, ANXIETY STRESS COPIN, V31, P245, DOI 10.1080/10615806.2018.1442615
   Jamieson JP, 2013, CLIN PSYCHOL SCI, V1, P363, DOI 10.1177/2167702613482119
   Jamieson JP, 2012, J EXP PSYCHOL GEN, V141, P417, DOI 10.1037/a0025719
   Jamieson JP, 2010, J EXP SOC PSYCHOL, V46, P208, DOI 10.1016/j.jesp.2009.08.015
   Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561
   Keller A, 2012, HEALTH PSYCHOL, V31, P677, DOI 10.1037/a0026743
   Kneeland ET, 2016, COGNITIVE THER RES, V40, P496, DOI 10.1007/s10608-016-9765-1
   Lazarus RS, 1984, STRESS APPRAISAL COP
   Liu JJW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173188
   Liu JJW, 2019, THESIS
   Mendes WB, 2002, PERS SOC PSYCHOL B, V28, P939
   Mendes WB, 2013, J EXP PSYCHOL GEN, V142, P923, DOI 10.1037/a0029663
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Moore LJ, 2015, J SPORT EXERCISE PSY, V37, P339, DOI 10.1123/jsep.2014-0186
   Popham L., 2014, THESIS
   Sammy N, 2017, ANXIETY STRESS COPIN, V30, P619, DOI 10.1080/10615806.2017.1330952
   Sapolsky R. M., 1994, WHY ZEBRAS DONT GET
   Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141
   Scult MA, 2017, CLIN PSYCHOL SCI, V5, P150, DOI 10.1177/2167702616654688
   Seery MD, 2013, SOC PERSONAL PSYCHOL, V7, P637, DOI 10.1111/spc3.12052
   Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0
   Shirtcliff EA, 2014, J PERS DISORD, V28, P40, DOI 10.1521/pedi.2014.28.1.40
   Souza-Talarico JN, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0886-6
   Veazie PJ, 2006, HEALTH SERV RES, V41, P804, DOI 10.1111/j.1475-6773.2006.00512.x
   Wang F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01604
   Williams VSL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-57
   Wong G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-20
   Woud ML, 2012, EMOTION, V12, P778, DOI 10.1037/a0024992
   Zhan J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01372
NR 60
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2019
VL 14
IS 2
AR e0212854
DI 10.1371/journal.pone.0212854
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM9LQ
UT WOS:000459806400092
PM 30811484
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sabarimurugan, S
   Kumarasamy, C
   Baxi, S
   Devi, A
   Jayaraj, R
AF Sabarimurugan, Shanthi
   Kumarasamy, Chellan
   Baxi, Siddhartha
   Devi, Arikketh
   Jayaraj, Rama
TI Systematic review and meta-analysis of prognostic microRNA biomarkers
   for survival outcome in nasopharyngeal carcinoma
SO PLOS ONE
LA English
DT Review
ID DIAGNOSTIC-TEST ACCURACY; THERAPEUTIC TARGETS; POOR-PROGNOSIS;
   UP-REGULATION; CANCER; PROLIFERATION; METASTASIS; BIOGENESIS;
   EXPRESSION; INVASION
AB Background
   Nasopharyngeal cancer (NPC), despite being one of the most malignant head and neck carcinomas (HNC), lacks comprehensive prognostic biomarkers that predict patient survival. Therefore, this systematic review and meta-analysis is aimed to evaluate the potential prognostic value of miRNAs as prognostic biomarkers in NPC.
   Methods
   PRISMA guidelines were used to conduct this systematic review and meta-analysis study. Permutations of multiple " search key-words" were used for the search strategy, which was limited to articles published between January 2012 and March 2018. The retrieved articles were meticulously searched with multi-level screening by two reviewers and confirmed by other reviewers. Meta-analysis was performed using Hazard Ratios (HR) and associated 95% Confidence Interval (CI) of survival obtained from previously published studies. Publication bias was assessed by Egger's bias indicator test and funnel plot symmetry.
   Results
   A total of 5069 patients across 21 studies were considered eligible for inclusion in the systematic review, with 65 miRNAs being evaluated in the subsequent meta-analysis. Most articles included in this study originated from China and one study from North Africa. The forest plot was generated using cumulated survival data, resulting in a pooled HR value of 1.196 (95% CI: 0.893-1.601) indicating that the upregulated miRNAs increased the likelihood of death of NPC patients by 19%.
   Conclusion
   To our knowledge, this is the first meta-analysis that examines the prognostic effectiveness of miRNAs as biomarkers in NPC patients. We noted that the combined effect estimate of HR across multiple studies indicated that increased miRNA expression in NPC potentially leads to poor overall survival. However, further large-scale prospective studies on the clinical significance of the miRNAs, with sizable cohorts are necessary in order to obtain conclusive results.
C1 [Sabarimurugan, Shanthi] VIT, Sch Biosci & Technol, Vellore, Tamil Nadu, India.
   [Kumarasamy, Chellan] Univ Adelaide, North Terrace Campus, Adelaide, SA, Australia.
   [Baxi, Siddhartha] Genesis Cancer Care Ctr, Bunbury, WA, Australia.
   [Devi, Arikketh] SRM Inst Sci & Technol, Dept Genet Engn, Kattangulathur, Tamil Nadu, India.
   [Jayaraj, Rama] Charles Darwin Univ, Coll Hlth & Human Sci, Clin Sci, Ellengowan Dr, Casuarina, NT, Australia.
RP Jayaraj, R (reprint author), Charles Darwin Univ, Coll Hlth & Human Sci, Clin Sci, Ellengowan Dr, Casuarina, NT, Australia.
EM Rama.Jayaraj@cdu.edu.au
RI ; Jayaraj, Rama/A-6526-2012
OI Sabarimurugan, Shanthi/0000-0003-2247-3426; ARIKKETH,
   DEVI/0000-0002-8542-3760; Jayaraj, Rama/0000-0002-2179-0510
CR Allaya N, 2015, TUMOR BIOL, V36, P3807, DOI 10.1007/s13277-014-3022-6
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bruce JP, 2015, J CLIN ONCOL, V33, P3346, DOI 10.1200/JCO.2015.60.7846
   Bruce JP, 2014, CHIN J CANCER, V33, P539, DOI 10.5732/cjc.014.10175
   Cao Su-Mei, 2011, Chin J Cancer, V30, P114
   Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353
   Chen C, 2016, CANCER MED-US, V5, P3489, DOI 10.1002/cam4.863
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Farias TP, 2003, ARCH OTOLARYNGOL, V129, P794, DOI 10.1001/archotol.129.7.794
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   He ML, 2012, BBA-REV CANCER, V1825, P1, DOI 10.1016/j.bbcan.2011.09.001
   He Y, 2017, INT J CLIN EXP PATHO, V10, P7362
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Huang T, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0465-1
   Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008
   Jayaraj R, 2018, CANCER MANAG RES, V10, P4669, DOI 10.2147/CMAR.S183181
   Jayaraj R, 2018, CANCER MANAG RES, V10, P3501, DOI 10.2147/CMAR.S177875
   Kim KW, 2015, KOREAN J RADIOL, V16, P1175, DOI 10.3348/kjr.2015.16.6.1175
   Kim YH, 2017, ONCOTARGET, V8, P8726, DOI 10.18632/oncotarget.14429
   Kumarasamy C, 2018, SYST REV, V7, DOI 10.1186/s13643-018-0812-8
   Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068
   Lee KTW, 2016, CRIT REV ONCOL HEMAT, V103, P1, DOI 10.1016/j.critrevonc.2016.04.006
   Liang SQ, 2016, DIS MARKERS, DOI 10.1155/2016/7648215
   Liu N, 2014, INT J CANCER, V134, P1359, DOI 10.1002/ijc.28468
   Liu N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-123
   Liu N, 2013, CANCER LETT, V329, P181, DOI 10.1016/j.canlet.2012.10.032
   Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X
   Long MJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016582
   Luan JW, 2016, ONCOTARGET, V7, P10513, DOI 10.18632/oncotarget.7013
   Lubov J, 2017, ONCOTARGET, V8, P55511, DOI 10.18632/oncotarget.19224
   Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329
   Ma L, 2014, FEBS LETT, V588, P1562, DOI 10.1016/j.febslet.2014.02.039
   Mahdavifar Neda, 2016, Osong Public Health Res Perspect, V7, P360, DOI 10.1016/j.phrp.2016.11.002
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Poddar A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020014
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Sabarimurugan S, 2018, MOL DIAGN THER, V22, P653, DOI 10.1007/s40291-018-0357-5
   Spence T, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.03.09
   Tan GJ, 2015, TUMOR BIOL, V36, P69, DOI 10.1007/s13277-014-2847-3
   Wang HY, 2014, CLIN CHEM, V60, P773, DOI 10.1373/clinchem.2013.214213
   Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6
   Xie SH, 2013, EUR J CANCER, V49, P150, DOI 10.1016/j.ejca.2012.07.004
   Xu XL, 2014, ANN THORAC SURG, V97, P1037, DOI 10.1016/j.athoracsur.2013.10.042
   Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044-579X(02)00085-8
   Yu QS, 2015, INT J CLIN EXP MED, V8, P13296
   YU X, 2013, CELL DEATH DIS, V4
   Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367
   Zhang AQ, 2017, ONCOTARGETS THER, V10, P4935, DOI 10.2147/OTT.S144223
   Zhang HX, 2016, ONCOTARGETS THER, V9, P3579, DOI 10.2147/OTT.S105470
   Zhao C, 2017, ONCOTARGET, V8, P91603, DOI 10.18632/oncotarget.21342
   Zhao MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11309
   ZHEN Y, 2013, CELL DEATH DIS, V4
   Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395
NR 55
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 8
PY 2019
VL 14
IS 2
AR e0209760
DI 10.1371/journal.pone.0209760
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK7PK
UT WOS:000458181200011
PM 30735523
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Su, LQ
   Fu, JM
   Sun, SL
   Zhao, GG
   Cheng, W
   Dou, CC
   Quan, MH
AF Su, LiQiang
   Fu, JinMei
   Sun, ShunLi
   Zhao, GuangGao
   Cheng, Wei
   Dou, ChuanChuan
   Quan, MingHui
TI Effects of HIIT and MICT on cardiovascular risk factors in adults with
   overweight and/or obesity: A meta-analysis
SO PLOS ONE
LA English
DT Article
ID HIGH-INTENSITY INTERVAL; METABOLIC SYNDROME; AEROBIC CAPACITY;
   BODY-COMPOSITION; LOW-VOLUME; PHYSIOLOGICAL ADAPTATIONS;
   CARDIORESPIRATORY FITNESS; CARDIOMETABOLIC DISEASE; MODERATE EXERCISE;
   GLYCEMIC CONTROL
AB Objective
   The purpose of this study was to evaluate the effects of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on cardiovascular disease (CVD) risk factors in adults with overweight and obesity.
   Methods
   Twenty-two articles were included by searching six databases, the total number of subjects was 620 in these articles. Outcomes were synthesised using a random-effects meta-analysis of the Standardized mean difference (SMD) in CVD risk factors.
   Results
   HIIT and MICT resulted in statistically significant reductions in Weight, BMI, fat%, total cholesterol( TC), and improvement in VO2max. Compared with MICT, subgroup of durations of HIIT training interval >= 2 min can significantly increaseVO(2max) (SMD = 0.444, 95% CI: 0.037 similar to 0.851, P = 0.032), subgroup of energy expenditure of HIIT equal to MICT can significantly increase VO2max (SMD = 0.399, 95% CI: 0.106 similar to 0.692, P = 0.008).
   Conclusions
   HIIT appears to provide similar benefits to MICT for improving body composition, VO2maxand TC, but HIIT spent less time than MICT by 9.7 min on one session. HIIT is superior to MICT in improving cardiopulmonary fitness when durations of HIIT training interval >= 2 min or energy expenditure of HIIT same as MICT. PROSPERO ID: CRD42016045835.
C1 [Su, LiQiang] Fujian Normal Univ, Sch Phys Educ & Sport Sci, Fuzhou, Fujian, Peoples R China.
   [Fu, JinMei; Sun, ShunLi] Jiangxi Res Inst Sports Sci, Nanchang, Jiangxi, Peoples R China.
   [Zhao, GuangGao] Nanchang Univ, Dept Phys Educ, Nanchang, Jiangxi, Peoples R China.
   [Cheng, Wei] Tongji Univ, Dept Endocrinol, Yangpu Hosp, Shanghai, Peoples R China.
   [Dou, ChuanChuan] Jiang Xi Univ Tradit Chinese Med, Coll Humanities, Nanchang, Jiangxi, Peoples R China.
   [Quan, MingHui] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.
RP Quan, MH (reprint author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.
EM quanminghui@163.com
FU National Natural Science Foundation of China [81703252]
FX This study was supported by the National Natural Science Foundation of
   China (81703252, to MingHui Quan).
CR Adedeji O O, 2000, West Afr J Med, V19, P283
   Eguia RA, 2015, NUTR HOSP, V32, P2460, DOI 10.3305/nh.2015.32.6.9776
   Ahluwalia A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003402
   Ahmadizad S, 2015, HORM MOL BIOL CLIN I, V21, P165, DOI 10.1515/hmbci-2014-0038
   ARNER P, 1990, J CLIN INVEST, V85, P893, DOI 10.1172/JCI114516
   Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3
   Batacan RB, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2015-095841
   Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Boutcher SH, 2011, J OBES, DOI 10.1155/2011/868305
   Bracken RM, 2009, AMINO ACIDS, V36, P209, DOI 10.1007/s00726-008-0049-2
   Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x
   Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109
   Cassidy S, 2017, DIABETOLOGIA, V60, P7, DOI 10.1007/s00125-016-4106-1
   Chang KT, 2018, ARCH GERONTOL GERIAT, V78, P165, DOI 10.1016/j.archger.2018.06.002
   Cheema BS, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/2052-1847-7-3
   Chung J, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0421-z
   Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72
   Ciolac EG, 2012, AM J CARDIOVASC DIS, V2, P102
   Cocks M, 2016, J PHYSIOL-LONDON, V594, P2307, DOI 10.1113/jphysiol.2014.285254
   Cornish AK, 2011, EUR J APPL PHYSIOL, V111, P579, DOI 10.1007/s00421-010-1682-5
   Costigan SA, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094490
   De Nardi AT, 2018, DIABETES RES CLIN PR, V137, P149, DOI 10.1016/j.diabres.2017.12.017
   Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eimarieskandari R., 2012, OVIDIUS U ANN SER PH, V12, P473
   Fisher G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138853
   Freda PU, 2008, J CLIN ENDOCR METAB, V93, P2334, DOI 10.1210/jc.2007-2780
   Garcia-Hermoso A, 2016, OBES REV, V17, P531, DOI 10.1111/obr.12395
   Gayda M, 2013, CAN J CARDIOL, V29, P990, DOI 10.1016/j.cjca.2012.11.005
   Gerosa-Neto J, 2016, J EXERC REHABIL, V12, P575, DOI 10.12965/jer.1632770.385
   Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094
   Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725
   GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639
   GREDIAGIN MA, 1995, J AM DIET ASSOC, V95, P661, DOI 10.1016/S0002-8223(95)00181-6
   Haff GG, 2016, ESSENTIALS STRENGTH, P53
   Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013c3180304570
   Higgins S, 2016, APPL PHYSIOL NUTR ME, V41, P1177, DOI 10.1139/apnm-2016-0240
   Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277
   Hussain SR, 2016, CARDIOL REV, V24, P273, DOI 10.1097/CRD.0000000000000124
   Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40
   Jelleyman C, 2015, OBES REV, V16, P942, DOI 10.1111/obr.12317
   Katzmarzyk PT, 2004, ARCH INTERN MED, V164, P1092, DOI 10.1001/archinte.164.10.1092
   Keating SE, 2017, OBES REV, V18, P943, DOI 10.1111/obr.12536
   Keating SE, 2014, J OBES, DOI 10.1155/2014/834865
   Kessler HS, 2012, SPORTS MED, V42, P489, DOI 10.2165/11630910-000000000-00000
   Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681
   Kong ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158589
   LeBlanc ES, 2018, JAMA-J AM MED ASSOC, V320, P1172, DOI 10.1001/jama.2018.7777
   Lee S, 2005, J APPL PHYSIOL, V99, P1220, DOI 10.1152/japplphysiol.00053.2005
   Little JP, 2014, APPL PHYSIOL NUTR ME, V39, P835, DOI 10.1139/apnm-2013-0512
   Liu HF, 2016, J SHANDONG SPORT U, V32, P95
   Lunt H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083256
   MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196
   Maillard F, 2018, SPORTS MED, V48, P269, DOI 10.1007/s40279-017-0807-y
   Martins C, 2016, INT J SPORT NUTR EXE, V26, P197, DOI 10.1123/ijsnem.2015-0078
   Metcalf BS, 2015, DIABETOLOGIA, V58, P2900, DOI 10.1007/s00125-015-3753-y
   MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248
   Mitranun W, 2014, SCAND J MED SCI SPOR, V24, pE69, DOI 10.1111/sms.12112
   Moholdt T, 2012, CLIN REHABIL, V26, P33, DOI 10.1177/0269215511405229
   Moreira MM, 2008, ARQ BRAS CARDIOL, V91, P200
   Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064
   Niiranen TJ, 2016, EXPERT REV CARDIOVAS, V14, P855, DOI 10.1080/14779072.2016.1176528
   Nilsson BB, 2008, AM J CARDIOL, V102, P1361, DOI 10.1016/j.amjcard.2008.07.016
   Peake JM, 2014, AM J PHYSIOL-ENDOC M, V307, pE539, DOI 10.1152/ajpendo.00276.2014
   Pritzlaff CJ, 2000, J APPL PHYSIOL, V89, P937
   Ramos JS, 2015, SPORTS MED, V45, P679, DOI 10.1007/s40279-015-0321-z
   Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c
   Sawyer BJ, 2016, J APPL PHYSIOL, V121, P279, DOI 10.1152/japplphysiol.00024.2016
   Schjerve IE, 2008, CLIN SCI, V115, P283, DOI 10.1042/CS20070332
   Sijie T, 2012, J SPORT MED PHYS FIT, V52, P255
   Smith-Ryan AE, 2015, PHYSICIAN SPORTSMED, V43, P107, DOI 10.1080/00913847.2015.1037231
   Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175
   Suh S, 2011, DIABETES METAB J, V35, P418, DOI 10.4093/dmj.2011.35.4.418
   Terada T, 2013, DIABETES RES CLIN PR, V99, P120, DOI 10.1016/j.diabres.2012.10.019
   Thompson PD, 2013, CURR SPORT MED REP, V12, P215, DOI 10.1249/JSR.0b013e31829a68cf
   Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822
   Trejo-Gutierrez JF, 2007, J CLIN LIPIDOL, V1, P175, DOI 10.1016/j.jacl.2007.05.006
   Vella CA, 2017, EUR J SPORT SCI, V17, P1203, DOI 10.1080/17461391.2017.1359679
   Wallman K, 2009, RES SPORTS MED, V17, P156, DOI 10.1080/15438620903120215
   [王京京 Wang Jingjing], 2015, [中国运动医学杂志, Chinese Journal of Sports Medicine], V34, P15
   Wang XM, 2017, J GUANGZHOU SPORT U, V37, P100, DOI [10.3969/j.issn.1007-323X.2017.01.024, DOI 10.3969/J.ISSN.1007-323X.2017.01.024]
   Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576
   Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z
   Wewege M, 2017, OBES REV, V18, P635, DOI 10.1111/obr.12532
   Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002
   Williams CB, 2013, APPL PHYSIOL NUTR ME, V38, P1236, DOI 10.1139/apnm-2013-0101
   Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041
   Zhang HF, 2017, J DIABETES RES, DOI 10.1155/2017/5071740
   Zhang HF, 2015, KINESIOLOGY, V47, P57
   Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004
   高艳敏, 2017, [中国运动医学杂志, Chinese Journal of Sports Medicine], V36, P628
NR 92
TC 0
Z9 0
U1 8
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2019
VL 14
IS 1
AR e0210644
DI 10.1371/journal.pone.0210644
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HJ3AL
UT WOS:000457041800010
PM 30689632
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shimamoto, CY
   Padial, AA
   da Rosa, CM
   Marques, MCM
AF Shimamoto, Carolina Y.
   Padial, Andre A.
   da Rosa, Carolina M.
   Marques, Marcia C. M.
TI Restoration of ecosystem services in tropical forests: A global
   meta-analysis
SO PLOS ONE
LA English
DT Article
ID ATLANTIC RAIN-FOREST; ECOLOGICAL RESTORATION; CARBON SEQUESTRATION;
   BIODIVERSITY CONSERVATION; SOIL FERTILITY; REGENERATION; COVER;
   CHRONOSEQUENCE; DEFORESTATION; REFORESTATION
AB To reverse the effects of deforestation, tropical areas have expanded restoration efforts in recent years. As ecological restoration positively affects the structure and function of degraded ecosystems, understanding to what extent restoration recovers ecosystem services (ES) is an important step in directing large-scale restoration actions. We evaluated the effect of restoration in increasing the provision of ES in tropical forests. We performed a global meta-analysis of ecological indicators of the ES provided in restored areas, degraded areas and reference ecosystems. We tested for the effects of different restoration strategies, different types of degradation and for the effects of restoration over time. Overall, restoration actions contributed to a significant increase in levels of ecological indicators of ES (carbon pool, soil attributes and biodiversity protection) compared to disturbed areas. Among the restoration strategies, the natural regeneration was the most effective. Biodiversity protection and carbon recovered better than soil attributes. All other restoration strategies recovered ES to a substantially lesser degree, and reforestation with exotics decreased the ES of areas degraded by agriculture. In areas degraded by pasture, restoration was more effective in recovering the biodiversity protection, whereas in areas degraded by agriculture, the restoration recovered mainly the carbon pool. Our results show that by choosing the correct strategy, restoration can recover much of the ES lost by the degradation of tropical forests. These results should be considered for large-scale conservation and management efforts for this biome.
C1 [Shimamoto, Carolina Y.; da Rosa, Carolina M.; Marques, Marcia C. M.] Univ Fed Parana, Setor Ciencias Biol, Lab Ecol Vegetal, Dept Bot, Curitiba, Parana, Brazil.
   [Padial, Andre A.] Univ Fed Parana, Setor Ciencias Biol, Dept Bot, Lab Anal & Sintese Biodiversidade, Curitiba, Parana, Brazil.
RP Marques, MCM (reprint author), Univ Fed Parana, Setor Ciencias Biol, Lab Ecol Vegetal, Dept Bot, Curitiba, Parana, Brazil.
EM mmarques@ufpr.br
RI Marques, Marcia Cristina Mendes/F-8699-2012
OI Marques, Marcia Cristina Mendes/0000-0002-1003-9596
FU Brazilian Education Council (CAPES); Brazilian Research Council (CNPq)
   [304650/2012-9, 229349-2013-7, 303897-2016-3]; Boticario Foundation
   (Fundacao Grupo Boticario) [A0004-2012]
FX This research is funded by Brazilian Education Council (CAPES),
   Boticario Foundation (Fundacao Grupo Boticario) Grant A0004-2012 and the
   Brazilian Research Council (CNPq), Grants 304650/2012-9; 229349-2013-7;
   303897-2016-3. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aide T.M., 2012, BIOTROPICA, V45, P1
   Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x
   Albrecht A, 2003, AGR ECOSYST ENVIRON, V99, P15, DOI 10.1016/S0167-8809(03)00138-5
   Alexander S, 2016, ECOL SOC, V21, DOI 10.5751/ES-08288-210134
   Alfaia SS, 2004, AGR ECOSYST ENVIRON, V102, P409, DOI 10.1016/j.agee.2003.08.011
   Amazonas NT, 2011, FOREST ECOL MANAG, V262, P1551, DOI 10.1016/j.foreco.2011.07.003
   Anderson SH, 2009, AGROFOREST SYST, V75, P5, DOI 10.1007/s10457-008-9128-3
   Baer S, 2012, SOIL ECOLOGY ECOSYST
   Bawa KS, 2004, BIOTROPICA, V36, P437, DOI 10.1111/j.1744-7429.2004.tb00341.x
   Blackham GV, 2013, BIOL CONSERV, V167, P215, DOI 10.1016/j.biocon.2013.08.015
   Blangy Sylvie, 2006, Journal for Nature Conservation (Jena), V14, P233, DOI 10.1016/j.jnc.2006.05.009
   Borenstein M., 2009, INTRO METAANALYSIS
   Boucher D., 2011, ROOT PROBLEM WHATS D
   Brancalion PHS, 2014, RESTOR ECOL, V22, P65, DOI 10.1111/rec.12025
   Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011
   Chazdon R., 2012, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V7, P195
   Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042
   Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365
   Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990
   Chazdon RL, 2016, BIOTROPICA, V48, P716, DOI 10.1111/btp.12381
   Chazdon RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501639
   Crouzeilles R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701345
   Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666
   de Almeida A, 2016, J NAT CONSERV, V34, P24, DOI 10.1016/j.jnc.2016.08.007
   De Beenhouwer M, 2013, AGR ECOSYST ENVIRON, V175, P1, DOI 10.1016/j.agee.2013.05.003
   Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532
   Ditt EH, 2010, LAND DEGRAD DEV, V21, P591, DOI 10.1002/ldr.1010
   Dougherty MC, 2009, AGR ECOSYST ENVIRON, V131, P77, DOI 10.1016/j.agee.2008.09.011
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ehrenfeld JG, 2000, RESTOR ECOL, V8, P2, DOI 10.1046/j.1526-100x.2000.80002.x
   Ellison D, 2012, GLOBAL CHANGE BIOL, V18, P806, DOI 10.1111/j.1365-2486.2011.02589.x
   FAO, 2012, STAT WORLDS FOR
   Fao, 2015, GLOB FOR RES ASS AR
   Farley KA, 2004, ECOSYSTEMS, V7, P729, DOI 10.1007/s10021-004-0047-5
   Fearnside PM, 2004, GLOBAL ENVIRON CHANG, V14, P299, DOI 10.1016/j.gloenvcha.2004.02.001
   Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225
   Ferraz SFB, 2014, LANDSCAPE ECOL, V29, P187, DOI 10.1007/s10980-014-9988-z
   Ferretti Andre Rocha, 2006, Journal for Nature Conservation (Jena), V14, P249, DOI 10.1016/j.jnc.2006.04.006
   Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x
   Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001
   Geist H. J., 2001, WHAT DRIVES TROPICAL
   Greipsson, 2011, RESTORATION ECOLOGY
   Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x
   Hall JM, 2012, LANDSCAPE ECOL, V27, P1135, DOI 10.1007/s10980-012-9755-y
   Hedges L. V., 1985, STAT METHODS METAANA
   Heneghan L, 2008, RESTOR ECOL, V16, P608, DOI 10.1111/j.1526-100X.2008.00477.x
   Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004
   Holl KD, 2007, OLD FIELDS, P93
   Houghton RA, 2015, NAT CLIM CHANGE, V5, P1022, DOI 10.1038/nclimate2869
   IUCN, 2011, BONN CHALL
   Jones HP, 2017, P R SOC B, V285
   Jones P, 2013, ENCY BIODIVERSITY
   Jose S, 2009, AGROFOREST SYST, V76, P1, DOI 10.1007/s10457-009-9229-7
   Kennard DK, 2002, J TROP ECOL, V18, P53, DOI 10.1017/S0266467402002031
   KissinGer G., 2012, DRIVERS DEFORESTATIO
   Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV
   Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773
   Lamb D., 2003, REHABILITATION RESTO
   Liebsch D, 2008, BIOL CONSERV, V141, P1717, DOI 10.1016/j.biocon.2008.04.013
   Lozano YM, 2014, SOIL BIOL BIOCHEM, V78, P298, DOI 10.1016/j.soilbio.2014.08.007
   Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006
   Marin-Spiotta E, 2007, ECOL APPL, V17, P828, DOI 10.1890/06-1268
   Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236
   Martinez-Garza C, 2003, J APPL ECOL, V40, P423, DOI 10.1046/j.1365-2664.2003.00819.x
   MEA, REL SINT AV
   Meli P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171368
   Melo A.C.G., 2006, SCI FOR, V71, P149
   Mesquita C. A. B., 2010, Ecological Restoration, V28, P199
   Montagnini F, 1998, ENVIRON MANAGE, V22, P459, DOI 10.1007/s002679900119
   Montoya D, 2012, TRENDS ECOL EVOL, V27, P666, DOI 10.1016/j.tree.2012.07.004
   Moreno-Mateos D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14163
   Neupane RP, 2001, AGR ECOSYST ENVIRON, V84, P157, DOI 10.1016/S0167-8809(00)00203-6
   Orwin RG, 1983, J ED STAT, V8, P157, DOI DOI 10.2307/1164923
   Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609
   Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4
   Barral MP, 2015, AGR ECOSYST ENVIRON, V202, P223, DOI 10.1016/j.agee.2015.01.009
   Poorter L, 2016, NATURE, P1
   Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138
   Reid JL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9143
   Ren YJ, 2017, LAND DEGRAD DEV, V28, P2062, DOI 10.1002/ldr.2728
   Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460
   Richards AE, 2007, SOIL BIOL BIOCHEM, V39, P2078, DOI 10.1016/j.soilbio.2007.03.012
   Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Scott NA, 1999, TELLUS B, V51, P326, DOI 10.1034/j.1600-0889.1999.00015.x
   SER, 2004, THE SER INTERNATIONA
   Shimamoto CY, 2014, FOREST ECOL MANAG, V329, P1, DOI 10.1016/j.foreco.2014.06.002
   Sierra CA, 2012, CARBON BAL MANAGE, V7, P1
   Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x
   Sobanski N, 2014, J NAT CONSERV, V22, P217, DOI 10.1016/j.jnc.2014.01.001
   Soto-Pinto L, 2010, AGROFOREST SYST, V78, P39, DOI 10.1007/s10457-009-9247-5
   van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452
   Verchot L. V., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P901, DOI 10.1007/s11027-007-9105-6
   Williams NM, 2011, RESTOR ECOL, V19, P450, DOI 10.1111/j.1526-100X.2010.00707.x
   Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028
   WRI, 2016, IN 20 20
   YOBTERIK AC, 1994, AGROFOREST SYST, V25, P153, DOI 10.1007/BF00705675
NR 97
TC 0
Z9 0
U1 19
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 27
PY 2018
VL 13
IS 12
AR e0208523
DI 10.1371/journal.pone.0208523
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF7KM
UT WOS:000454418200006
PM 30589896
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Farooqi, MAM
   Malhotra, N
   Mukherjee, SD
   Sanger, S
   Dhesy-Thind, SK
   Ellis, P
   Leong, DP
AF Farooqi, Mohammed A. M.
   Malhotra, Nikita
   Mukherjee, Som D.
   Sanger, Stephanie
   Dhesy-Thind, Sukhbinder K.
   Ellis, Peter
   Leong, Darryl P.
TI Statin therapy in the treatment of active cancer: A systematic review
   and meta-analysis of randomized controlled trials
SO PLOS ONE
LA English
DT Review
ID PREVIOUSLY TREATED PATIENTS; PHASE-II; PLUS SIMVASTATIN; DOUBLE-BLIND;
   PRAVASTATIN; BIAS; CHEMOTHERAPY; MULTICENTER; INHIBITION; CARCINOMA
AB Background
   Preclinical evidence suggests statins may have anti-tumor properties. Large observational studies are also consistent with improved survival and cancer-specific outcomes among cancer patients on statins. We sought to evaluate the randomized controlled trials of statins in addition to usual anti-cancer therapy.
   Methods
   A systematic search of MEDLINE, Embase, CINAHL, Cochrane Library, Web of Science, Papers First and Clinicaltrials. gov was performed from inception through to July 4, 2017 to identify randomized clinical trials that investigated statin therapy in cancer patients. Our primary outcome was overall survival and our secondary outcome was progression-free survival. We calculated summary hazard ratio's (HR) and 95% confidence intervals (CI) based on random-effects models using aggregate data. PROSPERO (CRD42017065503).
   Results
   Ten studies with 1,881 individuals were included with 1,572 deaths and a median follow-up of 23 months. All trials included patients with advanced (stage 3 or higher) disease. There was minimal between-study statistical heterogeneity (I-2 = 1.8%, for OS; I-2 = 0%, for PFS). The pooled HR for overall survival in patients randomized to statins plus standard anti-cancer therapy versus standard therapy alone was 0.94 (95% CI, 0.85 to 1.04). In the 9 studies that reported progression-free survival (1,798 participants), the pooled HR for statin plus standard therapy versus standard therapy alone was 0.97 (95% CI, 0.87 to 1.07).
   Conclusions In patients with advanced cancer and a prognosis < 2 years, the addition of statins to standard anti-cancer therapy does not appear to improve overall survival or progression-free survival. Future research should assess if cancer patients with better prognosis benefit from longer-term statin therapy.
C1 [Farooqi, Mohammed A. M.; Malhotra, Nikita; Leong, Darryl P.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Farooqi, Mohammed A. M.; Leong, Darryl P.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.
   [Farooqi, Mohammed A. M.; Leong, Darryl P.] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada.
   [Mukherjee, Som D.; Dhesy-Thind, Sukhbinder K.; Ellis, Peter] McMaster Univ, Div Med Oncol, Dept Oncol, Hamilton, ON, Canada.
   [Sanger, Stephanie] McMaster Univ, Hlth Sci Lib, Hamilton, ON, Canada.
RP Leong, DP (reprint author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Leong, DP (reprint author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.; Leong, DP (reprint author), McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada.
EM darryl.leong@phri.ca
OI Leong, Darryl/0000-0002-1968-169X; Farooqi, Mohammed/0000-0001-5282-4034
FU Hamilton Health Sciences Strategic Research Initiative; Heart and Stroke
   Foundation of Canada; Canadian Institutes of Health Research
FX Dr. Darryl Leong is supported by the Hamilton Health Sciences Strategic
   Research Initiative, the Heart and Stroke Foundation of Canada, and the
   Canadian Institutes of Health Research.
CR Altwairgi AK, 2015, ONCOL REP, V33, P1019, DOI 10.3892/or.2015.3741
   Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Chan KKW, 2003, CLIN CANCER RES, V9, P10
   Clutterbuck RD, 1998, BRIT J HAEMATOL, V102, P522, DOI 10.1046/j.1365-2141.1998.00783.x
   Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   El-Hamamsy M, 2016, ONCOL RES, V24, P521, DOI 10.3727/096504016X14719078133528
   Gbelcova H, 2008, INT J CANCER, V122, P1214, DOI 10.1002/ijc.23242
   Georgescu EF, 2011, HEPATOL INT, V5, P423
   Gizzo S, 2015, CURR DRUG TARGETS, V16, P1142, DOI 10.2174/1389450116666150330113239
   Han JY, 2011, CLIN CANCER RES, V17, P1553, DOI 10.1158/1078-0432.CCR-10-2525
   Higgins JPT, 2011, BMJ, V343
   Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306
   Hong JY, 2014, CANCER CHEMOTH PHARM, V73, P125, DOI 10.1007/s00280-013-2328-1
   Hus M, 2011, ANN HEMATOL, V90, P1161, DOI 10.1007/s00277-011-1276-2
   Inano H, 1997, CARCINOGENESIS, V18, P1723, DOI 10.1093/carcin/18.9.1723
   Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462
   Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2001.1716
   Khanzada UK, 2006, ONCOGENE, V25, P877, DOI 10.1038/sj.onc.1209117
   Kim ST, 2014, EUR J CANCER, V50, P2822, DOI 10.1016/j.ejca.2014.08.005
   Konings IRHM, 2010, EUR J CANCER, V46, P3200, DOI 10.1016/j.ejca.2010.07.036
   Lee Y, 2017, CANCER RES TREAT, V49, P1001, DOI 10.4143/crt.2016.546
   Lim SH, 2015, BRIT J CANCER, V113, P1421, DOI 10.1038/bjc.2015.371
   Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14
   Mei ZB, 2017, INT J CANCER, V140, P1068, DOI 10.1002/ijc.30526
   Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76
   Narisawa T, 1996, TOHOKU J EXP MED, V180, P131, DOI 10.1620/tjem.180.131
   Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735
   Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   Samura B, 2016, Georgian Med News, P56
   Seckl MJ, 2017, J CLIN ONCOL, V35, P1506, DOI 10.1200/JCO.2016.69.7391
   Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324
   Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393
   Wong WWL, 2001, CLIN CANCER RES, V7, P2067
   Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176
NR 40
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2018
VL 13
IS 12
AR e0209486
DI 10.1371/journal.pone.0209486
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HF0HP
UT WOS:000453841700081
PM 30571754
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Acar, F
   Seurinck, R
   Eickhoff, SB
   Moerkerke, B
AF Acar, Freya
   Seurinck, Ruth
   Eickhoff, Simon B.
   Moerkerke, Beatrijs
TI Assessing robustness against potential publication bias in Activation
   Likelihood Estimation (ALE) meta-analyses for fMRI
SO PLOS ONE
LA English
DT Article
ID FUNCTIONAL NEUROIMAGING DATA; SENSITIVITY; POWER
AB The importance of integrating research findings is incontrovertible and procedures for coordinate-based meta-analysis (CBMA) such as Activation Likelihood Estimation (ALE) have become a popular approach to combine results of fMRI studies when only peaks of activation are reported. As meta-analytical findings help building cumulative knowledge and guide future research, not only the quality of such analyses but also the way conclusions are drawn is extremely important. Like classical meta-analyses, coordinate-based meta-analyses can be subject to different forms of publication bias which may impact results and invalidate findings. The file drawer problem refers to the problem where studies fail to get published because they do not obtain anticipated results (e.g. due to lack of statistical significance). To enable assessing the stability of meta-analytical results and determine their robustness against the potential presence of the file drawer problem, we present an algorithm to determine the number of noise studies that can be added to an existing ALE fMRI meta-analysis before spatial convergence of reported activation peaks over studies in specific regions is no longer statistically significant. While methods to gain insight into the validity and limitations of results exist for other coordinate-based meta-analysis toolboxes, such as Galbraith plots for Multilevel Kernel Density Analysis (MKDA) and funnel plots and egger tests for seed-based d mapping, this procedure is the first to assess robustness against potential publication bias for the ALE algorithm. The method assists in interpreting meta-analytical results with the appropriate caution by looking how stable results remain in the presence of unreported information that may differ systematically from the information that is included. At the same time, the procedure provides further insight into the number of studies that drive the meta-analytical results. We illustrate the procedure through an example and test the effect of several parameters through extensive simulations. Code to generate noise studies is made freely available which enables users to easily use the algorithm when interpreting their results.
C1 [Acar, Freya; Seurinck, Ruth; Moerkerke, Beatrijs] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium.
   [Eickhoff, Simon B.] Heinrich Heine Univ Dusseldorf, Inst Syst Neurosci, Fac Med, Dusseldorf, Germany.
   [Eickhoff, Simon B.] Res Ctr Julich, Inst Neurosci & Med Brain & Behav INM 7, Julich, Germany.
RP Acar, F (reprint author), Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium.
EM freya.acar@ugent.be
RI Eickhoff, Simon B./K-2061-2013
OI Eickhoff, Simon B./0000-0001-6363-2759
FU Research Foundation Flanders (FWO) [G.0149.14N]; National Institute of
   Mental Health [R01-MH074457]; Helmholtz Portfolio Theme "Supercomputing
   and Modeling for the Human Brain"; European Union [7202070]
FX FA, RS and BM would like to acknowledge the Research Foundation Flanders
   (FWO) for financial support (Grant G.0149.14). SBE was supported by the
   National Institute of Mental Health (R01-MH074457), the Helmholtz
   Portfolio Theme "Supercomputing and Modeling for the Human Brain" and
   the European Union's Horizon 2020 Research and Innovation Programme
   under Grant Agreement No. 7202070 (HBP SGA1). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; FA, RS and BM would like to acknowledge
   the Research Foundation Flanders (FWO) for financial support (Grant
   G.0149.14N).; SBE was supported by the National Institute of Mental
   Health (R01-MH074457), the Helmholtz Portfolio Theme "Supercomputing and
   Modeling for the Human Brain" and the European Union's Horizon 2020
   Research and Innovation Programme under Grant Agreement No. 7202070 (HBP
   SGA1).
CR Carp J, 2012, NEUROIMAGE, V63, P289, DOI 10.1016/j.neuroimage.2012.07.004
   CARSON KP, 1990, EDUC PSYCHOL MEAS, V50, P233, DOI 10.1177/0013164490502001
   COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616
   Costafreda SG, 2012, J NEUROSCI METH, V210, P291, DOI 10.1016/j.jneumeth.2012.07.016
   David SP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23976-1
   David SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070104
   DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3
   Durnez J, 2014, NEUROIMAGE, V84, P45, DOI 10.1016/j.neuroimage.2013.07.072
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eickhoff SB, 2016, NEUROIMAGE, V137, P70, DOI 10.1016/j.neuroimage.2016.04.072
   Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017
   Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718
   Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139
   Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789
   Hsu L. M., 2002, Understanding Statistics, V1, P85, DOI 10.1207/S15328031US0102_02
   Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28
   Jennings RG, 2012, NEUROINFORMATICS, V10, P67, DOI 10.1007/s12021-011-9125-y
   Kang J, 2014, ANN APPL STAT, V8, P1561
   Kang J, 2011, J AM STAT ASSOC, V106, P124, DOI 10.1198/jasa.2011.ap09735
   Kicinski Michal, 2014, BMJ Open, V4, pe004831, DOI 10.1136/bmjopen-2014-004831
   Laird A, 2008, NEUROINFORMATICS, P65
   Laird AR, 2008, NEUROIMAGE, V41, P424, DOI 10.1016/j.neuroimage.2008.01.065
   Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976
   Maumet C, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.102
   Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054
   Radua J, 2014, NEUROPSYCHOPHARMACOL, V39, P1547, DOI 10.1038/npp.2014.5
   Radua J, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-6
   Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046
   RAUDENBUSH SW, 1984, J EDUC PSYCHOL, V76, P85, DOI 10.1037/0022-0663.76.1.85
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1
   Samartsidis P, 2017, BIORXIV, DOI [10.1101/225425, DOI 10.1101/225425]
   Scargle J., 2000, J SCI EXPLORATION, V14, P91
   Schonemann P. H., 2008, CHINESE J PSYCHOL, V50, P21
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Stouffer SES, 1949, AM SOLDIER, V1
   Sutton AJ, 2000, METHODS METAANALYSIS
   Tramer MR, 1997, BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635
   Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186
   Vevea JL, 2005, PSYCHOL METHODS, V10, P428, DOI 10.1037/1082-989X.10.4.428
   Wager TD, 2007, SOC COGN AFFECT NEUR, V2, P150, DOI 10.1093/scan/nsm015
   Wager TD, 2009, NEUROIMAGE, V45, pS210, DOI 10.1016/j.neuroimage.2008.10.061
   Yue YR, 2012, ANN APPL STAT, V6, P697, DOI 10.1214/11-AOAS523
NR 44
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2018
VL 13
IS 11
AR e0208177
DI 10.1371/journal.pone.0208177
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HC6AO
UT WOS:000451883700027
PM 30500854
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Milone, M
   Manigrasso, M
   Burati, M
   Velotti, N
   Milone, F
   De Palma, GD
AF Milone, Marco
   Manigrasso, Michele
   Burati, Morena
   Velotti, Nunzio
   Milone, Francesco
   De Palma, Giovanni Domenico
TI Surgical resection for rectal cancer. Is laparoscopic surgery as
   successful as open approach? A systematic review with meta-analysis
SO PLOS ONE
LA English
DT Review
ID TOTAL MESORECTAL EXCISION; SHORT-TERM OUTCOMES; PATHOLOGICAL OUTCOMES;
   ASSISTED RESECTION; OPEN COLECTOMY; PUBLICATION; CARE
AB Background
   Recently, it has been questioned if minimally invasive surgery for rectal cancer was surgically successful. We decided to perform a meta-analysis to determine if minimally invasive surgery is adequate to obtain a complete resection for curable rectal cancer.
   Methods
   A systematic search pertaining to evaluation between laparoscopic and open rectal resection for rectal cancer was performed until 30th November 2016 in the electronic databases (PubMed, Web of Science, Scopus, EMBASE), using the following search terms in all possible combinations: rectal cancer, laparoscopy, minimally invasive and open surgery. Outcomes analyzed were number of clear Distal Resection Margins (DRM or DM), complete Circumferential Resection Margins (CRM) and complete, nearly complete and incomplete Total Mesorectal Excision (TME) and of patients who received laparoscopic or open treatment for rectal cancer.
   Results
   12 articles were included in the final analysis. The prevalence of successful surgical resection was similar between open and laparoscopic surgery. About distance from distal margin of the specimen, clear CRM and complete TME there were no statistically significant difference between the two groups (MD = -0.090 cm, p = 0.364, 95% CI -0.283, 0.104; OR = 1.032, p = 0.821, 95% CI 0.784, 1.360; OR = 0.933, p = 0.720, 95% CI 0.638, 1.364, respectively).
   The analysis of nearly complete TME showed a significant difference between the two groups (OR = 1.407, p = 0.006, 95% CI 1.103, 1.795), while the analysis of incomplete TME showed a non-significant difference (OR = 1.010, p = 0.964, 95% CI 0.664, 1.534).
   Conclusions
   By pooling together data from 5 RCTs and 7 nRCTs, we are able to provide evidence of safety and efficacy of minimally invasive surgery. Waiting for further randomized clinical trials, our results are encouraging to introduce laparoscopic rectal resection in daily practice.
C1 [Milone, Marco; Manigrasso, Michele; Burati, Morena; Velotti, Nunzio; Milone, Francesco] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy.
   [De Palma, Giovanni Domenico] Univ Naples Federico II, Dept Surg & Adv Technol, Naples, Italy.
RP Milone, M (reprint author), Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy.
EM milone.marco.md@gmail.com
RI Velotti, Nunzio/O-2060-2015
OI Velotti, Nunzio/0000-0002-3478-6270; Milone, Marco/0000-0001-5612-1926
CR Bonjer HJ, 2007, ARCH SURG-CHICAGO, V142, P298
   Breukink SO, 2005, INT J COLORECTAL DIS, V20, P428, DOI 10.1007/s00384-004-0715-0
   Cheung HYC, 2018, ASIA-PAC J CLIN ONCO, V14, pE175, DOI 10.1111/ajco.12781
   Creavin B, 2017, BRIT J SURG, V104, P1609, DOI 10.1002/bjs.10664
   de'Angelis N, 2017, SURG ENDOSC, V31, P3106, DOI 10.1007/s00464-016-5332-9
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ferko A, 2014, VIDEOSURGERY MINIINV, V9, P569, DOI 10.5114/wiitm.2014.45733
   Fleshman J, 2016, J GASTROINTEST SURG, V20, P1056, DOI 10.1007/s11605-016-3085-3
   Fleshman J, 2015, JAMA-J AM MED ASSOC, V314, P1346, DOI 10.1001/jama.2015.10529
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Jiang JB, 2015, J GASTROINTEST SURG, V19, P1497, DOI 10.1007/s11605-015-2857-5
   Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5
   Keskin M, 2016, SURG LAPARO ENDO PER, V26, pE62, DOI 10.1097/SLE.0000000000000267
   Kitz J, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2018.1607
   Martinez-Perez A, 2017, WORLD J GASTROENTERO, V23, P7906, DOI 10.3748/wjg.v23.i44.7906
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Monson JRT, 2013, DIS COLON RECTUM, V56, P535, DOI 10.1097/DCR.0b013e31828cb66c
   Ng SSM, 2014, SURG ENDOSC, V28, P297, DOI 10.1007/s00464-013-3187-x
   Perdawood SK, 2018, SURG ENDOSC, V32, P2312, DOI 10.1007/s00464-017-5926-x
   Ramji KM, 2016, SURG ENDOSC, V30, P1337, DOI 10.1007/s00464-015-4390-8
   Rickles AS, 2015, ANN SURG, V262, P891, DOI 10.1097/SLA.0000000000001391
   Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101
   Stevenson ARL, 2015, JAMA-J AM MED ASSOC, V314, P1356, DOI 10.1001/jama.2015.12009
   van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0
   Wells GA, NEWCASTLE OTTAWA SCA
   Wilson MZ, 2014, COLORECTAL DIS, V16, P382, DOI 10.1111/codi.12537
   Zhang FW, 2014, ASIAN PAC J CANCER P, V15, P9985, DOI 10.7314/APJCP.2014.15.22.9985
   Zheng J, 2016, ONCOTARGET
NR 30
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 9
PY 2018
VL 13
IS 10
AR e0204887
DI 10.1371/journal.pone.0204887
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GW4OW
UT WOS:000446897200024
PM 30300377
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gonzalez-Valero, L
   Montiel-Company, JM
   Bellot-Arcis, C
   Almerich-Torres, T
   Iranzo-Cortes, JE
   Almerich-Silla, JM
AF Gonzalez-Valero, Lourdes
   Maria Montiel-Company, Jose
   Bellot-Arcis, Carlos
   Almerich-Torres, Teresa
   Enrique Iranzo-Cortes, Jose
   Manuel Almerich-Silla, Jose
TI Association between passive tobacco exposure and caries in children and
   adolescents. A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID 3-YEAR-OLD JAPANESE CHILDREN; PEDIATRIC DENTAL-CARIES; EARLY-CHILDHOOD
   CARIES; MATERNAL SMOKING; SECONDHAND SMOKE; PRESCHOOL-CHILDREN;
   HOUSEHOLD SMOKING; SCHOOL-CHILDREN; BIRTH-WEIGHT; EXPERIENCE
AB To examine the available evidence on the association between exposure to tobacco use in the womb and in infancy and the presence of caries in primary and permanent dentition in children and adolescents.
   A systematic review was conducted through searches in 4 data bases (Pubmed, Scopus, Embase and Web of Science), complemented by hand-searching. Of the 559 articles identified, 400 were duplicates. Finally, 28 articles were included in the qualitative review and 21 in the meta-analysis. Their quality was assessed using the Newcastle-Ottawa scale. The quality was medium in 44% of the articles included and high in 56%.
   The overall meta-analysis gave a significant odds ratio (OR = 1.53, 95% confidence interval 1.39-1.68, Z test p-value = 0.000) and high heterogeneity (Q = 200.3, p = 0.000; I-2 = 86.52%). Separate meta-analyses were also performed for three subgroups: exposure in the womb (prenatal) and caries in primary dentition, which resulted in a significant OR = 1.46 with a 95% CI of 1.41-1.52 (Z test p = 0.000), without heterogeneity (Q = 0.91, p = 0.824; I-2 = 0%); exposure in infancy (postnatal) and caries in primary dentition, with OR = 1.72 (95% CI 1.45-2.05) and high heterogeneity (Q = 76.59, p = 0.00; I-2 = 83.01%); and postnatal exposure and caries in permanent dentition, with OR = 1.30 (95% CI 1.25-1.34) and no heterogeneity (Q = 4.48, p = 0.880; I-2 = 0%). In children and adolescents, a significant though moderate association was found between passive tobacco exposure and caries.
C1 [Gonzalez-Valero, Lourdes; Maria Montiel-Company, Jose; Bellot-Arcis, Carlos; Almerich-Torres, Teresa; Enrique Iranzo-Cortes, Jose; Manuel Almerich-Silla, Jose] Univ Valencia, Stomatol Dept, Valencia, Spain.
RP Montiel-Company, JM (reprint author), Univ Valencia, Stomatol Dept, Valencia, Spain.
EM jose.maria.montiel@uv.es
RI Montiel-Company, Jose Maria/S-1836-2018
OI Montiel-Company, Jose Maria/0000-0002-3952-7681
CR Aida J, 2008, COMMUNITY DENT ORAL, V36, P149, DOI 10.1111/j.1600-0528.2007.00380.x
   Aligne CA, 2003, JAMA-J AM MED ASSOC, V289, P1258, DOI 10.1001/jama.289.10.1258
   Almerich-Torres T, 2013, GACETA DENT IND PROF, P116
   Arora M, 2008, ENVIRON HEALTH PERSP, V116, P821, DOI 10.1289/ehp.10947
   Avsar A, 2008, ARCH ORAL BIOL, V53, P969, DOI 10.1016/j.archoralbio.2008.05.007
   Ayo-Yusuf OA, 2007, J ADOLESCENT HEALTH, V41, P309, DOI 10.1016/j.jadohealth.2007.04.012
   Bakhurji EA, 2017, SAUDI MED J, V38, P748, DOI 10.15537/smj.2017.7.17601
   Bernabe E, 2017, J DENT RES, V96, P171, DOI 10.1177/0022034516678181
   Binnie V, 2004, ORAL DIS, V10, P287, DOI 10.1111/j.1601-0825.2004.01018.x
   Garcia SC, 2011, REV ESP SALUD PUBLIC, V85, P217, DOI [10.1590/S1135-57272011000200009, 10.1590/s1135-57272011000200009]
   Chowdhury IG, 2000, ANAT RECORD, V258, P397
   Claudia C, 2016, COMMUNITY DENT HLTH, V33, P297, DOI 10.1922/CDH_3937Claudia06
   Delpisheh A, 2006, PUBLIC HEALTH, V120, P65, DOI 10.1016/j.puhe.2005.05.003
   Ditmyer M, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-24
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Edelstein BL, 2006, BMC ORAL HLTH S1, V6
   Featherstone JD, 2004, J DENT RES
   Hanioka T, 2008, PAEDIATR PERINAT EP, V22, P546, DOI 10.1111/j.1365-3016.2008.00950.x
   Hanioka T, 2011, INT J ENV RES PUB HE, V8, P1503, DOI 10.3390/ijerph8051503
   Heikkinen T, 1997, EARLY HUM DEV, V47, P327, DOI 10.1016/S0378-3782(96)01792-6
   Iida H, 2007, PEDIATRICS, V120, pE944, DOI 10.1542/peds.2006-0124
   Jakhete N, 2012, INT J DISABIL HUM DE, V11, DOI [10.1515/ijdhd-2012-0049, DOI 10.1515/IJDHD-2012-0049]
   Julihn A, 2009, EUR J EPIDEMIOL, V24, P753, DOI 10.1007/s10654-009-9399-7
   Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272
   Leroy R, 2008, COMMUNITY DENT ORAL, V36, P249, DOI 10.1111/j.1600-0528.2007.00393.x
   LINDEMEYER RG, 1981, J AM DENT ASSOC, V103, P719, DOI 10.14219/jada.archive.1981.0372
   Majorana A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-45
   Marthaler TM, 2004, CARIES RES, V38, P173, DOI 10.1159/000077752
   Nakayama Y, 2015, J PUBLIC HEALTH DENT, V75, P157, DOI 10.1111/jphd.12085
   Nayani AA, 2018, J PAK MED ASSOC, V68, P203
   Pita-Fernandez S, 2011, ARCH BRONCONEUMOL, V47, P419, DOI 10.1016/j.arbres.2011.03.005
   Pitts NB, 2017, NAT REV DIS PRIMERS, V3, P1, DOI 10.1038/nrdp.2017.30
   Plonka KA, 2013, CARIES RES, V47, P117, DOI 10.1159/000345073
   Shenkin JD, 2004, J PUBLIC HEALTH DENT, V64, P184, DOI 10.1111/j.1752-7325.2004.tb02750.x
   Shulman JD, 2005, CARIES RES, V39, P161, DOI 10.1159/000084792
   Slayton Rebecca L, 2012, J Evid Based Dent Pract, V12, P8, DOI 10.1016/j.jebdp.2011.12.004
   Strauss RS, 2001, PEDIATRICS, V107, P540, DOI 10.1542/peds.107.3.540
   Tanaka K, 2006, J PUBLIC HEALTH DENT, V66, P279, DOI 10.1111/j.1752-7325.2006.tb04083.x
   Tanaka K, 2015, ENVIRON RES, V143, P148, DOI 10.1016/j.envres.2015.10.004
   Tanaka K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-335
   Tanaka K, 2009, J PEDIATR-US, V155, P410, DOI 10.1016/j.jpeds.2009.03.032
   Tanaka S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5397
   Vellappally Sajith, 2007, Central European Journal of Public Health, V15, P116
   Wells GA, 2014, NEWCASTLE OTTAWA SCA
   Wiener RC, 2013, J PSYCHOL ABNORM CHI, V1, DOI [10.4172/2329-9525.1000104, DOI 10.4172/2329-9525.1000104]
   Williams SA, 2000, CARIES RES, V34, P117, DOI 10.1159/000016578
   Wilson KM, 2011, CURR PEDIATR REV, V7, P76, DOI 10.2174/157339611795735594
   World Health Organization, 1999, CONS REP INT CONS EN
   Zhou S, 2014, CURR PROB PEDIATR AD, V44, P219, DOI 10.1016/j.cppeds.2014.03.007
NR 49
TC 0
Z9 0
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 16
PY 2018
VL 13
IS 8
AR e0202497
DI 10.1371/journal.pone.0202497
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ6RF
UT WOS:000441850400078
PM 30114212
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tang, M
   Shen, JF
   Li, P
   Zhou, LN
   Zeng, P
   Cui, XX
   Chen, MB
   Tian, Y
AF Tang, Min
   Shen, Jiao-Feng
   Li, Ping
   Zhou, Li-Na
   Zeng, Ping
   Cui, Xi-Xi
   Chen, Min-Bin
   Tian, Ye
TI Prognostic significance of CIP2A expression in solid tumors: A
   meta-analysis
SO PLOS ONE
LA English
DT Article
ID EPITHELIAL-MESENCHYMAL TRANSITION; PHOSPHATASE 2A CIP2A; CELL
   LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; ONCOGENIC NEXUS; PP2A;
   OVEREXPRESSION; ONCOPROTEIN; RESISTANCE; INHIBITOR
AB CIP2A, cancerous inhibitor of protein phosphatase 2A, was initially recognized as an oncoprotein. Recently several studies revealed that CIP2A could function as a prognosis bio-marker, however, the result remained not comprehensive, partly due to small number of patients included individually. Here we carried out a meta-analysis of published studies to assess the prognostic significance of CIP2A in solid tumors. All eligible studies were identified through searching PubMed, Embase and Web of Science database. In this meta-analysis, 22 studies involving 4,579 participants were included, and we verified that CIP2A over-expression was significantly related with poor overall survival (pooled HR = 1.844, 95% CI = 1.528-2.225, P<0.001) and short disease free survival (pooled HR = 1.808, 95% CI = 1.591-2.055, P<0.001) in solid tumors. Additionally, subgroup analysis suggested that the trend of a poor overall survival with an increased CIP2A expression was present in East-Asian and European patients, as well as in lung cancer and colorectal cancer. To sum up, CIP2A over-expression was associated with poor survival in human solid tumors and might be a predictive factor of poor prognosis.
C1 [Tang, Min; Li, Ping; Zhou, Li-Na; Tian, Ye] Soochow Univ, Inst Radiotherapy & Oncol, Dept Radiotherapy & Oncol, Affiliated Hosp 2, Suzhou, Jiangsu, Peoples R China.
   [Tang, Min; Li, Ping; Zhou, Li-Na; Zeng, Ping; Cui, Xi-Xi; Chen, Min-Bin] Jiangsu Univ, Dept Radiotherapy & Oncol, Kunshan Peoples Hosp 1, Kunshan, Jiangsu, Peoples R China.
   [Shen, Jiao-Feng] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Jiangsu, Peoples R China.
RP Tian, Y (reprint author), Soochow Univ, Inst Radiotherapy & Oncol, Dept Radiotherapy & Oncol, Affiliated Hosp 2, Suzhou, Jiangsu, Peoples R China.
EM dryetian@126.com
FU National Natural Science Foundation [81472786, 81773192]; Natural
   Science Foundation of Jiangsu Province [BK20171248]; Jiangsu Province
   Youth Medical Talents Project [QNRC2016527]; Foundation of tumor
   clinical and basic research team [KYC005]; Suzhou City Health Science
   and Technology Project [LCZX201619]
FX National Natural Science Foundation 81472786 and 81773192, Natural
   Science Foundation of Jiangsu Province BK20171248, Jiangsu Province
   Youth Medical Talents Project, QNRC2016527, the Foundation of tumor
   clinical and basic research team KYC005, and Suzhou City Health Science
   and Technology Project LCZX201619 to MBC. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bockelman C, 2011, BRIT J CANCER, V105, P989, DOI 10.1038/bjc.2011.346
   Bockelman C, 2011, BRIT J CANCER, V104, P1890, DOI 10.1038/bjc.2011.167
   Bockelman C, 2012, CANCER BIOL THER, V13, P289, DOI [10.4161/cbt.18922, 10.4161/cbt.13.5.18922]
   Chao TT, 2016, APMIS, V124, P1031, DOI 10.1111/apm.12602
   Chen JN, 2016, EUR J MED CHEM, V107, P12, DOI 10.1016/j.ejmech.2015.10.045
   Chen KF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1300-3
   Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283
   Cristobal I, 2017, ONCOGENE, V36, P3357, DOI 10.1038/onc.2016.474
   Cristobal I, 2016, MOL CELL BIOL, V36, P1734, DOI 10.1128/MCB.00130-16
   De P, 2015, AM J CANCER RES, V5, P2872
   De P, 2014, ONCOTARGET, V5, P4581, DOI 10.18632/oncotarget.2127
   Dey N, 2015, AM J CANCER RES, V5, P1
   Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005
   Florenes VA, 2015, CANCER MED-US, V4, P903, DOI 10.1002/cam4.425
   He H, 2012, DIAGN MOL PATHOL, V21, P143, DOI 10.1097/PDM.0b013e318249fd8b
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625
   Huang PZ, 2012, BIOMARKERS, V17, P422, DOI 10.3109/1354750X.2012.680608
   Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044
   Khanna A, 2016, INT J CANCER, V138, P525, DOI 10.1002/ijc.29431
   Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103
   Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008
   Liu N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-111
   Liu Z, 2014, ACS MED CHEM LETT, V5, P113, DOI 10.1021/ml400341k
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837
   Peng B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1899-0
   Rantanen T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0684-7
   Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492
   Routila J, 2016, J ORAL PATHOL MED, V45, P329, DOI 10.1111/jop.12372
   Ruvolo PP, 2016, BBA CLIN, V6, P87, DOI 10.1016/j.bbacli.2016.08.002
   Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Sung WW, 2013, CLIN CANCER RES, V19, P4092, DOI 10.1158/1078-0432.CCR-12-3439
   Tang QZ, 2015, ONCOL REP, V34, P2515, DOI 10.3892/or.2015.4217
   Teng HW, 2012, J GASTROINTEST SURG, V16, P1037, DOI 10.1007/s11605-012-1828-3
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136
   Wang L, 2013, TUMOR BIOL, V34, P2309, DOI 10.1007/s13277-013-0775-2
   Wiegering A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075292
   Xu P, 2013, HEPATO-GASTROENTEROL, V60, P669, DOI 10.5754/hge11139
   Xu P, 2012, MED ONCOL, V29, P1643, DOI 10.1007/s12032-011-0053-3
   Xue YJ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0406-6
   Yu GZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0524-9
NR 47
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2018
VL 13
IS 7
AR e0199675
DI 10.1371/journal.pone.0199675
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO4AN
UT WOS:000439942500016
PM 30044786
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Morgan, AJ
   Ross, A
   Reavley, NJ
AF Morgan, Amy J.
   Ross, Anna
   Reavley, Nicola J.
TI Systematic review and meta-analysis of Mental Health First Aid training:
   Effects on knowledge, stigma, and helping behaviour
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; AUSTRALIAN NATIONAL-SURVEY; IMPROVING
   KNOWLEDGE; DELPHI CONSENSUS; ATTITUDES; BELIEFS; DISORDERS; ILLNESS;
   INTERVENTIONS; INTENTIONS
AB Objective
   To provide an up-to-date assessment of the effectiveness of the Mental Health First Aid (MHFA) training program on improving mental health knowledge, stigma and helping behaviour.
   Design
   Systematic review and meta-analysis.
   Methods
   A systematic search of electronic databases was conducted in October 2017 to identify randomised controlled trials or controlled trials of the MHFA program. Eligible trials were in adults, used any comparison condition, and assessed one or more of the following outcomes: mental health first aid knowledge; recognition of mental disorders; treatment knowledge; stigma and social distance; confidence in or intentions to provide mental health first aid; provision of mental health first aid; mental health of trainees or recipients of mental health first aid. Risk of bias was assessed and effect sizes (Cohen's d) were pooled using a random effects model. Separate meta-analyses examined effects at post-training, up to 6 months post-training, and greater than 6 months post-training.
   Results
   A total of 18 trials (5936 participants) were included. Overall, effects were generally small-tomoderate post-training and up to 6 months later, with effects up to 12-months later unclear. MHFA training led to improved mental health first aid knowledge (ds 0.31 - 0.72), recognition of mental disorders (ds 0.22 - 0.52) and beliefs about effective treatments (ds 0.19 - 0.45). There were also small reductions in stigma (ds 0.08 - 0.14). Improvements were also observed in confidence in helping a person with a mental health problem (ds 0.21 - 0.58) and intentions to provide first aid (ds 0.26 - 0.75). There were small improvements in the amount of help provided to a person with a mental health problem at follow-up (d = 0.23) but changes in the quality of behaviours offered were unclear.
   Conclusion
   This review supports the effectiveness of MHFA training in improving mental health literacy and appropriate support for those with mental health problems up to 6 months after training.
C1 [Morgan, Amy J.; Ross, Anna; Reavley, Nicola J.] Univ Melbourne, Ctr Mental Hlth, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia.
RP Morgan, AJ (reprint author), Univ Melbourne, Ctr Mental Hlth, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia.
EM ajmorgan@unimelb.edu.au
RI Morgan, Amy/U-1315-2017
OI Morgan, Amy/0000-0003-3784-0540
FU National Health and Medical Research Council [GNT1083394]
FX This study was funded by the National Health and Medical Research
   Council (https://www.nhmrc.gov.au/) awarded to NR (GNT1083394). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Angermeyer MC, 2003, ACTA PSYCHIAT SCAND, V108, P304, DOI 10.1034/j.1600-0447.2003.00150.x
   Armstrong G, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-304
   Armstrong G, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1465-1
   Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x
   Burgess PM, 2009, AUST NZ J PSYCHIAT, V43, P615, DOI 10.1080/00048670902970858
   Burns S, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1278-2
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Corrigan Patrick W, 2002, World Psychiatry, V1, P16
   Cusack J, 2004, INT J ADV COUNS, V26, P271, DOI [10.1023/B:ADCO.0000035530.44111.a8, DOI 10.1023/B:ADCO.0000035530.44111.A8]
   Davies B, 2016, EUROPEAN HLTH PSYCHO, V18, P861
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Griffiths KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-25
   Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017
   Hadlaczky G, 2014, INT REV PSYCHIATR, V26, P467, DOI 10.3109/09540261.2014.924910
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2016, COCHRANE DATABASE S1, V10, DOI [10.1016/j.jclinepi.2010.04.026, DOI 10.1016/J.JCLINEPI.2010.04.026]
   Jensen KB, 2016, SOC PSYCH PSYCH EPID, V51, P597, DOI 10.1007/s00127-016-1176-9
   Jorm AF, 1997, BRIT J PSYCHIAT, V171, P233, DOI 10.1192/bjp.171.3.233
   Jorm AF, 1 AID TRAINING PAREN
   Jorm AF, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-43
   Jorm AF, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-33
   Jorm AF, 2010, AUST NZ J PSYCHIAT, V44, P1072, DOI 10.3109/00048674.2010.516426
   Jorm AF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-51
   Jorm AF, 2008, J AFFECT DISORDERS, V111, P227, DOI 10.1016/j.jad.2008.02.021
   Kassam A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-62
   Kingston AH, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-3
   Kitchener BA, 2010, MENTAL HLTH 1 AID MA
   Kitchener BA, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-23
   Kitchener BA, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-10
   Kitchener BA, 2008, EARLY INTERV PSYCHIA, V2, P55, DOI 10.1111/j.1751-7893.2007.00056.x
   Langlands RL, 2008, J AFFECT DISORDERS, V105, P157, DOI 10.1016/j.jad.2007.05.004
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328
   Lipson SK, 2014, J ADOLESCENT HEALTH, V55, P612, DOI 10.1016/j.jadohealth.2014.05.009
   Luty J, 2006, PSYCHIATR BULL, V30, P257, DOI 10.1192/pb.30.7.257
   Massey J, 2014, J STUD AFF RES PRACT, V51, P323, DOI 10.1515/jsarp-2014-0032
   Mental Health First Aid Australia, OUR IMP
   Moffitt J, 2014, J PUBLIC MENT HEALTH, V13, P103, DOI 10.1108/JPMH-02-2013-0004
   Mohatt NV, 2017, MIL MED, V182, DOI 10.7205/MILMED-D-16-00033
   Moll S, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0363-9
   Morgan AJ, 2017, SOC PSYCH PSYCH EPID, V52, P1395, DOI 10.1007/s00127-017-1391-z
   Morgan AJ, 2013, AUST NZ J PSYCHIAT, V47, P840, DOI 10.1177/0004867413490035
   O'Reilly CL, 2011, AUST NZ J PSYCHIAT, V45, P549, DOI 10.3109/00048674.2011.585454
   Reavley NJ, 2011, AUST NZ J PSYCHIAT, V45, P947, DOI 10.3109/00048674.2011.621060
   Reavley NR, WORKPLACEAID TRIAL I
   Rose T, 2019, RES SOCIAL WORK PRAC, V29, P291, DOI 10.1177/1049731517729039
   Rossetto A, 2016, PSYCHIAT RES, V240, P170, DOI 10.1016/j.psychres.2016.04.037
   Rossetto A, 2014, ANN GEN PSYCHIATR, V13, DOI 10.1186/1744-859X-13-2
   Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Svensson B, 2013, MENTAL HLTH 1 AID ED, P15
   Svensson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100911
   Vogel DL, 2007, J CLIN PSYCHOL, V63, P233, DOI 10.1002/jclp.20345
   Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249
   Wong DFK, 2017, RES SOCIAL WORK PRAC, V27, P59, DOI 10.1177/1049731515585149
   Yap MBH, 2012, PSYCHIAT RES, V196, P315, DOI 10.1016/j.psychres.2011.10.004
NR 59
TC 9
Z9 9
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2018
VL 13
IS 5
AR e0197102
DI 10.1371/journal.pone.0197102
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH8CD
UT WOS:000433893200011
PM 29851974
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wu, MN
   Tseng, PT
   Chen, TY
   Chen, YW
   Liou, LM
   Lin, PY
   Hsu, CY
AF Wu, Meng-Ni
   Tseng, Ping-Tao
   Chen, Tien-Yu
   Chen, Yen-Wen
   Liou, Li-Min
   Lin, Pao-Yen
   Hsu, Chung-Yao
TI The efficacy and tolerability of rotigotine on patients with periodic
   limb movement in sleep: A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID RESTLESS-LEGS-SYNDROME; DOPAMINE-RECEPTOR AGONISTS; DOUBLE-BLIND;
   TRANSDERMAL PATCH; BEHAVIOR DISORDER; PRAMIPEXOLE; ROPINIROLE;
   AUGMENTATION; SAFETY; MANAGEMENT
AB Objective
   There is still no consensus on the treatment for periodic limb movement in sleep (PLMS). This study aimed to determine the efficacy and tolerability of rotigotine in patients suffering from PLMS.
   Methods
   Publications listed in PubMed, ScienceDirect, The Cochrane Library, and ClinicalTrials.gov were reviewed to assess the efficacy of rotigotine on PLMS. Analyses of PLMS frequency before and after rotigotine treatments (pre- and post-intervention studies) and PLMS frequency between placebo and rotigotine treatments (placebo-controlled trial studies) were included in our study. A systematic review and meta-analysis was conducted.
   Results
   Five publications involving 197 participants were included in this study. Among these articles, pre- and post-intervention data involving 55 participants were available from three articles, while placebo-controlled trial data from 107 participants receiving rotigotine and 70 participants receiving a placebo were available from an additional three articles. In the pre and post-intervention studies, the periodic limb movement index was significantly decreased after therapy with rotigotine with a difference in means of -5.866/h (95% CI, -10.570 to - 1.162, p = 0.015). In comparison with the placebo, the use of rotigotine significantly lowered the periodic limb movement index, with a difference in means of -32.105/h (95% CI, - 42.539 to -21.671, p < 0.001), reduced the PLMS with arousal index, with a difference in means of 7.160/h (95% CI, -9.310 to -5.010, p < 0.001), and increased the withdrawal rate, with an odds ratio of 3.421 (95% CI, 1.230 to 9.512, p = 0.018).
   Conclusions
   This meta-analysis revealed the considerable efficacy of rotigotine in alleviating the frequency of PLMS. However, the high withdrawal rate should be taken into account.
C1 [Wu, Meng-Ni; Liou, Li-Min; Hsu, Chung-Yao] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.
   [Wu, Meng-Ni; Liou, Li-Min; Hsu, Chung-Yao] Kaohsiung Med Univ, Dept Masters Program Neurol, Fac Med, Kaohsiung, Taiwan.
   [Tseng, Ping-Tao] Tsyr Huey Mental Hosp, Dept Psychiat, Kaohsiung, Taiwan.
   [Tseng, Ping-Tao] WinShine Clin Specialty Psychiat, Kaohsiung, Taiwan.
   [Chen, Tien-Yu] Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Psychiat, Taipei, Taiwan.
   [Chen, Yen-Wen] Prospect Clin Otorhinolaryngol & Neurol, Kaohsiung, Taiwan.
   [Lin, Pao-Yen] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan.
   [Lin, Pao-Yen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.
   [Lin, Pao-Yen] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan.
RP Hsu, CY (reprint author), Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.; Hsu, CY (reprint author), Kaohsiung Med Univ, Dept Masters Program Neurol, Fac Med, Kaohsiung, Taiwan.
EM cyhsu@kmu.edu.tw
CR Allen R, 2004, SLEEP, V27, P907, DOI 10.1093/sleep/27.5.907
   Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003
   Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988
   Bauer A, 2016, NEUROLOGY, V86, P1785, DOI 10.1212/WNL.0000000000002649
   Bekci TT, 2012, SLEEP BREATH, V16, P117, DOI 10.1007/s11325-010-0464-y
   Bliwise DL, 2005, SLEEP MED, V6, P141, DOI 10.1016/j.sleep.2004.12.002
   Bogan RK, 2014, CLIN THER, V36, P436, DOI 10.1016/j.clinthera.2014.01.021
   Bogan RK, 2006, MAYO CLIN PROC, V81, P17, DOI 10.4065/81.1.17
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Chen JJ, 2009, PHARMACOTHERAPY, V29, P1452, DOI 10.1592/phco.29.12.1452
   Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9
   Coldwell MC, 1999, BRIT J PHARMACOL, V127, P1696, DOI 10.1038/sj.bjp.0702673
   Dauvilliers Y, 2016, AM J KIDNEY DIS, V68, P434, DOI 10.1053/j.ajkd.2015.12.027
   Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160
   de Mello MT, 2004, SPINAL CORD, V42, P218, DOI 10.1038/sj.sc.3101575
   Ding J, 2015, J HUAZHONG U SCI-MED, V35, P169, DOI 10.1007/s11596-015-1406-5
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elshoff JP, 2016, SLEEP MED
   EspinarSierra J, 1997, PSYCHIAT CLIN NEUROS, V51, P103, DOI 10.1111/j.1440-1819.1997.tb02370.x
   Fantini ML, 2002, NEUROLOGY, V59, P1889, DOI 10.1212/01.WNL.0000038348.94399.F6
   Ferini-Strambi L, 2002, SLEEP MED, V3, pS23, DOI 10.1016/S1389-9457(02)00144-2
   Fulda S, 2015, SLEEP MED CLIN, V10, P241, DOI 10.1016/j.jsmc.2015.05.013
   Garcia-Borreguero D, 2007, SLEEP MED, V8, P520, DOI 10.1016/j.sleep.2007.03.022
   Garcia-Borreguero D, 2014, SLEEP, V37, P635, DOI 10.5665/sleep.3558
   Garcia-Borreguero D, 2012, MOVEMENT DISORD, V27, P277, DOI 10.1002/mds.24889
   Hanly PJ, 1996, CHEST, V109, P1497, DOI 10.1378/chest.109.6.1497
   Happe S, 2004, CNS DRUGS, V18, P27, DOI 10.2165/00023210-200418010-00003
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Hornyak M, 2006, SLEEP MED REV, V10, P169, DOI 10.1016/j.smrv.2005.12.003
   Hornyak M, 2004, SLEEP MED, V5, P597, DOI 10.1016/j.sleep.2004.07.008
   Hornyak M, 2014, SLEEP MED REV, V18, P153, DOI 10.1016/j.smrv.2013.03.004
   Hornyak M, 2012, SLEEP MED, V13, P228, DOI 10.1016/j.sleep.2011.09.013
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   Inoue Y, 2013, PROG NEURO-PSYCHOPH, V40, P326, DOI 10.1016/j.pnpbp.2012.10.012
   Jama L, 2009, SLEEP MED, V10, P630, DOI 10.1016/j.sleep.2008.05.014
   Jung HH, 2010, CLIN J AM SOC NEPHRO, V5, P1607, DOI 10.2215/CJN.08881209
   Koo BB, 2016, AM J GERIAT PSYCHIAT, V24, P1105, DOI 10.1016/j.jagp.2016.04.003
   Koo BB, 2015, HYPERTENSION, V65, P70, DOI 10.1161/HYPERTENSIONAHA.114.04193
   Koo BB, 2011, CIRCULATION, V124, P1223, DOI 10.1161/CIRCULATIONAHA.111.038968
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Lindner A, 2012, J SLEEP RES, V21, P297, DOI 10.1111/j.1365-2869.2011.00956.x
   Lipford MC, 2012, SLEEP MED, V13, P1280, DOI 10.1016/j.sleep.2012.08.004
   Manconi M, 2011, NEUROLOGY, V77, P110, DOI 10.1212/WNL.0b013e3182242d91
   Mirza M, 2013, J AM SOC ECHOCARDIOG, V26, P783, DOI 10.1016/j.echo.2013.03.018
   Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111
   Montplaisir J, 2000, SLEEP MED, V1, P163, DOI 10.1016/S1389-9457(00)00014-9
   Moore H, 2014, SLEEP, V37, P1535, DOI 10.5665/sleep.4006
   Murase Kimihiko, 2014, Ann Am Thorac Soc, V11, P375, DOI 10.1513/AnnalsATS.201306-144OC
   Oertel W, 2011, LANCET NEUROL, V10, P710, DOI 10.1016/S1474-4422(11)70127-2
   Oertel WH, 2008, SLEEP MED, V9, P228, DOI 10.1016/j.sleep.2007.04.010
   Oertel WH, 2010, SLEEP MED, V11, P848, DOI 10.1016/j.sleep.2010.02.014
   Partinen M, 2006, SLEEP MED, V7, P407, DOI 10.1016/j.sleep.2006.03.011
   Piercey MF, 1998, CLIN NEUROPHARMACOL, V21, P141
   Priano L, 2006, DRUG AGING, V23, P357, DOI 10.2165/00002512-200623050-00001
   Quilici S, 2008, SLEEP MED, V9, P715, DOI 10.1016/j.sleep.2007.11.020
   Rijsman RM, 2004, NEPHROLOGY, V9, P353, DOI 10.1111/j.1440-1797.2004.00330.x
   Salas RE, 2010, CLIN CHEST MED, V31, P383, DOI 10.1016/j.ccm.2010.02.006
   Saletu M, 2002, EUR ARCH PSY CLIN N, V252, P185, DOI 10.1007/s00406-002-0380-7
   Sasai T, 2012, TOHOKU J EXP MED, V226, P177, DOI 10.1620/tjem.226.177
   Sasai T, 2011, J NEUROL, V258, P1971, DOI 10.1007/s00415-011-6051-8
   Scholz H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006009.pub2
   Sieb JP, 2015, CURR MED RES OPIN, V31, P967, DOI 10.1185/03007995.2015.1030376
   Silber Michael H, 2013, Continuum (Minneap Minn), V19, P170, DOI 10.1212/01.CON.0000427207.13553.68
   Soriano JB, 1999, INT J EPIDEMIOL, V28, P728, DOI 10.1093/ije/28.4.728
   Tobias A, 1999, STATA TECH B, V8, P15
   Trenkwalder C, 2008, LANCET NEUROL, V7, P595, DOI 10.1016/S1474-4422(08)70112-1
   Vignatelli L, 2006, EUR J NEUROL, V13, P1049, DOI 10.1111/J.1468-1331.2006.01410.x
   Wang Y, 2016, J CLIN SLEEP MED, V12, P1403, DOI 10.5664/jcsm.6200
   WARNES H, 1993, J SLEEP RES, V2, P38, DOI 10.1111/j.1365-2869.1993.tb00059.x
   Wijemanne Subhashie, 2017, Pract Neurol, V17, P444, DOI 10.1136/practneurol-2017-001762
   Wilt TJ, 2013, JAMA INTERN MED, V173, P496, DOI 10.1001/jamainternmed.2013.3733
   Winkelman JW, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx023
   Winkelman JW, 2016, SLEEP MED, V23, P18, DOI 10.1016/j.sleep.2016.05.004
   Wood M, 2015, BRIT J PHARMACOL, V172, P1124, DOI 10.1111/bph.12988
   Yumino D, 2011, AM J CARDIOL, V107, P447, DOI 10.1016/j.amjcard.2010.09.037
   Zou R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003294
NR 77
TC 0
Z9 0
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 18
PY 2018
VL 13
IS 4
AR e0195473
DI 10.1371/journal.pone.0195473
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD1VU
UT WOS:000430290200042
PM 29668694
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Huang, J
   Zhao, ZJ
   AlSmadi, JK
   Liang, XF
   Zhong, FL
   Zeng, T
   Wu, WZ
   Deng, T
   Lai, YC
   Liu, LH
   Zeng, GH
   Wu, WQ
AF Huang, Jian
   Zhao, Zhijian
   AlSmadi, Jad Khaled
   Liang, Xiongfa
   Zhong, Fangling
   Zeng, Tao
   Wu, Weizhou
   Deng, Tuo
   Lai, Yongchang
   Liu, Luhao
   Zeng, Guohua
   Wu, Wenqi
TI Use of the ureteral access sheath during ureteroscopy: A systematic
   review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID STONES; OUTCOMES; QUALITY; BIAS
AB The debate still rages on for the usefulness of ureteral access sheath (UAS). Therefore, a meta-analysis to discuss the effects of applying UAS during ureteroscopy was performed. The protocol for the review is available on PROSPERO (CRD42017052327). A literature search was conducted up to November, 2017 using the Web of science, PUBMED, EMBASE and Cochrane Library. The quality of articles was assessed by the Jadad scale and Newcastle Ottawa Scale (NOS). Egger's test and the trim-and-fill method were used to evaluate publication bias. Effect sizes were calculated by pooled odds ratio (ORs) and mean differences (MDs). Sensitivity analyses and subgroup analyses were performed to explore the origin of heterogeneity. Eight trials with a total of 3099 patients and 3127 procedures were identified. Results showed no significant difference in stone-free rate (SFR) (OR = 0.83, 95% CI 0.52-1.33, P = 0.45), intraoperative complications (OR = 1.16, 95% CI 0.81-7.69, P = 0.88), operative time (MD = 4.09, 95% CI -15.08-23.26, P = 0.68) and hospitalization duration (MD = -0.13, 95% CI -0.32-0.06, P = 0.18). However, the incidence of postoperative complications was higher in UAS group (OR = 1.46, 95% CI 1.06-2.00, P = 0.02). Evidence from meta-analysis indicated that the use of UAS during ureteroscopy did not manifest advantages. However, given the intrinsic restrictions of the quality of selected articles, more randomized controlled trials (RCTs) are warranted to update the findings of this analysis.
C1 [Huang, Jian; Zhao, Zhijian; AlSmadi, Jad Khaled; Liang, Xiongfa; Zhong, Fangling; Zeng, Tao; Wu, Weizhou; Deng, Tuo; Lai, Yongchang; Liu, Luhao; Zeng, Guohua; Wu, Wenqi] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Dept Urol,Minimally Invas Surg Ctr,Guangzhou Inst, Guangzhou, Guangdong, Peoples R China.
   [Liu, Luhao] Guangzhou Med Univ, Affiliated Hosp 2, Dept Organ Transplantat, Guangzhou, Guangdong, Peoples R China.
RP Wu, WQ (reprint author), Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Dept Urol,Minimally Invas Surg Ctr,Guangzhou Inst, Guangzhou, Guangdong, Peoples R China.
EM wwqwml@163.com
RI wu, weizhou/C-2399-2018
OI AlSmadi, Jad/0000-0002-4393-7405
FU National Natural Science Foundation of China [81570633]; Science and
   Technology Planning Project of Guangzhou City, China [201604020001,
   201607010359]; General Guide Project of Guangzhou City Bureau of
   Education [1201410963]
FX This work was financed by The National Natural Science Foundation of
   China (No.81570633); Science and Technology Planning Project of
   Guangzhou City, China (No.201604020001, 201607010359) and General Guide
   Project of Guangzhou City Bureau of Education (No.1201410963). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abrahams HM, 2004, UROL CLIN N AM, V31, P83, DOI 10.1016/S0094-0143(03)00085-5
   Berquet G, 2014, WORLD J UROL, V32, P229, DOI 10.1007/s00345-013-1181-5
   Breda A, 2016, CURR OPIN UROL, V26, P70, DOI 10.1097/MOU.0000000000000233
   Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019
   De Sio M, 2004, UROL INT, V72, P55, DOI 10.1159/000076595
   DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Geraghty RM, 2016, SCAND J UROL, V50, P216, DOI 10.3109/21681805.2015.1121407
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Kaplan AG, 2016, NAT REV UROL, V13, P135, DOI 10.1038/nrurol.2015.271
   Kourambas J, 2001, J UROLOGY, V165, P789, DOI 10.1016/S0022-5347(05)66527-5
   L'Esperance JO, 2005, UROLOGY, V66, P252, DOI 10.1016/j.urology.2005.03.019
   Lallas CD, 2002, J ENDOUROL, V16, P583, DOI 10.1089/089277902320913288
   Lildal SK, 2017, J ENDOUROL, V31, P307, DOI 10.1089/end.2016.0773
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Monga M, 2001, J ENDOUROL, V15, P831, DOI 10.1089/089277901753205843
   Pardalidis NP, 2006, UROL RES, V34, P211, DOI 10.1007/s00240-006-0044-6
   Rehman J, 2003, UROLOGY, V61, P713, DOI 10.1016/S0090-4295(02)02440-8
   Rizkala Emad R, 2013, Indian J Urol, V29, P244, DOI 10.4103/0970-1591.117287
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   TAKAYASU H, 1974, J UROLOGY, V112, P176, DOI 10.1016/S0022-5347(17)59675-5
   Traxer O, 2015, WORLD J UROL, V33, P2137, DOI 10.1007/s00345-015-1582-8
   Traxer O, 2013, J UROLOGY, V189, P580, DOI 10.1016/j.juro.2012.08.197
   Vanlangendonck R, 2004, UROL CLIN N AM, V31, P71, DOI 10.1016/S0094-0143(03)00095-8
   Wang HH, 2011, J UROLOGY, V186, P1728, DOI 10.1016/j.juro.2011.03.072
   Wells GA, NEWCASTLE OTTAWA SCA
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
NR 30
TC 8
Z9 8
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2018
VL 13
IS 2
AR e0193600
DI 10.1371/journal.pone.0193600
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX7ND
UT WOS:000426276000094
PM 29489912
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Vaessen, TSJ
   de Jong, L
   Schafer, AT
   Damen, T
   Uittenboogaard, A
   Krolinski, P
   Nwosu, CV
   Pinckaers, FME
   Rotee, ILM
   Smeets, APW
   Ermis, A
   Kennedy, JL
   Nieman, DH
   Tiwari, A
   van Os, J
   Drukker, M
AF Vaessen, Thomas Stephanus Johannes
   de Jong, Lea
   Schafer, Annika Theresia
   Damen, Thomas
   Uittenboogaard, Aniek
   Krolinski, Pauline
   Nwosu, Chinyere Vicky
   Pinckaers, Florentina Maria Egidius
   Rotee, Iris Leah Marije
   Smeets, Antonius Petrus Wilhelmus
   Ermis, Aysegui
   Kennedy, James L.
   Nieman, Dorien H.
   Tiwari, Arun
   van Os, Jim
   Drukker, Marjan
TI The interaction between cannabis use and the Val158Met polymorphism of
   the COMT gene in psychosis: A transdiagnostic meta - analysis
SO PLOS ONE
LA English
DT Article
ID O-METHYLTRANSFERASE GENE; ULTRA-HIGH-RISK; SUBSTANCE USE; SCHIZOPHRENIA;
   METAANALYSIS; EXPERIENCES; SYMPTOMS; GENOTYPE; ONSET; STATE
AB Background
   Neither environmental nor genetic factors are sufficient to predict the transdiagnostic expression of psychosis. Therefore, analysis of gene-environment interactions may be productive.
   Objective
   A meta-analysis was performed using papers investigating the interaction between cannabis use and catechol-O-methyl transferase (COMT) polymorphism Val158Met (COMTVal158Met).
   Data sources
   PubMed, Embase, PsychInfo.
   Study eligibility criteria
   All observational studies assessing the interaction between COMTVal158Met and cannabis with any psychosis or psychotic symptoms measure as an outcome.
   Study appraisal and synthesis methods
   A meta-analysis was performed using the Meta-analysis of Observational Studies in Epidemiology guidelines and forest plots were generated. Thirteen articles met the selection criteria: 7 clinical studies using a case-only design, 3 clinical studies with a dichotomous outcome, and 3 studies analysing a continuous outcome of psychotic symptoms below the threshold of psychotic disorder. The three study types were analysed separately. Validity of the included studies was assessed using "A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions".
   Results
   For case-only studies, a significant interaction was found between cannabis use and COMTVal158Met, with an OR of 1.45 (95% Confidence Interval = 1.05 +/- 2.00; Met/Met as the risk genotype). However, there was no evidence for interaction in either the studies including dichotomous outcomes (B = -0.51, 95% Confidence Interval -1.72, 0.70) or the studies including continuous outcomes (B = -0.04 95% Confidence Interval -0.16 +/- 0.08).
   Limitation
   A substantial part of the included studies used the case-only design, which has lower validity and tends to overestimate true effects.
   Conclusion
   The interaction term between cannabis use and COMTVal158Met was only statistically significant in the case-only studies, but not in studies using other clinical or non-clinical psychosis outcomes. Future additional high quality studies might change current perspectives, yet currently evidence for the interaction remains unconvincing.
C1 [Vaessen, Thomas Stephanus Johannes; de Jong, Lea; Schafer, Annika Theresia; Damen, Thomas; Uittenboogaard, Aniek; Krolinski, Pauline; Nwosu, Chinyere Vicky; Pinckaers, Florentina Maria Egidius; Rotee, Iris Leah Marije; Smeets, Antonius Petrus Wilhelmus] Maastricht Univ, Student Fac Hlth Med & Life Sci, Maastricht, Netherlands.
   [Ermis, Aysegui] Bakirkoy Mazhar Osman Mental Hlth & Neurol Dis Ed, Dept Psychiat, Istanbul, Turkey.
   [Kennedy, James L.; Tiwari, Arun] Campbell Family Mental Hlth Res Inst, Neurogenet Sect, Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Nieman, Dorien H.] Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands.
   [van Os, Jim; Drukker, Marjan] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands.
   [van Os, Jim] Univ Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Med Ctr, Utrecht, Netherlands.
   [van Os, Jim] Kings Coll London, Kings Hlth Partners Dept Psychosis Studies, London, England.
   [van Os, Jim] Kings Coll London, Inst Psychiat, London, England.
RP Drukker, M (reprint author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Psychol, Maastricht, Netherlands.
EM Marjan.Drukker@MaastrichtUniversity.nl
OI Smeets, Antonius/0000-0003-1868-3631
CR Albert PS, 2001, AM J EPIDEMIOL, V154, P687, DOI 10.1093/aje/154.8.687
   Alemany S, 2014, ACTA PSYCHIAT SCAND, V129, P54, DOI 10.1111/acps.12108
   [Anonymous], 2017, GENETICS MODIFY RESP
   Avramopoulos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116696
   Batalla A, 2014, ADDICT BIOL, V19, P722, DOI 10.1111/adb.12027
   Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4
   Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026
   CHEN JP, 1990, EUR J PHARMACOL, V190, P259
   Costas J, 2011, SCHIZOPHR RES, V127, P22, DOI 10.1016/j.schres.2011.01.014
   De Sousa KR, 2013, SCHIZOPHR RES, V151, P289, DOI 10.1016/j.schres.2013.10.037
   Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ermis A, 2015, IN VIVO, V29, P129
   Estrada G, 2011, ACTA PSYCHIAT SCAND, V123, P485, DOI 10.1111/j.1600-0447.2010.01665.x
   Fadda P, 2006, NEUROREPORT, V17, P1629, DOI 10.1097/01.wnr.0000236853.40221.8e
   Fatjo-Vilas M, 2017, HANDBOOK OF CANNABIS AND RELATED PATHOLOGIES: BIOLOGY, PHARMACOLOGY, DIAGNOSIS, AND TREATMENT, pE29, DOI 10.1016/B978-0-12-800756-3.00031-4
   French L, 2015, JAMA PSYCHIAT, V72, P1002, DOI 10.1001/jamapsychiatry.2015.1131
   Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469
   Goes FS, 2015, AM J MED GENET B, V168, P649, DOI 10.1002/ajmg.b.32349
   Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889
   Green B, 2005, BRIT J PSYCHIAT, V187, P306, DOI 10.1192/bjp.187.4.306
   Gutierrez B, 2009, REV PSIQUIATR SALUD, V2, P89, DOI 10.1016/S1888-9891(09)72250-5
   Harrison PJ, 2015, J PSYCHOPHARMACOL, V29, P85, DOI 10.1177/0269881114553647
   Henquet C, 2009, ACTA PSYCHIAT SCAND, V119, P156, DOI 10.1111/j.1600-0447.2008.01265.x
   Iyegbe C, 2014, SOC PSYCH PSYCH EPID, V49, P169, DOI 10.1007/s00127-014-0823-2
   Jeppesen P, 2015, SCHIZOPHRENIA BULL, V41, P1084, DOI 10.1093/schbul/sbu167
   Kantrowitz JT, 2009, PSYCHIAT QUART, V80, P213, DOI 10.1007/s11126-009-9108-4
   Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13
   Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911
   Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x
   Kuepper R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d738
   Laird NM, 2011, THE FUNDAMENTALS OF
   Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133
   Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626
   Mane A, 2015, PSYCHIAT RES, V229, P70, DOI 10.1016/j.psychres.2015.07.070
   Marcelis M, 1998, PSYCHOL MED, V28, P871, DOI 10.1017/S0033291798006898
   Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007
   Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040
   Nieman DH, 2016, SCHIZOPHR RES, V174, P24, DOI 10.1016/j.schres.2016.03.015
   NIMH, 2015, SCHIZ FACT SHEET
   O'Tuathaigh CMP, 2010, NEUROPSYCHOPHARMACOL, V35, P2262, DOI 10.1038/npp.2010.100
   Pelayo-Teran JM, 2010, PSYCHIAT RES, V179, P291, DOI 10.1016/j.psychres.2009.08.022
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Rognli EB, 2017, J SUBST ABUSE TREAT, V74, P42, DOI 10.1016/j.jsat.2016.12.007
   Russo EB, 2008, J EXP BOT, V59, P4171, DOI 10.1093/jxb/ern260
   Rutigliano G, 2016, J AFFECT DISORDERS, V203, P101, DOI 10.1016/j.jad.2016.05.053
   Simon AE, 2011, SCHIZOPHR RES, V132, P8, DOI 10.1016/j.schres.2011.07.002
   Stata Corporation, 2013, STAT STAT SOFTW REL
   Sterne J, 2014, A COCHRANE RISK OF B
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Trotta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163319
   Tunbridge EM, 2015, J PSYCHOPHARMACOL
   van der Knaap LJ, 2014, GENES BRAIN BEHAV, V13, P618, DOI 10.1111/gbb.12147
   van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814
   van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117
   van Winkel R, 2014, ANNU REV CLIN PSYCHO, V10, P767, DOI 10.1146/annurev-clinpsy-032813-153631
   Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050
   Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8
   Verrico CD, 2003, SYNAPSE, V49, P61, DOI 10.1002/syn.10215
   Vinkers CH, 2013, SCHIZOPHR RES, V150, P303, DOI 10.1016/j.schres.2013.07.020
   Williams HJ, 2007, SCHIZOPHRENIA BULL, V33, P635, DOI 10.1093/schbul/sbm019
   Yang QH, 1997, AM J EPIDEMIOL, V146, P713
   Yung A, 2005, AUST NZ J PSYCHIAT, V39, P67, DOI 10.1111/j.1440-1614.2005.01511.x
   Zammit S, 2007, BRIT J PSYCHIAT, V191, P402, DOI 10.1192/bjp.hp.107.036129
   Zammit S, 2011, BRIT J PSYCHIAT, V199, P380, DOI 10.1192/bjp.bp.111.091421
NR 65
TC 2
Z9 2
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 14
PY 2018
VL 13
IS 2
AR e0192658
DI 10.1371/journal.pone.0192658
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FW3CM
UT WOS:000425183500083
PM 29444152
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Andre, L
   van Vianen, AEM
   Peetsma, TTD
   Oort, FJ
AF Andre, Lucija
   van Vianen, Annelies E. M.
   Peetsma, Thea T. D.
   Oort, Frans J.
TI Motivational power of future time perspective: Meta-analyses in
   education, work, and health
SO PLOS ONE
LA English
DT Article
ID INDIVIDUAL-DIFFERENCES; PHYSICAL-ACTIVITY; SELF-EFFICACY; CONDOM USE;
   BODY-MASS; ACHIEVEMENT MOTIVES; STUDENT MOTIVATION; ACADEMIC DELAY;
   HIGH-SCHOOL; ORIENTATION
AB Future time perspective (FTP) may predict individual attitudes and behaviors. However, FTP research includes different FTP conceptualizations and outcomes which hinder generalizing its findings. To solve the inconsistencies in FTP research and generalize the magnitude of FTP as a driver of motivation and behavior, we conducted the first systematical synthesis of FTP relationships in three crucial life domains. Our meta-analyses of FTP studies in education (k = 28), work (k = 17), and health (k = 32) involved N = 31,558 participants, and used a conceptual model for grouping FTP constructs. To address different outcome types, we applied the Theory of Planned Behavior when coding the studies. FTP relationships with outcomes were small-to-medium, were generalizable across domains, and were strongest when the FTP construct included a mixture of cognition, behavioral intention, and affect and, in education, when the FTP measure was domain specific rather than general. There were cross-cultural differences in FTP-outcome relationships. The strength of the FTP-outcome types relationship varied for attitudes, perceived behavioral control, behavioral intention, and behaviors. The lowest effect sizes were found for FTP predicting actual behaviors in education, work, and health and between FTP and health attitudes. Theoretical implications of the findings and future research directions are discussed.
C1 [Andre, Lucija; Peetsma, Thea T. D.; Oort, Frans J.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands.
   [van Vianen, Annelies E. M.] Univ Amsterdam, Work & Org Psychol, Amsterdam, Netherlands.
RP Andre, L (reprint author), Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands.
EM L.Andre@uva.nl
OI van Vianen, Annelies/0000-0002-3931-0394
FU University of Amsterdam
FX This research is funded by the University of Amsterdam.
CR Abousselam N, 2016, J MENT HEALTH, V25, P176, DOI 10.3109/09638237.2015.1078884
   Adams J, 2012, HEALTH PSYCHOL, V31, P260, DOI 10.1037/a0025790
   Adams J, 2009, BRIT J HEALTH PSYCH, V14, P83, DOI 10.1348/135910708X299664
   Adams J, 2009, HEALTH PSYCHOL, V28, P83, DOI 10.1037/0278-6133.28.1.83
   Adelabu DH, 2008, URBAN EDUC, V43, P347, DOI 10.1177/0042085907311806
   Agnew CR, 1998, J SOC BEHAV PERS, V13, P755
   Ahn S, 2012, REV EDUC RES, V82, P436, DOI 10.3102/0034654312458162
   AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I., 1980, UNDERSTANDING ATTITU
   Ajzen I., 1988, ATTITUDES PERSONALIT
   Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142
   Andretta JR, 2014, PSYCHOL SCHOOLS, V51, P434, DOI 10.1002/pits.21762
   [Anonymous], FUTURE ORIENTATION H
   [Anonymous], 2014, COMPR MET AN VERS
   [Anonymous], 2010, 20 C INT ASS CROSS C
   [Anonymous], 2012, THESIS
   Apostolidis T, 2006, PSYCHOL HEALTH, V21, P571, DOI 10.1080/14768320500422683
   Atkinson JW, 1966, THEORY ACHIEVEMENT M
   Bain PG, 2016, NATURE CLIMATE CHANG, P6
   BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Barber LK, 2009, PERS INDIV DIFFER, V46, P250, DOI 10.1016/j.paid.2008.10.007
   Beenstock J, 2011, EUR J PUBLIC HEALTH, V21, P438, DOI 10.1093/eurpub/ckp225
   Bembenutty H, 2004, EDUC PSYCHOL REV, V16, P35, DOI 10.1023/B:EDPR.0000012344.34008.5c
   Bembenutty H., 2003, ANN M AM ED RES ASS
   Beresneviciene D., 2005, BALTIC J PSYCHOL, V6, P21, DOI DOI 10.1037/E557272013-003
   Bjorgvinsson T, 1999, HLTH SAFETY HABITS F
   Block RA, 1990, COGNITIVE MODELS PSY, P1
   Bluedorn AC, 2002, HUMAN ORG TIME TEMPO
   Boekaerts M., 2000, HDB SELF REGULATION
   Bond MH, 1996, ANNU REV PSYCHOL, V47, P205, DOI 10.1146/annurev.psych.47.1.205
   Borenstein M., 2009, INTRO METAANALYSIS
   Borenstein M, 2009, SOFTWARE INTRODUCTIO, P391
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Bowles T, 1999, J APPL HLTH BEHAV, V1, P1
   Bowles T, 2008, EDUC PSYCHOL-UK, V28, P551, DOI 10.1080/01443410701880134
   Brown W. T., 2004, J BLACK PSYCHOL, V30, P248, DOI [DOI 10.1177/0095798403260727, 10.1177/0095798403260727]
   Burns MJ, 2005, J BLACK PSYCHOL, V31, P172, DOI 10.1177/0095798404268288
   Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488
   CARSTENSEN LL, 1995, CURR DIR PSYCHOL SCI, V4, P151, DOI 10.1111/1467-8721.ep11512261
   Carstensen LL, 1996, FUTURE ORIENTATION S
   Chak HY, 2007, RELATIONSHIP PERCEIV, P40
   Chua LW, 2015, J YOUTH ADOLESCENCE, V44, P2028, DOI 10.1007/s10964-014-0230-8
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Cooper H., 2009, RES SYNTHESIS METAAN
   Cooper H. M., 1998, SYNTHESIZING RESEARC
   Cottle T, 1976, PERCEIVING TIME
   Crockett RA, 2009, PSYCHOL HEALTH, V24, P333, DOI 10.1080/08870440701813030
   D'Argembeau A, 2011, APPL COGNITIVE PSYCH, V25, P96, DOI 10.1002/acp.1647
   Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007
   Davis LE, 2002, J EDUC PSYCHOL, V94, P810, DOI 10.1037//0022-0663.94.4.810
   de Bilde J, 2011, LEARN INSTR, V21, P332, DOI 10.1016/j.learninstruc.2010.03.002
   de Boer BJ, 2011, EUR J PERSONALITY, V25, P349, DOI 10.1002/per.796
   DEVOLDER ML, 1982, J PERS SOC PSYCHOL, V42, P566, DOI 10.1037/0022-3514.42.3.566
   Duangpatra KNK, 2009, J APPL DEV PSYCHOL, V30, P298, DOI 10.1016/j.appdev.2008.12.011
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Elissa ES, 1999, J APPL SOC PSYCHOL, V29, P575
   Eren A, 2012, TEACH TEACH EDUC, V28, P111, DOI 10.1016/j.tate.2011.09.006
   Eren A, 2009, ELECTRON J RES EDUC, V7, P1217
   Eren A, 2010, TEACH TEACH EDUC, V26, P1416, DOI 10.1016/j.tate.2010.05.001
   Ferrari L, 2010, BRIT J GUID COUNS, V38, P61, DOI 10.1080/03069880903408612
   Fieulaine N, 2010, ADDICT BEHAV, V35, P799, DOI 10.1016/j.addbeh.2010.03.022
   Fishbein M., 1975, BELIEF ATTITUDE INTE
   Fishbein M., 2010, PREDICTING CHANGING
   Fong G, 2003, REDUCING ADOLESCENT, P106, DOI DOI 10.4135/9781452233611
   Frank L, 1939, J SOCIAL PHILOS JURI, P292
   Freelon D, 2013, INT J INTERNET SCI, V8, P10
   Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161
   GJESME T, 1983, INT J PSYCHOL, V18, P443, DOI 10.1080/00207598308247493
   GJESME T, 1975, J PSYCHOL, V91, P143, DOI 10.1080/00223980.1975.9915808
   GJESME T, 1979, J PSYCHOL, V101, P173, DOI 10.1080/00223980.1979.9915069
   GREENE AL, 1992, J YOUTH ADOLESCENCE, V21, P667, DOI 10.1007/BF01538738
   Greene BA, 2004, EDUC PSYCHOL REV, V16, P91, DOI 10.1023/B:EDPR.0000026608.50611.b4
   Greenhouse J.B., 1994, HDB RES SYNTHESIS, P383
   Group CCaCR, 2014, HETEROGENEITY AND SU
   Gulley T, 2013, J SCH NURS, V29, P123, DOI 10.1177/1059840512456552
   Gupta R, 2012, CURR PSYCHOL, V31, P195, DOI 10.1007/s12144-012-9136-3
   Guthrie LC, 2013, AM J HEALTH BEHAV, V37, P171, DOI 10.5993/AJHB.37.2.4
   Hall PA, 2003, PSYCHOL HEALTH, V18, P685, DOI 10.1080/0887044031000110447
   Hall PA, EXAMINING ROLE TIME
   Hall PA, 2013, PSYCHOL SPORT EXERC, V14, P50, DOI 10.1016/j.psychsport.2012.07.003
   HALVARI H, 1991, PERCEPT MOTOR SKILL, V72, P367, DOI 10.2466/PMS.72.2.367-381
   Halvari H, 1997, GENET SOC GEN PSYCH, V123, P343
   Heckman CJ, 2009, AM J HEALTH BEHAV, V33, P238, DOI 10.5993/AJHB.33.3.2
   Hedges L. V., 1985, STAT METHODS METAANA
   Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hilpert JC, 2012, JPN PSYCHOL RES, V54, P229, DOI 10.1111/j.1468-5884.2012.00525.x
   Hofstede G., 1980, CULTURES CONSEQUENCE
   Hofstede G., 2010, CULTURES ORG SOFTWAR
   Hofstede G., 2011, ONLINE READINGS PSYC, V2, P26
   Hofstede G., 2001, CULTURES CONSEQUENCE
   Horstmanshof L, 2007, BRIT J EDUC PSYCHOL, V77, P703, DOI 10.1348/000709906X160778
   House JR, 2004, CULTURE LEADERSHIP O
   Husman J, 1999, EDUC PSYCHOL, V34, P113, DOI 10.1207/s15326985ep3402_4
   Husman J., 2014, TIME PERSPECTIVE THE, P287
   Husman J, 2008, LEARN INDIVID DIFFER, V18, P166, DOI 10.1016/j.lindif.2007.08.001
   Janeiro IN, 2006, THESIS, P89
   Janeiro IN, 2010, INT J EDUC VOCAT GUI, V10, P35, DOI 10.1007/s10775-009-9170-3
   Jisc, EFF PRACT DIG AG GUI
   Johnson BT, 2008, SOC PERSONAL PSYCHOL, V2, P817, DOI 10.1111/j.1751-9004.2007.00048.x
   Joireman J, 2008, PERS INDIV DIFFER, V45, P15, DOI 10.1016/j.paid.2008.02.011
   Joireman J, 2012, PERS SOC PSYCHOL B, V38, P1272, DOI 10.1177/0146167212449362
   Kappes HB, 2011, J EXP SOC PSYCHOL, V47, P719, DOI 10.1016/j.jesp.2011.02.003
   Kauffman DF, 2004, EDUC PSYCHOL REV, V16, P1, DOI 10.1023/B:EDPR.0000012342.37854.58
   Kenny ME, 2003, J COUNS PSYCHOL, V50, P142, DOI 10.1037/0022-0167.50.2.142
   Keough KA, 1999, BASIC APPL SOC PSYCH, V21, P149, DOI 10.1207/S15324834BA210207
   King RB, 2015, PSYCHOL ASIAN LEARNE
   Kite M.E., 2008, PSYCHOL WOMEN HDB IS, P205
   Laghi F, 2012, J ADOLESCENCE, V35, P1277, DOI 10.1016/j.adolescence.2012.04.014
   LAMM H, 1976, J PERS SOC PSYCHOL, V34, P317, DOI 10.1037/0022-3514.34.3.317
   Lang FR, 2002, PSYCHOL AGING, V17, P125, DOI 10.1037//0882-7974.17.1.125
   Lee ES, 2015, PSYCHOL BULL, V141, P1049, DOI 10.1037/bul0000012
   Lens W, 2012, JPN PSYCHOL RES, V54, P321, DOI 10.1111/j.1468-5884.2012.00520.x
   Leondari A., 2007, NEW DIRECTIONS ADULT, V114, P17, DOI [10.1002/ace.253, DOI 10.1002/ACE.253]
   Levy B, 2004, ADDICT BEHAV, V29, P181, DOI 10.1016/S0306-4603(03)00073-X
   Lewin K, 1951, FIELD THEORY IN THE
   Lewin K, 1939, AM J SOCIOL, V44, P868, DOI 10.1086/218177
   Lipsey M., 2001, PRACTICAL METAANALYS
   Llewelyn WT, PSYCHOL B, V132, P249
   Locke EA, 2004, ACAD MANAGE REV, V29, P388
   Locke EA, 1990, A THEORY OF GOAL SET
   Loewenstein G, 2003, SER AFFECTIVE SCI, P619
   LOMRANZ J, 1983, INT J PSYCHOL, V18, P407, DOI 10.1080/00207598308247490
   Maddux J. E., 1995, SELF EFFICACY ADAPTA, P3, DOI DOI 10.1007/978-1-4419-6868-5_1
   Mahon NE, 2000, PERCEPT MOTOR SKILL, V90, P166, DOI 10.2466/PMS.90.1.166-168
   Malka A, 2005, CONTEMP EDUC PSYCHOL, V30, P60, DOI 10.1016/j.cedpsych.2004.04.001
   MANDERLINK G, 1984, J PERS SOC PSYCHOL, V47, P918, DOI 10.1037/0022-3514.47.4.918
   Marko KW, 1998, J VOCAT BEHAV, V52, P106, DOI 10.1006/jvbe.1996.1566
   Mazur J. E., 1987, QUANTITATIVE ANAL BE, V5
   McInerney DM, 2004, EDUC PSYCHOL REV, V16, P141, DOI 10.1023/B:EDPR.0000026610.18125.a3
   Mckay MT, 2013, J SUBST USE, V18, P377, DOI 10.3109/14659891.2012.685793
   Mello ZR, 2006, J EDUC GIFTED, V29, P271, DOI 10.1177/016235320602900302
   Mello ZR, 2010, ADOLESCENT TIME PERS
   Milfont TL, 2012, INT J PSYCHOL, V47, P325, DOI 10.1080/00207594.2011.647029
   Morselli D, 2013, CULT PSYCHOL, P19
   Mosher L. S., 2004, IDENTITY INT J THEOR, V4, P187, DOI DOI 10.1207/S1532706XID0402_5
   North MS, 2015, PSYCHOL BULL, V141, P993, DOI 10.1037/a0039469
   NURMI JE, 1989, INT J PSYCHOL, V24, P195, DOI 10.1080/00207594.1989.10600042
   NURMI JE, 1991, DEV REV, V11, P1, DOI 10.1016/0273-2297(91)90002-6
   Nuttin J, 1980, GEDRAG DYNAMISCHE RE
   Nuttin J., 1984, MOTIVATION PLANNING
   Nuttin J., 1985, FUTURE TIME PERSPECT
   Nuttin J. R., 1964, ACTA PSYCHOL, V23, P60, DOI DOI 10.1016/0001-6918(64)90075-7
   OECD, 2000, ED GLANC 2000 OECD I
   OECD, 2013, PISA 2013 ASS AN FRA
   Oettingen G, 2002, J PERS SOC PSYCHOL, V83, P1198, DOI 10.1037//0022-3514.83.5.1198
   Paulhus D. L., 2007, HDB RES METHODS PERS, P224
   Peetsma T, 2005, EUR J PSYCHOL EDUC, V20, P209, DOI 10.1007/BF03173553
   Peetsma T, 2015, S HON WILL LENS EARL
   Peetsma T. T. D., 2000, SCAND J EDUC RES, V44, P177, DOI DOI 10.1080/713696667
   Peetsma T. T. D, 1992, THESIS
   Peetsma T, 2012, JPN PSYCHOL RES, V54, P241, DOI 10.1111/j.1468-5884.2012.00526.x
   Peetsma T, 2011, LEARN INSTR, V21, P481, DOI 10.1016/j.learninstruc.2010.08.001
   Peetsma TTD, 2009, CONT MOTIVATION RES, P299
   Peetsma TTD, 5 EUR C RES LEARN IN
   Peetsma TTD, 1985, METING TOEKOMSTPERSP
   Peetsma TTD, 2008, 11TH INTERNATIONAL C
   Peters BR, 2005, PSYCHOL REP, V96, P817
   Phalet K, 2004, EDUC PSYCHOL REV, V16, P59, DOI 10.1023/B:EDPR.0000012345.71645.d4
   Phan HP, 2009, ELECTRON J RES EDUC, V7, P761
   Ping YD, 2014, ED BLUE BOOK CHINA E
   Pluck G, 2008, J PSYCHOL, V142, P159, DOI 10.3200/JRLP.142.2.159-168
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Polgar M, 2009, J HIV-AIDS SOC SERV, V8, P397, DOI 10.1080/15381500903417646
   RAYNOR JO, 1969, PSYCHOL REV, V76, P606, DOI 10.1037/h0028291
   Rise J, 2008, BRIT J HEALTH PSYCH, V13, P291, DOI 10.1348/135910707X187245
   Robbins RN, 2004, J ADOLESCENT RES, V19, P428, DOI 10.1177/074355840328860
   Rodrigues Nobre AS, 2009, THESIS, P35
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59
   ROSSEEL E, 1989, ADOLESCENCE, V24, P73
   Rothspan S, 1996, HEALTH PSYCHOL, V15, P131, DOI 10.1037/0278-6133.15.2.131
   SAVICKAS ML, 1991, CAREER DEV Q, V39, P315, DOI 10.1002/j.2161-0045.1991.tb00299.x
   SAVICKAS ML, 1984, J VOCAT BEHAV, V25, P258, DOI 10.1016/0001-8791(84)90049-6
   Scammacca N, 2014, REV EDUC RES, V84, P328, DOI 10.3102/0034654313500826
   SCHMITT N, 1994, J ORGAN BEHAV, V15, P393, DOI 10.1002/job.4030150504
   Schuitema J, 2014, J EDUC RES, V107, P467, DOI 10.1080/00220671.2013.836467
   Schultz DM, 2010, WEATHER CLIM SOC, V2, P249, DOI 10.1175/2010WCAS1067.1
   SCHUNK DH, 1991, EDUC PSYCHOL, V26, P207, DOI 10.1207/s15326985ep2603&4_2
   Schwartz S. H., 1994, INDIVIDUALISM COLLEC, P85
   Seginer R, 2004, PSYCHOL WOMEN QUART, V28, P122, DOI 10.1111/j.1471-6402.2004.00129.x
   Seginer R, 2009, FUTURE ORIENTATION D, pxviii
   Seginer R, 2014, IME PERSPECTIVE ORY, P287
   Seginer R, 1999, FUTURE ORIENTATION Q
   Seijts GH, 1998, J PSYCHOL, V132, P154, DOI 10.1080/00223989809599156
   Seligman MEP, 2013, PERSPECT PSYCHOL SCI, V8, P119, DOI 10.1177/1745691612474317
   Sevincer AT, 2014, PSYCHOL SCI, V25, P1010, DOI 10.1177/0956797613518350
   Shell DF, 2001, CONTEMP EDUC PSYCHOL, V26, P481, DOI 10.1006/ceps.2000.1073
   Shipp AJ, 2009, ORGAN BEHAV HUM DEC, V110, P1, DOI 10.1016/j.obhdp.2009.05.001
   Shipp AJ, DATA SET UNPUB
   Shirai T, 2013, INT J EDUC VOCAT GUI, V13, P95, DOI 10.1007/s10775-013-9241-3
   Simons J, 2003, J SPORT EXERCISE PSY, V25, P145, DOI 10.1123/jsep.25.2.145
   Sircova A., 2015, TIME PERSPECTIVE THE, P169
   Sircova A, 2014, SAGE OPEN, V4, DOI 10.1177/2158244013515686
   SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570
   Stachowski AA, 2011, THESIS
   Stolarski M., 2014, TIME PERSPECTIVE THE
   STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742
   Strauss K, 2012, J APPL PSYCHOL, V97, P580, DOI 10.1037/a0026423
   Szpunar KK, 2014, P NATL ACAD SCI USA, V111, P18414, DOI 10.1073/pnas.1417144111
   Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350
   Taber BJ, 2013, J CAREER ASSESSMENT, V21, P200, DOI 10.1177/1069072712466722
   Taylor SE, 1998, AM PSYCHOL, V53, P429, DOI 10.1037/0003-066X.53.4.429
   TEAHAN JE, 1958, J ABNORM SOC PSYCH, V57, P379, DOI 10.1037/h0042296
   TROMMSDORFF G, 1979, J YOUTH ADOLESCENCE, V8, P131, DOI 10.1007/BF02087616
   TROMMSDORFF G, 1983, INT J PSYCHOL, V18, P381, DOI 10.1080/00207598308247489
   Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963
   van Beek J, 2013, PERS INDIV DIFFER, V54, P785, DOI 10.1016/j.paid.2012.12.015
   Van Boven L, 2007, J EXP PSYCHOL GEN, V136, P289, DOI 10.1037/0096-3445.136.2.289
   van de Bongardt D, 2015, PERS SOC PSYCHOL REV, V19, P203, DOI 10.1177/1088868314544223
   Wakslak CJ, 2008, J PERS SOC PSYCHOL, V95, P757, DOI 10.1037/a0012939
   Walker TL, 2012, J VOCAT BEHAV, V81, P150, DOI 10.1016/j.jvb.2012.06.002
   Watson SJ, 2017, PERS INDIV DIFFER, V106, P57, DOI 10.1016/j.paid.2016.10.023
   Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249
   Worrell FC, 2007, EDUC PSYCHOL MEAS, V67, P487, DOI 10.1177/0013164406296985
   Zaleski Z., 1994, PSYCHOL FUTURE ORIEN
   ZEBARDAST A, 2011, PROC D SOC BEHAV, V30
   Zimbardo P. G., 2008, THE TIME PARADOX
   Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271
   Zimmerman BJ, HANDBOOK OF SELF REG
NR 222
TC 3
Z9 4
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 24
PY 2018
VL 13
IS 1
AR e0190492
DI 10.1371/journal.pone.0190492
PG 45
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT8OQ
UT WOS:000423412500015
PM 29364917
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Guo, HW
   Yuan, TZ
   Chen, JX
   Zheng, Y
AF Guo, Hui-Wen
   Yuan, Tang-Zhan
   Chen, Jia-Xi
   Zheng, Yang
TI Prognostic value of pretreatment albumin/globulin ratio in digestive
   system cancers: A meta-analysis
SO PLOS ONE
LA English
DT Article
ID TO-GLOBULIN RATIO; PREOPERATIVE ALBUMIN; COLORECTAL-CANCER; PUBLICATION
   BIAS; CELL CARCINOMA; SERUM GLOBULIN; SURVIVAL; INFLAMMATION; MORTALITY;
   RESECTION
AB The albumin/globulin ratio (AGR) has been widely reported to be a potential predictor of prognosis in digestive system cancers (DSCs), but convincing conclusions have not been made. Therefore, herein, we performed a meta-analysis of relevant studies regarding this topic to evaluate the prognostic value of AGR in patients with DSCs. Three databases, including PubMed, EMBase, and Web of science, were searched comprehensively for eligible studies through September 8, 2017. The outcomes of interest included overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS). In our meta-analysis, pooled analysis of 13 studies with 9269 patients showed that a low AGR was significantly correlated with poor OS (HR = 1.94; 95% CI: 1.57 +/- 2.38; P < 0.001). Five studies with 6538 participants involved DFS, and our pooled analysis of these studies also demonstrated that there was a significant association of a low AGR with worse DFS (HR = 1.49; 95% CI: 1.10 to 2.00; P < 0.001). In addition, only 2 studies referred to CSS, and we also detected a significant relationship between a low AGR and worse CSS from the results of our meta-analysis. In summary, a low pretreatment AGR was related to unfavorable survival in human digestive system cancers. A low pretreatment AGR may be a useful predictive prognostic biomarker in human digestive system cancers.
C1 [Guo, Hui-Wen; Yuan, Tang-Zhan; Chen, Jia-Xi; Zheng, Yang] Nan Chang Univ, Affiliated Hosp 4, Dept Gen Surg, Nanchang, Jiangxi, Peoples R China.
RP Zheng, Y (reprint author), Nan Chang Univ, Affiliated Hosp 4, Dept Gen Surg, Nanchang, Jiangxi, Peoples R China.
EM dryangz@126.com
OI Zheng, Yang/0000-0002-5304-1928
CR Azab B, VALUE PRETREATMENT A
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Boonpipattanapong T, 2006, J CLIN GASTROENTEROL, V40, P592, DOI 10.1097/00004836-200608000-00006
   Chen J, 2016, TUMOR BIOL, V37, P3905, DOI 10.1007/s13277-015-3778-3
   Chen Z, 2017, ONCOTARGET, V8, P48291, DOI 10.18632/oncotarget.15162
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611
   Fujii T, 2012, NUTR CANCER, V64, P1169, DOI 10.1080/01635581.2012.718034
   Fujikawa H, PROGNOSTIC IMPACT PR, P1791
   Heys SD, 1998, J ROY COLL SURG EDIN, V43, P163
   Isik A, 2014, MINERVA CHIR, V69, P147
   Li Q, HIGH PREOPERATIVE SE, P2156
   Li QG, 2015, AM J CANCER RES, V5, P2856
   Li XH, 2017, J CANCER, V8, P1833, DOI 10.7150/jca.19062
   Li Y, NOMOGRAMS PREDICTING, P1097
   Li YQ, 2016, INT J CANCER, V139, P220, DOI 10.1002/ijc.30071
   Lin Q, 2017, CURR RES TRANSL MED, V65, P83, DOI 10.1016/j.retram.2017.06.002
   Liu JJ, 2017, ONCOTARGETS THER, V10, P2155, DOI 10.2147/OTT.S99282
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Mao MJ, CLIN SIGNIFICANCE PR, P2314
   Oki S, 2017, AM J SURG
   Shibutani M, PRETREATMENT ALBUMIN, P1471
   Siddiqui A, 2007, AM J SURG, V194, P362, DOI 10.1016/j.amjsurg.2007.02.007
   Siegel RL, 2015, CANC STAT, P1542
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Toiyama Y, 2017, AM J SURG, V213, P120, DOI 10.1016/j.amjsurg.2016.05.012
   Wu J, POOR PROGNOSIS HEXOK, P1949
   Xu J, 2017, J GASTROEN HEPATOL, V32, P1394, DOI 10.1111/jgh.13676
   Zhang F, 2016, ONCOTARGET, V7, P30550, DOI 10.18632/oncotarget.8868
   Zhang JH, 2016, J BUON, V21, P925
NR 31
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 4
PY 2018
VL 13
IS 1
AR e0189839
DI 10.1371/journal.pone.0189839
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR7HZ
UT WOS:000419239900008
PM 29300750
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU del-Pino-Casado, R
   Frias-Osuna, A
   Palomino-Moral, PA
   Ruzafa-Martinez, M
   Ramos-Morcillo, AJ
AF del-Pino-Casado, Rafael
   Frias-Osuna, Antonio
   Palomino-Moral, Pedro A.
   Ruzafa-Martinez, Maria
   Ramos-Morcillo, Antonio J.
TI Social support and subjective burden in caregivers of adults and older
   adults: A meta-analysis
SO PLOS ONE
LA English
DT Article
ID TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FAMILY CAREGIVERS; INFORMAL
   CAREGIVERS; PUBLICATION BIAS; ALZHEIMERS-DISEASE; PERCEIVED BURDEN;
   MENTAL-HEALTH; NURSING-HOME; DEMENTIA
AB Background & para;& para;Despite the generally accepted belief that social support improves caregiver adjustment in general and subjective burden in particular, the literature shows mixed findings, and a recent review concluded that the predictive strength of caregiver social support in determining caregiver burden is less evident, due to the conceptual diversity of this determinant.& para;& para;Objective & para;& para;The purpose of this review is to analyse the relationship of perceived and received social support with subjective burden among informal caregivers of an adult or older adult.& para;& para;Methods & para;& para;A systematic search was carried out up to September 2017 in the following databases: MEDLINE (PubMed), CINAHL, EMBASE, PsycINFO), Scopus and ISI Proceedings, and a meta-analysis was performed with the results of the selected and included studies.& para;& para;Results & para;& para;Fifty-six studies were included in the meta-analysis, which provided 46 independent comparisons for perceived support and 16 for received support. Most of these studies were cross-sectional. There was a moderate, negative association of perceived social support on subjective burden (r =-0.36; CI 95%=-0.40,-0.32) and a very small, negative association of received support on subjective burden (r =-0.05; CI 95%=-0.095,-0.001). & para;& para;Conclusions & para;& para;1) perceived and received support are not redundant constructs, 2) the relationships between social support and subjective burden depend on whether the social support is measured as perceived or received, 3) the relationship of perceived social support with subjective burden has a bigger effect size than that of received social support, the relation between received support and subjective burden being clinically irrelevant, 4) perceived social support may be a good predictor of subjective burden.& para;& para;Implications of key findings & para;& para;Our findings broadly support interventions promoting social support in caregivers to prevent or alleviate subjective burden, and specifically, to intervene on the promotion of perceived social support more than on the promotion of received social support when preventing or alleviating burden.& para;& para;Implications of key findings & para;& para;Our findings broadly support interventions promoting social support in caregivers to prevent or alleviate subjective burden, and specifically, to intervene on the promotion of perceived social support more than on the promotion of received social support when preventing or alleviating burden.
C1 [del-Pino-Casado, Rafael; Frias-Osuna, Antonio; Palomino-Moral, Pedro A.] Univ Jaen, Fac Hlth Sci, Dept Nursing, Jaen, Spain.
   [Ruzafa-Martinez, Maria; Ramos-Morcillo, Antonio J.] Univ Murcia, Fac Nursing, Dept Nursing, Murcia, Spain.
RP del-Pino-Casado, R (reprint author), Univ Jaen, Fac Hlth Sci, Dept Nursing, Jaen, Spain.
EM rdelpino@ujaen.es
RI Ramos-Morcillo, Antonio Jesus/J-2195-2016; del-Pino-Casado,
   Rafael/L-3733-2018
OI Ramos-Morcillo, Antonio Jesus/0000-0002-3490-3326; Ruzafa-Martinez,
   Maria/0000-0001-6570-738X; del-Pino-Casado, Rafael/0000-0003-2263-2415
CR Adriaansen JJE, 2011, PATIENT EDUC COUNS, V85, pE48, DOI 10.1016/j.pec.2010.12.011
   Alvarez-Ude F, 2004, J NEPHROL, V17, P841
   Aneshensel CS, 1995, PROFILES CAREGIVING
   Annisa F, 2015, THAI PHARM HLTH SCI, V10, P87
   Artaso B., 2003, Revista Espanola de Geriatria y Gerontologia, V38, P212
   Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   Bainbridge D, 2009, AGING MENT HEALTH, V13, P537, DOI 10.1080/13607860802607322
   Barrera Jr M., 1983, CONNECTIONS, V3, P8
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Blake H, 2000, CLIN REHABIL, V14, P307, DOI 10.1191/026921500667530134
   Boyle M. H., 1998, EVID BASED MENT HLTH, V1, P37, DOI DOI 10.1136/EBMH.1.2.37
   Burton Allison M, 2008, Palliat Support Care, V6, P149, DOI 10.1017/S1478951508000230
   Carretero S, 2009, ARCH GERONTOL GERIAT, V49, P74, DOI 10.1016/j.archger.2008.05.004
   Cassidy T, 2013, PSYCHOL HEALTH, V28, P250, DOI 10.1080/08870446.2012.717623
   Chang BL, 2001, WOMEN HEALTH, V33, P39, DOI 10.1300/J013v33n01_04
   Cheng ST, 2013, GERONTOLOGIST, V53, P998, DOI 10.1093/geront/gns195
   Chiou CJ, 2009, ARCH GERONTOL GERIAT, V48, P419, DOI 10.1016/j.archger.2008.04.001
   CLAIR JM, 1995, SOCIOL PERSPECT, V38, P195, DOI 10.2307/1389290
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310
   Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676
   Cooper C, 2007, INT PSYCHOGERIATR, V19, P175, DOI 10.1017/S1041610206004297
   Cooper H, 2009, HDB RES SYNTHESIS ME
   Cotelo Natalia Verez, 2015, Pharm Pract (Granada), V13, P521
   Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008
   Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291
   del-Pino-Casado R, 2014, J NURS SCHOLARSHIP, V46, P176, DOI 10.1111/jnu.12070
   del-Pino-Casado R, 2011, J ADV NURS, V67, P2311, DOI 10.1111/j.1365-2648.2011.05725.x
   Dorfman LT, 1996, FAM RELAT, V45, P46, DOI 10.2307/584769
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Edwards Nancy E, 2002, J Neurosci Nurs, V34, P184
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elvish R, 2013, PSYCHOL INTERVENTION
   FOLKMAN S, 1994, J CONSULT CLIN PSYCH, V62, P746, DOI 10.1037/0022-006X.62.4.746
   Gallart A, 2013, J ADV NURS, V69, P642, DOI 10.1111/j.1365-2648.2012.06049.x
   Gold DP, 1995, INT J AGING HUM DEV, V41, P183, DOI 10.2190/RGYJ-5KA2-7THX-7BQ5
   Goldsworthy B, 2008, J GERONTOL B-PSYCHOL, V63, pP372, DOI 10.1093/geronb/63.6.P372
   Goris S, 2016, HOLIST NURS PRACT, V30, P227, DOI 10.1097/HNP.0000000000000153
   Gottlieb BH, 2010, J PSYCHOSOM RES, V69, P511, DOI 10.1016/j.jpsychores.2009.10.001
   Greenberger H, 2003, J ADV NURS, V41, P332, DOI 10.1046/j.1365-2648.2003.02531.x
   Greene MC, 2013, AIDS BEHAV, V17, P1775, DOI 10.1007/s10461-012-0396-6
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011
   Hanks RA, 2007, NEUROREHABILITATION, V22, P43
   Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674
   Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316
   Kahriman Fatma, 2015, Asian Pac J Cancer Prev, V16, P3313
   Kaur N, 2014, DELHI PSYCHIAT J, V17, P337
   Kim H, 2012, J ADV NURS, V68, P846, DOI 10.1111/j.1365-2648.2011.05787.x
   Kruithof WJ, 2016, PATIENT EDUC COUNS, V99, P1632, DOI 10.1016/j.pec.2016.04.007
   Lazarus RS, 1984, STRESS APPRAISAL COP
   LECHNER VM, 1993, SOC WORK, V38, P461
   Leibach G, 2013, EXAMINING RELATIONS
   Liu Y, 2012, NURS RES, V61, P39, DOI 10.1097/NNR.0b013e31823bc451
   Lopez S. R., 2005, ENFERMERIA COMUNITAR, V1, P12
   Losada A, 2010, AGING MENT HEALTH, V14, P193, DOI 10.1080/13607860903167838
   Losada A, 2010, ARCH GERONTOL GERIAT, V50, P347, DOI 10.1016/j.archger.2009.06.001
   Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503
   Majerovitz SD, 2007, AGING MENT HEALTH, V11, P323, DOI 10.1080/13607860600963380
   Manso Martínez Mª Esperanza, 2013, Clínica y Salud, V24, P37, DOI 10.5093/cl2013a5
   Marwit SJ, 2002, GERONTOLOGIST, V42, P751, DOI 10.1093/geront/42.6.751
   Meader N, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-82
   Meiland FJM, 2001, SCAND J PUBLIC HEALT, V29, P113, DOI 10.1177/14034948010290020801
   Melrose KL, 2015, PERS INDIV DIFFER, V77, P97, DOI 10.1016/j.paid.2014.12.047
   Moller-Leimkuhler AM, 2012, EUR ARCH PSY CLIN N, V262, P157, DOI 10.1007/s00406-011-0215-5
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Molina J. M., 2005, PSICOLOGIA SALUD, V15, P33
   Moral Serrano M S, 2003, Aten Primaria, V32, P77, DOI 10.1157/13049173
   Bermejo LM, 2015, REV ROL ENFERM, V38, P852
   Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112
   Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250
   Prati G, 2010, J COMMUNITY PSYCHOL, V38, P403, DOI 10.1002/jcop.20371
   REIS MF, 1994, INT J AGING HUM DEV, V39, P257, DOI 10.2190/6LYN-YFWQ-P87D-MKWX
   Riemsma RP, 1999, PSYCHOL HEALTH, V14, P773, DOI 10.1080/08870449908407347
   Robinson K M, 1990, Sch Inq Nurs Pract, V4, P189
   Rodakowski J, 2012, ARCH PHYS MED REHAB, V93, P2229, DOI 10.1016/j.apmr.2012.07.004
   Roe B, 2007, REVIEWING RESEARCH EVIDENCE FOR NURSING PRACTICE: SYSTEMATIC REVIEWS, P9, DOI 10.1002/9780470692127.ch2
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Ryan KA, 2012, DEMENT GERIATR COGN, V34, P206, DOI 10.1159/000339955
   SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127
   Schoenmakers B, 2010, MATURITAS, V66, P191, DOI 10.1016/j.maturitas.2010.02.009
   Shieh SC, 2012, J NURS SCHOLARSHIP, V44, P223, DOI 10.1111/j.1547-5069.2012.01453.x
   Smerglia VL, 2007, AGING MENT HEALTH, V11, P205, DOI 10.1080/13607860600844515
   Son Gwi-Ryung, 2003, J Gerontol Nurs, V29, P19
   SPAID WM, 1994, J GERONTOL SOC WORK, V21, P197
   Stevens LF, 2013, AM J PHYS MED REHABI
   STOMMEL M, 1990, J AGING HEALTH, V2, P81, DOI DOI 10.1177/089826439000200106
   Tang Y, 2006, OBLIGATION FILIAL PI
   Teixeira RJ, 2013, PSYCHO-ONCOLOGY, V22, P1587, DOI 10.1002/pon.3173
   THOMPSON EH, 1993, J GERONTOL, V48, pS245, DOI 10.1093/geronj/48.5.S245
   Uchino BN, 2012, SOC SCI MED, V74, P949, DOI 10.1016/j.socscimed.2011.11.023
   van der Lee J, 2014, AGEING RES REV, V15, P76, DOI 10.1016/j.arr.2014.03.003
   Verbakel E, 2016, CAREGIVING OLDER ADU
   Viswanathan M, 2013, ASSESSING RISK BIAS
   Vrabec N J, 1997, Image J Nurs Sch, V29, P383, DOI 10.1111/j.1547-5069.1997.tb01062.x
   Wang Hsiu-Hung, 2003, Kaohsiung Journal of Medical Sciences, V19, P345
   Wang Li-Chieh, 2011, Hu Li Za Zhi, V58, P54
   Wittenberg-Lyles E, 2014, HEALTH COMMUN, V29, P901, DOI 10.1080/10410236.2013.815111
   Yuksel MM, 2013, WELL BEING SIBLINGS
   Yurtsever S., 2013, J NURSING ED PRACTIC, V3, P1, DOI DOI 10.5430/JNEP.V3N9P1
   ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649
   Zegwaard MI, 2011, J CLIN NURS, V20, P2233, DOI 10.1111/j.1365-2702.2010.03524.x
NR 101
TC 1
Z9 1
U1 2
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 2
PY 2018
VL 13
IS 1
AR e0189874
DI 10.1371/journal.pone.0189874
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR5JA
UT WOS:000419101600038
PM 29293522
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, BJ
   Zhang, YC
   Wang, XB
   Hu, TT
   Li, J
   Geng, J
AF Wang, Bingjian
   Zhang, Yanchun
   Wang, Xiaobing
   Hu, Tingting
   Li, Ju
   Geng, Jin
TI Off-hours presentation is associated with short-term mortality but not
   with long-term mortality in patients with ST-segment elevation
   myocardial infarction: A meta-analysis
SO PLOS ONE
LA English
DT Article
ID PERCUTANEOUS CORONARY INTERVENTION; IN-HOSPITAL MORTALITY; WEEKEND;
   TIME; OUTCOMES; ADMISSION; WEEKDAY; IMPACT; CARE; BIAS
AB Background
   The association between off-hours presentation and mortality in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear. We performed a meta-analysis to assess the impact of off-hours presentation on short-and long-term mortality among STEMI patients.
   Methods
   We searched PubMed, EMBASE, and the Cochrane Library from their inception to 10 July 2016. Studies were eligible if they evaluated the relationship of off-hours (weekend and/or night) presentation with short-and/or long-term mortality.
   Results
   A total of 30 studies with 33 cohorts involving 192,658 STEMI patients were included. Offhours presentation was associated with short-term mortality (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.02-1.12, P = 0.004) but not with long-term mortality (OR 1.00, 95% CI 0.94-1.07, P = 0.979). No significant heterogeneity was observed. The outcomes remained the same after sensitivity analyses and trim and fill analyses. Subgroup analyses showed that STEMI patients undergoing primary percutaneous coronary intervention do not have a higher risk of short-term mortality (OR 1.061, 95% CI 0.993-1.151). In addition, higher mortality was observed only during hospitalization (OR 1.072, 95% CI 1.022-1.125), not at the 30-day, 1-year or long-term follow-ups.
   Conclusions
   Off-hours presentation was associated with an increase in short-term mortality, but not longterm mortality, among STEMI patients. Clinical approaches to decrease short-term mortality regardless of the time of presentation should be evaluated in future studies.
C1 [Wang, Bingjian; Hu, Tingting; Geng, Jin] Nanjing Med Univ, Huaian First Peoples Hosp, Dept Cardiol, Huaian, Jiangsu, Peoples R China.
   [Zhang, Yanchun] Xuzhou Med Univ, Affiliated Huaian Hosp, Huaian Second Peoples Hosp, Dept Cardiol, Huaian, Jiangsu, Peoples R China.
   [Wang, Xiaobing] Yangzhou Univ, Taizhou Second Peoples Hosp Affiliated, Dept Nephrol, Taizhou, Jiangsu, Peoples R China.
   [Li, Ju] Nanjing Med Univ, Huaian First Peoples Hosp, Dept Rheumatol, Huaian, Jiangsu, Peoples R China.
RP Geng, J (reprint author), Nanjing Med Univ, Huaian First Peoples Hosp, Dept Cardiol, Huaian, Jiangsu, Peoples R China.
EM gj885258@163.com
OI Geng, Jin/0000-0001-9336-9349
CR Abi Rafeh Nidal, 2009, J Healthc Qual, V31, P35
   Ahmar W, 2008, INTERN MED J, V38, P714, DOI 10.1111/j.1445-5994.2007.01476.x
   Al Faleh HF, 2012, ANN SAUDI MED, V32, P366, DOI 10.5144/0256-4947.2012.366
   Albuquerque Gustavo Oliveira de, 2009, Rev. Bras. Cardiol. Invasiva, V17, P52, DOI 10.1590/S2179-83972009000100011
   Aldridge C, 2016, LANCET
   Evangelista PA, 2008, ARQ BRAS CARDIOL, V90, P130, DOI 10.1590/S0066-782X2008000200009
   Assali AR, 2006, CATHETER CARDIO INTE, V67, P221, DOI 10.1002/ccd.20608
   Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376
   Beohar N, 2001, J Invasive Cardiol, V13, P669
   Black N., 2016, LANCET
   Blecker S, 2015, J GEN INTERN MED, V30, P1657, DOI 10.1007/s11606-015-3330-6
   Borenstein M., 2009, INTRO METAANALYSIS
   Cardoso Cristiano de Oliveira, 2010, Rev. Bras. Cardiol. Invasiva, V18, P273, DOI 10.1590/S2179-83972010000300008
   Cubeddu RJ, 2013, AM J CARDIOL, V111, P946, DOI 10.1016/j.amjcard.2012.11.062
   Cubeddu RJ, 2009, J INVASIVE CARDIOL, V21, P518
   de Boer SPM, 2012, EUR HEART J-ACUTE CA, V1, P33, DOI 10.1177/2048872612441581
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Garceau P, 2007, CAN J CARDIOL, V23, p53B, DOI 10.1016/S0828-282X(07)71011-5
   Geng J, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006784
   Geng J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004093
   Gyenes GT, 2013, CAN J CARDIOL, V29, P1429, DOI 10.1016/j.cjca.2013.04.035
   Hannan EL, 2010, AM J CARDIOL, V106, P143, DOI 10.1016/j.amjcard.2010.02.029
   Hansen KW, 2013, INT J CARDIOL, V168, P1167, DOI 10.1016/j.ijcard.2012.11.071
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hong JS, 2010, CIRC J, V74, P496, DOI 10.1253/circj.CJ-09-0678
   Isogai T, 2015, INT J CARDIOL, V179, P315, DOI 10.1016/j.ijcard.2014.11.070
   Jneid H, 2008, CIRCULATION, V117, P2502, DOI 10.1161/CIRCULATIONAHA.107.752113
   Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355
   Kruth P, 2008, CLIN RES CARDIOL, V97, P742, DOI 10.1007/s00392-008-0671-8
   Kumar G, 2015, J AM COLL CARDIOL, V65, P217, DOI 10.1016/j.jacc.2014.09.083
   Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803
   Maier B, 2010, CLIN RES CARDIOL, V99, P565, DOI 10.1007/s00392-010-0158-2
   McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072
   Noman A, 2012, EUR HEART J, V33, P3046, DOI 10.1093/eurheartj/ehs261
   Rathod KS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003063
   Rathore SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1807
   Snelder SM, 2013, INT J CARDIOL, V168, P1576, DOI 10.1016/j.ijcard.2013.01.053
   Sorita A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7393
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
NR 41
TC 0
Z9 0
U1 3
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 28
PY 2017
VL 12
IS 12
AR e0189572
DI 10.1371/journal.pone.0189572
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FR4KF
UT WOS:000419033400013
PM 29284008
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Stratton, E
   Lampit, A
   Choi, I
   Calvo, RA
   Harvey, SB
   Glozier, N
AF Stratton, Elizabeth
   Lampit, Amit
   Choi, Isabella
   Calvo, Rafael A.
   Harvey, Samuel B.
   Glozier, Nicholas
TI Effectiveness of eHealth interventions for reducing mental health
   conditions in employees: A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL;
   STRESS-MANAGEMENT; FOLLOW-UP; WORK; DEPRESSION; WORKPLACE; DISORDERS;
   EFFICACY; PSYCHOEDUCATION
AB Background
   Many organisations promote eHealth applications as a feasible, low-cost method of addressing mental ill-health and stress amongst their employees. However, there are good reasons why the efficacy identified in clinical or other samples may not generalize to employees, and many Apps are being developed specifically for this group. The aim of this paper is to conduct the first comprehensive systematic review and meta-analysis evaluating the evidence for the effectiveness and examine the relative efficacy of different types of eHealth interventions for employees.
   Methods
   Systematic searches were conducted for relevant articles published from 1975 until November 17, 2016, of trials of eHealth mental health interventions (App or web-based) focused on the mental health of employees. The quality and bias of all identified studies was assessed. We extracted means and standard deviations from published reports, comparing the difference in effect sizes (Hedge's g) in standardized mental health outcomes. We meta-analysed these using a random effects model, stratified by length of follow up, intervention type, and whether the intervention was universal (unselected) or targeted to selected groups e.g. "stressed".
   Results
   23 controlled trials of eHealth interventions were identified which overall suggested a small positive effect at both post intervention (g = 0.24, 95% CI 0.13 to 0.35) and follow up (g = 0.23, 95% CI 0.03 to 0.42). There were differential short term effects seen between the intervention types whereby Mindfulness based interventions (g = 0.60, 95% CI 0.34 to 0.85, n = 6) showed larger effects than the Cognitive Behaviour Therapy (CBT) based (g = 0.15, 95% CI 0.02 to 0.29, n = 11) and Stress Management based (g = 0.17, 95% CI -0.01 to 0.34, n = 6) interventions. The Stress Management interventions however differed by whether delivered to universal or targeted groups with a moderately large effect size at both post-intervention (g = 0.64, 95% CI 0.54 to 0.85) and follow-up (g = 0.69, 95% CI 0.06 to 1.33) in targeted groups, but no effect in unselected groups.
   Interpretation
   There is reasonable evidence that eHealth interventions delivered to employees may reduce mental health and stress symptoms post intervention and still have a benefit, although reduced at follow-up. Despite the enthusiasm in the corporate world for such approaches, employers and other organisations should be aware not all such interventions are equal, many lack evidence, and achieving the best outcomes depends upon providing the right type of intervention to the correct population.
C1 [Stratton, Elizabeth; Choi, Isabella; Glozier, Nicholas] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Sydney, NSW, Australia.
   [Lampit, Amit] Univ Sydney, Sch Psychiat, Sydney, NSW, Australia.
   [Calvo, Rafael A.] Univ Sydney, Sch Elect & Informat Engn, Sydney, NSW, Australia.
   [Harvey, Samuel B.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia.
   [Harvey, Samuel B.] Black Dog Inst, Sydney, NSW, Australia.
   [Harvey, Samuel B.] St George Hosp, Sydney, NSW, Australia.
RP Stratton, E (reprint author), Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Sydney, NSW, Australia.
EM eodg5192@uni.sydney.edu.au
RI Choi, Isabella/J-3156-2019
OI Choi, Isabella/0000-0001-6033-1563; Glozier, Nick/0000-0002-0476-9146;
   Stratton, Elizabeth/0000-0003-0699-7588; Lampit,
   Amit/0000-0001-6522-8397
FU NHMRC-ARC Dementia Research Development Fellowship; Australian Research
   Council Future Fellowship
FX ES, IC, SH & NG are supported in partnership with beyondblue with
   donations from the Movember Foundation. AL is supported by NHMRC-ARC
   Dementia Research Development Fellowship. RAC is funded by an Australian
   Research Council Future Fellowship.
CR Abbott J-A, 2009, ELECT J APPL PSYCHOL, V5, P89, DOI DOI 10.7790/EJAP.V5I1.145
   Ahthes E, 2016, POCKET PSYCHIAT NATU, V532
   Ahtinen A, 2013, JMIR MHEALTH UHELATH, V1
   Aikens K, 2014, JOEM, V56
   Allexandre D, 2016, JOEM, V58
   Andersson G, 2009, COGNITIVE BEHAV THER, V38, P4
   Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151
   Andersson G, 2013, J AFFECT DISORDERS, V151, P986, DOI 10.1016/j.jad.2013.08.022
   Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196
   Billings DW, 2008, J OCCUP ENVIRON MED, V50, P960, DOI 10.1097/JOM.0b013e31816c435b
   Birgit W, 2013, J AFFECTIVE DISORDER
   Birney A, 2016, JMIR MHEALTH UHELATH, V4
   Black C., 2008, D C BLACKS REV HLTH
   Boiler L, 2014, INTERNET INTERV, V1, P196, DOI DOI 10.1016/J.INVENT.2014.10.002
   Borness C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059982
   Brunton G, 2016, DEV EVIDENCE INFORME
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cook RF, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e17
   Cook RF, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3399
   Deady M, 2017, BMC PSYCHIATRY, P17
   Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377
   Dunning M, 2014, EMPLOYEE ASSISTANCE
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ebert DD, 2014, SCAND J WORK ENV HEA, V40, P582, DOI 10.5271/sjweh.3449
   Eisen KP, 2008, COMPUT HUM BEHAV, V24, P486, DOI 10.1016/j.chb.2007.02.003
   Flanagan P, 2011, EAP COUNSELLING OUTC
   Geraedts A, 2014, J MED INTERNET RES, V16
   Gilbody S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5627
   Glozier N, 2002, OCCUP ENVIRON MED, V59, P714, DOI 10.1136/oem.59.10.714
   Gluck TM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-175
   Grime PR, 2004, OCCUP MED-OXFORD, V54, P353, DOI 10.1093/occmed/kqh077
   Harrison V, 2011, J MENT HEALTH, V20, P509, DOI 10.3109/09638237.2011.608746
   Harvey SB, 2017, MED J AUSTRALIA, V206, P490, DOI 10.5694/mja16.00295
   Harvey SB, 2017, OCCUP ENVIRON MED, V74, P301, DOI 10.1136/oemed-2016-104015
   Harvey SB, 2013, AUST NZ J PSYCHIAT, V47, P421, DOI 10.1177/0004867413476351
   Harvey SB, 2009, BRIT J PSYCHIAT, V194, P201, DOI 10.1192/bjp.bp.108.055111
   Hasson D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-78
   Heber E, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5112
   Henderson M, 2011, J ROY SOC MED, V104, P198, DOI 10.1258/jrsm.2011.100231
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Higins J, COCHRANE HDB SYSTEMA
   Imamura K, 2015, PSYCHOL MED, V45, P1907, DOI 10.1017/S0033291714003006
   Imamura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097167
   Joyce S, 2016, PSYCHOL MED, V46, P683, DOI 10.1017/S0033291715002408
   Knudsen AK, 2013, ACTA PSYCHIAT SCAND, V127, P287, DOI 10.1111/j.1600-0447.2012.01902.x
   Knudsen AK, 2010, J PSYCHOSOM RES, V69, P59, DOI 10.1016/j.jpsychores.2010.03.007
   Lappalainen P., 2013, J MED INTERNET RES, V2, P1, DOI [10.2196/resprot.2389, DOI 10.2196/RESPROT.2389]
   Ly KH, 2014, INTERNET INTERV, V1, P95, DOI DOI 10.1016/J.INVENT.2014.06.003
   Mak W, 2015, J MED INTERNET RES, V17, P1
   Mathers CD, 2006, PLOS MED, P3, DOI DOI 10.1371/JOURNAL.PMED.0030442
   McIntyre RS, 2017, J CLIN PSYCHIAT, V78, P115, DOI 10.4088/JCP.16m10744
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mori M, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3629
   National Institute for Health and Clinical Excellence, 2008, NICE PUBL HLTH GUID, V13
   Phillips R, 2014, PSYCHOL MED, V44, P741, DOI 10.1017/S0033291713001323
   PricewaterhouseCoopers, 2014, CREAT MENT HLTH WORK
   Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004
   Rose G., 1994, STRATEGY PREVENTION
   Rothstein H, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, pIX
   Samoocha D, 2010, J MED INTERNET RES, P12
   Schroder J, 2016, DIALOGUES CLIN NEURO, V18, P203
   Schwarzer G, 2015, META ANAL R USE R
   Sheffield JK, 2006, J CONSULT CLIN PSYCH, V74, P66, DOI 10.1037/0022-006X.74.1.66
   Shimazu A, 2005, J OCCUP HEALTH, V47, P405, DOI 10.1539/joh.47.405
   So M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-113
   Spek V, 2008, PSYCHOL MED, V38, P635, DOI 10.1017/S0033291707002590
   Spijkerman MPJ, 2016, CLIN PSYCHOL REV, V45, P102, DOI 10.1016/j.cpr.2016.03.009
   Stansfeld SA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007981
   Stewart WF, 2003, J OCCUP ENVIRON MED, V45, P1234, DOI 10.1097/01.jom.0000099999.27348.78
   Takechi S, 2015, ADVANCES IN PHYSICAL, V5, P263
   Tan L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-74
   Umanodan R, 2014, IND HEALTH, V52, P480, DOI 10.2486/indhealth.2013-0209
   Wessely S, 2003, BRIT J PSYCHIAT, V183, P12, DOI 10.1192/bjp.183.1.12
   Wessely S, 2008, PSYCHIATRY, V71, P287, DOI 10.1521/psyc.2008.71.4.287
   Wolever RQ, 2012, J OCCUP HEALTH PSYCH, V17, P246, DOI 10.1037/a0027278
   Yamagishi M, 2008, J OCCUP HEALTH, V50, P191, DOI 10.1539/joh.L7086
   Yamagishi Manaho, 2007, J Nurs Manag, V15, P603, DOI 10.1111/j.1365-2834.2007.00739.x
NR 77
TC 11
Z9 11
U1 5
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 21
PY 2017
VL 12
IS 12
AR e0189904
DI 10.1371/journal.pone.0189904
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FQ8BI
UT WOS:000418587400059
PM 29267334
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ben, J
   Cormack, D
   Harris, R
   Paradies, Y
AF Ben, Jehonathan
   Cormack, Donna
   Harris, Ricci
   Paradies, Yin
TI Racism and health service utilisation: A systematic review and
   meta-analysis
SO PLOS ONE
LA English
DT Review
ID AFRICAN-AMERICAN MEN; PERCEIVED DISCRIMINATION; CARE DISCRIMINATION;
   MEDICAL MISTRUST; RACIAL/ETHNIC DISCRIMINATION; RACE/ETHNIC
   DISCRIMINATION; SEXUAL ORIENTATION; ETHNIC DISPARITIES; COMMUNITY
   SAMPLE; PUBLICATION BIAS
AB Although racism has been posited as driver of racial/ethnic inequities in healthcare, the relationship between racism and health service use and experience has yet to be systematically reviewed or meta-analysed. This paper presents a systematic review and meta-analysis of quantitative empirical studies that report associations between self-reported racism and various measures of healthcare service utilisation. Data were reviewed and extracted from 83 papers reporting 70 studies. Studies included 250,850 participants and were conducted predominately in the U.S. The meta-analysis included 59 papers reporting 52 studies, which were analysed using random effects models and mean weighted effect sizes. Racism was associated with more negative patient experiences of health services (HSU-E) (OR = 0.351 (95% CI [0.236,0.521], k = 19), including lower levels of healthcare-related trust, satisfaction, and communication. Racism was not associated with health service use (HSU-U) as an outcome group, and was not associated with most individual HSU-U outcomes, including having had examinations, health service visits and admissions to health professionals and services. Racism was associated with health service use outcomes such as delaying/not getting healthcare, and lack of adherence to treatment uptake, although these effects may be influenced by a small sample of studies, and publication bias, respectively. Limitations to the literature reviewed in terms of study designs, sampling methods and measurements are discussed along with suggested future directions in the field.
C1 [Ben, Jehonathan; Paradies, Yin] Deakin Univ, Fac Arts & Educ, Alfred Deakin Inst Citizenship & Globalizat, Melbourne, Vic, Australia.
   [Cormack, Donna; Harris, Ricci] Univ Otago, Dept Publ Hlth, Eru Pomare Maori Hlth Res Ctr, Wellington, New Zealand.
RP Paradies, Y (reprint author), Deakin Univ, Fac Arts & Educ, Alfred Deakin Inst Citizenship & Globalizat, Melbourne, Vic, Australia.
EM yin.paradies@deakin.edu.au
FU ARC [FT130101148]; New Zealand Ministry of Health-funded fellowship;
   Health Research Council of New Zealand [HRC 14/262]
FX YP is supported by ARC grant FT130101148. Initial work by RH and DC on
   the systematic review was supported by a New Zealand Ministry of
   Health-funded fellowship. Contributions by DC and RH to the current
   systematic review and meta-analysis was supported (in part) by a
   contract from Health Research Council of New Zealand (HRC 14/262). The
   funders did not play a role in the research. The work is the authors'
   own.
CR Adegbembo AO, 2006, ETHNIC DIS, V16, P792
   Ahmed S, 2016, J IMMIGR MINOR HEALT, V18, P1522, DOI 10.1007/s10903-015-0276-z
   Albert MA, 2008, AM HEART J, V156, P1103, DOI 10.1016/j.ahj.2008.07.027
   Anyon Y, ASIAN AM J PSYCHOL
   Armstrong K, 2013, MED CARE, V51, P144, DOI 10.1097/MLR.0b013e31827310a1
   Auslander WF, 1997, HEALTH SOC WORK, V22, P190, DOI 10.1093/hsw/22.3.190
   Banks AD, 2006, AM J CRIT CARE, V15, P149
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Benjamins MR, 2012, MED CARE, V50, P870, DOI 10.1097/MLR.0b013e31825a8c63
   Benjamins MR, 2013, J BEHAV MED
   Benkert R, 2006, J NATL MED ASSOC, V98, P1532
   Bird Sheryl Thorburn, 2001, Ethnicity and Disease, V11, P554
   Bird ST, 2004, AIDS PATIENT CARE ST, V18, P19, DOI 10.1089/108729104322740884
   Blanchard J, 2004, J FAM PRACTICE, V53, P721
   Boarts JM, 2008, J BEHAV MED, V31, P445, DOI 10.1007/s10865-008-9169-0
   Bogart LM, 2013, AIDS BEHAV, V17, P1431, DOI 10.1007/s10461-012-0397-5
   Bogart LM, 2010, ANN BEHAV MED, V40, P184, DOI 10.1007/s12160-010-9200-x
   Borenstein M., 2010, COMPREHENSIVE METAAN
   Brondolo E, 2009, J BEHAV MED, V32, P1, DOI 10.1007/s10865-008-9190-3
   Burgess DJ, 2008, J HEALTH CARE POOR U, V19, P894, DOI 10.1353/hpu.0.0063
   Butler M, 2016, COMP EFFECTIVENESS R, V170
   Byrne A, 2015, ADV HEALTH SCI EDUC, V20, P1255, DOI 10.1007/s10459-015-9600-6
   Casagrande SS, 2007, J GEN INTERN MED, V22, P389, DOI 10.1007/s11606-006-0057-4
   Chen DH, 2014, SOC SCI MED, V104, P64, DOI 10.1016/j.socscimed.2013.12.021
   Cho H, 2014, COMMUNITY MENT HLT J, V50, P960, DOI 10.1007/s10597-014-9719-6
   Clay OJ, 2011, J GERONTOL A-BIOL, V66, P910, DOI 10.1093/gerona/glr082
   Cooper H., 1998, SYNTHESIZING RES GUI
   Crawford ND, 2010, ETHNIC DIS, V20, P359
   Crawley LM, 2008, CANCER EPIDEM BIOMAR, V17, P1937, DOI 10.1158/1055-9965.EPI-08-0005
   Cuffee YL, 2013, AM J PUBLIC HEALTH, V103, pE55, DOI 10.2105/AJPH.2013.301554
   Dailey AB, 2007, AM J EPIDEMIOL, V165, P1287, DOI 10.1093/aje/kwm004
   Degrie L, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-016-0163-8
   Dolezsar CM, 2014, HEALTH PSYCHOL, V33, P20, DOI 10.1037/a0033718
   Dovidio JF, 2008, SOC SCI MED, V67, P478, DOI 10.1016/j.socscimed.2008.03.019
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fiscella K, 2016, ANNU REV PUBL HEALTH, V37, P375, DOI 10.1146/annurev-publhealth-032315-021439
   Ford CL, 2009, AM J PUBLIC HEALTH, V99, pS137, DOI 10.2105/AJPH.2007.120865
   Fowler-Brown A, 2006, J HEALTH CARE POOR U, V17, P86, DOI 10.1353/hpu.2006.0022
   Gizlice Z, 2004, RELATIONSHIPS HLTH P
   Gonzales KL, 2014, DIABETES EDUCATOR, V40, P747, DOI 10.1177/0145721714551422
   Gonzales KL, 2013, WOMEN HEALTH ISS, V23, pE61, DOI 10.1016/j.whi.2012.10.004
   Greer TM, 2014, HEALTH PSYCHOL, V33, P35, DOI 10.1037/a0032777
   Hagiwara N, 2013, SOC SCI MED, V87, P123, DOI 10.1016/j.socscimed.2013.03.016
   Halim ML, 2012, HLTH PSYCHOL
   Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903
   Hammond WP, 2010, AM J COMMUN PSYCHOL, V45, P87, DOI 10.1007/s10464-009-9280-6
   Harris R, 2012, AM J PUBLIC HEALTH, V102, P1012, DOI 10.2105/AJPH.2011.300626
   Hausmann LRM, 2008, J GEN INTERN MED, V23, P1679, DOI 10.1007/s11606-008-0730-x
   Hausmann LRM, 2008, MED CARE, V46, P905, DOI 10.1097/MLR.0b013e3181792562
   Hausmann LRM, 2011, MED CARE, V49, P626, DOI 10.1097/MLR.0b013e318215d93c
   Hausmann Leslie R M, 2009, Am J Public Health, V99 Suppl 3, pS718, DOI 10.2105/AJPH.2008.150730
   Hausmann LRM, 2010, ETHNIC DIS, V20, P40
   Hausmann LRM, 2013, RACE SOC PROBL, V5, P113, DOI DOI 10.1007/S12552-013-9092-Z
   Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486
   Hoyo C, 2005, PREV MED, V41, P439, DOI 10.1016/j.ypmed.2004.11.021
   Insaf TZ, 2010, ETHNIC DIS, V20, P148
   Irvin R, 2014, AIDS BEHAV, V18, P1272, DOI 10.1007/s10461-014-0734-y
   Jacobs EA, 2014, J WOMENS HEALTH, V23, P138, DOI 10.1089/jwh.2013.4328
   Jamieson LM, 2013, AUST NZ J PUBL HEAL, V37, P92, DOI 10.1111/1753-6405.12018
   Jang Y, 2005, J AM GERIATR SOC, V53, P1613, DOI 10.1111/j.1532-5415.2005.53518.x
   Jongen CS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00024
   Kaphingst KA, 2012, PATIENT EDUC COUNS, V88, P291, DOI 10.1016/j.pec.2011.11.013
   Kelaher MA, 2014, MED J AUSTRALIA, V201, P44, DOI 10.5694/mja13.10503
   Keller SC, 2010, HISP HLTH CARE INT, V8, P4, DOI DOI 10.1891/1540-4153.8.1.4
   Kelso GA, 2014, AIDS BEHAV, V18, P1237, DOI 10.1007/s10461-013-0621-y
   Klonoff EA, 2009, J BEHAV MED, V32, P48, DOI 10.1007/s10865-008-9192-1
   Lamkaddem M, 2012, EUR J PUBLIC HEALTH, V22, P473, DOI 10.1093/eurpub/ckr113
   LaVeist TA, 2000, MED CARE RES REV, V57, P146, DOI 10.1177/107755800773743637
   Lopez-Cevallos DF, 2014, J RURAL HEALTH, V30, P344, DOI 10.1111/jrh.12063
   Lyles CR, 2011, PATIENT EDUC COUNS, V85, pE216, DOI 10.1016/j.pec.2011.04.031
   Maina IW, 2017, SOCIAL SCI MED
   Mandelblatt JS, 2003, J CLIN ONCOL, V21, P855, DOI 10.1200/JCO.2003.05.007
   McCracken MO, 2013, ENDNOTE X7 1
   Moore AD, 2013, J NATL MED ASSOC, V105, P59, DOI 10.1016/S0027-9684(15)30086-9
   Moore AD, 2013, MIL MED, V178, P291, DOI 10.7205/MILMED-D-12-00443
   Mouton CP, 2010, J HEALTH CARE POOR U, V21, P287, DOI 10.1353/hpu.0.0273
   Musa D, 2009, AM J PUBLIC HEALTH, V99, P1293, DOI 10.2105/AJPH.2007.123927
   Nguyen DD, 2011, SOC WORK HEALTH CARE, V50, P390, DOI 10.1080/00981389.2011.567130
   Padela AI, 2015, J IMMIGR MINOR HEALT, V17, P660, DOI 10.1007/s10903-014-0014-y
   Paradies Y. C., 2006, CRITICAL PUBLIC HLTH, V16, P143, DOI [10.1080/09581590600828881, DOI 10.1080/09581590600828881]
   Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511
   Paradies Y, 2014, J GEN INTERN MED, V29, P364, DOI 10.1007/s11606-013-2583-1
   Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059
   Peek ME, 2011, ETHNIC DIS, V21, P502
   Peek ME, 2011, MED CARE, V49, P618, DOI 10.1097/MLR.0b013e318215d925
   Pieterse AL, 2012, J COUNS PSYCHOL, V59, P1, DOI 10.1037/a0026208
   Piette JD, 2006, PATIENT EDUC COUNS, V60, P41, DOI 10.1016/j.pec.2004.12.001
   Pullen E, 2014, SOCIOL HEALTH ILL, V36, P1037, DOI 10.1111/1467-9566.12141
   Quintana SM, 2006, COUNS PSYCHOL, V34, P839, DOI 10.1177/001100006286991
   Richman LS, 2007, J SOC CLIN PSYCHOL, V26, P960, DOI 10.1521/jscp.2007.26.8.960
   Richman LS, 2014, SOC SCI MED, V103, P94, DOI 10.1016/j.socscimed.2013.12.029
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Saha S, 2003, AM J PUBLIC HEALTH, V93, P1713, DOI 10.2105/AJPH.93.10.1713
   Salway S, 2016, SOC SCI MED, V152, P102, DOI 10.1016/j.socscimed.2016.01.031
   Sellers SL, 2009, HEALTH EDUC BEHAV, V36, P31, DOI 10.1177/1090198106293526
   Shariff-Marco S, 2010, AM J PUBLIC HEALTH, V100, P364, DOI 10.2105/AJPH.2009.163899
   Shavers VL, 2012, AM J PUBLIC HEALTH, V102, P953, DOI 10.2105/AJPH.2012.300773
   Sheppard VB, 2014, J NATL MED ASSOC, V106, P15
   Sheppard VB, 2008, J GEN INTERN MED, V23, P2024, DOI 10.1007/s11606-008-0815-6
   Slaughter-Acey JC, 2013, WOMEN HEALTH ISS, V23, pE381, DOI 10.1016/j.whi.2013.08.001
   Smedley BD, 2003, UNEQUAL TREATMENT CO
   Smith TB, 2016, FDN MULTICULTURAL PS, P67
   Sorkin DH, 2010, J GEN INTERN MED, V25, P390, DOI 10.1007/s11606-010-1257-5
   Spencer MS, 2010, AM J PUBLIC HEALTH, V100, P2410, DOI 10.2105/AJPH.2009.176321
   Spencer MS, 2004, AM J PUBLIC HEALTH, V94, P809, DOI 10.2105/AJPH.94.5.809
   Tanner AE, 2014, J HEALTH CARE POOR U, V25, P1679, DOI 10.1353/hpu.2014.0156
   Thorburn S, 2005, WOMEN HEALTH, V42, P23, DOI 10.1300/J013v42n01_
   Valdovinos C, 2015, CANC CAUSES CONTROL
   Van Houtven CH, 2005, J GEN INTERN MED, V20, P578, DOI 10.1111/j.1525-1497.2005.0123.x
   van Ryn M, 2011, DU BOIS REV, V8, P199, DOI 10.1017/S1742058X11000191
   Vina ER, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2015-000110
   Voils CI, 2011, J EVAL CLIN PRACT, V17, P429, DOI 10.1111/j.1365-2753.2010.01444.x
   Wagner GJ, 2012, J BEHAV MED, V35, P8, DOI 10.1007/s10865-011-9320-1
   Wagner J, 2007, DIABETES CARE, V30, P364, DOI 10.2337/dc06-1756
   Walls ML, 2015, J AM BOARD FAM MED, V28, P231, DOI 10.3122/jabfm.2015.02.140194
   Wamala S, 2007, J EPIDEMIOL COMMUN H, V61, P409, DOI 10.1136/jech.2006.049999
   Weech-Maldonado R, 2012, MED CARE, V50, pS62, DOI 10.1097/MLR.0b013e31825fb235
   White AA, 2018, J RACIAL ETHN HEALTH, V5, P34, DOI 10.1007/s40615-017-0340-6
   Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0
   Woodward A. T., 2011, RACE SOCIAL PROBLEMS, V31, P146, DOI DOI 10.1007/S12552-011-9049-Z
NR 123
TC 10
Z9 10
U1 4
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 18
PY 2017
VL 12
IS 12
AR e0189900
DI 10.1371/journal.pone.0189900
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FQ5HM
UT WOS:000418389500072
PM 29253855
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kang'''', N
   Cauraugh, JH
AF Kang, Nyeonju
   Cauraugh, James H.
TI Does non-invasive brain stimulation reduce essential tremor? A
   systematic review and meta-analysis
SO PLOS ONE
LA English
DT Article
ID TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; MOTOR
   CORTEX; PERIPHERAL STIMULATION; REPEATED SESSIONS; RTMS; EXCITABILITY;
   CONNECTIVITY; IMPROVEMENT; PREVALENCE
AB Essential tremor (ET) is the most common age-related disease leading to abnormal tremulous behaviors in the upper and lower extremities. Non-invasive brain stimulation (NIBS) may be an effective ET therapy by modulating the oscillating network of the brain. The current systematic review and meta-analysis examined the effects of NIBS interventions on tremor symptoms in ET patients. Our comprehensive search identified eight studies that used 1 Hz of rTMS, cTBS, or ctDCS protocols. Twenty total comparisons from the eight qualified studies were statistically synthesized, and the meta-analytic findings revealed that NIBS techniques reduced tremulous behaviors in individuals with ET. Moreover, the four moderator variable analyses demonstrated that the positive therapeutic effects of NIBS appeared across the following subgroups: (a) tremor assessment (clinical test vs. quantitative tremor assessment), (b) stimulation site (cerebellum vs. motor cortex), (c) session number (single session vs. multiple sessions), and (d) sustained positive treatment effect (posttest vs. retention test). This comprehensive systematic review and meta-analysis provided evidence that support positive treatment effects of NIBS techniques on ET motor therapy.
C1 [Kang, Nyeonju] Univ Florida, Lab Rehabil Neurosci, Dept Appl Physiol & Kinesiol, Gainesville, FL USA.
   [Kang, Nyeonju; Cauraugh, James H.] Univ Florida, Motor Behav Lab, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.
   [Kang, Nyeonju] Incheon Natl Univ, Div Sport Sci, Incheon, South Korea.
RP Cauraugh, JH (reprint author), Univ Florida, Motor Behav Lab, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.
EM cauraugh@ufl.edu
OI KANG, NYEONJU/0000-0003-4440-4413
FU University of Florida Open Access Publishing Fund
FX Publication of this article was funded in part by the University of
   Florida Open Access Publishing Fund.
CR Avanzino L, 2009, EUR J NEUROSCI, V30, P1971, DOI 10.1111/j.1460-9568.2009.06984.x
   Badran BW, 2016, BRAIN STIMUL, V9, P945, DOI 10.1016/j.brs.2016.08.003
   BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805
   Baumer T, 2003, NEUROIMAGE, V20, P550, DOI 10.1016/S1053-8119(03)00310-0
   Blobaum P, 2006, J MED LIBR ASSOC, V94, P477
   Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123
   Bologna M, 2015, CEREBELLUM, V14, P133, DOI 10.1007/s12311-014-0621-0
   Borenstein M., 2009, INTRO METAANALYSIS
   Borenstein M, 2013, PREV SCI, V14, P134, DOI 10.1007/s11121-013-0377-7
   Borich M, 2009, RESTOR NEUROL NEUROS, V27, P55, DOI 10.3233/RNN-2009-0461
   Chalah MA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00440
   Chen R, 2012, CLIN NEUROPHYSIOL, V123, P850, DOI 10.1016/j.clinph.2011.09.015
   Chuang WL, 2014, MOVEMENT DISORD, V29, P501, DOI 10.1002/mds.25809
   Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288
   Dupuis MJM, 2010, MOVEMENT DISORD, V25, P2884, DOI 10.1002/mds.23328
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Elble RJ, 2009, CURR NEUROL NEUROSCI, V9, P273, DOI 10.1007/s11910-009-0041-6
   Ferrucci Roberta, 2016, Cerebellum Ataxias, V3, P16, DOI 10.1186/s40673-016-0054-2
   Gironell A, 2002, ARCH NEUROL-CHICAGO, V59, P413, DOI 10.1001/archneur.59.3.413
   Gironell A, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D8DV1HQC
   Grimaldi G, 2008, TREATMENT PATHOGENES
   Hellriegel H, 2012, CLIN NEUROPHYSIOL, V123, P1010, DOI 10.1016/j.clinph.2011.08.033
   Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806
   Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021
   Lindenberg R, 2012, NEUROREHAB NEURAL RE, V26, P479, DOI 10.1177/1545968311427568
   Louis ED, 2000, ARCH NEUROL-CHICAGO, V57, P1194, DOI 10.1001/archneur.57.8.1194
   Louis ED, 2001, MOVEMENT DISORD, V16, P914, DOI 10.1002/mds.1184
   Louis Elan D, 2011, Front Neurol, V2, P91, DOI 10.3389/fneur.2011.00091
   Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838
   Louis ED, 2009, NEUROEPIDEMIOLOGY, V32, P208, DOI 10.1159/000195691
   Lu R, 2017, BRAIN STIMUL, V10, P513
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Nettekoven C, 2014, J NEUROSCI, V34, P6849, DOI 10.1523/JNEUROSCI.4993-13.2014
   Ni Z, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0045-x
   Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x
   Obeso I, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00486
   PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847
   Pinto AD, 2003, NEUROLOGY, V60, P1985, DOI 10.1212/01.WNL.0000065890.75790.29
   Popa T, 2013, BRAIN STIMUL, V6, P175, DOI 10.1016/j.brs.2012.04.009
   Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024
   Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59
   Sandvik U, 2012, NEUROSURGERY, V70, P840, DOI 10.1227/NEU.0b013e318236a809
   Shih LC, 2017, TREMOR OTHER HYPERK, V7, DOI 10.7916/D8G44W01
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Vanneste S, 2013, BRAIN STIMUL, V6, P155, DOI 10.1016/j.brs.2012.03.019
   Yilmaz NH, 2016, NEUROLOGIST, V21, P28, DOI 10.1097/NRL.0000000000000070
   Zhang K, 2010, J NEUROSURG, V112, P1271, DOI 10.3171/2009.10.JNS09371
NR 51
TC 2
Z9 2
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 28
PY 2017
VL 12
IS 9
AR e0185462
DI 10.1371/journal.pone.0185462
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI4YC
UT WOS:000411985200063
PM 28957367
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nilsson, T
   Wahlstrom, J
   Burstrom, L
AF Nilsson, Tohr
   Wahlstrom, Jens
   Burstrom, Lage
TI Hand-arm vibration and the risk of vascular and neurological diseases -
   A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID INDUCED WHITE FINGER; THERMAL PERCEPTION THRESHOLDS; DOSE-RESPONSE
   RELATION; CARPAL-TUNNEL-SYNDROME; TRANSMITTED VIBRATION;
   RAYNAUDS-PHENOMENON; FORESTRY WORKERS; COLD RESPONSE; EXPOSURE;
   PREVALENCE
AB Background
   Increased occurrence of Raynaud's phenomenon, neurosensory injury and carpal tunnel syndrome has been reported for more than 100 years in association with work with vibrating machines. The current risk prediction modelling (ISO-5349) for "Raynaud's phenomenon" is based on a few studies published 70 to 40 years ago. There are no corresponding risk prediction models for neurosensory injury or carpal tunnel syndrome, nor any systematic reviews comprising a statistical synthesis (meta-analysis) of the evidence.
   Objectives
   Our aim was to provide a systematic review of the literature on the association between Raynaud's phenomenon, neurosensory injuries and carpal tunnel syndrome and hand-arm vibration (HAV) exposure. Moreover the aim was to estimate the magnitude of such an association using meta-analysis.
   Methods
   This systematic review covers the scientific literature up to January 2016. The databases used for the literature search were PubMed and Science Direct. We found a total of 4,335 abstracts, which were read and whose validity was assessed according to pre-established criteria. 294 articles were examined in their entirety to determine whether each article met the inclusion criteria. The possible risk of bias was assessed for each article. 52 articles finally met the pre-established criteria for inclusion in the systematic review.
   Results
   The results show that workers who are exposed to HAV have an increased risk of vascular and neurological diseases compared to non-vibration exposed groups. The crude estimate of the risk increase is approximately 4-5 fold. The estimated effect size (odds ratio) is 6.9 for the studies of Raynaud's phenomenon when including only the studies judged to have a low risk of bias. The corresponding risk of neurosensory injury is 7.4 and the equivalent of carpal tunnel syndrome is 2.9.
   Conclusion
   At equal exposures, neurosensory injury occurs with a 3-time factor shorter latency than Raynaud's phenomenon. Which is why preventive measures should address this vibration health hazard with greater attention.
C1 [Nilsson, Tohr; Wahlstrom, Jens; Burstrom, Lage] Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden.
RP Nilsson, T (reprint author), Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden.
EM Tohr.Nilsson@envmed.umu.se
OI Nilsson, Tohr/0000-0003-2789-6321
FU Swedish AFA Insurance [090326]
FX The financial support of the Swedish AFA Insurance is gratefully
   acknowledged (Dnr: part of project 090326
   https://www.afaforsakring.se/forskning/projektkatalog/Projekt/3889/ and
   supplied through Occupational and Environmental medicine,
   https://gupea.ub.gu.se/handle/2077/42452. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aiba Y, 2012, J OCCUP HEALTH, V54, P96, DOI 10.1539/joh.11-0058-OA
   Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219
   [Anonymous], 2001, 53491 ISO
   Anttonen H, 1994, Arctic Med Res, V53 Suppl 3, P19
   Barregard L, 2003, OCCUP ENVIRON MED, V60, P287, DOI 10.1136/oem.60.4.287
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Borenstein M., 2009, INTRO METAANALYSIS
   BOVENZI M, 1980, INT ARCH OCC ENV HEA, V46, P251, DOI 10.1007/BF00380015
   Bovenzi M, 1998, INT ARCH OCC ENV HEA, V71, P493, DOI 10.1007/s004200050311
   Bovenzi M, 2000, INT ARCH OCC ENV HEA, V73, P519, DOI 10.1007/s004200000177
   Bovenzi M, 2005, INT ARCH OCC ENV HEA, V78, P303, DOI 10.1007/s00420-004-0574-6
   BOVENZI M, 1985, BRIT J IND MED, V42, P253
   BOVENZI M, 1995, OCCUP ENVIRON MED, V52, P722, DOI 10.1136/oem.52.11.722
   BOVENZI M, 1994, OCCUP ENVIRON MED, V51, P603, DOI 10.1136/oem.51.9.603
   Bovenzi M, 2010, OCCUP ENVIRON MED, V67, P38, DOI 10.1136/oem.2009.046128
   BOVENZI M, 1988, INT ARCH OCC ENV HEA, V61, P25, DOI 10.1007/BF00381604
   Bovenzi M, 1998, SCAND J WORK ENV HEA, V24, P138, DOI 10.5271/sjweh.291
   Bovenzi M, 2008, INT ARCH OCC ENV HEA, V81, P613, DOI 10.1007/s00420-007-0255-3
   Bovenzi M, 2008, INT ARCH OCC ENV HEA, V81, P401, DOI 10.1007/s00420-007-0225-9
   Bovenzi M, 2011, SCAND J WORK ENV HEA, V37, P244, DOI 10.5271/sjweh.3129
   Bovenzi M, 2011, INT ARCH OCC ENV HEA, V84, P325, DOI 10.1007/s00420-010-0549-8
   Bovenzi M, 2010, INT ARCH OCC ENV HEA, V83, P259, DOI 10.1007/s00420-009-0461-2
   BRAMMER AJ, 1986, SCAND J WORK ENV HEA, V12, P284, DOI 10.5271/sjweh.2139
   BRAMMER AJ, 1987, SCAND J WORK ENV HEA, V13, P279, DOI 10.5271/sjweh.2050
   Brubaker R, 1985, J LOW FREQ NOISE VIB, V4, P66
   BRUBAKER RL, 1987, SCAND J WORK ENV HEA, V13, P305, DOI 10.5271/sjweh.2035
   BURDORF A, 1991, ANN OCCUP HYG, V35, P287, DOI 10.1093/annhyg/35.3.287
   Burstrom L, 2010, SCAND J WORK ENV HEA, V36, P509, DOI 10.5271/sjweh.3072
   Carmeli Y, 1999, ARCH INTERN MED, V159, P2461, DOI 10.1001/archinte.159.20.2461
   CHATTERJEE DS, 1978, BRIT J IND MED, V35, P208
   Cherniack M, 2004, AM J IND MED, V45, P500, DOI 10.1002/ajim.20019
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Edlund M, 2013, SCAND J WORK ENV HLT
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Futatsuka M, 2005, J OCCUP HEALTH, V47, P165, DOI 10.1539/joh.47.165
   FUTATSUKA M, 1985, J OCCUP ENVIRON MED, V27, P257
   GEMNE G, 1987, SCAND J WORK ENV HEA, V13, P275, DOI 10.5271/sjweh.2038
   Gerhardsson L, 2005, APPL ERGON, V36, P55, DOI 10.1016/j.apergo.2004.09.001
   Hagberg Mats, 2008, J Occup Med Toxicol, V3, P13, DOI 10.1186/1745-6673-3-13
   Hamilton A., 1918, US BUREAU LABOUR STA, P53
   Hamilton A., 1943, EXPLORING DANGEROUS
   Harazin B, 1996, Cent Eur J Public Health, V4, P130
   Hewitt S, 2015, CRITICAL REV EVIDENC
   HO ST, 1986, INT ARCH OCC ENV HEA, V58, P259, DOI 10.1007/BF00377883
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Jang JY, 2002, AIHAJ, V63, P305, DOI 10.1080/15428110208984718
   KOSKIMIES K, 1992, INT ARCH OCC ENV HEA, V64, P251, DOI 10.1007/BF00378282
   Lawson IJ, 2010, HUNTER'S DISEASES OF OCCUPATIONS, 10TH EDITION, P489
   LETZ R, 1992, BRIT J IND MED, V49, P53
   Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006
   Loriga G., 1911, BOLL INSPETT LAVORO, V2, P35
   Lundstrom R, 1999, AM J IND MED, V35, P456, DOI 10.1002/(SICI)1097-0274(199905)35:5<456::AID-AJIM2>3.0.CO;2-#
   Malchaire J, 2001, ANN OCCUP HYG, V45, P479, DOI 10.1016/S0003-4878(00)00084-3
   Matsumoto T, 1995, Cent Eur J Public Health, V3 Suppl, P93
   MIRBOD SM, 1994, INT ARCH OCC ENV HEA, V66, P13
   MIRBOD SM, 1992, INT ARCH OCC ENV HEA, V64, P93, DOI 10.1007/BF00381475
   Mirbod SM, 1999, IND HEALTH, V37, P415, DOI 10.2486/indhealth.37.415
   MUSSON Y, 1989, ANN OCCUP HYG, V33, P85, DOI 10.1093/annhyg/33.1.85
   Nilsson T, 2008, INT ARCH OCC ENV HEA, V81, P519, DOI 10.1007/s00420-007-0258-0
   NILSSON T, 1994, SCAND J WORK ENV HEA, V20, P189, DOI 10.5271/sjweh.1409
   Nilsson T, 2002, INT ARCH OCC ENV HEA, V75, P55
   Nilsson T, 2001, OCCUP ENVIRON MED, V58, P472, DOI 10.1136/oem.58.7.472
   NILSSON T, 1989, INT ARCH OCC ENV HEA, V61, P473, DOI 10.1007/BF00386482
   Palmer K, 1998, OCCUP ENVIRON MED, V55, P716, DOI 10.1136/oem.55.10.716
   Palmer KT, 2011, BEST PRACT RES CL RH, V25, P15, DOI 10.1016/j.berh.2011.01.014
   Pelmear PL, 1998, HAND ARM VIBRATION, P1
   Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091
   Sanden H, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-21
   Seyring M, 1931, B HYGIENE, V6
   Su AT, 2013, OCCUP ENVIRON MED, V70, P498, DOI 10.1136/oemed-2012-101321
   Tominaga Y, 1994, Nagoya J Med Sci, V57 Suppl, P235
   van Rijn RM, 2009, SCAND J WORK ENV HEA, V35, P19, DOI 10.5271/sjweh.1306
   Virokannas H, 1995, Cent Eur J Public Health, V3 Suppl, P109
   WALKER DD, 1985, BRIT J IND MED, V42, P672
   Yamada S, 1995, Nagoya J Med Sci, V58, P1
NR 75
TC 8
Z9 8
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 13
PY 2017
VL 12
IS 7
AR e0180795
DI 10.1371/journal.pone.0180795
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA7TL
UT WOS:000405649700050
PM 28704466
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Onyedum, CC
   Alobu, I
   Ukwaja, KN
AF Onyedum, Cajetan C.
   Alobu, Isaac
   Ukwaja, Kingsley Nnanna
TI Prevalence of drug-resistant tuberculosis in Nigeria: A systematic
   review and metaanalysis
SO PLOS ONE
LA English
DT Review
ID SUB-SAHARAN AFRICA; MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANCE;
   RISK-FACTORS; RIFAMPICIN
AB Background
   Drug-resistant tuberculosis TB) undermines control efforts and its burden is poorly understood in resource-limited settings. We performed a systematic review and meta-analysis to provide an up-to-date summary of the extent of drug-resistant TB in Nigeria.
   Methods
   We searched PubMed, Scopus, Embase, HINARI, AJOL, the Cochrane library, Web of Science, and Google Scholar for reports published before January 31 2017, that included any resistance, mono-resistance or multidrug resistance to anti-TB drugs in Nigeria. Summary estimates were calculated using random effects models.
   Results
   We identified 34 anti-TB drug resistance surveys with 8002 adult TB patients consisting of 2982 new and 5020 previously-treated cases. The prevalence rate of any drug resistance among new TB cases was 32.0% 95% CI 24.0 -40.0%; 734/ 2892) and among previouslytreated cases, the rate was 53.0% 95% CI 35.0 -71.0%; 1467/ 5020). Furthermore, multidrug resistance among new and previously-treated cases was 6.0% 95% CI 4.0 -8.0%; 161/ 2502) and 32.0% 95% CI 20.0 -44.0; 357/ 949), respectively. There was significant heterogeneity between the studies p< 0.001, I 2 tests). The prevalence of drug-resistant TB varied according to methods of drug susceptibility testing and geographic region of Nigeria.
   Conclusion
   The burden of drug-resistant TB in Nigeria is high. We recommend that a national anti-TB drug resistance survey be carried out, and strategies for case detection and programmatic management of drug-resistant TB in Nigeria need to be strengthened.
C1 [Onyedum, Cajetan C.] Univ Nigeria, Dept Med, Coll Med, Enugu Campus, Enugu, Nigeria.
   [Alobu, Isaac] Minist Hlth, Natl TB & Leprosy Control Programme, Abakaliki, Ebonyi State, Nigeria.
   [Ukwaja, Kingsley Nnanna] Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria.
RP Ukwaja, KN (reprint author), Fed Teaching Hosp, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria.
EM ukwajakingsley@yahoo.co.uk
RI Ukwaja, Kingsley N./A-7794-2013
OI Ukwaja, Kingsley N./0000-0002-1974-8735
CR Adamu A. U., 2015, The Journal of American Science, V11, P293
   Aghaji MN, 2010, NIGER J CLIN PRACT, V13, P58
   Aliyu Gambo, 2013, Tuberc Res Treat, V2013, P650561, DOI 10.1155/2013/650561
   Alobu I, 2014, ASIAN PAC J TROP MED, V7, P977, DOI 10.1016/S1995-7645(14)60172-3
   Ani AE, 2009, T ROY SOC TROP MED H, V103, P67, DOI 10.1016/j.trstmh.2008.08.004
   Antunes ML, 2000, INT J TUBERC LUNG D, V4, P223
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bello LA, 2014, INT J RES MED SCI, V2, P1134
   Berhan A, 2013, ETHIOP J HEALTH SCI, V23, P271, DOI 10.4314/ejhs.v23i3.10
   Blondal K, 2007, BULL WORLD HEALTH OR, V85
   Daniel O, 2011, AFR J RESPIR MED, V6, P18
   Daniel O, 2011, ASIAN PAC J TROP MED, V4, P148, DOI 10.1016/S1995-7645(11)60057-6
   Deutschendorf C, 2012, BRAZ J INFECT DIS, V16, P142, DOI 10.1590/S1413-86702012000200006
   Dosumu EA, 2008, AFR J RESP MED, V4, P22
   Duan QH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148041
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egbe K, 2016, SCI J PUBLIC HLTH, V4, P214
   Eltayeb O, J PULMON RESP MED S, VS6
   FAWCETT IW, 1976, TUBERCLE, V57, P71, DOI 10.1016/0041-3879(76)90020-9
   Federal Ministry of Health, 2015, NATIONAL TUBERCULOSI
   Gehre F, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0704-5
   Halilu TB, 2013, J PHARM COSMET SCI V, V1, P45
   Hamza TH, 2008, J CLIN EPIDEMIOL, V61, P41, DOI 10.1016/j.jclinepi.2007.03.016
   IDIGBE EO, 1992, J TROP MED HYG, V95, P186
   Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421
   Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9
   Kehinde A O, 2013, Niger J Physiol Sci, V28, P187
   Kehinde AO, 2007, J NATL MED ASSOC, V99, P1185
   Kehinde AO, 2012, J MED MICROB DIAGN S, VS3
   Kolo I, 1991, THESIS
   Lawson L, 2011, TROP MED INT HEALTH, V16, P974, DOI 10.1111/j.1365-3156.2011.02792.x
   Lawson L, 2010, ANN AFR MED, V9, P184, DOI 10.4103/1596-3519.68355
   Lukoye D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1614-8
   Mawak JD, 2006, NIG J EXP APPL BIOL, V7, P128
   Mustapha G, 2015, SAARC J TUBERC LUNG, VXII, P1
   Nasiri MJ, 2014, AM J INFECT CONTROL, V42, P1212, DOI 10.1016/j.ajic.2014.07.017
   Nwachukwu NO, 2016, J INFEC DIS TREAT, V2, P1
   Nwofor AC, 2015, CURR HIV RES, V13, P308, DOI 10.2174/1570162X13666150407143147
   Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39
   Okodua M, 2012, INT J BASIC APPL INN, V1, P48
   Oluwaseun E., 2013, AM J RES COMMUN, V1, P224
   Otu A, 2013, NIGERIA PULM MED, V2013
   Pokam BT, 2013, INT J MYCOBACT, V2, P89, DOI 10.1016/j.ijmyco.2013.03.002
   Rasaki SO, 2014, J INFECT DIS THER, V2, P3
   Rikoto JA, 2015, THESIS
   Sanders M, 2006, INT J TUBERC LUNG D, V10, P178
   Sogaolu OM, 2012, AM J RESP CRIT CARE, V185, pA3257
   Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561
   The Joanna Briggs Institute, 2014, JOANNA BRIGGS INSTIT
   Ukaegbu CO, 2016, BR J PHARM RES, V9, P1
   Ukoli CO, 2012, JOS J MED, V6, P26
   Umubyeyi AN, 2007, INT J TUBERC LUNG D, V11, P860
   Uzoewulu NG, 2014, J MED MICROB DIAGN, V3, P2, DOI DOI 10.4172/2161-0703.1000141
   van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711
   Weldegebreal S, 2017, INT J TUBERC LUNG D, V21, P18, DOI 10.5588/ijtld.16.0286
   World Health Organization, 2016, GLOBAL TUBERCULOSIS
   World Health Organization, 2015, GUIDELINES FOR SURVE
   Zhao P, 2012, J INT MED RES, V40, P436, DOI 10.1177/147323001204000205
NR 58
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 13
PY 2017
VL 12
IS 7
AR 0180996
DI 10.1371/journal.pone.0180996
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA7TL
UT WOS:000405649700071
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lori, M
   Symnaczik, S
   Mader, P
   De Deyn, G
   Gattinger, A
AF Lori, Martina
   Symnaczik, Sarah
   Maeder, Paul
   De Deyn, Gerlinde
   Gattinger, Andreas
TI Organic farming enhances soil microbial abundance and activity-A
   meta-analysis and meta-regression
SO PLOS ONE
LA English
DT Article
ID LONG-TERM; COMMUNITY STRUCTURE; PUBLICATION BIAS; AGRICULTURAL
   MANAGEMENT; CONVENTIONAL MANAGEMENT; BIOLOGICAL-CONTROL; TILLAGE
   SYSTEMS; MATTER DYNAMICS; CROP DIVERSITY; BIOMASS
AB Population growth and climate change challenge our food and farming systems and provide arguments for an increased intensification of agriculture. A promising option is eco-functional intensification through organic farming, an approach based on using and enhancing internal natural resources and processes to secure and improve agricultural productivity, while minimizing negative environmental impacts. In this concept an active soil microbiota plays an important role for various soil based ecosystem services such as nutrient cycling, erosion control and pest and disease regulation. Several studies have reported a positive effect of organic farming on soil health and quality including microbial community traits. However, so far no systematic quantification of whether organic farming systems comprise larger and more active soil microbial communities compared to conventional farming systems was performed on a global scale. Therefore, we conducted a meta-analysis on current literature to quantify possible differences in key indicators for soil microbial abundance and activity in organic and conventional cropping systems. All together we integrated data from 56 mainly peer-reviewed papers into our analysis, including 149 pairwise comparisons originating from different climatic zones and experimental duration ranging from 3 to more than 100 years. Overall, we found that organic systems had 32% to 84% greater microbial biomass carbon, microbial biomass nitrogen, total phospholipid fatty-acids, and dehydrogenase, urease and protease activities than conventional systems. Exclusively the metabolic quotient as an indicator for stresses on microbial communities remained unaffected by the farming systems. Categorical subgroup analysis revealed that crop rotation, the inclusion of legumes in the crop rotation and organic inputs are important farming practices affecting soil microbial community size and activity. Furthermore, we show that differences in microbial size and activity between organic and conventional farming systems vary as a function of land use (arable, orchards, and grassland), plant life cycle (annual and perennial) and climatic zone. In summary, this study shows that overall organic farming enhances total microbial abundance and activity in agricultural soils on a global scale.
C1 [Lori, Martina; Symnaczik, Sarah; Maeder, Paul; Gattinger, Andreas] Res Inst Organ Agr FiBL, Dept Soil Sci, Frick, Switzerland.
   [Lori, Martina; Gattinger, Andreas] Justus Liebig Univ Giessen, Karl Glockner Str 21 C, Giessen, Germany.
   [De Deyn, Gerlinde] Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands.
RP Lori, M (reprint author), Res Inst Organ Agr FiBL, Dept Soil Sci, Frick, Switzerland.; Lori, M (reprint author), Justus Liebig Univ Giessen, Karl Glockner Str 21 C, Giessen, Germany.
EM martina.lori@fibl.org
RI De Deyn, Gerlinde B/C-1593-2009
OI De Deyn, Gerlinde B/0000-0003-4823-6912
CR Aciego P. J. C., 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI DOI 10.1016/J.S0ILBI0.2008.03.020
   Adamtey N, 2016, AGR ECOSYST ENVIRON, V235, P61, DOI 10.1016/j.agee.2016.10.001
   Affaires PD, 2014, INT ASSESSMENT AGR K
   Alef K, 1995, METHODS APPL SOIL MI
   ANDERSON TH, 1990, SOIL BIOL BIOCHEM, V22, P251, DOI 10.1016/0038-0717(90)90094-G
   Aparna K, 2014, ECOL ENG, V71, P268, DOI 10.1016/j.ecoleng.2014.07.016
   Appl M., 2006, ULLMANNS ENCY IND CH
   Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8
   Bahlai CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011250
   Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082
   Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007
   Borenstein M, 2009, INTRO METAANALYSIS, V20
   Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087
   Bulluck LR, 2002, APPL SOIL ECOL, V19, P147, DOI 10.1016/S0929-1393(01)00187-1
   Bunemann EK, 2006, AUST J SOIL RES, V44, P379, DOI 10.1071/SR05125
   Burger M, 2005, BIOL FERT SOILS, V42, P109, DOI 10.1007/s00374-005-0007-z
   Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031
   Cooper J, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0354-1
   COPELAND PJ, 1992, AGRON J, V84, P503, DOI 10.2134/agronj1992.00021962008400030028x
   Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046
   de Ponti T, 2012, AGR SYST, V108, P1, DOI 10.1016/j.agsy.2011.12.004
   Debosz K, 1999, APPL SOIL ECOL, V13, P209, DOI 10.1016/S0929-1393(99)00034-7
   DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L
   Dickersin K., 2006, PUBLICATION BIAS MET, P9, DOI 10.1002/0470870168.ch2/summary
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Emmerling C, 2002, J PLANT NUTR SOIL SC, V165, P408, DOI 10.1002/1522-2624(200208)165:4<408::AID-JPLN408>3.0.CO;2-3
   Esperschuetz J, 2007, FEMS MICROBIOL ECOL, V61, P26, DOI 10.1111/j.1574-6941.2007.00318.x
   Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6
   FAUCI MF, 1994, SOIL SCI SOC AM J, V58, P801, DOI 10.2136/sssaj1994.03615995005800030023x
   Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580
   Forster D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081039
   Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8
   Fu R. V. B., 2013, METHODS GUIDE EFFECT
   Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455
   Gattinger A, 2003, ACTA BIOTECHNOL, V23, P21, DOI 10.1002/abio.200390003
   Gattinger A, 2012, P NATL ACAD SCI USA, V109, P18226, DOI 10.1073/pnas.1209429109
   Ge TD, 2013, EUR J SOIL BIOL, V58, P122, DOI 10.1016/j.ejsobi.2013.07.005
   Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4
   Gurr GM, 2003, BASIC APPL ECOL, V4, P107, DOI 10.1078/1439-1791-00122
   Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z
   Hartmann M, 2014, INT SOC MICROBIOL EC, P1
   Hartmann M., 2006, THESIS
   Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2
   Heinze S, 2010, PLANT SOIL, V328, P203, DOI 10.1007/s11104-009-0102-2
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   IFOAM OI, 2016, FUT CONS ANN REP IF, P24
   Kicinski M, 2015, STAT MED, V34, P2781, DOI 10.1002/sim.6525
   KILLHAM K, 1985, ENVIRON POLLUT A, V38, P283, DOI 10.1016/0143-1471(85)90133-3
   Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482
   Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930
   LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7
   Lagomarsino A, 2009, ECOL INDIC, V9, P518, DOI 10.1016/j.ecolind.2008.07.003
   Lal R., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P303, DOI 10.1007/s11027-006-9036-7
   Larsen E, 2014, SOIL TILL RES, V139, P37, DOI 10.1016/j.still.2014.02.002
   Li RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037127
   Liu B, 2007, APPL SOIL ECOL, V37, P202, DOI 10.1016/j.apsoil.2007.06.007
   Lorenz K, 2016, ADV AGRON, V139, P99, DOI 10.1016/bs.agron.2016.05.003
   Lotter DW, 2003, AM J ALTERNATIVE AGR, V18, P146, DOI 10.1079/AJAA200345
   Luan JW, 2012, SOIL BIOL BIOCHEM, V44, P143, DOI 10.1016/j.soilbio.2011.08.012
   Lynch J. M., 1985, Advances in Soil Science, USA, V2, P133
   Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148
   Mader P, 2012, RENEW AGR FOOD SYST, V27, P7, DOI 10.1017/S1742170511000470
   McDaniel MD, 2014, ECOL APPL, V24, P560, DOI 10.1890/13-0616.1
   McKnight T, 2000, PHYS GEOGRAPHY LANDS, P235
   McLauchlan K, 2006, ECOSYSTEMS, V9, P1364, DOI 10.1007/s10021-005-0135-1
   Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005
   Nickel JL., 1972, S AGR ENT DEV COUNTR
   Nielsen UN, 2015, ANNU REV ENV RESOUR, V40, P63, DOI 10.1146/annurev-environ-102014-021257
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Petersen SO, 1997, GEODERMA, V78, P181, DOI 10.1016/S0016-7061(97)00032-3
   Pulleman M, 2003, SOIL USE MANAGE, V19, P157, DOI 10.1079/SUM2003186
   Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458
   Reeve JR, 2016, ADV AGRON, V137, P319, DOI 10.1016/bs.agron.2015.12.003
   Reganold J. P., 1988, American Journal of Alternative Agriculture, V3, P144
   Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346
   Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x
   Romaniuk R, 2011, ECOL INDIC, V11, P1345, DOI 10.1016/j.ecolind.2011.02.008
   Schneider M, 2016, EXP AGR, P1
   Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069
   Siegrist S, 1998, AGR ECOSYST ENVIRON, V69, P253, DOI 10.1016/S0167-8809(98)00113-3
   Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x
   Skinner C, 2014, SCI TOTAL ENVIRON, V468, P553, DOI 10.1016/j.scitotenv.2013.08.098
   Smith RG, 2008, ECOSYSTEMS, V11, P355, DOI 10.1007/s10021-008-9124-5
   Stark CH, 2008, SOIL BIOL BIOCHEM, V40, P1352, DOI 10.1016/j.soilbio.2007.09.025
   Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0
   Stocker T, 2013, IPCC 2013 CLIMATE CH
   Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090
   Sun HY, 2016, APPL SOIL ECOL, V108, P16, DOI 10.1016/j.apsoil.2016.07.014
   Tebrugge F, 1999, SOIL TILL RES, V53, P15, DOI 10.1016/S0167-1987(99)00073-2
   Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002
   van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x
   van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003
   VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6
   Venter ZS, 2016, PEDOBIOLOGIA JENA, V59, P1
   Vian JF, 2009, SOIL USE MANAGE, V25, P1, DOI 10.1111/j.1475-2743.2008.00176.x
   Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111
   WANDER MM, 1995, PLANT SOIL, V170, P87, DOI 10.1007/BF02183057
   Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4
   Xue K, 2013, APPL ENVIRON MICROB, V79, P1284, DOI 10.1128/AEM.03393-12
   Yeates GW, 1997, J APPL ECOL, V34, P453, DOI 10.2307/2404890
   Yu HY, 2012, SOIL TILL RES, V124, P170, DOI 10.1016/j.still.2012.06.011
   Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263
   ZELLES L, 1993, SOIL BIOL BIOCHEM, V25, P495, DOI 10.1016/0038-0717(93)90075-M
   Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533
   Zuber SM, 2016, SOIL BIOL BIOCHEM, V97, P176, DOI 10.1016/j.soilbio.2016.03.011
NR 106
TC 20
Z9 20
U1 7
U2 86
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 12
PY 2017
VL 12
IS 7
AR e0180442
DI 10.1371/journal.pone.0180442
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA7TK
UT WOS:000405649600030
PM 28700609
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Li, H
   Jiang, CX
   Wu, DW
   Shi, SP
   Liao, MT
   Wang, J
   Li, YW
   Xu, ZH
AF Li, Hui
   Jiang, Chunxiang
   Wu, Dongwen
   Shi, Shupeng
   Liao, Mengting
   Wang, Jing
   Li, Yanwen
   Xu, Zihao
TI The prognostic and clinicopathologic characteristics of CD147 and
   esophagus cancer: A meta-analysis
SO PLOS ONE
LA English
DT Article
ID SQUAMOUS-CELL CARCINOMA; EXPRESSION; ADENOCARCINOMA; SIGNIFICANCES;
   EMMPRIN
AB Objective The prognostic significance of CD147 expression in esophageal cancer patients remains controversial. Using a meta-analysis, we investigated the prognostic and clinicopathologic characteristics of CD147 in esophageal cancer.
   Methods A comprehensive literature search of the PubMed (1966-2016), EMBASE (1980-2016), Cochrane Library (1996-2016), Web of Science (1945-2016), China National Knowledge Infrastructure (1982-2016), and Wanfang databases (1988-2016) was performed to identify studies of all esophageal cancer subtypes. Correlations between CD147 expression and survival outcomes and clinicopathological features were analyzed using meta-analysis methods.
   Results Seventeen studies were included. High CD147 expression reduced the 3-year survival rate (OR = 3.26, 95% CI = (1.53, 6.93), p = 0.02) and 5-year survival rate(OR = 4.35, 95% CI = (2.13, 8.90), p < 0.0001). High CD147 expression reduced overall survival in esophageal cancer (HR = 1.60, 95% CI = (1.19, 2.15), p = 0.02). Additionally, higher CD147 expression was detected in esophageal cancer tissues than noncancerous tissues (OR = 9.45, 95% CI = (5.39, 16.59), p < 0.00001), normal tissues (OR = 12.73, 95% CI = (3.49, 46.46), p = 0.0001), para-carcinoma tissues (OR = 12.80, 95% CI = (6.57, 24.92), p < 0.00001), and hyperplastic tissues (OR = 3.27, 95% CI = (1.47, 7.29), p = 0.004). CD147 expression was associated with TNM stage (OR = 3.66, 95% CI = (2.20, 6.09), p < 0.00001), tumor depth (OR = 7.97, 95% CI = (4.13, 15.38), p < 0.00001), and lymph node status (OR = 5.14, 95% CI = (2.03,13.01), p = 0.0005), but not with tumor differentiation, age, or sex.
   Conclusion Our meta-analysis suggests that CD147 is an efficient prognostic factor in esophageal cancer. High CD147 expression in patients with esophageal cancer was associated with worse survival outcomes and common clinicopathological indicators of poor prognosis.
C1 [Li, Hui] Cent S Univ, Xiangya Hosp, Reprod Dept, Changsha, Hunan, Peoples R China.
   [Jiang, Chunxiang; Wu, Dongwen; Shi, Shupeng; Wang, Jing; Li, Yanwen; Xu, Zihao] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China.
   [Liao, Mengting] Cent S Univ, Xiangya Hosp, Oncol Dept, Changsha, Hunan, Peoples R China.
RP Li, H (reprint author), Cent S Univ, Xiangya Hosp, Reprod Dept, Changsha, Hunan, Peoples R China.
EM HUILI257@hotmail.com
CR Abdel-Latif MMM, 2015, EUR J CANCER, V51, P464, DOI 10.1016/j.ejca.2014.11.014
   BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0
   Cheng MF, 2006, DIS ESOPHAGUS, V19, P482, DOI 10.1111/j.1442-2050.2006.00613.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   ELLIS SM, 1989, CANCER RES, V49, P3385
   Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726
   Guang MA, 2009, J NEW MED, V19, P12
   Haiming L, 2010, CHINA FOREIGN MED TR, V29, P3
   Hemdan T, 2015, J UROLOGY, V194, P1575, DOI 10.1016/j.juro.2015.06.085
   Huang L, 2015, INT J CLIN EXP PATHO, V8, P1929
   Huang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0651-3
   Ishibashi Y, 2004, CANCER-AM CANCER SOC, V101, P1994, DOI 10.1002/cncr.20593
   Jiang LY, 2015, CANCER LETT, V357, P69, DOI 10.1016/j.canlet.2014.11.045
   Jin-xu C, 2009, CANC RES PREVENTION, V07, P596
   LI Chang-xiu, 2013, LAB MED CLIN, V10, P129
   Li H, 2017, ONCOTARGET
   Li H, 2017, J NEUROONCOL
   Li-na X, 2011, CLIN FOCUS, V01, P20
   Ling X, 2008, J INT ONCOLOGY, V35, P156
   Peng F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163678
   Reimers N, 2004, CLIN CANCER RES, V10, P3422, DOI 10.1158/1078-0432.CCR-03-0610
   Shi Q, 2008, MED INFORM SECTION O, V10, P886
   Siegel R, 2014, CA CANC J CLIN, V64
   Song-bai X, 2007, PROGR MODERN BIOMEDI, V01, P42
   Tang WR, 2014, ASIAN PAC J CANCER P, V15, P6929, DOI DOI 10.7314/APJCP.2014.15.16.6929
   Wan Yong, 2012, Zhonghua Zhong Liu Za Zhi, V34, P44
   Wang CY, 2015, ONCOTARGET, V6, P18674, DOI 10.18632/oncotarget.4367
   Wang Q, 2015, GENET MOL RES, V14, P6844, DOI 10.4238/2015.June.18.27
   Wells GA, 2000, NEWCASTLE OTTAWA SCA
   Xiao X., 2011, CLIN RES RELATIONSHI, V05, P58
   Zhang H, 2006, CHINESE J EXPT SURG, V10, P1248
   Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60
   Zhao J, 2004, ACTA U MED NANJING N, V06, P621
   Zhao J, 2015, ONCOL REP, V34, P67, DOI 10.3892/or.2015.3999
   Zhu S, 2011, DIG DIS SCI, V56
   Zhu S, 2011, CHINESE J CELLULAR M, V07, P784
   Zhu SJ, 2011, DIGEST DIS SCI, V56, P3569, DOI 10.1007/s10620-011-1812-x
NR 37
TC 1
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 11
PY 2017
VL 12
IS 7
AR e0180271
DI 10.1371/journal.pone.0180271
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA7TI
UT WOS:000405649400010
PM 28700599
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Huang, XYN
   Ribeiro, JD
   Musacchio, KM
   Franklin, JC
AF Huang, Xieyining
   Ribeiro, Jessica D.
   Musacchio, Katherine M.
   Franklin, Joseph C.
TI Demographics as predictors of suicidal thoughts and behaviors: A
   meta-analysis
SO PLOS ONE
LA English
DT Article
ID CROSS-SECTIONAL SURVEY; PUBLICATION BIAS; FOLLOW-UP; RISK-FACTORS;
   EFFECT SIZE; PREVALENCE; MORTALITY; IDEATION; PERSONALITY; PSYCHACHE
AB Background
   Certain demographic factors have long been cited to confer risk or protection for suicidal thoughts and behaviors. However, many studies have found weak or non-significant effects. Determining the effect strength and clinical utility of demographics as predictors is crucial for suicide risk assessment and theory development. As such, we conducted a meta-analysis to determine the effect strength and clinical utility of demographics as predictors.
   Methods
   We searched PsycInfo, PubMed, and GoogleScholar for studies published before January 1st, 2015. Inclusion criteria required that studies use at least one demographic factor to longitudinally predict suicide ideation, attempt, or death. The initial search yielded 2,541 studies, 159 of which were eligible. A total of 752 unique statistical tests were included in analysis.
   Results
   Suicide death was the most commonly studied outcome, followed by attempt and ideation. The average follow-up length was 9.4 years. The overall effects of demographic factors studied in the field as risk factors were significant but weak, and that of demographic factors studied as protective factors were non-significant. Adjusting for publication bias further reduced effect estimates. No specific demographic factors appeared to be strong predictors. The effects were consistent across multiple moderators.
   Conclusions
   At least within the narrow methodological constraints of the existing literature, demographic factors were statistically significant risk factors, but not protective factors. Even as risk factors, demographics offer very little improvement in predictive accuracy. Future studies that go beyond the limitations of the existing literature are needed to further understand the effects of demographics.
C1 [Huang, Xieyining; Ribeiro, Jessica D.; Musacchio, Katherine M.; Franklin, Joseph C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.
   [Ribeiro, Jessica D.] Mil Suicide Res Consortium, Tallahassee, FL USA.
RP Huang, XYN (reprint author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.
EM huang@psy.fsu.edu
FU Military Suicide Research Consortium (MSRC); Office of the Assistant
   Secretary of Defense for Health Affairs [W81XWH-10-2-0181]; National
   Institute of Mental Health (NIH) [T32MH18921]
FX This work was supported in part by funding from the Military Suicide
   Research Consortium (MSRC; msrc.fsu.edu), an effort supported by the
   Office of the Assistant Secretary of Defense for Health Affairs (Award
   No. W81XWH-10-2-0181). This work was also supported in part through a
   training grant (T32MH18921) from the National Institute of Mental Health
   (NIH; nih.gov). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
   Opinions, interpretations, conclusions, and recommendations are those of
   the authors and are not necessarily endorsed by the funding agencies.
CR Angst J, 1998, J AFFECT DISORDERS, V51, P55, DOI 10.1016/S0165-0327(98)00156-6
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Blosnich JR, 2013, AM J PUBLIC HEALTH, V103, pE27, DOI 10.2105/AJPH.2013.301507
   Borenstein M., 2009, INTRO METAANALYSIS
   Centers for Disease Control and Prevention, 2016, SUICIDE RISK AND PRO
   Cha CB, ACCOUNTING DIVERSITY
   Chan LF, 2014, PSYCHIAT RES, V220, P867, DOI 10.1016/j.psychres.2014.08.055
   Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383
   Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025
   Corcoran P, 2010, SOC PSYCH PSYCH EPID, V45, P795, DOI 10.1007/s00127-009-0120-7
   CULLBERG J, 1988, ACTA PSYCHIAT SCAND, V77, P598, DOI 10.1111/j.1600-0447.1988.tb05173.x
   Dekovic M, 1999, J YOUTH ADOLESCENCE, V28, P667, DOI 10.1023/A:1021635516758
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eynan R, 2002, SUICIDE LIFE-THREAT, V32, P418, DOI 10.1521/suli.32.4.418.22341
   HOYER G, 1993, ARCH GEN PSYCHIAT, V50, P134
   Joiner T. E, 2005, WHY PEOPLE DIE SUICI
   Kaplan KJ, 2012, SUICIDE LIFE-THREAT, V42, P614, DOI 10.1111/j.1943-278X.2012.00116.x
   Kessler RC, 2005, TRENDS SUICIDE IDEAT, V293, P1990
   Kposowa AJ, 2001, PSYCHOL MED, V31, P127, DOI 10.1017/S0033291799002925
   Kraemer HC, 1997, ARCH GEN PSYCHIAT, V54, P337
   Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274
   Loas G, 2009, PSYCHOPATHOLOGY, V42, P185, DOI 10.1159/000209331
   Lukaschek K, 2014, BRIT J PSYCHIAT, V205, P398, DOI 10.1192/bjp.bp.113.139352
   LUTHAR SS, 1993, J CHILD PSYCHOL PSYC, V34, P441, DOI 10.1111/j.1469-7610.1993.tb01030.x
   Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002
   Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113
   Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258
   O'Connor RC, 2013, J CONSULT CLIN PSYCH, V81, P1137, DOI 10.1037/a0033751
   Okamura T, 2014, SOC PSYCH PSYCH EPID, V49, P573, DOI 10.1007/s00127-013-0791-y
   Orwin RG, 1983, J ED STAT, V8, P157, DOI DOI 10.2307/1164923
   Panczak R, 2013, SUICIDE LIFE-THREAT, V43, P213, DOI 10.1111/sltb.12009
   Platt B, 2010, OCCUP MED-OXFORD, V60, P436, DOI 10.1093/occmed/kqq044
   Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797
   Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765
   Rahman A, 2003, ACTA PSYCHIAT SCAND, V108, P392, DOI 10.1034/j.1600-0447.2003.00220.x
   Rahman S, 2014, PLOS ONE, V9
   Ramberg IL, 2000, PSYCHOL MED, V30, P1189, DOI 10.1017/S003329179900238X
   Rasic DT, 2009, J AFFECT DISORDERS, V114, P32, DOI 10.1016/j.jad.2008.08.007
   Ribeiro JD, 2016, PSYCHOL MED, V46, P2009, DOI 10.1017/S0033291716000611
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Russell ST, 2001, AM J PUBLIC HEALTH, V91, P1276, DOI 10.2105/AJPH.91.8.1276
   Sauvola A, 2001, EUR J PUBLIC HEALTH, V11, P284, DOI 10.1093/eurpub/11.3.284
   Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295
   Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a
   Shneidman ES, 1998, SUICIDE LIFE-THREAT, V28, P245
   SHNEIDMAN ES, 1993, J NERV MENT DIS, V181, P145, DOI 10.1097/00005053-199303000-00001
   Shneidman ES, 1999, PERTURBATION LETHALI
   Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988
   Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242
   Soloff PH, 2012, AM J PSYCHIAT, V169, P484, DOI 10.1176/appi.ajp.2011.11091378
   STACK S, 1990, SOCIOL QUART, V31, P359, DOI 10.1111/j.1533-8525.1990.tb00333.x
   TROVATO F, 1987, J MARRIAGE FAM, V49, P193, DOI 10.2307/352683
   Tyssen R, 2001, PHYSIOL REV, V11, P10
   Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697
   Vevea JL, 2005, PSYCHOL METHODS, V10, P428, DOI 10.1037/1082-989X.10.4.428
   VEVEA JL, 1995, PSYCHOMETRIKA, V60, P419, DOI 10.1007/BF02294384
   Votta E, 2004, J ADOLESCENT HEALTH, V34, P237, DOI 10.1016/j.jadohealth.2003.06.002
   Wells K, 2009, RES SOCIAL WORK PRAC, V19, P52, DOI 10.1177/1049731508317278
   World Health Organisation, 2016, SUICIDE
   Wyder M, 2009, J AFFECT DISORDERS, V116, P208, DOI 10.1016/j.jad.2008.11.007
NR 61
TC 6
Z9 6
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2017
VL 12
IS 7
AR e0180793
DI 10.1371/journal.pone.0180793
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA6HV
UT WOS:000405544800077
PM 28700728
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Joustra, ML
   Minovic, I
   Janssens, KAM
   Bakker, SJL
   Rosmalen, JGM
AF Joustra, Monica L.
   Minovic, Isidor
   Janssens, Karin A. M.
   Bakker, Stephan J. L.
   Rosmalen, Judith G. M.
TI Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia
   syndrome: A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; OXIDATIVE STRESS; PHYSICAL-ACTIVITY;
   PUBLICATION BIAS; MAGNESIUM LEVELS; D DEFICIENCY; WOMEN; EXERCISE;
   ASSOCIATION; SYMPTOMS
AB Background
   Many chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS) patients (35-68%) use nutritional supplements, while it is unclear whether deficiencies in vitamins and minerals contribute to symptoms in these patients. Objectives were (1) to determine vitamin and mineral status in CFS and FMS patients as compared to healthy controls; (2) to investigate the association between vitamin and mineral status and clinical parameters, including symptom severity and quality of life; and (3) to determine the effect of supplementation on clinical parameters.
   Methods
   The databases PubMed, EMBASE, Web of Knowledge, and PsycINFO were searched for eligible studies. Articles published from January 1st 1994 for CFS patients and 1990 for FMS patients till March 1st 2017 were included. Articles were included if the status of one or more vitamins or minerals were reported, or an intervention concerning vitamins or minerals was performed. Two reviewers independently extracted data and assessed the risk of bias.
   Results
   A total of 5 RCTs and 40 observational studies were included in the qualitative synthesis, of which 27 studies were included in the meta-analyses. Circulating concentrations of vitamin E were lower in patients compared to controls (pooled standardized mean difference (SMD): -1.57, 95% CI: -3.09, -0.05; p =.042). However, this difference was not present when restricting the analyses to the subgroup of studies with high quality scores. Poor study quality and a substantial heterogeneity in most studies was found. No vitamins or minerals have been repeatedly or consistently linked to clinical parameters. In addition, RCTs testing supplements containing these vitamins and/or minerals did not result in clinical improvements.
   Discussion
   Little evidence was found to support the hypothesis that vitamin and mineral deficiencies play a role in the pathophysiology of CFS and FMS, and that the use of supplements is effective in these patients.
   Registration
   Study methods were documented in an international prospective register of systematic reviews (PROSPERO) protocol, registration number:
C1 [Joustra, Monica L.; Janssens, Karin A. M.; Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.
   [Minovic, Isidor; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.
   [Minovic, Isidor; Bakker, Stephan J. L.] Top Inst Food & Nutr, Wageningen, Netherlands.
RP Joustra, ML (reprint author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.
EM m.l.joustra@umcg.nl
FU DSM; Friesland Campina; Top Institute Food and Nutrition (TIFN) [CH-003,
   CH-001]
FX S.J.L.B. obtained grants from DSM and Friesland Campina, and S.J.L.B.
   and I.M. obtained funding from the Top Institute Food and Nutrition
   (TIFN, grants CH-001 and CH-003, respectively). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aaron LA, 2000, ARCH INTERN MED, V160, P221, DOI 10.1001/archinte.160.2.221
   Akkus S, 2009, CELL BIOCHEM FUNCT, V27, P181, DOI 10.1002/cbf.1548
   Al-Allaf AW, 2003, RHEUMATOLOGY, V42, P1202, DOI 10.1093/rheumatology/keg356
   Al-Khalifa II, 2016, IJPSR, V8, P306
   Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132
   Arranz LI, 2010, RHEUMATOL INT, V30, P1417, DOI 10.1007/s00296-010-1443-0
   Bagis S, 2013, RHEUMATOL INT, V33, P167, DOI 10.1007/s00296-011-2334-8
   Batista ED, 2016, REV BRAS REUMATOL, V56, P105, DOI 10.1016/j.rbre.2015.08.015
   Baygutalp NK, 2014, DICLE TIP DERGISI, V41, P446
   Bazzichi L, 2008, CLIN BIOCHEM, V41, P1084, DOI 10.1016/j.clinbiochem.2008.06.012
   Bennett RM, 2008, BMC MUSCULOSKEL DIS, V8, P1
   BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491
   Brouwers FM, 2002, QJM-INT J MED, V95, P677, DOI 10.1093/qjmed/95.10.677
   Costa JMDT, 2016, REV BRAS REUMATOL, V56, P391, DOI [10.1016/j.rbre.2016.03.008, 10.1016/j.rbr.2016.01.003]
   Deeks J J, 2003, Health Technol Assess, V7, piii
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Dykman KD, 1998, INTEGR PHYS BEH SCI, V33, P61, DOI 10.1007/BF02688676
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eisinger J, 1996, MAGNESIUM RES, V9, P313
   Eisinger J, 1997, J MUSCULOSKELET PAIN, V5, P5, DOI 10.1300/J094v05n04_02
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   Grant JE, 1996, J AM DIET ASSOC, V96, P383, DOI 10.1016/S0002-8223(96)00104-6
   Halsted CH, 2003, AM J CLIN NUTR, V77, p1001S, DOI 10.1093/ajcn/77.4.1001S
   Heidari B, 2010, INT J RHEUM DIS, V13, P340, DOI 10.1111/j.1756-185X.2010.01561.x
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hsiao MY, 2015, PAIN PHYSICIAN, V18, pE877
   Jammes Y, 2012, J INTERN MED, V272, P74, DOI 10.1111/j.1365-2796.2011.02488.x
   Jammes Y, 2009, J INTERN MED, V266, P196, DOI 10.1111/j.1365-2796.2009.02079.x
   Janssens KAM, 2015, PSYCHOSOM MED, V77, P449, DOI 10.1097/PSY.0000000000000161
   Kim YS, 2011, J KOREAN MED SCI, V26, P1253, DOI 10.3346/jkms.2011.26.10.1253
   Kurup RK, 2003, ACTA NEUROPSYCHIATR, V15, P266, DOI 10.1034/j.1601-5215.2003.00045.x
   La Rubia M, 2013, CLIN EXP RHEUMATOL, V31, pS121
   Lauche R, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/610615
   Maafi AA, 2016, KOREAN J PAIN, V29, P172, DOI 10.3344/kjp.2016.29.3.172
   Mader R, 2012, CLIN RHEUMATOL, V31, P595, DOI 10.1007/s10067-011-1888-x
   Maes M, 2006, J AFFECT DISORDERS, V90, P141, DOI 10.1016/j.jad.2005.11.002
   Mateos F, 2014, OSTEOPOROSIS INT, V25, P525, DOI 10.1007/s00198-013-2434-2
   McCully Kevin K, 2006, Dyn Med, V5, P1, DOI 10.1186/1476-5918-5-1
   Mechtouf A, 1998, LYON MEDITERR MED ME, V34, P28
   Metin B, 2017, MYCOPATHOLOGIA, V182, P45, DOI 10.1007/s11046-016-0072-x
   Miwa K, 2010, HEART VESSELS, V25, P319, DOI 10.1007/s00380-009-1206-6
   Miwa K, 2009, INT J CARDIOL, V136, P238, DOI 10.1016/j.ijcard.2008.04.051
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Naziroglu M, 2010, STRESS, V13, P498, DOI 10.3109/10253890.2010.486064
   Ng SY, 1999, J MANIP PHYSIOL THER, V22, P586, DOI 10.1016/S0161-4754(99)70019-9
   NORREGAARD J, 1994, CLIN PHYSIOL, V14, P159, DOI 10.1111/j.1475-097X.1994.tb00502.x
   Nutrition Business Journal, 2011, NBJS SUPPL BUS REP A
   Okyay R, 2016, ACTA MEDICA MEDITERR, V32, P243
   Olama SM, 2013, RHEUMATOL INT, V33, P185, DOI 10.1007/s00296-012-2361-0
   Ortancil O, 2010, EUR J CLIN NUTR, V64, P308, DOI 10.1038/ejcn.2009.149
   Patra J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001835
   Pena CD, 2010, JCR-J CLIN RHEUMATOL, V16, P365, DOI 10.1097/RHU.0b013e3181fe8a90
   Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010
   Reinhard P, 1998, TOXICOL LETT, V96-7, P177, DOI 10.1016/S0378-4274(98)00066-6
   Rosborg I, 2007, SCI TOTAL ENVIRON, V385, P20, DOI 10.1016/j.scitotenv.2007.05.014
   Sakarya ST, 2011, CLIN RHEUMATOL, V30, P1039, DOI 10.1007/s10067-011-1697-2
   Samborski Wlodzimierz, 1997, Reumatologia (Warsaw), V35, P160
   Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018
   Sendur OF, 2008, RHEUMATOL INT, V28, P1117, DOI 10.1007/s00296-008-0593-9
   Ozcan DS, 2014, TURK FIZ TIP REHAB D, V60, P329, DOI 10.5152/tftrd.2014.45143
   Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2
   Tak LM, 2009, BIOL PSYCHOL, V82, P101, DOI 10.1016/j.biopsycho.2009.05.002
   Tandeter H, 2009, ISR MED ASSOC J, V11, P339
   Turkyilmaz AK, 2010, OSTEOPOROSIS WORLD, P53
   Ulusoy H, 2010, BRATISL MED J, V111, P604
   van Rossum CTM, 2011, 350050006 RIVM
   van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113
   Vecchiet J, 2003, NEUROSCI LETT, V335, P151, DOI 10.1016/S0304-3940(02)01058-3
   von Elm E, 2007, PREV MED, V45, P247, DOI [10.1016/j.ypmed.2007.08.012, 10.7326/0003-4819-147-8-200710160-00010]
   Wahner-Roedler DL, 2005, MAYO CLIN PROC, V80, P55
   Wepner F, 2014, PAIN
   Werbach M R, 2000, Altern Med Rev, V5, P93
   Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2
   Witham MD, 2015, NUTR METAB CARDIOVAS, V25, P287, DOI 10.1016/j.numecd.2014.10.007
   WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203
   Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140
   Yildirim T, 2016, BIOMED RES-INDIA, V27, P1265
NR 77
TC 1
Z9 1
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 28
PY 2017
VL 12
IS 4
AR e0176631
DI 10.1371/journal.pone.0176631
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET6EO
UT WOS:000400383900035
PM 28453534
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wu, SQ
   Xu, JJ
AF Wu, Suqian
   Xu, Jianjiang
TI Incidence and risk factors for post-penetrating keratoplasty glaucoma: A
   systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID INCREASED INTRAOCULAR-PRESSURE; CORNEAL TRANSPLANTATION;
   STATISTICAL-METHODS; GRAFT-SURVIVAL; MANAGEMENT; PHACOEMULSIFICATION;
   COMPLICATIONS; PUBLICATION; PREVALENCE; GOLDMANN
AB Objectives
   To establish the incidence and risk factors for post penetrating keratoplasty glaucoma (PKKG).
   Methods
   Studies published between 1947 and 2016 regarding penetrating keratoplasty (PK) were identified using an electronic search and reviewed. For search purpose, PKKG was defined as ocular hypertension (> 21mmHg) after PK. The incidence and risk factors of PKKG were extracted for all studies. Pooled incidence, odd ratios (ORs) and 95% confidence intervals (CIs) were calculated.
   Results
   Thirty studies reporting on 27146 patients were included in the analysis of the incidence and risk factors for PKKG. Exact PKKG definitions used in the literature could be classified in to three subgroups: I, ocular hypertension (> 21mmHg) after PK; II, I plus > 4 weeks medical treatment required; III, II plus treatment escalation among patients with preexisting glaucoma. Overall (Definition I) pooled incidence in all studies was 21.5% (95% CI 17.8%, 25.7%). The incidence varied according to different definitions. The highest incidence value was found when only studies using Goldmann tonometer were included (22.5%), while the lowest incidence was found when a strict definition was used and steroid-induced PPKG was excluded (12.1%). The incidence was higher in patients with preexisting glaucoma, bullous keratopathy (BK), aphakia, pseudophakia, failed graft, and surgical indication of trauma. A triple procedure (combined PK with extra capsular cataract extraction and intraocular lens implantation) was not identified as being associated with the increased risk for PKKG.
   Conclusions
   The overall pooled incidence of PKKG was 21.5%, but it varied according to the criteria used to define the presence of PPKG. Strong risk factors for PKKG included preexisting glaucoma and aphakia, while modest predictors included pseudophakia, regrafting, and pre-operative diagnosis like BK and trauma. There may not be sufficient evidence to identify a significant association between a triple procedure and PKKG.
C1 [Wu, Suqian; Xu, Jianjiang] Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China.
RP Xu, JJ (reprint author), Fudan Univ, Eye Ear Nose & Throat Hosp, Shanghai Med Coll, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China.
EM jianjiangxu@126.com
FU Key Clinic Medicine Research Program, the Ministry of Health, China
   [201302015]; National Science and Technology Research Program, the
   Ministry of Science and Technology, China [2012BA108B01]; National
   Natural Science Foundation of China [81170817, 81200658, 81300735,
   81270978, U1205025, 81330022]; Scientific Research Program, Science and
   Technology Commission of Shanghai Municipality, Shanghai [13441900900,
   13430720400]; New Technology Joint Research Project in Shanghai
   Hospitals [SHDC12014114]
FX This study was supported by grants from the Key Clinic Medicine Research
   Program, the Ministry of Health, China (201302015); the National Science
   and Technology Research Program, the Ministry of Science and Technology,
   China (2012BA108B01); the National Natural Science Foundation of China
   (81170817, 81200658, 81300735, 81270978, U1205025, and 81330022); the
   Scientific Research Program, Science and Technology Commission of
   Shanghai Municipality, Shanghai (13441900900, 13430720400); and the New
   Technology Joint Research Project in Shanghai Hospitals (SHDC12014114).
   The sponsors or funding organizations had no role in the design or
   conduct of this research.
CR Al-Mohaimeed M, 2007, OPHTHALMOLOGY, V114, P2281, DOI 10.1016/j.ophtha.2007.08.043
   Bachmann B, 2010, OPHTHALMOLOGY, V117, P1300, DOI 10.1016/j.ophtha.2010.01.039
   Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650
   CHIEN AM, 1993, AM J OPHTHALMOL, V115, P711, DOI 10.1016/S0002-9394(14)73636-0
   Dandona Lalit, 1998, Indian Journal of Ophthalmology, V46, P149
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   FOULKS GN, 1987, OPHTHALMOLOGY, V94, P871
   Franca ET, 2002, CORNEA, V21, P284, DOI 10.1097/00003226-200204000-00009
   GOLDBERG DB, 1981, AM J OPHTHALMOL, V92, P372, DOI 10.1016/0002-9394(81)90527-4
   Haddadin RI, 2014, SEMIN OPHTHALMOL, V29, P380, DOI 10.3109/08820538.2014.959201
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Huber KK, 2013, GRAEF ARCH CLIN EXP, V251, P105, DOI 10.1007/s00417-012-2065-x
   Ing JJ, 1998, OPHTHALMOLOGY, V105, P1855, DOI 10.1016/S0161-6420(98)91030-2
   Karadag O, 2010, CORNEA, V29, P278, DOI 10.1097/ICO.0b013e3181b6eb9e
   KARESH JW, 1983, AM J OPHTHALMOL, V96, P160, DOI 10.1016/S0002-9394(14)77783-9
   KIRKNESS CM, 1992, CORNEA, V11, P427, DOI 10.1097/00003226-199209000-00012
   Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930
   Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008
   Kornmann HL, 2016, CURR OPIN OPHTHALMOL, V27, P132, DOI 10.1097/ICU.0000000000000237
   Kushwaha D C, 1981, Indian J Ophthalmol, V29, P167
   MCMILLAN F, 1975, ARCH OPHTHALMOL-CHIC, V93, P420
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Neuburger M, 2013, J GLAUCOMA, V22, P584, DOI 10.1097/IJG.0b013e31824cef11
   OLSON RJ, 1977, INVEST OPHTH VIS SCI, V16, P1085
   Orucoglu F, 2014, J GLAUCOMA, V23, P599, DOI 10.1097/IJG.0b013e31828700f5
   Pershing S, 2011, CURR OPIN OPHTHALMOL, V22, P37, DOI 10.1097/ICU.0b013e3283414fb3
   Rahman I, 2009, EYE, V23, P1288, DOI 10.1038/eye.2008.305
   Rao SK, 1999, OPHTHALMIC SURG LAS, V30, P488
   Reinhard T, 1997, GRAEF ARCH CLIN EXP, V235, P553, DOI 10.1007/BF00947083
   Sharma RA, 2016, CAN J OPHTHALMOL, V51, P19, DOI 10.1016/j.jcjo.2015.09.014
   Sihota R, 1998, AUST NZ J OPHTHALMOL, V26, P305, DOI 10.1111/j.1442-9071.1998.tb01334.x
   Simmons R B, 1989, Trans Am Ophthalmol Soc, V87, P79
   Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Wagoner MD, 2009, CORNEA, V28, P385, DOI 10.1097/ICO.0b013e31818d3aef
   WILLIAMS KA, 1995, EYE, V9, P219, DOI 10.1038/eye.1995.43
   WILLIAMS KA, 1993, AUST NZ J OPHTHALMOL, V21, P1
   Williams KA, 2007, AUSTR CORNEAL GRAFT
   Xie L, 2000, Zhonghua Yan Ke Za Zhi, V36, P116
   Yildirim N, 2011, J OPHTHALMOL, V2011
NR 40
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 21
PY 2017
VL 12
IS 4
AR e0176261
DI 10.1371/journal.pone.0176261
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES9KN
UT WOS:000399876100036
PM 28430806
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, HN
   Li, XW
   Han, BX
   Liu, XQ
AF Liu, Haining
   Li, Xianwen
   Han, Buxin
   Liu, Xiaoqian
TI Effects of cognitive bias modification on social anxiety: A
   meta-analysis
SO PLOS ONE
LA English
DT Article
ID ATTENTION MODIFICATION PROGRAM; GENDER-DIFFERENCES; EMOTIONAL
   VULNERABILITY; APPROACH-AVOIDANCE; PUBLICATION BIAS; PHOBIA; DISORDER;
   MODEL; INFORMATION; INDIVIDUALS
AB Background
   Cognitive bias modification (CBM), a set of techniques for modifying bias in information processing D is considered a novel intervention for social anxiety disorder (SAD), which has drawn considerable interest from researchers. However, the effects of CBM on SAD are not consistent. Some studies have demonstrated significant positive effects compared to control groups, while others have found no such effects.
   Aims
   We conducted a meta-analysis aimed at quantitatively assessing the effects of CBM on SAD at post-test.
   Method
   Through a systematic literature search by two independent raters, 34 articles (36 randomized studies) including 2,550 participants were identified. A multilevel modeling approach was employed to assess the effects of CBM on SAD, and to explore the potentially crucial procedures and sample characteristics that enhance the effectiveness of benign training.
   Results
   In general, there were small but significant effects of CBM on the primary symptoms of SAD (g = 0.17), cognitive bias (CB) toward threat (g = 0.32), and reactivity in stressful situations (g = 0.25), but non-significant effects on secondary symptoms. However, the interpretation modification program was more effective than was attentional bias modification in reducing SAD primary symptoms and negative CB. Laboratory training procedures produced larger primary symptom reductions compared to Internet-based training, whereas the percentage of contingency and feedback about training performance boosted cognitive effects only. Finally, the following groups were more likely to benefit from CBM: younger participants (primary symptoms and cognitive effects), women (primary symptom effects), and samples with stronger CB (stressor effects). The quality of the randomized controlled trials was less than desirable, as there was some indication of publication bias in our study.
   Conclusions
   Current findings broadly supported cognitive theories of SAD that consider a bidirectional or mutually reinforcing relationship between symptoms and CBs. However, the small therapeutic effect observed here indicates that it is necessary to develop more reliable and efficient CBM interventions that are specific to SAD.
C1 [Liu, Haining; Han, Buxin; Liu, Xiaoqian] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China.
   [Liu, Haining] Chengde Med Univ, Psychol Dept, Chengde, Peoples R China.
   [Liu, Haining; Han, Buxin; Liu, Xiaoqian] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Li, Xianwen] Nanjing Med Univ, Sch Nursing, Nanjing, Jiangsu, Peoples R China.
RP Han, BX (reprint author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China.; Han, BX (reprint author), Univ Chinese Acad Sci, Beijing, Peoples R China.
EM hanbx@psych.ac.cn
FU Scientific Foundation of the Key Lab of Mental Health, Institute of
   Psychology, Chinese Academy of Sciences [KLMH2014K02]; National Social
   Science Foundation (Major Project) [16ZDA233]
FX This work was supported by the Scientific Foundation of the Key Lab of
   Mental Health, Institute of Psychology, Chinese Academy of Sciences
   under Grant KLMH2014K02 and the National Social Science Foundation
   (Major Project, 16ZDA233). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amir N, 2008, J ABNORM PSYCHOL, V117, P860, DOI 10.1037/a0013445
   Amir N, 2012, J CONSULT CLIN PSYCH, V80, P497, DOI 10.1037/a0026928
   Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808
   Amir N, 2010, J ANXIETY DISORD, V24, P178, DOI 10.1016/j.janxdis.2009.10.005
   Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685
   Asnaani A, 2014, COGNITIVE THER RES, V38, P226, DOI 10.1007/s10608-013-9580-x
   Beard C, 2008, BEHAV RES THER, V46, P1135, DOI 10.1016/j.brat.2008.05.012
   Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002
   Beard C, 2012, BEHAV COGN PSYCHOTH, V40, P618, DOI 10.1017/S1352465811000671
   Beard C, 2011, DEPRESS ANXIETY, V28, P981, DOI 10.1002/da.20873
   Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1
   Boettcher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071760
   Boettcher J, 2012, COGNITIVE THER RES, V36, P522, DOI 10.1007/s10608-011-9374-y
   Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746
   Bunnell BE, 2013, BEHAV THER, V44, P662, DOI 10.1016/j.beth.2013.04.010
   Butler E, 2015, COGENT PSYCHOL, V2, DOI 10.1080/23311908.2015.1011905
   Cannon MF, 2010, J ANXIETY DISORD, V24, P751, DOI 10.1016/j.janxdis.2010.05.008
   Carlbring P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-66
   Carleton RN, 2015, J ANXIETY DISORD, V33, P35, DOI 10.1016/j.janxdis.2015.03.011
   Clark D. M., 1995, COGNITIVE MODEL SOCI, P69
   Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3
   Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003
   Clarke PJF, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-8
   Cohen J, 1988, STAT POWER ANAL BEHA
   Collimore KC, 2010, DEPRESS ANXIETY, V27, P1017, DOI [10.1002/da.20759, 10.1002/da.20771]
   Cooper H, 2009, HDB RES SYNTHESIS ME
   Cortina JM, 2003, ORGAN RES METHODS, V6, P415, DOI 10.1177/1094428103257358
   Cramer Phebe, 2015, Psychodyn Psychiatry, V43, P523, DOI 10.1521/pdps.2015.43.4.523
   Crippa J. A. S., 2013, INT J BEHAV CONSULTA, V7, P16, DOI DOI 10.1037/h0100961
   Cristea IA, 2015, BRIT J PSYCHIAT, V206, P7, DOI 10.1192/bjp.bp.114.146761
   Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001
   De Voogd EL, 2014, J BEHAV THER EXP PSY, V45, P252, DOI 10.1016/j.jbtep.2013.11.006
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780
   Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61
   Emmelkamp PMG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-63
   Enock PM, 2014, COGNITIVE THER RES, V38, P200, DOI 10.1007/s10608-014-9606-z
   Epkins CC, 2011, CLIN CHILD FAM PSYCH, V14, P329, DOI 10.1007/s10567-011-0101-8
   Fox E, 2014, COGNITIVE THER RES, V38, P239, DOI 10.1007/s10608-014-9604-1
   Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021
   Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355
   Hedges C, 1985, STAT TECHNIQUES META
   Heeren A, 2012, BEHAV RES THER, V50, P30, DOI 10.1016/j.brat.2011.10.005
   Heeren A, 2015, CLIN PSYCHOL REV, V40, P76, DOI 10.1016/j.cpr.2015.06.001
   Heeren A, 2015, J ANXIETY DISORD, V29, P35, DOI 10.1016/j.janxdis.2014.10.007
   Heeren A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00538
   Heeren A, 2011, J ANXIETY DISORD, V25, P1108, DOI 10.1016/j.janxdis.2011.08.001
   Hertel PT, 2011, PERSPECT PSYCHOL SCI, V6, P521, DOI 10.1177/1745691611421205
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hirsch CR, 2006, BEHAV THER, V37, P223, DOI 10.1016/j.beth.2006.02.001
   Hirsch CR, 2012, BEHAV RES THER, V50, P636, DOI 10.1016/j.brat.2012.06.007
   Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313
   Hoppitt L, 2014, BEHAV RES THER, V52, P45, DOI 10.1016/j.brat.2013.10.008
   Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281
   Julian K, 2012, BEHAV RES THER, V50, P350, DOI 10.1016/j.brat.2012.02.015
   Katzelnick DJ, 2014, AM J PSYCHIAT
   Keefe JR, 2014, CLIN PSYCHOL REV, V34, P309, DOI 10.1016/j.cpr.2014.03.004
   Keogh E, 2004, PAIN, V111, P209, DOI 10.1016/j.pain.2004.06.017
   Khalili-Torghabeh S, 2014, J EXP PSYCHOPATHOL, V5, P514, DOI 10.5127/jep.037713
   Kimbrel NA, 2008, CLIN PSYCHOL REV, V28, P592, DOI 10.1016/j.cpr.2007.08.003
   Kimbrel NA, 2012, PERS INDIV DIFFER, V52, P395, DOI 10.1016/j.paid.2011.10.041
   Klumpp H, 2010, COGNITIVE THER RES, V34, P263, DOI 10.1007/s10608-009-9251-0
   Kuckertz JM, 2014, BEHAV RES THER, V53, P30, DOI 10.1016/j.brat.2013.12.003
   Leichsenring F, 2007, B MENNINGER CLIN, V71, P56, DOI 10.1521/bumc.2007.71.1.56
   LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2
   Li SW, 2008, BEHAV RES THER, V46, P905, DOI 10.1016/j.brat.2008.04.005
   Lipsey M., 2001, PRACTICAL METAANALYS
   MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107
   MacLeod C, 2015, CLIN PSYCHOL SCI, V3, P58, DOI 10.1177/2167702614560749
   Mansell W, 2011, CLIN PSYCHOL REV, V31, P189, DOI 10.1016/j.cpr.2010.06.009
   Maoz K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00389
   Mayo-Wilson E, 2014, LANCET PSYCHIAT, V1, P368, DOI 10.1016/S2215-0366(14)70329-3
   McNally RJ, 2013, BEHAV RES THER, V51, P882, DOI 10.1016/j.brat.2013.10.001
   Mellings TMB, 2000, BEHAV RES THER, V38, P243, DOI 10.1016/S0005-7967(99)00040-6
   Menne-Lothmann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100925
   Mobini S, 2013, COGNITIVE THER RES, V37, P173, DOI 10.1007/s10608-012-9445-8
   Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Morrison AS, 2013, ANNU REV CLIN PSYCHO, V9, P249, DOI 10.1146/annurev-clinpsy-050212-185631
   Moser JS, 2012, BIOL PSYCHOL, V89, P387, DOI 10.1016/j.biopsycho.2011.12.001
   Mozolic JL, 2011, NEUROBIOL AGING, V32, P655, DOI 10.1016/j.neurobiolaging.2009.04.013
   Murphy R, 2007, BEHAV RES THER, V45, P1517, DOI 10.1016/j.brat.2007.01.007
   National Collaborating Centre for Mental Health, 2013, SOC ANX DIS REC ASS
   Neubauer K, 2013, BEHAV RES THER, V51, P87, DOI 10.1016/j.brat.2012.10.006
   Nowalcowski ME, 2015, J BEHAV THER EXP PSY, V49, P44, DOI 10.1016/j.jbtep.2015.04.004
   Opitz PC, 2012, NEUROBIOL AGING, V33, P645, DOI 10.1016/j.neurobiolaging.2010.06.004
   Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3
   Rapee RM, 2013, BEHAV RES THER, V51, P207, DOI 10.1016/j.brat.2013.01.005
   Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549
   Rinck M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00481
   Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023
   Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x
   Schmidt NB, 2009, J ABNORM PSYCHOL, V118, P5, DOI 10.1037/a0013643
   Schneier F., 2015, ANXIETY DISORDERS GE, P49
   Sportel BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064355
   Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2
   Steinman SA, 2010, J ANXIETY DISORD, V24, P71, DOI 10.1016/j.janxdis.2009.08.008
   Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640
   Stewart SH, 1997, J ANXIETY DISORD, V11, P179, DOI 10.1016/S0887-6185(97)00005-4
   Taylor CT, 2012, BEHAV RES THER, V50, P529, DOI 10.1016/j.brat.2012.05.004
   Turk CL, 1998, J ANXIETY DISORD, V12, P209, DOI 10.1016/S0887-6185(98)00010-3
   Van Bockstaele B, 2014, PSYCHOL BULL, V140, P682, DOI 10.1037/a0034834
   Vassilopoulos SP, 2016, J CHILD FAM STUD, V25, P299, DOI 10.1007/s10826-015-0194-7
   Vassilopoulos SP, 2013, BEHAV COGN PSYCHOTH, V41, P103, DOI 10.1017/S1352465812000537
   Vassilopoulos SP, 2009, BEHAV RES THER, V47, P1085, DOI 10.1016/j.brat.2009.07.018
   Wiers CE, 2016, NEUROIMAGE
   Williams AD, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004049
   Woody SR, 2015, ASIAN AM J PSYCHOL, V6, P47, DOI 10.1037/a0036548
   Xu Y, 2012, J ANXIETY DISORD, V26, P12, DOI 10.1016/j.janxdis.2011.08.006
   Zhao X, 2014, PERS INDIV DIFFER, V71, P108, DOI 10.1016/j.paid.2014.07.023
NR 111
TC 5
Z9 6
U1 3
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 6
PY 2017
VL 12
IS 4
AR e0175107
DI 10.1371/journal.pone.0175107
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ES2QB
UT WOS:000399371900086
PM 28384301
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Burkner, PC
   Bittner, N
   Holling, H
   Buhlmann, U
AF Buerkner, Paul-Christian
   Bittner, Nadine
   Holling, Heinz
   Buhlmann, Ulrike
TI D-cycloserine augmentation of behavior therapy for anxiety and
   obsessive-compulsive disorders: A meta-analysis
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL;
   POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; EXPOSURE THERAPY;
   CLINICAL-IMPLICATIONS; COGNITIVE ENHANCERS; FEAR EXTINCTION; PANIC
   DISORDER; BIAS
AB Objective
   The present meta-analysis investigates whether the antibiotic D-cycloserine (DCS), a partial agonist at the glutamatergic N-methyl-D- aspartate receptor, can augment the effect of behavior therapy in humans with anxiety and obsessive-compulsive disorders.
   Method
   A keyword-based computer search was conducted using common electronic databases. Only studies investigating the effect of DCS in humans with anxiety and obsessive-compulsive disorders were included, resulting in 23 studies with a combined sample size of 1314 patients. Effect sizes were coded as Hedges' g and SMCC, the latter also incorporating differences in pre-treatment values. Bayesian multilevel meta-analysis was applied to take dependencies of effect sizes obtained from the same study into account.
   Results
   While previous meta-analyses found small to moderate improvements, the current results including the most recent research indicate that the overall effect of DCS is very small and almost indistinguishable from zero (g = -0.12, CI =[-0.27, 0.02]; SMCC = -0.10,CI = [-0.29, 0.07]). Slightly larger effects were found for social anxious patients. Further, study quality and year of publication were relevant moderators, with higher quality / more recent studies reported smaller effects of DCS.
   Conclusions
   These findings raise the question of the usefulness of DCS as an augmentation of exposure therapy for anxiety and obsessive-compulsive disorders. At least, it seems to be less promising than initially thought. The fact that study quality was inversely related to the reported effect sizes underlines the importance of high quality primary research in order to avoid over-estimation of treatment effects in clinical psychology.
C1 [Buerkner, Paul-Christian; Bittner, Nadine; Holling, Heinz; Buhlmann, Ulrike] Univ Munster, Inst Psychol, Munster, Germany.
RP Buhlmann, U (reprint author), Univ Munster, Inst Psychol, Munster, Germany.
EM paul.buerkner@wwu.de; ulrike.buhlmann@wwu.de
OI Burkner, Paul-Christian/0000-0001-5765-8995
CR American Psychiatric Association, 2013, DIAGNOSTIC AND STATI
   American Psychiatric Association, 2000, DIAGNOSTIC AND STATI
   Andersson E, 2015, JAMA PSYCHIAT, V72, P659, DOI 10.1001/jamapsychiatry.2015.0546
   [Anonymous], 1992, THE ICD 10 CLASSIFIC
   Baldwin DS, 2005, J PSYCHOPHARMACOL, V19, P567, DOI 10.1177/0269881105059253
   Barlow DH, 2000, JAMA-J AM MED ASSOC, V283, P2529, DOI 10.1001/jama.283.19.2529
   BOJE KM, 1993, BRAIN RES, V603, P207, DOI 10.1016/0006-8993(93)91239-O
   Bontempo A, 2012, J CLIN PSYCHIAT, V73, P533, DOI 10.4088/JCP.11r07356
   Burkner PC., 2016, BRMS BAYESIAN REGRES
   Bystritsky A, 2006, MOL PSYCHIATR, V11, P805, DOI 10.1038/sj.mp.4001852
   Carpenter B, 2015, JOURNAL OF STATISTIC
   Clark DM, 2003, J CONSULT CLIN PSYCH, V71, P1058, DOI 10.1037/0022-006X.71.6.1058
   Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x
   de Kleine RA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21626
   de Kleine RA, 2012, BIOL PSYCHIAT, V71, P962, DOI 10.1016/j.biopsych.2012.02.033
   Deeks JJ, 2008, COCHRANE HDB SYSTEMA, P243, DOI DOI 10.1002/9780470712184.CH9
   Doi SAR, 2008, EPIDEMIOLOGY, V19, P94, DOI 10.1097/EDE.0b013e31815c24e7
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 2003, Health Technol Assess, V7, P1
   Farrell LJ, 2013, DEPRESS ANXIETY, V30, P723, DOI 10.1002/da.22132
   Foa EB, 2005, AM J PSYCHIAT, V162, P151, DOI 10.1176/appi.ajp.162.1.151
   Frantz J, 2009, G3DATA, V1
   Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hofmann SG, 2006, ARCHIVES OF GENERAL, V63
   Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621
   Hofmann SG, 2014, DEPRESS ANXIETY, V31, P175, DOI 10.1002/da.22257
   Hofmann SG, 2014, RESTOR NEUROL NEUROS, V32, P183, DOI 10.3233/RNN-139002
   Hofmann SG, 2013, AM J PSYCHIAT, V170, P751, DOI 10.1176/appi.ajp.2013.12070974
   Hopewell S, 2007, COCHRANE DATABASE SY
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   Hulley SB, 2013, DESIGNING CLINICAL R
   Huppert JD, 2009, DEPRESS ANXIETY, V26, P39, DOI 10.1002/da.20506
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020
   Litz BT, 2012, J PSYCHIATR RES, V46, P1184, DOI 10.1016/j.jpsychires.2012.05.006
   Mataix-Cols D., 2017, JAMA PSYCHIAT
   Mataix-Cols D, 2014, BRIT J PSYCHIAT, V204, P77, DOI 10.1192/bjp.bp.113.126284
   McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105
   Nave AM, 2012, J CLIN PSYCHIAT, V73, P1179, DOI 10.4088/JCP.11m07564
   Norberg MM, 2008, BIOL PSYCHIAT, V63, P1118, DOI 10.1016/j.biopsych.2008.01.012
   Otto MW, 2016, DEPRESS ANXIETY, V33, P737, DOI 10.1002/da.22531
   Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036
   Pollack MH, 2008, DEPRESS ANXIETY, V25, P467, DOI 10.1002/da.20329
   Rapee RM, 2016, BEHAV RES THER, V87, P225, DOI 10.1016/j.brat.2016.10.004
   Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136
   Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204
   Rodrigues H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093519
   Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625
   Rothstein HR, 2005, PUBLICATION BIAS IN
   Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94
   Scheeringa MS, 2014, J CHILD ADOL PSYCHOP, V24, P69, DOI 10.1089/cap.2013.0106
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Sheerin CM., 2013, SLOPE OF CHANGE THRO
   Siegmund A, 2011, J PSYCHIATR RES, V45, P1042, DOI 10.1016/j.jpsychires.2011.01.020
   Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632
   Stein DJ, 2000, CNS SPECTRUMS, V5, P37
   Sterne J. A. C., 2011, BMJ-BRIT MED J, V343, P1, DOI [10.1136/bmj.d4002, DOI 10.1136/BMJ.D4002]
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Storch EA, 2007, INT CLIN PSYCHOPHARM, V22, P230, DOI 10.1097/YIC.0b013e32819f8480
   Storch EA, 2016, JAMA PSYCHIAT, V73, P779, DOI 10.1001/jamapsychiatry.2016.1128
   Storch EA, 2010, BIOL PSYCHIAT, V68, P1073, DOI 10.1016/j.biopsych.2010.07.015
   Tart CD, 2013, J PSYCHIATR RES, V47, P168, DOI 10.1016/j.jpsychires.2012.09.024
   Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187
   Tritchler D, 1999, STAT MED, V18, P2135, DOI 10.1002/(SICI)1097-0258(19990830)18:16<2135::AID-SIM183>3.3.CO;2-X
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776
NR 70
TC 5
Z9 5
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 10
PY 2017
VL 12
IS 3
AR e0173660
DI 10.1371/journal.pone.0173660
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN6CJ
UT WOS:000396091800063
PM 28282427
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Birkhauer, J
   Gaab, J
   Kossowsky, J
   Hasler, S
   Krummenacher, P
   Werner, C
   Gerger, H
AF Birkhauer, Johanna
   Gaab, Jens
   Kossowsky, Joe
   Hasler, Sebastian
   Krummenacher, Peter
   Werner, Christoph
   Gerger, Heike
TI Trust in the health care professional and health outcome: A
   meta-analysis
SO PLOS ONE
LA English
DT Article
ID PHYSICIAN SCALE; INTERPERSONAL-TRUST; EMPIRICAL-EVIDENCE; PLACEBO; BIAS;
   COMMUNICATION; PROVIDERS; MEDICINE; DOCTORS; QUALITY
AB Objective
   To examine whether patients' trust in the health care professional is associated with health outcomes.
   Study selection
   We searched 4 major electronic databases for studies that reported quantitative data on the association between trust in the health care professional and health outcome. We screened the full-texts of 400 publications and included 47 studies in our meta-analysis.
   Data extraction and data synthesis
   We conducted random effects meta-analyses and meta-regressions and calculated correlation coefficients with corresponding 95% confidence intervals. Two interdependent researchers assessed the quality of the included studies using the Strengthening the Reporting of Observational Studies in Epidemiology guidelines.
   Results
   Overall, we found a small to moderate correlation between trust and health outcomes (r = 0.24, 95% CI: 0.19-0.29). Subgroup analyses revealed a moderate correlation between trust and self-rated subjective health outcomes (r = 0.30, 0.24-0.35). Correlations between trust and objective (r = -0.02, -0.08-0.03) as well as observer-rated outcomes (r = 0.10, -0.16-0.36) were non-significant. Exploratory analyses showed a large correlation between trust and patient satisfaction and somewhat smaller correlations with health behaviours, quality of life and symptom severity. Heterogeneity was small to moderate across the analyses.
   Conclusions
   From a clinical perspective, patients reported more beneficial health behaviours, less symptoms and higher quality of life and to be more satisfied with treatment when they had higher trust in their health care professional. There was evidence for upward bias in the summarized results. Prospective studies are required to deepen our understanding of the complex interplay between trust and health outcomes.
C1 [Birkhauer, Johanna; Gaab, Jens; Kossowsky, Joe; Hasler, Sebastian; Werner, Christoph; Gerger, Heike] Univ Basel, Dept Psychol, Clin Psychol & Psychotherapy, Basel, Switzerland.
   [Kossowsky, Joe] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA.
   [Kossowsky, Joe] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Program Placebo Studies & Therapeut Encounter, Boston, MA USA.
   [Krummenacher, Peter] Univ Zurich, Coll Helveticum, Zurich, Switzerland.
   [Krummenacher, Peter] Swiss Fed Inst Technol, Zurich, Switzerland.
RP Birkhauer, J (reprint author), Univ Basel, Dept Psychol, Clin Psychol & Psychotherapy, Basel, Switzerland.
EM j.birkhaeuer@unibas.ch
RI Gerger, Heike/Q-6862-2017
OI Gerger, Heike/0000-0002-7077-658X; Werner, Christoph
   Patrick/0000-0001-9250-4529
FU Swiss National Science Foundation [POBSP1_155446]
FX Johanna Birkhauer's contributions to this study were supported by the
   Swiss National Science Foundation (http://www.snf.ch), grant project
   (POBSP1_155446). The funder had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091
   BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006
   Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012
   Blendon RJ, 2014, NEW ENGL J MED, V371, P1570, DOI 10.1056/NEJMp1407373
   Boothroyd RA, 2008, EVAL HEALTH PROF, V31, P81, DOI 10.1177/0163278707311882
   Borenstein M, 2009, INTRO METAANALYSIS C
   Borenstein M, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P193
   Calnan Michael, 2006, J Health Organ Manag, V20, P349, DOI 10.1108/14777260610701759
   Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897
   Cohen J, 1988, STAT POWER ANAL BEHA
   Coulter A, 2002, BRIT MED J, V325, P668, DOI 10.1136/bmj.325.7366.668
   Croker JE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002762
   Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027
   Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6
   Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570
   Durant RW, 2010, ETHNIC DIS, V20, P282
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Freburger JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P51, DOI 10.1002/art.10925
   Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9
   Giordano GN, 2016, J EPIDEMIOL COMMUN H, V70, P10, DOI 10.1136/jech-2015-205822
   Gopichandran V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007305
   Graham JL, 2013, AIDS BEHAV, V17, P266, DOI 10.1007/s10461-011-0114-9
   Hall MA, 2002, MED CARE RES REV, V59, P293, DOI 10.1177/1077558702059003004
   Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223
   Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3
   Keating NL, 2004, ARCH INTERN MED, V164, P1015, DOI 10.1001/archinte.164.9.1015
   Kelley JM, 2014, PLOS ONE, V9
   Lee YY, 2011, PATIENT EDUC COUNS, V85, P406, DOI 10.1016/j.pec.2010.12.005
   Lee YY, 2008, BRIT J HOSP MED, V69, P42, DOI 10.12968/hmed.2008.69.1.28040
   Lewicki RJ, 2006, J MANAGE, V32, P991, DOI 10.1177/0149206306294405
   LINDEN M, 1988, FORTSCHR NEUROL PSYC, V56, P35, DOI 10.1055/s-2007-1001215
   Mechanic D, 1996, JAMA-J AM MED ASSOC, V275, P1693, DOI 10.1001/jama.275.21.1693
   Moustgaard H, 2014, J CLIN EPIDEMIOL, V67, P1327, DOI 10.1016/j.jclinepi.2014.06.020
   Nursing & Midwifery Council (NMC), COD NURS MIDW READ C
   Ommen O, 2011, INT J PUBLIC HEALTH, V56, P319, DOI 10.1007/s00038-010-0212-x
   Pearson SD, 2000, J GEN INTERN MED, V15, P509, DOI 10.1046/j.1525-1497.2000.11002.x
   Pfaff H. FD, 2003, KOLNER PATIENTENFRAG
   Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI [10.1186/1471-2288-8-79, DOI 10.1186/1471-2288-8-79]
   Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79
   Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012
   Sakallaris Bonnie R, 2016, Glob Adv Health Med, V5, P51, DOI 10.7453/gahmj.2015.085
   Schwarz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122051
   Shortell SM, 1998, JAMA-J AM MED ASSOC, V280, P1102, DOI 10.1001/jama.280.12.1102
   Simpson SH, 2006, BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55
   Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015
   The British Psychological Society, COD ETH COND GUID PU
   Thom DH, 1999, MED CARE, V37, P510, DOI 10.1097/00005650-199905000-00010
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Wampold BE, 2015, GREAT PSYCHOTHERAPY DEBATE: THE EVIDENCE FOR WHAT MAKES PSYCHOTHERAPY WORK, 2ND EDITION, P1
   Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319
   Weech-Maldonado R, 2012, MED CARE, V50, pS22, DOI 10.1097/MLR.0b013e318263134b
   Wood L, 2008, BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD
   Wright EB, 2004, BMJ-BRIT MED J, V328, P864, DOI 10.1136/bmj.38046.771308.7C
NR 54
TC 26
Z9 26
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 7
PY 2017
VL 12
IS 2
AR e0170988
DI 10.1371/journal.pone.0170988
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK1SG
UT WOS:000393705500015
PM 28170443
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cristea, IA
   Gentili, C
   Pietrini, P
   Cuijpers, P
AF Cristea, Ioana A.
   Gentili, Claudio
   Pietrini, Pietro
   Cuijpers, Pim
TI Is investigator background related to outcome in head to head trials of
   psychotherapy and pharmacotherapy for adult depression? A systematic
   review and meta-analysis
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CLINICAL-TRIALS; BIAS
AB Background
   The influence of factors related to the background of investigators conducting trials comparing psychotherapy and pharmacotherapy has remained largely unstudied. Specializations emphasizing biological determinants of mental disorders, like psychiatry, might favor pharmacotherapy, while others stressing psychosocial factors, like psychology, could promote psychotherapy. Yet financial conflict of interest (COI) could be a confounding factor as authors with a medical specialization might receive more sponsoring from the pharmaceutical industry.
   Method
   We conducted a meta-analysis with subgroup and meta-regression analysis examining whether the specialization and affiliation of trial authors were associated to outcomes in the direct comparison of psychotherapy and pharmacotherapy for the acute treatment of depression. Meta-regression analysis also included trial risk of bias and author conflict of interest in relationship to the pharmaceutical industry.
   Results
   We included 45 trials. In half, the first author was psychologist. The last author was psychiatrist/MD in half of the trials, and a psychologist or statistician/other technical in the rest. Most lead authors had medical affiliations. Subgroup analysis indicated that studies with last authors statisticians favored pharmacotherapy. Univariate analysis showed a negative relationship between the presence of statisticians and outcomes favoring psychotherapy. Multivariate analysis showed that trials including authors with financial COI reported findings more favorable to pharmacotherapy.
   Discussion
   We report the first detailed overview of the background of authors conducting head to head trials for depression. Trials co-authored by statisticians appear to subtly favor pharmacotherapy. Receiving funding from the industry is more closely related to finding better outcomes for the industry's elective treatment than are factors related to authors' background.
   Limitations
   For a minority of authors we could not retrieve background information. The number of trials was insufficient to evidence subtler effects.
C1 [Cristea, Ioana A.] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania.
   [Cristea, Ioana A.] Stanford Univ, Metares Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.
   [Gentili, Claudio] Univ Padua, Dept Gen Psychol, Padua, Italy.
   [Pietrini, Pietro] IMT Inst Adv Studies, Lucca, Italy.
   [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Cuijpers, Pim] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
RP Cristea, IA (reprint author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania.; Cristea, IA (reprint author), Stanford Univ, Metares Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.
EM ioana.cristea@ubbcluj.ro
RI Cristea, Ioana Alina/E-7490-2011; Cuijpers, Pim/G-1703-2013
OI Cristea, Ioana Alina/0000-0002-9854-7076; Pietrini,
   Pietro/0000-0002-6768-5556
FU Romanian National Authority for Scientific Research and Innovation
   (Unitatea Executiva pentru Finantarea Invatamantului Superior, a
   Cercetarii, Dezvoltarii si Inovarii) CNCS - UEFISCDI
   [PN-II-RU-TE-2014-4-1316]
FX Ioana A. Cristea was supported for this work by a grant of the Romanian
   National Authority for Scientific Research and Innovation (Unitatea
   Executiva pentru Finantarea Invatamantului Superior, a Cercetarii,
   Dezvoltarii si Inovarii) CNCS - UEFISCDI, project number
   PN-II-RU-TE-2014-4-1316 awarded to Ioana A. Cristea. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Borenstein M., 2009, INTRO METAANALYSIS
   Cristea IA, 2016, BR J PSYCHIAT
   Cuijpers P, 2016, EPIDEMIOL PSYCH SCI, V25, P428, DOI 10.1017/S2045796015000864
   Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114
   Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038
   Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eisner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142803
   Gournay K, 2000, J ADV NURS, V32, P343, DOI 10.1046/j.1365-2648.2000.01482.x
   Hedges L. V., 1985, STAT METHODS METAANA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Imel ZE, 2008, J AFFECT DISORDERS, V110, P197, DOI 10.1016/j.jad.2008.03.018
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8
   Krogh J, 2015, J AFFECT DISORDERS, V179, P121, DOI 10.1016/j.jad.2015.03.042
   Orsini N., 2006, HETEROGI STATA MODUL
   Peron J, 2013, ANTI-CANCER DRUG, V24, P306, DOI 10.1097/CAD.0b013e32835c3561
   Siddiqui O, 2009, J BIOPHARM STAT, V19, P227, DOI 10.1080/10543400802609797
   White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40
NR 21
TC 0
Z9 0
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2017
VL 12
IS 2
AR e0171654
DI 10.1371/journal.pone.0171654
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7DG
UT WOS:000396161700118
PM 28158281
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, JS
   Kwon, SH
AF Kim, Jong Seung
   Kwon, Sam Hyun
TI Mupirocin in the Treatment of Staphylococcal Infections in Chronic
   Rhinosinusitis: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID BACTERIAL BIOFILMS; CONFIDENCE-INTERVALS; PUBLICATION BIAS; SINUS
   SURGERY; AUREUS; SUPERANTIGENS; IRRIGATION; EFFICACY; AGENTS; SALINE
AB Background
   Saline irrigation of the nasal cavity is a classic and effective treatment for acute or chronic rhinosinusitis. Topical antibiotics such as mupirocin have been widely used for recalcitrant chronic rhinosinusitis. Therefore, the purpose of this study was to evaluate the effect of saline irrigation using mupirocin.
   Methods
   A systematic literature review and meta-analysis of mupirocin saline irrigation were performed using EMBASE, MEDLINE, and Cochrane library through December 2015. Data were analyzed with R 3.2.2 software. A random effects model was used because of the diversity of included studies. Sensitivity analysis of particular tested groups and single proportion tests were also performed. The main outcome measure was residual staphylococcal infection, as confirmed by culture or PCR.
   Results
   Two RCTs, two prospective studies and two retrospective studies were included. A random effects model meta-analysis of the pooled data identified a relative risk of residual infection of 0.13 (95% CI: 0.06-0.26, p<0.05) with low heterogeneity (I-2 = 0%). The proportion of residual staphylococcal infections after 1 month was 0.08 (95% Cl: 0.04-0.16). However, this proportion increased to 0.53 at 6 months (95% Cl: 0.27-0.78).
   Conclusions
   The short-term use of mupirocin has a strongly reductive effect on staphylococcal infection in chronic rhinosinusitis. Although there is currently a lack of clear evidence, future studies with well-designed inclusion criteria and randomized controlled trials are needed to examine mupirocin's long-term effect on chronic rhinosinusitis.
C1 [Kim, Jong Seung; Kwon, Sam Hyun] Chonbuk Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Jeonju, South Korea.
   [Kim, Jong Seung; Kwon, Sam Hyun] Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Chonbuk Natl Univ Hosp, Jeonju, South Korea.
RP Kwon, SH (reprint author), Chonbuk Natl Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Jeonju, South Korea.; Kwon, SH (reprint author), Chonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Chonbuk Natl Univ Hosp, Jeonju, South Korea.
EM shkwon@jbnu.ac.kr
OI Kim, Jong Seung/0000-0002-1384-6799
FU Biomedical Research Institute at Chonbuk National University Hospital
FX This paper was supported by a fund of the Biomedical Research Institute
   at Chonbuk National University Hospital.
CR Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781
   Al-Mutairi D, 2011, CURR OPIN ALLERGY CL, V11, P18, DOI 10.1097/ACI.0b013e3283423376
   Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f
   Barham HP, 2015, BRAZ J OTORHINOLAR, V81, P457, DOI 10.1016/j.bjorl.2015.07.002
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Borenstein M, 2009, INTRO METAANALYSIS, P84
   Brown Christopher L, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P9, DOI 10.1097/00020840-200402000-00004
   Brown CL, 2004, LARYNGOSCOPE, V114, P2021, DOI 10.1097/01.mlg.0000147939.90249.47
   Conley DB, 2006, AM J RHINOL, V20, P451, DOI 10.2500/ajr.2006.20.2880
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DOEBBELING BN, 1994, ARCH INTERN MED, V154, P1505, DOI 10.1001/archinte.154.13.1505
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Edmundson SP, 2011, EUR J CLIN MICROBIOL, V30, P1063, DOI 10.1007/s10096-011-1192-3
   Ezzat WF, 2015, EUR ARCH OTO-RHINO-L, V272, P2355, DOI 10.1007/s00405-014-3301-2
   Grossman EM, 2012, J DRUGS DERMATOL, V11, P1490
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jervis-Bardy J, 2012, LARYNGOSCOPE, V122, P2148, DOI 10.1002/lary.23486
   Jervis-Bardy J, 2012, INT FORUM ALLERGY RH, V2, P111, DOI 10.1002/alr.20106
   Khalil Yaser, 2011, Ear Nose Throat J, V90, pE1
   Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482
   Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136
   Matthijs S, 2014, RES MICROBIOL, V165, P695, DOI 10.1016/j.resmic.2014.09.009
   McConeghy KW, 2009, PHARMACOTHERAPY, V29, P263, DOI 10.1592/phco.29.3.263
   Moore EJ, 2001, AM J RHINOL, V15, P355, DOI 10.1177/194589240101500601
   Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
   Nikfar R, 2015, IRAN J MICROBIOL, V7, P67
   Ou J, 2016, INT FORUM ALLERGY RH, V6, P792, DOI 10.1002/alr.21758
   Park SH, 2015, ANN DERMATOL, V27, P551, DOI 10.5021/ad.2015.27.5.551
   Psaltis AJ, 2008, AM J RHINOL, V22, P1, DOI 10.2500/ajr.2008.22.3119
   Rezai MS, 2016, CASP J INTERN MED, V7, P114
   Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549
   Rohrer JW, 2012, AM J RHINOL ALLERGY, V26, P197, DOI 10.2500/ajra.2012.26.3761
   Rotenberg BW, 2011, LARYNGOSCOPE, V121, P2702, DOI 10.1002/lary.22396
   Seiberling KA, 2013, INT FORUM ALLERGY RH, V3, P94, DOI 10.1002/alr.21076
   Solares CA, 2006, AM J OTOLARYNG, V27, P161, DOI 10.1016/j.amjoto.2005.09.006
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   Uren B, 2008, LARYNGOSCOPE, V118, P1677, DOI 10.1097/MLG.0b013e31817aec47
   Xie S, 2015, CANCER MED-US, V4, P1639, DOI 10.1002/cam4.504
   Zabner J, 2000, P NATL ACAD SCI USA, V97, P11614, DOI 10.1073/pnas.97.21.11614
   Zhang N, 2005, RHINOLOGY, V43, P162
NR 43
TC 4
Z9 4
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 1
PY 2016
VL 11
IS 12
AR e0167369
DI 10.1371/journal.pone.0167369
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE3JC
UT WOS:000389482700132
PM 27907108
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, SG
   Xin, XY
   Hua, T
   Shi, R
   Chi, SQ
   Jin, ZS
   Wang, HB
AF Liu, Shuangge
   Xin, Xiaoyan
   Hua, Teng
   Shi, Rui
   Chi, Shuqi
   Jin, Zhishan
   Wang, Hongbo
TI Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID GROWTH-FACTOR; PUBLICATION BIAS; MOUSE MODEL; RAT MODEL; THERAPY;
   ANGIOGENESIS; INHIBITION; SORAFENIB; VEGF; SUNITINIB
AB Background/Objective
   Vascular endothelial growth factor (VEGF) is the most important promotor of angiogenesis. Some studies indicate that anti-angiogenic agents that interfere with VEGF and its receptor (VEGFR), i.e., anti-VEGF/VEGFR agents, may be applied to treat endometriosis. This meta-analysis investigated the efficacy of anti-VEGF/VEGFR agents in animal models of endometriosis.
   Methods
   A systematic literature search was performed for animal studies published in English or Chinese from January 1995 to June 2016, which evaluated the effect of anti-VEGF/VEGFR agents on endometriosis. The databases were: PubMed, Web of Science, BIOSIS, Embase, and CNKI. The quality of included studies was assessed using the SYRCLE tool. The random-effect models were used to combine the results of selected studies. Heterogeneity was assessed using H-2 statistic and I-2 statistic. Subgroup analyses were performed to determine the source of heterogeneity in endometriosis scores and follicle numbers.
   Results
   We identified 13 studies that used anti-VEGF/VEGFR agents in various animal models. The meta-analysis showed that anti-VEGF/VEGFR agents were associated with smaller size (standardized mean difference (SMD) -0.96, 95% CI - 1.31 to -0.62; P < 0.0001) and weight (SMD-1.70, 95% CI -2.75 to -0.65; P = 0.002) of endometriosis lesions, relative to the untreated controls, as well as a lower incidence rate of endometriosis (risk ratio 0.26, 95% CI 0.07 to 0.93; P = 0.038) and endometriosis score (SMD -1.17, 95% CI -1.65 to -0.69; P < 0.0001); the number of follicles were similar (SMD -0.78, 95% CI -1.65 to 0.09; P = 0.08).
   Conclusions
   Anti-VEGF/VEGFR agents appeared to inhibit the growth of endometriosis, with no effect on ovarian function. Anti-angiogenic therapy may be a novel strategy in treating endometriosis.
C1 [Liu, Shuangge; Xin, Xiaoyan; Hua, Teng; Shi, Rui; Chi, Shuqi; Jin, Zhishan; Wang, Hongbo] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China.
RP Wang, HB (reprint author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China.
EM whbdoc@163.com
CR Abbas MA, 2013, EUR J PHARM SCI, V49, P732, DOI 10.1016/j.ejps.2013.05.021
   Becker CM, 2006, FERTIL STERIL, V85, P71, DOI 10.1016/j.fertnstert.2005.07.1290
   Becker CM, 2005, FERTIL STERIL, V84, P1144, DOI 10.1016/j.fertnstert.2005.04.040
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650
   Delgado-Rosas F, 2011, REPRODUCTION, V142, P745, DOI 10.1530/REP-11-0223
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ricci AG, 2011, REPROD SCI, V18, P614, DOI 10.1177/1933719110395406
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5
   Groothuis P. G., 2005, Angiogenesis, V8, P147, DOI 10.1007/s10456-005-9005-x
   Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hong SD, 2015, J CANCER RES CLIN, V141, P909, DOI 10.1007/s00432-014-1862-5
   Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43
   Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912
   [蒋红清 JIANG Hongqing], 2007, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V23, P361
   Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813
   Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930
   Krajewska J, 2015, EXPERT OPIN PHARMACO, V16, P573, DOI 10.1517/14656566.2015.1005601
   Laschke MW, 2012, HUM REPROD UPDATE, V18, P682, DOI 10.1093/humupd/dms026
   Laschke MW, 2006, HUM REPROD, V21, P262, DOI 10.1093/humrep/dei308
   Leconte M, 2015, REPROD SCI, V22, P1171, DOI 10.1177/1933719115592708
   Light RJ, 1984, SUMMING SCI REV RES
   Liu F, 2015, INT J CLIN EXP PATHO, V8, P1165
   Meuleman C, 2009, FERTIL STERIL, V92, P68, DOI 10.1016/j.fertnstert.2008.04.056
   Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692
   Moraloglu O, 2011, FERTIL STERIL, V95, P2638, DOI 10.1016/j.fertnstert.2011.02.005
   Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406
   Novella-Maestre E, 2012, FERTIL STERIL, V98, P1209, DOI 10.1016/j.fertnstert.2012.07.1103
   Novella-Maestre E, 2009, HUM REPROD, V24, P1025, DOI 10.1093/humrep/den499
   Ozer H, 2013, REPROD SCI, V20, P26, DOI 10.1177/1933719112452941
   Pala HG, 2015, J OBSTET GYNAECOL, V35, P183, DOI 10.3109/01443615.2014.941345
   Park A, 2004, FERTIL STERIL, V82, pS71, DOI 10.1016/j.fertnstert.2004.07.181
   Sevket O, 2013, REPROD SCI, V20, P1224, DOI 10.1177/1933719113483012
   Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073
   Song WW, 2014, INT J CLIN EXP PATHO, V7, P7752
   Soysal D, 2014, BALK J MED GENET, V17, P73, DOI 10.2478/bjmg-2014-0077
   Yildiz C, 2015, REPROD SCI, V22, P1445, DOI 10.1177/1933719115584448
   Zhang TT, 2012, J INT MED RES, V40, P1840, DOI 10.1177/030006051204000522
NR 41
TC 4
Z9 6
U1 0
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2016
VL 11
IS 11
AR e0166658
DI 10.1371/journal.pone.0166658
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC2AC
UT WOS:000387910200042
PM 27855197
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gao, LL
   Gu, Y
   Yin, XH
AF Gao, Lingling
   Gu, Yang
   Yin, Xianghua
TI High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic
   Ovary Syndrome: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID NORMAL-WEIGHT WOMEN; SUBCUTANEOUS ADIPOSE-TISSUE; GRADE CHRONIC
   INFLAMMATION; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; SYNDROME PCOS;
   TNF-ALPHA; DIABETES-MELLITUS; GLUCOSE-INGESTION; PERIPHERAL-BLOOD
AB The objective of the study is to assess the TNF-alpha levels in PCOS patients and healthy controls. A comprehensive electronic search in Medline, Embase, and the Cochrane Library database was conducted up to July 2016. Random-effects model was used to estimate the standardized mean differences (SMDs) with 95% confidence intervals (CIs). Twenty-nine studies with a total of 1960 participants (1046 PCOS patients and 914 controls) were included in this meta-analysis. The TNF-alpha levels in PCOS patients were significantly higher than those in controls (random-effects, SMD = 0.60, 95% CI = 0.28-0.92, P<0.001). With regard to the subgroup analyses stratified by ethnicity, study quality, methods, and BMI, significantly high TNF-alpha levels were found in patients with PCOS in almost all of these subgroups. In the subgroup stratified by HOMA-IR ratio and T ratio, significant differences were only observed in the subgroups with HOMA-IR ratio of >1.72(SMD = 0.967, 95% CI = 0.103-1.831, P = 0.028, I-2 = 93.5%) and T ratio>2.10 (SMD = 1.420, 95% CI = 0.429-2.411, P = 0.005, I-2 = 96.1%). By meta-regression it was suggested that ethnicity might contribute little to the heterogeneity between the included studies. Through cumulative meta-analysis and sensitivity analysis it was supposed that the higher TNF-alpha levels of PCOS patients compared to healthy controls was stable and reliable. This meta-analysis suggests that the circulating TNF-alpha levels in women with PCOS are significantly higher than those in healthy controls. It may be involved in promoting insulin resistance and androgen excess of PCOS.
C1 [Gao, Lingling; Gu, Yang; Yin, Xianghua] Yangzhou Univ, Clin Med Coll, Dept Obstet & Gynecol, Subei Peoples Hosp Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China.
RP Yin, XH (reprint author), Yangzhou Univ, Clin Med Coll, Dept Obstet & Gynecol, Subei Peoples Hosp Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China.
EM yinxh1965@126.com
FU National Natural Science Foundation of China [81401173]; Natural Science
   Foundation from Yangzhou [YZ2014021]
FX This research was supported by National Natural Science Foundation of
   China (81401173), and Natural Science Foundation from Yangzhou
   (YZ2014021).
CR Agacayak E, 2015, MED SCI MONITOR, V21, P2446, DOI 10.12659/MSM.894368
   Almario RU, 2015, HORM METAB RES, V47, P152, DOI 10.1055/s-0034-1384521
   Amato G, 2003, OBSTET GYNECOL, V101, P1177, DOI 10.1016/S0029-7844(03)00233-3
   Araya AV, 2002, EUR CYTOKINE NETW, V13, P419
   Arikan S, 2009, FERTIL STERIL, V91, P450, DOI 10.1016/j.fertnstert.2007.11.057
   Choi YS, 2012, STEROIDS, V77, P1352, DOI 10.1016/j.steroids.2012.08.005
   Covington JD, 2016, BIOCHIMIE, V124, P27, DOI 10.1016/j.biochi.2014.10.028
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036
   Escobar-Morreale HF, 2003, DIABETOLOGIA, V46, P625, DOI 10.1007/s00125-003-1090-z
   Escobar-Morreale HF, 2001, J CLIN ENDOCR METAB, V86, P3761, DOI 10.1210/jc.86.8.3761
   FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307
   Gao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067727
   Gonzalez F, 1999, METABOLISM, V48, P437, DOI 10.1016/S0026-0495(99)90100-2
   Gonzalez F, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.044
   Gonzalez F, 2014, J CLIN ENDOCR METAB, V99, pE2244, DOI 10.1210/jc.2014-2046
   Gonzalez F, 2012, J CLIN ENDOCR METAB, V97, P4071, DOI 10.1210/jc.2012-2131
   Gower BA, 2015, J NUTR, V145, P177, DOI 10.3945/jn.114.195065
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Barcellos CRG, 2015, HORM-INT J ENDOCRINO, V14, P251, DOI 10.14310/horm.2002.1584
   Halawa B, 1999, Pol Arch Med Wewn, V101, P197
   HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495
   Huang ZH, 2013, J CLIN ENDOCR METAB, V98, pE17, DOI 10.1210/jc.2012-2697
   Ilie IR, 2011, CENT EUR J MED, V6, P64, DOI 10.2478/s11536-010-0054-1
   Jakubowska J, 2008, GYNECOL ENDOCRINOL, V24, P378, DOI 10.1080/09513590802128968
   Kawamura S, 2011, NEUROPSYCH DIS TREAT, V7, P655, DOI 10.2147/NDT.S25504
   Knebel B, 2008, EXP CLIN ENDOCR DIAB, V116, P481, DOI 10.1055/s-2008-1058085
   Lee H, 2013, KOREAN J INTERN MED, V28, P456, DOI 10.3904/kjim.2013.28.4.456
   Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165
   Legro RS, 2003, ENDOCR REV, V24, P302, DOI 10.1210/er.2003-0004
   Li S, 2013, HORM METAB RES, V45, P802, DOI 10.1055/s-0033-1345186
   Lindholm A, 2011, HUM REPROD, V26, P1478, DOI 10.1093/humrep/der096
   Moran LJ, 2007, J CLIN ENDOCR METAB, V92, P2944, DOI 10.1210/jc.2006-2336
   Olszanecka-Glinianowicz M, 2007, EUR J OBSTET GYN R B, V133, P197, DOI 10.1016/j.ejogrb.2006.10.037
   Olszanecka-Glinianowicz Magdalena, 2008, Endokrynol Pol, V59, P13
   Omu AE, 2003, ACTA OBSTET GYN SCAN, V82, P603, DOI 10.1034/j.1600-0412.2003.00045.x
   Oner G, 2013, J OBSTET GYNAECOL, V33, P289, DOI 10.3109/01443615.2012.751365
   Oner G, 2011, EUR J OBSTET GYN R B, V159, P127, DOI 10.1016/j.ejogrb.2011.07.005
   Ozcaka O, 2012, J PERIODONTOL, V83, P1529, DOI 10.1902/jop.2012.110588
   Pawelczak M, 2014, J PEDIATR ADOL GYNEC, V27, P356, DOI 10.1016/j.jpag.2014.01.104
   Puder JJ, 2006, EUR J CLIN INVEST, V36, P883, DOI 10.1111/j.1365-2362.2006.01734.x
   Puder JJ, 2005, J CLIN ENDOCR METAB, V90, P6014, DOI 10.1210/jc.2005-1002
   Alvarado MMR, 2012, NUTR HOSP, V27, P1751, DOI 10.3305/nh.2012.27.6.6004
   Samy N, 2009, DIS MARKERS, V26, P163, DOI 10.3233/DMA-2009-0627
   Sayin NC, 2003, J REPROD MED, V48, P165
   Seow KM, 2011, HUM REPROD, V26, P431, DOI 10.1093/humrep/deq351
   Shroff R, 2007, J CLIN ENDOCR METAB, V92, P4609, DOI 10.1210/jc.2007-1343
   Soares GM, 2009, CLIN ENDOCRINOL, V71, P406, DOI 10.1111/j.1365-2265.2008.03506.x
   dos Santos ACS, 2015, GYNECOL ENDOCRINOL, V31, P225, DOI 10.3109/09513590.2014.976546
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   STEPHENS JM, 1991, J BIOL CHEM, V266, P21839
   Svendsen PF, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.056
   Tao T, 2012, EUR J ENDOCRINOL, V167, P705, DOI 10.1530/EJE-12-0340
   Tarkun Ilhan, 2006, Metabolic Syndrome and Related Disorders, V4, P122, DOI 10.1089/met.2006.4.122
   Thathapudi S, 2014, GENET TEST MOL BIOMA, V18, P605, DOI 10.1089/gtmb.2014.0151
   Thomann R, 2008, GYNECOL ENDOCRINOL, V24, P199, DOI 10.1080/09513590801893398
   Toulis KA, 2011, HUM REPROD UPDATE, V17, P741, DOI 10.1093/humupd/dmr025
   Vgontzas AN, 2006, METABOLISM, V55, P1076, DOI 10.1016/j.metabol.2006.04.002
   Vgontzas AN, 2003, J INTERN MED, V254, P32, DOI 10.1046/j.1365-2796.2003.01177.x
   Victor VM, 2015, ATHEROSCLEROSIS, V242, P167, DOI 10.1016/j.atherosclerosis.2015.07.017
   Victor VM, 2011, J CLIN ENDOCR METAB, V96, P3115, DOI 10.1210/jc.2011-0651
   Victor VM, 2009, J CLIN ENDOCR METAB, V94, P3505, DOI 10.1210/jc.2009-0466
   Wang YX, 2012, J REPROD CONTRACEPT, V23, P237
   Xiong YL, 2011, EUR J OBSTET GYN R B, V159, P148, DOI 10.1016/j.ejogrb.2011.07.012
NR 64
TC 9
Z9 11
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 20
PY 2016
VL 11
IS 10
AR e0164021
DI 10.1371/journal.pone.0164021
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ9NZ
UT WOS:000386204500016
PM 27764100
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Peng, F
   Li, H
   Ning, ZZ
   Yang, ZY
   Li, HR
   Wang, YG
   Chen, F
   Wu, Y
AF Peng, Fei
   Li, Hui
   Ning, Zhaoze
   Yang, Zhenyu
   Li, Hongru
   Wang, Yonggang
   Chen, Fang
   Wu, Yi
TI CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID MATRIX METALLOPROTEINASE INDUCER; RADICAL PROSTATECTOMY; EXPRESSION;
   CARCINOMA; RECURRENCE; PROGNOSIS; ANTIGEN; CELLS; TRIAL; MEN
AB Background
   Prostate cancer is one of the most common non-cutaneous malignancies in men. We aimed to systemically evaluate the relationship between the expression of CD147 in tissues and the clinicopathological features of prostate cancer.
   Methods and Findings
   PubMed (1966-2016), EMBASE (1980-2016), the Cochrane Library (1996-2016), Web of Science (1945-2016), China National Knowledge Infrastructure (1982-2016), and the WanFang databases (1988-2016) were searched. Literature quality assessment was performed with the Newcastle-Ottawa Scale. Meta-analysis was performed by using Review Manager 5.3 and Stata 13.0. A total of 12591 prostate cancer patients from 14 studies were included. The results of the meta-analysis showed that there were significant differences in the positive expression rate in the following comparisons: prostatic cancer tissues vs. normal prostate tissues (odds ratio [OR] = 26.93, 95% confidence interval [CI] 7.95-91.20, P < 0.00001), prostatic cancer tissues vs. benign prostatic hyperplasia tissues (OR = 20.54, 95% CI 8.20-51.44, P < 0.00001), high Gleason score vs. low Gleason score (OR = 2.39, 95% CI 1.33-4.27, P = 0.03), TNM III to IV vs. TNM I to II (OR = 9.95, 95% CI 4.96-19.96, P < 0.00001), low or moderate differentiation vs. high differentiation (OR = 8.12, 95% CI 3.69-17.85, P < 0.00001), lymph node metastasis vs. non-lymph node metastasis (OR = 4.31, 95% CI 1.11-16.71, P = 0.03), and distant metastasis vs. non-distant metastasis (OR = 8.90, 95% CI 3.24-24.42, P < 0.00001). Conclusion
   The CD147 positive expression rate was closely related to the clinical characteristics of prostate cancer, but more research is needed to confirm the findings owing to the results of the subgroups.
C1 [Peng, Fei; Ning, Zhaoze; Chen, Fang; Wu, Yi] Peoples Hosp Hunan Prov, Changsha, Hunan, Peoples R China.
   [Li, Hui; Wang, Yonggang] Cent S Univ, Xiangya Hosp, Dept Reprod, Changsha, Hunan, Peoples R China.
   [Yang, Zhenyu] Cent S Univ, Xiangya Hosp, Urol, Changsha, Hunan, Peoples R China.
   [Li, Hongru] Cent S Univ, Xiangya Med Sch, Changsha, Hunan, Peoples R China.
RP Wu, Y (reprint author), Peoples Hosp Hunan Prov, Changsha, Hunan, Peoples R China.
EM wuyi19701210@outlook.com
CR Bauman TM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1559-4
   Bi XC, 2011, CLIN INVEST MED, V34, pE358
   Cai CY, 2015, J CLIN RES, V32, P2088
   Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054
   Chen WH, 2016, ONCOL LETT, V11, P1375, DOI 10.3892/ol.2015.4070
   Chen Zhong, 2013, CHINESE J CRITICAL C, V33, P34
   Cho Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147191
   Chu DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101027
   Dai L, 2013, AM J PATHOL, V182, P577, DOI 10.1016/j.ajpath.2012.10.011
   Dogru EB, 2014, TUMOR BIOL, V35, P11647, DOI 10.1007/s13277-014-2514-8
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Feng ME, 2010, J NANCHANG U, V50, P12
   Fu ZG, 2016, ONCOTARGET, V7, P9430, DOI 10.18632/oncotarget.6990
   Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6
   Grupp K, 2013, EXP MOL PATHOL, V95, P227, DOI 10.1016/j.yexmp.2013.08.002
   Han ZD, 2009, PATHOL ONCOL RES, V15, P369, DOI 10.1007/s12253-008-9131-z
   Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749
   Hochreiter WW, 2008, ANDROLOGIA, V40, P130, DOI 10.1111/j.1439-0272.2007.00820.x
   Huang JL, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE SECURITY AND RELIABILITY (QRS 2015), P37, DOI 10.1109/QRS.2015.16
   Huang JL, 2013, EUR J PHARMACOL, V698, P429, DOI 10.1016/j.ejphar.2012.10.030
   Ito K, 2013, WORLD J UROL, V31, P305, DOI 10.1007/s00345-012-0927-9
   Javanmard B, 2014, UROL J, V11, P1788
   Kaira K, 2015, AM J TRANSL RES, V7, P356
   Kristiansen G, 2016, PATHOLOGE, V37, P17, DOI 10.1007/s00292-015-0136-6
   Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5
   Ma Zhen, 2014, EXPRESSION CD147 MMP
   Madigan MC, 2008, CANCER IMMUNOL IMMUN, V57, P1367, DOI 10.1007/s00262-008-0473-x
   Marchiq I, 2015, CANCER RES, V75, P171, DOI 10.1158/0008-5472.CAN-14-2260
   Martinez-Salamanca JI, 2011, EUR UROL, V59, P120, DOI 10.1016/j.eururo.2010.10.001
   Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7
   Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312
   Schroder FH, 2015, J UROLOGY, V194, P392
   Spratt DE, 2016, BJU INT, V118, P763, DOI 10.1111/bju.13488
   Vasiljevic N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-655
   Wang Q, 2015, GENET MOL RES, V14, P6844, DOI 10.4238/2015.June.18.27
   Wang SY, 2013, CHIN J CANCER, V32, P342, DOI 10.5732/cjc.012.10161
   Wells GA, 2000, NEWCASTLE OTTAWA SCA
   Zhao J, 2015, ONCOL REP, V34, P67, DOI 10.3892/or.2015.3999
   Zhao LY, 2014, CANCER EPIDEM BIOMAR, V23, P1047, DOI 10.1158/1055-9965.EPI-13-0696
   Zhong W D, 2009, CHINA J MODERN MED, V19, p[801, 810]
   Zhong WD, 2012, INT J CANCER, V130, P300, DOI 10.1002/ijc.25982
   Zou Jun, 2007, CHINESE J UROLOGY, V28, P763
NR 42
TC 9
Z9 9
U1 4
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 29
PY 2016
VL 11
IS 9
AR e0163678
DI 10.1371/journal.pone.0163678
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DX4CV
UT WOS:000384328500094
PM 27684938
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kim, YG
   Shim, J
   Choi, JI
   Kim, YH
AF Kim, Yun Gi
   Shim, Jaemin
   Choi, Jong-Il
   Kim, Young-Hoon
TI Radiofrequency Catheter Ablation Improves the Quality of Life Measured
   with a Short Form-36 Questionnaire in Atrial Fibrillation Patients: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID ANTIARRHYTHMIC-DRUG THERAPY; PULMONARY-VEIN ABLATION; FOLLOW-UP;
   PROCEDURAL OUTCOMES; 1ST-LINE TREATMENT; RHYTHM MANAGEMENT; PUBLICATION
   BIAS; IMPACT; PERFORMANCE; DEPRESSION
AB Background
   The main purpose of performing radiofrequency catheter ablation (RFCA) in atrial fibrillation (AF) patients is to improve the quality of life (QoL) and alleviate AF-related symptoms. We aimed to determine the qualitative and quantitative effects of RFCA on the QoL in AF patients.
   Methods
   We performed a systemic review and meta-analysis using a random effects model. We searched for the studies that reported the physical component summary score (PCS) and mental component summary score (MCS) of the short form-36, a validated system to assess and quantify the QoL, before and after RFCA in AF patients. PCS and MCS are T-scores with a mean of 50 and standard deviation of 10.
   Results
   Of the 470 studies identified through systematic search, we included 13 studies for pre-RFCA vs. the post-RFCA analysis and 5 studies for treatment success vs. AF recurrence analyses. In the pre-RFCA vs. post-RFCA analysis, RFCA was associated with a significant increase in both the PCS (weighted mean difference [WMD] = 6.33 [4.81-7.84]; p < 0.001) and MCS (WMD = 7.80 [6.15-9.44]; p < 0.001). The Delta PCS (post-RFCA PCS-pre-RFCA PCS) and Delta MCS values were used for the treatment success vs. AF recurrence analysis. Patients with successful ablation had a higher Delta PCS (WMD = 7.46 [4.44-10.49]; p < 0.001) and Delta MCS (WMD = 7.59 [4.94-10.24]; p < 0.001).
   Conclusions
   RFCA is associated with a significant increase in the PCS and MCS in AF patients. Patients without AF recurrence after RFCA had a better improvement in the PCS and MCS than patients who had AF recurrence.
C1 [Kim, Yun Gi; Shim, Jaemin; Choi, Jong-Il; Kim, Young-Hoon] Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Kim, YH (reprint author), Korea Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea.
EM yhkmd@unitel.co.kr
CR Aliot E, 2014, EUROPACE, V16, P787, DOI 10.1093/europace/eut369
   Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031
   Atrial Fibrillation Investigators, 1994, ARCH INTERN MED, V154, P1449
   Brooks AG, 2010, HEART RHYTHM, V7, P835, DOI 10.1016/j.hrthm.2010.01.017
   Carnlof C, 2010, EUR J CARDIOVASC NUR, V9, P45, DOI 10.1016/j.ejcnurse.2009.09.002
   Cha YM, 2008, CIRCULATION, V117, P2583, DOI 10.1161/CIRCULATIONAHA.107.716712
   Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11
   Dorian P, 2000, J AM COLL CARDIOL, V36, P1303, DOI 10.1016/S0735-1097(00)00886-X
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Efremidis M, 2014, PACE, V37, P703, DOI 10.1111/pace.12420
   Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370
   Gu J, 2013, J CARDIOVASC ELECTR, V24, P148, DOI 10.1111/j.1540-8167.2012.02448.x
   Hagens VE, 2004, J AM COLL CARDIOL, V43, P241, DOI 10.1016/j.jacc.2003.08.037
   Hakalahti A, 2015, EUROPACE, V17, P370, DOI 10.1093/europace/euu376
   Hoglund N, 2013, UPSALA J MED SCI, V118, P240, DOI 10.3109/03009734.2013.821190
   Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X
   Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582
   Koci F, 2014, AM J CARDIOL, V114, P260, DOI 10.1016/j.amjcard.2014.04.032
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136
   Mantovan R, 2013, CAN J CARDIOL, V29, P1211, DOI 10.1016/j.cjca.2013.06.006
   Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140
   Mohanty S, 2014, J CARDIOVASC ELECTR, V25, P1057, DOI 10.1111/jce.12467
   Mohanty S, 2012, J AM COLL CARDIOL, V59, P1295, DOI 10.1016/j.jacc.2011.11.051
   Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467
   Natale A, 2014, J AM COLL CARDIOL, V64, P647, DOI 10.1016/j.jacc.2014.04.072
   Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566
   Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955
   Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064
   Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037
   Pappone C, 2011, CIRC-ARRHYTHMIA ELEC, V4, P808, DOI 10.1161/CIRCEP.111.966408
   Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889
   Purerfellner H, 2004, AM HEART J, V148, P318, DOI 10.1016/j.ahj.2004.03.036
   Reynolds MR, 2008, J CARDIOVASC ELECTR, V19, P762, DOI 10.1111/j.1540-8167.2007.01091.x
   Reynolds MR, 2010, CIRC-CARDIOVASC QUAL, V3, P615, DOI 10.1161/CIRCOUTCOMES.110.957563
   Sang CH, 2013, CLIN CARDIOL, V36, P40, DOI 10.1002/clc.22039
   Shi LZ, 2015, EXP THER MED, V10, P816, DOI 10.3892/etm.2015.2545
   STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907
   Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6
   Tada H, 2003, CIRC J, V67, P861, DOI 10.1253/circj.67.861
   Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634
   Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029
   Wokhlu A, 2010, J AM COLL CARDIOL, V55, P2308, DOI 10.1016/j.jacc.2010.01.040
   Wynn G, 2015, HEART RHYTHM
   Wyse DG, 2002, NEW ENGL J MED, V347, P1825
NR 46
TC 8
Z9 8
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 28
PY 2016
VL 11
IS 9
AR e0163755
DI 10.1371/journal.pone.0163755
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DX2BH
UT WOS:000384171400055
PM 27681507
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cristea, IA
   Kok, RN
   Cuijpers, P
AF Cristea, Ioana A.
   Kok, Robin N.
   Cuijpers, Pim
TI The Effectiveness of Cognitive Bias Modification Interventions for
   Substance Addictions: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ATTENTIONAL BIAS
AB Background and Aims
   Cognitive bias modification (CBM) interventions, presumably targeting automatic processes, are considered particularly promising for addictions. We conducted a meta-analysis examining randomized controlled trials (RCTs) of CBM for substance addiction outcomes.
   Methods
   Studies were identified through systematic searches in bibliographical databases. We included RCTs of CBM interventions, alone or in combination with other treatments, for any type of addiction. We examined trial risk of bias, publication bias and possible moderators. Effects sizes were computed for post-test and follow-up, using a random-effects model. We grouped outcome measures and reported results for addiction (all related measures), craving and cognitive bias.
   Results
   We identified 25 trials, 18 for alcohol problems, and 7 for smoking. At post-test, there was no significant effect of CBM for addiction, g = 0.08 (95% CI -0.02 to 0.18) or craving, g = 0.05 (95% CI -0.06 to 0.16), but there was a significant, moderate effect on cognitive bias, g = 0.60 (95% CI 0.39 to 0.79). Results were similar for alcohol and smoking outcomes taken separately. Follow-up addiction outcomes were reported in 7 trials, resulting in a small but significant effect of CBM, g = 0.18 (95% CI 0.03 to 0.32). Results for addiction and craving did not differ by substance type, sample type, delivery setting, bias targeted or number of sessions. Risk of bias was high or uncertain in most trials, for most criteria considered. Meta-regression analyses revealed significant inverse relationships between risk of bias and effect sizes for addiction outcomes and craving. The relationship between cognitive bias and respectively addiction ESs was not significant. There was consistent evidence of publication bias in the form of funnel plot asymmetry.
   Conclusions
   Our results cast serious doubts on the clinical utility of CBM interventions for addiction problems, but sounder methodological trials are necessary before this issue can be settled. We found no indication that positive effects on biases translate into effects on addiction outcomes.
C1 [Cristea, Ioana A.] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania.
   [Cristea, Ioana A.] Univ Padua, Dept Gen Psychol, Padua, Italy.
   [Kok, Robin N.] Univ Southern Denmark, Dept Psychol, Fac Hlth Sci, Odense, Denmark.
   [Kok, Robin N.] Odense Univ Hosp, Dept Clin Innovat, Ctr Innovat Med Technol, Odense, Denmark.
   [Kok, Robin N.; Cuijpers, Pim] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Psychol, Amsterdam, Netherlands.
   [Kok, Robin N.; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Kok, Robin N.; Cuijpers, Pim] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.
RP Cristea, IA (reprint author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania.; Cristea, IA (reprint author), Univ Padua, Dept Gen Psychol, Padua, Italy.
EM ioana.cristea@ubbcluj.ro
RI Cuijpers, Pim/G-1703-2013; Cristea, Ioana Alina/E-7490-2011
OI Cristea, Ioana Alina/0000-0002-9854-7076; Kok, Robin/0000-0001-9845-282X
CR Beard C, 2011, EXPERT REV NEUROTHER, V11, P299, DOI [10.1586/ern.10.194, 10.1586/ERN.10.194]
   Borenstein M., 2009, INTRO METAANALYSIS
   Carey B., 2012, NY TIMES
   Christiansen P, 2015, ADDICT BEHAV, V44, P43, DOI 10.1016/j.addbeh.2014.10.005
   Clarke PJF, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-8
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cox WM, 2014, CNS SPECTRUMS, V19, P215, DOI 10.1017/S1092852914000091
   Cristea IA, BR J PSYCHI IN PRESS
   Cristea IA, 2015, J CHILD PSYCHOL PSYC, V56, P723, DOI 10.1111/jcpp.12383
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Hedges L. V., 1985, STAT METHODS METAANA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014
   LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605
   Leeman Robert F, 2014, Curr Addict Rep, V1, P41
   MacLeod C, 2012, ANNU REV CLIN PSYCHO, V8, P189, DOI 10.1146/annurev-clinpsy-032511-143052
   Macleod C, 2012, AM J PSYCHIAT, V169, P118, DOI 10.1176/appi.ajp.2011.11111682
   MacLeod C, 2012, CURR OPIN PSYCHIATR, V25, P114, DOI 10.1097/YCO.0b013e32834fda4a
   Marhe R, 2014, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00185
   Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Orsini N., 2006, HETEROGI STATA MODUL
   Wiers RW, 2015, ADDICT BEHAV, V40, P21, DOI 10.1016/j.addbeh.2014.08.010
   Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547
NR 26
TC 46
Z9 46
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2016
VL 11
IS 9
AR e0162226
DI 10.1371/journal.pone.0162226
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV9JE
UT WOS:000383255900062
PM 27611692
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Da Mata, FAF
   Pereira, PPD
   de Andrade, KRC
   Figueiredo, ACMG
   Silva, MT
   Pereira, MG
AF Figueiredo Da Mata, Fabiana Araujo
   Da Silva Pereira, Priscilla Perez
   Cordeiro de Andrade, Keitty Regina
   Morais Godoy Figueiredo, Ana Claudia
   Silva, Marcus Tolentino
   Pereira, Mauricio Gomes
TI Prevalence of Frailty in Latin America and the Caribbean: A Systematic
   Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID ALL-CAUSE MORTALITY; OLDER-ADULTS; HEALTH CONDITIONS; LIFE EXPECTANCY;
   SEX-DIFFERENCES; MEXICAN HEALTH; ASSOCIATION; MEN; POPULATION;
   DISABILITY
AB Background
   Countries in Latin America and the Caribbean ( LAC) have experienced a rapid increase in their proportion of older people. This region is marked by a high prevalence of chronic diseases and disabilities among aging adults. Frailty appears in the context of LAC negatively affecting quality of life among many older people.
   Aim
   To investigate the prevalence of frailty among community-dwelling older people in LAC through a systematic review and meta-analysis.
   Methods
   A literature search was performed in indexed databases and in the grey literature. Studies investigating the prevalence of frailty with representative samples of community-dwelling older people in Latin America and the Caribbean were retrieved. Independent investigators carried out the study selection process and the data extraction. A meta-analysis and meta-regression were performed using STATA 11 software. The systematic review was registered at the International Prospective Register of Systematic Reviews under the number CRD42014015203.
   Results
   A total of 29 studies and 43,083 individuals were included in the systematic review. The prevalence of frailty was 19.6%(95% CI: 15.4-24.3%) in the investigated region, with a range of 7.7% to 42.6% in the studies reviewed. The year of data collection influenced the heterogeneity between the studies.
   Conclusion
   Frailty is very common among older people in LAC. As a result, countries in the region need to adapt their health and social care systems to demands of an older population.
C1 [Figueiredo Da Mata, Fabiana Araujo; Cordeiro de Andrade, Keitty Regina; Pereira, Mauricio Gomes] Univ Brasilia, Dept Med Sci, Brasilia, DF, Brazil.
   [Da Silva Pereira, Priscilla Perez; Morais Godoy Figueiredo, Ana Claudia] Univ Brasilia, Dept Hlth Sci, Brasilia, DF, Brazil.
   [Silva, Marcus Tolentino] Univ Fed Amazonas, Dept Hlth Sci, Manaus, Amazonas, Brazil.
RP Da Mata, FAF (reprint author), Univ Brasilia, Dept Med Sci, Brasilia, DF, Brazil.
EM fagfigueiredo@hotmail.com
RI Silva, Marcus Tolentino/J-1791-2014
OI Silva, Marcus Tolentino/0000-0002-7186-9075
FU NIA NIH HHS [R01 AG018016]
CR Aguilar-Navarro S, 2012, J FRAILTY AGING, V1
   Aguilar-Navarro SG, 2015, SALUD PUBLICA MEXICO, V57, pS62
   Avila-Funes JA, 2016, GERIATR GERONTOL INT, V16, P606, DOI 10.1111/ggi.12523
   Alexandre TD, 2014, J AGING HEALTH, V26, P441, DOI 10.1177/0898264313519818
   Alvarado BE, 2008, J GERONTOL A-BIOL, V63, P1399, DOI 10.1093/gerona/63.12.1399
   Amaral FLJS, SOCIAL SUPPORT FRAIL
   Arroyo N, 2012, FATORES ASS DESEMPEN
   Avila-Funes JA, 2014, J FRALITY AGING, V3, P206, DOI 10.14283/jfa.2014.25
   da Silva SLA, 2012, TOP GERIATR REHABIL, V28, P128, DOI 10.1097/TGR.0b013e318255320e
   Barbosa EA, 2013, AVALICAO FATORES RIS
   Barendregt SAD, 2013, J EPIDEMIOL COMMUNIT
   Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731
   Bollwein J, 2011, CLIN NUTR, V6, P128
   Brasil, 2014, DIR MET EL REV SIST
   Calado LB, 2013, J CLIN HYPERTENS, P15
   Quevedo-Tejero ED, 2011, UNIV MED, V52, P255
   Carvalho EMS, 2012, ASSOCIACAO POSTURA C
   Cesari M, 2016, J AM MED DIR ASSOC, V17, P188, DOI 10.1016/j.jamda.2015.12.016
   Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9
   Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x
   Corona LP, 2015, J NUTR HEALTH AGING, V19, P935, DOI 10.1007/s12603-015-0502-3
   Curcio CL, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-2
   Da Silva Coqueiro R, 2016, J SPORTS MED PHYS FI
   de Andrade FB, 2013, J AM GERIATR SOC, V61, P809, DOI 10.1111/jgs.12221
   Llibre JD, 2014, MEDICC REV, V16, P24
   Diaz de Leon Gonzalez E, 2015, AGING CLIN EXP RES
   dos Santos AA, 2013, REV ESC ENFERM USP, V47, P1345, DOI 10.1590/S0080-623420130000600014
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ebert N, 2012, DOENCAS CRONICAS FRA
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Erusalimsky JD, 2016, GERONTOLOGY, V62, P182, DOI 10.1159/000435853
   Fattori A, 2013, ARCH GERONTOL GERIAT, V56, P343, DOI 10.1016/j.archger.2012.08.004
   Ferrer A, 2013, J AM GERIATR SOC, V61, P294, DOI 10.1111/jgs.12154
   Fohn EA, 2012, ACTA PAUL ENFERM, V25
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Fried LP, 2004, J GERONTOL A-BIOL, V59, P255
   Galban PA, 2009, REV CUBANA SALUD PUB, V35
   Garcia-Pena C, 2016, EXP GERONTOL, V79, P55, DOI 10.1016/j.exger.2016.03.016
   Garre-Olmo J, 2013, AGE AGEING, V42, P46, DOI 10.1093/ageing/afs047
   Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P344, DOI 10.1016/j.jamda.2009.11.003
   Gonzalez-Pichardo AM, 2014, J FRALITY AGING, V3, P104, DOI 10.14283/jfa.2014.9
   Guerra M, 2016, J AFFECT DISORDERS, V190, P362, DOI 10.1016/j.jad.2015.09.004
   Haas AL, 2013, CLINICAL GERONTOLOGI, V36
   Harttgen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075847
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hubbard RE, 2011, MATURITAS, V69, P203, DOI 10.1016/j.maturitas.2011.04.006
   Ilhan B, 2014, EUROPEAN GERIATRIC M, V5, P126
   Jotheeswaran AT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0378-4
   Jurschik P, 2014, MED CLIN-BARCELONA, V143, P191, DOI 10.1016/j.medcli.2013.08.009
   Kulmala J, 2014, GERIATR GERONTOL INT, V14, P899, DOI 10.1111/ggi.12190
   Lally F, 2007, POSTGRAD MED J, V83, P16, DOI 10.1136/pgmj.2006.048587
   da Silva SLA, 2015, J FRALITY AGING, V4, P50, DOI 10.14283/jfa.2015.43
   Maia FdOM, 2015, VULNERABILIDADE ENVE
   Manrique-Espinoza bS-R, 2015, J AGIN HLTH
   Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x
   Mitnitski A B, 2001, ScientificWorldJournal, V1, P323
   Macuco CRM, 2012, INT PSYCHOGERIATR, V24, P1725, DOI 10.1017/S1041610212000907
   Montes JFG, 2012, REVMEDICASANITAS, V15, P8
   Moraes ZV, 2011, ESTUDO SINDROME FRAG
   Moreira VG, 2013, CLINICS, V68, P979, DOI 10.6061/clinics/2013(07)15
   Moretto M, 2012, ESTADO NUTR ADIPOSID
   Munn Z, 2015, INT J EVID-BASED HEA, V13, P147, DOI 10.1097/XEB.0000000000000054
   Munn Z, 2014, INT J HEALTH POLICY, V3, P123, DOI 10.15171/ijhpm.2014.71
   Neri AL, 2013, CAD SAUDE PUBLICA, V29, P778, DOI 10.1590/S0102-311X2013000400015
   Nguyen TN, 2015, J NUTR HEALTH AGING, V19, P941, DOI 10.1007/s12603-015-0503-2
   Nunes D, 2011, VALIDACAO AVALICAO S
   Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39
   Ocampo-Chaparro JM, 2013, COLOMB MEDICA, V44, P224
   Palloni A, 2002, INT J EPIDEMIOL, V31, P762, DOI 10.1093/ije/31.4.762
   Palloni A, 2005, REV GALEGA EC, V14, P1
   Panes V, 2010, ADAPTACAO COMPONENTE
   Papiol M, 2015, J AGING PHYS ACT
   Sousa ACPD, 2012, ARCH GERONTOL GERIAT, V54, pE95, DOI 10.1016/j.archger.2011.08.010
   Pegorari MS, 2013, REV BRAS FISIOTER, V17, P9, DOI 10.1590/S1413-35552012005000065
   Perez-Suarez TG, 2015, AGING CLIN EXP RES
   Prina AM, 2016, INT J EPIDEMIOL
   Puts MTE, 2005, J AM GERIATR SOC, V53, P40, DOI 10.1111/j.1532-5415.2005.53008.x
   Ramos CGEL, 2013, REV CUBANA MED MILIT, V42
   Ramos GCF, 2015, J BRASILEIRO PSIQUIA, V64
   Reis Junior WMR, 2014, REV LATINOAM ENFERMA, V22
   Ricci NA, 2014, CLIN INTERV AGING, V9, P1677, DOI 10.2147/CIA.S68642
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Romero-Ortuno R, 2014, AGE AGEING, V43, P222, DOI 10.1093/ageing/aft115
   Roppolo M, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S92328
   Rosero-Bixby L, 2008, DEMOGRAPHY, V45, P673, DOI 10.1353/dem.0.0011
   Rosero-Bixby L, 2009, J GERONTOL B-PSYCHOL, V64, P105, DOI 10.1093/geronb/gbn004
   Ruiz-Arregui L, 2013, COYOACAN COHORT STUD, P1
   Runzer-Colmenares FM, 2014, ARCH GERONTOL GERIAT, V58, P69, DOI 10.1016/j.archger.2013.07.005
   Salmito M, 2012, ASSOCIACAO EQUILIBRI
   Samper-Terent R, 2015, AGING CLIN EXP RES
   Sanchez-Garcia EA, 2011, FRAILTY MEXICAN COMM
   Sanchez-Garcia S, 2014, GERIATR GERONTOL INT, V14, P395, DOI 10.1111/ggi.12114
   Sansoea, 2010, VACCIMONITOR, V19
   Santiago LM, 2013, FRAGILIDADE IDOSOS B
   Santos A, 2013, REV BRAS ENFERM, V66
   Santos AA, 2014, ACTA PAUL ENFERM, V27
   Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012
   Shamliyan T, 2013, AGEING RES REV, V12, P719, DOI 10.1016/j.arr.2012.03.001
   Shibasaki K, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.06.007
   Silva A, 2012, INFLUENCIA HABITOS V
   Silva Debora Dias da, 2011, Rev Saude Publica, V45, P1145
   Silva JC, 2014, ARCH GERONTOL GERIAT, V59, P636, DOI 10.1016/j.archger.2014.07.014
   Duarte MCS, 2013, REV BRAS ENFERM, V66, P901, DOI 10.1590/S0034-71672013000600014
   St John PD, 2013, INT PSYCHOGERIATR, V25, P1709, DOI 10.1017/S1041610213000902
   Sternberg EA, 2011, OSTEOPOROSIS FRAILTY, V22
   Sterne JAC, 2003, ESSENTIAL MED STAT
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Tavares DMS, 2014, REV LATINOAM ENFERMA, V22
   Theou O, 2012, PREVALENCE FRAILY CO
   Theou O, 2015, AGEING RES REV, V21, P78, DOI 10.1016/j.arr.2015.04.001
   Tribess S, 2012, REV ASSOC MED BRAS, V58, P341, DOI 10.1590/S0104-42302012000300015
   Valcarcel EA, 2014, CORREO CIENTIFICO ME
   Valdiglesias V, 2015, MUTAT RES-FUND MOL M, V780, P47, DOI 10.1016/j.mrfmmm.2015.07.010
   Varela Pinedo Luis, 2010, Rev Esp Geriatr Gerontol, V45, P22, DOI 10.1016/j.regg.2009.07.011
   Varela-Pinedo L, 2008, REV SOC PERUANA MED, V14
   Vieira RA, 2013, PREVALENCE FRAILY AS, V8
   Wong YYE, 2013, J GERONTOL A-BIOL, V68, P590, DOI 10.1093/gerona/gls211
   World Health Organization, 2008, AG FRIENDL PRIM HLTH
   ZIEGELMANN P.K., 2010, REV HOSP CLIN PORTO, V30, P436
NR 119
TC 21
Z9 21
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2016
VL 11
IS 8
AR e0160019
DI 10.1371/journal.pone.0160019
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3IE
UT WOS:000381373500011
PM 27500953
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, JR
   Yang, CH
   Guo, B
   Sena, ES
   Macleod, MR
   Yuan, YW
   Hirst, TC
AF Chen, Jiarong
   Yang, Canhong
   Guo, Bin
   Sena, Emily S.
   Macleod, Malcolm R.
   Yuan, Yawei
   Hirst, Theodore C.
TI The Efficacy of Trastuzumab in Animal Models of Breast Cancer: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID HER2/NEU-OVEREXPRESSING METASTATIC BREAST; PRACTICE GUIDELINE UPDATE;
   MONOCLONAL-ANTIBODY; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY;
   PUBLICATION BIAS; PHASE-II; RECEPTOR; GROWTH; CHEMOTHERAPY
AB Background
   Breast cancer is the most frequent cancers and is the second leading cause of cancer death among women. Trastuzumab is an effective treatment, the first monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). To inform the development of other effective treatments we report summary estimates of efficacy of trastuzumab on survival and tumour volume in animal models of breast cancer.
   Methods
   We searched PubMed and EMBASE systematically to identify publications testing trastuzumab in animal models of breast cancer. Data describing tumour volume, median survival and animal features were extracted and we assessed quality using a 12-item checklist. We analysed the impact of study design and quality and evidence for publication bias.
   Results
   We included data from 83 studies reporting 169 experiments using 2076 mice. Trastuzumab treatment caused a substantial reduction in tumour growth, with tumours in treated animals growing to 32.6% of the volume of tumours in control animals (95% CI 27.8%-38.2%). Median survival was prolonged by a factor of 1.45 (1.30-1.62). Many study design and quality features accounted for between-study heterogeneity and we found evidence suggesting publication bias.
   Conclusion
   We have found trastuzumab to be effective in animal breast cancer models across a range of experimental circumstances. However the presence of publication bias and a low prevalence of measures to reduce bias provide a focus for future improvements in preclinical breast cancer research.
C1 [Chen, Jiarong] Sun Yat Sen Univ, Affiliated Jiangmen Hosp, Jiangmen Cent Hosp, Dept Oncol, Jiangmen 529030, Guangdong, Peoples R China.
   [Chen, Jiarong; Yuan, Yawei] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, 1838 Guangzhou DaDao Bei, Guangzhou 510515, Guangdong, Peoples R China.
   [Yang, Canhong] Southern Med Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510630, Guangdong, Peoples R China.
   [Guo, Bin] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg, Guangzhou 510282, Guangdong, Peoples R China.
   [Sena, Emily S.; Macleod, Malcolm R.; Hirst, Theodore C.] Univ Edinburgh, Ctr Clin Brain Sci, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.
RP Yuan, YW (reprint author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, 1838 Guangzhou DaDao Bei, Guangzhou 510515, Guangdong, Peoples R China.; Hirst, TC (reprint author), Univ Edinburgh, Ctr Clin Brain Sci, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.
EM theodore.hirst@ed.ac.uk
OI Sena, Emily S/0000-0002-3282-8502
FU NC3Rs; NHS Lothian RD department
FX This work was supported by the NC3Rs and NHS Lothian R&D department. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; The authors
   acknowledge support with study retrieval from Ng Chat Fong MBBS(HK) and
   funding from the NC3Rs and NHS Lothian R&D department.
CR Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1
   Albanell J, 2001, J NATL CANCER I, V93, P1830, DOI 10.1093/jnci/93.24.1830
   [Anonymous], 2015, Prescrire Int, V24, P93
   Baselga J, 2014, ANN ONCOL, V25, P592, DOI 10.1093/annonc/mdt543
   Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737
   Bianchini G, 2014, LANCET ONCOL, V15, pE58, DOI 10.1016/S1470-2045(13)70477-7
   Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278
   Borowsky AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009670
   CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285
   Castagnetta L, 2004, ANN NY ACAD SCI, V1028, P233, DOI 10.1196/annnals.1321.028
   Cheng H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-326
   de Vries RBM, 2014, ILAR J, V55, P427, DOI 10.1093/ilar/ilu043
   DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134
   Dimitrakakis C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2413
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fallowfield L, 2015, BREAST, V24, P166, DOI 10.1016/j.breast.2015.01.002
   Fojo T, 2010, CLIN CANCER RES, V16, P5972, DOI 10.1158/1078-0432.CCR-10-1277
   Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427
   Hirst TC, 2013, BRIT J CANCER, V108, P64, DOI 10.1038/bjc.2012.504
   Hirst TC, 2015, SYSTEMATIC REV METAA, DOI [10.1002/ebm2.6, DOI 10.1002/EBM2.6]
   Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117
   Ismael G, 2012, LANCET ONCOL, V13, P869, DOI 10.1016/S1470-2045(12)70329-7
   Jiang Zhansheng, 2014, Zhonghua Yi Xue Za Zhi, V94, P3854
   Kawalec P, 2015, CLIN BREAST CANCER, V15, P90, DOI 10.1016/j.clbc.2014.10.006
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   KUMAR R, 1991, MOL CELL BIOL, V11, P979, DOI 10.1128/MCB.11.2.979
   Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556
   Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273
   Moja L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006243.pub2
   Nuciforo P, 2016, MOL ONCOL, V10, P138, DOI 10.1016/j.molonc.2015.09.002
   Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825
   Pegram M, 2006, ADV DRUG DELIVER REV, V58, P723, DOI 10.1016/j.addr.2006.05.003
   Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659
   Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868
   Pickar James H, 2015, Post Reprod Health, V21, P112, DOI 10.1177/2053369115599090
   Reznikov A., 2015, Experimental Oncology, V37, P162
   Sena ES, 2014, J CEREBR BLOOD F MET, V34, P737, DOI 10.1038/jcbfm.2014.28
   Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116
   SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936
   SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679
   Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988
   SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152
   Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101
   SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106
   Stanislawska-Sachadyn A, 2015, CURR PHARM BIOTECHNO
   Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281
   van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915
   Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010
   Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719
   Watzlawick R, 2014, JAMA NEUROL, V71, P91, DOI 10.1001/jamaneurol.2013.4684
   Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA
   Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984
NR 52
TC 3
Z9 3
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 27
PY 2016
VL 11
IS 7
AR e0158240
DI 10.1371/journal.pone.0158240
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5IJ
UT WOS:000381515900008
PM 27463246
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Endendijk, JJ
   Groeneveld, MG
   Bakermans-Kranenburg, MJ
   Mesman, J
AF Endendijk, Joyce J.
   Groeneveld, Marleen G.
   Bakermans-Kranenburg, Marian J.
   Mesman, Judi
TI Gender-Differentiated Parenting Revisited: Meta-Analysis Reveals Very
   Few Differences in Parental Control of Boys and Girls
SO PLOS ONE
LA English
DT Article
ID MOTHER-CHILD INTERACTION; SEX-DIFFERENCES; MATERNAL CONTROL;
   PSYCHOLOGICAL CONTROL; CORPORAL PUNISHMENT; BEHAVIOR PROBLEMS;
   PUBLICATION BIAS; SELF-REGULATION; TRANSACTIONAL-ANALYSIS;
   CONFIDENCE-INTERVALS
AB Although various theories describe mechanisms leading to differential parenting of boys and girls, there is no consensus about the extent to which parents do treat their sons and daughters differently. The last meta-analyses on the subject were conducted more than fifteen years ago, and changes in gender-specific child rearing in the past decade are quite plausible. In the current set of meta-analyses, based on 126 observational studies (15,034 families), we examined mothers' and fathers' differential use of autonomy-supportive and controlling strategies with boys and girls, and the role of moderators related to the decade in which the study was conducted, the observational context, and sample characteristics. Databases of Web of Science, ERIC, PsychInfo, Online Contents, Picarta, and Proquest were searched for studies examining differences in observed parental control of boys and girls between the ages of 0 and 18 years. Few differences were found in parents' use of control with boys and girls. Parents were slightly more controlling with boys than with girls, but the effect size was negligible (d = 0.08). The effect was larger, but still small, in normative groups and in samples with younger children. No overall effect for gender-differentiated autonomy-supportive strategies was found (d = 0.03). A significant effect of time emerged: studies published in the 1970s and 1980s reported more autonomy-supportive strategies with boys than toward girls, but from 1990 onwards parents showed somewhat more autonomy-supportive strategies with girls than toward boys. Taking into account parents' gender stereotypes might uncover subgroups of families where gender-differentiated control is salient, but based on our systematic review of the currently available large data base we conclude that in general the differences between parenting of boys versus girls are minimal.
C1 [Endendijk, Joyce J.; Groeneveld, Marleen G.; Bakermans-Kranenburg, Marian J.; Mesman, Judi] Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands.
   [Endendijk, Joyce J.] Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands.
RP Mesman, J (reprint author), Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands.
EM mesmanj@fsw.leidenuniv.nl
OI , marian/0000-0001-7763-0711
FU European Research Council [240885]; Netherlands Organization for
   Scientific Research [453-09-003]
FX This research was supported by a European Research Council
   (https://erc.europa.eu/) Starting Grant awarded to JM (project #
   240885). MJBK was supported by the Netherlands Organization for
   Scientific Research (http://www.nwo.nl/en; VICI Grant 453-09-003). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ahl RE, 2013, INFANT BEHAV DEV, V36, P199, DOI 10.1016/j.infbeh.2013.01.005
   Ainsworth M. I. S., 1978, PATTERNS ATTACHMENT
   Alink LRA, 2006, CHILD DEV, V77, P954, DOI 10.1111/j.1467-8624.2006.00912.x
   Andersson G, 2006, DEMOGRAPHY, V43, P255, DOI 10.1353/dem.2006.0010
   [Anonymous], 2013, GLOBAL GENDER GAP RE
   Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291
   Arnold F, 1984, J COMP FAM STUD, V15, P299
   Baillargeon RH, 2007, DEV PSYCHOL, V43, P13, DOI 10.1037/0012-1649.43.1.13
   Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195
   Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.1111/j.1467-8624.1996.tb01915.x
   BARBER BK, 1994, CHILD DEV, V65, P1120, DOI 10.2307/1131309
   Barber BK, 2002, INTRUSIVE PARENTING, P262, DOI DOI 10.1037/10422-009
   BARKLEY RA, 1989, J CHILD PSYCHOL PSYC, V30, P379, DOI 10.1111/j.1469-7610.1989.tb00253.x
   Barnett D, 1998, CHILD DEV, V69, P1657, DOI 10.2307/1132138
   Basow S. A., 1999, APPEARANCE NEW LOOK, P25, DOI DOI 10.1037/10325-001
   BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372
   BEFERA MS, 1985, J CHILD PSYCHOL PSYC, V26, P439, DOI 10.1111/j.1469-7610.1985.tb01945.x
   Belden AC, 2007, ATTACH HUM DEV, V9, P239, DOI 10.1080/14616730701455395
   BELLINGER DC, 1982, SEX ROLES, V8, P1123, DOI 10.1007/BF00290968
   BEM SL, 1981, PSYCHOL REV, V88, P354, DOI 10.1037/0033-295X.88.4.354
   BEM SL, 1983, SIGNS, V8, P598, DOI 10.1086/493998
   Bender HL, 2007, DEV PSYCHOPATHOL, V19, P227, DOI 10.1017/S0954579407070125
   Bernstein VJ, 2005, J APPL DEV PSYCHOL, V26, P241, DOI 10.1016/j.appdev.2005.02.002
   BEZIRGANIAN S, 1992, J AM ACAD CHILD PSY, V31, P790, DOI 10.1097/00004583-199209000-00004
   BLACKWELDER DE, 1986, J PERS SOC PSYCHOL, V50, P80
   Block JH, 1979, PSYCHOL WOMEN FUTURE, P29
   Boeldt DL, 2012, INFANT CHILD DEV, V21, P85, DOI 10.1002/icd.764
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Borenstein M., 2009, INTRO METAANALYSIS
   Bowlby J., 1969, ATTACHMENT LOSS, V1
   BraungartRieker U, 1997, J APPL DEV PSYCHOL, V18, P411
   BRIGHT MC, 1984, J GENET PSYCHOL, V144, P219, DOI 10.1080/00221325.1984.9923428
   BRODY GH, 1985, BEHAV RES THER, V23, P291, DOI 10.1016/0005-7967(85)90007-5
   BRODY GH, 1992, CHILD DEV, V63, P82, DOI 10.2307/1130903
   BRODY GH, 1986, DEV PSYCHOL, V22, P291, DOI 10.1037/0012-1649.22.3.291
   BRONSTEIN P, 1984, DEV PSYCHOL, V20, P995, DOI 10.1037/0012-1649.20.6.995
   Bronstein P, 2007, SEX ROLES, V56, P661, DOI 10.1007/s11199-007-9182-8
   Buckholtz JW, 2008, MOL PSYCHIATR, V13, P313, DOI 10.1038/sj.mp.4002020
   Bumpus MF, 2001, DEV PSYCHOL, V37, P163, DOI 10.1037/0012-1649.37.2.163
   Cabrera NJ, 2000, CHILD DEV, V71, P127, DOI 10.1111/1467-8624.00126
   CALDERA YM, 1989, CHILD DEV, V60, P70, DOI 10.2307/1131072
   Calkins SD, 1998, SOC DEV, V7, P350, DOI 10.1111/1467-9507.00072
   Campbell JJ., 1999, THESIS
   CAMPBELL SB, 1986, J ABNORM CHILD PSYCH, V14, P425, DOI 10.1007/BF00915436
   Celano M, 2008, FAM PROCESS, V47, P7, DOI 10.1111/j.1545-5300.2008.00236.x
   Chaplin TM, 2005, EMOTION, V5, P80, DOI 10.1037/1528-3542.5.1.80
   Chen XY, 2001, PARENT-SCI PRACT, V1, P159, DOI 10.1207/S15327922PAR0103_01
   Chen XY, 2000, INT J BEHAV DEV, V24, P119, DOI 10.1080/016502500383557
   CHERRY L, 1976, DEV PSYCHOL, V12, P278, DOI 10.1037/0012-1649.12.4.278
   Christopoulou C, 1988, THESIS
   Ciarrocchi JW., 1983, THESIS
   Cipriano EA, 2010, J APPL DEV PSYCHOL, V31, P221, DOI 10.1016/j.appdev.2010.02.004
   Cohen J., 1977, STAT POWER ANAL BEHA
   COPELAND AP, 1984, J DIVORCE, V8, P17
   Coulson SL., 2001, THESIS
   CROCKENBERG S, 1990, DEV PSYCHOL, V26, P961, DOI 10.1037/0012-1649.26.6.961
   CULP RE, 1983, SEX ROLES, V9, P475, DOI 10.1007/BF00289787
   Cyr M, 2014, CHILD PSYCHIAT HUM D, V45, P555, DOI 10.1007/s10578-013-0424-4
   Das Eiden R, 2001, ALCOHOL CLIN EXP RES, V25, P1621, DOI 10.1097/00000374-200111000-00010
   Deater-Deckard K, 2000, CHILD DEV, V71, P468, DOI 10.1111/1467-8624.00158
   Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01
   DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x
   DEKOVIC M, 1992, J MARRIAGE FAM, V54, P675, DOI 10.2307/353253
   Dennis T, 2006, DEV PSYCHOL, V42, P84, DOI 10.1037/0012-1649.42.1.84
   DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107
   Dodson TA, 2006, CAREER DEV Q, V54, P283, DOI 10.1002/j.2161-0045.2006.tb00194.x
   Donovan WL, 2000, DEV PSYCHOL, V36, P402, DOI 10.1037/0012-1649.36.3.402
   DUMAS JE, 1995, J ABNORM PSYCHOL, V104, P104, DOI 10.1037/0021-843X.104.1.104
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eddy JM, 2001, AGGRESSIVE BEHAV, V27, P14, DOI 10.1002/1098-2337(20010101/31)27:1<14::AID-AB2>3.3.CO;2-U
   Eley TC, 2010, J CHILD PSYCHOL PSYC, V51, P772, DOI 10.1111/j.1469-7610.2010.02227.x
   Else-Quest NM, 2006, PSYCHOL BULL, V132, P33, DOI 10.1037/0033-2909.132.1.33
   EMBER CR, 1994, J CONFLICT RESOLUT, V38, P620, DOI 10.1177/0022002794038004002
   Emmons YD, 2001, THESIS
   Endendijk JJ, 2016, CHILD DEV
   Endendijk JJ, 2014, PARENT-SCI PRACT, V14, P141, DOI 10.1080/15295192.2014.972753
   Ex CTGM, 1998, SEX ROLES, V38, P171
   FAGOT BI, 1993, CHILD DEV, V64, P258, DOI 10.2307/1131450
   Fagot BI, 1996, J SOC PERS RELAT, V13, P295, DOI 10.1177/0265407596132008
   FAGOT BI, 1985, SEX ROLES, V12, P471, DOI 10.1007/BF00288169
   FAGOT BI, 1985, SEX ROLES, V12, P341, DOI 10.1007/BF00287600
   FALENDER CA, 1975, DEV PSYCHOL, V11, P830, DOI 10.1037/0012-1649.11.6.830
   Fatherhood Institute, 2010, FATH REP 2010 11 FAI
   Feldman R, 2003, DEV PSYCHOL, V39, P680, DOI 10.1037/0012-1649.39.4.680
   FELDMAN SS, 1986, MERRILL PALMER QUART, V32, P365
   Fisher P. A., 1993, J FAMILY PSYCHOL, V7, P250, DOI DOI 10.1037/0893-3200.7.2.250
   Flynn CP, 1999, J MARRIAGE FAM, V61, P971, DOI 10.2307/354017
   Frampton KL., 2012, THESIS
   FRANKEL MT, 1983, DEV PSYCHOL, V19, P694
   Frodi A., 1985, INFANT MENT HEALTH J, V6, P60, DOI DOI 10.1002/1097-0355(198522)6:2<60::AID-
   Fuligni AJ, 1998, DEV PSYCHOL, V34, P782, DOI 10.1037/0012-1649.34.4.782
   Gaertner BM, 2008, INFANT CHILD DEV, V17, P339, DOI 10.1002/ICD.580
   Gardner F, 2000, Clin Child Fam Psychol Rev, V3, P185, DOI 10.1023/A:1009503409699
   Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539
   Gjerde PF, J RES ADOLESC, V1, P63
   GOLDSTEIN H, 1995, J ROY STAT SOC A STA, V158, P175, DOI 10.2307/2983411
   GOLINKOFF RM, 1979, CHILD DEV, V50, P28, DOI 10.1111/j.1467-8624.1979.tb02975.x
   GORDON BN, 1983, CHILD PSYCHIAT HUM D, V13, P153, DOI 10.1007/BF00705856
   Grolnick WS., 2013, PSYCHOL PARENTAL CON
   Grolnick WS, 1994, PARENTING CHILDRENS, P78
   Gross D, 2009, PREV SCI, V10, P54, DOI 10.1007/s11121-008-0116-7
   Gunnoe ML, 1999, J EARLY ADOLESCENCE, V19, P199, DOI 10.1177/0272431699019002004
   Gustafsson HC, 2012, J FAM PSYCHOL, V26, P115, DOI 10.1037/a0026283
   Hank K, 2000, DEMOGR RES, V2, P133, DOI DOI 10.4054/DEMRES.2000.2.1)
   Harris RJ, 1998, SEX ROLES, V38, P239, DOI 10.1023/A:1018785100469
   Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203
   Henderson SH, 2007, THESIS
   HESS RD, 1984, CHILD DEV, V55, P2017, DOI 10.2307/1129776
   Higgins KN, 2008, THESIS
   Holt EC., 2007, THESIS
   Huang CY, 2014, J CROSS CULT PSYCHOL, V45, P507, DOI 10.1177/0022022113513652
   Huerta M, 2013, OECD SOCIAL EMPLOYME, V140, DOI [10.1787/5k4dlw9w6czq-en, DOI 10.1787/5K4DLW9W6CZQ-EN]
   Hughes C, 1999, SOC DEV, V8, P143, DOI 10.1111/1467-9507.00088
   HYDE JS, 1984, DEV PSYCHOL, V20, P722, DOI 10.1037/0012-1649.20.4.722
   Infa Lloyd CA., 2010, THESIS
   Inglehart R, 2003, RISING TIDE GENDER E
   Inoff-Germain G, 1988, J EARLY ADOLESC, V8, P17, DOI [10.1177/0272431688081002, DOI 10.1177/0272431688081002]
   Jaffee SR, 2004, DEV PSYCHOL, V40, P1047, DOI 10.1037/0012-1649.40.6.1047
   Janssens JMAM, 1997, INT J BEHAV DEV, V20, P509, DOI 10.1080/016502597385252
   Joosen KJ, 2012, ATTACH HUM DEV, V14, P101, DOI 10.1080/14616734.2012.661217
   Julious SA, 2004, PHARM STAT, V3, P217, DOI 10.1002/pst.126
   JURICH AP, 1976, PSYCHOL REP, V38, P883, DOI 10.2466/pr0.1976.38.3.883
   KAGAN J, 1963, CHILD DEV, V34, P899, DOI 10.2307/1126534
   Kalpidou MD, 1998, J GENET PSYCHOL, V159, P103, DOI 10.1080/00221329809596138
   Kapungu CT, 2006, J YOUTH ADOLESCENCE, V35, P787, DOI 10.1007/s10964-006-9102-1
   Karreman A, 2006, INFANT CHILD DEV, V15, P561, DOI 10.1002/icd.478
   Kauffman CM, 1985, THESIS
   Kawabata Y, 2011, DEV REV, V31, P240, DOI 10.1016/j.dr.2011.08.001
   Keenan K, 1997, PSYCHOL BULL, V121, P95, DOI 10.1037/0033-2909.121.1.95
   Kenney-Benson GA, 2005, J PERS, V73, P23, DOI 10.1111/j.1467-6494.2004.00303.x
   KERIG PK, 1993, DEV PSYCHOL, V29, P931, DOI 10.1037/0012-1649.29.6.931
   Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851
   Kochanska G, 2001, CHILD DEV, V72, P1091, DOI 10.1111/1467-8624.00336
   KOCHANSKA G, 1995, CHILD DEV, V66, P597, DOI 10.2307/1131937
   Kochanska G, 2003, DEV PSYCHOL, V39, P949, DOI 10.1037/0012-1649.39.6.949
   Kochanska G, 2009, CHILD DEV, V80, P1288, DOI 10.1111/j.1467-8624.2009.01332.x
   Kok R, 2013, DEV PSYCHOBIOL, V55, P451, DOI 10.1002/dev.21049
   KUCZYNSKI L, 1984, DEV PSYCHOL, V20, P1061, DOI 10.1037/0012-1649.20.6.1061
   LAFRENIERE PJ, 1992, DEV PSYCHOPATHOL, V4, P385, DOI 10.1017/S0954579400000857
   Lamb M., 2010, ROLE FATHER CHILD DE
   LAOSA LM, 1978, CHILD DEV, V49, P1129, DOI 10.1111/j.1467-8624.1978.tb04081.x
   Larsson H, 2008, J ABNORM CHILD PSYCH, V36, P633, DOI 10.1007/s10802-007-9151-2
   Leaper C, 1998, DEV PSYCHOL, V34, P3, DOI 10.1037/0012-1649.34.1.3
   Lee IC, 2011, PSYCHOL BULL, V137, P1029, DOI 10.1037/a0025410
   Lengua LJ, 2007, J APPL DEV PSYCHOL, V28, P40, DOI 10.1016/j.appdev.2006.10.001
   Lengua LJ, 2014, SOC DEV, V23, P631, DOI 10.1111/sode.12071
   Li JJ, 2013, J CLIN CHILD ADOLESC, V42, P174, DOI 10.1080/15374416.2012.736355
   Lindsey EW, 2005, INFANT BEHAV DEV, V28, P165, DOI 10.1016/j.infbeh.2005.02.004
   Linver MR, 2002, DEV PSYCHOL, V38, P719, DOI 10.1037//0012-1649.38.5.719
   Liu MW, 2010, SCAND J PSYCHOL, V51, P109, DOI 10.1111/j.1467-9450.2009.00795.x
   LOEB RC, 1980, MERRILL PALMER QUART, V26, P205
   Loeber R, 2013, BRAIN RES FDN S SERI, V1, P137, DOI [10.1007/978-1-4614-7557-6_6, DOI 10.1007/978-1-4614-7557-6_6]
   Longeway KP., 1983, THESIS
   Lundberg S, 2005, OXFORD REV ECON POL, V21, P340, DOI 10.1093/oxrep/gri020
   LYTTON H, 1991, PSYCHOL BULL, V109, P267, DOI 10.1037/0033-2909.109.2.267
   Maccoby E. E., 1974, PSYCHOL SEX DIFFEREN
   MACCOBY EE, 1984, DEV PSYCHOL, V20, P459, DOI 10.1037/0012-1649.20.3.459
   Mandara J, 2012, FAM RELAT, V61, P129, DOI 10.1111/j.1741-3729.2011.00688.x
   MARGOLIN G, 1975, DEV PSYCHOL, V11, P537, DOI 10.1037/h0076682
   MARTINEZ EA, 1988, FAM RELAT, V37, P275, DOI 10.2307/584562
   McFadyenKetchum SA, 1996, CHILD DEV, V67, P2417, DOI 10.1111/j.1467-8624.1996.tb01865.x
   McHale SM, 2003, SOC DEV, V12, P125, DOI 10.1111/1467-9507.00225
   MCLAUGHLIN B, 1983, DEV PSYCHOL, V19, P667
   MCLAUGHLIN B, 1980, CHILD DEV, V51, P580
   Mills RSL, 1998, CAN J BEHAV SCI, V30, P132, DOI 10.1037/h0085803
   MINTON C, 1971, CHILD DEV, V42, P1873, DOI 10.2307/1127592
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Morrell J, 2003, J CHILD PSYCHOL PSYC, V44, P489, DOI 10.1111/1469-7610.t01-1-00139
   Morsbach SK, 2006, CLIN CHILD FAM PSYCH, V9, P1, DOI 10.1007/s10567-006-0001-5
   MULLIS RL, 1985, PERCEPT MOTOR SKILL, V60, P567, DOI 10.2466/pms.1985.60.2.567
   Mulvaney MK, 2007, J FAM PSYCHOL, V21, P389, DOI 10.1037/0893-3200.21.3.389
   Nelson D. A., 2002, INTRUSIVE PARENTING, P161, DOI DOI 10.1037/10422-006
   Nelson DA, 2013, J APPL DEV PSYCHOL, V34, P1, DOI 10.1016/j.appdev.2012.07.003
   Neppl TK, 2009, DEV PSYCHOL, V45, P1241, DOI 10.1037/a0014850
   OBRIEN M, 1987, J CHILD LANG, V14, P269, DOI 10.1017/S0305000900012927
   OLDERSHAW L, 1986, CHILD DEV, V57, P722
   Huber MO, 2012, REV LAT AM PSICOL, V44, P75
   Patterson GR, 1982, COERCIVE FAMILY PROC
   Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34
   Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298
   POMERLEAU A, 1990, SEX ROLES, V22, P359, DOI 10.1007/BF00288339
   POWER TG, 1985, CHILD DEV, V56, P1514
   Roberts WL., 1983, FAMILY INTERATIONS C
   ROBINSON EA, 1981, J CONSULT CLIN PSYCH, V49, P245, DOI 10.1037/0022-006X.49.2.245
   Rodriguez MMD, 2009, FAM PROCESS, V48, P195
   ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55
   Russell A, 1996, INT J BEHAV DEV, V19, P291, DOI 10.1080/016502596385794
   Scaramella LV, 2008, SOC DEV, V17, P578, DOI 10.1111/j.1467-9507.2007.00439.x
   SCHAEFER ES, 1965, CHILD DEV, V36, P413, DOI 10.1111/j.1467-8624.1965.tb05305.x
   SERBIN LA, 1990, SEX ROLES, V23, P613, DOI 10.1007/BF00289251
   Shaw DS, 1998, J ABNORM CHILD PSYCH, V26, P95, DOI 10.1023/A:1022665704584
   Silverman IW, 1995, J APPL DEV PSYCHOL, V16, P569, DOI 10.1016/0193-3973(95)90005-5
   Smith CL, 2004, DEV PSYCHOL, V40, P29, DOI 10.1037/0012-1649.40.1.29
   Smith CL, 2010, PARENT-SCI PRACT, V10, P1, DOI 10.1080/15295190903014588
   Smith JR, 1997, ARCH PEDIAT ADOL MED, V151, P777, DOI 10.1001/archpedi.1997.02170450027004
   SMITH PK, 1977, CHILD DEV, V48, P1250, DOI 10.1111/j.1467-8624.1977.tb03929.x
   Soenens B, 2007, DEV PSYCHOL, V43, P633, DOI 10.1037/0012-1649.43.3.633
   Soenens B, 2010, DEV REV, V30, P74, DOI 10.1016/j.dr.2009.11.001
   Stormshak EA, 2000, J CLIN CHILD PSYCHOL, V29, P17, DOI 10.1207/S15374424jccp2901_3
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   SWIM JK, 1995, J PERS SOC PSYCHOL, V68, P199, DOI 10.1037/0022-3514.68.2.199
   Tabachnick B.G., 2001, USING MULTIVARIATE S
   Tam VCW, 2004, MARRIAGE FAM REV, V35, P45, DOI [10.1300/J002v35n03_04, DOI 10.1300/J002V35N03_04]
   Tamis-LeMonda CS, 2009, J APPL DEV PSYCHOL, V30, P321, DOI 10.1016/j.appdev.2008.12.018
   Thomson RM, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-247
   Trautmann-Villalba P, 2006, PRAX KINDERPSYCHOL K, V55, P169
   Tulananda O, 2001, J FAM PSYCHOL, V15, P676, DOI 10.1037//0893-3200.15.4.676
   U.S. Department of Labor, 2012, 1038 US DEP LAB BUR
   van Ijzendoorn MH, 2005, PSYCHOL BULL, V131, P301, DOI 10.1037/0033-2909.131.2.301
   Van Zeijl J, 2007, J FAM PSYCHOL, V21, P626, DOI 10.1037/0893-3200.21.4.626
   Van Zeijl J, 2006, J CONSULT CLIN PSYCH, V74, P994, DOI 10.1037/0022-006X.74.6.994
   Webster-Stratton C, 1999, J CHILD PSYCHOL PSYC, V40, P917, DOI 10.1017/S0021963099004199
   Whipple EE, 1997, CHILD ABUSE NEGLECT, V21, P431, DOI 10.1016/S0145-2134(97)00004-5
   Williamson NE, 1976, SONS DAUGHTERS CROSS
   Wilson EC., 1980, THESIS
   Wood W, 2002, PSYCHOL BULL, V128, P699, DOI 10.1037//0033-2909.128.5.699
   Wood W, 2012, ADV EXP SOC PSYCHOL, V46, P55, DOI 10.1016/B978-0-12-394281-4.00002-7
   Yagmur S, 2014, ATTACH HUM DEV, V16, P371, DOI 10.1080/14616734.2014.912489
   Yaman A, 2010, J CHILD FAM STUD, V19, P617, DOI 10.1007/s10826-009-9346-y
   Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI [10.1146/annurev.clinpsy.3.022806.091358, 10.1146/annurev.clinpsy.3.022806.0913]
   Zevalkink J, 2001, INT J BEHAV DEV, V25, P167, DOI 10.1080/01650250042000113
NR 222
TC 29
Z9 29
U1 4
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 14
PY 2016
VL 11
IS 7
AR e0159193
DI 10.1371/journal.pone.0159193
PG 33
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR0DZ
UT WOS:000379579500096
PM 27416099
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cao, J
   Zhu, X
   Zhao, XK
   Li, XF
   Xu, R
AF Cao, Jian
   Zhu, Xuan
   Zhao, Xiaokun
   Li, Xue-Feng
   Xu, Ran
TI Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in
   Prostate Cancer: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID SUPPRESSOR-CELLS; INFLAMMATION; SURVIVAL; MEN; INFILTRATION;
   ASSOCIATION; IMMUNITY; OUTCOMES; ANTIGEN; SCORE
AB An unprecedented advance has been seen in castration-resistant prostate cancer (CRPC) treatments in the past few years. With a number of novel agents were approved, there is a pressing need to develop improved prognostic biomarkers to facilitate the personalised selection and sequencing of these novel agents. Emerging evidence indicates that the neutrophil-to-lymphocyte ratio (NLR) is associated with poorer survival in patients with prostate cancer (PCa). However, the importance of the NLR for the prediction of the PSA response (PSARS) and biochemical recurrence (BCR) has been largely neglected. Here, we conducted a systematic review and meta-analysis to evaluate the prognostic value of the NLR for the PSARS, BCR, and survival in PCa. A systematic database search was performed using Embase, PubMed, the Cochrane Library, and the China National Knowledge Infrastructure (CNKI). A meta-analysis was performed by pooling hazard ratios (HRs), odds ratios (ORs) and the corresponding 95% confidence intervals (CIs). A total of 22 studies were included in the meta-analysis. Our results suggest that an elevated NLR predicts a lower PSARS rate (OR = 1.69, 95% CI: 1.40-1.98) and a higher possibility of BCR (HR = 1.12, 95% CI: 1.02-1.21). Additionally, we confirmed that an elevated NLR was a prognostic predictor of shorter overall survival (OS) in both metastatic castration-resistant PCa (mCRPC) (HR = 1.45, 95% CI: 1.32-1.59) and localized PCa (LPC) (HR = 1.12, 95% CI: 1.01-1.23) and that it predicted worse progression-free survival (PFS) in CRPC (HR = 1.42, 95% CI: 1.23-1.61) and poorer recurrence-free survival (RFS) (HR = 1.38, 95% CI: 1.01-1.75) in LPC. Our results suggest that an elevated NLR might be employed as a prognostic marker of biochemical changes and prognosis to facilitate risk stratification and decision making for individual treatment of PCa patients. The potential mechanisms underlying these associations and future research directions are also discussed.
C1 [Cao, Jian; Zhu, Xuan; Zhao, Xiaokun; Xu, Ran] Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.
   [Cao, Jian; Li, Xue-Feng] Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.
RP Xu, R (reprint author), Cent S Univ, Dept Urol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.
EM ddf20@sina.com
FU China Scholarship Council [201506370137]
FX Jian Cao is sponsored by the China Scholarship Council (201506370137) as
   a visiting researcher in at the University of Edinburgh
   (http://www.csc.edu.cn/). The funder (China Scholarship Council) had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Bahig H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1599-9
   Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028
   Chung CH, 2008, ONCOLOGIST, V13, P725, DOI 10.1634/theoncologist.2008-0012
   Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282
   Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Flammiger A, 2012, APMIS, V120, P901, DOI 10.1111/j.1600-0463.2012.02924.x
   Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506
   Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003
   Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Heidenreich A, 2011, EUR ASS UROL, V53, P31, DOI [10.1016/j.eururo.2007.09.002, DOI 10.1016/J.EURURO.2007.09.002]
   Kawahara T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2134-3
   Kim J, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/6058147
   Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842
   Kwon YS, 2016, CLIN GENITOURIN CANC, V14, pE1, DOI 10.1016/j.clgc.2015.07.018
   Lee H, 2016, WORLD J UROL, V34, P821, DOI 10.1007/s00345-015-1701-6
   Leibowitz-Amit R, 2014, ANN ONCOL, V25, P657, DOI 10.1093/annonc/mdt581
   Li J, 2012, PROSTATE CANCER, DOI 10.1155/2012/691380
   Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536
   Li XF, 2015, J HEPATOL, V62, P131, DOI 10.1016/j.jhep.2014.08.023
   Linton A, 2013, CLIN GENITOURIN CANC, V11, P423, DOI 10.1016/j.clgc.2013.04.020
   Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587
   McDonald AC, 2014, PROSTATE, V74, P561, DOI 10.1002/pros.22782
   McLachlan JM, 2015, CANC TREAT COMMUN, V4, P81, DOI DOI 10.1016/J.CTRC.2015.06.001
   Minardi D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1036-1
   Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004
   Ness N, 2014, PROSTATE, V74, P1452, DOI 10.1002/pros.22862
   Nuhn P, 2014, BJU INT, V114, pE11, DOI 10.1111/bju.12531
   Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740
   Pezaro C, 2014, INTERN MED J, V44, P433, DOI 10.1111/imj.12407
   POTOSKY AL, 1990, J NATL CANCER I, V82, P1624, DOI 10.1093/jnci/82.20.1624
   POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548
   Poyet C, 2015, J UROLOGY, V193, pE817, DOI 10.1016/j.juro.2015.02.2358
   Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028
   Ramanathan S, 2008, ARCH IMMUNOL THER EX, V56, P311, DOI 10.1007/s00005-008-0033-2
   Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60
   Sharma V, 2015, J UROLOGY, V193, pE55, DOI 10.1016/j.juro.2015.02.252
   Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sumbul AT, 2014, INT UROL NEPHROL, V46, P1531, DOI 10.1007/s11255-014-0664-7
   Sutton AJ, 2000, METHODS METAANALYSIS
   Tazzyman S, 2013, SEMIN CANCER BIOL, V23, P149, DOI 10.1016/j.semcancer.2013.02.003
   Templeton AJ, 2014, CANCER-AM CANCER SOC, V120, P3346, DOI 10.1002/cncr.28890
   Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   van Soest RJ, 2015, ANN ONCOL, V26, P743, DOI 10.1093/annonc/mdu569
   Wei Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092079
   Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x
   Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981
   Yao A, 2015, INT J UROL, V22, P827, DOI 10.1111/iju.12839
   Yin XT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002544
   Zhang GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001473
   [张姣 Zhang Jiao], 2015, [肿瘤, Tumor], V35, P333
   Zhang Y, 2013, CANCER IMMUNOL IMMUN, V62, P87, DOI 10.1007/s00262-012-1313-6
NR 59
TC 25
Z9 25
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 1
PY 2016
VL 11
IS 7
AR e0158770
DI 10.1371/journal.pone.0158770
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0TX
UT WOS:000378914900052
PM 27368058
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pimpin, L
   Wu, JHY
   Haskelberg, H
   Del Gobbo, L
   Mozaffarian, D
AF Pimpin, Laura
   Wu, Jason H. Y.
   Haskelberg, Hila
   Del Gobbo, Liana
   Mozaffarian, Dariush
TI Is Butter Back? A Systematic Review and Meta-Analysis of Butter
   Consumption and Risk of Cardiovascular Disease, Diabetes, and Total
   Mortality
SO PLOS ONE
LA English
DT Article
ID TRANS-PALMITOLEIC ACID; OLIVE OIL CONSUMPTION; SATURATED FATTY-ACIDS;
   BETA-CELL FUNCTION; DOSE-RESPONSE DATA; UPDATED METAANALYSIS; INSULIN
   SENSITIVITY; PROSPECTIVE COHORT; DAIRY CONSUMPTION; DIETARY PATTERNS
AB Background
   Dietary guidelines recommend avoiding foods high in saturated fat. Yet, emerging evidence suggests cardiometabolic benefits of dairy products and dairy fat. Evidence on the role of butter, with high saturated dairy fat content, for total mortality, cardiovascular disease, and type 2 diabetes remains unclear. We aimed to systematically review and meta-analyze the association of butter consumption with all-cause mortality, cardiovascular disease, and diabetes in general populations.
   Methods and Findings
   We searched 9 databases from inception to May 2015 without restriction on setting, or language, using keywords related to butter consumption and cardiometabolic outcomes. Prospective cohorts or randomized clinical trials providing estimates of effects of butter intake on mortality, cardiovascular disease including coronary heart disease and stroke, or diabetes in adult populations were included. One investigator screened titles and abstracts; and two reviewed full-text articles independently in duplicate, and extracted study and participant characteristics, exposure and outcome definitions and assessment methods, analysis methods, and adjusted effects and associated uncertainty, all independently in duplicate. Study quality was evaluated by a modified Newcastle-Ottawa score. Random and fixed effects meta-analysis pooled findings, with heterogeneity assessed using the I-2 statistic and publication bias by Egger's test and visual inspection of funnel plots. We identified 9 publications including 15 country-specific cohorts, together reporting on 636,151 unique participants with 6.5 million person-years of follow-up and including 28,271 total deaths, 9,783 cases of incident cardiovascular disease, and 23,954 cases of incident diabetes. No RCTs were identified. Butter consumption was weakly associated with all-cause mortality (N = 9 country-specific cohorts; per 14g(1 tablespoon)/day: RR = 1.01, 95% CI = 1.00, 1.03, P = 0.045); was not significantly associated with any cardiovascular disease (N = 4; RR = 1.00, 95% CI = 0.98, 1.02; P = 0.704), coronary heart disease (N = 3; RR = 0.99, 95% CI = 0.96, 1.03; P = 0.537), or stroke (N = 3; RR = 1.01, 95% CI = 0.98, 1.03; P = 0.737), and was inversely associated with incidence of diabetes (N = 11; RR = 0.96, 95% CI = 0.93, 0.99; P = 0.021). We did not identify evidence for heterogeneity nor publication bias.
   Conclusions
   This systematic review and meta-analysis suggests relatively small or neutral overall associations of butter with mortality, CVD, and diabetes. These findings do not support a need for major emphasis in dietary guidelines on either increasing or decreasing butter consumption, in comparison to other better established dietary priorities; while also highlighting the need for additional investigation of health and metabolic effects of butter and dairy fat.
C1 [Pimpin, Laura; Del Gobbo, Liana; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.
   [Wu, Jason H. Y.; Haskelberg, Hila] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia.
   [Del Gobbo, Liana] Stanford Sch Med, Cardiovasc Med, Palo Alto, CA USA.
RP Mozaffarian, D (reprint author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.
EM Dariush.Mozaffarian@tufts.edu
RI Wu, Jason/J-2936-2019
OI Wu, Jason/0000-0003-2073-3562; Pimpin, Laura/0000-0001-5021-0143
FU Circulating Dietary and Metabolic Fatty Acids, Major CVD Outcomes and
   Healthy Aging [5R01HL085710-08]
FX This work was supported by grant number 5R01HL085710-08: Circulating
   Dietary and Metabolic Fatty Acids, Major CVD Outcomes and Healthy Aging.
   The funders had no role in the study data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030
   Avalos EE, 2013, PUBLIC HEALTH NUTR, V16, P2055, DOI 10.1017/S1368980012004168
   Bentley J, 2014, FOOD AV PER CAP DAT
   Bittman M, 2014, NY TIMES
   Bjornshave Ann, 2014, Rev Diabet Stud, V11, P153, DOI 10.1900/RDS.2014.11.153
   Bonham MP, 2013, LIPIDS, V48, P39, DOI 10.1007/s11745-012-3735-5
   Bryan Walsh, 2014, TIME MAGAZINE
   Buijsse B, 2015, EUR J CLIN NUTR, V69, P455, DOI 10.1038/ejcn.2014.249
   Chen M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0215-1
   Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788
   Cormick G, 2015, COCHRANE DB SYST REV, V6
   Deeks J J, 2003, Health Technol Assess, V7, piii
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU
   DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ejtahed HS, 2012, NUTRITION, V28, P539, DOI 10.1016/j.nut.2011.08.013
   Ericson U, 2015, AM J CLIN NUTR, V101, P1065, DOI 10.3945/ajcn.114.103010
   Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9
   Fortes C, 2000, EPIDEMIOLOGY, V11, P440, DOI 10.1097/00001648-200007000-00013
   Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y
   Goldbohm RA, 2011, AM J CLIN NUTR, V93, P615, DOI 10.3945/ajcn.110.000430
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   Guasch-Ferre M, 2015, AM J CLIN NUTR, V102, P479, DOI 10.3945/ajcn.115.112029
   Guasch-Ferre M, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-78
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701
   Hu D, 2014, NUTR METAB CARDIOVAS, V24, P460, DOI 10.1016/j.numecd.2013.12.006
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Jacobs DR, 2003, AM J CLIN NUTR, V78, p508S, DOI 10.1093/ajcn/78.3.508S
   Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269
   Kratz M, 2014, AM J CLIN NUTR, V99, P1385, DOI 10.3945/ajcn.113.075457
   Larsson SC, 2009, EPIDEMIOLOGY, V20, P355, DOI 10.1097/EDE.0b013e3181935dd5
   Lopez S, 2008, AM J CLIN NUTR, V88, P638
   Martinez-Gonzalez MA, 2014, CIRCULATION, V130, P18, DOI 10.1161/CIRCULATIONAHA.113.006921
   Micha R, 2010, LIPIDS, V45, P893, DOI 10.1007/s11745-010-3393-4
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Mozaffarian D, 2013, AM J CLIN NUTR, V97, P854, DOI 10.3945/ajcn.112.045468
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005
   Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116
   O'Sullivan TA, 2013, AM J PUBLIC HEALTH, V103, pE31, DOI 10.2105/AJPH.2013.301492
   Onakpoya IJ, 2011, NUTR REV, V69, P335, DOI 10.1111/j.1753-4887.2011.00397.x
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Otto MCD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000092
   Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x
   Qin LQ, 2015, ASIA PAC J CLIN NUTR, V24, P90, DOI 10.6133/apjcn.2015.24.1.09
   Reid IR, 2013, NUTRIENTS, V5, P2522, DOI 10.3390/nu5072522
   Schulz M, 2008, BRIT J NUTR, V100, P942, DOI 10.1017/S0007114508966149
   Sluik D, 2014, DIABETOLOGIA, V57, P63, DOI 10.1007/s00125-013-3074-y
   Sonestedt E, 2011, EUR J EPIDEMIOL, V26, P609, DOI 10.1007/s10654-011-9589-y
   Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109
   United States Department of Agriculture, 2014, HOUS USDA FOODS FACT
   van Schalkwijk DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100376
   Whiteman D, 1999, PUBLIC HEALTH NUTR, V2, P477, DOI 10.1017/S136898009900066X
   Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563
   Zazpe I, 2011, BRIT J NUTR, V105, P765, DOI 10.1017/S0007114510004149
   Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212
NR 59
TC 44
Z9 44
U1 3
U2 50
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2016
VL 11
IS 6
AR e0158118
DI 10.1371/journal.pone.0158118
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0AM
UT WOS:000378859400028
PM 27355649
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU da Silva, SM
   Boivin, J
   Gameiro, S
AF da Silva, Sara Mesquita
   Boivin, Jacky
   Gameiro, Sofia
TI Self-Regulation and Wellbeing When Facing a Blocked Parenthood Goal: A
   Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID QUALITY-OF-LIFE; DEVELOPMENTAL REGULATION; FERTILITY; ADJUSTMENT;
   HEALTH; WOMEN; SPAN; DISENGAGEMENT; CHILDLESSNESS; INTENTIONS
AB Developmental regulation theories claim that continuing to pursue a goal when it becomes blocked contributes to poorer wellbeing. This consequence is expected to lead to the use of self-regulation strategies in the form of higher disengagement from the goal and higher reengagement in other meaningful goals. The use of these strategies is expected to lead to better wellbeing. A systematic-review and meta-analyses were conducted to test the major predictions of developmental regulation theories for blocked parenthood goal and to investigate possible moderator variables, particularly type and degree of blockage. A total of eight meta-analyses were performed using random-effects models. Moderation was tested with subgroup analysis. After searching eight databases, 4977 potential relevant manuscripts were identified but only six met inclusion criteria. From the eight meta-analyses conducted, only two were significant. In line with prediction, higher goal blockage was related to higher negative mood and reengagement in other life goals was associated to higher positive mood (p < .001). From a total of eight subgroup analyses performed, results showed that disengaging had a positive impact on wellbeing for people experiencing an unanticipated type of blockage (i.e., infertility) but not for those with an anticipated one (i.e., postponing parenthood; X2 = 4.867, p = .03). From the total of twelve sensitivity analyses performed only one suggested that results might differ. The association between disengagement and mood varied according to study quality. When only average studies were included this association was negative, although non-significant. The evidence obtained did not fully support developmental regulation theories for the pursuit of parenthood goal, but primary research had too many methodological limitations to reach firm conclusions. Future studies aimed at investigating blocked parenthood goal are required to evaluate the value of developmental regulation theories.
C1 [da Silva, Sara Mesquita; Boivin, Jacky; Gameiro, Sofia] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.
RP da Silva, SM (reprint author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.
EM DaSilvaSM@cardiff.ac.uk
RI Boivin, Jacky/A-1666-2010; Gameiro, Sofia/E-2866-2010
OI Boivin, Jacky/0000-0001-9498-1708; Gameiro, Sofia/0000-0003-2496-2004
FU Portuguese Foundation for Science and Technology [SFRH/BD/86626/2012]
FX SMdS holds a doctoral fellowship from the Portuguese Foundation for
   Science and Technology (http://www.fct.pt/index.phtml.pt) (grant number:
   SFRH/BD/86626/2012). The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson CJ, 2003, PSYCHOL BULL, V129, P139, DOI 10.1037//0033-2909.129.1.139
   Baird DT, 2005, HUM REPROD UPDATE, V11, P261, DOI 10.1093/humupd/dmi006
   Baltes P. B., 1990, SUCCESSFUL AGING PER, P1, DOI DOI 10.1017/CBO9780511665684.003
   Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Borenstein M., 2009, INTRO METAANALYSIS
   Brandtstadter J, 2002, DEV REV, V22, P117, DOI 10.1006/drev.2001.0539
   Brandtstadter J, 1999, ACTION SELF DEV THEO, P373, DOI DOI 10.4135/9781452204802.N13
   Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004
   Cameron L. D., 2003, SELF REGULATION HLTH, P1
   Carver C. S, 1998, SELF REGULATION BEHA
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082
   Daniluk JC, 2001, J COUNS DEV, V79, P439, DOI 10.1002/j.1556-6676.2001.tb01991.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eriksson C, 2013, UPSALA J MED SCI, V118, P122, DOI 10.3109/03009734.2012.762074
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fitzsimons GM, 2015, PSYCHOL REV, V122, P648, DOI 10.1037/a0039654
   FREEMAN EW, 1987, ACTA OBSTET GYN SCAN, V66, P517, DOI 10.3109/00016348709015727
   Freund AM, 2000, CONTROL HUMAN BEHAV, P32
   Fulford B, 2013, HUM REPROD, V28, P3253, DOI 10.1093/humrep/det373
   Gameiro S, 2014, HUM REPROD, V29, P2238, DOI 10.1093/humrep/deu178
   Greve W., 2005, ADAPTIVE SELF PERSON, P117
   Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152
   Haase CM, 2013, DEV PSYCHOL, V49, P964, DOI 10.1037/a0029231
   Hamilton BE, 2014, NATL VITAL STAT REP, V63, P1
   Haynes TL, 2009, J SOC CLIN PSYCHOL, V28, P165, DOI 10.1521/jscp.2009.28.2.165
   Heaton TB, 1999, J MARRIAGE FAM, V61, P531, DOI 10.2307/353767
   Heckhausen J, 2002, J VOCAT BEHAV, V60, P199, DOI 10.1006/jvbe.2001.1864
   Heckhausen J, 2001, PSYCHOL AGING, V16, P400, DOI 10.1037//0882-7974.16.3.400
   Heckhausen J, 2010, PSYCHOL REV, V117, P32, DOI 10.1037/a0017668
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Kotter-Gruhn D, 2009, PSYCHOL AGING, V24, P634, DOI 10.1037/a0016359
   Kraaij V, 2009, J HEALTH PSYCHOL, V14, P18, DOI 10.1177/1359105308097939
   Lazarus RS, 1984, STRESS APPRAISAL COP
   Leahey TM, 2012, OBESITY, V20, P1413, DOI 10.1038/oby.2012.18
   Light JC, 2006, COGNITION EMOTION, V20, P623, DOI 10.1080/02699930500336540
   Martinez Gladys M, 2006, Vital Health Stat 23, P1
   McQueeney DA, 1997, J BEHAV MED, V20, P313, DOI 10.1023/A:1025560912766
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Moskowitz JT, 1996, ANN BEHAV MED, V18, P49, DOI 10.1007/BF02903939
   National Collaborating Centre for Women's and Children's Health, 2004, ASS TREATM PEOPL FER
   Ordonez LD, 2000, ORGAN BEHAV HUM DEC, V81, P132, DOI 10.1006/obhd.1999.2834
   Practice Comm Amer Soc Reprod Med, 2015, FERTIL STERIL, V103, pE18, DOI 10.1016/j.fertnstert.2014.12.103
   Practice Committee of the American Society for Reproductive Medicine, 2015, FERTIL STERIL, V103, P44
   Riskind RG, 2010, J FAM PSYCHOL, V24, P78, DOI 10.1037/a0017941
   Salmela-Aro K, 2008, J RES PERS, V42, P988, DOI 10.1016/j.jrp.2008.02.007
   Smith ADAC, 2015, JAMA-J AM MED ASSOC, V314, P2654, DOI 10.1001/jama.2015.17296
   Szabo S, 1997, EUR PSYCHOL, V2, P270, DOI [DOI 10.1027/1016-9040.2.3.270, 10.1027/1016-9040.2.3.270]
   Terry DJ, 1998, J PERS SOC PSYCHOL, V74, P1078, DOI 10.1037/0022-3514.74.4.1078
   Thompson EH, 2011, J BEHAV MED, V34, P275, DOI 10.1007/s10865-010-9309-1
   Van Bavel J., 2013, EUROPEAN SOCIOLOGICA, V29, P1149, DOI [10.1093/esr/jct003, DOI 10.1093/ESR/JCT003]
   VANNOORDZAADSTRA BM, 1991, BMJ-BRIT MED J, V302, P1361, DOI 10.1136/bmj.302.6789.1361
   Weitzenkamp DA, 2000, BRIT J HEALTH PSYCH, V5, P57, DOI 10.1348/135910700168766
   Wrosch C, 2005, PSYCHOL AGING, V20, P657, DOI 10.1037/0882-7974.20.4.657
   Wrosch C, 2003, PERS SOC PSYCHOL B, V29, P1494, DOI 10.1177/0146167203256921
   Wrosch C, 1999, J PERS SOC PSYCHOL, V77, P415, DOI 10.1037/0022-3514.77.2.415
   Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343
NR 58
TC 1
Z9 1
U1 1
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 23
PY 2016
VL 11
IS 6
AR e0157649
DI 10.1371/journal.pone.0157649
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP3JL
UT WOS:000378389200029
PM 27336597
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kaufmann, E
   Wittmann, WW
AF Kaufmann, Esther
   Wittmann, Werner W.
TI The Success of Linear Bootstrapping Models: Decision Domain-,
   Expertise-, and Criterion-Specific Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID SOCIAL JUDGMENT THEORY; LENS MODEL; CLINICAL JUDGMENT; PREDICTIONS;
   ACCURACY; TASK; ACHIEVEMENT; STRATEGY; ANALYST; FRUGAL
AB The success of bootstrapping or replacing a human judge with a model (e.g., an equation) has been demonstrated in Paul Meehl's (1954) seminal work and bolstered by the results of several meta-analyses. To date, however, analyses considering different types of metaanalyses as well as the potential dependence of bootstrapping success on the decision domain, the level of expertise of the human judge, and the criterion for what constitutes an accurate decision have been missing from the literature. In this study, we addressed these research gaps by conducting a meta-analysis of lens model studies. We compared the results of a traditional (bare-bones) meta-analysis with findings of a meta-analysis of the success of bootstrap models corrected for various methodological artifacts. In line with previous studies, we found that bootstrapping was more successful than human judgment. Furthermore, bootstrapping was more successful in studies with an objective decision criterion than in studies with subjective or test score criteria. We did not find clear evidence that the success of bootstrapping depended on the decision domain (e.g., education or medicine) or on the judge's level of expertise (novice or expert). Correction of methodological artifacts increased the estimated success of bootstrapping, suggesting that previous analyses without artifact correction (i.e., traditional meta-analyses) may have underestimated the value of bootstrapping models.
C1 [Kaufmann, Esther] Univ Zurich, Inst Educ, Zurich, Switzerland.
   [Wittmann, Werner W.] Univ Mannheim, Otto Selz Inst Appl Psychol, D-68131 Mannheim, Germany.
RP Kaufmann, E (reprint author), Univ Zurich, Inst Educ, Zurich, Switzerland.
EM esther.kaufmann@gmx.ch
OI Kaufmann, Esther/0000-0003-1177-5146
CR AEgisdottir S, 2006, COUNS PSYCHOL, V34, P341, DOI 10.1177/0011000005285875
   Armstrong JS, 2001, INT SER OPER RES MAN, V30, P171
   ASHTON AH, 1982, J ACCOUNTING RES, V20, P440, DOI 10.2307/2490751
   BRUNSWIK E, 1955, PSYCHOL REV, V62, P193, DOI 10.1037/h0047470
   CAMERER C, 1981, ORGAN BEHAV HUM PERF, V27, P411, DOI 10.1016/0030-5073(81)90031-3
   Camerer CA, 1979, GEN THEORY JUDGMENT
   Cooksey R., 1996, JUDGMENT ANAL THEORY
   COOKSEY RW, 1986, AM EDUC RES J, V23, P41, DOI 10.2307/1163041
   Cooksey RW, 2001, J VOCATIONAL ED RES, V26, P1
   COOPER RP, 1990, CRIM JUSTICE BEHAV, V17, P431, DOI 10.1177/0093854890017004004
   Czerlinski J, 1999, SIMPLE HEURISTICS MA, P97
   DAWES RM, 1971, AM PSYCHOL, V26, P180, DOI 10.1037/h0030868
   DAWES RM, 1974, PSYCHOL BULL, V81, P95, DOI 10.1037/h0037613
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   EBERT RJ, 1978, J APPL PSYCHOL, V63, P110, DOI 10.1037/0021-9010.63.1.110
   EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552
   EINHORN HJ, 1974, ORGAN BEHAV HUM PERF, V12, P30, DOI 10.1016/0030-5073(74)90035-X
   Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650
   GOLDBERG LR, 1976, ORGAN BEHAV HUM PERF, V16, P13, DOI 10.1016/0030-5073(76)90003-9
   GOLDBERG LR, 1970, PSYCHOL BULL, V73, P422, DOI 10.1037/h0029230
   GORMAN CD, 1978, ORGAN BEHAV HUM PERF, V22, P165, DOI 10.1016/0030-5073(78)90011-9
   GREBSTEIN LC, 1963, J CONSULT PSYCHOL, V27, P127, DOI 10.1037/h0040580
   Grove WM, 2000, PSYCHOL ASSESSMENT, V12, P19, DOI 10.1037/1040-3590.12.1.19
   HAMMOND KR, 1955, PSYCHOL REV, V62, P255, DOI 10.1037/h0046845
   Hammond KR, 2007, RATIONALITY SEARCH W
   Harvey N, 2004, INT J FORECASTING, V20, P391, DOI 10.1016/j.ijforecast.2003.09.012
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Karelaia N, 2008, PSYCHOL BULL, V134, P404, DOI 10.1037/0033-2909.134.3.404
   Katsikopoulos KV, 2008, THEOR PSYCHOL, V18, P443, DOI 10.1177/0959354308091824
   Kaufmann E, 2010, THESIS
   Kaufmann E, 2007, INT J IDIOGRAPHIC SC, P2
   Kaufmann E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083528
   Kaufmann E, 2009, SWISS J PSYCHOL, V68, P99, DOI 10.1024/1421-0185.68.2.99
   Kim CN, 1997, DECIS SUPPORT SYST, V21, P83, DOI 10.1016/S0167-9236(97)00022-5
   Kuncel NR, 2013, J APPL PSYCHOL, V98, P1060, DOI 10.1037/a0034156
   LADUCA A, 1988, EVAL HEALTH PROF, V11, P178, DOI 10.1177/016327878801100203
   Larrick RP, 2016, WILEY BLACKWELL HDB, P696
   Lehman HA, 1992, THESIS
   LEVI K, 1989, IEEE T SYST MAN CYB, V19, P647, DOI 10.1109/21.31070
   MacGregor D., 1986, HUMAN COMPUTER INTER, V2, P179, DOI DOI 10.1207/S15327051HCI0203_
   MCCLELLAN PG, 1984, PERCEPT PSYCHOPHYS, V36, P234, DOI 10.3758/BF03206364
   MEAR R, 1987, ACCOUNT ORG SOC, V12, P331, DOI 10.1016/0361-3682(87)90022-5
   Meehl Paul E., 1954, CLIN VERSUS STAT PRE
   NYSTEDT L, 1975, PERCEPT MOTOR SKILL, V40, P343, DOI 10.2466/pms.1975.40.2.343
   Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176
   ROOSE JE, 1976, ORGAN BEHAV HUM PERF, V16, P231, DOI 10.1016/0030-5073(76)90015-5
   Schmidt F. L., 2014, METHODS METAANALYSIS
   SINGH H, 1990, Q REV ECON BUS, V30, P64
   Smith L, 2003, APPL COGNITIVE PSYCH, V17, P51, DOI 10.1002/acp.844
   SPEROFF T, 1989, MED DECIS MAKING, V9, P243, DOI 10.1177/0272989X8900900403
   STEINMANN DO, 1972, ORGAN BEHAV HUM PERF, V8, P450, DOI 10.1016/0030-5073(72)90062-1
   STEWART TR, 1990, WEATHER FORECAST, V5, P661, DOI 10.1175/1520-0434(1990)005<0661:ADOTCC>2.0.CO;2
   Stewart TR, 1997, ORGAN BEHAV HUM DEC, V69, P205, DOI 10.1006/obhd.1997.2682
   Swets J A, 2000, Psychol Sci Public Interest, V1, P1, DOI 10.1111/1529-1006.001
   SZUCKO JJ, 1981, AM PSYCHOL, V36, P488, DOI 10.1037/0003-066X.36.5.488
   Tetlock PE, 2005, EXPERT POLITICAL JUDGMENT: HOW GOOD IS IT, HOW CAN WE KNOW, P1
   Trailer JW, 2004, J AM ACAD BUSINESS C, V3, P42
   TUCKER LR, 1964, PSYCHOL REV, V71, P528, DOI 10.1037/h0047061
   WERNER PD, 1983, J CONSULT CLIN PSYCH, V51, P815, DOI 10.1037/0022-006X.51.6.815
   WERNER PD, 1989, SOC WORK RES ABSTR, V25, P17, DOI 10.1093/swra/25.3.17
   WHITENER EM, 1990, J APPL PSYCHOL, V75, P315, DOI 10.1037/0021-9010.75.3.315
   WIGGINS JS, 1973, PERSONALITY PREDICTI
   WIGGINS N, 1971, J PERS SOC PSYCHOL, V19, P100, DOI 10.1037/h0031147
   Wittmann W.W., 1995, EUROPEAN J PSYCHOL A, V11, P59
   WRIGHT WF, 1979, ORGAN BEHAV HUM PERF, V23, P73, DOI 10.1016/0030-5073(79)90047-3
   YNTEMA DB, 1961, IRE T HUM FACT ELECT, VHFE2, P20, DOI 10.1109/THFE2.1961.4503294
NR 66
TC 0
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2016
VL 11
IS 6
AR e0157914
DI 10.1371/journal.pone.0157914
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WU
UT WOS:000378212400063
PM 27327085
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Large, M
   Kaneson, M
   Myles, N
   Myles, H
   Gunaratne, P
   Ryan, C
AF Large, Matthew
   Kaneson, Muthusamy
   Myles, Nicholas
   Myles, Hannah
   Gunaratne, Pramudie
   Ryan, Christopher
TI Meta-Analysis of Longitudinal Cohort Studies of Suicide Risk Assessment
   among Psychiatric Patients: Heterogeneity in Results and Lack of
   Improvement over Time
SO PLOS ONE
LA English
DT Article
ID EVENTUAL SUICIDE; INPATIENT SUICIDE; CLINICAL PREDICTORS; SELF-HARM;
   INTENT; SCALE; HOPELESSNESS; 5-YEAR; SCHIZOPHRENIA; ASSOCIATION
AB Objective
   It is widely assumed that the clinical care of psychiatric patients can be guided by estimates of suicide risk and by using patient characteristics to define a group of high-risk patients. However, the statistical strength and reliability of suicide risk categorization is unknown. Our objective was to investigate the odds of suicide in high-risk compared to lower-risk categories and the suicide rates in high-risk and lower-risk groups.
   Method
   We located longitudinal cohort studies where psychiatric patients or people who had made suicide attempts were stratified into high-risk and lower-risk groups for suicide with suicide mortality as the outcome by searching for peer reviewed publications indexed in PubMed or PsychINFO. Electronic searches were supplemented by hand searching of included studies and relevant review articles. Two authors independently extracted data regarding effect size, study population and study design from 53 samples of risk-assessed patients reported in 37 studies.
   Results
   The pooled odds of suicide among high-risk patients compared to lower-risk patients calculated by random effects meta-analysis was of 4.84 (95% Confidence Interval (CI) 3.79-6.20). Between-study heterogeneity was very high (I-2 = 93.3). There was no evidence that more recent studies had greater statistical strength than older studies. Over an average follow up period of 63 months the proportion of suicides among the high-risk patients was 5.5% and was 0.9% among lower-risk patients. The meta-analytically derived sensitivity and specificity of a high-risk categorization were 56% and 79% respectively. There was evidence of publication bias in favour of studies that inflated the pooled odds of suicide in high-risk patients.
   Conclusions
   The strength of suicide risk categorizations based on the presence of multiple risk factors does not greatly exceed the association between individual suicide risk factors and suicide. A statistically strong and reliable method to usefully distinguish patients with a high-risk of suicide remains elusive.
C1 [Large, Matthew] Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia.
   [Large, Matthew; Gunaratne, Pramudie] Prince Wales Hosp, Randwick, NSW 2031, Australia.
   [Kaneson, Muthusamy] Univ New S Wales, Fac Med, Randwick, NSW, Australia.
   [Myles, Nicholas] Queen Elizabeth Hosp, Woodville South, Australia.
   [Myles, Hannah] Univ Adelaide, Sch Med, Discipline Psychiat, Adelaide, SA 5005, Australia.
   [Myles, Hannah] Country Hlth SA Mental Hlth, Adelaide, SA, Australia.
   [Ryan, Christopher] Univ Sydney, Discipline Psychiat, Sydney, NSW 2006, Australia.
   [Ryan, Christopher] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia.
   [Ryan, Christopher] Westmead Hosp, Dept Psychiat, Westmead, NSW 2145, Australia.
RP Large, M (reprint author), Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia.; Large, M (reprint author), Prince Wales Hosp, Randwick, NSW 2031, Australia.
EM mmbl@bigpond.com
CR ALLGULANDER C, 1990, EUR ARCH PSY CLIN N, V239, P270, DOI 10.1007/BF01738583
   BECK AT, 1989, J AFFECT DISORDERS, V17, P203, DOI 10.1016/0165-0327(89)90001-3
   Beck AT, 1999, SUICIDE LIFE-THREAT, V29, P1
   BECK AT, 1989, J CONSULT CLIN PSYCH, V57, P309, DOI 10.1037/0022-006X.57.2.309
   BECK AT, 1985, AM J PSYCHIAT, V142, P559
   Beck AT, 1974, PREDICTION SUICIDE B
   BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445
   Berman AL, 2014, SUICIDE LIFE-THREAT, V44, P432, DOI 10.1111/sltb.12067
   Boudreaux ED, 2014, AM J PREV MED, V47, pS163, DOI 10.1016/j.amepre.2014.06.005
   Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371
   BUGLASS D, 1974, BRIT J PSYCHIAT, V124, P573, DOI 10.1192/bjp.124.6.573
   BUGLASS D, 1970, BRIT J PSYCHIAT, V116, P483, DOI 10.1192/bjp.116.534.483
   Chapman CL, 2015, ACTA PSYCHIAT SCAND, V131, P162, DOI 10.1111/acps.12359
   Chu C, 2015, J CLIN PSYCHOL, V71, P1186, DOI 10.1002/jclp.22210
   CLARK DC, 1987, AM J PSYCHIAT, V144, P923
   Cohen J, 1986, Ann N Y Acad Sci, V487, P34, DOI 10.1111/j.1749-6632.1986.tb27883.x
   Department of Health, 2010, SUIC RISK ASS MAN SY
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Gaynes BN, 2004, ANN INTERN MED, V140, P822, DOI 10.7326/0003-4819-140-10-200405180-00015
   GOLDSTEIN RB, 1991, ARCH GEN PSYCHIAT, V48, P418
   Haney E.M., 2012, SUICIDE RISK FACTORS
   Harriss L, 2005, J AFFECT DISORDERS, V86, P225, DOI 10.1016/j.jad.2005.02.009
   Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9
   Hawton K, 2005, J CLIN PSYCHIAT, V66, P693, DOI 10.4088/JCP.v66n0604
   Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004
   Hjorthoj CR, 2014, SOC PSYCH PSYCH EPID, V49, P1357, DOI 10.1007/s00127-014-0860-x
   Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754
   Krupinski M, 2000, NERVENARZT, V71, P906, DOI 10.1007/s001150050682
   Krupinski M, 1998, EUR ARCH PSY CLIN N, V248, P141, DOI 10.1007/s004060050031
   Large M, 2011, ACTA PSYCHIAT SCAND, V124, P18, DOI 10.1111/j.1600-0447.2010.01672.x
   Large M, 2011, AUST NZ J PSYCHIAT, V45, P619, DOI 10.3109/00048674.2011.590465
   Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006
   Loas G, 2007, PSYCHOL REP, V100, P183, DOI 10.2466/PR0.100.1.183-190
   Madsen T, 2012, J CLIN PSYCHIAT, V73, P1034, DOI 10.4088/JCP.12lr07795a
   Madsen T, 2012, J CLIN PSYCHIAT, V73, P144, DOI 10.4088/JCP.10m06473
   Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064
   McCarthy JF, 2015, AM J PUBLIC HEALTH, V105, P1935, DOI 10.2105/AJPH.2015.302737
   McMillan D, 2007, PSYCHOL MED, V37, P769, DOI 10.1017/S0033291706009664
   Motto J A, 1990, Crisis, V11, P52
   MOTTO JA, 1985, AM J PSYCHIAT, V142, P680
   National Institute for Health and Care Excellence, 2012, SELF HARM LONG TERM
   Neuner T, 2008, GEN HOSP PSYCHIAT, V30, P324, DOI 10.1016/j.genhosppsych.2008.03.003
   Nimeus A, 1997, J AFFECT DISORDERS, V42, P137, DOI 10.1016/S0165-0327(96)01404-8
   Nimeus A, 2000, EUR PSYCHIAT, V15, P416, DOI 10.1016/S0924-9338(00)00512-5
   Nimeus A., 2002, ARCH SUICIDE RES, V6, P211, DOI DOI 10.1080/13811110214142
   NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637
   NORDSTROM P, 1995, ACTA PSYCHIAT SCAND, V92, P345, DOI 10.1111/j.1600-0447.1995.tb09595.x
   PALLIS DJ, 1984, BRIT J PSYCHIAT, V144, P139, DOI 10.1192/bjp.144.2.139
   POKORNY AD, 1993, SUICIDE LIFE-THREAT, V23, P1
   POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249
   Rajalin M, 2013, J AFFECT DISORDERS, V148, P92, DOI 10.1016/j.jad.2012.11.055
   Ribeiro JD, 2015, PSYCHOL MED, P1
   ROSEN DH, 1976, JAMA-J AM MED ASSOC, V235, P2105, DOI 10.1001/jama.235.19.2105
   Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02
   Runeson B, 2015, J CLIN PSYCHIAT
   Schneider B, 2001, EUR PSYCHIAT, V16, P283, DOI 10.1016/S0924-9338(01)00579-X
   Skogman K, 2004, SOC PSYCH PSYCH EPID, V39, P113, DOI 10.1007/s00127-004-0709-9
   Steeg S, 2012, PSYCHOL MED, V42, P2012, DOI 10.1017/S0033291712001389
   Stefansson J, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0607-6
   Stefansson J, 2012, J AFFECT DISORDERS, V136, P167, DOI 10.1016/j.jad.2010.11.016
   Stephens SH, 1999, J NERV MENT DIS, V187, P10, DOI 10.1097/00005053-199901000-00003
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Suominen K, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-11
   Tejedor MC, 1999, ACTA PSYCHIAT SCAND, V100, P205, DOI 10.1111/j.1600-0447.1999.tb10847.x
   Walsh G, 2015, ACTA PSYCHIAT SCAND, V131, P174, DOI 10.1111/acps.12383
   Wells G., 2013, NEWCASTLE OTTAWA SCA
NR 66
TC 58
Z9 59
U1 2
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2016
VL 11
IS 6
AR e0156322
DI 10.1371/journal.pone.0156322
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO1UG
UT WOS:000377564000011
PM 27285387
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zheng, W
   Cao, XL
   Ungvari, GS
   Xiang, YQ
   Guo, T
   Liu, ZR
   Wang, YY
   Forester, BP
   Seiner, SJ
   Xiang, YT
AF Zheng, Wei
   Cao, Xiao-Lan
   Ungvari, Gabor S.
   Xiang, Ying-Qiang
   Guo, Tong
   Liu, Zheng-Rong
   Wang, Yuan-Yuan
   Forester, Brent P.
   Seiner, Stephen J.
   Xiang, Yu-Tao
TI Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic
   Medication for Treatment Resistant Schizophrenia: Meta-Analysis of
   Randomized Controlled Trials
SO PLOS ONE
LA English
DT Article
ID AUGMENTATION STRATEGIES; SYSTEMATIC REVIEWS; CLINICAL-TRIALS; QUALITY;
   BIAS; ECT
AB This meta-analysis of randomized controlled trials (RCTs) examined the efficacy and safety of the combination of electroconvulsive therapy (ECT) and antipsychotic medication (except for clozapine) versus the same antipsychotic monotherapy for treatment-resistant schizophrenia (TRS). Two independent investigators extracted data for a random effects meta-analysis and pre-specified subgroup and meta-regression analyses. Weighted and standard mean difference (WMD/SMD), risk ratio (RR) +/- 95% confidence intervals (CIs), number needed to treat (NNT), and number needed to harm (NNH) were calculated. Eleven studies (n = 818, duration = 10.2 +/- 5.5 weeks) were identified for meta-analysis. Adjunctive ECT was superior to antipsychoticmonotherapy regarding (1) symptomatic improvement at last-observation endpoint with an SMD of -0.67 (p<0.00001; I-2 = 62%), separating the two groups as early as weeks 1-2with anSMDof -0.58 (p<0.00001; I-2 = 0%); (2) study-defined response (RR = 1.48, p<0.0001) with an NNT of 6 (CI = 4-9) and remission rate (RR = 2.18, p = 0.0002) with an NNT of 8 (CI = 6-16); (3) PANSS positive and general symptom sub-scores at endpoint with a WMDbetween -3.48 to -1.32 (P = 0.01 to 0.009). Subgroup analyses were conducted comparing double blind/rater-masked vs. open RCTs, those with and without randomization details, and high quality (Jadad >= adadup analyses were Jadad<3) studies. The ECT-antipsychotic combination causedmore headache (p = 0.02) with anNNHof 6 (CI = 4-11) and memory impairment (p = 0.001) with an NNH of 3 (CI = 2-5). The use of ECT to augment antipsychotic treatment (clozapine excepted) can be an effective treatment option for TRS, with increased frequency of self-reportedmemory impairment and headache.
C1 [Zheng, Wei] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China.
   [Cao, Xiao-Lan] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.
   [Cao, Xiao-Lan] Shenzhen Kangning Hosp, Shenzhen Key Lab Psychol Healthcare, Shenzhen, Peoples R China.
   [Cao, Xiao-Lan] Shenzhen Kangning Hosp, Shenzhen Inst Mental Hlth, Shenzhen, Peoples R China.
   [Cao, Xiao-Lan] Shenzhen Mental Hlth Ctr, Shenzhen, Peoples R China.
   [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia.
   [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia.
   [Xiang, Ying-Qiang; Guo, Tong] Capital Med Univ, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China.
   [Xiang, Ying-Qiang; Guo, Tong] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China.
   [Liu, Zheng-Rong] Mental Hosp Guangzhou Civil Adm, Guangzhou 510430, Guangdong, Peoples R China.
   [Wang, Yuan-Yuan] Wuhan Univ, Fac Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Hubei Province, Peoples R China.
   [Forester, Brent P.; Seiner, Stephen J.] McLean Hosp Belmont, Boston, MA USA.
   [Forester, Brent P.; Seiner, Stephen J.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.
   [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Zhuhai, Macao Sar, Peoples R China.
RP Zheng, W (reprint author), Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China.; Xiang, YT (reprint author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Zhuhai, Macao Sar, Peoples R China.
EM zhengwei0702@163.com; xyutly@gmail.com
FU McLean Hospital-Chinese Psychiatric Society Initiative in Psychiatry
   (MCIP); University of Macau [SRG2014-00019-FHS, MYRG2015-00230-FHS]
FX The study was supported by the McLean Hospital-Chinese Psychiatric
   Society Initiative in Psychiatry (MCIP), the Start-up Research Grant
   (SRG2014-00019-FHS) and the Multi-Year Research Grant
   (MYRG2015-00230-FHS) from the University of Macau. The funder had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Chanpattana W, 1999, J ECT, V15, P178
   Chanpattana W, 1999, J ECT, V15, P129
   Cohen J, 1988, STAT POWER ANAL BEHA
   Correll CU, 2009, SCHIZOPHRENIA BULL, V35, P443, DOI 10.1093/schbul/sbn018
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Englisch Susanne, 2012, Mens Sana Monogr, V10, P20, DOI 10.4103/0973-1229.91588
   Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f
   Goswami Utpal, 2003, Indian J Psychiatry, V45, P26
   Higgins JP, 2008, COCHRANE HDB SYSTEMA
   Iqbal Mohammad Masud, 2003, Ann Clin Psychiatry, V15, P33, DOI 10.3109/10401230309085668
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   [姜小琴 JIANG Xiaoqin], 2009, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V35, P79
   Kay SR, 1987, SCHIZOPHR B, V13, P463
   Kendell RE, 1981, BRIT J PSYCHIAT, P139
   Kho KH, 2004, EUR ARCH PSY CLIN N, V254, P372, DOI 10.1007/s00406-004-0517-y
   Lally J, 2016, SCHIZOPHR RES, V171, P215, DOI 10.1016/j.schres.2016.01.024
   Li N, 2015, MED INFORM, V28, P194
   Li Q, 2015, SCHIZOPHR RES, V168, P523, DOI 10.1016/j.schres.2015.07.048
   Liu W, 2012, ZHONGGUO YAOWU YU LI, V12, P115, DOI 10.3969/j.issn.1671-2560.2012.01.058
   MELTZER HY, 1992, BRIT J PSYCHIAT, V160, P46, DOI 10.1192/S000712500029692X
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   OVERALL JE, 1962, PSYCHOL REP, V10, P799
   Petrides G, 2015, AM J PSYCHIAT, V172, P52, DOI 10.1176/appi.ajp.2014.13060787
   Porcelli S, 2012, EUR NEUROPSYCHOPHARM, V22, P165, DOI 10.1016/j.euroneuro.2011.08.005
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2
   Shen YF, 2009, ELECTROCONVULSIVE TH
   Tang WK, 2003, PROG NEURO-PSYCHOPH, V27, P373, DOI 10.1016/S0278-5846(02)00354-8
   Tharyan P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000076
   Vayisoglu S, 2014, TURK PSIKIYATR DERG, V25, P201, DOI 10.5080/u7455
   Wang F, 2013, CHINESE J CLIN RATIO, V6, P99
   Wang GK, 2015, MED INFORM, V28, P43
   Wang Wenzheng, 2015, Shanghai Arch Psychiatry, V27, P206, DOI 10.11919/j.issn.1002-0829.215093
   Weiner R. D, 2008, PRACTICE ELECTROCONV
   Young CR, 1998, SCHIZOPHRENIA BULL, V24, P381, DOI 10.1093/oxfordjournals.schbul.a033333
   Zhang JY, 2014, YANBIAN YIXUE, V9, p[35, 7]
   Zhang SR, 2012, RENMIN JUNYI, V55, P141
   Zhang ZP, 2012, J CLIN PSYCHOSOMATIC, V18, P77, DOI 10.3969/j.issn.1672-187X.2012.01.031-0077-02
   Zhou HJ, 2009, J NEUROSCIENCE MENTA, V9, P328, DOI 10.3969/j.issn.1009-6574.2009.04.017
NR 43
TC 11
Z9 12
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2016
VL 11
IS 6
AR e0156510
DI 10.1371/journal.pone.0156510
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO1UG
UT WOS:000377564000014
PM 27285996
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tang, L
   Li, XT
   Wang, BJ
   Luo, GX
   Gu, LY
   Chen, LY
   Liu, K
   Gao, Y
   Zhang, X
AF Tang, Lu
   Li, Xintao
   Wang, Baojun
   Luo, Guoxiong
   Gu, Liangyou
   Chen, Luyao
   Liu, Kan
   Gao, Yu
   Zhang, Xu
TI Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and
   Advanced Prostate Cancer: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID RENAL-CELL CARCINOMA; PRETREATMENT NEUTROPHIL; PSA RESPONSE; SURVIVAL;
   PREDICTOR; INFLAMMATION; PROGRESSION; VALIDATION; MARKER; CRP
AB Objective and Background
   Increasing evidence suggests that inflammation plays an essential role in cancer development and progression. The inflammation marker neutrophil-lymphocyte ratio (NLR) is correlated with prognosis across a wide variety of tumor types, but its prognostic value in prostate cancer (PCa) remains controversial. In the present meta-analysis, the prognostic value of NLR in PCa patients is investigated.
   Methods
   We performed a meta-analysis to determine the predictive value of NLR for overall survival (OS), recurrence-free survival (RFS), and clinical features in patients with PCa. We systematically searched PubMed, ISI Web of Science, and Embase for relevant studies published up to October 2015.
   Results
   A total of 9418 patients from 18 studies were included in the meta-analysis. Elevated pretreatment NLR predicted poor OS (HR 1.628, 95% CI 1.410-1.879) and RFS (HR 1.357, 95% CI 1.126-1.636) in all patients with PCa. However, NLR was insignificantly associated with OS in the subgroup of patients with localized PCa (HR 1.439, 95% CI 0.753-2.75). Increased NLR was also significantly correlated with lymph node involvement (OR 1.616, 95% CI 1.167-2.239) but not with pathological stage (OR 0.827, 95% CI 0.637-1.074) or Gleason score (OR 0.761, 95% CI 0.555-1.044).
   Conclusions
   The present meta-analysis indicated that NLR could predict the prognosis for patients with locally advanced or castration-resistant PCa. Patients with higher NLR are more likely to have poorer prognosis than those with lower NLR.
C1 [Tang, Lu; Li, Xintao; Wang, Baojun; Luo, Guoxiong; Gu, Liangyou; Chen, Luyao; Liu, Kan; Gao, Yu; Zhang, Xu] Chinese PLA Med Acad, Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing 100853, Peoples R China.
RP Zhang, X (reprint author), Chinese PLA Med Acad, Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing 100853, Peoples R China.
EM xzhang@tjh.tjmu.edu.cn
FU National Natural Science Foundation of China [81100561]
FX The authors received funding from the National Natural Science
   Foundation of China (No.81100561).
CR Alkhouri N, 2012, LIVER INT, V32, P297, DOI 10.1111/j.1478-3231.2011.02639.x
   Bahig H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1599-9
   Balta S, 2013, CLIN APPL THROMB-HEM, V19, P579, DOI 10.1177/1076029612475023
   CALMAN KC, 1975, GUT, V16, P490, DOI 10.1136/gut.16.6.490
   Chen Hengqi, 2014, Zhonghua Zhong Liu Za Zhi, V36, P294
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   de Martino M, 2013, BJU INT, V111, pE348, DOI 10.1111/bju.12067
   de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369
   Gokce MI, 2015, CUAJ-CAN UROL ASSOC, V9, pE761, DOI 10.5489/cuaj.3091
   Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]
   Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024
   Karaman M, 2013, CLIN EXP HYPERTENS, V35, P516, DOI 10.3109/10641963.2012.758734
   Kawahara T, 2015, ONCOTARGET, V6, P32169, DOI 10.18632/oncotarget.5081
   Leibowitz-Amit R, 2014, ANN ONCOL, V25, P657, DOI 10.1093/annonc/mdt581
   Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536
   LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499
   Luo Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001670
   Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Minardi D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1036-1
   Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257
   Nuhn P, 2014, BJU INT, V114, pE11, DOI 10.1111/bju.12531
   Pinato DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083279
   Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702
   Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005
   Steffens S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-399
   Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332
   Sumbul AT, 2014, INT UROL NEPHROL, V46, P1531, DOI 10.1007/s11255-014-0664-7
   Tanik S, 2014, ASIAN PAC J CANCER P, V15, P6375, DOI 10.7314/APJCP.2014.15.15.6375
   Templeton AJ, 2014, CANCER-AM CANCER SOC, V120, P3346, DOI 10.1002/cncr.28890
   Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124
   Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023
   Wells G, 2008, NEWCASTLE OTTAWA SCA
   Xue TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096072
   Yodying H, 2015, ANN SURG ONCOLOGY
   Zhang GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001473
   Zhao QT, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S90875
NR 43
TC 35
Z9 35
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 20
PY 2016
VL 11
IS 4
AR e0153981
DI 10.1371/journal.pone.0153981
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ9OU
UT WOS:000374543600078
PM 27096158
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Belluco, S
   Mancin, M
   Conficoni, D
   Simonato, G
   Pietrobelli, M
   Ricci, A
AF Belluco, Simone
   Mancin, Marzia
   Conficoni, Daniele
   Simonato, Giulia
   Pietrobelli, Mario
   Ricci, Antonia
TI Investigating the Determinants of Toxoplasma gondii Prevalence in Meat:
   A Systematic Review and Meta-Regression
SO PLOS ONE
LA English
DT Review
ID SAO-PAULO STATE; GENETIC-CHARACTERIZATION; TISSUE CYSTS; MOLECULAR
   CHARACTERIZATION; SCIENTIFIC OPINION; HUMAN CONSUMPTION;
   NEOSPORA-CANINUM; SLAUGHTERED PIGS; RISK-ASSESSMENT; FINISHING PIGS
AB Background
   Toxoplasma gondii is one of the most widespread parasites in humans and can cause severe illness in immunocompromised individuals. However, its role in healthy people is probably under-appreciated. The complex epidemiology of this protozoan recognizes several infection routes but consumption of contaminated food is likely to be the predominant one. Among food, consumption of raw and undercooked meat is a relevant route of transmission, but the role of different meat producing animal species and meats thereof is controversial.
   Objectives
   The aim of the present work is to summarize and analyse literature data reporting prevalence estimates of T. gondii in meat animals/meats.
   Data Sources
   We searched Medline, Web of Science, Science Direct (last update 31/03/2015).
   Eligibility Criteria
   Relevant papers should report data from primary studies dealing with the prevalence of T. gondii in meat from livestock species as obtained through direct detection methods. Meta-analysis and meta-regression were performed.
   Results
   Of 1915 papers screened, 69 papers were included, dealing mainly with cattle, pigs and sheep. Pooled prevalences, based on random-effect models, were 2.6% (CI95 [0.5-5.8]) for cattle, 12.3% (CI95 [7.6-17.8]) for pigs and 14.7%(CI95 [8.9-21.5]) for sheep. Due to the high heterogeneity observed, univariable and multivariable meta-regression models were fitted showing that the geographic area for cattle (p = 0.032), the farming type for pigs (p = 0.0004) and the sample composition for sheep (p = 0.03) had significant effects on the prevalences of Toxoplasma detected/estimated. Moreover, the role of different animal species was dependent on the geographic location of animals' origin.
   Limitations
   Limitations were due mainly to a possible publication bias.
   Conclusions and Implications
   The present work confirms the role of meat, including beef, as T. gondii sources, and highlights the need for a control system for this parasite to be implemented along the meat production chain. Moreover, consumer knowledge should be strengthened in order to reduce the impact of disease.
C1 [Belluco, Simone; Mancin, Marzia; Ricci, Antonia] Ist Zooprofilatt Sperimentale Venezie, Food Safety Dept, Viale Univ 10, I-35020 Legnaro, PD, Italy.
   [Belluco, Simone; Conficoni, Daniele; Simonato, Giulia; Pietrobelli, Mario] Univ Padua, Dept Anim Med Prod & Hlth, Viale Univ, I-35020 Legnaro, PD, Italy.
RP Belluco, S (reprint author), Ist Zooprofilatt Sperimentale Venezie, Food Safety Dept, Viale Univ 10, I-35020 Legnaro, PD, Italy.; Belluco, S (reprint author), Univ Padua, Dept Anim Med Prod & Hlth, Viale Univ, I-35020 Legnaro, PD, Italy.
EM sbelluco@izsvenezie.it
RI BELLUCO, Simone/L-8107-2019
OI BELLUCO, Simone/0000-0002-3764-4040; CONFICONI,
   DANIELE/0000-0003-1975-6716; mancin, marzia/0000-0002-7260-6031; Ricci,
   Antonia/0000-0002-4774-9655
CR ALKHALIDI NW, 1979, J PARASITOL, V65, P331, DOI 10.2307/3280181
   ARIAS ML, 1994, VET PARASITOL, V55, P133, DOI 10.1016/0304-4017(94)90063-9
   Asgari Q, 2011, TROP ANIM HEALTH PRO, V43, P389, DOI 10.1007/s11250-010-9704-1
   Aspinall TV, 2002, INT J PARASITOL, V32, P1193, DOI 10.1016/S0020-7519(02)00070-X
   Azizi H, 2014, IRAN J PARASITOL, V9, P429
   Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104
   Belbacha I, 2004, SCHWEIZ ARCH TIERH, V146, P561, DOI 10.1024/0036-7281.146.12.561
   Belfort-Neto R, 2007, AN ACAD BRAS CIENC, V79, P111, DOI 10.1590/S0001-37652007000100013
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Berger-Schoch AE, 2011, VET PARASITOL, V177, P290, DOI 10.1016/j.vetpar.2010.11.046
   Bezerra RA, 2012, PARASITOL RES, V110, P509, DOI 10.1007/s00436-011-2514-1
   Boughattas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085044
   Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3
   Cademartori BG, 2014, VET PARASITOL, V203, P207, DOI 10.1016/j.vetpar.2014.02.009
   Campo-Portacio DM, 2014, ASOCIACION COLOMBIAN, V18, P93
   CATAR G, 1969, J PARASITOL, V55, P952, DOI 10.2307/3277157
   Andrade MMC, 2013, RES VET SCI, V94, P587, DOI 10.1016/j.rvsc.2013.01.006
   Collins JD, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2393, 10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2481]
   Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142
   da Silva AV, 2001, VET PARASITOL, V97, P191, DOI 10.1016/S0304-4017(00)00381-2
   da Silva RC, 2009, VET PARASITOL, V165, P332, DOI 10.1016/j.vetpar.2009.07.016
   De Oliveira Medonca A, 2004, PARASITOL LATINOAM, V59, P42, DOI DOI 10.4067/S0717-77122004000100008
   de Sousa S, 2006, VET PARASITOL, V135, P133, DOI 10.1016/j.vetpar.2005.08.012
   DESMONTS G, 1965, REV FR ETUD CLIN BIO, V10, P952
   Dias Rafael André Ferreira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P185, DOI 10.1590/S0036-46652005000400002
   dos Santos CBD, 2005, VET PARASITOL, V131, P207, DOI 10.1016/j.vetpar.2005.04.039
   Dubey JP, 2008, INT J PARASITOL, V38, P999, DOI 10.1016/j.ijpara.2007.11.012
   Dubey JP, 2012, VET PARASITOL, V188, P14, DOI 10.1016/j.vetpar.2012.03.008
   Dubey JP, 2011, INT J PARASITOL, V41, P827, DOI 10.1016/j.ijpara.2011.03.006
   DUBEY JP, 1986, J AM VET MED ASSOC, V188, P1035
   DUBEY JP, 1993, AM J VET RES, V54, P270
   Dubey JP, 2005, J PARASITOL, V91, P1082, DOI 10.1645/GE-683.1
   DUBEY JP, 1976, J AM VET MED ASSOC, V169, P1197
   Dubey JP, 2002, J PARASITOL, V88, P1234, DOI 10.2307/3285499
   DUBEY JP, 1995, J PARASITOL, V81, P48, DOI 10.2307/3284004
   Dumetre A, 2006, VET PARASITOL, V142, P376, DOI 10.1016/j.vetpar.2006.07.005
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013, EFSA J, V11, P3266, DOI [10.2903/j.efsa.2013.3266., DOI 10.2903/J.EFSA.2013.3266]
   EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013, EFSA J, V11, P3265, DOI [10.2903/j.efsa.2013.3265, DOI 10.2903/J.EFSA.2013.3265]
   Ergin S, 2009, B VET I PULAWY, V53, P657
   Esteves F, 2014, VET PARASITOL, V200, P8, DOI 10.1016/j.vetpar.2013.12.017
   Evers F, 2013, REV BRAS PARASITOL V, V22, P58, DOI 10.1590/S1984-29612013005000009
   Fabiani S, 2015, J NEUROL SCI, V351, P3, DOI 10.1016/j.jns.2015.02.028
   Feitosa TF, 2014, VET PARASITOL, V202, P305, DOI 10.1016/j.vetpar.2014.03.015
   Fortier B, 1990, MED MALADIES INFECT, P551
   Frazao-Teixeira E, 2011, VET PARASITOL, V175, P33, DOI 10.1016/j.vetpar.2010.09.030
   Frazao-teixeira E, 2006, BRAZIALIAN J VET PAR, V36, P33
   Gajadhar AA, 1998, J PARASITOL, V84, P759, DOI 10.2307/3284584
   Galvan-Ramirez ML, 2010, J FOOD PROTECT, V73, P1121, DOI 10.4315/0362-028X-73.6.1121
   Gharbi M, 2013, Bull Soc Pathol Exot, V106, P184, DOI 10.1007/s13149-013-0290-4
   Glor SB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-85
   Gomez-Samblas M, 2015, FOOD MICROBIOL, V46, P107, DOI 10.1016/j.fm.2014.07.003
   Guo M, 2015, J FOOD PROTECT, V78, P457, DOI 10.4315/0362-028X.JFP-14-328
   Halos L, 2010, INT J PARASITOL, V40, P193, DOI 10.1016/j.ijpara.2009.06.009
   Halova D, 2013, ZOONOSES PUBLIC HLTH, V60, P168, DOI 10.1111/j.1863-2378.2012.01514.x
   Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   JACOBS L, 1960, J PARASITOL, V46, P23, DOI 10.2307/3275327
   Jacobs L, 1963, AM J VET RES
   Jamba L. F., 1969, Revista do Instituto de Medicina Tropical de Sao Paulo, V11, P169
   Khayeche M, 2013, B SOC PATHOL EXOT
   Maciel BM, 2014, PARASITOL INT, V63, P567, DOI 10.1016/j.parint.2014.03.001
   Martins C, 1989, REV I MED TROP S PAU
   MCCABE RE, 1987, REV INFECT DIS, V9, P754
   Miao Q, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0673-0
   Montoya JG, 1997, CLIN INFECT DIS, V24, P676, DOI 10.1093/clind/24.4.676
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Navarro IT, 1992, CIENC AGR
   Opsteegh M, 2011, INT J FOOD MICROBIOL, V150, P103, DOI 10.1016/j.ijfoodmicro.2011.07.022
   Opsteegh M, 2011, INT J PARASITOL, V41, P343, DOI 10.1016/j.ijpara.2010.10.006
   Opsteegh M, 2010, INT J FOOD MICROBIOL, V139, P193, DOI 10.1016/j.ijfoodmicro.2010.02.027
   PASSOS L M F, 1984, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V36, P581
   R Core Team, 2012, R LANG ENV STAT COMP
   Ragozo AMA, 2008, J PARASITOL, V94, P1259, DOI 10.1645/GE-1641.1
   Rahdar M, 2012, JUNDISHAPUR J MICROB, V5, P570, DOI 10.5812/jjm.4280
   Raudenbush SW, 2009, HDB RES SYNTHESIS ME, V2, P295
   ROTHE J, 1985, PATHOLOGY, V17, P497, DOI 10.3109/00313028509105508
   Fernandes EFTS, 2012, J PARASITOL, V98, P690, DOI 10.1645/GE-3032.1
   Santos SL, 2010, PARASITOL RES, V106, P457, DOI 10.1007/s00436-009-1686-4
   Shaapan R M, 2007, Pak J Biol Sci, V10, P174
   Siam M A, 1979, J Egypt Public Health Assoc, V54, P163
   Silva MSA, 2009, VET PARASITOL, V162, P156, DOI 10.1016/j.vetpar.2009.02.007
   Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   Thomas J, 2010, EPPI REV 4 SOFTWARE
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   Turcekova L, 2013, ACTA PARASITOL, V58, P361, DOI 10.2478/s11686-013-0154-6
   van der Giessen J, 2007, VET PARASITOL, V148, P371, DOI 10.1016/j.vetpar.2007.06.009
   Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Vostalova E, 2000, ACTA VET BRNO, V69, P209, DOI 10.2754/avb200069030209
   Wang H, 2012, INT J FOOD MICROBIOL, V157, P393, DOI 10.1016/j.ijfoodmicro.2012.06.011
   Wang L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-273
   Warnekulasuriya MR, 1998, INT J FOOD MICROBIOL, V45, P211, DOI 10.1016/S0168-1605(98)00158-5
   Yildiz K, 2014, TURK J VET ANIM SCI, V38, P169, DOI 10.3906/vet-1308-49
   Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201
NR 97
TC 20
Z9 20
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 15
PY 2016
VL 11
IS 4
AR e0153856
DI 10.1371/journal.pone.0153856
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ6AH
UT WOS:000374291800058
PM 27082633
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Breckenridge, CB
   Berry, C
   Chang, ET
   Sielken, RL
   Mandel, JS
AF Breckenridge, Charles B.
   Berry, Colin
   Chang, Ellen T.
   Sielken, Robert L., Jr.
   Mandel, Jack S.
TI Association between Parkinson's Disease and Cigarette Smoking, Rural
   Living, Well-Water Consumption, Farming and Pesticide Use: Systematic
   Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID ENVIRONMENTAL RISK-FACTORS; OCCUPATIONAL-EXPOSURE; COFFEE CONSUMPTION;
   EPIDEMIOLOGIC EVIDENCE; CAUSAL INFERENCE; ALPHA-SYNUCLEIN; CAFFEINE
   INTAKE; YOUNG-ONSET; NEURODEGENERATIVE DISEASES; MULTIETHNIC COMMUNITY
AB Objective
   Bradford Hill's viewpoints were used to conduct a weight-of-the-evidence assessment of the association between Parkinson's disease (PD) and rural living, farming and pesticide use. The results were compared with an assessment based upon meta-analysis. For comparison, we also evaluated the association between PD and cigarette smoking as a "positive control" because a strong inverse association has been described consistently in the literature.
   Methods
   PubMed was searched systematically to identify all published epidemiological studies that evaluated associations between Parkinson's disease (PD) and cigarette smoking, rural living, well-water consumption, farming and the use of pesticides, herbicides, insecticides, fungicides or paraquat. Studies were categorized into two study quality groups (Tier 1 or Tier 2); data were abstracted and a forest plot of relative risks (RRs) was developed for each risk factor. In addition, when available, RRs were tabulated for more highly exposed individuals compared with the unexposed. Summary RRs for each risk factor were calculated by meta-analysis of Tier 1, Tier 2 and all studies combined, with sensitivity analyses stratified by other study characteristics. Indices of between-study heterogeneity and evidence of reporting bias were assessed. Bradford Hill's viewpoints were used to determine if a causal relationship between PD and each risk factor was supported by the weight of the evidence.
   Findings
   There was a consistent inverse (negative) association between current cigarette smoking and PD risk. In contrast, associations between PD and rural living, well-water consumption, farming and the use of pesticides, herbicides, insecticides, fungicides or paraquat were less consistent when assessed quantitatively or qualitatively.
   Conclusion
   The weight of the evidence and meta-analysis support the conclusion that there is a causal relationship between PD risk and cigarette smoking, or some unknown factor correlated with cigarette smoking. There may be risk factors associated with rural living, farming, pesticide use or well-water consumption that are causally related to PD, but the studies to date have not identified such factors. To overcome the limitations of research in this area, future studies will have to better characterize the onset of PD and its relationship to rural living, farming and exposure to pesticides.
C1 [Breckenridge, Charles B.] Syngenta Crop Protect LLC, Greensboro, NC 27419 USA.
   [Berry, Colin] Univ London, London E1 4NS, England.
   [Chang, Ellen T.; Mandel, Jack S.] Exponent Inc, Menlo Pk, CA 94025 USA.
   [Sielken, Robert L., Jr.] Sielken & Associates Consulting Inc, College Stn, TX 77845 USA.
RP Mandel, JS (reprint author), Exponent Inc, Menlo Pk, CA 94025 USA.
EM jckmandel@yahoo.com
FU Syngenta Crop Protection, LLC; Syngenta; Exponent, Inc.; Sielken &
   Associates Consulting, Inc.
FX This project was supported by a grant from Syngenta Crop Protection,
   LLC. Syngenta paid hourly fees for the time spent by the following
   co-authors of the study: Drs. Jack S. Mandel (JSM), Sir Colin Berry
   (CB), Ellen T. Chang (ETC), and Robert L. Sielken, Jr. (RLS). Dr.
   Charles B. Breckenridge (CBB), who is an employee of Syngenta, received
   annual compensation in the form of salary and company benefits, however
   Syngenta did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. Exponent, Inc. and Sielken & Associates Consulting, Inc.
   provided support in the form of salaries for authors ETC, JSM, and RLS,
   but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section.
CR Adami HO, 2011, TOXICOL SCI, V122, P223, DOI 10.1093/toxsci/kfr113
   Allam MF, 2004, MOVEMENT DISORD, V19, P614, DOI 10.1002/mds.20029
   Allen MT, 2013, CRIT REV TOXICOL, V43, P515, DOI 10.3109/10408444.2013.798719
   Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312
   Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904
   Baldereschi M, 2003, ACTA NEUROL SCAND, V108, P239, DOI 10.1046/j.1600-0404.2003.00128.x
   Baldi I, 2003, NEUROEPIDEMIOLOGY, V22, P305, DOI 10.1159/000071194
   Baldi I, 2003, AM J EPIDEMIOL, V157, P409, DOI 10.1093/aje/kwf216
   Barbeau A, 1987, Adv Neurol, V45, P299
   Barbeau A, 1986, ADV NEUROL, V45, P299
   Beaman B. L., 1992, Vulnerable brain and environmental risks. Volume 2: Toxins in food., P147
   Beaman BL, 2000, MED MICROBIOL IMMUN, V188, P161, DOI 10.1007/s004309900030
   Behari M, 2001, J NEUROL SCI, V190, P49, DOI 10.1016/S0022-510X(01)00578-0
   Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350
   Berry C, 2013, RE PATHS PESTICIDES
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Boffetta P, 2008, JNCI-J NATL CANCER I, V100, P988, DOI 10.1093/jnci/djn191
   Boffetta P, 2009, INT J EPIDEMIOL, V38, P678, DOI 10.1093/ije/dyn362
   Bonifati V., 2010, MOVEMENT DISORD, V4, P83
   Borenstein M, 2007, METAANALYSIS FIXED E
   Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9
   Breckenridge CB, 2013, NEUROTOXICOLOGY, V37, P1, DOI 10.1016/j.neuro.2013.03.005
   Brighina L, 2008, NEUROLOGY, V70, P1461, DOI 10.1212/01.wnl.0000304049.31377.f2
   Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095
   BURN DJ, 1994, J NEUROL NEUROSUR PS, V57, P278, DOI 10.1136/jnnp.57.3.278
   BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150
   Chan DKY, 1998, J NEUROL NEUROSUR PS, V65, P781, DOI 10.1136/jnnp.65.5.781
   CHATURVEDI S, 1995, CAN J NEUROL SCI, V22, P232, DOI 10.1017/S0317167100039901
   Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732
   Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38
   Cole P., 1997, J MARKETING RES, V27, P10279
   Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400
   Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006
   Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003
   Das K, 2011, NEURODEGENER DIS, V8, P345, DOI 10.1159/000323797
   De Palma G, 1998, LANCET, V352, P1986
   DeMichele G, 1996, MOVEMENT DISORD, V11, P17, DOI 10.1002/mds.870110105
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215
   Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003
   Dick S, 2007, OCCUP MED-OXFORD, V57, P50, DOI 10.1093/occmed/kql109
   Dong JQ, 2003, BIOMED ENVIRON SCI, V16, P173
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Duzcan F, 2003, MOVEMENT DISORD, V18, P799, DOI 10.1002/mds.10440
   Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elbaz A, 2004, ANN NEUROL, V55, P430, DOI 10.1002/ana.20051
   Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717
   Engel LS, 2001, OCCUP ENVIRON MED, V58, P582, DOI 10.1136/oem.58.9.582
   Evans AH, 2006, J NEUROL NEUROSUR PS, V77, P317, DOI 10.1136/jnnp.2005.065417
   Fall PA, 1999, MOVEMENT DISORD, V14, P28, DOI 10.1002/1531-8257(199901)14:1<28::AID-MDS1007>3.3.CO;2-F
   Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132
   Farrer MJ, 2010, MOVEMENT DISORD, P102
   Feldman AL, 2011, PARKINSONISM RELAT D, V17, P677, DOI 10.1016/j.parkreldis.2011.06.009
   Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91
   Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788
   Fitzmaurice AG, 2014, NEUROLOGY, V82, P419, DOI 10.1212/WNL.0000000000000083
   Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110
   Fong CS, 2007, CLIN CHIM ACTA, V378, P136, DOI 10.1016/j.cca.2006.11.006
   Fowler JS, 1996, NATURE, V379, P733, DOI 10.1038/379733a0
   Freire C, 2012, NEUROTOXICOLOGY, V33, P947, DOI 10.1016/j.neuro.2012.05.011
   Frigerio R, 2005, NEUROLOGY, V65, P1575, DOI 10.1212/01.wnl.0000184520.21744.a2
   Frigerio R, 2006, MOVEMENT DISORD, V21, P1688, DOI 10.1002/mds.21009
   Galanaud JP, 2005, MOVEMENT DISORD, V20, P181, DOI 10.1002/mds.20307
   Gasser T, 2010, PROG BRAIN RES, V183, P3, DOI 10.1016/S0079-6123(10)83001-8
   Gatto NM, 2009, ENVIRON HEALTH PERSP, V117, P1912, DOI 10.1289/ehp.0900852
   Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216
   Goldman SM, 2005, NEUROLOGY, V65, P1430, DOI 10.1212/01.wnl.0000180361.74060.70
   Goodman M, 2014, BIRTH DEFECTS RES B, V101, P215, DOI 10.1002/bdrb.21101
   Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346
   Gorell JM, 2004, J NEUROL SCI, V217, P169, DOI 10.1016/j.jns.2003.09.014
   Gorell JM, 1999, NEUROLOGY, V52, P115, DOI 10.1212/WNL.52.1.115
   GRANDINETTI A, 1994, AM J EPIDEMIOL, V139, P1129, DOI 10.1093/oxfordjournals.aje.a116960
   GREENLAND S, 1994, AM J EPIDEMIOL, V140, P783, DOI 10.1093/oxfordjournals.aje.a117326
   Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6
   Hancock DB, 2007, ARCH NEUROL-CHICAGO, V64, P576, DOI 10.1001/archneur.64.4.576
   Harris MA, 2012, J OCCUP ENVIRON HYG, V9, P371, DOI 10.1080/15459624.2012.679853
   Hatcher JM, 2008, TRENDS PHARMACOL SCI, V29, P322, DOI 10.1016/j.tips.2008.03.007
   Hattori N, 2010, MOVEMENT DISORD, V4, P54
   Hellenbrand W, 1997, INT J EPIDEMIOL, V26, P328, DOI 10.1093/ije/26.2.328
   Hernan MA, 2001, ANN NEUROL, V50, P780, DOI 10.1002/ana.10028
   Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   HERTZMAN C, 1994, MOVEMENT DISORD, V9, P69, DOI 10.1002/mds.870090111
   HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HIGGINS PT, 2008, COCHRANE HDB SYSTEMA
   HILL AB, 1965, P ROY SOC MED, V58, P295
   HO SC, 1989, NEUROLOGY, V39, P1314, DOI 10.1212/WNL.39.10.1314
   Hristina VD, 2010, INT J NEUROSCI, V120, P361, DOI 10.3109/00207451003668374
   HUBBLE JP, 1993, NEUROLOGY, V43, P1693, DOI 10.1212/WNL.43.9.1693
   HUBBLE JP, 1995, J CLIN MICROBIOL, V33, P2768
   Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7
   Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e
   Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124
   Jackson-Lewis Vernice, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS183, DOI 10.1016/S1353-8020(11)70057-8
   JIMENEZJIMENEZ FJ, 1992, MOVEMENT DISORD, V7, P149, DOI 10.1002/mds.870070209
   Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024
   Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619
   Kirkey KL, 2001, AM J IND MED, V39, P564, DOI 10.1002/ajim.1055
   Kivimaki M, 2013, INT J EPIDEMIOL, V42, P367, DOI 10.1093/ije/dyt036
   Kiyohara C, 2010, PARKINSONISM RELAT D, V16, P447, DOI 10.1016/j.parkreldis.2010.04.009
   Kiyohara Chikako, 2011, Fukuoka Acta Medica, V102, P254
   KLEIN C, 2010, MOVEMENT DISORD, V4, P15
   KOLLER W, 1990, NEUROLOGY, V40, P1218, DOI 10.1212/WNL.40.8.1218
   Kuopio AM, 1999, MOVEMENT DISORD, V14, P928, DOI 10.1002/1531-8257(199911)14:6<928::AID-MDS1004>3.0.CO;2-Z
   Kyrozis A, 2013, EUR J EPIDEMIOL, V28, P67, DOI 10.1007/s10654-012-9760-0
   Le WD, 2014, NEUROTHERAPEUTICS, V11, P92, DOI 10.1007/s13311-013-0234-1
   Lee E, 2002, AM J IND MED, V42, P410, DOI 10.1002/ajim.10131
   Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28
   Li AA, 2005, J OCCUP ENVIRON MED, V47, P1059, DOI 10.1097/01.jom.0000174294.58575.3e
   Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583
   Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459
   Liu R, 2012, AM J EPIDEMIOL, V175, P1200, DOI 10.1093/aje/kwr451
   Ma L, 2006, ACTA NEUROL SCAND, V113, P278, DOI 10.1111/j.1600-0404.2005.00571.x
   Mandel JS, 2012, REGUL TOXICOL PHARM, V62, P385, DOI 10.1016/j.yrtph.2011.10.004
   Marder K, 1998, NEUROLOGY, V50, P279, DOI 10.1212/WNL.50.1.279
   Martin I, 2010, PROG BRAIN RES, V183, P21, DOI 10.1016/S0079-6123(10)83002-X
   Martinez-Vicente M, 2011, PROTEIN CHAPERONES P, P101
   MARTYN CN, 1995, J NEUROL SCI, V132, P201, DOI 10.1016/0022-510X(95)00148-U
   MAYEUX R, 1994, MOVEMENT DISORD, V9, P207, DOI 10.1002/mds.870090215
   McCann SJ, 1998, NEUROEPIDEMIOLOGY, V17, P310, DOI 10.1159/000026185
   McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x
   McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507
   Minnema DJ, 2014, REGUL TOXICOL PHARM, V68, P250, DOI 10.1016/j.yrtph.2013.12.010
   MORANO A, 1994, ACTA NEUROL SCAND, V89, P164
   Moretto A, 2013, TOXICOLOGY, V307, P24, DOI 10.1016/j.tox.2012.11.021
   Nicoletti A, 2010, NEUROL SCI, V31, P47, DOI 10.1007/s10072-009-0182-z
   Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687
   Ntzani EE, 2013, EFSA SUPPORTING PUBL, VEN-497, P159, DOI DOI 10.2903/SP.EFSA.2013.EN-497
   Olsen J, 2003, J EPIDEMIOL COMMUN H, V57, P86, DOI 10.1136/jech.57.2.86
   Paganini-Hill A, 2001, NEUROEPIDEMIOLOGY, V20, P118, DOI 10.1159/000054770
   Pals P, 2003, EUR J EPIDEMIOL, V18, P1133
   Park J, 2005, NEUROTOXICOLOGY, V26, P99, DOI 10.1016/j.neuro.2004.07.001
   Park J, 2004, IND HEALTH, V42, P352, DOI 10.2486/indhealth.42.352
   Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178
   Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223
   Petersen MS, 2008, NEUROTOXICOLOGY, V29, P584, DOI 10.1016/j.neuro.2008.03.001
   Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782
   Preux PM, 2000, NEUROEPIDEMIOLOGY, V19, P333, DOI 10.1159/000026273
   Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264
   Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435
   Quik M, 2004, TRENDS NEUROSCI, V27, P561, DOI 10.1016/j.tins.2004.06.008
   Ragonese P, 2003, NEUROEPIDEMIOLOGY, V22, P297, DOI 10.1159/000071193
   Ravina BM, 2003, NEUROLOGY, V60, P1234, DOI 10.1212/01.WNL.0000058760.13152.1A
   Ray NJ, 2013, J NEURAL TRANSM, V120, P659, DOI 10.1007/s00702-012-0933-5
   Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990
   Ritz B, 2014, NEUROLOGY, V83, P1396, DOI 10.1212/WNL.0000000000000879
   Ritz BR, 2009, ENVIRON HEALTH PERSP, V117, P964, DOI 10.1289/ehp.0800277
   Rocca WA, 1996, MOVEMENT DISORD, V11, P201, DOI 10.1002/mds.870110214
   Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Rugbjerg K, 2011, SCAND J WORK ENV HEA, V37, P427, DOI 10.5271/sjweh.3142
   Saaksjarvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788
   Sanyal J, 2010, CAN J NEUROL SCI, V37, P637, DOI 10.1017/S0317167100010829
   Sasco A J, 1990, Epidemiology, V1, P460, DOI 10.1097/00001648-199011000-00008
   Scott WK, 2005, NEUROLOGY, V64, P442, DOI 10.1212/01.WNL.0000150905.93241.B2
   Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275
   SEMCHUK KM, 1992, NEUROLOGY, V42, P1328, DOI 10.1212/WNL.42.7.1328
   SHAPIRO S, 1994, AM J EPIDEMIOL, V140, P771, DOI 10.1093/oxfordjournals.aje.a117324
   Sharma V, 2012, INT J PHARM PHARM SC, V4, P55
   Shino MY, 2010, MOVEMENT DISORD, V25, P2587, DOI 10.1002/mds.23361
   Skeie GO, 2010, MOVEMENT DISORD, V25, P1847, DOI 10.1002/mds.23178
   Smargiassi A, 1998, NEUROTOXICOLOGY, V19, P709
   Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469
   STERN M, 1991, ARCH NEUROL-CHICAGO, V48, P903, DOI 10.1001/archneur.1991.00530210029018
   Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008
   Stevens JT, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P711
   Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006
   Tan LC, 2008, AM J EPIDEMIOL, V167, P553, DOI 10.1093/aje/kwm338
   Tanaka K, 2010, ACTA NEUROL SCAND, V122, P377, DOI 10.1111/j.1600-0404.2010.01327.x
   Tanaka K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-83
   Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839
   Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195
   TANNER CM, 1989, NEUROLOGY, V39, P660, DOI 10.1212/WNL.39.5.660
   TANNER CM, 1990, NEUROLOGY, V40, P17
   Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.3.CO;2-R
   Thacker EL, 2007, NEUROLOGY, V68, P764, DOI 10.1212/01.wnl.0000256374.50227.4b
   Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233
   Tomenson JA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000283
   Torta DME, 2008, PSYCHIAT CLIN NEUROS, V62, P203, DOI 10.1111/j.1440-1819.2008.01756.x
   Tsai CH, 2002, CLIN NEUROL NEUROSUR, V104, P328, DOI 10.1016/S0303-8467(02)00027-6
   Tsui JKC, 1999, CAN J PUBLIC HEALTH, V90, P334
   Tuchsen F, 2000, SCAND J WORK ENV HEA, V26, P359
   Tzourio C, 1997, NEUROLOGY, V49, P1267, DOI 10.1212/WNL.49.5.1267
   Uversky VN, 2012, WILEY SER PROTEIN P, P1
   Valente EM, 2010, MOVEMENT DISORD, V4, P66
   van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881
   Van Maele-Fabry G, 2012, ENVIRON INT, V46, P30, DOI 10.1016/j.envint.2012.05.004
   Vanacore N, 2000, NEUROLOGY, V54, P114, DOI 10.1212/WNL.54.1.114
   Viswanathan M., 2011, DEV RTI ITEM BANK RI
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5
   WANG WZ, 1993, NEUROEPIDEMIOLOGY, V12, P209, DOI 10.1159/000110319
   Weed DL, 2005, RISK ANAL, V25, P1545, DOI 10.1111/j.1539-6925.2005.00699.x
   Weed DL, 2010, ANN EPIDEMIOL, V20, P347, DOI 10.1016/j.annepidem.2010.02.001
   Wells G., 2013, NEWCASTLE OTTAWA SCA
   Werneck ALD, 1999, ARQ NEURO-PSIQUIAT, V57, P347, DOI 10.1590/S0004-282X1999000300001
   Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167
   Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa
   Willis AW, 2010, NEUROEPIDEMIOLOGY, V34, P143, DOI 10.1159/000275491
   Wirdefeldt K, 2005, ANN NEUROL, V57, P27, DOI 10.1002/ana.20307
   Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6
   Wright JM, 2005, ARCH ENVIRON HEALTH, V60, P32, DOI 10.3200/AEOH.60.1.32-38
   Zorzon M, 2002, ACTA NEUROL SCAND, V105, P77, DOI 10.1034/j.1600-0404.2002.1o040.x
NR 206
TC 29
Z9 29
U1 3
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 7
PY 2016
VL 11
IS 4
AR e0151841
DI 10.1371/journal.pone.0151841
PG 42
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI6KO
UT WOS:000373608000008
PM 27055126
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Qin, XX
   Deng, YY
   Wu, DD
   Yu, LH
   Huang, RZ
AF Qin, Xiaoxia
   Deng, Yanye
   Wu, Dandong
   Yu, Lehua
   Huang, Rongzhong
TI Does Enhanced External Counterpulsation (EECP) Significantly Affect
   Myocardial Perfusion?: A Systematic Review & Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID ISCHEMIC-HEART-DISEASE; ANGINA-PECTORIS; STABLE ANGINA; NITRIC-OXIDE;
   THERAPY; REVASCULARIZATION; MULTICENTER; OUTCOMES; CURTAIN; FLOW
AB Background
   Enhanced external counterpulsation (EECP) is currently applied for treating coronary artery disease (CAD) patients. However, the mechanism(s) by which EECP ameliorates angina pectoris and long-term left ventricular function remain largely unknown. The aim of this study will be to assess whether EECP significantly affects myocardial perfusion in CAD patients through a systematic review and meta-analysis of the available literature.
   Methods
   MEDLINE, EMBASE, and Cochrane CENTRAL databases were searched for prospective studies on CAD patients that underwent EECP and reported myocardial perfusion data pre-and post-EECP. The impact of EECP was assessed based on the weighted mean difference (WMD) in myocardial perfusion from pre-EECP to post-EECP. Statistical heterogeneity was assessed by the I-2 index. Publication bias was assessed through visual inspection of the funnel plot as well as Begg's and Egger's testing.
   Results
   Standard EECP therapy (i.e., 35-36 one-hour sessions within a seven-week period) significantly increased myocardial perfusion in CAD patients (pooled WMD: -0.19, 95% CI: -0.38 to 0.00, p = 0.049). A random effects analysis was applied on account of significant heterogeneity (I-2 = 89.1%, p = 0.000). There was no evidence of significant publication bias (Begg's p = 0.091; Egger's p = 0.282).
   Conclusions
   Standard EECP therapy significantly increases myocardial perfusion in CAD patients. This study's findings support the continued use of standard EECP therapy in CAD patients and provides one putative physiological mechanism to help explain the improvements in angina
C1 [Qin, Xiaoxia; Deng, Yanye; Wu, Dandong; Yu, Lehua; Huang, Rongzhong] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China.
RP Yu, LH; Huang, RZ (reprint author), Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China.
EM yulehuadoc@aliyun.com; rzhuang@live.com
FU National Natural Science Foundation of China [31300137, 81171859]
FX This work was supported by the National Natural Science Foundation of
   China (grant nos. 31300137 and 81171859). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; This work was supported by the National
   Natural Science Foundation of China (grant nos. 31300137 and 81171859).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akhtar M, 2006, AM J CARDIOL, V98, P28, DOI 10.1016/j.amjcard.2006.01.053
   Arora Rohit R, 2007, Am J Ther, V14, P519, DOI 10.1097/01.mjt.0000249890.00290.30
   Arora RR, 1999, J AM COLL CARDIOL, V33, P1833, DOI 10.1016/S0735-1097(99)00140-0
   Bart BA, 2012, CORONARY ARTERY DIS, P53
   Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1918, DOI 10.1016/S0735-1097(03)00428-5
   Braith RW, 2012, EXERC SPORT SCI REV, V40, P145, DOI 10.1097/JES.0b013e318253de5e
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fitzgerald CP, 2003, CARDIOLOGY, V100, P129, DOI 10.1159/000073930
   Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193
   Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156
   Lawson WE, 2006, CLIN CARDIOL, V29, P69, DOI 10.1002/clc.4960290207
   LAWSON WE, 1992, AM J CARDIOL, V70, P859, DOI 10.1016/0002-9149(92)90727-G
   Masuda D, 2001, EUR HEART J, V22, P1451, DOI 10.1053/euhj.2000.2545
   Masuda D, 2001, CIRCULATION
   Michaels AD, 2005, AM HEART J, V150, P1066, DOI 10.1016/j.ahn.2005.01.054
   Michaels AD, 2002, CIRCULATION, V106, P1237, DOI 10.1161/01.CIR.0000028336.95269.B0
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Soran O, 2006, AM J CARDIOL, V97, P17, DOI 10.1016/j.amjcard.2005.07.122
   Soran O, 2014, CARDIOL CLIN, V32, P429, DOI 10.1016/j.ccl.2014.04.009
   Soran O, 2012, TURK KARDIYOL DERN A, V40, P323, DOI 10.5543/tkda.2012.59144
   Tartaglia J, 2003, CLIN CARDIOL, V26, P287, DOI 10.1002/clc.4950260610
   Wells GA, 2014, NEWCASTLE OTTAWA SCA
   Wu GF, 2006, AM J PHYSIOL-HEART C, V290, pH248, DOI 10.1152/ajpheart.01225.2004
NR 24
TC 3
Z9 3
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 5
PY 2016
VL 11
IS 4
AR e0151822
DI 10.1371/journal.pone.0151822
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI6HK
UT WOS:000373599600005
PM 27045935
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yuan, C
   Wang, J
   Ying, M
AF Yuan, Chuang
   Wang, Jing
   Ying, Michael
TI Predictive Value of Carotid Distensibility Coefficient for
   Cardiovascular Diseases and All-Cause Mortality: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; ARTERIAL STIFFNESS;
   CLINICAL-APPLICATIONS; TASK-FORCE; PULSE-WAVE; RISK; EVENTS; STROKE;
   RECOMMENDATIONS
AB Aims
   The aim of the present study is to determine the pooled predictive value of carotid distensibility coefficient (DC) for cardiovascular (CV) diseases and all-cause mortality.
   Background
   Arterial stiffness is associated with future CV events. Aortic pulse wave velocity is a commonly used predictor for CV diseases and all-cause mortality; however, its assessment requires specific devices and is not always applicable in all patients. In addition to the aortic artery, the carotid artery is also susceptible to atherosclerosis, and is highly accessible because of the surficial property. Thus, carotid DC, which indicates the intrinsic local stiffness of the carotid artery and may be determined using ultrasound and magnetic resonance imaging, is of interest for the prediction. However, the role of carotid DC in the prediction of CV diseases and all-cause mortality has not been thoroughly characterized, and the pooled predictive value of carotid DC remains unclear.
   Methods
   A meta-analysis, which included 11 longitudinal studies with 20361 subjects, was performed.
   Results
   Carotid DC significantly predicted future total CV events, CV mortality and all-cause mortality. The pooled risk ratios (RRs) of CV events, CV mortality and all-cause mortality were 1.19 (1.06-1.35, 95% CI, 9 studies with 18993 subjects), 1.09 (1.01-1.18, 95% CI, 2 studies with 2550 subjects) and 1.65 (1.15-2.37, 95% CI, 6 studies with 3619 subjects), respectively, for the subjects who had the lowest quartile of DC compared with their counterparts who had higher quartiles. For CV events, CV mortality and all-cause mortality, a decrease in DC of 1 SD increased the risk by 13%, 6% and 41% respectively, whereas a decrease in DC of 1 unit increased the risk by 3%, 1% and 6% respectively.
   Conclusions
   Carotid DC is a significant predictor of future CV diseases and all- cause mortality, which may facilitate the identification of high-risk patients for the early diagnosis and prompt treatment of CV diseases.
C1 [Yuan, Chuang] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.
   [Wang, Jing; Ying, Michael] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.
   [Wang, Jing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Neurosurg Neurooncol, Guangzhou 510275, Guangdong, Peoples R China.
RP Yuan, C (reprint author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.; Ying, M (reprint author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.
EM aeolus.yc@connect.polyu.hk; htmying@polyu.edu.hk
OI Ying, Michael/0000-0001-5979-6072
CR Barenbrock M, 2002, J HYPERTENS, V20, P79, DOI 10.1097/00004872-200201000-00012
   Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358
   Blacher J, 1998, HYPERTENSION, V32, P570, DOI 10.1161/01.HYP.32.3.570
   Bramwell JC, 1922, LANCET, V1, P891
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004
   Dijk JM, 2005, EUR HEART J, V26, P1213, DOI 10.1093/eurheartj/ehi254
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   GREENLAND S, 1987, EPIDEMIOL REV, V9, P1
   Haluska BA, 2010, ATHEROSCLEROSIS, V209, P474, DOI 10.1016/j.atherosclerosis.2009.10.018
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Karras A, 2012, HYPERTENSION, V60, P1451, DOI 10.1161/HYPERTENSIONAHA.112.197210
   Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
   Leone N, 2008, ARTERIOSCL THROM VAS, V28, P1392, DOI 10.1161/ATVBAHA.108.164582
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   MASAWA N, 1994, STROKE, V25, P122, DOI 10.1161/01.STR.25.1.122
   Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Orwin RG, 1983, J ED STAT, V8, P157, DOI DOI 10.2307/1164923
   Paini A, 2006, HYPERTENSION, V47, P371, DOI 10.1161/01.HYP.0000202052.25238.68
   Safar ME, 2000, J HYPERTENS, V18, P1527, DOI 10.1097/00004872-200018110-00001
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Stork S, 2004, CIRCULATION, V110, P344, DOI 10.1161/01.CIR.0000134966.10793.C9
   Sung SH, 2014, PULSE, V2, P18, DOI 10.1159/000367645
   Valentine JC, 2010, J EDUC BEHAV STAT, V35, P215, DOI 10.3102/1076998609346961
   Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3
   van Sloten TT, 2015, J AM COLL CARDIOL, V66, P2116, DOI 10.1016/j.jacc.2015.08.888
   van Sloten TT, 2014, J AM COLL CARDIOL, V63, P1739, DOI 10.1016/j.jacc.2013.12.041
   Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061
   Yang EY, 2012, STROKE, V43, P103, DOI 10.1161/STROKEAHA.111.626200
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
NR 33
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 5
PY 2016
VL 11
IS 4
AR e0152799
DI 10.1371/journal.pone.0152799
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI6HK
UT WOS:000373599600035
PM 27045958
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Du, QX
   Jin, JM
   Liu, XF
   Sun, YC
AF Du, Qingxia
   Jin, Jianmin
   Liu, Xiaofang
   Sun, Yongchang
TI Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary
   Disease: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID RESOLUTION COMPUTED-TOMOGRAPHY; PSEUDOMONAS-AERUGINOSA; COPD
   EXACERBATIONS; COLONIZATION; INFLAMMATION; PHENOTYPES; SEVERITY;
   BACTERIA; SPUTUM
AB Background
   Bronchiectasis revealed by chest computed tomography in COPD patients and its comorbid effect on prognosis have not been addressed by large-sized studies. Understanding the presence of bronchiectasis in COPD is important for future intervention and preventing disease progression.
   Methods
   Observational studies were identified from electronic literature searches in Cochrane library, PubMed, ScienceDirect databases, American Thoracic Society and European Respiratory Society meeting abstracts. A systematic review and meta-analysis of studies was performed to summarize the factors associated with bronchiectasis in COPD patients. Primary outcomes included the risks for exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality. Odds ratios (ORs) were pooled by random effects models.
   Results
   Fourteen observational studies were eligible for the study. Compared with COPD without bronchiectasis, comorbid bronchiectasis in COPD increased the risk of exacerbation (1.97, 95% CI, 1.29-3.00), isolation of a potentially pathogenic microorganism (4.11, 95% CI, 2.16-7.82), severe airway obstruction (1.31, 95% CI, 1.09-1.58) and mortality (1.96, 95% CI, 1.04-3.70).
   Conclusions
   The presence of bronchiectasis in patients with COPD was associated with exacerbation frequency, isolation of a potentially pathogenic microorganism, severe airway obstruction and mortality.
C1 [Du, Qingxia; Jin, Jianmin; Liu, Xiaofang; Sun, Yongchang] Capital Med Univ, Beijing Tongren Hosp, Dept Resp Med, Beijing 100730, Peoples R China.
   [Du, Qingxia; Jin, Jianmin; Liu, Xiaofang; Sun, Yongchang] Capital Med Univ, Beijing Tongren Hosp, Dept Emergency, Beijing 100730, Peoples R China.
   [Sun, Yongchang] Peking Univ, Hosp 3, Dept Resp & Crit Care Med, Beijing 100191, Peoples R China.
RP Sun, YC (reprint author), Capital Med Univ, Beijing Tongren Hosp, Dept Resp Med, Beijing 100730, Peoples R China.; Sun, YC (reprint author), Capital Med Univ, Beijing Tongren Hosp, Dept Emergency, Beijing 100730, Peoples R China.; Sun, YC (reprint author), Peking Univ, Hosp 3, Dept Resp & Crit Care Med, Beijing 100191, Peoples R China.
EM suny@ccmu.edu.cn
FU National Natural Science Foundation of China [81170039, 81470239];
   Beijing Natural Science Foundation [7152037, 7153163]
FX This work was supported by the National Natural Science Foundation of
   China (81170039 and 81470239) and the Beijing Natural Science Foundation
   (7152037 and 7153163).
CR ADLER KB, 1986, AM J PATHOL, V125, P501
   Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758
   Arram EO, 2012, EGYPT J CHEST DIS TU, V61, P307, DOI 10.1016/j.ejcdt.2012.07.001
   Aziz ZA, 2005, AM J ROENTGENOL, V185, P1509, DOI 10.2214/AJR.04.1578
   Bafadhel M, 2011, CHEST, V140, P634, DOI 10.1378/chest.10-3007
   Berger JS, 2004, AM J CARDIOL, V94, P649, DOI 10.1016/j.amjcard.2004.05.034
   Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114
   Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505
   Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605
   Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fujimoto K, 2006, RESPIROLOGY, V11, P731, DOI 10.1111/j.1440-1843.2006.00930.x
   Gallego M, 2014, BMC PULM MED, V14, P48
   Garcia-Vidal C, 2009, EUR RESPIR J, V34, P1072, DOI 10.1183/09031936.00003309
   Gatheral T, 2014, COPD, V11, P605, DOI 10.3109/15412555.2014.922174
   Habesoglu MA, 2011, MULTIDISCIP RESP MED, V6, P284, DOI 10.1186/2049-6958-6-5-284
   Han MeiLan K, 2013, Ann Am Thorac Soc, V10 Suppl, pS131, DOI 10.1513/AnnalsATS.201303-046AW
   Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883
   Jairam PM, 2015, THORAX, V70, P725, DOI 10.1136/thoraxjnl-2014-206160
   Katsura H, 2001, Monaldi Arch Chest Dis, V56, P195
   Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S
   Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC
   Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Murray MP, 2009, EUR RESPIR J, V33, P312, DOI 10.1183/09031936.00122508
   Ni YM, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S83910
   Novosad SA, 2013, CURR OPIN PULM MED, V19, P133, DOI 10.1097/MCP.0b013e32835d8312
   Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC
   Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759
   Pieretti P, 2006, RESPIRATION, V73, P157, DOI 10.1159/000088096
   Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421
   Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891
   Sadigov AS, 2014, AM J RESP CRIT CARE, V189
   Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561
   Steward JI, 2012, AM J RESP CRIT CARE, V185, pA3656
   Tulek B, 2013, CAN RESPIR J, V20, P91, DOI 10.1155/2013/727523
   Valderrey AD, 2010, DIAGN MICR INFEC DIS, V68, P20, DOI 10.1016/j.diagmicrobio.2010.04.008
   Wedzicha Jadwiga A, 2007, Proc Am Thorac Soc, V4, P602, DOI 10.1513/pats.200707-106TH
   White AJ, 2003, THORAX, V58, P680, DOI 10.1136/thorax.58.8.680
   Wilson R, 2012, EUR RESPIR J, V40, P17, DOI 10.1183/09031936.00090311
NR 42
TC 32
Z9 34
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 15
PY 2016
VL 11
IS 3
AR e0150532
DI 10.1371/journal.pone.0150532
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH1VK
UT WOS:000372572800028
PM 26978269
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kunutsor, SK
   Whitehouse, MR
   Lenguerrand, E
   Blom, AW
   Beswick, AD
AF Kunutsor, Setor K.
   Whitehouse, Michael R.
   Lenguerrand, Erik
   Blom, Ashley W.
   Beswick, Andrew D.
CA INFORM Team
TI Re-Infection Outcomes Following One- And Two-Stage Surgical Revision of
   Infected Knee Prosthesis: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ONE-STAGE REVISION; HIP-ARTHROPLASTY; SINGLE-STAGE; REIMPLANTATION;
   MANAGEMENT; BIAS; REPLACEMENT; PROJECTIONS; DIAGNOSIS; BURDEN
AB Background
   Periprosthetic joint infection (PJI) is a serious complication of total knee arthroplasty. Two-stage revision is the most widely used technique and considered as the most effective for treating periprosthetic knee infection. The one-stage revision strategy is an emerging alternative option, however, its performance in comparison to the two-stage strategy is unclear. We therefore sought to ask if there was a difference in re-infection rates and other clinical outcomes when comparing the one-stage to the two-stage revision strategy.
   Objective
   Our first objective was to compare re-infection (new and recurrent infections) rates for one-and two-stage revision surgery for periprosthetic knee infection. Our second objective was to compare between the two revision strategies, clinical outcomes as measured by postoperative Knee Society Knee score, Knee Society Function score, Hospital for Special Surgery knee score, WOMAC score, and range of motion.
   Design
   Systematic review and meta-analysis.
   Data sources
   MEDLINE, EMBASE, Web of Science, Cochrane Library, reference lists of relevant studies to August 2015, and correspondence with investigators.
   Study selection
   Longitudinal (prospective or retrospective cohort) studies conducted in generally unselected patients with periprosthetic knee infection treated exclusively by one-or two-stage revision and with re-infection outcomes reported within two years of revision surgery. No clinical trials comparing both revision strategies were identified.
   Review methods
   Two independent investigators extracted data and discrepancies were resolved by consensus with a third investigator. Re-infection rates from 10 one-stage studies (423 participants) and 108 two-stage studies (5,129 participants) were meta-analysed using random-effect models after arcsine transformation.
   Results
   The rate (95% confidence intervals) of re-infection was 7.6% (3.4-13.1) in one-stage studies. The corresponding re-infection rate for two-stage revision was 8.8% (7.2-10.6). In subgroup analyses, re-infection rates remained generally similar for several study-level and clinically relevant characteristics. Postoperative clinical outcomes of knee scores and range of motion were similar for both revision strategies.
   Limitations
   Potential bias owing to the limited number of one-stage revision studies and inability to explore heterogeneity in greater detail.
   Conclusions
   Available evidence from aggregate published data suggest the one-stage revision strategy may be as effective as the two-stage revision strategy in treating infected knee prostheses in generally unselected patients. Further investigation is warranted.
C1 [Kunutsor, Setor K.; Whitehouse, Michael R.; Lenguerrand, Erik; Blom, Ashley W.; Beswick, Andrew D.; INFORM Team] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Southmead Hosp, Learning & Res Bldg Level 1,Southmead Rd, Bristol BS10 5NB, Avon, England.
RP Kunutsor, SK (reprint author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Southmead Hosp, Learning & Res Bldg Level 1,Southmead Rd, Bristol BS10 5NB, Avon, England.
EM skk31@cantab.net
RI Kunutsor, Setor K/H-9807-2019
OI Kunutsor, Setor K/0000-0002-2625-0273; Whitehouse,
   Michael/0000-0003-2436-9024; Beswick, Andrew/0000-0002-7032-7514;
   Gooberman-Hill, Rachael/0000-0003-3353-2882
FU National Institute for Health Research (NIHR) [RP-PG-1210-12005];
   National Institute for Health Research [1313, RP-PG-1210-12005]
FX This article presents independent research funded by the National
   Institute for Health Research (NIHR) under its Programme Grants for
   Applied Research program (RP-PG-1210-12005). The views expressed in this
   article are those of the authors and not necessarily those of the NHS,
   the NIHR, or the Department of Health. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   Bauer T, 2006, REV CHIR ORTHOP, V92, P692
   Bernard L, 2004, J ANTIMICROB CHEMOTH, V53, P127, DOI 10.1093/jac/dkh033
   BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342
   Buechel Frederick F, 2004, Am J Orthop (Belle Mead NJ), V33, P190
   Burnett RSJ, 2007, CLIN ORTHOP RELAT R, P164, DOI 10.1097/BLO.0b013e318157eble
   Buttaro MA, 2005, J BONE JOINT SURG BR, V87B, P314, DOI 10.1302/0301-620X.87B3.14788
   Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756
   GOKSAN SB, 1992, J BONE JOINT SURG BR, V74, P78
   Gulhane S, 2012, J BONE JOINT SURG BR, V94B, P120, DOI 10.1302/0301-620X.94B11.30746
   Hanssen AD, 1998, J BONE JOINT SURG AM, V80A, P910, DOI 10.2106/00004623-199806000-00016
   Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x
   Hunter JP, 2014, J CLIN EPIDEMIOL, V67, P897, DOI 10.1016/j.jclinepi.2014.03.003
   INSALL JN, 1983, J BONE JOINT SURG AM, V65, P1087, DOI 10.2106/00004623-198365080-00008
   Iorio R, 1999, ORTHOPEDICS, V22, P195
   Jamsen E, 2009, ACTA ORTHOP, V80, P67, DOI 10.1080/17453670902805064
   Kallala RF, 2015, BONE JOINT J, V97B, P197, DOI 10.1302/0301-620X.97B2.33707
   Kendoff D, 2014, J KNEE SURG, V27, P273, DOI 10.1055/s-0034-1376882
   Kunutsor SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139166
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Leone S, 2010, INT J INFECT DIS, V14, pS67, DOI 10.1016/j.ijid.2010.05.005
   Masters JPM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-222
   Matthews PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1773
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mortazavi SMJ, 2010, CLIN ORTHOP RELAT R, V468, P2052, DOI 10.1007/s11999-010-1308-6
   Oduwole KO, 2010, KNEE SURG SPORT TR A, V18, P945, DOI 10.1007/s00167-010-1074-8
   Parkinson RW, 2011, KNEE, V18, P1, DOI 10.1016/j.knee.2010.04.008
   Patel A, 2015, BONE JOINT J, V97B, P1076, DOI 10.1302/0301-620X.97B8.35170
   RASUL AT, 1991, CLIN ORTHOP RELAT R, P98
   Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549
   Romano CL, 2012, KNEE SURG SPORT TR A, V20, P2445, DOI 10.1007/s00167-012-1885-x
   Sabry FY, 2014, J ARTHROPLASTY, V29, P115, DOI 10.1016/j.arth.2013.04.016
   Schwarzer G, 2010, J CLIN EPIDEMIOL, V63, P282, DOI 10.1016/j.jclinepi.2009.05.008
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tanner J, 2013, J HOSP INFECT, V83, P87, DOI 10.1016/j.jhin.2012.11.010
   Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V
   Vanhegan IS, 2012, J BONE JOINT SURG BR, V94B, P875, DOI 10.1302/0301-620X.94B7.28710
   VONFOERSTER G, 1991, ORTHOPADE, V20, P244
NR 48
TC 5
Z9 6
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 11
PY 2016
VL 11
IS 3
AR e0151537
DI 10.1371/journal.pone.0151537
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG3SC
UT WOS:000371989200061
PM 26967645
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Modesti, PA
   Reboldi, G
   Cappuccio, FP
   Agyemang, C
   Remuzzi, G
   Rapi, S
   Perruolo, E
   Parati, G
AF Modesti, Pietro Amedeo
   Reboldi, Gianpaolo
   Cappuccio, Francesco P.
   Agyemang, Charles
   Remuzzi, Giuseppe
   Rapi, Stefano
   Perruolo, Eleonora
   Parati, Gianfranco
CA ESH Working Grp CV Risk Low
TI Panethnic Differences in Blood Pressure in Europe: A Systematic Review
   and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID CORONARY-HEART-DISEASE; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR
   RISK; ETHNIC-DIFFERENCES; SOUTH-ASIANS; ORIGIN POPULATIONS;
   INSULIN-RESISTANCE; PUBLICATION BIAS; UK HIGHER
AB Background
   People of Sub Saharan Africa (SSA) and South Asians(SA) ethnic minorities living in Europe have higher risk of stroke than native Europeans(EU). Study objective is to provide an assessment of gender specific absolute differences in office systolic(SBP) and diastolic (DBP) blood pressure(BP) levels between SSA, SA, and EU.
   Methods and Findings
   We performed a systematic review and meta-analysis of observational studies conducted in Europe that examined BP in non-selected adult SSA, SA and EU subjects. Medline, PubMed, Embase, Web of Science, and Scopus were searched from their inception through January 31st 2015, for relevant articles. Outcome measures were mean SBP and DBP differences between minorities and EU, using a random effects model and tested for heterogeneity. Twenty-one studies involving 9,070 SSA, 18,421 SA, and 130,380 EU were included. Compared with EU, SSA had higher values of both SBP (3.38 mmHg, 95% CI 1.28 to 5.48 mmHg; and 6.00 mmHg, 95% CI 2.22 to 9.78 in men and women respectively) and DBP (3.29 mmHg, 95% CI 1.80 to 4.78; 5.35 mmHg, 95% CI 3.04 to 7.66). SA had lower SBP than EU(-4.57 mmHg, 95% CI -6.20 to -2.93; -2.97 mmHg, 95% CI -5.45 to -0.49) but similar DBP values. Meta-analysis by subgroup showed that SA originating from countries where Islam is the main religion had lower SBP and DBP values than EU. In multivariate meta-regression analyses, SBP difference between minorities and EU populations, was influenced by panethnicity and diabetes prevalence.
   Conclusions
   1) The higher BP in SSA is maintained over decades, suggesting limited efficacy of prevention strategies in such group in Europe; 2) The lower BP in Muslim populations suggests that yet untapped lifestyle and behavioral habits may reveal advantages towards the development of hypertension; 3) The additive effect of diabetes, emphasizes the need of new strategies for the control of hypertension in groups at high prevalence of diabetes.
C1 [Modesti, Pietro Amedeo; Rapi, Stefano; Perruolo, Eleonora] Univ Florence, Dept Med Sperimentale & Clin, Florence, Italy.
   [Reboldi, Gianpaolo] Univ Perugia, Dept Med, I-06100 Perugia, Italy.
   [Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
   [Cappuccio, Francesco P.] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England.
   [Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Dept Med, IRCCS Ist Ric Farmacol Mario Negri, Unit Nephrol Dialysis & Transplantat, Bergamo, Italy.
   [Parati, Gianfranco] Univ Milano Bicocca, S Luca Hosp, Dept Cardiol, IRCCS Ist Auxol,Dept Hlth Sci, Milan, Italy.
RP Modesti, PA (reprint author), Univ Florence, Dept Med Sperimentale & Clin, Florence, Italy.
EM pamodesti@unifi.it
RI Del Prato, Stefano/K-3405-2016; Cifkova, Renata/O-5731-2017; Modesti,
   Pietro Amedeo/B-2638-2012; Parati, Gianfranco/K-7151-2016; Reboldi,
   Gianpaolo/A-3444-2009; Remuzzi, Giuseppe/V-9766-2017; Perlini,
   Stefano/E-2670-2012; Bruno, Rosa Maria/C-3594-2015; Rapi,
   Stefano/U-8841-2017
OI Del Prato, Stefano/0000-0002-5388-0270; Cifkova,
   Renata/0000-0003-2765-3821; Modesti, Pietro Amedeo/0000-0002-9511-2173;
   Parati, Gianfranco/0000-0001-9402-7439; Reboldi,
   Gianpaolo/0000-0002-9877-0702; Remuzzi, Giuseppe/0000-0002-6194-3446;
   Perlini, Stefano/0000-0002-0320-8574; Stuckler,
   David/0000-0002-1288-8401; Ceriello, Antonio/0000-0001-8122-3203;
   Kalyesubula, Robert/0000-0003-3211-163X; WATFA,
   GHASSAN/0000-0002-1559-6930; Bruno, Rosa Maria/0000-0002-6107-3356;
   Rapi, Stefano/0000-0001-8564-518X
CR Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964
   Agyemang C, 2014, HEART, V100, P239, DOI 10.1136/heartjnl-2013-304721
   Agyemang C, 2003, J HUM HYPERTENS, V17, P523, DOI 10.1038/sj.jhh.1001586
   Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488
   Agyemang C, 2005, J HYPERTENS, V23, P1971, DOI 10.1097/01.hjh.0000186835.63996.d4
   Agyemang C, 2015, INT J CARDIOL, V183, P180, DOI 10.1016/j.ijcard.2015.01.061
   Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6
   Barba C, 2004, LANCET, V363, P157
   Becker E, 2006, HLTH SURVEY ENGLAND, P1
   Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215
   Bhopal RS, 2014, LANCET DIABETES ENDO, V2, P218, DOI 10.1016/S2213-8587(13)70204-3
   Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516
   Cappuccio FP, 2002, BRIT MED J, V325, P1271, DOI 10.1136/bmj.325.7375.1271
   Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555
   Cappuccio FP, 2003, BR J DIABETES VASC D, V3, P286
   Chaturvedi N, 2004, J HYPERTENS, V22, P1731, DOI 10.1097/00004872-200409000-00017
   CHATURVEDI N, 1993, HYPERTENSION, V22, P90, DOI 10.1161/01.HYP.22.1.90
   COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644
   CRUICKSHANK JK, 1991, LANCET, V338, P842, DOI 10.1016/0140-6736(91)91501-K
   Dong YB, 1999, HYPERTENSION, V34, P1193, DOI 10.1161/01.HYP.34.6.1193
   Dorairaj P, 2003, CIRCULATION, V108, P773
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Erlinger TP, 2003, PREV MED, V37, P327, DOI 10.1016/S0091-7435(03)00140-3
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   Flack JM, 2010, HYPERTENSION, V56, P780, DOI 10.1161/HYPERTENSIONAHA.110.152892
   Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2
   GALBRAITH RF, 1994, J AM STAT ASSOC, V89, P1232, DOI 10.2307/2290987
   Gilbert PA, 2008, NUTR REV, V66, P203, DOI 10.1111/j.1753-4887.2008.00025.x
   Glenday K, 2006, EUR J CARDIOV PREV R, V13, P348
   Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464
   Greer SL, 2013, LANCET, V381, P1135, DOI 10.1016/S0140-6736(12)62083-2
   Gualdi-Russo E, 2009, J TRAVEL MED, V16, P88, DOI 10.1111/j.1708-8305.2008.00280.x
   Gunarathne A, 2009, STROKE, V40, pE415, DOI 10.1161/STROKEAHA.108.535724
   Gupta M, 2006, CIRCULATION, V113, pE924, DOI 10.1161/CIRCULATIONAHA.105.583815
   HAINES AP, 1987, J HUM HYPERTENS, V1, P39
   Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403
   Harding S, 2008, HEART, V94, P463, DOI 10.1136/hrt.2007.122044
   Harding S, 2003, EPIDEMIOLOGY, V14, P287, DOI 10.1097/00001648-200305000-00007
   He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144
   Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117
   Jin ZC, 2015, STAT MED, V34, P343, DOI 10.1002/sim.6342
   Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6
   Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002
   Khan JM, 2005, HEART, V91, P1105, DOI 10.1136/hrt.2004.044560
   Kim AH, 2010, AM J SOCIOL, V115, P1558, DOI 10.1086/651375
   KNIGHT T, 1993, J EPIDEMIOL COMMUN H, V47, P89, DOI 10.1136/jech.47.2.89
   KNIGHT TM, 1992, BRIT HEART J, V67, P343
   Kumar BN, 2009, OSLO IMMIGRANT HLTH, P1503
   Lambie M, 2008, NEPHROL DIAL TRANSPL, V23, P3983, DOI 10.1093/ndt/gfn366
   Lane D, 2002, J HUM HYPERTENS, V16, P267, DOI 10.1038/sj/jhh/1001371
   Lemic-Stojcevic N, 2001, ETHNIC HEALTH, V6, P87, DOI 10.1080/13557850120068414
   Lyratzopoulos G, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-125
   MCKEIGUE PM, 1988, BRIT HEART J, V60, P390
   MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4
   MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P
   MEADE TW, 1978, BRIT HEART J, V40, P789
   Miller MA, 2004, THROMB HAEMOSTASIS, V92, P1060, DOI 10.1160/TH04-04-0228
   Millett C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029836
   Modesti PA, 2014, J HYPERTENS, V32, P951, DOI 10.1097/HJH.0000000000000125
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Nanchahal K, 2001, J PUBLIC HEALTH MED, V23, P278, DOI 10.1093/pubmed/23.4.278
   Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569
   Palloni A, 2001, ANN NY ACAD SCI, V954, P140
   Patel S, 1999, DIABETIC MED, V16, P853, DOI 10.1046/j.1464-5491.1999.00163.x
   Primatesta P, 2000, J HUM HYPERTENS, V14, P143, DOI 10.1038/sj.jhh.1000960
   Rabanal KS, 2013, EUR J PREV CARDIOL, V20, P1013, DOI 10.1177/2047487312450539
   Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8
   Regidor E, 2009, EUR J EPIDEMIOL, V24, P503, DOI 10.1007/s10654-009-9363-6
   Schwarzer G, 2014, METAMETAANALYSIS R R
   SEVER PS, 1979, CLIN EXP HYPERTENS, V1, P733, DOI 10.3109/10641967909068636
   SILMAN AJ, 1987, J EPIDEMIOL COMMUN H, V41, P152, DOI 10.1136/jech.41.2.152
   SIMMONS D, 1993, DIABETIC MED, V10, P751, DOI 10.1111/j.1464-5491.1993.tb00159.x
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Valles SA, 2012, PREV MED, V55, P405, DOI 10.1016/j.ypmed.2012.08.022
   Waterworth DM, 2001, DIABETOLOGIA, V44, P245, DOI 10.1007/s001250051607
   Whitty CJM, 1999, ATHEROSCLEROSIS, V142, P279, DOI 10.1016/S0021-9150(98)00239-1
NR 78
TC 59
Z9 59
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 25
PY 2016
VL 11
IS 1
AR e0147601
DI 10.1371/journal.pone.0147601
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9FZ
UT WOS:000369527800146
PM 26808317
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, WL
   Xie, H
   Wang, HX
   Chen, L
   Sun, Y
   Chen, ZC
   Li, QB
AF Chen, Wenlan
   Xie, Hui
   Wang, Hongxiang
   Chen, Li
   Sun, Yi
   Chen, Zhichao
   Li, Qiubai
TI Prognostic Significance of KIT Mutations in Core-Binding Factor Acute
   Myeloid Leukemia: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID MINIMAL RESIDUAL DISEASE; C-KIT; GENETIC LESIONS; FLT3 MUTATIONS;
   IMPACT; AML; INV(16); T(8/21); EXPRESSION; DIAGNOSIS
AB The prognostic significance of KIT mutations in core-binding factor acute myeloid leukemia (CBF-AML), including inv(16) and t(8;21) AML, is uncertain. We performed a systematic review and meta-analysis of the effect of KIT mutations on the complete remission (CR) and relapse rates and overall survival (OS) of CBF-AML. PubMed, Embase, Web of Science, and the Cochrane Library were searched and relevant studies were included. Negative effect was indicated on relapse risk of CBF-AML (RR [relative risk], 1.43; 95% CI [confidence interval], 1.20-1.70) and t(8;21) AML (RR, 1.70; 95% CI, 1.31-2.21), not on OS of CBF-AML (RR, 1.09; 95% CI, 0.97-1.23), CR (OR [odds ratio], 0.95; 95% CI, 0.52-1.74), relapse risk (RR, 1.12; 95% CI, 0.90-1.41) or OS (RR, 1.03; 95% CI, 0.90-1.18) of inv(16) AML. Subgroup analysis of t(8,21) AML showed negative effect of KIT mutations on CR (OR, 2.03; 95% CI: 1.02-4.05), relapse risk (RR, 1.89; 95% CI: 1.51-2.37) and OS (RR, 2.26; 95% CI: 1.35-3,78) of non-Caucasians, not on CR (OR, 0.61; 95% CI: 0.19-1.95) or OS (RR, 1.12; 95% CI: 0.90-1.40) of Caucasians. This study indicates KIT mutations in CBF-AML to be included in the initial routine diagnostic workup and stratification system of t (8,21) AML. Prospective large-scale clinical trials are warranted to evaluate these findings.
C1 [Chen, Wenlan; Xie, Hui; Chen, Zhichao; Li, Qiubai] Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
   [Wang, Hongxiang; Chen, Li] Wuhan Cent Hosp, Dept Hematol, Wuhan 430000, Peoples R China.
   [Sun, Yi] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Social Med, Tongji Med Coll, Wuhan 430030, Peoples R China.
RP Chen, ZC; Li, QB (reprint author), Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
EM chenzhichao@hust.edu.cn; qiubaili@hust.edu.cn
FU National Natural Science Foundation of China [81272624, 81071943,
   81470330]
FX This study was supported by the National Natural Science Foundation of
   China to QBL (No. 81272624 and No. 81071943) and to ZCC (No. 81470330).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Allen C, 2013, LEUKEMIA, V27, P1891, DOI 10.1038/leu.2013.186
   Beghini A, 1998, BLOOD CELL MOL DIS, V24, P262, DOI 10.1006/bcmd.1998.0191
   Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188
   Byrd JC, 2004, J CLIN ONCOL, V22, P1087, DOI 10.1200/JCO.2004.07.012
   Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640
   Cairoli R, 2003, LEUKEMIA, V17, P471, DOI 10.1038/sj.leu.2402795
   Cairoli R, 2013, AM J HEMATOL, V88, P594, DOI 10.1002/ajh.23461
   Care RS, 2003, BRIT J HAEMATOL, V121, P775, DOI 10.1046/j.1365-2141.2003.04362.x
   CHESON BD, 1990, J CLIN ONCOL, V8, P813, DOI 10.1200/JCO.1990.8.5.813
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Huh J, 2011, BLOOD, V118, P1499
   Iwanaga E, 2009, HAEMATOL-HEMATOL J, V94, P433, DOI 10.3324/haematol.13283
   Jones D, 2010, GENE CHROMOSOME CANC, V49, P182, DOI 10.1002/gcc.20732
   Jourdan E, 2013, BLOOD, V121, P2213, DOI 10.1182/blood-2012-10-462879
   Jung HA, 2014, ANTICANCER RES, V34, P1037
   Kim HJ, 2013, ANN HEMATOL, V92, P163, DOI 10.1007/s00277-012-1580-5
   Kok CH, 2013, BRIT J HAEMATOL, V160, P557, DOI 10.1111/bjh.12131
   Krauth MT, 2014, LEUKEMIA, V28, P1449, DOI 10.1038/leu.2014.4
   Kurosawa S, 2013, HAEMATOLOGICA, V98, P1525, DOI 10.3324/haematol.2012.078030
   Luck SC, 2010, BRIT J HAEMATOL, V148, P925, DOI 10.1111/j.1365-2141.2009.08035.x
   Manara E, 2014, LEUKEMIA, V28, P1132, DOI 10.1038/leu.2013.339
   Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610
   Markova J, 2009, LEUKEMIA LYMPHOMA, V50, P1448, DOI 10.1080/10428190903085951
   National Comprehensive Cancer, 2015, NETW CLIN PRACT GUID
   Park SH, 2013, LEUKEMIA RES, V37, P784, DOI 10.1016/j.leukres.2013.02.010
   Park SH, 2011, LEUKEMIA RES, V35, P1376, DOI 10.1016/j.leukres.2011.06.003
   Paschka P, 2008, SEMIN ONCOL, V35, P410, DOI 10.1053/j.seminoncol.2008.04.011
   Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500
   Paschka P, 2013, HEMATOL-AM SOC HEMAT, P209, DOI 10.1182/asheducation-2013.1.209
   Paschka P, 2013, BLOOD, V121, P170, DOI 10.1182/blood-2012-05-431486
   Pollard JA, 2010, BLOOD, V115, P2372, DOI 10.1182/blood-2009-09-241075
   Qin YZ, 2014, LEUKEMIA RES, V38, P1435, DOI 10.1016/j.leukres.2014.09.017
   Riera L, 2013, ONCOL REP, V29, P1867, DOI 10.3892/or.2013.2328
   Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028
   Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466
   Schwind S, 2013, BLOOD, V121, P385, DOI 10.1182/blood-2012-07-442772
   Shih LY, 2008, LEUKEMIA, V22, P303, DOI 10.1038/sj.leu.2404995
   Shimada A, 2006, BLOOD, V107, P1806, DOI 10.1182/blood-2005-08-3408
   Shimada A, 2007, INT J HEMATOL, V86, P289, DOI 10.1532/IJH97.07098
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Wakita S, 2011, LEUKEMIA, V25, P1423, DOI 10.1038/leu.2011.104
   Wang D, 2012, BIOCHEM BIOPH RES CO, V428, P411, DOI 10.1016/j.bbrc.2012.10.069
   Zhu HH, 2013, BLOOD, V121, P4056, DOI 10.1182/blood-2012-11-468348
NR 48
TC 12
Z9 13
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 15
PY 2016
VL 11
IS 1
AR e0146614
DI 10.1371/journal.pone.0146614
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB6ME
UT WOS:000368628300026
PM 26771376
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Feng, YG
   Cheng, DJ
   Zhang, CF
   Li, YC
   Zhang, ZY
   Wang, J
   Shi, YZ
AF Feng, Yanguo
   Cheng, Dejun
   Zhang, Chaofeng
   Li, Yuchun
   Zhang, Zhiying
   Wang, Juan
   Shi, Yuzhong
TI Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia:
   A Meta-Analysis of Case-Control Studies
SO PLOS ONE
LA English
DT Article
ID PSYCHIATRIC-DISORDERS; GENETIC ASSOCIATION; DISC1; PHOSPHODIESTERASES;
   POPULATION; VARIANTS; GENOMICS; RISK; TWIN
AB Background
   The PDE4B single nucleotide polymorphisms (SNPs) have been reported to be associated with schizophrenia risk. However, current findings are ambiguous or even conflicting. To better facilitate the understanding the genetic role played by PDE4B in susceptibility to schizophrenia, we collected currently available data and conducted this meta-analysis.
   Methods
   A comprehensive electronic literature searching of PubMed, Embase, Web of Science and Cochrane Library was performed. The association between PDE4B SNPs and schizophrenia was evaluated by odds ratios (ORs) and 95% confidence intervals (CIs) under allelic, dominant and recessive genetic models. The random effects model was utilized when high between-study heterogeneity (I-2 > 50%) existed, otherwise the fixed effects model was used.
   Results
   Five studies comprising 2376 schizophrenia patients and 3093 controls were finally included for meta-analysis. The rs1040716 was statistically significantly associated with schizophrenia risk in Asian and Caucasian populations under dominant model (OR = 0.87, 95% CI: 0.76-0.99, P = 0.04). The rs2180335 was significantly related with schizophrenia risk in Asian populations under allelic (OR = 0.82, 95% CI: 0.72-0.93, P = 0.003) and dominant (OR = 0.75, 95% CI: 0.64-0.88, P < 0.001) models. A significant association was also observed between rs4320761 and schizophrenia in Asian populations under allelic model (OR = 0.87, 95% CI: 0.75-1.00, P = 0.048). In addition, a strong association tendency was found between rs6588190 and schizophrenia in Asian populations under allelic model (OR = 0.87, 95% CI: 0.76-1.00, P = 0.055).
   Conclusion
   This meta-analysis suggests that PDE4B SNPs are genetically associated with susceptibility to schizophrenia. However, due to limited sample size, more large-scale, multi-racial association studies are needed to further clarify the genetic association between various PDE4B variants and schizophrenia.
C1 [Feng, Yanguo; Cheng, Dejun; Zhang, Chaofeng; Li, Yuchun; Zhang, Zhiying; Wang, Juan; Shi, Yuzhong] Xinxiang Med Univ, Affiliated Hosp 2, Henan Mental Hosp, Dept Psychiat, Xinxiang, Peoples R China.
RP Shi, YZ (reprint author), Xinxiang Med Univ, Affiliated Hosp 2, Henan Mental Hosp, Dept Psychiat, Xinxiang, Peoples R China.
EM syzscience123@163.com
CR Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171
   Bae JS, 2015, GEN PHYSIOL BIOPHYS, V34, P277, DOI 10.4149/gpb_2015004
   Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120
   Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U
   DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588
   Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fatemi SH, 2008, SCHIZOPHR RES, V101, P36, DOI 10.1016/j.schres.2008.01.029
   Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708
   Guan FL, 2012, HUM GENET, V131, P1047, DOI 10.1007/s00439-011-1120-8
   Holliday EG, 2009, AM J PSYCHIAT, V166, P206, DOI 10.1176/appi.ajp.2008.08030442
   Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698
   Kahler AK, 2010, AM J MED GENET B, V153B, P86, DOI 10.1002/ajmg.b.30958
   KAIYA H, 1992, PROSTAG LEUKOTR ESS, V46, P33, DOI 10.1016/0952-3278(92)90056-O
   Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004
   Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022
   Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007
   McCarthy SE, 2014, SCHIZOPHRENIA BULL, V40, P492, DOI 10.1093/schbul/sbu042
   Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915
   Numata S, 2008, J PSYCHIATR RES, V43, P7, DOI 10.1016/j.jpsychires.2008.01.013
   Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011
   Pickard BS, 2007, PSYCHIAT GENET, V17, P129, DOI 10.1097/YPG.0b013e328014492b
   Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009
   Rastogi A, 2009, SCHIZOPHR RES, V114, P39, DOI 10.1016/j.schres.2009.06.019
   Shi WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127995
   Singh S, 2014, GENE, V535, P97, DOI 10.1016/j.gene.2013.09.110
   Siuciak JA, 2008, CNS DRUGS, V22, P983, DOI 10.2165/0023210-200822120-00002
   Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186
   Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240
   Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187
   SZPIRER C, 1995, CYTOGENET CELL GENET, V69, P11, DOI 10.1159/000133927
   Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014
NR 32
TC 2
Z9 2
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 12
PY 2016
VL 11
IS 1
AR e0147092
DI 10.1371/journal.pone.0147092
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA6CG
UT WOS:000367888800045
PM 26756575
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, J
   Dong, M
   Sun, XR
   Li, WW
   Xing, LG
   Yu, JM
AF Liu, Jing
   Dong, Min
   Sun, Xiaorong
   Li, Wenwu
   Xing, Ligang
   Yu, Jinming
TI Prognostic Value of F-18-FDG PET/CT in Surgical Non-Small Cell Lung
   Cancer: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; TOTAL LESION
   GLYCOLYSIS; METABOLIC TUMOR BURDEN; STAGE-I; VOLUMETRIC PARAMETERS; FDG
   PET/CT; F-18-FLUORODEOXYGLUCOSE UPTAKE; DISEASE PROGRESSION; SURVIVAL
AB Background
   The identification of surgical non-small cell lung cancer (NSCLC) patients with poor prognosis is a priority in clinical oncology because of their high 5-year mortality. This meta-analysis explored the prognostic value of maximal standardized uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) on disease-free survival (DFS) and overall survival (OS) in surgical NSCLC patients.
   Materials and Methods
   MEDLINE, EMBASE and Cochrane Libraries were systematically searched until August 1, 2015. Prospective or retrospective studies that evaluated the prognostic roles of preoperative 18F-FDG PET/CT with complete DFS and OS data in surgical NSCLC patients were included. The impact of SUVmax, MTV or TLG on survival was measured using hazard ratios (HR). Sub-group analyses were performed based on disease stage, pathological classification, surgery only and cut-off values.
   Results
   Thirty-six studies comprised of 5807 patients were included. The combined HRs for DFS were 2.74 (95% CI 2.33-3.24, unadjusted) and 2.43 (95% CI: 1.76-3.36, adjusted) for SUVmax, 2.27 (95% CI 1.77-2.90, unadjusted) and 2.49 (95% CI 1.23-5.04, adjusted) for MTV, and 2.46 (95% CI 1.91-3.17, unadjusted) and 2.97 (95% CI 1.68-5.28, adjusted) for TLG. The pooled HRs for OS were 2.54 (95% CI 1.86-3.49, unadjusted) and 1.52 (95% CI 1.16-2.00, adjusted) for SUVmax, 2.07 (95% CI 1.16-3.69, unadjusted) and 1.91 (95% CI 1.13-3.22, adjusted) for MTV, and 2.47 (95% CI 1.38-4.43, unadjusted) and 1.94 (95% CI 1.12-3.33, adjusted) for TLG. Begg's test detected publication bias, the trim and fill procedure was performed, and similar HRs were obtained. The prognostic role of SUVmax, MTV and TLG remained similar in the sub-group analyses.
   Conclusions
   High values of SUVmax, MTV and TLG predicted a higher risk of recurrence or death in patients with surgical NSCLC. We suggest the use of FDG PET/CT to select patients who are at high risk of disease recurrence or death and may benefit from aggressive treatments.
C1 [Liu, Jing; Xing, Ligang; Yu, Jinming] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China.
   [Liu, Jing; Xing, Ligang; Yu, Jinming] Shandong Canc Hosp & Inst, Shandong Key Lab Radiat Oncol, Jinan, Shandong, Peoples R China.
   [Dong, Min] Peoples Hosp Pingyi Cty, Dept Oncol, Pingyi, Shandong, Peoples R China.
   [Sun, Xiaorong; Li, Wenwu] Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China.
RP Xing, LG (reprint author), Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China.
EM xinglg@medmail.com.cn
FU National Health and Family Planning Commission Institutes of the
   People's Republic of China [201402011]; National Natural Science
   Foundation of China [81272502, L1322016]
FX This work was supported in part by the grant from National Health and
   Family Planning Commission Institutes of the People's Republic of China
   (201402011), and the grants from National Natural Science Foundation of
   China (81272502 and L1322016) to LX. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal M, 2010, EUR J NUCL MED MOL I, V37, P691, DOI 10.1007/s00259-009-1291-x
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b
   Bille A, 2013, CLIN LUNG CANCER, V14, P149, DOI 10.1016/j.cllc.2012.04.007
   Boellaard R, 2004, J NUCL MED, V45, P1519
   Cistaro A, 2013, RADIOL ONCOL, V47, P219, DOI 10.2478/raon-2013-0023
   Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375
   Davison J, 2013, AM J ROENTGENOL, V200, P635, DOI 10.2214/AJR.12.9138
   Dhital K, 2000, EUR J CARDIO-THORAC, V18, P425, DOI 10.1016/S1010-7940(00)00535-2
   Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120
   Domachevsky L, 2015, EUR RADIOL, V25, P3361, DOI 10.1007/s00330-015-3754-8
   Dooms C, 2009, J THORAC ONCOL, V4, P822, DOI 10.1097/JTO.0b013e3181a97df7
   Downey RJ, 2007, J THORAC CARDIOV SUR, V133, P1419, DOI 10.1016/j.tcvs.2007.01.041
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a
   Goodgame B, 2008, J THORAC ONCOL, V3, P130, DOI 10.1097/JTO.0b013e318160c122
   Hanin FX, 2008, EUR J CARDIO-THORAC, V33, P819, DOI 10.1016/j.ejcts.2008.02.005
   Higashi K, 2002, J NUCL MED, V43, P39
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hyun SH, 2013, ANN SURG, V257, P364, DOI 10.1097/SLA.0b013e318262a6ec
   Im HJ, 2015, EUR J NUCL MED MOL I, V42, P241, DOI 10.1007/s00259-014-2903-7
   Kang SR, 2014, NUCL MED MOLEC IMAG, V48, P16, DOI 10.1007/s13139-013-0231-7
   Kim DH, 2014, ANN SURG ONCOL, V21, P589, DOI 10.1245/s10434-013-3270-5
   Kim HR, 2009, EUR J CARDIO-THORAC, V35, P712, DOI 10.1016/j.ejcts.2008.12.030
   Kim K, 2012, NUCL MED COMMUN, V33, P613, DOI 10.1097/MNM.0b013e328351d4f5
   Kim YS, 2011, NEOPLASMA, V58, P245, DOI 10.4149/neo_2011_03_245
   Ko KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000434
   Koo HK, 2011, LUNG CANCER, V73, P222, DOI 10.1016/j.lungcan.2010.11.013
   Lee P, 2007, INT J RADIAT ONCOL, V69, P328, DOI 10.1016/j.ijrobp.2007.04.036
   Lin Y, 2012, ANTICANCER RES, V32, P5087
   Machtay M, 2013, J CLIN ONCOL, V31, P3823, DOI 10.1200/JCO.2012.47.5947
   Melloni G, 2013, EJSO-EUR J SURG ONC, V39, P1254, DOI 10.1016/j.ejso.2013.07.092
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Moon SH, 2013, KOREAN J RADIOL, V14, P1, DOI 10.3348/kjr.2013.14.1.1
   Motono N, 2014, ASIAN PAC J CANCER P, V15, P10171, DOI 10.7314/APJCP.2014.15.23.10171
   Na FF, 2014, J THORAC ONCOL, V9, P834, DOI 10.1097/JTO.0000000000000185
   Nair VS, 2009, J THORAC ONCOL, V4, P1473, DOI 10.1097/JTO.0b013e3181bccbc6
   Nair VS, 2010, CHEST, V137, P1150, DOI 10.1378/chest.09-2356
   Naruke T, 2001, ANN THORAC SURG, V71, P1759, DOI 10.1016/S0003-4975(00)02609-6
   Ohtaka K, 2013, ANTICANCER RES, V33, P5193
   Ohtsuka T, 2006, CANCER, V107, P2468, DOI 10.1002/cncr.22268
   Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5
   Paidpally Vasavi, 2012, Imaging Med, V4, P633
   Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801
   Pan LL, 2009, EUR J GASTROEN HEPAT, V21, P1008, DOI 10.1097/MEG.0b013e328323d6fa
   Park SY, 2015, J NUCL MED, V56, P45, DOI 10.2967/jnumed.114.147561
   Pelosi E, 2011, Q J NUCL MED MOL IM, V55, P72
   Shimizu K, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-343
   Shiono S, 2011, J THORAC ONCOL, V6, P43, DOI 10.1097/JTO.0b013e3181f9abca
   Stahl A, 2004, EUR J NUCL MED MOL I, V31, P1471, DOI 10.1007/s00259-004-1626-6
   Stiles BM, 2013, ANN THORAC SURG, V95, P397, DOI 10.1016/j.athoracsur.2012.07.038
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Tixier F, 2014, J NUCL MED, V55, P1235, DOI 10.2967/jnumed.113.133389
   Tomita M, 2012, ASIA-PAC J CLIN ONCO, V8, P244, DOI 10.1111/j.1743-7563.2012.01549.x
   Tsutani Y, 2011, JPN J CLIN ONCOL, V41, P890, DOI 10.1093/jjco/hyr062
   Um SW, 2009, J THORAC ONCOL, V4, P1331, DOI 10.1097/JTO.0b013e3181b6be3e
   Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014
   van Baardwijk A, 2007, EUR J CANCER, V43, P1392, DOI 10.1016/j.ejca.2007.03.027
   Vesselle H, 2007, CLIN CANCER RES, V13, P3255, DOI 10.1158/1078-0432.CCR-06-1128
   Yoo IR, 2014, BIO-MED MATER ENG, V24, P3091, DOI 10.3233/BME-141131
   Zhang H, 2013, ACAD RADIOL, V20, P32, DOI 10.1016/j.acra.2012.07.002
   Zhang ZJ, 2007, CHINESE MED J-PEKING, V120, P125, DOI 10.1097/00029330-200701020-00010
   Zheng XP, 2014, INT J RADIAT ONCOL, V90, P603, DOI 10.1016/j.ijrobp.2014.05.055
   Zhu AZ, 2011, SEMIN ONCOL, V38, P55, DOI 10.1053/j.seminoncol.2010.11.012
NR 66
TC 45
Z9 48
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 4
PY 2016
VL 11
IS 1
AR e0146195
DI 10.1371/journal.pone.0146195
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA3FF
UT WOS:000367681500065
PM 26727114
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Marti, C
   Grosgurin, O
   Harbarth, S
   Combescure, C
   Abbas, M
   Rutschmann, O
   Perrier, A
   Garin, N
AF Marti, Christophe
   Grosgurin, Olivier
   Harbarth, Stephan
   Combescure, Christophe
   Abbas, Mohamed
   Rutschmann, Olivier
   Perrier, Arnaud
   Garin, Nicolas
TI Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic
   Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID INFLAMMATORY MARKERS; SEVERE SEPSIS; DOUBLE-BLIND; CORTICOSTEROIDS;
   HYDROCORTISONE; MORTALITY; MANAGEMENT; EFFICACY; ADULTS; DEXAMETHASONE
AB Background
   Community-acquired pneumonia (CAP) induces lung and systemic inflammation, leading to high morbidity and mortality. We systematically reviewed the risks and benefits of adjunctive corticotherapy in the management of patients with CAP.
   Methods
   We systematically searched Pubmed, Embase and the Cochrane Library for randomized controlled trials comparing adjunctive corticotherapy and antimicrobial therapy with antimicrobial therapy alone in patients with CAP. The primary outcome was 30-day mortality. Secondary outcomes were length of hospital stay, time to clinical stability and severe complications.
   Results
   14 trials (2077 patients) were included. The reported 30-day mortality was 7.9% (80/1018) among patients treated with adjunctive corticotherapy versus 8.3% (85/1028) among patients treated with antimicrobial therapy alone (RR 0.84; 95%CI 0.55 to 1.29). Adjunctive corticotherapy was associated with a reduction of severe complications (RR 0.36; 95%CI 0.23 to 0.56), a shorter length of stay (9.0 days; 95%CI 7.6 to 10.7 vs 10.6 days; 95%CI 7.4 to 15.3) and a shorter time to clinical stability (3.3 days; 95%CI 2.8 to 4.1 vs 4.3 days; 95%CI 3.6 to 5.1). The risk of hyperglycemia was higher among patients treated with adjunctive corticotherapy (RR 1.59; 95%CI 1.06 to 2.38), whereas the risk of gastro-intestinal bleeding was similar (RR 0.83; 95%CI 0.35 to 1.93). In the subgroup analysis based on CAP severity, a survival benefit was found among patients with severe CAP (RR 0.47; 95%CI 0.23 to 0.96).
   Conclusion
   Adjunctive corticotherapy is associated with a reduction of length of stay, time to clinical stability, and severe complications among patients with CAP, but the effect on mortality remains uncertain.
C1 [Marti, Christophe; Grosgurin, Olivier; Perrier, Arnaud; Garin, Nicolas] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Gen Internal Med, Geneva, Switzerland.
   [Marti, Christophe; Grosgurin, Olivier; Harbarth, Stephan; Combescure, Christophe; Abbas, Mohamed; Rutschmann, Olivier; Perrier, Arnaud; Garin, Nicolas] Geneva Fac Med, Geneva, Switzerland.
   [Harbarth, Stephan; Abbas, Mohamed] Univ Hosp Geneva, Div Infect Dis, Dept Med Specialties, Geneva, Switzerland.
   [Combescure, Christophe] Univ Hosp Geneva, Dept Hlth & Community Med, Geneva, Switzerland.
   [Rutschmann, Olivier] Univ Hosp Geneva, Div Emergency Med, Geneva, Switzerland.
   [Garin, Nicolas] Hop Riviera Chablais, Div Internal Med, Monthey, Switzerland.
RP Marti, C (reprint author), Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Gen Internal Med, Geneva, Switzerland.
EM christophe.marti@hcuge.ch
RI Abbas, Mohamed/M-1724-2019
OI Abbas, Mohamed/0000-0002-7265-1887
CR Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862
   Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815
   AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759
   Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310
   Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8
   Cheng M, 2014, RESP CARE, V59, P557, DOI 10.4187/respcare.02758
   Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC
   Confalonieri M, 2013, CURR INFECT DIS REP, V15, P158, DOI 10.1007/s11908-013-0322-8
   de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   El-Ghamrawy AH, 2006, EGYPT J CHEST DIS TU, V55, P91
   Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785
   Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655
   KLASTERSKY J, 1971, NEW ENGL J MED, V284, P1248, DOI 10.1056/NEJM197106032842206
   Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7
   Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434
   Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   MARIK P, 1993, CHEST, V104, P389, DOI 10.1378/chest.104.2.389
   MCHARDY VU, 1972, BRIT MED J, V4, P569, DOI 10.1136/bmj.4.5840.569
   Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7
   Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Nafae RM, 2013, EGYPT J CHEST DIS TU, V62, P439, DOI 10.1016/j.ejcdt.2013.03.009
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Nie W, 2011, RESPIROLOGY, V16, P54
   Niederman MS, 2001, MED CLIN N AM, V85, P1493, DOI 10.1016/S0025-7125(05)70392-8
   Sabry NA, 2011, PHARM PHARM, V28, P73, DOI DOI 10.4236/PP.2011.22009
   Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715
   Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC
   Steinberg KP, 2006, NEW ENGL J MED, V354, P1671
   Study DB, 1963, JAMA-J AM MED ASSOC, V183, P462, DOI 10.1001/jama.1963.63700060029012
   Tagami T, 2015, EUR RESPIR J, V45, P463, DOI 10.1183/09031936.00081514
   Tian L, 2009, BIOSTATISTICS, V10, P275, DOI 10.1093/biostatistics/kxn034
   Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88
   WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197
   Walden AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13812
   Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135
   Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC
   Zhang Y, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0764-5
NR 44
TC 26
Z9 26
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 7
PY 2015
VL 10
IS 12
AR e0144032
DI 10.1371/journal.pone.0144032
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CZ1YS
UT WOS:000366902700049
PM 26641253
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wever, KE
   Hooijmans, CR
   Riksen, NP
   Sterenborg, TB
   Sena, ES
   Ritskes-Hoitinga, M
   Warle, MC
AF Wever, Kimberley E.
   Hooijmans, Carlijn R.
   Riksen, Niels P.
   Sterenborg, Thomas B.
   Sena, Emily S.
   Ritskes-Hoitinga, Merel
   Warle, Michiel C.
TI Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A
   Systematic Review and Meta-Analysis of Animal Studies
SO PLOS ONE
LA English
DT Review
ID REPERFUSION INJURY; SEARCH FILTER; BIAS; PUBLICATION; QUALITY; DISEASE;
   TRIALS
AB Background
   Ischemic preconditioning (IPC) of the heart is a protective strategy in which a brief ischemic stimulus immediately before a lethal ischemic episode potently limits infarct size. Although very promising in animal models of myocardial infarction, IPC has not yet been successfully translated to benefit for patients.
   Objective
   To appraise all preclinical evidence on IPC for myocardial infarction and identify factors hampering translation.
   Methods and results
   Using systematic review and meta-analysis, we identified 503 animal studies reporting infarct size data from 785 comparisons between IPC-treated and control animals. Overall, IPC reduced myocardial infarction by 24.6% [95% CI 23.5, 25.6]. Subgroup analysis showed that IPC efficacy was reduced in comorbid animals and non-rodents. Efficacy was highest in studies using 2-3 IPC cycles applied < 45 minutes before myocardial infarction. Local and remote IPC were equally effective. Reporting of study quality indicators was low: randomization, blinding and a sample size calculation were reported in 49%, 11% and 2% of publications, respectively.
   Conclusions
   Translation of IPC to the clinical setting may be hampered by the observed differences between the animals used in preclinical IPC studies and the patient population, regarding comorbidity, sex and age. Furthermore, the IPC protocols currently used in clinical trials could be optimized in terms of timing and the number of ischemic cycles applied. In order to inform future clinical trials successfully, future preclinical studies on IPC should aim to maximize both internal and external validity, since poor methodological quality may limit the value of the preclinical evidence.
C1 [Wever, Kimberley E.; Hooijmans, Carlijn R.; Ritskes-Hoitinga, Merel] Radboud Univ Nijmegen Med Ctr, Systemat Review Ctr Lab Anim Experimentat SYRCLE, Nijmegen, Netherlands.
   [Riksen, Niels P.] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands.
   [Riksen, Niels P.] Radboud Univ Nijmegen Med Ctr, Dept Pharmacol Toxicol, Nijmegen, Netherlands.
   [Sterenborg, Thomas B.; Warle, Michiel C.] Radboud Univ Nijmegen Med Ctr, Dept Surg, Nijmegen, Netherlands.
   [Sena, Emily S.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.
RP Wever, KE (reprint author), Radboud Univ Nijmegen Med Ctr, Systemat Review Ctr Lab Anim Experimentat SYRCLE, Nijmegen, Netherlands.
EM kim.wever@radboudumc.nl
RI Hooijmans, C.R./L-4390-2015; Warle, M.C./L-4743-2015; Wever,
   Kimberley/D-9705-2016; Ritskes-Hoitinga, J./H-8083-2014; Riksen, Niels
   P/G-8260-2015
OI Hooijmans, C.R./0000-0001-6435-5714; Wever,
   Kimberley/0000-0003-3635-3660; Sena, Emily S/0000-0002-3282-8502
FU Netherlands Organization for Health Research and Development (ZonMW)
   [104024065]; Laboratory Animal Science Association; Company of
   Biologists Ltd.; Clinical Fellowship of ZonMW; Netherlands Heart
   Foundation; National Centre for the Replacement, Refinement and
   Reduction of Animals in Research (NC3Rs) infrastructure award: ivSyRMAF,
   the CAMARADES-NC3Rs in vivo systematic review and meta-analysis
   facility; Company of Biologists
FX This work was supported by The Netherlands Organization for Health
   Research and Development (ZonMW, project #104024065). KEW performed part
   of this work with support of the Laboratory Animal Science Association
   and The Company of Biologists Ltd. NPR is supported by a Clinical
   Fellowship of ZonMW and the Netherlands Heart Foundation (dr. Dekker
   fellowship). ES' contribution was funded by the National Centre for the
   Replacement, Refinement and Reduction of Animals in Research (NC3Rs)
   infrastructure award: ivSyRMAF, the CAMARADES-NC3Rs in vivo systematic
   review and meta-analysis facility. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; This work was supported by The
   Netherlands Organization for Health Research and Development (ZonMW,
   project #104024065). KEW performed part of this work with support of the
   Laboratory Animal Science Association and The Company of Biologists. NPR
   is supported by a Clinical Fellowship of ZonMW and the Netherlands Heart
   Foundation (dr. Dekker fellowship). ES' contribution was funded by the
   National Centre for the Replacement, Refinement and Reduction of Animals
   in Research (NC3Rs) infrastructure award: ivSyRMAF, the CAMARADES-NC3Rs
   in vivo systematic review and meta-analysis facility.
CR Alreja G, 2012, J INVASIVE CARDIOL, V24, P42
   Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179
   de Vries RBM, 2014, LAB ANIM-UK, V48, P88, DOI 10.1177/0023677213494374
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Healy DA, 2014, INT J SURG
   Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43
   Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117
   Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208
   Jansen Of, 2014, CIRC RES
   Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x
   Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824
   Ludman AJ, 2010, DIS MODEL MECH, V3, P35, DOI 10.1242/dmm.003855
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Pilcher JM, 2012, J ROY SOC MED, V105, P436, DOI 10.1258/jrsm.2012.120049
   Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3
   Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116
   [Shanthi Mendis PPaBN Organisation WH], 2011, POLICIES STRATEGIES, P164
   Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0
   Takagi H, 2011, VASC ENDOVASC SURG, V45, P511, DOI 10.1177/1538574410379654
   Tie HT, 2014, INT J CARDIOL
   van den Munckhof I, 2013, AM J PHYSIOL-HEART C, V304, pH1727, DOI 10.1152/ajpheart.00054.2013
   van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245
   Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010
   Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296
   Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667
NR 28
TC 19
Z9 19
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 18
PY 2015
VL 10
IS 11
AR e0142021
DI 10.1371/journal.pone.0142021
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CW7CD
UT WOS:000365154600031
PM 26580958
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dotson, KB
   Dunn, ME
   Bowers, CA
AF Dotson, Keri B.
   Dunn, Michael E.
   Bowers, Clint A.
TI Stand-Alone Personalized Normative Feedback for College Student
   Drinkers: A Meta-Analytic Review, 2004 to 2014
SO PLOS ONE
LA English
DT Review
ID DESCRIPTIVE DRINKING NORMS; SOCIAL-NORMS; ALCOHOL-CONSUMPTION; BRIEF
   INTERVENTION; PREVENTION; MISPERCEPTIONS; EFFICACY; MISUSE
AB Background
   Norms clarification has been identified as an effective component of college student drinking interventions, prompting research on norms clarification as a single-component intervention known as Personalized Normative Feedback (PNF). Previous reviews have examined PNF in combination with other components but not as a stand-alone intervention.
   Objectives
   To investigate the degree to which computer-delivered stand-alone personalized normative feedback interventions reduce alcohol consumption and alcohol-related harms among college students and to compare gender-neutral and gender-specific PNF.
   Data Sources
   Electronic databases were searched systematically through November 2014. Reference lists were reviewed manually and forward and backward searches were conducted.
   Selection Criteria
   Outcome studies that compared computer-delivered, stand-alone PNF intervention with an assessment only, attention-matched, or active treatment control and reported alcohol use and harms among college students.
   Methods
   Between-group effect sizes were calculated as the standardized mean difference in change scores between treatment and control groups divided by pooled standard deviation. Withingroup effect sizes were calculated as the raw mean difference between baseline and followup divided by pooled within-groups standard deviation.
   Results
   Eight studies (13 interventions) with a total of 2,050 participants were included. Compared to control participants, students who received gender-neutral (d(between) = 0.291, 95% CI [0.159, 0.423]) and gender-specific PNF (d(between) = 0.284, 95% CI [0.117, 0.451]) reported greater reductions in drinking from baseline to follow-up. Students who received genderneutral PNF reported 3.027 (95% CI [2.171, 3.882]) fewer drinks per week at first follow-up and gender-specific PNF reported 3.089 (95% CI [0.992, 5.186]) fewer drinks. Intervention effects were small for harms (d(between) = 0.157, 95% CI [0.037, 0.278]).
   Conclusions
   Computer-delivered PNF is an effective stand-alone approach for reducing college student drinking and has a small impact on alcohol-related harms. Effects are small but clinically relevant when considered from a public health perspective. Additional research is needed to examine computer-delivered, stand-alone PNF as a population-level prevention program.
C1 [Dotson, Keri B.; Dunn, Michael E.; Bowers, Clint A.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.
RP Dotson, KB (reprint author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.
EM keri.dotson@knights.ucf.edu
CR [Anonymous], 2013, GLOB ALC POL C SEOUL
   BAER JS, 1991, J STUD ALCOHOL, V52, P580, DOI 10.15288/jsa.1991.52.580
   Baer JS, 2001, AM J PUBLIC HEALTH, V91, P1310, DOI 10.2105/AJPH.91.8.1310
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331
   Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045
   Centers for Disease Control and Prevention, 2014, EXC DRINK COSTS US 2
   Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015
   Cohen J., 1977, STAT POWER ANAL BEHA
   COLLINS RL, 1985, J CONSULT CLIN PSYCH, V53, P189, DOI 10.1037/0022-006X.53.2.189
   Collins SE, 2002, J STUD ALCOHOL, V63, P559, DOI 10.15288/jsa.2002.63.559
   Cunningham JA, 2000, J STUD ALCOHOL, V61, P794, DOI 10.15288/jsa.2000.61.794
   Curtis M, 2005, THESIS
   DIMEFF LA, 1999, BRIEF ALCOHOL SCREEN
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699
   Foxcroft DR, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006748.pub3
   Hedges L.V., 1994, HDB RES SYNTHESIS, P285
   Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Hingson R. W., 2009, J STUDIES ALCOHOL S, P12, DOI DOI 10.15288/JSADS.2009.S16.12
   Hingson R, 2014, J STUD ALCOHOL DRUGS, V75, P158, DOI 10.15288/jsad.2014.75.158
   Hunter J. E, 2004, METHODS METAANALYSIS
   Johnston Lloyd D., 2012, MONITORING FUTURE NA, V2
   LaBrie JW, 2013, J CONSULT CLIN PSYCH, V81, P1074, DOI 10.1037/a0034087
   Lewis MA, 2006, J AM COLL HEALTH, V54, P213, DOI 10.3200/JACH.54.4.213-218
   Lewis MA, 2004, PSYCHOL ADDICT BEHAV, V18, P334, DOI 10.1037/0893-164X.18.4.334
   Lewis MA, 2005, GENDER SPECIFIC MISP
   Lewis MA, 2007, ADDICT BEHAV, V32, P2495, DOI 10.1016/j.addbeh.2007.06.019
   Lewis MA, 2007, J STUD ALCOHOL DRUGS, V68, P228, DOI 10.15288/jsad.2007.68.228
   Lewis MA, 2015, PSYCHOL ADDICT BEHAV, V29, P162, DOI 10.1037/adb0000003
   Lewis MA, 2014, J CONSULT CLIN PSYCH, V82, P429, DOI 10.1037/a0035550
   Lipsey M., 2001, PRACTICAL METAANALYS
   Miller MB, 2013, PSYCHOL ADDICT BEHAV, V27, P909, DOI 10.1037/a0031174
   Monk RL, 2013, PSYCHOL ADDICT BEHAV, V27, P814, DOI 10.1037/a0033948
   Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105
   Murphy JG, 2004, J STUD ALCOHOL, V65, P200, DOI 10.15288/jsa.2004.65.200
   Neighbors C, 2004, J CONSULT CLIN PSYCH, V72, P434, DOI 10.1037/0022-006X.72.3.434
   Neighbors C, 2007, J STUD ALCOHOL DRUGS, V68, P556, DOI 10.15288/jsad.2007.68.556
   Neighbors C, 2006, HEALTH PSYCHOL, V25, P571, DOI 10.1037/0278-6133.25.5.571
   Neighbors Clayton, 2005, Rep Soc Norms, V4, P1
   Neighbors C, 2011, GROUP PROCESS INTERG, V14, P651, DOI 10.1177/1368430210398014
   Perkins HW, 2002, J STUD ALCOHOL, P164, DOI 10.15288/jsas.2002.s14.164
   Prince MA, 2014, PSYCHOL ADDICT BEHAV, V28, P538, DOI 10.1037/a0036402
   Riper H, 2009, ALCOHOL CLIN EXP RES, V33, P1401, DOI 10.1111/j.1530-0277.2009.00970.x
   Riper H, 2009, AM J PREV MED, V36, P247, DOI 10.1016/j.amepre.2008.10.016
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183
   Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530
   Smith ML, 1980, BENEFITS PSYCHOTHERA
   Substance Abuse and Mental Health Services Administration, 2014, PUBL SMA
   Walters ST, 2000, J AM COLL HEALTH, V48, P235, DOI 10.1080/07448480009599310
   Walters ST, 2005, ADDICT BEHAV, V30, P1168, DOI 10.1016/j.addbeh.2004.12.005
   Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713
   Wechsler H, 2008, J STUD ALCOHOL DRUGS, V69, P481, DOI 10.15288/jsad.2008.69.481
NR 56
TC 46
Z9 46
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 8
PY 2015
VL 10
IS 10
AR e0139518
DI 10.1371/journal.pone.0139518
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT0TW
UT WOS:000362511000030
PM 26447792
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dai, MY
   Chen, XL
   Liu, XX
   Peng, Z
   Meng, J
   Dai, SM
AF Dai, Meiyu
   Chen, Xiaoli
   Liu, Xuexiang
   Peng, Zheng
   Meng, Jie
   Dai, Shengming
TI Diagnostic Value of the Combination of Golgi Protein 73 and
   Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID SYSTEMATIC REVIEWS; CHRONIC HEPATITIS; PUBLICATION BIAS; SERUM MARKER;
   GP73; CANCER; COMPLEMENTARY; HETEROGENEITY; GLYCOPROTEIN; EXPRESSION
AB Conflicting results have been widely reported on the use of Golgi protein 73 (GP73) as a serum biomarker for diagnosing hepatocellular carcinoma (HCC). This study evaluated the accuracy of GP73, alpha-fetoprotein (AFP), and GP73 + AFP for diagnosing HCC. The meta-analysis was performed on 11 studies that were selected by means of a comprehensive systematic literature review. Summary diagnostic accuracy, meta-regression analysis for heterogeneity and publication bias, and other statistical analyses were performed using Meta-Disc (version 1.4) and Stata (version 12.0). Pooled sensitivity, specificity, and diagnostic odds ratio were 0.77 (95% CI: 0.75-0.79), 0.91 (95% CI: 0.90-0.92), and 12.49 (95% CI: 4.91-31.79) for GP73; 0.62 (95% CI: 0.60-0.64), 0.84 (95% CI: 0.83-0.85), and 11.61 (95% CI: 8.02-16.81) for AFP; and 0.87 (95% CI: 0.85-0.89), 0.85 (95% CI: 0.84-0.86), and 30.63 (95% CI: 18.10-51.84) for GP73 + AFP. The area under the curve values were 0.86, 0.84, and 0.91 for GP73, AFP, and GP73 + AFP, respectively. These results indicate that for HCC diagnosis, the accuracy of GP73 was higher than that of AFP, and that GP73 + AFP exhibited significantly higher diagnostic accuracy than did GP73 or AFP alone.
C1 [Dai, Meiyu; Chen, Xiaoli; Liu, Xuexiang; Peng, Zheng; Meng, Jie; Dai, Shengming] Guangxi Med Univ, Hosp 4, Dept Clin Lab, Liuzhou City, Guangxi Provinc, Peoples R China.
RP Dai, SM (reprint author), Guangxi Med Univ, Hosp 4, Dept Clin Lab, Liuzhou City, Guangxi Provinc, Peoples R China.
EM daishm@sina.com
RI Sethi, Gautam/F-2372-2011
OI Sethi, Gautam/0000-0002-8677-8475
CR Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ertle JM, 2013, DIGESTION, V87, P121, DOI 10.1159/000346080
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hou SC, 2013, ONCOL LETT, V6, P1152, DOI 10.3892/ol.2013.1522
   Hu JS, 2010, MED ONCOL, V27, P339, DOI 10.1007/s12032-009-9215-y
   Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x
   Jia XB, 2014, ARCH MED RES, V45, P580, DOI 10.1016/j.arcmed.2014.11.002
   Jia Zhiling, 2014, Contemp Oncol (Pozn), V18, P192, DOI 10.5114/wo.2014.43157
   Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525
   Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0
   Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008
   Li YW, 2015, WORLD J GASTROENTERO, V21, P4334, DOI 10.3748/wjg.v21.i14.4334
   Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185
   Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001
   Ma C, 2015, J PROTEOMICS, V114, P61, DOI 10.1016/j.jprot.2014.09.001
   Maitra A, 2004, AM J GASTROENTEROL, V99, P1096, DOI 10.1111/j.1572-0241.2004.40410.x
   Mao YL, 2010, GUT, V59, P1687, DOI 10.1136/gut.2010.214916
   Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028
   Morimoto M, 2012, INT J CLIN ONCOL, V17, P373, DOI 10.1007/s10147-011-0306-3
   Morota K, 2011, CLIN CHEM LAB MED, V49, P711, DOI 10.1515/CCLM.2011.097
   Njei B, 2015, HEPATOLOGY, V61, P191, DOI 10.1002/hep.27388
   Ozkan H, 2011, DIGESTION, V83, P83, DOI 10.1159/000320379
   Schwegler EE, 2005, HEPATOLOGY, V41, P634, DOI 10.1002/hep.20577
   Shi Y, 2011, TECHNOL CANCER RES T, V10, P287, DOI 10.7785/tcrt.2012.500205
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263
   Tian LY, 2011, INT J CANCER, V129, P1923, DOI 10.1002/ijc.25838
   Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099
   Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980
   Wang YC, 2014, J GASTROEN HEPATOL, V29, P597, DOI 10.1111/jgh.12461
   Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19
   Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25
   Witjes CDM, 2013, HEPATOL INT, V7, P59, DOI 10.1007/s12072-012-9374-3
   Yamamoto K, 2009, ANN SURG ONCOL, V16, P2795, DOI 10.1245/s10434-009-0618-y
   Yang J, 2015, EXP THER MED, V9, P1413, DOI 10.3892/etm.2015.2231
   Zhang Zhi-Ming, 2015, Asian Pac J Cancer Prev, V16, P3479
   Zhou Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-17
NR 39
TC 27
Z9 28
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 6
PY 2015
VL 10
IS 10
AR e0140067
DI 10.1371/journal.pone.0140067
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT0TP
UT WOS:000362510300096
PM 26441340
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Schurz, H
   Daya, M
   Moller, M
   Hoal, EG
   Salie, M
AF Schurz, Haiko
   Daya, Michelle
   Moeller, Marlo
   Hoal, Eileen G.
   Salie, Muneeb
TI TLR1, 2, 4, 6 and 9 Variants Associated with Tuberculosis
   Susceptibility: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID TOLL-LIKE RECEPTOR; GENOME-WIDE ASSOCIATION; PULMONARY TUBERCULOSIS;
   GENE POLYMORPHISMS; CHINESE POPULATION; MICROSATELLITE POLYMORPHISMS;
   INDIAN POPULATION; PUBLICATION BIAS; HAN CHINESE; RISK
AB Background
   Studies investigating the influence of toll-like receptor (TLR) polymorphisms and tuberculosis susceptibility have yielded varying and often contradictory results in different ethnic groups. A meta-analysis was conducted to investigate the relationship between TLR variants and susceptibility to tuberculosis, both across and within specific ethnic groups.
   Methods
   An extensive database search was performed for studies investigating the relationship between TLR and tuberculosis (TB) susceptibility. Data was subsequently extracted from included studies and statistically analysed.
   Results
   32 articles involving 18907 individuals were included in this-meta-analysis, and data was extracted for 14 TLR polymorphisms. Various genetic models were employed. An increased risk of TB was found for individuals with the TLR2 rs3804100 CC and the TLR9 rs352139 GA and GG genotypes, while decreased risk was identified for those with the AG genotype of TLR1 rs4833095. The T allele of TLR6 rs5743810 conferred protection across all ethnic groups. TLR2 rs5743708 subgroup analysis identified the A allele to increase susceptibility to TB in the Asian ethnic group, while conferring protection in the Hispanic group. The T allele of TLR4 rs4986791 was also found to increase the risk of TB in the Asian subgroup. All other TLR gene variants investigated were not found to be associated with TB in this meta-analysis.
   Discussion
   Although general associations were identified, most TLR variants showed no significant association with TB, indicating that additional studies investigating a wider range of pattern recognition receptors is required to gain a better understanding of this complex disease.
C1 [Salie, Muneeb] Univ Stellenbosch, SA MRC Ctr TB Res, ZA-7505 Tygerberg, South Africa.
   Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa.
RP Salie, M (reprint author), Univ Stellenbosch, SA MRC Ctr TB Res, ZA-7505 Tygerberg, South Africa.
EM msalie@sun.ac.za
OI Salie, Muneeb/0000-0002-7980-0048; Schurz, Haiko/0000-0002-0009-3409;
   Moller, Marlo/0000-0002-0805-6741
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Arji N, 2014, J INFECT DEV COUNTR, V8, P430, DOI 10.3855/jidc.3820
   Bukhari M, 2015, INT J IMMUNOGENET, V42, P46, DOI 10.1111/iji.12170
   Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034
   Chen YC, 2010, BMC MED GENET, V11, DOI [10.1186/1471-2350-11-17, 10.1186/1471-2350-11-46]
   Chen Z, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0049-4
   Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462
   Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7
   Dalgic N, 2011, DIS MARKERS, V31, P33, DOI 10.3233/DMA-2011-0800
   Dalgic N, 2011, HUM IMMUNOL, V72, P440, DOI 10.1016/j.humimm.2011.02.001
   Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218
   Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012
   Di Pietrantonio T, 2013, ADV EXP MED BIOL, V783, P33, DOI 10.1007/978-1-4614-6111-1_2
   Dittrich N, 2015, TUBERCULOSIS, V95, P328, DOI 10.1016/j.tube.2015.02.045
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x
   Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341
   Hashemi-Shahri SM, 2014, GENE CELL TISSUE, V1
   Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034
   Hawn TR, 2015, IMMUNOL REV, V264, P344, DOI 10.1111/imr.12255
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Huang LY, 2005, J IMMUNOL, V175, P3964, DOI 10.4049/jimmunol.175.6.3964
   Jahantigh D, 2013, SCI WORLD J, DOI 10.1155/2013/534053
   Ji LD, 2013, SCAND J INFECT DIS, V45, P310, DOI 10.3109/00365548.2012.726739
   Kobayashi K, 2012, TISSUE ANTIGENS, V79, P190, DOI 10.1111/j.1399-0039.2011.01821.x
   Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14
   Ma MJ, 2010, HUM IMMUNOL, V71, P1005, DOI 10.1016/j.humimm.2010.07.009
   Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318
   Naderi M, 2013, BRAZ J INFECT DIS, V17, P516, DOI 10.1016/j.bjid.2012.12.009
   Najmi N, 2010, TISSUE ANTIGENS, V76, P102, DOI 10.1111/j.1399-0039.2010.01481.x
   Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001
   Cavalcanti YVN, 2012, PULM MED, DOI 10.1155/2012/745483
   Ocejo-Vinyals JG, 2013, INT J TUBERC LUNG D, V17, P652, DOI 10.5588/ijtld.12.0767
   Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703
   Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410
   Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676
   Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5
   Qi H, 2015, TUBERCULOSIS, V95, P197, DOI 10.1016/j.tube.2014.12.001
   Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174
   Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147
   Salie M, 2015, INFECT GENET EVOL, V34, P221, DOI 10.1016/j.meegid.2015.07.004
   Sanchez D, 2012, INT J IMMUNOGENET, V39, P216, DOI 10.1111/j.1744-313X.2011.01077.x
   Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534
   Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001
   Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-03880C
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14
   Sinha E, 2014, HUM IMMUNOL, V75, P880, DOI 10.1016/j.humimm.2014.06.014
   Sultani Masooma, 2012, Chemother Res Pract, V2012, P490804, DOI 10.1155/2012/490804
   Sun Q, 2015, J HUAZHONG U SCI-MED, V35, P157, DOI 10.1007/s11596-015-1405-6
   Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961
   Thada S, 2013, SCAND J IMMUNOL, V78, P221, DOI 10.1111/sji.12066
   Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352
   Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639
   Tian T, 2013, INFECT GENET EVOL, V14, P156, DOI 10.1016/j.meegid.2012.11.009
   Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023
   Torres-Garcia D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-220
   Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Wang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075090
   Wei LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070195
   WHO, GLOB TUB REP 2014
   Wu LL, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0166-1
   Xue Y, 2010, INT J IMMUNOGENET, V37, P135, DOI 10.1111/j.1744-313X.2009.00892.x
   Xue Y, 2010, CLIN CHEM LAB MED, V48, P785, DOI 10.1515/CCLM.2010.154
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   Yang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-511
   Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274
   Zhao LL, 2015, MED SCI MONITOR, V21, P1097, DOI 10.12659/MSM.893755
NR 69
TC 37
Z9 41
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 2
PY 2015
VL 10
IS 10
AR e0139711
DI 10.1371/journal.pone.0139711
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS6HH
UT WOS:000362178700101
PM 26430737
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Driessen, E
   Hollon, SD
   Bockting, CLH
   Cuijpers, P
   Turner, EH
AF Driessen, Ellen
   Hollon, Steven D.
   Bockting, Claudi L. H.
   Cuijpers, Pim
   Turner, Erick H.
TI Does Publication Bias Inflate the Apparent Efficacy of Psychological
   Treatment for Major Depressive Disorder? A Systematic Review and
   Meta-Analysis of US National Institutes of Health-Funded Trials
SO PLOS ONE
LA English
DT Article
ID COGNITIVE-BEHAVIOR THERAPY; RANDOMIZED CONTROLLED-TRIAL; INTERPERSONAL
   PSYCHOTHERAPY; ANTIDEPRESSANT MEDICATION; OLDER-ADULTS;
   DIAGNOSTIC-CRITERIA; RAW DATA; WOMEN; PHARMACOTHERAPY; NORTRIPTYLINE
AB Background
   The efficacy of antidepressant medication has been shown empirically to be overestimated due to publication bias, but this has only been inferred statistically with regard to psychological treatment for depression. We assessed directly the extent of study publication bias in trials examining the efficacy of psychological treatment for depression.
   Methods and Findings
   We identified US National Institutes of Health grants awarded to fund randomized clinical trials comparing psychological treatment to control conditions or other treatments in patients diagnosed with major depressive disorder for the period 1972-2008, and we determined whether those grants led to publications. For studies that were not published, data were requested from investigators and included in the meta-analyses. Thirteen (23.6%) of the 55 funded grants that began trials did not result in publications, and two others never started. Among comparisons to control conditions, adding unpublished studies (Hedges' g = 0.20; CI95% -0.11 similar to 0.51; k = 6) to published studies (g = 0.52; 0.37 similar to 0.68; k = 20) reduced the psychotherapy effect size point estimate (g = 0.39; 0.08 similar to 0.70) by 25%. Moreover, these findings may overestimate the "true" effect of psychological treatment for depression as outcome reporting bias could not be examined quantitatively.
   Conclusion
   The efficacy of psychological interventions for depression has been overestimated in the published literature, just as it has been for pharmacotherapy. Both are efficacious but not to the extent that the published literature would suggest. Funding agencies and journals should archive both original protocols and raw data from treatment trials to allow the detection and correction of outcome reporting bias. Clinicians, guidelines developers, and decision makers should be aware that the published literature overestimates the effects of the predominant treatments for depression.
C1 [Driessen, Ellen; Cuijpers, Pim] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands.
   [Driessen, Ellen; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Driessen, Ellen; Cuijpers, Pim] Vrije Univ Amsterdam, Med Ctr Amsterdam, Amsterdam, Netherlands.
   [Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.
   [Bockting, Claudi L. H.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands.
   [Bockting, Claudi L. H.] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands.
   [Turner, Erick H.] VA Portland Hlth Care Syst, Behav Hlth & Neurosci Div, Portland, OR USA.
   [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA.
   [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Pharmacol, Portland, OR 97201 USA.
RP Driessen, E (reprint author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands.
EM e.driessen@vu.nl
RI Cuijpers, Pim/G-1703-2013; Bockting, Claudi L/K-3768-2019
OI Bockting, Claudi L/0000-0002-9220-9244; Turner,
   Erick/0000-0002-3522-3357
CR Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357
   American Psychiatric Association, 2010, PRACT GUID TREATM PA
   Arean PA, 2010, AM J PSYCHIAT, V167, P1391, DOI 10.1176/appi.ajp.2010.09091327
   Barber JP, 2012, J CLIN PSYCHIAT, V73, P66, DOI 10.4088/JCP.11m06831
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   BEUTLER LE, 1991, J CONSULT CLIN PSYCH, V59, P333, DOI 10.1037/0022-006X.59.2.333
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Borenstein M., 2009, INTRO METAANALYSIS
   Chan AW, 2006, BMJ-BRIT MED J, V332, P1086, DOI 10.1136/bmj.332.7549.1086
   Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086
   CLARKIN JF, 1990, J AFFECT DISORDERS, V18, P17, DOI 10.1016/0165-0327(90)90113-M
   COVI L, 1987, PSYCHOPHARMACOL BULL, V23, P173
   Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001
   Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36
   Cuijpers P, 2009, INT PSYCHOGERIATR, V21, P16, DOI 10.1017/S1041610208008089
   Denton WH, 2012, J MARITAL FAM THER, V38, P23, DOI 10.1111/j.1752-0606.2012.00291.x
   DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409
   DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385
   Dickersin K, 1993, ONLINE J CURR CLIN T, V2
   DIMASCIO A, 1979, ARCH GEN PSYCHIAT, V36, P1450
   Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971
   FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57
   Flint J, 2015, PSYCHOL MED, V45, P439, DOI 10.1017/S0033291714001421
   FOLEY S H, 1989, International Journal of Family Psychiatry, V10, P29
   Frank E, 2011, PSYCHOL MED, V41, P151, DOI 10.1017/S0033291710000553
   GALLAGHER DE, 1982, PSYCHOTHER-THEOR RES, V19, P482, DOI 10.1037/h0088461
   GLICK ID, 1993, HOSP COMMUNITY PSYCH, V44, P869
   Goldman RN, 2006, PSYCHOTHER RES, V16, P536, DOI 10.1080/10503300600589456
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Hayden T, 2012, J CLIN PSYCHOL MED S, V19, P285, DOI 10.1007/s10880-011-9294-8
   HERSEN M, 1984, BEHAV THER, V15, P21, DOI 10.1016/S0005-7894(84)80039-8
   HOLLON SD, 1992, ARCH GEN PSYCHIAT, V49, P774
   Hollon SD, 2014, JAMA PSYCHIAT, V71, P1157, DOI 10.1001/jamapsychiatry.2014.1054
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P547, DOI 10.1037/0022-006X.59.4.547
   Jarrett RB, 1999, ARCH GEN PSYCHIAT, V56, P431, DOI 10.1001/archpsyc.56.5.431
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005
   Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Linde JA, 2011, ANN BEHAV MED, V41, P119, DOI 10.1007/s12160-010-9232-2
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Lynch TR, 2003, AM J GERIAT PSYCHIAT, V11, P33, DOI 10.1176/appi.ajgp.11.1.33
   Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489
   Marcus SC, 2010, ARCH GEN PSYCHIAT, V67, P1265, DOI 10.1001/archgenpsychiatry.2010.151
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   MILLER IW, 1989, BEHAV THER, V20, P25, DOI 10.1016/S0005-7894(89)80116-9
   Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57
   Mohr DC, 2001, J CONSULT CLIN PSYCH, V69, P942, DOI 10.1037//0022-006X.69.6.942
   MURPHY GE, 1995, PSYCHOL REP, V77, P403, DOI 10.2466/pr0.1995.77.2.403
   MURPHY GE, 1984, ARCH GEN PSYCHIAT, V41, P33
   National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR
   O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039
   Orsini N, 2005, HETEROGI STATA MODUL
   Perneger TV, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3035
   Reynolds CF, 1999, AM J PSYCHIAT, V156, P202
   Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39
   Rohan KJ, 2007, J CONSULT CLIN PSYCH, V75, P489, DOI 10.1037/0022-006X.75.3.489
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292
   Rush Al, 1977, COGNITIVE THERAPY RE, V1, P17, DOI DOI 10.1007/BF01173502
   Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913
   Smith R, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010006
   Spinelli MG, 2003, AM J PSYCHIAT, V160, P555, DOI 10.1176/appi.ajp.160.3.555
   SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773
   StataCorp, 2009, STAT STAT SOFTW REL
   Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101
   Strachowski Diane, 2008, Depress Anxiety, V25, pE1, DOI 10.1002/da.20302
   Swartz HA, 2008, AM J PSYCHIAT, V165, P1155, DOI 10.1176/appi.ajp.2008.07081339
   Talbot NL, 2011, PSYCHIAT SERV, V62, P374, DOI 10.1176/ps.62.4.pss6204_0374
   THOMPSON LW, 1987, J CONSULT CLIN PSYCH, V55, P385, DOI 10.1037/0022-006X.55.3.385
   Thompson LW, 2001, AM J GERIAT PSYCHIAT, V9, P225, DOI 10.1176/appi.ajgp.9.3.225
   Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779
   Vickers AJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2323
   Wampold BE, 1997, PSYCHOL BULL, V122, P203, DOI 10.1037/0033-2909.122.3.203
   Waters SJ, 2015, PSYCHOTHER RES, V16, P1
   WEISSMAN MM, 1979, AM J PSYCHIAT, V136, P469
   Wright AGC, 2014, J CONSULT CLIN PSYCH, V82, P839, DOI 10.1037/a0034430
   Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158
NR 83
TC 64
Z9 64
U1 0
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 30
PY 2015
VL 10
IS 9
AR e0137864
DI 10.1371/journal.pone.0137864
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS6GF
UT WOS:000362175700020
PM 26422604
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Alleva, JM
   Sheeran, P
   Webb, TL
   Martijn, C
   Miles, E
AF Alleva, Jessica M.
   Sheeran, Paschal
   Webb, Thomas L.
   Martijn, Carolien
   Miles, Eleanor
TI A Meta-Analytic Review of Stand-Alone Interventions to Improve Body
   Image
SO PLOS ONE
LA English
DT Article
ID PHYSICAL SELF-PERCEPTIONS; PUBLICATION BIAS; SOCIOCULTURAL ATTITUDES;
   CONTROLLED-TRIALS; ADOLESCENT GIRLS; ESTEEM SCALE; VALIDATION;
   APPEARANCE; DISSATISFACTION; QUESTIONNAIRE
AB Objective
   Numerous stand-alone interventions to improve body image have been developed. The present review used meta-analysis to estimate the effectiveness of such interventions, and to identify the specific change techniques that lead to improvement in body image.
   Methods
   The inclusion criteria were that (a) the intervention was stand-alone (i.e., solely focused on improving body image), (b) a control group was used, (c) participants were randomly assigned to conditions, and (d) at least one pretest and one posttest measure of body image was taken. Effect sizes were meta-analysed and moderator analyses were conducted. A taxonomy of 48 change techniques used in interventions targeted at body image was developed; all interventions were coded using this taxonomy.
   Results
   The literature search identified 62 tests of interventions (N = 3,846). Interventions produced a small-to-medium improvement in body image (d(+) = 0.38), a small-to-medium reduction in beauty ideal internalisation (d(+) = -0.37), and a large reduction in social comparison tendencies (d(+) = -0.72). However, the effect size for body image was inflated by bias both within and across studies, and was reliable but of small magnitude once corrections for bias were applied. Effect sizes for the other outcomes were no longer reliable once corrections for bias were applied. Several features of the sample, intervention, and methodology moderated intervention effects. Twelve change techniques were associated with improvements in body image, and three techniques were contra-indicated.
   Conclusions
   The findings show that interventions engender only small improvements in body image, and underline the need for large-scale, high-quality trials in this area. The review identifies effective techniques that could be deployed in future interventions.
C1 [Alleva, Jessica M.; Martijn, Carolien] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands.
   [Sheeran, Paschal] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA.
   [Webb, Thomas L.] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.
   [Miles, Eleanor] Univ Sussex, Sch Psychol, Brighton, E Sussex, England.
RP Alleva, JM (reprint author), Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands.
EM Jessica.alleva@maastrichtuniversity.nl
RI Webb, Thomas/E-8946-2010
OI Webb, Thomas/0000-0001-9320-0068; Miles, Eleanor/0000-0002-8375-4638
FU NWO (The Netherlands Organisation for Scientific Research) [404-10-118]
FX The contribution of JMA was supported by NWO (The Netherlands
   Organisation for Scientific Research; www.nwo.nl) grant 404-10-118:
   Novel strategies to enhance body satisfaction, awarded to CM. The funder
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379
   Albertson ER, 2015, MINDFULNESS, V6, P444, DOI 10.1007/s12671-014-0277-3
   Alleva JM, 2016, J BEHAV THER EXP PSY, V50, P33, DOI 10.1016/j.jbtep.2015.04.012
   Arroyo A, 2012, J APPL COMMUN RES, V40, P167, DOI 10.1080/00909882.2012.654500
   Aspen V, 2015, BEHAV RES THER, V69, P93, DOI 10.1016/j.brat.2015.04.003
   Avalos Laura, 2005, Body Image, V2, P285, DOI 10.1016/j.bodyim.2005.06.002
   BARNARD PJ, 1991, COGNITION EMOTION, V5, P1, DOI 10.1080/02699939108411021
   Bennett-Levy J, 2003, BEHAV COGN PSYCHOTH, V31, P261, DOI 10.1017/S1352465803003035
   BENTOVIM DI, 1991, PSYCHOL MED, V21, P775, DOI 10.1017/S0033291700022406
   BERSCHEID E, 1973, PSYCHOL TODAY, V7, P119
   Blashill AJ, 2015, HEALTH PSYCHOL, V34, P93, DOI 10.1037/hea0000100
   BROWN TA, 1990, J PERS ASSESS, V55, P135, DOI 10.1207/s15327752jpa5501&2_13
   BUTTERS JW, 1987, J CONSULT CLIN PSYCH, V55, P889, DOI 10.1037/0022-006X.55.6.889
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Cafri G, 2005, CLIN PSYCHOL-SCI PR, V12, P421, DOI 10.1093/clipsy/bpi053
   Campbell A, 2009, J HEALTH PSYCHOL, V14, P780, DOI 10.1177/1359105309338977
   CAMPBELL DT, 1957, PSYCHOL BULL, V54, P297, DOI 10.1037/h0040950
   Cash T. F., 2011, BODY IMAGE HDB SCI P, P39
   Cash TF, 2002, INT J EAT DISORDER, V32, P362, DOI 10.1002/eat.10100
   Cash TF, 2002, BODY IMAGE: A HANDBOOK OF THEORY, RESEARCH, AND CLINICAL PRACTICE, P277
   Cash TF, 2002, INT J EAT DISORDER, V31, P455, DOI 10.1002/eat.10033
   Cash TF, 2004, BODY IMAGE, V1, P363, DOI DOI 10.1016/J.B0DYIM.2004.10.001
   Cash TF, 1990, BODY IMAGES DEV DEVI
   Cash Thomas F, 2002, Eat Disord, V10, P103, DOI 10.1080/10640260290081678
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Cooley E, 2001, INT J EAT DISORDER, V30, P28, DOI 10.1002/eat.1051
   Cooper H. M., 1989, INTEGRATING RES GUID
   COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O
   Corning AF, 2010, BODY IMAGE, V7, P289, DOI 10.1016/j.bodyim.2010.08.001
   Coyne JC, 2010, HEALTH PSYCHOL, V29, P107, DOI 10.1037/a0017633
   Deeks AA, 2001, PSYCHOL HEALTH, V16, P367, DOI 10.1080/08870440108405513
   Dohnt HK, 2008, EUR EAT DISORD REV, V16, P222, DOI 10.1002/erv.814
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   EVANS C, 1993, INT J EAT DISORDER, V13, P315, DOI 10.1002/1098-108X(199304)13:3<315::AID-EAT2260130310>3.0.CO;2-3
   FAIRBURN CG, 1986, INT J EAT DISORDER, V5, P403, DOI 10.1002/1098-108X(198603)5:3<403::AID-EAT2260050302>3.0.CO;2-Z
   Farrell C, 2006, EUR EAT DISORD REV, V14, P289, DOI 10.1002/erv.693
   Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733
   Fisher E, 2002, J SOC CLIN PSYCHOL, V21, P566, DOI 10.1521/jscp.21.5.566.22618
   FOX KR, 1989, J SPORT EXERCISE PSY, V11, P408, DOI 10.1123/jsep.11.4.408
   FRANZOI SL, 1984, J PERS ASSESS, V48, P173, DOI 10.1207/s15327752jpa4802_12
   FURNHAM A, 1983, PSYCHOL MED, V13, P829, DOI 10.1017/S0033291700051540
   Garner D. M, 1991, EATING DISORDER INVE
   Garner D. M., 1997, PSYCHOL TODAY, V30, P30
   Ginis KAM, 2011, BODY IMAGE HDB SCI P, P378
   Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460
   Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005
   Grogan S, 2004, J GENDER STUD, V13, P49, DOI 10.1080/0958923032000184970
   Grogan S., 2011, BODY IMAGE HDB SCI P, P93
   Grogan S, 2006, J HEALTH PSYCHOL, V11, P523, DOI 10.1177/1359105306065013
   HART EA, 1989, J SPORT EXERCISE PSY, V11, P94, DOI 10.1123/jsep.11.1.94
   Harter S., 1985, MANUAL SELF PERCEPTI
   HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895
   Hefner V, 2014, MEDIA PSYCHOL, V17, P185, DOI 10.1080/15213269.2013.838903
   HEINBERG LJ, 1995, INT J EAT DISORDER, V17, P81, DOI 10.1002/1098-108X(199501)17:1<81::AID-EAT2260170111>3.0.CO;2-Y
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA, P481, DOI DOI 10.1002/9780470712184.CH16
   Horowitz JL, 2006, J CONSULT CLIN PSYCH, V74, P401, DOI 10.1037/0022-006X.74.3.401
   Howard GS, 2009, REV GEN PSYCHOL, V13, P146, DOI 10.1037/a0015319
   Hunter J. E, 2004, METHODS METAANALYSIS
   Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7
   Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010
   Irving LM, 2001, PSYCHOL WOMEN QUART, V25, P103, DOI 10.1111/1471-6402.00012
   Jakatdar Tejal A, 2006, Body Image, V3, P325, DOI 10.1016/j.bodyim.2006.09.001
   Jarry JL, 2011, BODY IMAGE HDB SCI P, P415
   Jarry Josee L, 2005, Body Image, V2, P317, DOI 10.1016/j.bodyim.2005.10.001
   Jarry Josee L, 2004, Body Image, V1, P319, DOI 10.1016/j.bodyim.2004.10.005
   Johnson B. T., 2000, HDB RES METHODS SOCI, P496
   Jones D. C., 2011, BODY IMAGE HDB SCI P, V2, P110
   KARASU TB, 1986, AM J PSYCHIAT, V143, P687
   Klar Y, 2012, SELF CHANGE SOCIAL P
   Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031
   Larimer ME, 2002, J STUD ALCOHOL, P148, DOI 10.15288/jsas.2002.s14.148
   Levine Michael P, 2004, Body Image, V1, P57, DOI 10.1016/S1740-1445(03)00006-8
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Light RJ, 1984, SUMMING SCI REV RES
   Lindwall M, 2005, PSYCHOL SPORT EXERC, V6, P643, DOI 10.1016/j.psychsport.2005.03.003
   Littleton Heather, 2005, Body Image, V2, P193, DOI 10.1016/j.bodyim.2005.02.003
   MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P270, DOI 10.1123/jsep.16.3.270
   Martijn C, 2013, HEALTH PSYCHOL, V32, P433, DOI 10.1037/a0028592
   Martijn C, 2010, HEALTH PSYCHOL, V29, P514, DOI 10.1037/a0020770
   Martin KA, 2002, BODY IMAGE: A HANDBOOK OF THEORY, RESEARCH, AND CLINICAL PRACTICE, P414
   McCabe MP, 2006, J HEALTH PSYCHOL, V11, P589, DOI 10.1177/1359105306065019
   McCabe MP, 2003, HEALTH PSYCHOL, V22, P39, DOI 10.1037/0278-6133.22.1.39
   Mendelson BK, 2001, J PERS ASSESS, V76, P90, DOI 10.1207/S15327752JPA7601_6
   MENDELSON BK, 1982, PERCEPT MOTOR SKILL, V54, P899, DOI 10.2466/pms.1982.54.3.899
   Menzel JE, 2011, BODY IMAGE HDB SCI P, P3
   Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6
   Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136
   Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059
   Myers TA, 2009, J ABNORM PSYCHOL, V118, P683, DOI 10.1037/a0016763
   Niemeyer H, 2012, SCHIZOPHR RES, V138, P103, DOI 10.1016/j.schres.2012.03.023
   O'Connor D, 2008, COCHRANE HDB SYSTEMA, P83
   O'Dea J, 2011, BODY IMAGE A HANDBOO, P434
   O'Dea Jennifer A, 2004, Eat Disord, V12, P225, DOI 10.1080/10640260490481438
   Pais-Ribeiro José L., 2003, Aná. Psicológica, V21, P431
   Patrick D, 2008, COCHRANE HDB SYSTEMA, P531
   Paxton SJ, 2006, J CLIN CHILD ADOLESC, V35, P539, DOI 10.1207/s15374424jccp3504_5
   Peters GJY, 2015, HEALTH PSYCHOL REV, V9, P1, DOI [10.1080/17437199.2013.848409, 10.1080/17437199.2015.1124240]
   Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087
   Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014
   Reas DL, 2002, INT J EAT DISORDER, V31, P324, DOI 10.1002/eat.10012
   Reboussin BA, 2000, PSYCHOL HEALTH, V15, P239, DOI 10.1080/08870440008400304
   REED DL, 1991, J ANXIETY DISORD, V5, P323, DOI 10.1016/0887-6185(91)90032-O
   Ricciardelli Lina A, 2002, Eat Behav, V3, P45, DOI 10.1016/S1471-0153(01)00044-7
   Rosen J. C., 1991, PSYCHOL ASSESSMENT, V3, P32, DOI DOI 10.1037/1040-3590.3.1.32
   ROSEN JC, 1989, BEHAV THER, V20, P393, DOI 10.1016/S0005-7894(89)80058-9
   ROSEN JC, 1995, BEHAV THER, V26, P25, DOI 10.1016/S0005-7894(05)80081-4
   ROSEN JC, 1995, J CONSULT CLIN PSYCH, V63, P263, DOI 10.1037/0022-006X.63.2.263
   Rosen JC, 1996, INT J EAT DISORDER, V20, P331, DOI 10.1002/(SICI)1098-108X(199612)20:4<331::AID-EAT1>3.0.CO;2-O
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Salk RH, 2011, PSYCHOL WOMEN QUART, V35, P18, DOI 10.1177/0361684310384107
   Schilder P., 2013, IMAGE APPEARANCE HUM
   Schooler D, 2013, SEX RES SOC POLICY, V10, P52, DOI 10.1007/s13178-012-0099-9
   Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332
   Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216
   Slevec JH, 2011, CLIN PSYCHOL REV, V31, P515, DOI 10.1016/j.cpr.2010.12.002
   Smolak L, 2001, BODY IMAGE, EATING DISORDERS, AND OBESITY IN YOUTH: ASSESSMENT, PREVENTION, AND TREATMENT, P41, DOI 10.1037/10404-002
   Smolak L., 2011, BODY IMAGE HDB SCI P, P67
   Stice E, 2007, ANNU REV CLIN PSYCHO, V3, P207, DOI 10.1146/annurev.clinpsy.3.022806.091447
   Thompson J. K., 1991, BEHAV THERAPIST, V14, P174
   Thompson JK, 2004, INT J EAT DISORDER, V35, P293, DOI 10.1002/eat.10257
   THOMPSON MA, 1995, J PERS ASSESS, V64, P258, DOI 10.1207/s15327752jpa6402_6
   Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0
   Tschacher W, 2014, CLIN PSYCHOL PSYCHOT, V21, P82, DOI 10.1002/cpp.1822
   van den Berg P, 2007, J ADOLESCENT HEALTH, V41, P415, DOI 10.1016/j.jadohealth.2007.06.001
   Weaver AD, 2006, PSYCHOL WOMEN QUART, V30, P333, DOI 10.1111/j.1471-6402.2006.00308.x
   Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249
   WHITEHEAD JR, 1995, PEDIATR EXERC SCI, V7, P132
   Williamson DA, 2004, BEHAV MODIF, V28, P711, DOI 10.1177/0145445503259853
   Winstead BA, 1984, M SE PSYCH ASS NEW O
   Wiseman CV, 1998, INT J EAT DISORDER, V24, P429
   Wood KC, 1996, J APPL DEV PSYCHOL, V17, P85, DOI 10.1016/S0193-3973(96)90007-6
   Wood L, 2008, BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD
   Yager Z, 2013, BODY IMAGE, V10, P271, DOI 10.1016/j.bodyim.2013.04.001
NR 137
TC 34
Z9 34
U1 1
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 29
PY 2015
VL 10
IS 9
AR e0139177
DI 10.1371/journal.pone.0139177
PG 32
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS6EV
UT WOS:000362171400057
PM 26418470
OA DOAJ Gold, Green Accepted, Green Published
DA 2019-07-16
ER

PT J
AU Paradies, Y
   Ben, J
   Denson, N
   Elias, A
   Priest, N
   Pieterse, A
   Gupta, A
   Kelaher, M
   Gee, G
AF Paradies, Yin
   Ben, Jehonathan
   Denson, Nida
   Elias, Amanuel
   Priest, Naomi
   Pieterse, Alex
   Gupta, Arpana
   Kelaher, Margaret
   Gee, Gilbert
TI Racism as a Determinant of Health: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID PERCEIVED ETHNIC DISCRIMINATION; AFRICAN-AMERICAN WOMEN; SELF-REPORTED
   RACISM; LATINO PSYCHOLOGICAL DISTRESS; AMBULATORY BLOOD-PRESSURE;
   OTHER-GROUP ORIENTATION; ARTERY RISK DEVELOPMENT; RACE-RELATED STRESS;
   OF-THE-LITERATURE; BODY-MASS INDEX
AB Despite a growing body of epidemiological evidence in recent years documenting the health impacts of racism, the cumulative evidence base has yet to be synthesized in a comprehensive meta-analysis focused specifically on racism as a determinant of health. This meta-analysis reviewed the literature focusing on the relationship between reported racism and mental and physical health outcomes. Data from 293 studies reported in 333 articles published between 1983 and 2013, and conducted predominately in the U.S., were analysed using random effects models and mean weighted effect sizes. Racism was associated with poorer mental health (negative mental health: r = -.23, 95% CI [-.24,-.21], k = 227; positive mental health: r = -.13, 95% CI [-.16,-.10], k = 113), including depression, anxiety, psychological stress and various other outcomes. Racism was also associated with poorer general health (r = -.13 (95% CI [-.18,-.09], k = 30), and poorer physical health (r = -.09, 95% CI [-.12,-.06], k = 50). Moderation effects were found for some outcomes with regard to study and exposure characteristics. Effect sizes of racism on mental health were stronger in cross-sectional compared with longitudinal data and in non-representative samples compared with representative samples. Age, sex, birthplace and education level did not moderate the effects of racism on health. Ethnicity significantly moderated the effect of racism on negative mental health and physical health: the association between racism and negative mental health was significantly stronger for Asian American and Latino(a) American participants compared with African American participants, and the association between racism and physical health was significantly stronger for Latino(a) American participants compared with African American participants.
C1 [Paradies, Yin; Ben, Jehonathan; Elias, Amanuel] Deakin Univ, Fac Arts & Educ, Alfred Deakin Inst Citizenship & Globalizat, Melbourne, Vic, Australia.
   [Denson, Nida] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia.
   [Priest, Naomi] Australian Natl Univ, Australian Ctr Appl Social Res Methods, Canberra, ACT, Australia.
   [Pieterse, Alex] SUNY Albany, Div Counseling Psychol, New York, NY USA.
   [Gupta, Arpana] Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Ctr Neurobiol Stress, Los Angeles, CA 90095 USA.
   [Kelaher, Margaret] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia.
   [Gee, Gilbert] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA.
RP Paradies, Y (reprint author), Deakin Univ, Fac Arts & Educ, Alfred Deakin Inst Citizenship & Globalizat, Melbourne, Vic, Australia.
EM yin.paradies@deakin.edu.au
OI kelaher, Margaret/0000-0002-9899-858X; Denson, Nida/0000-0001-5543-0487
FU Australian Research Council; Victorian Health Promotion Foundation;
   Australian Human Rights Commission; Australian Research Council Future
   Fellowship grant [FF130101148];  [LP100200057]
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. This research was
   partially funded by grant LP100200057 (YP, MK) funded by the Australian
   Research Council (http://www.arc.gov.au/), Victorian Health Promotion
   Foundation (https://www.vichealth.vic.gov.au/ YP, MK, NP) and the
   Australian Human Rights Commission (https://www.humanrights.gov.au/ YP).
   YP is supported by an Australian Research Council Future Fellowship
   grant (http://www.arc.gov.au/ FF130101148).
CR Abbassi-Zoabi MJ, 2012, DISCRIMINATION ETHNI
   Abdulrahim S, 2012, SOC SCI MED, V75, P2116, DOI 10.1016/j.socscimed.2012.07.030
   Agaskar VR, 2011, MEDIATING MODERATING
   Agudelo-Suarez AA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-652
   Ahmed SR, 2011, AM J COMMUN PSYCHOL, V48, P181, DOI 10.1007/s10464-011-9424-3
   Alamilla SG, 2010, HISPANIC J BEHAV SCI, V32, P55, DOI 10.1177/0739986309352770
   Albert MA, 2010, ARCH INTERN MED, V170, P896, DOI 10.1001/archinternmed.2010.116
   Almeida-Filho N., 2007, CHILD ADOLESCENT MEN, V12, P125, DOI [10.1111/j.1475-3588.2007.00447.x, DOI 10.1111/J.1475-3588.2007.00447.X]
   Anderson ME, 2007, PERCEIVED DISCRIMINA
   [Anonymous], 2015, PRACTICAL METAANALYS
   [Anonymous], 2014, GUARDIAN
   Appel RE, 2003, PERCEIVED ETHNIC DIS
   Armenta BE, 2009, GROUP PROCESS INTERG, V12, P23, DOI 10.1177/1368430208098775
   Asamen JK, 1983, EFFECTS PERCEIVED PR
   Ashburn-Nardo L, 2007, GROUP PROCESS INTERG, V10, P471, DOI 10.1177/1368430207081536
   Ayalon L, 2011, AGING MENT HEALTH, V15, P376, DOI 10.1080/13607863.2010.519323
   Bailey T-KM, 2008, CONSTRUCT VALIDATION
   Barksdale Debra J, 2009, Issues Ment Health Nurs, V30, P104, DOI 10.1080/01612840802597879
   Barnes PW, 2005, J MULTICULT COUNS D, V33, P48, DOI 10.1002/j.2161-1912.2005.tb00004.x
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   BARRETT ME, 1991, HISPANIC J BEHAV SCI, V13, P276, DOI 10.1177/07399863910133005
   Barry DT, 2003, AM J ORTHOPSYCHIAT, V73, P223, DOI 10.1037/0002-9432.73.2.223
   Bastos JL, 2010, SOC SCI MED, V70, P1091, DOI 10.1016/j.socscimed.2009.12.020
   Basurto Jr R, 1996, RELATIONSHIP ETHNIC
   Becares L, 2009, HEALTH PLACE, V15, P700, DOI 10.1016/j.healthplace.2008.10.008
   Behnke AO, 2011, J CROSS CULT PSYCHOL, V42, P1179, DOI 10.1177/0022022110383424
   Benjamins MR, 2014, J BEHAV MED, V37, P402, DOI 10.1007/s10865-013-9496-7
   Benjamins MR, 2013, J URBAN HEALTH, V90, P832, DOI 10.1007/s11524-013-9787-x
   Benjamins MR, 2012, MED CARE, V50, P870, DOI 10.1097/MLR.0b013e31825a8c63
   Berg AO, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-77
   Berger M, 2015, STRESS, V18, P1, DOI 10.3109/10253890.2014.989204
   Berkel C, 2010, J RES ADOLESCENCE, V20, P893, DOI 10.1111/j.1532-7795.2010.00668.x
   Berman G, 2010, ETHNIC RACIAL STUD, V33, P214, DOI 10.1080/01419870802302272
   Best JL, 2005, INTEGRATIVE ANAL RAC
   Bird ST, 2004, AIDS PATIENT CARE ST, V18, P19, DOI 10.1089/108729104322740884
   Blank R. M., 2004, MEASURING RACIAL DIS
   Blankenau J, 2000, GREAT PLAINS RES, V10, P275
   Bodkin-Andrews GH, 2010, AUST J GUID COUNS, V20, P1, DOI 10.1375/ajgc.20.1.1
   Bogart LM, 2011, CULT DIVERS ETHN MIN, V17, P295, DOI 10.1037/a0024056
   Borders A, 2011, CULT DIVERS ETHN MIN, V17, P125, DOI 10.1037/a0023357
   Borenstein M., 2010, COMPREHENSIVE METAAN
   Borges G, 2011, SUICIDE LIFE-THREAT, V41, P193, DOI 10.1111/j.1943-278X.2010.00016.x
   Borrell LN, 2007, AM J EPIDEMIOL, V166, P1068, DOI 10.1093/aje/kwm180
   Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008
   Bowen-Reid Terra, 2002, J BLACK PSYCHOL, V28, P18, DOI DOI 10.1177/0095798402028001002
   Bowman NA, 2012, RES HIGH EDUC, V53, P475
   Bowman T, 2008, EXPLORATION RELATION
   Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135
   Brika J, 1997, RACISM XENOPHOBIA EU
   Brody GH, 2006, CHILD DEV, V77, P1170, DOI 10.1111/j.1467-8624.2006.00927.x
   BROMAN CL, 1997, J BLACK PSYCHOL, V0023
   Brondolo E, 2003, ANN BEHAV MED, V25, P55, DOI 10.1207/S15324796ABM2501_08
   Brondolo E, 2011, HDB HLTH PSYCHOL, P569
   Brondolo E, 2011, HDB STRESS SCI, P167
   Brondolo E, 2011, AM J HYPERTENS, V24, P518, DOI 10.1038/ajh.2011.9
   Brondolo E, 2011, ANN BEHAV MED, V42, P14, DOI 10.1007/s12160-011-9265-1
   Broudy R, 2007, J BEHAV MED, V30, P31, DOI 10.1007/s10865-006-9081-4
   Brown JF, 1991, RELATIONSHIPS RACIAL
   Brown Tony, 2002, SOCIOL FOCUS, V35, P55, DOI DOI 10.1080/00380237.2002.10571220
   Buchanan NT, 2008, J OCCUP HEALTH PSYCH, V13, P137, DOI 10.1037/1076-8998.13.2.137
   Buchanan NT, 2002, EXAMINING IMPACT RAC
   Burgess DJ, 2009, PAIN MED, V10, P1341, DOI 10.1111/j.1526-4637.2009.00742.x
   Burrow AL, 2010, SELF IDENTITY, V9, P383, DOI 10.1080/15298860903192496
   Byrd DR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120042
   Cakir SG, 2011, INT J PSYCHOL, V46, P223, DOI 10.1080/00207594.2010.532800
   Camacho-Gonsalves T, 2002, DEPRESSIVE SYMPTOMAT
   Cardarelli R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-285
   Carlisle SK, 2015, ETHNIC HEALTH, V20, P309, DOI 10.1080/13557858.2014.921891
   Cassidy C, 2005, J APPL SOC PSYCHOL, V35, P1246, DOI 10.1111/j.1559-1816.2005.tb02169.x
   Cassidy C, 2004, J COUNS PSYCHOL, V51, P329, DOI 10.1037/0022-0167.51.3.329
   Chae DH, 2012, PSYCHOSOM MED, V74, P961, DOI 10.1097/PSY.0b013e3182733665
   Chae DH, 2011, AM J ORTHOPSYCHIAT, V81, P498, DOI 10.1111/j.1939-0025.2011.01122.x
   Chae DH, 2010, SOC SCI MED, V71, P1182, DOI 10.1016/j.socscimed.2010.05.045
   Chakraborty A, 2011, SOC PSYCH PSYCH EPID, V46, P915, DOI 10.1007/s00127-010-0261-8
   Chakraborty AT, 2010, SOC PSYCH PSYCH EPID, V45, P1115, DOI 10.1007/s00127-009-0156-8
   Chambers EC, 2004, J NATL MED ASSOC, V96, P1594
   Chan KTK, 2012, J ETHN CULT DIVERSIT, V21, P20, DOI 10.1080/15313204.2011.647348
   Chen H-J, 2002, ASIAN J COUNSELING, V9, P27
   Cho-Chang Y-Y, 2013, MODERATING ROLE RELI
   Choi KH, 2013, AM J PUBLIC HEALTH, V103, P868, DOI 10.2105/AJPH.2012.301052
   Chrobot-Mason D, 2013, J MANAGE PSYCHOL, V28, P470, DOI 10.1108/JMP-02-2012-0064
   Cislo AM, 2008, PSYCHOL DISTRESS CUB
   Clark R, 2004, J ADOLESCENCE, V27, P363, DOI 10.1016/j.adolescence.2003.09.004
   Clark R, 2003, ANN BEHAV MED, V25, P127, DOI 10.1207/S15324796ABM2502_09
   Clark R, 2000, ANN BEHAV MED, V22, P214, DOI 10.1007/BF02895116
   Clark R, 1999, AM PSYCHOL, V54, P805, DOI 10.1037/0003-066X.54.10.805
   Clark R, 2004, CRIT PERSPECT, P540
   Clark R, 2006, ANN BEHAV MED, V32, P1, DOI 10.1207/s15324796abm3201_1
   Clark Rodney, 2001, Ethnicity and Disease, V11, P286
   Clark VR, 2009, ETHNIC DIS, V19, P2
   Clement R, 2001, J SOC ISSUES, V57, P559, DOI 10.1111/0022-4537.00229
   Cogburn CD, 2010, RACIAL COGNITION SCH
   Cogburn Courtney D, 2011, Race Soc Probl, V3, P25
   Cohen J., 2003, APPL MULTIPLE REGRES
   Coker TR, 2009, AM J PUBLIC HEALTH, V99, P878, DOI 10.2105/AJPH.2008.144329
   Combs DR, 2006, J BLACK PSYCHOL, V32, P87, DOI 10.1177/0095798405283175
   Conklin HD, 2011, PERCEIVED RACISM MEN
   Contrada RJ, 2001, J APPL SOC PSYCHOL, V31, P1775, DOI 10.1111/j.1559-1816.2001.tb00205.x
   Cooke DY, 2002, RACIAL DISCRIMINATIO
   Cooper DC, 2009, AM J HYPERTENS, V22, P698, DOI 10.1038/ajh.2009.72
   Cooper H., 1998, SYNTHESIZING RES GUI
   Copeland-Linder N, 2011, J YOUTH ADOLESCENCE, V40, P158, DOI 10.1007/s10964-010-9520-y
   COppedal B., 2011, DEVELOPMENTAL SCI, V5, P85, DOI [10.3233/DEV-2011-11076, DOI 10.3233/DEV-2011-11076]
   Crengle S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-45
   Cronin TJ, 2012, GROUP PROCESS INTERG, V15, P393, DOI 10.1177/1368430211427171
   Crouter AC, 2006, J MARRIAGE FAM, V68, P843, DOI 10.1111/j.1741-3737.2006.00299.x
   Cuffee YL, 2012, ETHNIC DIS, V22, P422
   Cunningham TJ, 2013, J BIOSOC SCI, V45, P267, DOI 10.1017/S0021932012000429
   Cunningham TJ, 2011, AM J EPIDEMIOL, V174, P1266, DOI 10.1093/aje/kwr253
   Currie CL, 2013, J GAMBL STUD, V29, P393, DOI 10.1007/s10899-012-9323-z
   CVasquez J., 2010, DISS ABSTR INT B, V70, P6610
   CWickrama T. K. A., 2010, DISS ABSTR INT A, V71, P601
   Dailey AB, 2006, INFLUENCE NEIGHBORHO
   Dang TA, 2012, EFFECTS PERCEIVED DI
   Dawson BA, 2010, HISPANIC J BEHAV SCI, V32, P216, DOI 10.1177/0739986310364750
   de Castro AB, 2008, AM J PUBLIC HEALTH, V98, P520, DOI 10.2105/AJPH.2007.110163
   De Maio FG, 2010, GLOB PUBLIC HEALTH, V5, P462, DOI 10.1080/17441690902942480
   Deblaere C., 2009, DISS ABSTR INT B, V73, P612
   Delgado MY, 2011, J YOUTH ADOLESCENCE, V40, P125, DOI 10.1007/s10964-009-9467-z
   DESNYDER VNS, 1987, PSYCHOL WOMEN QUART, V11, P475, DOI 10.1111/j.1471-6402.1987.tb00919.x
   Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927
   Dixon B, 2012, J DEV ORIG HLTH DIS, V3, P433, DOI 10.1017/S2040174412000384
   Dolezsar CM, 2014, HEALTH PSYCHOL, V33, P20, DOI 10.1037/a0033718
   Dominguez TP, 2008, HEALTH PSYCHOL, V27, P194, DOI 10.1037/0278-6133.27.2.194
   Donovan RA, 2013, J CLIN PSYCHOL, V69, P397, DOI 10.1002/jclp.21936
   Downie MS, 1998, DISS ABSTR INT B, V59, P2483
   DuBois DL, 2002, CHILD DEV, V73, P1573, DOI 10.1111/1467-8624.00491
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134
   Enchautegui de Jesus N, 2001, RELATIONSHIPS NORMAT
   English D, 2014, DEV PSYCHOL, V50, P1190, DOI 10.1037/a0034703
   Epel OB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-282
   Everage NJ, 2012, ANN EPIDEMIOL, V22, P183, DOI 10.1016/j.annepidem.2012.01.005
   Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010
   Finch Brian Karl, 2003, J Immigr Health, V5, P109, DOI 10.1023/A:1023987717921
   Fischer AR, 1999, J COUNS PSYCHOL, V46, P395, DOI 10.1037/0022-0167.46.3.395
   Flores E, 2008, HISPANIC J BEHAV SCI, V30, P401, DOI 10.1177/0739986308323056
   Flores E, 2010, J COUNS PSYCHOL, V57, P264, DOI 10.1037/a0020026
   Ford KR, 2013, CHILD DEV, V84, P485, DOI 10.1111/j.1467-8624.2012.01864.x
   Freedenthal S, 2004, SUICIDE LIFE-THREAT, V34, P160, DOI 10.1521/suli.34.2.160.32789
   French SE, 2013, J APPL SOC PSYCHOL, V43, pE339, DOI 10.1111/jasp.12028
   Gallup Poll, 2014, RAC REL
   Galvan N, 2010, EXPERIENCES ETHNIC R
   Gee G, 2009, SOC SCI MED, V68, P1676, DOI 10.1016/j.socscimed.2009.02.002
   Gee GC, 2008, AM J PUBLIC HEALTH, V98, P493, DOI 10.2105/AJPH.2007.114025
   Gee GC, 2006, AM J PUBLIC HEALTH, V96, P1821, DOI 10.2105/AJPH.2005.080085
   Gee GC, 2012, AM J PUBLIC HEALTH, V102, P967, DOI 10.2105/AJPH.2012.300666
   Gee GC, 2009, EPIDEMIOL REV, V31, P130, DOI 10.1093/epirev/mxp009
   Gerrard M, 2012, PSYCHOL ADDICT BEHAV, V26, P550, DOI 10.1037/a0027711
   Giamo LS, 2012, CULT DIVERS ETHN MIN, V18, P319, DOI 10.1037/a0029729
   Gibbons FX, 2007, DRUG ALCOHOL DEPEN, V88, pS27, DOI 10.1016/j.drugalcdep.2006.12.015
   Gibbons FX, 2010, J PERS SOC PSYCHOL, V99, P785, DOI 10.1037/a0019880
   Gibbons FX, 2004, J PERS SOC PSYCHOL, V86, P517, DOI 10.1037/0022-3514.86.4.517
   Giurgescu C, 2012, JOGNN-J OBST GYN NEO, V41, pE51, DOI 10.1111/j.1552-6909.2012.01409.x
   Gonzales KL, 2010, PERCEIVED MED DISCRI
   Goto JB, 2013, CAD SAUDE PUBLICA, V29, P445, DOI 10.1590/S0102-311X2013000300004
   Green NL, 1991, STRESS SELF ESTEEM R
   Greene ML, 2006, DEV PSYCHOL, V42, P218, DOI 10.1037/0012-1649.42.2.218
   Grekin ER, 2012, PSYCHOL ADDICT BEHAV, V26, P924, DOI 10.1037/a0029593
   Gutierres SE, 1994, JOB STRESS CHANGING, P107
   Halim ML, 2013, HEALTH PSYCHOL, V32, P203, DOI 10.1037/a0027279
   Hamilton C., 1967, BLACK POWER
   Hammond WP, 2010, AM J COMMUN PSYCHOL, V45, P87, DOI 10.1007/s10464-009-9280-6
   Han M, 2011, J COLL STUDENT DEV, V52, P154, DOI 10.1353/csd.2011.0032
   Hansen KL, 2012, TRANSCULT PSYCHIATRY, V49, P26, DOI 10.1177/1363461511433944
   Harrell CJP, 2011, DU BOIS REV, V8, P143, DOI 10.1017/S1742058X11000178
   Harrell SP, 1997, THE RACISM AND LIFE
   Harris-Britt A, 2007, J RES ADOLESCENCE, V17, P669, DOI 10.1111/j.1532-7795.2007.00540.x
   Hausmann Leslie R M, 2009, Am J Public Health, V99 Suppl 3, pS718, DOI 10.2105/AJPH.2008.150730
   Hausmann LRM, 2010, ETHNIC DIS, V20, P40
   Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486
   Heim D, 2011, J CROSS CULT PSYCHOL, V42, P1145, DOI 10.1177/0022022110383310
   Helms JE, 2006, COUNS PSYCHOL, V34, P630, DOI 10.1177/0011000006288308
   Hicken MT, 2014, AM J PUBLIC HEALTH, V104, P117, DOI 10.2105/AJPH.2013.301395
   Hicken Margaret T, 2013, Race Soc Probl, V5, P100
   Hickman NJ, 2008, DOES CIGARETTE SMOKI
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS39, DOI 10.1089/apc.2011.9877
   Hill LK, 2007, J BLACK PSYCHOL, V33, P404, DOI 10.1177/0095798407307042
   Himmelstein MS, 2015, PSYCHOL HEALTH, V30, P253, DOI 10.1080/08870446.2014.966104
   Hirschel MJ, 2011, RELATIONSHIP DISCRIM
   Hocoy D, 1997, APARTHEID RACISM BLA
   Howarter AD, 2013, J SOC PSYCHOL, V153, P62, DOI 10.1080/00224545.2012.703973
   Banks KH, 2007, J BLACK PSYCHOL, V33, P331, DOI 10.1177/0095798407302540
   Hunte HER, 2011, AM J EPIDEMIOL, V173, P1232, DOI 10.1093/aje/kwq463
   Huynh VW, 2010, J RES ADOLESCENCE, V20, P916, DOI 10.1111/j.1532-7795.2010.00670.x
   Huynh VW, 2011, ETHNIC MICROAGGRESSI
   Jackson FM, 2005, ETHNIC DIS, V15, P594
   Jackson James S., 1996, Ethnicity and Disease, V6, P132
   Jackson KF, 2012, J COUNS PSYCHOL, V59, P240, DOI 10.1037/a0027639
   Jagusztyn NE, 2007, INTERNALIZED RACISM
   Jamieson LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-656
   Jasinskaja-Lahti I, 2001, INT J PSYCHOL, V36, P174, DOI 10.1080/00207590042000074
   Jasinskaja-Lahti I, 2007, INT J INTERCULT REL, V31, P223, DOI 10.1016/j.ijintrel.2006.02.003
   Jasinskaja-Lahti I, 2009, APPL PSYCHOL-INT REV, V58, P105, DOI 10.1111/j.1464-0597.2008.00384.x
   Jasperse M, 2012, APPL PSYCHOL-INT REV, V61, P250, DOI 10.1111/j.1464-0597.2011.00467.x
   Jenifer ES, 2009, ANGER RACISM CASTE D
   Jones HL, 2007, J BLACK PSYCHOL, V33, P208, DOI 10.1177/0095798407299517
   Jones M. D, 2008, LONGITUDINAL RECIPRO
   Juang LP, 2010, AM J PUBLIC HEALTH, V100, P2403, DOI 10.2105/AJPH.2009.185959
   Juang LP, 2009, J PRIM PREV, V30, P475, DOI 10.1007/s10935-009-0177-9
   Kaduvettoor-Davidson A, 2013, ASIAN AM J PSYCHOL, V4, P155, DOI 10.1037/a0030634
   Kaholokula JK, 2012, J BEHAV MED, V35, P27, DOI 10.1007/s10865-011-9330-z
   Kemp-Blackmon V, 2000, PERCEIVED DISCRIMINA
   Kim G, 2014, PSYCHOL ASSESSMENT, V26, P892, DOI 10.1037/a0036431
   Kim IH, 2014, J IMMIGR MINOR HEALT, V16, P1167, DOI 10.1007/s10903-013-9969-3
   Kim JGS, 2002, RACIAL PERCEPTIONS P
   Klonoff E. A., 1999, J BLACK PSYCHOL, V25, P231, DOI [10.1177/0095798499025002006, DOI 10.1177/0095798499025002006]
   Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370
   Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006
   KRIEGER N, 1993, AM J PREV MED, V9, P82
   Krieger N, 2011, AM J PUBLIC HEALTH, V101, P1704, DOI 10.2105/AJPH.2011.300168
   Krieger N, 2011, J EPIDEMIOL COMMUN H, V65, P260, DOI 10.1136/jech.2009.087387
   Krieger N, 2010, AM J PUBLIC HEALTH, V100, P1485, DOI 10.2105/AJPH.2009.159517
   Krieger N, 2008, SOC SCI MED, V67, P1970, DOI 10.1016/j.socscimed.2008.09.039
   Kulis S, 2009, J HEALTH SOC BEHAV, V50, P443, DOI 10.1177/002214650905000405
   Lam Amy Mong Chow, 2005, Int J Adolesc Med Health, V17, P157
   Lambert SF, 2009, J YOUTH ADOLESCENCE, V38, P519, DOI 10.1007/s10964-009-9393-0
   LaMonica J, 2000, OCCUPATIONAL STRESSO
   LANDRINE H, 1996, J BLACK PSYCHOL, V22, P144, DOI DOI 10.1177/00957984960222002
   Larson C, 2008, AMBULATORY CARE MANA, V29, P133
   LaVeist TA, 2014, J SOC ISSUES, V70, P241, DOI 10.1111/josi.12058
   Lay C, 1998, CAN J BEHAV SCI, V30, P172, DOI 10.1037/h0087060
   LeBel TP, 2012, PRISON J, V92, P63, DOI 10.1177/0032885511429243
   Lee DL, 2013, J COUNS PSYCHOL, V60, P1, DOI 10.1037/a0031275
   Lee DL, 2012, COUNS PSYCHOL, V40, P28, DOI 10.1177/0011000011403326
   Lee DL, 2011, COUNS PSYCHOL, V39, P463, DOI 10.1177/0011000010381791
   Lee RM, 2005, J COUNS PSYCHOL, V52, P36, DOI 10.1037/0022-0167-52.1.36
   Lee RM, 2003, J COUNS PSYCHOL, V50, P133, DOI 10.1037/0022-0167.50.2.133
   Lee S, 2001, IMPACT ETHNIC IDENTI
   LeFevre AL, 2011, SOCIOCULTURAL MECH A
   Lewin A, 2011, J BLACK PSYCHOL, V37, P286, DOI 10.1177/0095798410381242
   Lewis TT, 2006, PSYCHOSOM MED, V68, P362, DOI 10.1097/01.psy.0000221360.94700.16
   Lewis TT, 2014, CURR CARDIOVASC RISK, V8, DOI 10.1007/s12170-013-0365-2
   Lewis TT, 2012, AM J EPIDEMIOL, V175, P391, DOI 10.1093/aje/kwr287
   Liddell AL, 1998, LENGTH INCARCERATION
   Liebkind K, 2000, J ADOLESCENT RES, V15, P446, DOI 10.1177/0743558400154002
   Llacer A, 2009, J EPIDEMIOL COMMUN H, V63, P766, DOI 10.1136/jech.2008.085530
   Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296
   Loo CM, 2001, PSYCHOL ASSESSMENT, V13, P503, DOI 10.1037//1040-3590.13.4.503
   Lorenzo-Blanco EI, 2011, J YOUTH ADOLESCENCE, V40, P1519, DOI 10.1007/s10964-011-9633-y
   Low KSD, 2007, J APPL SOC PSYCHOL, V37, P2261, DOI 10.1111/j.1559-1816.2007.00258.x
   Lyles CR, 2011, J GEN INTERN MED, V26, P1138, DOI 10.1007/s11606-011-1729-2
   Lyles CR, 2011, J HEALTH CARE POOR U, V22, P211, DOI 10.1353/hpu.2011.0033
   Mahonen TA, 2013, J CROSS CULT PSYCHOL, V44, P786, DOI 10.1177/0022022112466699
   Majied KF, 2003, IMPACT RACISM HOMOPH
   Major B, 2007, J PERS SOC PSYCHOL, V92, P1068, DOI 10.1037/0022-3514.92.6.1068
   Mak AS, 2001, J APPL SOC PSYCHOL, V31, P2632, DOI 10.1111/j.1559-1816.2001.tb00194.x
   Mansouri F, 2009, IMPACT RACISM HLTH W
   Markus A., 2014, MAPPING SOCIAL COHES
   Martin MJ, 2005, RACIAL DISCRIMINATIO
   Matthews C. J., 2012, GENERATIONAL STATUS
   Matthews DD, 2013, PSYCHOL MEN MASCULIN, V14, P35, DOI 10.1037/a0028436
   Mayrl D, 2013, SOC SCI RES, V42, P742, DOI 10.1016/j.ssresearch.2012.12.007
   McCracken MO, 2013, ENDNOTE X7 1
   McNeil S, 2014, J CHILD FAM STUD, V23, P381, DOI 10.1007/s10826-013-9788-0
   McNeilly M D, 1996, Ethn Dis, V6, P154
   Medley-Proctor KN, 2005, RACIAL DISCRIMINATIO
   Mesch GS, 2008, J YOUTH ADOLESCENCE, V37, P592, DOI 10.1007/s10964-007-9210-6
   Moghaddam FM, 2002, INT J INTERCULT REL, V26, P381, DOI 10.1016/S0147-1767(02)00012-3
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Moore KM, 2012, MENTAL HLTH IMPLICAT
   Moore-Greene GM, 2012, ETHNIC DIS, V22, P185
   Moradi B, 2004, J COUNS PSYCHOL, V51, P418, DOI 10.1037/0022-0167.51.4.418
   Moradi B, 2003, COUNS PSYCHOL, V31, P451, DOI 10.1177/0011000003254767
   Moradi B, 2006, J COUNS PSYCHOL, V53, P411, DOI 10.1037/0022-0169.53.4.411
   Morris JK, 1997, LATINA COLL STUDENTS
   Mulia N, 2012, J STUD ALCOHOL DRUGS, V73, P570, DOI 10.15288/jsad.2012.73.570
   Murry VM, 2008, FAM RELAT, V57, P117, DOI 10.1111/j.1741-3729.2008.00488.x
   Murry VM, 2001, J MARRIAGE FAM, V63, P915, DOI 10.1111/j.1741-3737.2001.00915.x
   Nair RL, 2008, CULTURAL STRESSORS S
   Neblett EW, 2008, J RES ADOLESCENCE, V18, P477, DOI 10.1111/j.1532-7795.2008.00568.x
   Neblett EW, 2012, PSYCHOSOM MED, V74, P509, DOI 10.1097/PSY.0b013e3182583a50
   Neto F, 2006, J ETHN MIGR STUD, V32, P89, DOI 10.1080/13691830500335507
   Neto F, 2001, J YOUTH ADOLESCENCE, V30, P53, DOI 10.1023/A:1005272805052
   Neto F, 2000, SOC BEHAV PERSONAL, V28, P193, DOI 10.2224/sbp.2000.28.2.193
   Nyborg VM, 2003, J CLIN CHILD ADOLESC, V32, P258, DOI 10.1207/S15374424JCCP3202_11
   Odom EC, 2010, J MARRIAGE FAM, V72, P346, DOI 10.1111/j.1741-3737.2010.00704.x
   Oh MY, 2001, DISS ABSTR INT B, V2B
   Omma L, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18381
   Ong AD, 2009, J PERS SOC PSYCHOL, V96, P1259, DOI 10.1037/a0015335
   Oppedal B, 2005, J CHILD PSYCHOL PSYC, V46, P646, DOI 10.1111/j.1469-7610.2004.00381.x
   Ornelas IJ, 2011, SOC SCI MED, V73, P1169, DOI 10.1016/j.socscimed.2011.07.002
   Pachter LM, 2009, J DEV BEHAV PEDIATR, V30, P255, DOI 10.1097/DBP.0b013e3181a7ed5a
   Padela AI, 2010, AM J PUBLIC HEALTH, V100, P284, DOI 10.2105/AJPH.2009.164954
   Pan SW, 2013, GLOB PUBLIC HEALTH, V8, P685, DOI 10.1080/17441692.2013.799218
   Paradies Y. C., 2006, CRITICAL PUBLIC HLTH, V16, P143, DOI [10.1080/09581590600828881, DOI 10.1080/09581590600828881]
   Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056
   Paradies Y, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-85
   Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059
   Pavalko EK, 2003, J HEALTH SOC BEHAV, V44, P18, DOI 10.2307/1519813
   Peek ME, 2011, ETHNIC DIS, V21, P502
   Peters RM, 2004, WESTERN J NURS RES, V26, P612, DOI 10.1177/0193945904265816
   Peters RM, 2006, J NURS SCHOLARSHIP, V38, P234, DOI 10.1111/j.1547-5069.2006.00108.x
   Phinney JS, 1998, J APPL SOC PSYCHOL, V28, P937, DOI 10.1111/j.1559-1816.1998.tb01661.x
   Piedrahita Palacio SP, 2007, EXAMINING SOCIAL SUP
   Pieterse AL, 2007, J COUNS PSYCHOL, V54, P101, DOI 10.1037/0022-0167.54.1.101
   Pieterse AL, 2012, J COUNS PSYCHOL, V59, P1, DOI 10.1037/a0026208
   Pieterse AL, 2010, J APPL SOC PSYCHOL, V40, P1028, DOI 10.1111/j.1559-1816.2010.00609.x
   Pieterse AL, 2010, J HEALTH CARE POOR U, V21, P334, DOI 10.1353/hpu.0.0244
   Pointer MA, 2008, ETHNIC DIS, V18, P289
   Pole N, 2009, CULTURAL DIVERSITY E, V11, P144
   Polek E, 2010, CROSS-CULT RES, V44, P60, DOI 10.1177/1069397109352779
   Postmes T, 2002, J PERS SOC PSYCHOL, V83, P735, DOI 10.1037//0022-3514.83.3.735
   Poston WSC, 2001, J HUM HYPERTENS, V15, P341
   Prelow HM, 2006, J BLACK PSYCHOL, V32, P442, DOI 10.1177/0095798406292677
   Prelow HM, 2004, J COMMUNITY PSYCHOL, V32, P375, DOI 10.1002/jcop.20007
   Priest N, 2013, SOC SCI MED, V95, P115, DOI 10.1016/j.socscimed.2012.11.031
   Priest N, 2012, J EPIDEMIOL COMMUN H, V66, P440, DOI 10.1136/jech.2010.117366
   Priest N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-568
   Priest NC, 2011, MED J AUSTRALIA, V194, P546
   Huynh QL, 2012, CULT DIVERS ETHN MIN, V18, P26, DOI 10.1037/a0026601
   Quintana SM, 2006, COUNS PSYCHOL, V34, P839, DOI 10.1177/001100006286991
   Raver JL, 2010, J APPL PSYCHOL, V95, P236, DOI 10.1037/a0018377
   Rees CA, 2010, PATIENT PROVIDER FAC
   Reeve BB, 2011, FIELD METHOD, V23, P397, DOI 10.1177/1525822X11416564
   Reisen CA, 2013, CULT DIVERS ETHN MIN, V19, P208, DOI 10.1037/a0031906
   Revollo HW, 2011, INT REV PSYCHIATR, V23, P84, DOI 10.3109/09540261.2010.545988
   Rich Rice KL, 2008, EFFECTS PERCEIVED RA
   Rivas-Drake D, 2008, J YOUTH ADOLESCENCE, V37, P12, DOI 10.1007/s10964-007-9227-x
   Roberts CB, 2008, AM J EPIDEMIOL, V167, P624, DOI 10.1093/aje/kwm334
   Roberts ME, 2012, DEV PSYCHOL, V48, P89, DOI 10.1037/a0025430
   Rodriguez MG, 2002, JOB STRESS PERCEPTIO
   Rosas MC, 1999, IMPACT AFFIRMATIVE A
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Rospenda KM, 2009, J INTERPERS VIOLENCE, V24, P819, DOI 10.1177/0886260508317182
   Rousseau C, 2009, HEALTH PLACE, V15, P751, DOI 10.1016/j.healthplace.2008.12.004
   Rucker LS, 2010, BEHAV THER, V41, P245, DOI 10.1016/j.beth.2009.04.001
   Rucker LS, 2005, DISS ABSTR INT B, V66
   Sanders-Phillips K, 2009, CLIN CHILD FAM PSYCH, V12, P174, DOI 10.1007/s10567-009-0053-4
   Schaafsma J, 2011, EUR J SOC PSYCHOL, V41, P786, DOI 10.1002/ejsp.825
   Schmitt MT, 2014, PSYCHOL BULL, V140, P921, DOI 10.1037/a0035754
   Schmitt MT, 2003, EUR J SOC PSYCHOL, V33, P1, DOI 10.1002/ejsp.131
   Schneider KT, 2000, J APPL PSYCHOL, V85, P3, DOI 10.1037/0021-9010.85.1.3
   Schnittker J, 2005, ANNU REV SOCIOL, V31, P75, DOI 10.1146/annurev.soc.30.012703.110622
   Seaton EK, 2011, CHILD DEV, V82, P1850, DOI 10.1111/j.1467-8624.2011.01651.x
   Sellers RM, 2006, J RES ADOLESCENCE, V16, P187, DOI 10.1111/j.1532-7795.2006.00128.x
   Sellers RM, 2003, J HEALTH SOC BEHAV, V44, P302, DOI 10.2307/1519781
   Sellers RM, 2003, J PERS SOC PSYCHOL, V84, P1079, DOI 10.1037/0022-3514.84.5.1079
   Sellers SL, 2009, HEALTH EDUC BEHAV, V36, P31, DOI 10.1177/1090198106293526
   Semyonov M, 2006, AM SOCIOL REV, V71, P426, DOI 10.1177/000312240607100304
   Sharif H., 2007, OBESITY RELATED BEHA
   Shariff-Marco S., 2006, RACISM CANC PREVENTI
   Shariff-Marco S, 2010, AM J PUBLIC HEALTH, V100, P364, DOI 10.2105/AJPH.2009.163899
   Sharma A., 1995, ACCULTURATION PSYCHO
   Sheridan LP, 2006, J INTERPERS VIOLENCE, V21, P317, DOI 10.1177/0886260505282885
   Shigemoto Y, 2015, J COUNS PSY IN PRESS
   Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754
   Shorey HS, 2002, HISPANIC J BEHAV SCI, V24, P3, DOI 10.1177/0739986302024001001
   Shrake EK, 2004, ADOLESCENCE, V39, P601
   Siefert K, 2000, AM J ORTHOPSYCHIAT, V70, P510, DOI 10.1037/h0087688
   Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351
   Simons RL, 2003, JUSTICE Q, V20, P827, DOI 10.1080/07418820300095711
   Simons RL, 2002, DEV PSYCHOPATHOL, V14, P371, DOI 10.1017/S0954579402002109
   Sinkule JA, 2008, PSYCHOL FUNCTIONING
   Smith J, 2003, STUDY STRESS PERCEIV
   Smokowski PR, 2007, CHILD PSYCHIAT HUM D, V37, P273, DOI 10.1007/s10578-006-0035-4
   Smokowski PR, 2010, CHILD PSYCHIAT HUM D, V41, P133, DOI 10.1007/s10578-009-0157-6
   Smokowski PR, 2009, J COMMUNITY PSYCHOL, V37, P1024, DOI 10.1002/jcop.20346
   SORIANO FI, 1991, HISPANIC J BEHAV SCI, V13, P391, DOI 10.1177/07399863910134003
   Soylu A, 2008, DISS ABSTR INT A, V69, P290
   Staggers-Hakim R, 2009, MODERATING EFFECT DI
   Steffen PR, 2006, ETHNIC DIS, V16, P16
   Steffen PR, 2003, PSYCHOSOM MED, V65, P746, DOI 10.1097/01.PSY.0000079380.95903.78
   Stein GL, 2012, J YOUTH ADOLESCENCE, V41, P1339, DOI 10.1007/s10964-012-9765-8
   Stevens GWJM, 2005, SOC PSYCH PSYCH EPID, V40, P1003, DOI 10.1007/s00127-005-0988-9
   Stevens-Watkins D, 2012, J BLACK PSYCHOL, V38, P471, DOI 10.1177/0095798412438395
   Stucky BD, 2011, CULT DIVERS ETHN MIN, V17, P175, DOI 10.1037/a0023356
   Suleiman Gonzalez LP, 1999, STRESS SOCIOCULTURAL
   Swami V, 2010, SOC PSYCH PSYCH EPID, V45, P57, DOI 10.1007/s00127-009-0042-4
   Szalacha Laura A, 2003, Cultur Divers Ethnic Minor Psychol, V9, P141, DOI 10.1037/1099-9809.9.2.141
   Szanton SL, 2012, INT J BEHAV MED, V19, P489, DOI 10.1007/s12529-011-9188-z
   Szymanski DM, 2011, COUNS PSYCHOL, V39, P438, DOI 10.1177/0011000010378895
   Tartakovsky E, 2007, SOC PSYCH PSYCH EPID, V42, P485, DOI 10.1007/s00127-007-0184-1
   Tartakovsky E, 2009, J RES ADOLESCENCE, V19, P177, DOI 10.1111/j.1532-7795.2009.00589.x
   Tawa J, 2012, BASIC APPL SOC PSYCH, V34, P349, DOI 10.1080/01973533.2012.693425
   TAYLOR J, 1990, INT J ADDICT, V25, P1287, DOI 10.3109/10826089009056222
   Taylor J, 2002, SOC PSYCHOL QUART, V65, P213, DOI 10.2307/3090120
   Terrell BP, 2003, IMPACT ETHNIC SOCIAL
   Thoma BC, 2013, CULT DIVERS ETHN MIN, V19, P404, DOI 10.1037/a0031739
   Thomas A, 2010, AUST NZ J PSYCHIAT, V44, P40, DOI 10.3109/00048670903393589
   Thomas D-M, 2006, INFLUENCE PERCEPTION
   Thompson HS, 1999, RELATIONSHIP CHRONIC
   Todorova ILG, 2010, SOCIOL HEALTH ILL, V32, P843, DOI 10.1111/j.1467-9566.2010.01257.x
   Torres L, 2012, CULT DIVERS ETHN MIN, V18, P17, DOI 10.1037/a0026710
   Torres L, 2011, AM J ORTHOPSYCHIAT, V81, P526, DOI 10.1111/j.1939-0025.2011.01117.x
   Torres L, 2010, J SOC CLIN PSYCHOL, V29, P1074, DOI 10.1521/jscp.2010.29.10.1074
   Torres L, 2010, CULT DIVERS ETHN MIN, V16, P561, DOI 10.1037/a0020652
   Tran AGTT, 2014, AM J COMMUN PSYCHOL, V53, P37, DOI 10.1007/s10464-013-9607-1
   Tran N, 2010, USING COLOR BLINDNES
   Trevino B, 2012, HISPANIC J BEHAV SCI, V34, P340, DOI 10.1177/0739986311435900
   Tull ES, 1999, J NATL MED ASSOC, V91, P447
   Tull ES, 2001, DIABETES CARE, V24, P1498, DOI 10.2337/diacare.24.8.1498
   Tull ES, 2007, ETHNIC DIS, V17, P731
   Tummala-Narra P, 2013, CULT DIVERS ETHN MIN, V19, P257, DOI 10.1037/a0032960
   Tynes BM, 2012, DEV PSYCHOL, V48, P343, DOI 10.1037/a0027032
   Ullah J, 2011, EXAMINATION ROLE SOC
   Umana-Taylor AJ, 2007, J ADOLESCENCE, V30, P549, DOI 10.1016/j.adolescence.2006.08.002
   United Nations, 2009, WORLD C RAC RAC DISC
   Utsey SO, 2013, J BLACK PSYCHOL, V39, P532, DOI 10.1177/0095798412461808
   Utsey SO, 1999, MEAS EVAL COUNS DEV, V32, P149
   Verkuyten M, 2001, J APPL SOC PSYCHOL, V31, P1058, DOI 10.1111/j.1559-1816.2001.tb02662.x
   Verkuyten M, 1998, J SOC PSYCHOL, V138, P479, DOI 10.1080/00224549809600402
   Verkuyten M, 2005, SELF IDENTITY, V4, P177, DOI 10.1080/13576500444000290
   Vremaroiu Ana-Maria, 2013, Clujul Med, V86, P53
   Wadsworth E, 2007, OCCUP MED-OXFORD, V57, P18, DOI 10.1093/occmed/kql088
   Wagner GJ, 2012, J BEHAV MED, V35, P8, DOI 10.1007/s10865-011-9320-1
   Wagner J, 2007, DIABETES CARE, V30, P364, DOI 10.2337/dc06-1756
   Walls ML, 2007, MIXED METHODS EXAMIN
   Walters JM, 2004, TESTING BIOPSYCHOSOC
   Wei MF, 2013, J COUNS PSYCHOL, V60, P453, DOI 10.1037/a0032344
   Wei MF, 2012, CULT DIVERS ETHN MIN, V18, P340, DOI 10.1037/a0029453
   Wei MF, 2012, J COUNS PSYCHOL, V59, P486, DOI 10.1037/a0028000
   Wei MF, 2008, J COUNS PSYCHOL, V55, P451, DOI 10.1037/a0012511
   Whitbeck LB, 2001, J HEALTH SOC BEHAV, V42, P405, DOI 10.2307/3090187
   Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305
   Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0
   Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200
   Williams DR, 1999, RUTG SELF SOC ID, V2, P71
   WILLIAMS DR, 1994, PUBLIC HEALTH REP, V109, P26
   Williams DR, 2000, ETHNIC HEALTH, V5, P243, DOI 10.1080/713667453
   Wong CA, 1997, THE RISKS AND PROTEC
   Wyatt SB, 2003, AM J MED SCI, V325, P315, DOI 10.1097/00000441-200306000-00003
   Yap SCY, 2011, UNDERSTANDING ASS PE
   Yap SCY, 2011, CULT DIVERS ETHN MIN, V17, P89, DOI 10.1037/a0022535
   Yoder Kevin A, 2006, Arch Suicide Res, V10, P177, DOI 10.1080/13811110600558240
   Yoo HC, 2005, J COUNS PSYCHOL, V52, P497, DOI 10.1037/0022-0167.52.4.497
   Yoo HC, 2013, APA HDB PSYCHOL, P605
   Yoon E, 2012, J COUNS PSYCHOL, V59, P86, DOI 10.1037/a0025366
   Zeiders KH, 2013, DEV PSYCHOL, V49, P951, DOI 10.1037/a0028866
NR 433
TC 193
Z9 194
U1 6
U2 106
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 23
PY 2015
VL 10
IS 9
AR e0138511
DI 10.1371/journal.pone.0138511
PG 48
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CS1BM
UT WOS:000361797500073
PM 26398658
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Conner, LM
   Morris, G
AF Conner, L. Mike
   Morris, Gail
TI Impacts of Mesopredator Control on Conservation of Mesopredators and
   Their Prey
SO PLOS ONE
LA English
DT Article
ID PREDATOR REMOVAL; PUBLICATION BIAS; MAMMALIAN CARNIVORES;
   POPULATION-DYNAMICS; BREEDING SUCCESS; COYOTE REMOVAL; RELEASE;
   ABUNDANCE; BIODIVERSITY; MANAGEMENT
AB Declining large carnivore populations, increased habitat fragmentation, declining interests in fur trapping, and other anthropogenic factors can all lead to increased mesopredator populations and these may negatively impact biodiversity. Lethal mesopredator control potentially mitigates some of these effects but can be controversial, largely because impacts on mesopredator populations have not been evaluated. Estimating these impacts may reduce controversies while increasing our understanding of when lethal control may be beneficial. Therefore, we analyzed published mesopredator removal data to determine if mesopredator removal rates changed over time. Removals of medium,(e.g., raccoons (Procyon lotor) or red foxes (Vulpes vulpes), and large, i.e., bobcats (Lynx rufus) or coyotes (Canis latrans), mesopredators were consistent from year to year and over the duration of study (i.e., number removed during the first and last years of studies were similar). In contrast, removals of small mesopredators, e.g., weasels (Mustela spp.) or spotted skunks (Spilogale putorius), declined over the duration of study. Study area size, number of species targeted for removal, and duration of removal effort were poor predictors of removal rates. Our analyses suggest that: (1) control, as typically implemented, is unlikely to cause negative long-term impacts on populations of medium and large mesopredators but may negatively impact small mesopredators, (2) if mesopredator control benefits prey, recurring removals will generally be needed to maintain benefits, and (3) timing of removals will be important to achieve management goals. We suggest that mesopredator control efforts are frequently spatially structured harvests from continuously distributed populations. This may explain (1) why removal of small mesopredators declined over time; whereas, medium and large mesopredator removals remained consistent, and (2) why some prey failed to respond to mesopredator control efforts.
C1 [Conner, L. Mike; Morris, Gail] Joseph W Jones Ecol Res Ctr, Newton, GA 39870 USA.
RP Conner, LM (reprint author), Joseph W Jones Ecol Res Ctr, Newton, GA 39870 USA.
EM mconner@jonesctr.org
FU W. Jones Ecological Research Center
FX This study was entirely funded by the Joseph W. Jones Ecological
   Research Center.
CR Allen BL, 2014, ECOL MANAG RESTOR, V15, P191, DOI 10.1111/emr.12118
   Allen BL, 2013, BIOL CONSERV, V159, P158, DOI 10.1016/j.biocon.2012.12.004
   Beasley JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058982
   BEASOM SL, 1974, J WILDLIFE MANAGE, V38, P854, DOI 10.2307/3800056
   BEKOFF M, 1977, Mammalian Species, V79, P1
   Bergstrom BJ, 2014, CONSERV LETT, V7, P131, DOI 10.1111/conl.12045
   Bodey TW, 2011, BIOL INVASIONS, V13, P2817, DOI 10.1007/s10530-011-9965-2
   Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x
   Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x
   Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x
   Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028
   Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x
   Cypher Brian L., 1992, Proceedings of the Vertebrate Pest Conference, V15, P42
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ellis-Felege SN, 2012, J APPL ECOL, V49, P661, DOI 10.1111/j.1365-2664.2012.02126.x
   Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106
   Fletcher K, 2010, J APPL ECOL, V47, P263, DOI 10.1111/j.1365-2664.2010.01793.x
   Frey SN, 2007, J WILDLIFE MANAGE, V71, P303, DOI 10.2193/2005-417
   Frey SN, 2003, WILDLIFE SOC B, V31, P727
   Garrettson PR, 2001, J WILDLIFE MANAGE, V65, P398, DOI 10.2307/3803091
   Gehrt SD, 2003, WILDLIFE SOC B, V31, P836
   Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718
   Gordon CE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2870
   Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826
   Hola M, 2015, EUR J WILDLIFE RES, V61, P73, DOI 10.1007/s10344-014-0875-3
   Holt AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002400
   Imperio S, 2010, WILDLIFE BIOL, V16, P205, DOI 10.2981/08-051
   Jennions MD, 2002, BIOL REV, V77, P211, DOI 10.1017/S1464793101005875
   Kauhala K, 2004, FOLIA ZOOL, V53, P367
   Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764
   King C, 1989, NATURAL HIST WEASELS
   King CM, 2009, BIOL CONSERV, V142, P806, DOI 10.1016/j.biocon.2008.12.010
   Kirkwood R, 2014, WILDLIFE RES, V41, P222, DOI 10.1071/WR13196
   Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972
   Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]
   LINT JR, 1995, WILDLIFE SOC B, V23, P164
   Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x
   McCullough DR, 1996, J WILDLIFE MANAGE, V60, P1, DOI 10.2307/3802033
   MILLS LS, 2007, CONSERVATION WILDLIF
   Morris G, 2011, OECOLOGIA, V167, P1005, DOI 10.1007/s00442-011-2053-6
   Newsome TM, 2015, J ANIM ECOL, V84, P49, DOI 10.1111/1365-2656.12258
   Palmer WE, 2005, WILDLIFE SOC B, V33, P1398, DOI 10.2193/0091-7648(2005)33[1398:EOFBAN]2.0.CO;2
   Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774
   Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9
   R Core Team, 2015, R LANG ENV STAT COMP
   Reiter DK, 1999, WILDLIFE SOC B, V27, P746
   Remy A, 2011, J ANIM ECOL, V80, P929, DOI 10.1111/j.1365-2656.2011.01849.x
   Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484
   Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033
   Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x
   Rogers CM, 1998, OECOLOGIA, V116, P227, DOI 10.1007/s004420050583
   Rollins D, 2001, WILDLIFE SOC B, V29, P39
   Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1
   Schmidt KA, 2008, BEHAV ECOL, V19, P759, DOI 10.1093/beheco/arn034
   Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x
   Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x
   Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x
   Sundell J, 2006, MAMMAL REV, V36, P107, DOI 10.1111/j.1365-2907.2006.00083.x
   Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4
   VanGilder Cory L., 2009, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V63, P11
   WADE-SMITH J, 1982, Mammalian Species, P1, DOI 10.2307/3503883
   Wallach AD, 2015, OIKOS, V124, P1453, DOI 10.1111/oik.01977
   Whitmee S, 2013, J ANIM ECOL, V82, P211, DOI 10.1111/j.1365-2656.2012.02030.x
   Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908
NR 64
TC 14
Z9 14
U1 3
U2 79
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 11
PY 2015
VL 10
IS 9
AR e0137169
DI 10.1371/journal.pone.0137169
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CR0WB
UT WOS:000361043100024
PM 26361211
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, P
   Liu, HF
   Jiang, T
   Yang, JL
AF Wang, Peng
   Liu, Huifang
   Jiang, Ting
   Yang, Julun
TI Cigarette Smoking and the Risk of Adult Myeloid Disease: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ABERRANT DNA METHYLATION; HAIR DYE USE; MYELODYSPLASTIC SYNDROMES;
   CYTOGENETIC ABNORMALITIES; TELOMERE LENGTH; LEUKEMIA RISK; BONE-MARROW;
   EXPRESSION; PROGRESSION; ASSOCIATION
AB Background
   The adult myeloid diseases, myelodysplastic syndrome and acute myeloid leukemia, have been reported to be associated with cigarette smoking, but the results have been conflicting. Previous studies may have ignored the relationship between myelodysplastic syndrome and acute myeloid leukemia, where approximately one-third of myelodysplastic syndrome cases will progress to acute myeloid leukemia, which could induce a serious bias in independent analyses. For the purposes of researching pathogenesis, we suggest that myelodysplastic syndrome and acute myeloid leukemia should be regarded as a single class of adult myeloid disease, and herein assessed the relationship between cigarette smoking and the risk of adult myeloid disease.
   Methods
   The PubMed, Cochrane Library, EBSCO, and EMBASE databases were systematically searched for reports published from 1990 to 2015. Two authors independently assessed the methodological quality and the extracted data. The odds ratios and adjusted odds ratios (OR), a sensitivity analysis, and the publication bias were analyzed using the CMA v2 (Comprehensive Meta Analysis Version 2) software program.
   Results
   Twenty-five studies were included in this meta-analysis. The publication dates ranged from 1990 to 2014. The pooled OR in current smokers and ever-smokers showed an increased risk of adult myeloid disease, with ORs of 1.45 (95% CI, 1.30-1.62; p<0.001) and 1.23 (95% CI 1.15-1.32; p<0.001) versus non-smokers, respectively. In the subset analyses, the OR of adult myeloid disease was increased regardless of the form of disease, geographical region, NOS (Newcastle Ottawa Scale) score, and source of controls. The smoking status was divided into <20 and >= 20 cigarettes per day, and these groups had ORs of developing adult myeloid disease of 1.24 (95% CI, 1.09-1.40; p = 0.001) and 1.32 (95% CI, 1.14-1.53; p<0.001), respectively. In the groups divided based on the number of years the subjects had smoked (<20 and >= 20 years), the ORs were 1.05 (95% CI, 0.90-1.23; p = 0.25) and 1.30 (95% CI, 1.16-1.45; p<0.001), respectively. Similarly, <20 and >= 20 pack-years were associated with ORs of 1.15 (95% CI, 1.03-1.29; p = 0.017) and 1.34 (95% CI, 1.18-1.52; p<0.001), respectively.
   Conclusions
   This meta-analysis, for the first time, combined myelodysplastic syndrome with acute myeloid leukemia to assess the overall risk of adult myeloid disease, and it demonstrated that cigarette smoking is associated with a significantly increased risk of adult myeloid disease.
C1 [Wang, Peng; Liu, Huifang; Yang, Julun] Kunming Univ Sci & Technol, Fac Med, Dept Pathol, Kunming, Peoples R China.
   [Jiang, Ting] Kunming Med Univ, Kunming Gen Hosp, Dept Pathol, Clin Coll, Kunming, Peoples R China.
   [Yang, Julun] Kunming Gen Hosp, Dept Pathol, Kunming, Peoples R China.
RP Yang, JL (reprint author), Kunming Univ Sci & Technol, Fac Med, Dept Pathol, Kunming, Peoples R China.
EM yangjulun@sina.com
CR Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7
   [Anonymous], 2013, SURVEILLANCE EPIDEMI
   Aul C, 1998, HAEMATOLOGICA, V83, P71
   BELL DA, 1995, JNCI-J NATL CANCER I, V87, P223, DOI 10.1093/jnci/87.3.223
   Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019
   Bjork J, 2001, LEUKEMIA RES, V25, P865, DOI 10.1016/S0145-2126(01)00048-0
   Bjork J, 2009, LEUKEMIA RES, V33, P788, DOI 10.1016/j.leukres.2008.10.009
   Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41
   BROWN LM, 1992, AM J EPIDEMIOL, V135, P763
   BROWNSON RC, 1991, AM J EPIDEMIOL, V134, P938, DOI 10.1093/oxfordjournals.aje.a116177
   Chia VM, 2006, CANCER RES, V66, P6877, DOI 10.1158/0008-5472.CAN-06-1535
   Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047
   Dalamaga M, 2002, CANCER CAUSE CONTROL, V13, P603, DOI 10.1023/A:1019573319803
   Davis RE, 1998, LEUKEMIA RES, V22, P767, DOI 10.1016/S0145-2126(98)00051-4
   Duarte-Davidson R, 2001, OCCUP ENVIRON MED, V58, P2, DOI 10.1136/oem.58.1.2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ettou S, 2012, LEUKEMIA, V26, P2297, DOI 10.1038/leu.2012.152
   Fenaux P, 2014, ANN ONCOL, V25, P57, DOI 10.1093/annonc/mdu180
   Fircanis S, 2014, AM J HEMATOL, V89, pE125, DOI 10.1002/ajh.23744
   Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751
   Heinrichs S, 2005, BRIT J HAEMATOL, V130, P83, DOI 10.1111/j.1365-2141.2005.05555.x
   Hofmann WK, 2005, ANNU REV MED, V56, P1, DOI 10.1146/annurev.med.56.082103.104704
   Huang JJ, 2013, REPROD TOXICOL, V35, P89, DOI 10.1016/j.reprotox.2012.07.003
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V83, P1
   Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2009-10-050476
   Kao HW, 2011, NEOPLASIA, V13, P1035, DOI 10.1593/neo.111192
   Kasim K, 2005, CANCER CAUSE CONTROL, V16, P489, DOI 10.1007/s10552-004-7115-1
   Kim DH, 2001, CANCER RES, V61, P3419
   Kim HN, 2012, LEUKEMIA LYMPHOMA, V53, P681, DOI 10.3109/10428194.2011.625576
   Lichtman MA, 2007, LEUKEMIA, V21, P1137, DOI 10.1038/sj.leu.2404698
   Liu YQ, 2013, CHINA CANC, V7, P528
   Lv L, 2011, AM J HEMATOL, V86, P163, DOI 10.1002/ajh.21941
   Ma X, 2007, CANCER, V109, P1536, DOI 10.1002/cncr.22570
   MCLAUGHLIN JK, 1989, JNCI-J NATL CANCER I, V81, P1262, DOI 10.1093/jnci/81.16.1262
   MELE A, 1994, AM J EPIDEMIOL, V139, P609, DOI 10.1093/oxfordjournals.aje.a117050
   Mohammad H, 2002, BRIT J HAEMATOL, V117, P359, DOI 10.1046/j.1365-2141.2002.03458.x
   Mori N, 2000, CANCER RES, V60, P3039
   Musselman JRB, 2013, CANCER EPIDEMIOL, V37, P410, DOI 10.1016/j.canep.2013.03.012
   Nagata C, 1999, LEUKEMIA RES, V23, P57, DOI 10.1016/S0145-2126(98)00135-0
   National Comprehensive Cancer Network, 2014, CLIN PRACT GUID ONC
   Nisse C, 2001, BRIT J HAEMATOL, V112, P927, DOI 10.1046/j.1365-2141.2001.02645.x
   Ohyashiki K, 2001, LEUKEMIA LYMPHOMA, V42, P291, DOI 10.3109/10428190109064585
   Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394
   Ozcan MA, 2013, EXPERT REV HEMATOL, V6, P165, DOI [10.1586/ehm.13.7, 10.1586/EHM.13.7]
   PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P12
   Pekmezovic T, 2006, ANN HEMATOL, V85, P514, DOI 10.1007/s00277-006-0128-y
   Pogoda JM, 2002, AM J EPIDEMIOL, V155, P546, DOI 10.1093/aje/155.6.546
   Poloni A, 2013, LEUKEMIA RES, V37, P1538, DOI 10.1016/j.leukres.2013.07.022
   Poynter JN, 2009, CANCER EPIDEM BIOMAR, V18, P2745, DOI 10.1158/1055-9965.EPI-09-0517
   Richardson DB, 2008, CANCER CAUSE CONTROL, V19, P43, DOI 10.1007/s10552-007-9068-7
   Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468
   SANDLER DP, 1993, J NATL CANCER I, V85, P1994, DOI 10.1093/jnci/85.24.1994
   Sarir H, 2010, BIOCHEM PHARMACOL, V79, P698, DOI 10.1016/j.bcp.2009.10.001
   SEVERSON RK, 1990, AM J EPIDEMIOL, V132, P418, DOI 10.1093/oxfordjournals.aje.a115676
   Speer SA, 2002, J ENVIRON HEALTH, V64, P9
   Stagnaro E, 2001, CANCER CAUSE CONTROL, V12, P325, DOI 10.1023/A:1011216102871
   Stifter G, 2005, EUR J HAEMATOL, V75, P485, DOI 10.1111/j.1600-0609.2005.00551.x
   Strom SS, 2012, CANCER-AM CANCER SOC, V118, P4589, DOI 10.1002/cncr.27442
   Strom SS, 2005, LEUKEMIA, V19, P1912, DOI 10.1038/sj.leu.2403945
   Swerdlow SH, 2008, WHO CLASSIFICATION T
   Tasaka T, 1996, LEUKEMIA RES, V20, P113, DOI 10.1016/0145-2126(95)00119-0
   Tong HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067537
   Verde Z, 2015, ENVIRON RES, V140, P488, DOI 10.1016/j.envres.2015.05.008
   WAKABAYASHI I, 1994, INTERNAL MED, V33, P198, DOI 10.2169/internalmedicine.33.198
   Wang HY, 2003, TOXICOL PATHOL, V31, P220, DOI 10.1080/01926230390183715
   WEST RR, 1995, LEUKEMIA RES, V19, P127, DOI 10.1016/0145-2126(94)00141-V
   Wilson AB, 2014, CANCER EPIDEMIOL, V38, P544, DOI 10.1016/j.canep.2014.08.003
   Wong O, 2009, REGUL TOXICOL PHARM, V55, P340, DOI 10.1016/j.yrtph.2009.08.007
   Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812
   Zhang LP, 2011, CARCINOGENESIS, V32, P605, DOI 10.1093/carcin/bgq286
NR 71
TC 7
Z9 8
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 4
PY 2015
VL 10
IS 9
AR e0137300
DI 10.1371/journal.pone.0137300
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CQ6BA
UT WOS:000360688200044
PM 26340093
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lin, SC
   Gan, ZH
   Yao, Y
   Min, DL
AF Lin, Shu Chen
   Gan, Zhi Hua
   Yao, Yang
   Min, Da Liu
TI The Prognostic Value of Forkhead Box P3 Expression in Operable Breast
   Cancer: A Large-Scale Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; FOXP3 EXPRESSION;
   ESTROGEN-RECEPTOR; PUBLICATION BIAS; GASTRIC-CANCER; SURVIVAL;
   PROLIFERATION; ANGIOGENESIS; CHEMOTHERAPY
AB Background
   Recent studies have shown that the forkhead box P3 (FOXP3) protein has a prognostic role in breast cancer. However, these results are controversial. Therefore, the aim of this metaanalysis was to clarify the prognostic role of FOXP3 expression in operable breast cancer cases.
   Methods
   Eligible studies describing the use of FOXP3 as a prognostic factor for operable breast cancer cases were identified. Clinicopathological features, disease-free survival (DFS), and overall survival (OS) data were collected from these studies and were analyzed using Stata software.
   Results
   A total of 16 articles containing data from 13,217 breast cancer patients met the inclusion criteria established for this study. The subsequent meta-analysis that was performed showed that high levels of FOXP3 are not significantly associated with DFS and OS with significant heterogeneity. An additional subgroup analysis demonstrated that intratumoral FOXP3+ regulatory T cells (Tregs) were positively correlated with adverse clinicopathological parameters, yet they did not show an association with DFS or OS. For tumor cells, the pooled results revealed that FOXP3 is significantly associated with DFS (HR: 2.55, 95% CI: 1.23-5.30) but is not associated with clinicopathological parameters or OS. We also observed a significant correlation between FOXP3 expression and survival in the estrogen receptor-positive (ER)+ subgroup (HR: 1.83, 95% CI: 1.36-2.47 for DFS, HR: 1.87, 95% CI 1.28-2.73 for OS), in the Asian region (HR: 1.98, 95% CI: 1.56-2.50 for DFS, HR: 1.93, 95% CI: 1.12-3.35 for OS) and using the median as the FOXP3-positive cut-off value (HR: 1.94, 95% CI: 1.57-2.39 for DFS, HR: 2.06; 95% CI: 1.36-3.11 for OS).
   Conclusion
   This meta-analysis indicates that a prognostic role for FOXP3 expression in operable breast cancer cases depends on the FOXP3-positive region, ER status, geographic region and the FOXP3-positive cut-off value.
C1 [Lin, Shu Chen; Gan, Zhi Hua; Min, Da Liu] Shanghai Jiao Tong Univ, Dept Oncol, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China.
   [Yao, Yang] Shanghai Jiao Tong Univ, Dept Oncol, Peoples Hosp 6, Shanghai 200030, Peoples R China.
RP Min, DL (reprint author), Shanghai Jiao Tong Univ, Dept Oncol, Shanghai Peoples Hosp 6, East Campus, Shanghai 200030, Peoples R China.
EM scl543042177@163.com
CR Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191
   Ali HR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3061
   Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Chu R, 2015, MOL CELL ENDOCRINOL, V399, P228, DOI 10.1016/j.mce.2014.10.006
   deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216
   Devaud C, 2014, CANCER IMMUNOL IMMUN, V63, P869, DOI 10.1007/s00262-014-1581-4
   Droeser R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-134
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Earl HM, 2012, BRIT J CANCER, V107, P1257, DOI 10.1038/bjc.2012.370
   Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687
   Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360
   Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304
   Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189
   Gupta S, 2007, ACTA ONCOL, V46, P792, DOI 10.1080/02841860701233443
   Hao Q, 2014, CELL SIGNAL, V26, P564, DOI 10.1016/j.cellsig.2013.11.030
   Kim MH, 2013, ONCOLOGY-BASEL, V85, P128, DOI 10.1159/000351473
   Kim ST, 2013, AM J CLIN ONCOL-CANC, V36, P224, DOI 10.1097/COC.0b013e3182467d90
   Kim S, 2014, J BREAST CANCER, V17, P8, DOI 10.4048/jbc.2014.17.1.8
   Ladoire S, 2012, ANN ONCOL, V23, P2552, DOI 10.1093/annonc/mds028
   Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491
   Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y
   Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3
   Liu SZ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0432-8
   Ma GF, 2014, BRIT J CANCER, V110, P1552, DOI 10.1038/bjc.2014.47
   Maeda N, 2014, ANN SURG ONCOL, V21, pS546, DOI 10.1245/s10434-014-3564-2
   Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8
   Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036
   Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005
   Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x
   Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006
   Prieto GA, 2006, IMMUNOLOGY, V118, P58, DOI 10.1111/j.1365-2567.2006.02339.x
   Stockmann C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00069
   Sun SY, 2014, CANCER IMMUNOL IMMUN, V63, P395, DOI 10.1007/s00262-014-1519-x
   Takenaka M, 2013, MOL CLIN ONCOL, V1, P625, DOI 10.3892/mco.2013.107
   Tan B, 2014, ONCOTARGET, V5, P264, DOI 10.18632/oncotarget.1600
   Tanchot C, 2013, CANCER MICROENVIRON, V6, P147, DOI 10.1007/s12307-012-0122-y
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Triulzi T, 2013, J CELL PHYSIOL, V228, P30, DOI 10.1002/jcp.24125
   Weller P, 2014, EUR J CANCER, V50, P1291, DOI 10.1016/j.ejca.2014.02.016
   Wells GA, 2003, 11 INT COCHR C, P26
   West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524
   Won KY, 2013, PATHOL RES PRACT, V209, P767, DOI 10.1016/j.prp.2013.08.010
   Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869
   YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7
NR 45
TC 7
Z9 8
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2015
VL 10
IS 8
AR e0136374
DI 10.1371/journal.pone.0136374
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP6KK
UT WOS:000359995500070
PM 26305693
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Verkuil, B
   Atasayi, S
   Molendijk, ML
AF Verkuil, Bart
   Atasayi, Serpil
   Molendijk, Marc L.
TI Workplace Bullying and Mental Health: A Meta-Analysis on Cross-Sectional
   and Longitudinal Data
SO PLOS ONE
LA English
DT Article
ID PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; GRADUATE NURSES; MEDIATING
   ROLE; NEGATIVE ACTS; WORK; EXPOSURE; HARASSMENT; JOB; CHILDHOOD
AB Background
   A growing body of research has confirmed that workplace bullying is a source of distress and poor mental health. Here we summarize the cross-sectional and longitudinal literature on these associations.
   Methods
   Systematic review and meta-analyses on the relation between workplace bullying and mental health.
   Results
   The cross-sectional data (65 effect sizes, N = 115.783) showed positive associations between workplace bullying and symptoms of depression (r = .28, 95% CI = .23-.34), anxiety (r = .34, 95% CI = .29-.40) and stress-related psychological complaints (r = .37, 95% CI = .30-.44). Pooling the literature that investigated longitudinal relationships (26 effect sizes, N = 54.450) showed that workplace bullying was related to mental health complaints over time (r = 0.21, 95% CI = 0.13-0.21). Interestingly, baseline mental health problems were associated with subsequent exposure to workplace bullying (r = 0.18, 95% CI = 0.10-0.27; 11 effect sizes, N = 27.028).
   Limitations
   All data were self-reported, raising the possibility of reporting-and response set bias.
   Conclusions
   Workplace bullying is consistently, and in a bi-directional manner, associated with reduced mental health. This may call for intervention strategies against bullying at work.
C1 [Verkuil, Bart; Atasayi, Serpil; Molendijk, Marc L.] Leiden Univ, Inst Psychol, Leiden, Netherlands.
   [Verkuil, Bart; Molendijk, Marc L.] Leiden Univ, Med Ctr, Leiden Inst Brain & Cognit, Leiden, Netherlands.
   [Verkuil, Bart] Skils, Leiden, Netherlands.
RP Verkuil, B (reprint author), Leiden Univ, Inst Psychol, Leiden, Netherlands.
EM bverkuil@fsw.leidenuniv.nl
OI Verkuil, Bart/0000-0002-9991-0690
CR Agervold M, 2004, WORK STRESS, V18, P336, DOI 10.1080/02678370412331319794
   Agervold M, 2009, SCAND J PSYCHOL, V50, P267, DOI 10.1111/j.1467-9450.2009.00710.x
   Balducci C, 2011, ANXIETY STRESS COPIN, V24, P499, DOI 10.1080/10615806.2011.555533
   Bardakci E, 2016, J TRANSCULT NURS, V27, P166, DOI 10.1177/1043659614549073
   Bhui KS, 2012, J ENVIRON PUBLIC HEA, DOI 10.1155/2012/515874
   Bilgel N, 2006, OCCUP MED-OXFORD, V56, P226, DOI 10.1093/occmed/kqj041
   Bjorkqvist K, 2001, PHYSIOL BEHAV, V73, P435, DOI 10.1016/S0031-9384(01)00490-5
   Bond SA, 2010, ORGANIZATION DEVELOP
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90
   Carter M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002628
   Cassidy T, 2014, WORK STRESS, V28, P255, DOI 10.1080/02678373.2014.927020
   Copeland WE, 2014, P NATL ACAD SCI USA, V111, P7570, DOI 10.1073/pnas.1323641111
   Dehue F, 2012, INT J STRESS MANAGE, V19, P175, DOI 10.1037/a0028969
   Demir D, 2013, ASIA PAC J HUM RESOU, V51, P392, DOI 10.1111/1744-7941.12002
   Duncan R. D., 1999, CHILD MALTREATMENT, V4, P45, DOI DOI 10.1177/1077559599004001005
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Einarsen S, 2009, WORK STRESS, V23, P24, DOI 10.1080/02678370902815673
   Einarsen S, 2015, INT ARCH OCC ENV HEA, V88, P131, DOI 10.1007/s00420-014-0944-7
   Eriksen W, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-290
   Figueiredo-Ferraz H, 2015, J INTELL DISABIL RES, V59, P39, DOI 10.1111/jir.12084
   Finne LB, 2011, SCAND J WORK ENV HEA, V37, P276, DOI 10.5271/sjweh.3156
   Gardner D, 2013, ETHNICITY WORKPLACE
   Glaso L, 2012, VIOLENCE VICTIMS, V27, P360, DOI 10.1891/0886-6708.27.3.360
   Glaso L, 2011, SCAND J PSYCHOL, V52, P484, DOI 10.1111/j.1467-9450.2011.00895.x
   Gullander M, 2014, J OCCUP ENVIRON MED, V56, P1258, DOI 10.1097/JOM.0000000000000339
   Hansen AM, 2006, J PSYCHOSOM RES, V60, P63, DOI 10.1016/j.jpsychores.2005.06.078
   Hansen AM, 2011, J PSYCHOSOM RES, V70, P19, DOI 10.1016/j.jpsychores.2010.05.010
   Hansson M, 2010, J AFFECT DISORDERS, V124, P54, DOI 10.1016/j.jad.2009.10.032
   Hauge LJ, 2010, SCAND J PSYCHOL, V51, P426, DOI 10.1111/j.1467-9450.2010.00813.x
   Hershcovis MS, 2010, J ORGAN BEHAV, V31, P24, DOI 10.1002/job.621
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Hogh A, 2005, INT J BEHAV MED, V12, P256, DOI 10.1207/s15327558ijbm1204_6
   Hogh A, 2012, J PSYCHOSOM RES, V73, P47, DOI 10.1016/j.jpsychores.2012.04.004
   Hogh A, 2011, J NURS MANAGE, V19, P742, DOI 10.1111/j.1365-2834.2011.01264.x
   Hoobler JM, 2010, J OCCUP HEALTH PSYCH, V15, P434, DOI 10.1037/a0021000
   Hyyti J., 2002, EUROPEAN J WORK ORG, V11, P113, DOI DOI 10.1080/13594320143000870
   Johannessen HA, 2013, J OCCUP ENVIRON MED, V55, P605, DOI 10.1097/JOM.0b013e3182917899
   Karasek RA, 1990, HEALTHY WORK STRESS
   Karsten J, 2011, BRIT J PSYCHIAT, V198, P206, DOI 10.1192/bjp.bp.110.080572
   Khubchandani J, 2015, J COMMUN HEALTH, V40, P555, DOI 10.1007/s10900-014-9971-2
   Kingdom S E, 2011, Int Marit Health, V62, P200
   Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P779, DOI 10.1136/oem.60.10.779
   Kivimaki M, 2000, OCCUP ENVIRON MED, V57, P656, DOI 10.1136/oem.57.10.656
   Kostev K, 2014, GER MED SCI, V12
   Lahelma E, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.115212
   Laine H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-588
   Laschinger HKS, 2015, J NURS MANAGE, V23, P252, DOI 10.1111/jonm.12122
   Laschinger HKS, 2014, EUR J WORK ORGAN PSY, V23, P739, DOI 10.1080/1359432X.2013.804646
   Laschinger HKS, 2012, INT J NURS STUD, V49, P282, DOI 10.1016/j.ijnurstu.2011.09.004
   Laschinger HKS, 2010, J ADV NURS, V66, P2732, DOI 10.1111/j.1365-2648.2010.05420.x
   Law R, 2011, ACCIDENT ANAL PREV, V43, P1782, DOI 10.1016/j.aap.2011.04.010
   Lee RT, 2006, EUR J WORK ORGAN PSY, V15, P352, DOI 10.1080/13594320600636531
   Lereya ST, 2015, LANCET PSYCHIAT, V2, P524, DOI 10.1016/S2215-0366(15)00165-0
   Lopresti AL, 2013, J AFFECT DISORDERS, V148, P12, DOI 10.1016/j.jad.2013.01.014
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Malik S., 2014, WORLD J MED SCI, V10, P43
   Malinauskiene V, 2014, INT J OCCUP MED ENV, V27, P919, DOI 10.2478/s13382-014-0328-y
   Mathisen GE, 2008, SCAND J PSYCHOL, V49, P59, DOI 10.1111/j.1467-9450.2007.00602.x
   Matthiesen SB, 2004, BRIT J GUID COUNS, V32, P335, DOI 10.1080/03069880410001723558
   McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X
   McTernan WP, 2013, WORK STRESS, V27, P321, DOI 10.1080/02678373.2013.846948
   Mikkelsen EG, 2002, SCAND J PSYCHOL, V43, P397, DOI 10.1111/1467-9450.00307
   Mikkelsen EG, 2001, EUROPEAN J WORK ORG, V10, P393, DOI DOI 10.1080/13594320143000816
   Moreno-Jimenez B, 2007, PSYCHOL SPAIN, P85
   Moreno-Jimenez B, 2009, PERS INDIV DIFFER, V46, P359, DOI 10.1016/j.paid.2008.10.031
   Niedhammer I, 2014, OCC MED
   Niedhammer I, 2006, J PSYCHOSOM RES, V61, P251, DOI 10.1016/j.jpsychores.2006.03.051
   Nielsen MB, 2008, J OCCUP HEALTH PSYCH, V13, P128, DOI 10.1037/1076-8998.13.2.128
   Nielsen Morten Birkeland, 2014, Tidsskr Nor Laegeforen, V134, P1233, DOI 10.4045/tidsskr.13.0880
   Nielsen MB, 2015, AGGRESS VIOLENT BEH, V21, P17, DOI 10.1016/j.avb.2015.01.001
   Nielsen MB, 2013, INT ARCH OCC ENV HEA, V86, P875, DOI 10.1007/s00420-012-0825-x
   Nielsen MB, 2012, WORK STRESS, V26, P309, DOI 10.1080/02678373.2012.734709
   Nielsen MB, 2012, SCAND J WORK ENV HEA, V38, P38, DOI 10.5271/sjweh.3178
   Nurius PS, 2015, CHILD ABUSE NEGLECT, V45, P143, DOI 10.1016/j.chiabu.2015.03.008
   Ortega A, 2011, J NURS MANAGE, V19, P752, DOI 10.1111/j.1365-2834.2010.01179.x
   Ortega A, 2009, INT ARCH OCC ENV HEA, V82, P417, DOI 10.1007/s00420-008-0339-8
   Quine L, 2003, CAMB Q HEALTHC ETHIC, V12, P91, DOI 10.1017/S0963180103121111
   Quine L, 1999, BRIT MED J, V318, P228
   Reijntjes A, 2010, CHILD ABUSE NEGLECT, V34, P244, DOI 10.1016/j.chiabu.2009.07.009
   Reknes I, 2014, INT J NURS STUD, V51, P479, DOI 10.1016/j.ijnurstu.2013.06.017
   Rodriguez-Munoz A, 2011, BEHAV PSYCHOL, V19, P453
   Rodriguez-Tobon A, 2015, RECIPROCAL RELATIONS, V0, P1
   Rodwell J, 2012, INT NURS REV, V59, P539, DOI 10.1111/j.1466-7657.2012.01018.x
   Rodwell J, 2012, HEALTH CARE MANAGE R, V37, P329, DOI 10.1097/HMR.0b013e31823dc2ec
   Rugulies R, 2012, SCAND J WORK ENV HEA, V38, P218, DOI 10.5271/sjweh.3278
   RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x
   Sa Luis, 2008, Issues Ment Health Nurs, V29, P411, DOI 10.1080/01612840801904480
   Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36
   Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27
   Tepper BJ, 2000, ACAD MANAGE J, V43, P178, DOI 10.2307/1556375
   Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014
   Trepanier SG, 2013, WORK STRESS, V27, P123, DOI 10.1080/02678373.2013.782158
   Tuckey MR, 2014, J OCCUP HEALTH PSYCH, V19, P413, DOI 10.1037/a0037728
   van Veen T, 2013, J AFFECT DISORDERS, V146, P238, DOI 10.1016/j.jad.2012.09.011
   Verkuil B., 2010, J EXPT PSYCHOPATHOLO, V1, P87, DOI DOI 10.5127/JEP.009110
   Vie TL, 2011, J PSYCHOSOM RES, V70, P37, DOI 10.1016/j.jpsychores.2010.06.007
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Wells G., 2014, THE NEWCASTLE OTTAWA
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
   Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018
   Wolke D, 2013, PSYCHOL SCI, V24, P1958, DOI 10.1177/0956797613481608
NR 103
TC 52
Z9 53
U1 4
U2 90
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 25
PY 2015
VL 10
IS 8
AR e0135225
DI 10.1371/journal.pone.0135225
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CP6KK
UT WOS:000359995500017
PM 26305785
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, ML
   Wu, L
   Ming, QS
AF Liu, Mingli
   Wu, Lang
   Ming, Qingsen
TI How Does Physical Activity Intervention Improve Self-Esteem and
   Self-Concept in Children and Adolescents? Evidence from a Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID BODY-COMPOSITION; OVERWEIGHT CHILDREN; PUBLIC-HEALTH; DEPRESSION;
   EXERCISE; PROGRAM; ANXIETY; PARTICIPATION; VALIDATION; SYMPTOMS
AB Objective
   To perform a systematic review and meta-analysis for the effects of physical activity intervention on self-esteem and self-concept in children and adolescents, and to identify moderator variables by meta-regression. Design A meta-analysis and meta-regression.
   Method
   Relevant studies were identified through a comprehensive search of electronic databases. Study inclusion criteria were: (1) intervention should be supervised physical activity, (2) reported sufficient data to estimate pooled effect sizes of physical activity intervention on self-esteem or self-concept, (3) participants' ages ranged from 3 to 20 years, and (4) a control or comparison group was included. For each study, study design, intervention design and participant characteristics were extracted. R software (version 3.1.3) and Stata (version 12.0) were used to synthesize effect sizes and perform moderation analyses for determining moderators.
   Results
   Twenty-five randomized controlled trial (RCT) studies and 13 non-randomized controlled trial (non-RCT) studies including a total of 2991 cases were identified. Significant positive effects were found in RCTs for intervention of physical activity alone on general self outcomes (Hedges' g = 0.29, 95% confidence interval [CI]: 0.14 to 0.45; p = 0.001), self-concept (Hedges' g = 0.49, 95% CI: 0.10 to 0.88, p = 0.014) and self-worth (Hedges' g = 0.31, 95% CI: 0.13 to 0.49, p = 0.005). There was no significant effect of intervention of physical activity alone on any outcomes in non-RCTs, as well as in studies with intervention of physical activity combined with other strategies. Meta-regression analysis revealed that higher treatment effects were associated with setting of intervention in RCTs (beta = 0.31, 95% CI: 0.07 to 0.55, p = 0.013).
   Conclusion
   Intervention of physical activity alone is associated with increased self-concept and self-worth in children and adolescents. And there is a stronger association with school-based and gymnasium-based intervention compared with other settings.
C1 [Liu, Mingli; Ming, Qingsen] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha 410011, Hunan, Peoples R China.
   [Liu, Mingli] Hunan Univ Sci & Technol, Sch Educ, Xiangtan 411201, Hunan, Peoples R China.
   [Wu, Lang] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN 55905 USA.
RP Liu, ML (reprint author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha 410011, Hunan, Peoples R China.
EM mlliupsy@163.com
RI Wu, Lang/M-4053-2017
FU Hunan Provincial Education Department [914 \ B41120]
FX This research was supported by Scientific Research Fund of Hunan
   Provincial Education Department (grant number 914 vertical bar B41120)
   (URL: http://gov.hnedu.cn/). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107
   ALPERT B, 1990, HEALTH PSYCHOL, V9, P48, DOI 10.1037/0278-6133.9.1.48
   Annesi JJ, 2006, J PSYCHOSOM RES, V61, P515, DOI 10.1016/j.jpsychores.2006.04.009
   Atlas WHO, 2005, CHILD AD MENT HLTH R
   Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006
   Baumeister R. F., 1998, HDB SOCIAL PSYCHOL, P680
   BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x
   Borenstein M., 2009, INTRO METAANALYSIS
   Brown HE, 2013, SPORTS MED, V43, P195, DOI 10.1007/s40279-012-0015-8
   Buffart LM, 2014, J SCI MED SPORT, V17, P67, DOI 10.1016/j.jsams.2013.02.015
   Butler R. J., 2005, CHILD ADOLESCENT MEN, V4, P190, DOI DOI 10.1111/J.1475-3588.2005.00368.X
   CAMPBELL JD, 1990, J PERS SOC PSYCHOL, V59, P538, DOI 10.1037/0022-3514.59.3.538
   CROCKER J, 1989, PSYCHOL REV, V96, P608, DOI 10.1037/0033-295X.96.4.608
   Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766
   Dishman R, 1986, MENTAL HLTH, P303
   DISHMAN RK, 1995, QUEST, V47, P362, DOI 10.1080/00336297.1995.10484164
   Dishman RK, 2006, HEALTH PSYCHOL, V25, P396, DOI 10.1037/0278-6133.25.3.396
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ekeland E, 2005, BRIT J SPORT MED, V39, P792, DOI 10.1136/bjsm.2004.017707
   Green JPHaS, 2008, COCHRANE HDB SYSTEMA
   Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D
   Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HILYER JC, 1982, J COUNS PSYCHOL, V29, P292, DOI 10.1037/0022-0167.29.3.292
   Hoagwood K, 2003, J SCHOOL PSYCHOL, V41, P3, DOI 10.1016/S0022-4405(02)00141-3
   Holley J, 2011, BRIT J CLIN PSYCHOL, V50, P84, DOI 10.1348/014466510X496220
   Hutzler Y, 1998, PERCEPT MOTOR SKILL, V86, P111, DOI 10.2466/pms.1998.86.1.111
   IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25
   Jelalian E, 2011, CHILD HEALTH CARE, V40, P197, DOI 10.1080/02739615.2011.590391
   Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2
   Lee A, 2009, J CLIN CHILD ADOLESC, V38, P219, DOI 10.1080/15374410802698396
   Lubans DR, 2010, PSYCHOL SPORT EXERC, V11, P497, DOI 10.1016/j.psychsport.2010.06.009
   Marsh HW, 1990, EDUC PSYCHOL REV, V2, P77, DOI 10.1007/BF01322177
   Mazzoni ER, 2009, ADAPT PHYS ACT Q, V26, P259, DOI 10.1123/apaq.26.3.259
   McGee R, 2000, J ADOLESCENCE, V23, P569, DOI 10.1006/jado.2000.0344
   McGee R, 2001, J ABNORM CHILD PSYCH, V29, P281, DOI 10.1023/A:1010353711369
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105
   O'Brien E, 2006, SELF ESTEEM ISSUES A, P306
   Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695
   Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013
   PERCY LE, 1981, PERCEPT MOTOR SKILL, V52, P42, DOI 10.2466/pms.1981.52.1.42
   Robinson TN, 2010, ARCH PEDIAT ADOL MED, V164, P995, DOI 10.1001/archpediatrics.2010.197
   Rosenberg M, 1985, SELF CONCEPT PSYCHOL, P205
   Schranz N, 2014, BRIT J SPORT MED, V48, P1482, DOI 10.1136/bjsports-2013-092209
   Seabra AC, 2014, SCAND J MED SCI SPOR, V24, P10, DOI 10.1111/sms.12268
   SHAVELSON RJ, 1976, REV EDUC RES, V46, P407, DOI 10.2307/1170010
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Staiano AE, 2013, OBESITY, V21, P598, DOI [10.1002/oby.20282, 10.1038/oby.2012.143]
   Trzesniewski KH, 2006, DEV PSYCHOL, V42, P381, DOI 10.1037/0012-1649.42.2.381
   Van Wely L, 2014, CLIN REHABIL, V28, P972, DOI 10.1177/0269215513500971
   Velez A, 2010, J STRENGTH COND RES, V24, P1065, DOI 10.1519/JSC.0b013e3181cc230a
   Weintraub DL, 2008, ARCH PEDIAT ADOL MED, V162, P232, DOI 10.1001/archpediatrics.2007.43
NR 56
TC 53
Z9 53
U1 8
U2 126
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 4
PY 2015
VL 10
IS 8
AR e0134804
DI 10.1371/journal.pone.0134804
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO1VB
UT WOS:000358942700068
PM 26241879
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lin, CJ
   Wu, V
   Wu, PC
   Wu, CJ
AF Lin, Cheng-Jui
   Wu, Vincent
   Wu, Pei-Chen
   Wu, Chih-Jen
TI Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl
   Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in
   Patients with Chronic Renal Failure
SO PLOS ONE
LA English
DT Article
ID CHRONIC KIDNEY-DISEASE; BOUND UREMIC TOXINS; ELDERLY
   HEMODIALYSIS-PATIENTS; PUBLICATION BIAS; CLINICAL-OUTCOMES; RISK-FACTOR;
   PROTEIN; DIALYSIS; SOLUTES; STAGE
AB Background
   Indoxyl sulfate (IS) and p-cresyl sulfate (PCS) are protein-bound uremic toxins that increase in the sera of patients with chronic kidney disease (CKD), and are not effectively removed by dialysis. The purpose of this meta-analysis was to investigate the relationships of PCS and IS with cardiovascular events and all-cause mortality in patients with CKD stage 3 and above.
   Methodology/Principle Findings
   Medline, Cochrane, and EMBASE databases were searched until January 1, 2014 with combinations of the following keywords: chronic renal failure, end-stage kidney disease, uremic toxin, uremic retention, indoxyl sulfate, p-cresyl sulfate. Inclusion criteria were: 1) Patients with stage 1 to 5 CKD; 2) Prospective study; 3) Randomized controlled trial; 4) English language publication. The associations between serum levels of PCS and IS and the risks of all-cause mortality and cardiovascular events were the primary outcome measures. Of 155 articles initially identified, 10 prospective and one cross-sectional study with a total 1,572 patients were included. Free PCS was significantly associated with all-cause mortality among patients with chronic renal failure (pooled OR = 1.16, 95% CI = 1.03 to 1.30, P = 0.013). An elevated free IS level was also significantly associated with increased risk of all-cause mortality (pooled OR = 1.10, 95% CI = 1.03 to 1.17, P = 0.003). An elevated free PCS level was significantly associated with an increased risk of cardiovascular events among patients with chronic renal failure (pooled OR = 1.28, 95% CI = 1.10 to 1.50, P = 0.002), while free IS was not significantly associated with risk of cardiovascular events ( pooled OR = 1.05, 95% CI = 0.98 to 1.13, P = 0.196).
   Conclusions/Significance
   Elevated levels of PCS and IS are associated with increased mortality in patients with CKD, while PCS, but not IS, is associated with an increased risk of cardiovascular events.
C1 [Lin, Cheng-Jui; Wu, Pei-Chen; Wu, Chih-Jen] Mackay Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.
   [Lin, Cheng-Jui] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan.
   [Wu, Vincent] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan.
   [Wu, Chih-Jen] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.
   [Wu, Chih-Jen] Mackay Med Coll, Dept Med, New Taipei City, Taiwan.
RP Wu, CJ (reprint author), Mackay Mem Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.
EM wcjyali@yahoo.com.tw
OI WU, VIN-CENT/0000-0001-7935-0991
CR Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115
   Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609
   Chen TC, 2012, KIDNEY BLOOD PRESS R, V35, P583, DOI 10.1159/000339709
   CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701
   Dai WM, 2013, CHINESE MED J-PEKING, V126, P1957, DOI 10.3760/cma.j.issn.0366-6999.20130391
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Huang ST, 2012, TRANSPL P, V44, P621, DOI 10.1016/j.transproceed.2011.11.023
   Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665
   Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3
   Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008
   Levin A, 2000, AM J KIDNEY DIS, V36, pS24, DOI 10.1053/ajkd.2000.19928
   Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592
   Lin CJ, 2014, BIOMED RES INT, DOI 10.1155/2014/526932
   Lin CJ, 2013, ARCH MED RES, V44, P535, DOI 10.1016/j.arcmed.2013.09.007
   Lin CJ, 2013, ARCH MED SCI, V9, P662, DOI 10.5114/aoms.2013.36901
   Lin CJ, 2012, ARCH MED RES, V43, P451, DOI [10.1016/j.aremed.2012.08.002, 10.1016/j.arcmed.2012.08.002]
   Lin CJ, 2011, J CLIN LAB ANAL, V25, P191, DOI 10.1002/jcla.20456
   Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251
   Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.IE
   Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109
   Melamed ML, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-134
   Meyer TW, 2012, KIDNEY INT, V81, P949, DOI 10.1038/ki.2011.504
   Neirynck N, 2013, BLOOD PURIFICAT, V35, P45, DOI 10.1159/000346223
   Poesen R, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-87
   Poveda J, 2014, NEPHROL DIAL TRANSPL, V29, P56, DOI 10.1093/ndt/gft367
   Rossi M, 2014, NUTR METAB CARDIOVAS, V24, P1035, DOI 10.1016/j.numecd.2014.04.006
   Rossi M, 2014, ARCH MED RES, V45, P309, DOI 10.1016/j.arcmed.2014.04.002
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   Sutton AJ, 2000, STAT METHODS MED RES, V9, P421, DOI 10.1191/096228000701555244
   Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813
   Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062
   Viaene L, 2013, BIOPHARM DRUG DISPOS, V34, P165, DOI 10.1002/bdd.1834
   Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2
   Wu IW, 2012, NEPHROL DIAL TRANSPL, V27, P1169, DOI 10.1093/ndt/gfr453
   Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580
NR 39
TC 104
Z9 106
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 14
PY 2015
VL 10
IS 7
AR e0132589
DI 10.1371/journal.pone.0132589
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1QN
UT WOS:000358194900062
PM 26173073
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Song, YZ
   Han, FJ
   Liu, M
   Xia, CC
   Shi, WY
   Dong, LH
AF Song, Yu-Zhe
   Han, Fu-Jun
   Liu, Min
   Xia, Cheng-Cheng
   Shi, Wei-Yan
   Dong, Li-Hua
TI Association between Single Nucleotide Polymorphisms in XRCC3 and
   Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; BREAST-CANCER RISK; DOUBLE-STRAND BREAKS;
   DNA-REPAIR; THR241MET POLYMORPHISM; GENETIC POLYMORPHISMS;
   HEPATOCELLULAR-CARCINOMA; ERECTILE DYSFUNCTION; EPIGENETIC FEATURES;
   PROTEIN-KINASE
AB The X-ray repair cross-complementing group 3 (XRCC3) protein plays an important role in the repair of DNA double-strand breaks. The relationship between XRCC3 polymorphisms and the risk of radiation-induced adverse effects on normal tissue remains inconclusive. Thus, we performed a meta-analysis to elucidate the association between XRCC3 polymorphisms and radiation-induced adverse effects on normal tissue. All eligible studies up to December 2014 were identified through a search of the PubMed, Embase and Web of Science databases. Seventeen studies involving 656 cases and 2193 controls were ultimately included in this meta-analysis. The pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated to evaluate the association between XRCC3 polymorphisms and the risk of radiation-induced normal tissue adverse effects. We found that the XRCC3 p.Thr241Met (rs861539) polymorphism was significantly associated with early adverse effects induced by radiotherapy (OR = 1.99, 95% CI: 1.31-3.01, P = 0.001). A positive association lacking statistical significance with late adverse effects was also identified (OR = 1.28, 95% CI: 0.97-1.68, P = 0.08). In addition, the rs861539 polymorphism was significantly correlated with a higher risk of adverse effects induced by head and neck area irradiation (OR = 2.41, 95% CI: 1.49-3.89, p = 0.0003) and breast irradiation (OR = 1.41, 95% CI: 1.02-1.95, p = 0.04), whereas the correlation was not significant for lung irradiation or pelvic irradiation. Furthermore, XRCC3 rs1799794 polymorphism may have a protective effect against late adverse effects induced by radiotherapy (OR = 0.47, 95% CI: 0.26-0.86, P = 0.01). Well-designed large-scale clinical studies are required to further validate our results.
C1 [Song, Yu-Zhe; Liu, Min; Xia, Cheng-Cheng; Shi, Wei-Yan; Dong, Li-Hua] Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130023, Jilin, Peoples R China.
   [Han, Fu-Jun] Jilin Univ, Hosp 1, Ctr Canc, Changchun 130023, Jilin, Peoples R China.
RP Dong, LH (reprint author), Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130023, Jilin, Peoples R China.
EM songyz37@126.com
CR Allen C, 2002, P NATL ACAD SCI USA, V99, P3758, DOI 10.1073/pnas.052545899
   Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1
   Alsner J, 2008, SEMIN RADIAT ONCOL, V18, P126, DOI 10.1016/j.semradonc.2007.10.004
   Andreassen CN, 2012, RADIOTHER ONCOL, V105, P337, DOI 10.1016/j.radonc.2012.11.004
   Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010
   Andreassen CN, 2002, RADIOTHER ONCOL, V64, P131, DOI 10.1016/S0167-8140(02)00154-8
   Andreassen CN, 2005, ACTA ONCOL, V44, P801, DOI 10.1080/02841860500374513
   Araujo FD, 2002, ONCOGENE, V21, P4176, DOI 10.1038/sj.onc.1205539
   Azria D, 2008, CLIN CANCER RES, V14, P6284, DOI 10.1158/1078-0432.CCR-08-0700
   Barnett GC, 2014, RADIOTHER ONCOL, V111, P178, DOI 10.1016/j.radonc.2014.02.012
   Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bentzen SM, 2003, SEMIN RADIAT ONCOL, V13, P189, DOI 10.1016/S1053-4296(03)00036-5
   Bourguignon MH, 2005, EUR J NUCL MED MOL I, V32, P351, DOI 10.1007/s00259-004-1731-6
   Bourguignon MH, 2005, EUR J NUCL MED MOL I, V32, P229, DOI 10.1007/s00259-004-1730-7
   Brenneman MA, 2002, MOL CELL, V10, P387, DOI 10.1016/S1097-2765(02)00595-6
   Burri RJ, 2008, RADIAT RES, V170, P49, DOI 10.1667/RR1219.1
   Chang-Claude J, 2009, BRIT J CANCER, V100, P1680, DOI 10.1038/sj.bjc.6605036
   Cheuk IWY, 2014, MOL CLIN ONCOL, V2, P553, DOI 10.3892/mco.2014.276
   De Ruyck K, 2005, INT J RADIAT ONCOL, V62, P1140, DOI 10.1016/j.ijrobp.2004.12.027
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dikomey E, 1998, INT J RADIAT BIOL, V73, P269, DOI 10.1080/095530098142365
   Du L, 2014, TUMOR BIOL, V35, P1371, DOI 10.1007/s13277-013-1187-z
   Duan CY, 2013, TUMOR BIOL, V34, P2827, DOI 10.1007/s13277-013-0841-9
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fachal L, 2014, NAT GENET, V46, P891, DOI 10.1038/ng.3020
   Fachal L, 2012, RADIOTHER ONCOL, V105, P321, DOI 10.1016/j.radonc.2012.09.013
   Fahmideh MA, 2014, NEURO-ONCOLOGY, V16, P807, DOI 10.1093/neuonc/nou003
   Falvo E, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-7
   Falvo E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-291
   Fang F, 2011, MED ONCOL, V28, P999, DOI 10.1007/s12032-010-9591-3
   Fernet M, 2004, DNA REPAIR, V3, P1237, DOI 10.1016/j.dnarep.2004.03.019
   Ghazali N, 2012, ORAL ONCOL, V48, P1090, DOI 10.1016/j.oraloncology.2012.08.002
   Haber JE, 2000, PARTNERS PATHWAYS, P259
   He XF, 2012, MOL BIOL REP, V39, P5125, DOI 10.1007/s11033-011-1308-y
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Ho AY, 2006, INT J RADIAT ONCOL, V65, P646, DOI 10.1016/j.ijrobp.2006.03.006
   Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687
   Kerns SL, 2013, RADIOTHER ONCOL, V107, P372, DOI 10.1016/j.radonc.2013.05.001
   Kerns SL, 2013, J UROLOGY, V190, P102, DOI 10.1016/j.juro.2013.01.096
   Kerns SL, 2013, INT J RADIAT ONCOL, V85, pE21, DOI 10.1016/j.ijrobp.2012.08.003
   Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036
   Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384
   LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602
   Liang HJ, 2013, ASIAN PAC J CANCER P, V14, P4243, DOI 10.7314/APJCP.2013.14.7.4243
   Liu L, 2013, MOL BIOL REP, V40, P3943, DOI 10.1007/s11033-012-2471-5
   Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7
   Liu Y, 2015, J CELL PHYSIOL, V230, P1094, DOI 10.1002/jcp.24841
   Ma QT, 2014, TUMOR BIOL, V35, P1473, DOI 10.1007/s13277-013-1203-3
   Mangoni M, 2011, INT J RADIAT ONCOL, V81, P52, DOI 10.1016/j.ijrobp.2010.04.023
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Mao CF, 2014, ASIAN PAC J CANCER P, V15, P6613, DOI 10.7314/APJCP.2014.15.16.6613
   Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437
   Peng QL, 2014, TUMOR BIOL, V35, P1933, DOI 10.1007/s13277-013-1259-0
   Popanda O, 2006, CANCER EPIDEM BIOMAR, V15, P1048, DOI 10.1158/1055-9965.EPI-06-0046
   Pratesi N, 2011, RADIOTHER ONCOL, V99, P356, DOI 10.1016/j.radonc.2011.05.062
   Qin LY, 2013, ASIAN PAC J CANCER P, V14, P6703, DOI 10.7314/APJCP.2013.14.11.6703
   Qiu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077005
   Raabe A, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-65
   Rosenstein BS, 2014, INT J RADIAT ONCOL, V89, P709, DOI 10.1016/j.ijrobp.2014.03.009
   ROTH DB, 1985, P NATL ACAD SCI USA, V82, P3355, DOI 10.1073/pnas.82.10.3355
   Rube CE, 2008, INT J RADIAT ONCOL, V72, P1180, DOI 10.1016/j.ijrobp.2008.07.017
   Sakano S, 2010, PHARMACOGENOMICS, V11, P1377, DOI [10.2217/pgs.10.106, 10.2217/PGS.10.106]
   Shen MR, 1998, CANCER RES, V58, P604
   Shen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069553
   Sterpone S, 2010, J CANCER RES CLIN, V136, P631, DOI 10.1007/s00432-010-0791-1
   Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4
   Tucker SL, 2013, INT J RADIAT ONCOL, V85, P251, DOI 10.1016/j.ijrobp.2012.02.021
   Wang Z, 2014, TUMOR BIOL, V35, P1589, DOI 10.1007/s13277-013-1219-8
   Wang ZZ, 2013, TUMOR BIOL, V34, P1421, DOI 10.1007/s13277-012-0639-1
   Werbrouck J, 2009, INT J RADIAT ONCOL, V73, P1187, DOI 10.1016/j.ijrobp.2008.08.073
   Wu D, 2013, TUMOR BIOL, V34, P3865, DOI 10.1007/s13277-013-0973-y
   Yin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020055
   Zou Y, 2014, JPN J CLIN ONCOL, V44, P241, DOI 10.1093/jjco/hyt202
NR 76
TC 7
Z9 7
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2015
VL 10
IS 6
AR e0130388
DI 10.1371/journal.pone.0130388
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL3FE
UT WOS:000356835000111
PM 26091483
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pletzer, JL
   Nikolova, R
   Kedzior, KK
   Voelpel, SC
AF Pletzer, Jan Luca
   Nikolova, Romina
   Kedzior, Karina Karolina
   Voelpel, Sven Constantin
TI Does Gender Matter? Female Representation on Corporate Boards and Firm
   Financial Performance - A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ETHNIC DIVERSITY; ROLE AMBIGUITY; ROLE-CONFLICT; WOMEN; IMPACT;
   MANAGEMENT; LEADERSHIP; TEAM; GOVERNANCE; DIRECTORS
AB In recent years, there has been an ongoing, worldwide debate about the representation of females in companies. Our study aimed to meta-analytically investigate the controversial relationship between female representation on corporate boards and firm financial performance. Following a systematic literature search, data from 20 studies on 3097 companies published in peer-reviewed academic journals were included in the meta-analysis. On average, the boards consisted of eight members and female participation was low (mean 14%) in all studies. Half of the 20 studies were based on data from developing countries and 62% from higher income countries. According to the random-effects model, the overall mean weighted correlation between percentage of females on corporate boards and firm performance was small and non-significant (r = .01, 95% confidence interval: - .04, .07). Similar small effect sizes were observed when comparing studies based on developing vs. developed countries and higher vs. lower income countries. The mean board size was not related to the effect sizes in studies. These results indicate that the mere representation of females on corporate boards is not related to firm financial performance if other factors are not considered. We conclude our study with a discussion of its implications and limitations.
C1 [Pletzer, Jan Luca; Voelpel, Sven Constantin] Jacobs Univ Bremen, Focus Area Div, D-28759 Bremen, Germany.
   [Pletzer, Jan Luca] Vrije Univ Amsterdam, Social & Org Psychol, Amsterdam, Netherlands.
   [Nikolova, Romina] Katholieke Univ Leuven, Leuven, Belgium.
   [Nikolova, Romina; Kedzior, Karina Karolina; Voelpel, Sven Constantin] Jacobs Univ Bremen, BIGSSS, D-28759 Bremen, Germany.
   [Kedzior, Karina Karolina] Univ Bremen, Inst Psychol & Transfer, D-28359 Bremen, Germany.
RP Pletzer, JL (reprint author), Jacobs Univ Bremen, Focus Area Div, D-28759 Bremen, Germany.
EM j.pletzer@jacobs-university.de
RI Pletzer, Jan Luca/I-5632-2019; Voelpel, Sven/C-7227-2014
OI Pletzer, Jan Luca/0000-0002-8313-4447; Voelpel, Sven/0000-0002-7808-3227
CR *Abdillahi UA, 2013, INTERNATIONAL JOURNA, V3, P159
   ABRAMS D, 1990, BRIT J SOC PSYCHOL, V29, P87, DOI 10.1111/j.2044-8309.1990.tb00889.x
   Ahern KR, 2012, Q J ECON, V127, P137, DOI 10.1093/qje/qjr049
   Ali M, 2014, J BUS ETHICS, V125, P497, DOI 10.1007/s10551-013-1930-9
   Amason AC, 1996, ACAD MANAGE J, V39, P123, DOI 10.2307/256633
   Bassett-Jones N., 2005, CREATIVITY INNOVATIO, V14, P169, DOI [DOI 10.1111/J.1467-8691.00337.X, 10.1111/j.1467-8691.00337.x]
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bertrand M, 2003, Q J ECON, V118, P1169, DOI 10.1162/003355303322552775
   Bohren O, 2014, J CORP FINANC, V28, P152, DOI 10.1016/j.jcorpfin.2013.12.005
   Borenstein M, 2009, INTRODUCTION TO META
   Brammer S, 2007, CORP GOV, V15, P393, DOI 10.1111/j.1467-8683.2007.00569.x
   Campbell K, 2008, J BUS ETHICS, V83, P435, DOI 10.1007/s10551-007-9630-y
   Carpenter MA, 2001, ACAD MANAGE J, V44, P639, DOI 10.2307/3069408
   Carter DA, 2010, CORP GOV-OXFORD, V18, P396, DOI 10.1111/j.1467-8683.2010.00809.x
   Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007
   Cohen J., 1988, STATISTICAL POWER AN
   Conyon M., 1998, EUROPEAN J FINANCE, V4, P291, DOI [10.1080/135184798337317, DOI 10.1080/135184798337317]
   Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448
   Dale-Olsen H, 2013, FEM ECON, V19, P110, DOI 10.1080/13545701.2013.830188
   DARMADI S, 2011, CORPORATE OWNERSHIP, V9, P524
   Dechant K., 1997, ACAD MANAGEMENT EXEC, V11, P21, DOI [10.5465/AME.1997.9709231661, DOI 10.5465/AME.1997.9709231661]
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eagly AH, 2003, PSYCHOL BULL, V129, P569, DOI 10.1037/0033-2909.129.4.569
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Farrell KA, 2005, J CORP FINANC, V11, P85, DOI 10.1016/j.jcorpfin.2003.12.001
   Fondas N., 2000, GLOBAL FOCUS, V12, P13
   Galbreath J, 2011, J MANAGE ORGAN, V17, P17
   Garba T, 2014, ASIAN EC FINANCIAL R, V4, P257
   Gardiner M, 1999, J OCCUP ORGAN PSYCH, V72, P301, DOI 10.1348/096317999166699
   Haslam SA, 2010, BRIT J MANAGE, V21, P484, DOI 10.1111/j.1467-8551.2009.00670.x
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   JACKSON SE, 1985, ORGAN BEHAV HUM DEC, V36, P16, DOI 10.1016/0749-5978(85)90020-2
   Jackson SE, 2003, J MANAGE, V29, P801, DOI 10.1016/S0149-2063(03)00080-1
   Jackson SE, 1995, TEAM EFFECTIVENESS D, V204, P261
   Jehn KA, 1999, ADMIN SCI QUART, V44, P741, DOI 10.2307/2667054
   Jianakoplos NA, 1998, ECON INQ, V36, P620, DOI 10.1111/j.1465-7295.1998.tb01740.x
   Joecks J, 2013, J BUS ETHICS, V118, P61, DOI 10.1007/s10551-012-1553-6
   Julizaerma MK, 2012, PROCD SOC BEHV, V65, P1077, DOI 10.1016/j.sbspro.2012.11.374
   KANTER RM, 1977, AM J SOCIOL, V82, P965, DOI 10.1086/226425
   Knight D, 1999, STRATEGIC MANAGE J, V20, P445, DOI 10.1002/(SICI)1097-0266(199905)20:5<445::AID-SMJ27>3.0.CO;2-V
   Kochan T, 2003, HUM RESOURCE MANAGE, V42, P3, DOI 10.1002/hrm.10061
   Koenig AM, 2011, PSYCHOL BULL, V137, P616, DOI 10.1037/a0023557
   *Kyereboah-Coleman A, 2006, J STUDIES EC ECONOME, V30, P19
   Luckerath-Rovers M, 2013, J MANAG GOV, V17, P491, DOI 10.1007/s10997-011-9186-1
   Mahadeo JD, 2012, J BUS ETHICS, V105, P375, DOI 10.1007/s10551-011-0973-z
   Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010
   McLeod PL, 1996, SMALL GR RES, V27, P248, DOI 10.1177/1046496496272003
   Miller T, 2009, J MANAGE STUD, V46, P755, DOI 10.1111/j.1467-6486.2009.00839.x
   Milliken FJ, 1996, ACAD MANAGE REV, V21, P402, DOI 10.2307/258667
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Pande R, 2011, WORLD DEVELOPMENT RE
   Pathan S, 2013, J BANK FINANC, V37, P1573, DOI 10.1016/j.jbankfin.2012.12.016
   Post C, 2015, ACAD MANAGE J, V58, P1546, DOI 10.5465/amj.2013.0319
   Richard OC, 2004, ACAD MANAGE J, V47, P255, DOI 10.2307/20159576
   Rodriguez-Dominguez L, 2012, EUR J LAW ECON, V33, P603, DOI 10.1007/s10657-010-9144-4
   Rose C, 2007, CORP GOV-OXFORD, V15, P404, DOI 10.1111/j.1467-8683.2007.00570.x
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Sanders WG, 1998, ACAD MANAGE J, V41, P158, DOI 10.2307/257100
   Shafique Y, 2014, EUROPEAN J BUSINESS, V6, P296
   Shukeri S.N., 2012, INT BUSINESS RES, V5, P120, DOI DOI 10.5539/IBR.V5N9P120
   Strom RO, 2014, J BANK FINANC, V42, P60, DOI 10.1016/j.jbankfin.2014.01.014
   Tajfel HE, 1978, DIFFERENTIATION BETW
   Terjesen S, 2008, J BUS ETHICS, V83, P55, DOI 10.1007/s10551-007-9656-1
   Terjesen S, 2009, CORP GOV-OXFORD, V17, P320, DOI 10.1111/j.1467-8683.2009.00742.x
   Tubre TC, 2000, J MANAGE, V26, P155, DOI 10.1177/014920630002600104
   Tuggle CS, 2011, FROM SEATS AT THE TA, P1
   United Nations, 2012, WORLD ECONOMIC SITUA, P131
   van Knippenberg D, 2004, J APPL PSYCHOL, V89, P1008, DOI 10.1037/0021-9010.89.6.1008
   Van Ness RK, 2010, ACAD BUSINESS EC J, V10, P56
   WATSON WE, 1993, ACAD MANAGE J, V36, P590, DOI 10.2307/256593
   Webber SS, 2001, J MANAGE, V27, P141, DOI 10.1016/S0149-2063(00)00093-3
   Wellalage NH, 2013, ASIAN J BUS ETHICS, V2, P113, DOI 10.1007/s13520-012-0020-x
   Westphal JD, 2005, ADMIN SCI QUART, V50, P262, DOI 10.2189/asqu.2005.50.2.262
   Williams KY, 1998, RES ORGAN BEHAV, V20, P77
   Zhou Z, 2012, FRONTIERS OF BUSINES, V6, P261
NR 76
TC 31
Z9 31
U1 3
U2 59
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2015
VL 10
IS 6
AR e0130005
DI 10.1371/journal.pone.0130005
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK9NT
UT WOS:000356567500075
PM 26086454
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Iozzino, L
   Ferrari, C
   Large, M
   Nielssen, O
   de Girolamo, G
AF Iozzino, Laura
   Ferrari, Clarissa
   Large, Matthew
   Nielssen, Olav
   de Girolamo, Giovanni
TI Prevalence and Risk Factors of Violence by Psychiatric Acute Inpatients:
   A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID SHORT-TERM PREDICTION; THERAPEUTIC ALLIANCE; INTERPERSONAL STYLE;
   PUBLICATION BIAS; SELF-HARM; AGGRESSION; BEHAVIOR; PATIENT; INCIDENTS;
   GENDER
AB Background
   Violence in acute psychiatric wards affects the safety of other patients and the effectiveness of treatment. However, there is a wide variation in reported rates of violence in acute psychiatric wards.
   Objectives
   To use meta-analysis to estimate the pooled rate of violence in published studies, and examine the characteristics of the participants, and aspects of the studies themselves that might explain the variation in the reported rates of violence (moderators).
   Method
   Systematic meta-analysis of studies published between January 1995 and December 2014, which reported rates of violence in acute psychiatric wards of general or psychiatric hospitals in high-income countries. Results Of the 23,972 inpatients described in 35 studies, the pooled proportion of patients who committed at least one act of violence was 17% (95% confidence interval (CI) 14-20%). Studies with higher proportions of male patients, involuntary patients, patients with schizophrenia and patients with alcohol use disorder reported higher rates of inpatient violence.
   Conclusion
   The findings of this study suggest that almost 1 in 5 patients admitted to acute psychiatric units may commit an act of violence. Factors associated with levels of violence in psychiatric units are similar to factors that are associated with violence among individual patients (male gender, diagnosis of schizophrenia, substance use and lifetime history of violence).
C1 [Iozzino, Laura; Ferrari, Clarissa; de Girolamo, Giovanni] IRCCS Ctr San Giovanni Dio Fatebenefratelli, Psychiat Epidemiol & Evaluat Unit, Brescia, Italy.
   [Iozzino, Laura] Univ Verona, Sect Psychiat, Dept Publ Hlth & Community Med, I-37100 Verona, Italy.
   [Large, Matthew] Prince Wales Hosp Sydney, Sydney, NSW, Australia.
   [Nielssen, Olav] St Vincents Hosp, Sydney, NSW 2010, Australia.
   [Large, Matthew; Nielssen, Olav] Univ New S Wales, Sydney, NSW, Australia.
RP de Girolamo, G (reprint author), IRCCS Ctr San Giovanni Dio Fatebenefratelli, Psychiat Epidemiol & Evaluat Unit, Brescia, Italy.
EM gdegirolamo@fatebenefratelli.it
RI de Girolamo, Giovanni/K-3062-2016; IOZZINO, LAURA/I-8467-2018; Ferrari,
   Clarissa/D-6862-2017
OI de Girolamo, Giovanni/0000-0002-1611-8324; IOZZINO,
   LAURA/0000-0002-3633-8316; Ferrari, Clarissa/0000-0002-4101-6872;
   Nielssen, Olav/0000-0001-5172-2781
CR Abderhalden C, 2006, BMC PSYCHIATRY, V25, P6
   Abderhalden C, 2008, BRIT J PSYCHIAT, V193, P44, DOI 10.1192/bjp.bp.107.045534
   Amore M, 2008, PSYCHIAT CLIN NEUROS, V62, P247, DOI 10.1111/j.1440-1819.2008.01790.x
   Ash D, 2003, INT J SOC PSYCHIATR, V49, P112, DOI 10.1177/0020764003049002004
   Audit Commission, 2001, CHANG HER MAN CHANG
   Barlow K, 2000, AUST NZ J PSYCHIAT, V34, P967, DOI 10.1046/j.1440-1614.2000.00802.x
   Beauford JE, 1997, AM J PSYCHIAT, V154, P1272
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Biancosino B, 2009, J NERV MENT DIS, V197, P772, DOI 10.1097/NMD.0b013e3181bb0d6b
   Bjorkdahl A, 2006, ACTA PSYCHIAT SCAND, V113, P224, DOI 10.1111/j.1600-0447.2005.00679.x
   BLOMHOFF S, 1990, HOSP COMMUNITY PSYCH, V41, P771
   Boggild AK, 2004, CAN J PSYCHIAT, V49, P114, DOI 10.1177/070674370404900206
   BOLLEN KA, 1985, SOCIOL METHOD RES, V13, P510, DOI 10.1177/0049124185013004004
   Bowers L, 2003, SOC PSYCH PSYCH EPID, V38, P402, DOI 10.1007/s00127-003-0648-x
   Bowers L., 2005, J MENTAL HLTH, V14, P625, DOI [10.1080/09638230500389105, DOI 10.1080/09638230500389105]
   Bowers Len, 2009, Issues Ment Health Nurs, V30, P260, DOI 10.1080/01612840802710829
   Budd T., 1999, VIOLENCE WORK FINDIN
   CALDWELL MF, 1992, HOSP COMMUNITY PSYCH, V43, P838
   Carr VJ, 2008, AUST NZ J PSYCHIAT, V42, P267, DOI 10.1080/00048670701881520
   Cohen DP, 2008, PSYCHIATR BULL, V32, P455, DOI 10.1192/pb.bp.107.015412
   Cookson A, 2012, INT J MENT HEALTH NU, V21, P20, DOI 10.1111/j.1447-0349.2011.00764.x
   Cooper CL, 2002, WORKPLACE VIOLENCE H
   Cornaggia CM, 2011, PSYCHIAT RES, V189, P10, DOI 10.1016/j.psychres.2010.12.024
   Dack C, 2013, ACTA PSYCHIAT SCAND, V127, P255, DOI 10.1111/acps.12053
   Daffern M, 2006, INT J MENT HEALTH NU, V15, P93, DOI 10.1111/j.1447-0349.2006.00408.x
   Daffern M, 2010, PSYCHIATRY, V73, P365, DOI 10.1521/psyc.2010.73.4.365
   Dumais Alexandre, 2012, Issues Ment Health Nurs, V33, P670
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Duxbury J, 2002, J Psychiatr Ment Health Nurs, V9, P325, DOI 10.1046/j.1365-2850.2002.00497.x
   Eaton S, 2000, MED SCI LAW, V40, P143, DOI 10.1177/002580240004000210
   Ehmann TS, 2001, J NERV MENT DIS, V189, P716, DOI 10.1097/00005053-200110000-00009
   Fajnzylber P, 2002, J LAW ECON, V45, P1, DOI 10.1086/338347
   Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120
   Fisher William A, 2003, J Psychiatr Pract, V9, P7, DOI 10.1097/00131746-200301000-00003
   Garcia I, 2005, ACUTE CARE 2004 NATL
   Gilbody SM, 2000, ACTA PSYCHIAT SCAND, V102, P241, DOI 10.1034/j.1600-0447.2000.102004241.x
   Grassi L, 2001, ACTA PSYCHIAT SCAND, V104, P273, DOI 10.1034/j.1600-0447.2001.00292.x
   Hartvig P, 2011, EUR PSYCHIAT, V26, P92, DOI 10.1016/j.eurpsy.2010.01.003
   Hatch-Maillette Mary A, 2007, Violence Vict, V22, P449, DOI 10.1891/088667007781553982
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Ketelsen R, 2007, J PSYCHIATR MENT HLT, V14, P92
   Krakowski M, 2004, AM J PSYCHIAT, V161, P459, DOI 10.1176/appi.ajp.161.3.459
   Lam JN, 2000, PSYCHIATR SERV, V51, P1167, DOI 10.1176/appi.ps.51.9.1167
   Large MM, 2008, SOC PSYCH PSYCH EPID, V43, P251, DOI 10.1007/s00127-007-0287-8
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Mauri MC, 2011, PROG NEURO-PSYCHOPH, V35, P1631, DOI 10.1016/j.pnpbp.2011.05.008
   McNiel DE, 2003, J CONSULT CLIN PSYCH, V71, P945, DOI 10.1037/0022-006X.71.5.945
   MCNIEL DE, 1988, AM J PSYCHIAT, V145, P965
   Mellesdal L, 2003, PSYCHOL REP, V92, P1229, DOI 10.2466/pr0.2003.92.3c.1229
   Monahan J., 1983, CRIME JUSTICE ANN RE, V4, P145
   Needham I, 2005, INT J NURS STUD, V42, P649, DOI 10.1016/j.ijnurstu.2004.10.003
   Nielssen O, 2012, PSYCHIAT SERV, V63, P500, DOI 10.1176/appi.ps.201100290
   Nijman H, 2002, ACTA PSYCHIAT SCAND, V105, P390, DOI 10.1034/j.1600-0447.2002.0o426.x
   Nijman HLI, 1997, EUR J PSYCHIAT, V11, P106
   Olofsson B, 2001, J Psychiatr Ment Health Nurs, V8, P357, DOI 10.1046/j.1365-2850.2001.00404.x
   Oulis P, 1996, PSYCHOPATHOLOGY, V29, P174, DOI 10.1159/000284988
   Owen C, 1998, PSYCHIATR SERV, V49, P1452, DOI 10.1176/ps.49.11.1452
   POWELL G, 1994, BRIT J PSYCHIAT, V165, P107, DOI 10.1192/bjp.165.1.107
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Raja M, 1997, SOC PSYCH PSYCH EPID, V32, P428
   Raja M, 2005, CLIN PRACTICE EPIDEM, V29, P1
   Ross J, 2012, J CLIN NURS, V21, P2306, DOI 10.1111/j.1365-2702.2012.04073.x
   Royal College of Nursing, 2005, VIOL SHORT TERM MAN
   Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018
   Saverimuttu A, 2000, Nurs Stand, V14, P33
   Soliman AED, 2001, PSYCHIATR SERV, V52, P75, DOI 10.1176/appi.ps.52.1.75
   Swanson JW, 2006, AM J PSYCHIAT, V163, P1404, DOI 10.1176/appi.ajp.163.8.1404
   Troisi A, 2003, J CLIN PSYCHIAT, V64, P1460, DOI 10.4088/JCP.v64n1210
   Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202
   Vaaler AE, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-44
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Whittington R, 2006, VIOLENCE MENTAL HLTH
NR 73
TC 66
Z9 68
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 10
PY 2015
VL 10
IS 6
AR e0128536
DI 10.1371/journal.pone.0128536
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK1PO
UT WOS:000355979500086
PM 26061796
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Schwendicke, F
   Karimbux, N
   Allareddy, V
   Gluud, C
AF Schwendicke, Falk
   Karimbux, Nadeem
   Allareddy, Veerasathpurush
   Gluud, Christian
TI Periodontal Treatment for Preventing Adverse Pregnancy Outcomes: A Meta-
   and Trial Sequential Analysis
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED-CONTROLLED-TRIAL; LOW-BIRTH-WEIGHT; CONTROLLED
   CLINICAL-TRIAL; STRICT PLAQUE CONTROL; PRETERM BIRTH; THERAPY;
   METAANALYSIS; DISEASE; REDUCE; WOMEN
AB Objectives
   Periodontal treatment might reduce adverse pregnancy outcomes. The efficacy of periodontal treatment to prevent preterm birth, low birth weight, and perinatal mortality was evaluated using meta-analysis and trial sequential analysis.
   Methods
   An existing systematic review was updated and meta-analyses performed. Risk of bias, heterogeneity, and publication bias were evaluated, and meta-regression performed. Subgroup analysis was used to compare different studies with low and high risk of bias and different populations, i.e., risk groups. Trial sequential analysis was used to assess risk of random errors.
   Results
   Thirteen randomized clinical trials evaluating 6283 pregnant women were meta-analyzed. Four and nine trials had low and high risk of bias, respectively. Overall, periodontal treatment had no significant effect on preterm birth (odds ratio [95% confidence interval] 0.79 [0.57-1.10]) or low birth weight (0.69 [0.43-1.13]). Trial sequential analysis demonstrated that futility was not reached for any of the outcomes. For populations with moderate occurrence (<20%) of preterm birth or low birth weight, periodontal treatment was not efficacious for any of the outcomes, and trial sequential analyses indicated that further trials might be futile. For populations with high occurrence (>= 20%) of preterm birth and low birth weight, periodontal treatment seemed to reduce the risk of preterm birth (0.42 [0.24-0.73]) and low birth weight (0.32 [0.15-0.67]), but trial sequential analyses showed that firm evidence was not reached. Periodontal treatment did not significantly affect perinatal mortality, and firm evidence was not reached. Risk of bias, but not publication bias or patients' age modified the effect estimates.
   Conclusions
   Providing periodontal treatment to pregnant women could potentially reduce the risks of perinatal outcomes, especially in mothers with high risks. Conclusive evidence could not be reached due to risks of bias, risks of random errors, and unclear effects of confounding. Further randomized clinical trials are required.
C1 [Schwendicke, Falk] Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany.
   [Karimbux, Nadeem] Tufts Univ, Sch Dent Med, Boston, MA 02111 USA.
   [Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Orthodont, Iowa City, IA 52242 USA.
   [Gluud, Christian] Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Rigshosp, Copenhagen, Denmark.
RP Schwendicke, F (reprint author), Charite, Dept Operat & Prevent Dent, D-13353 Berlin, Germany.
EM falk.schwendicke@charite.de
OI Gluud, Christian/0000-0002-8861-0799
CR Baccaglini L, 2011, J AM DENT ASSOC, V142, P1192, DOI 10.14219/jada.archive.2011.0089
   Boggess KA, 2010, AM J OBSTET GYNECOL, V202, P101, DOI 10.1016/j.ajog.2009.12.018
   Boots AB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.004
   Chambrone L, 2011, J CLIN PERIODONTOL, V38, P902, DOI 10.1111/j.1600-051X.2011.01761.x
   Copenhagen Trial Unit, TSA TRIAL SEQ AN
   Davidoff F, 2001, NEW ENGL J MED, V345, P825, DOI 10.1056/NEJMed20010093
   DeFranco EA, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.015
   DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308
   Deshpande SN, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17400
   Dudley NJ, 2005, ULTRASOUND OBST GYN, V25, P80, DOI 10.1002/uog.1751
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fogacci MF, 2011, OBSTET GYNECOL, V117, P153, DOI 10.1097/AOG.0b013e3181fdebc0
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Jakobsen J. C., 2013, British Journal of Medicine and Medical Research, V3, P1453
   Jakobsen JC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-120
   Jeffcoat M, 2011, BJOG-INT J OBSTET GY, V118, P250, DOI 10.1111/j.1471-0528.2010.02713.x
   Jeffcoat MK, 2003, J PERIODONTOL, V74, P1214, DOI 10.1902/jop.2003.74.8.1214
   Keus F, 2010, J CLIN EPIDEMIOL, V63, P246, DOI 10.1016/j.jclinepi.2009.08.023
   Kim AJ, 2012, J PERIODONTOL, V83, P1508, DOI 10.1902/jop.2012.110636
   Lafaurie GI, 2007, J CLIN PERIODONTOL, V34, P873, DOI 10.1111/j.1600-051X.2007.01125.x
   Lopez NJ, 2015, PERIODONTOL 2000, V67, P87, DOI 10.1111/prd.12073
   Lopez NJ, 2014, CLIN ORAL INVEST, V18, P343, DOI 10.1007/s00784-013-1145-6
   Lopez NJ, 2002, J PERIODONTOL, V73, P911, DOI 10.1902/jop.2002.73.8.911
   Lundh A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000033.pub2
   Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249
   Michalowicz BS, 2013, J PERIODONTOL, V84, pS195, DOI [10.1902/jop.2013.1340014, 10.1111/jcpe.12081]
   Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40
   OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245
   Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233
   Offenbacher S, 2006, J PERIODONTOL, V77, P2011, DOI 10.1092/jop.2006.060047
   Offenbacher S, 2009, OBSTET GYNECOL, V114, P551, DOI 10.1097/AOG.0b013e3181b1341f
   Pirie M, 2013, J PERIODONTOL, V84, P1391, DOI 10.1902/jop.2012.120572
   PLoS Medicine Editors, 2008, PLoS Med, V5, pe199, DOI 10.1371/journal.pmed.0050199
   Polyzos NP, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7017
   Radnai M, 2009, J DENT RES, V88, P280, DOI 10.1177/0022034508330229
   Sadatmansouri S, 2006, J Indian Soc Pedod Prev Dent, V24, P23
   Shaw DM, 2014, JAMA-J AM MED ASSOC, V312, P697, DOI 10.1001/jama.2014.8035
   Oliveira AMSD, 2011, CLIN ORAL INVEST, V15, P609, DOI 10.1007/s00784-010-0424-8
   Suvan JE, 2000, PERIODONTOLOGY, V37, P48, DOI [10.1111/j.1600-0757.2004.03794.x, DOI 10.1111/J.1600-0757.2004.03794.X]
   Tarannum F, 2007, J PERIODONTOL, V78, P2095, DOI 10.1902/jop.2007.060388
   Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187
   Thorlund K, 2011, USER MANUAL TRIAL SE, P1, DOI DOI 10.1158/1055-9965.EPI-08-0169
   Vergnes JN, 2007, AM J OBSTET GYNECOL, V196, P135, DOI DOI 10.1016/J.AJ0G.2006.09.028
   Weidlich P, 2013, CLIN ORAL INVEST, V17, P37, DOI 10.1007/s00784-012-0679-3
   Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013
   Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86
   Worthington HV, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004625.pub4
NR 49
TC 14
Z9 14
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2015
VL 10
IS 6
AR UNSP e0129060
DI 10.1371/journal.pone.0129060
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ7SJ
UT WOS:000355699100066
PM 26035835
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cheng, Y
   Zhu, Y
   Huang, XP
   Zhang, W
   Han, ZL
   Liu, SD
AF Cheng, Yang
   Zhu, Yun
   Huang, Xiuping
   Zhang, Wei
   Han, Zelong
   Liu, Side
TI Association between TLR2 and TLR4 Gene Polymorphisms and the
   Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID TOLL-LIKE RECEPTOR-4; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE;
   ULCERATIVE-COLITIS; ASP299GLY POLYMORPHISM; PUBLICATION BIAS; CD14
   POLYMORPHISMS; IMMUNE-RESPONSE; GRAPHICAL TEST; MUTATIONS
AB Background
   The associations between toll-like receptor 2 (TLR2) and toll-like receptor 4(TLR4) polymorphisms and inflammatory bowel disease (IBD) susceptibility remain controversial. A meta-analysis was performed to assess these associations.
   Methods
   A systematic search was performed to identify all relevant studies relating TLR2 and TLR4 polymorphisms and IBD susceptibility. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Subgroup analyses were performed by ethnicity and publication quality.
   Results
   Thirty-eight eligible studies, assessing 10970 cases and 7061 controls were included. No TLR2 Arg677Trp polymorphism was found. No significant association was observed between TLR2 Arg753Gln polymorphism and Crohn's disease (CD) or ulcerative colitis (UC) in all genetic models. Interestingly, TLR4 Asp299Gly polymorphism was significantly associated with increased risk of CD and UC in all genetic models, except for the additive one in CD. In addition, a statistically significant association between TLR4 Asp299Gly polymorphism and IBD was observed among high quality studies evaluating Caucasians, but not Asians. Associations between TLR4 Thr399Ile polymorphisms and CD risk were found only in the allele and dominant models. The TLR4 Thr399Ile polymorphism was associated with UC risk in pooled results as well as subgroup analysis of high quality publications assessing Caucasians, in allele and dominant models.
   Conclusions
   The meta-analysis provides evidence that TLR2 Arg753Gln is not associated with CD and UC susceptibility in Asians; TLR4 Asp299Gly is associated with CD and UC susceptibility in Caucasians, but not Asians. TLR4 Thr399Ile may be associated with IBD susceptibility in Caucasians only. Additional well-powered studies of Asp299Gly and other TLR4 variants are warranted.
C1 [Cheng, Yang; Huang, Xiuping; Zhang, Wei; Han, Zelong] Southern Med Univ, Clin Coll 1, Guangzhou, Guangdong, Peoples R China.
   [Zhu, Yun] Southern Med Univ, Nanfang Hosp, Liver Tumor Ctr, Guangzhou, Guangdong, Peoples R China.
   [Liu, Side] Southern Med Univ, Nanfang Hosp, Dept Digest, Guangzhou, Guangdong, Peoples R China.
RP Liu, SD (reprint author), Southern Med Univ, Nanfang Hosp, Dept Digest, Guangzhou, Guangdong, Peoples R China.
EM huangzl0924@sina.com
CR Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   Akin H, 2008, GASTROENTEROLOGY, V134, pA465
   Arnott IDR, 2004, GENES IMMUN, V5, P417, DOI 10.1038/sj.gene.6364111
   Azzam N, 2012, INT J MOL SCI, V13, P4268, DOI 10.3390/ijms13044268
   Baumgart DC, 2007, DIGESTION, V76, P196, DOI 10.1159/000112646
   Braat H, 2005, J MOL MED, V83, P601, DOI 10.1007/s00109-005-0685-x
   Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2
   Brittain EH, 2012, BIOSTATISTICS, V13, P637, DOI 10.1093/biostatistics/kxs006
   Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x
   Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001
   Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000
   Chen L., 2011, CORRELATION ATG16L1
   Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340
   Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046
   Chootrakool H, 2011, STAT MED, V30, P1183, DOI 10.1002/sim.4143
   Coelho T, 2014, INFLAMM BOWEL DIS, V20, P1813, DOI 10.1097/MIB.0000000000000174
   de Mesquita MB, 2009, EUR J PEDIATR, V168, P575, DOI 10.1007/s00431-008-0798-7
   Ding-Liang Z, 2006, CHIN J INT, V45, P585
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078
   Figueroa C, 2006, EUR CYTOKINE NETW, V17, P125
   Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205
   Fries W, 2005, AM J GASTROENTEROL, V100, P2730, DOI 10.1111/j.1572-0241.2005.00325.x
   Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681
   Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662
   Henckaerts L, 2007, GUT, V56, P1536, DOI 10.1136/gut.2007.125468
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hong J, 2007, J GASTROEN HEPATOL, V22, P1760, DOI 10.1111/j.1440-1746.2006.04727.x
   Hume GE, 2008, INFLAMM BOWEL DIS, V14, P585, DOI 10.1002/ibd.20362
   Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582
   Kim EJ, 2012, J KOREAN MED SCI, V27, P72, DOI [10.3346/jkms.2011.27.1.72, 10.3346/jkms.2012.27.1.72]
   Lakatos PL, 2005, WORLD J GASTROENTERO, V11, P1489
   Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431
   Queiroz DMM, 2009, INFLAMM BOWEL DIS, V15, P353, DOI 10.1002/ibd.20757
   Manolakis AC, 2013, DIGEST DIS SCI, V58, P371, DOI 10.1007/s10620-012-2348-4
   Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203
   Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001
   Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011
   Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845
   Okayama N, 2002, J CLIN LAB ANAL, V16, P56, DOI 10.1002/jcla.2075
   Oostenbrug LE, 2005, INFLAMM BOWEL DIS, V11, P567, DOI 10.1097/01.MIB.0000161305.81198.0f
   Ouburg S, 2005, GUT, V54, P439
   Pagnini C, 2012, DIGEST LIVER DIS, V44, P800, DOI 10.1016/j.dld.2012.03.024
   Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab
   Rigoli L, 2008, WORLD J GASTROENTERO, V14, P4454, DOI 10.3748/wjg.14.4454
   Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588
   Rodriguez-Bores L, 2007, WORLD J GASTROENTERO, V13, P5560, DOI 10.3748/wjg.v13.i42.5560
   Seitz M, 2003, ALLERGY, V58, P1247, DOI 10.1046/j.1398-9995.2003.00225.x
   Shen Xiu-yun, 2010, Zhonghua Yi Xue Za Zhi, V90, P1416
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Singh JCI, 2005, AM J PHYSIOL-GASTR L, V288, pG514, DOI 10.1152/ajpgi.00377.2004
   Sivaram G, 2012, HUM IMMUNOL, V73, P201, DOI 10.1016/j.humimm.2011.12.006
   Song FJ, 1998, BRIT MED J, V316, P471
   Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3
   Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265
   Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002
   Wagner J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015376
   WETERMAN IT, 1984, GASTROENTEROLOGY, V86, P449
   Xiong L-F, 2006, WORLD J CHIN DIG, V14, P212
   [薛惠平 XUE Huiping], 2007, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V27, P1226
   Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193
   Ye Byong Duk, 2009, Korean J Gastroenterol, V54, P377
   Zouiten-Mekki L, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-62
NR 65
TC 16
Z9 17
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2015
VL 10
IS 5
AR e0126803
DI 10.1371/journal.pone.0126803
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ2MQ
UT WOS:000355319400023
PM 26023918
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yan, SP
   Chen, LZ
   Wu, WQ
   Fu, ZX
   Zhang, H
   Li, ZZ
   Fu, CC
   Mou, JS
   Xue, J
   Hu, YY
AF Yan, Shipeng
   Chen, Lizhang
   Wu, Wenqiong
   Fu, Zhongxi
   Zhang, Heng
   Li, Zhanzhan
   Fu, Chenchao
   Mou, Jingsong
   Xue, Jing
   Hu, Yingyun
TI Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis
   Co-Infected Patients: A Systematic Review and Meta-Analysis of
   Randomized Controlled Trials
SO PLOS ONE
LA English
DT Article
ID INITIATION; ADULTS; SURVIVAL; START; RISK; AIDS
AB Objective
   To compare important clinical outcomes between early and delayed initiation of antiretroviral therapy (ART) in adults who had a co-infection of human immunodeficiency virus (HIV) and tuberculosis (TB).
   Methods
   We performed a systematic search for relevant publications on PubMed, EMBASE, and the International Clinical Trials Registry Platform. We included randomized controlled trials (RCTs) that compared early ART initiation (within four weeks after anti-TB treatment starting) and delayed ART initiation (after eight weeks but less than twelve weeks of anti-TB treatment starting) in the course of TB treatment. Pooled estimates with corresponding 95% confidence interval (95% CI) were calculated with random-effects model. Sensitivity analysis was performed to investigate the stability of pooled estimates.
   Results
   A meta-analysis was evaluated from six RCTs with 2272 participants. Compared to delayed ART initiation, early ART initiation significantly reduces all-cause mortality in HIV-positive patients with TB [incidence rate ratio (IRR) 0.75, 95% CI 0.59 to 0.95; I-2 = 0.00%; p = 0.67], even though there is an increased risk for IRD [IRR 2.29, 95% CI 1.81 to 2.91; I(2)2 = 0.00%; p = 0.56]. Additionally, early ART initiation was not associated with an increased risk for grade 3-4 drug-related adverse events [IRR 0.99, 95% CI 0.83 to 1.18; I-2 = 0.00%; p = 0.56].
   Conclusions
   Although limited evidence, our results provide support for early ART initiation in the course of anti-TB treatment. However, more well-designed cohort or intervention studies are required to further confirm our findings.
C1 [Yan, Shipeng; Wu, Wenqiong; Li, Zhanzhan; Xue, Jing] Cent S Univ, Xiangya Scholl Med, Affiliated Canc Hosp, Changsha 410013, Hunan, Peoples R China.
   [Chen, Lizhang; Hu, Yingyun] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410078, Hunan, Peoples R China.
   [Fu, Zhongxi] Ctr Dis Control & Prevent Hunan Prov, Changsha 410005, Hunan, Peoples R China.
   [Zhang, Heng] Ctr Dis Control & Prevent Changsha City, Changsha 410013, Hunan, Peoples R China.
   [Fu, Chenchao] Cent S Univ, Xiangya Hosp, Changsha 41008, Hunan, Peoples R China.
   [Mou, Jingsong] Changsha Med Univ, Changsha 410000, Hunan, Peoples R China.
RP Chen, LZ (reprint author), Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha 410078, Hunan, Peoples R China.
EM liche4005@126.com
CR Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911
   Chootrakool H, 2011, STAT MED, V30, P1183, DOI 10.1002/sim.4143
   Curran A, 2012, AIDS REV, V14, P231
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492
   Gray JM, 2013, SEMIN RESP CRIT CARE, V34, P32, DOI 10.1055/s-0032-1333469
   Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026
   Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607
   Higgins JP, 2008, COCHRANE HDB SYSTEMA
   Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667
   Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1
   Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181
   Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848
   Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10
   Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d
   Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86
   Manosuthi W, 2012, JAIDS-J ACQ IMM DEF, V60, P377, DOI 10.1097/QAI.0b013e31825b5e06
   Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361
   McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655
   Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9
   Moreno S, 2006, AIDS REV, V8, P115
   Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9
   Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
   Njei B, 2013, COCHRANE DB SYST REV, V2
   Piggott DA, 2011, CLIN DEV IMMUNOL, V2011, DOI [10.1155/2011/103917, DOI 10.1155/2011/103917]
   Shao HJ, 2009, AIDS RES HUM RETROV, V25, P1277, DOI 10.1089/aid.2009.0100
   Sinha S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-168
   Sungkanuparph S, 2006, J INFECTION, V52, P188, DOI 10.1016/j.jinf.2005.05.010
   Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230
   Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7
   World Health Organization, WORLD HLTH ORG GLOB
   World Health Organization, WHO POLICY ON COLLAB
NR 32
TC 8
Z9 9
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 22
PY 2015
VL 10
IS 5
AR e0127645
DI 10.1371/journal.pone.0127645
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CI7GR
UT WOS:000354931700070
PM 26000446
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sun, J
   Zheng, JY
   Tang, LJ
   Healy, J
   Sinnett, D
   Dai, YE
AF Sun, Jian
   Zheng, Jinyu
   Tang, Linjun
   Healy, Jasmine
   Sinnett, Daniel
   Dai, Yue-e
TI Association between CEBPE Variant and Childhood Acute Leukemia Risk:
   Evidence from a Meta-Analysis of 22 Studies
SO PLOS ONE
LA English
DT Article
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; SUSCEPTIBILITY
   LOCI; PUBLICATION BIAS; CLINICAL-TRIALS; 10Q21.2; ARID5B; 7P12.2;
   POLYMORPHISMS; POPULATION
AB The CCAAT/enhancer binding proteins (CEBPs) have been involved in the etiology of acute leukemia (AL) and investigated in numerous genetic association studies, however, the results were inconclusive. The current meta-analysis was conducted to clarify the effect of CEBPE rs2239633 variant on childhood AL risk. Electronic literature search was performed on August 15, 2014, from databases of Medline, PubMed, Embase, and Web of Science. A total of 22 case-control studies were eligible for the pooled analysis. The results demonstrated that rs2239633 A allele was significantly associated with a decreased risk of childhood AL (A vs G: OR=0.87, 95% CI = 0.80, 0.94, p<0.001), especially in B-cell ALL subgroup (A vs G: OR = 0.79, 95% CI = 0.74, 0.83, p<0.001), but not among T-cell ALL or AML subgroups. In the stratified analysis by ethnicity, the association was observed in Europeans (A vs G: OR = 0.80, 95% CI = 0.76, 0.84, p<0.001) but not in Asian and mixed populations. Moreover, the results of sensitivity and cumulative meta-analysis indicated the robustness of our results. Also, Begg's and Egger's tests did not indicate any evidence of obvious asymmetry. In summary, our study provided evidence that CEBPE rs2239633 variant is associated with decreased risk of childhood B-cell ALL in Europeans.
C1 [Sun, Jian] Huaian Matenal & Child Hlth Hosp, Dept Anesthesiol, Huaian, Jiangsu, Peoples R China.
   [Zheng, Jinyu] Xuzhou Med Coll, Affiliated Huaian Hosp, Dept Neurosurg, Huaian, Peoples R China.
   [Tang, Linjun] Tongling Peoples Hosp, Dept Neurosurg, Tongling, Anhui, Peoples R China.
   [Healy, Jasmine; Sinnett, Daniel] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada.
   [Sinnett, Daniel] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3C 3J7, Canada.
   [Dai, Yue-e] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China.
RP Dai, YE (reprint author), Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China.
EM yueedai@163.com
RI Sinnett, Daniel/S-4589-2017
OI Sinnett, Daniel/0000-0003-3625-6676
FU Science and Technology Development Foundation of Nanjing Medical
   University [2014NLMU144]
FX The study was supported by Science and Technology Development Foundation
   of Nanjing Medical University (No. 2014NLMU144). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015419
   Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012
   Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395
   Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dores GM, 2001, BLOOD, V119, P34
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302
   Emerenciano M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-127
   GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807
   Gibson BES, 2011, BRIT J HAEMATOL, V155, P366, DOI 10.1111/j.1365-2141.2011.08851.x
   Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816
   He J, 2015, LEUKEMIA LYMPHOMA, V56, P763, DOI 10.3109/10428194.2014.935370
   Healy J, 2010, HAEMATOL-HEMATOL J, V95, P1608, DOI 10.3324/haematol.2010.022459
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018
   Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4
   Li SH, 2015, LEUKEMIA LYMPHOMA, V56, P978, DOI 10.3109/10428194.2014.939965
   Lim JYS, 2014, CANCER-AM CANCER SOC, V120, P955, DOI 10.1002/cncr.28531
   Lu XC, 2014, AM J EPIDEMIOL, V179, P267, DOI 10.1093/aje/kwt262
   Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148
   Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430
   Pastorczak A, 2011, LEUKEMIA RES, V35, P1534, DOI 10.1016/j.leukres.2011.07.034
   Prasad RB, 2010, BLOOD, V115, P1765, DOI 10.1182/blood-2009-09-241513
   PUI CH, 1995, NEW ENGL J MED, V332, P1618, DOI 10.1056/NEJM199506153322407
   Qin LY, 2014, TUMOR BIOL, V35, P2521, DOI 10.1007/s13277-013-1333-7
   Ross JA, 2013, PEDIATR BLOOD CANCER, V60, P31, DOI 10.1002/pbc.24131
   Rubnitz JE, 2012, BLOOD, V119, P5980, DOI 10.1182/blood-2012-02-392506
   Rubnitz JE, 2010, LANCET ONCOL, V11, P543, DOI 10.1016/S1470-2045(10)70090-5
   Schmiegelow K, 2008, LEUKEMIA, V22, P2137, DOI 10.1038/leu.2008.212
   Tang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078810
   Vijayakrishnan J, 2010, LEUKEMIA LYMPHOMA, V51, P1870, DOI 10.3109/10428194.2010.511356
   Wang C, 2015, ANN HEMATOL, V94, P181, DOI 10.1007/s00277-014-2186-x
   Wang YP, 2013, GENE, V524, P203, DOI 10.1016/j.gene.2013.04.028
   Wiemels J, 2012, CHEM-BIOL INTERACT, V196, P59, DOI 10.1016/j.cbi.2012.01.007
   Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042
   Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011
NR 40
TC 4
Z9 4
U1 2
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 4
PY 2015
VL 10
IS 5
AR UNSP e0125657
DI 10.1371/journal.pone.0125657
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CH3PP
UT WOS:000353943000085
PM 25938438
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Li, H
   Wang, B
   Chang, C
   Wu, MH
   Xu, Y
   Jiang, YJ
AF Li, Hui
   Wang, Bing
   Chang, Cheng
   Wu, Minghua
   Xu, Yun
   Jiang, Yajun
TI The Roles of Variants in Human Multidrug Resistance (MDR1) Gene and
   Their Haplotypes on Antiepileptic Drugs Response: A Meta-Analysis of 57
   Studies
SO PLOS ONE
LA English
DT Article
ID ABCB1 POLYMORPHISMS; C3435T POLYMORPHISM; REFRACTORY EPILEPSY;
   FUNNEL-PLOT; ASSOCIATION; PHARMACORESISTANCE; CARBAMAZEPINE;
   TRANSPORTER; EXPRESSION; RISK
AB Objective
   Previous studies reported the associations between the ATP-binding cassette sub-family B member 1 (ABCB1, also known as MDR1) polymorphisms and their haplotypes with risk of response to antiepileptic drugs in epilepsy, however, the results were inconclusive.
   Methods
   The Pubmed, Embase, Web of Science, CNKI and Chinese Biomedicine databases were searched up to July 15, 2014. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a fixed-effects or random-effects model based on heterogeneity tests. Meta-regression and Galbraith plot analysis were carried out to explore the possible heterogeneity.
   Results
   A total of 57 studies involving 12407 patients (6083 drug-resistant and 6324 drug-responsive patients with epilepsy) were included in the pooled-analysis. For all three polymorphisms (C3435T, G2677T/A, and C1236T), we observed a wide spectrum of minor allele frequencies across different ethnicities. A significantly decreased risk of AEDs resistance was observed in Caucasian patients with T allele of C3435T variant, which was still significant after adjusted by multiple testing corrections (T vs C: OR=0.83, 95% CI=0.71-0.96, p=0.01). However, no significant association was observed between the other two variants and AEDs resistance. Of their haplotypes in ABCB1 gene (all studies were in Indians and Asians), no significant association was observed with AEDs resistance. Moreover, sensitivity and Cumulative analysis showed that the results of this meta-analysis were stable.
   Conclusion
   In summary, this meta-analysis demonstrated that effect of C3435T variant on risk of AEDs resistance was ethnicity-dependent, which was significant in Caucasians. Additionally, further studies in different ethnic groups are warranted to clarify possible roles of haplotypes in ABCB1 gene in AEDs resistance, especially in Caucasians.
C1 [Li, Hui; Chang, Cheng; Wu, Minghua; Jiang, Yajun] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Tradit Chinese Med TCM, Dept Neurol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.
   [Wang, Bing] Huaian Hosp Tradit Chinese Med, Dept Neurol, Huaian, Jiangsu, Peoples R China.
   [Xu, Yun] Nanjing Univ, Nanjing Drum Tower Hosp, Sch Med, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China.
RP Jiang, YJ (reprint author), Nanjing Univ Chinese Med, Jiangsu Prov Hosp Tradit Chinese Med TCM, Dept Neurol, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.
EM yunxugulou@126.com; jiangyjtcm@sina.com
CR Balan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089253
   Sanchez MB, 2010, SEIZURE-EUR J EPILEP, V19, P93, DOI 10.1016/j.seizure.2009.12.004
   Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x
   Brodie MJ, 1997, EPILEPSIA, V38, P1245, DOI 10.1111/j.1528-1157.1997.tb01224.x
   Brodie MJ, 1996, NEW ENGL J MED, V334, P168, DOI 10.1056/NEJM199601183340308
   Buathet K, 2013, THAI J PHARM SCI, P146
   Casetta I, 1999, ACTA NEUROL SCAND, V99, P329, DOI 10.1111/j.1600-0404.1999.tb07360.x
   Chen Li, 2007, Zhongguo Dang Dai Er Ke Za Zhi, V9, P11
   Cheng JX, 2014, INTERNATIONAL CONFERENCE ON ELECTRICAL, CONTROL AND AUTOMATION (ICECA 2014), P1
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   [狄睛 DI Qing], 2011, [中华神经医学杂志, Chinese Journal of Neuromedicine], V10, P127
   Dong L, 2011, BRAIN RES, V1391, P114, DOI 10.1016/j.brainres.2011.03.028
   [董通 Dong Tong], 2011, [中风与神经疾病杂志, Journal of Apoplexy and Nervous Diseases], V28, P237
   Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Emich-Widera E, 2013, BIOMED RES INT, DOI 10.1155/2013/526837
   GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807
   [高萱 GAO Xuan], 2009, [临床儿科杂志, Journal of Chinical Pediatrics], V27, P1014
   Grover S, 2010, BIOCHIMIE, V92, P1207, DOI 10.1016/j.biochi.2010.04.008
   Haerian BS, 2011, SEIZURE-EUR J EPILEP, V20, P387, DOI 10.1016/j.seizure.2011.01.008
   Haerian BS, 2010, SEIZURE-EUR J EPILEP, V19, P339, DOI 10.1016/j.seizure.2010.05.004
   Haerian BS, 2011, PHARMACOGENOMICS, V12, P713, DOI 10.2217/PGS.10.212
   Huang H, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461913
   Hung CC, 2005, PHARMACOGENOMICS, V6, P411, DOI 10.1517/14622416.6.4.411
   Hung CC, 2007, PHARMACOGENOMICS, V8, P1151, DOI 10.2217/14622416.8.9.1151
   Huy NT, 2010, CRIT CARE, V14, DOI [10.1186/cc9395, 10.1186/cc9268]
   JETTE L, 1993, BIOCHIM BIOPHYS ACTA, V1150, P147, DOI 10.1016/0005-2736(93)90083-C
   Jin R, 2010, J APPL CLIN PEDIAT, V25, P1583
   Jin R., 2010, CHIN J CLIN, V4, P2153
   Kim DW, 2006, SEIZURE-EUR J EPILEP, V15, P344, DOI 10.1016/j.seizure.2006.02.015
   Kim DW, 2009, EPILEPSY RES, V84, P86, DOI 10.1016/j.eplepsyres.2008.12.001
   Kim YO, 2006, SEIZURE-EUR J EPILEP, V15, P67, DOI 10.1016/j.seizure.2005.11.001
   Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308
   Kriston L, 2006, INT J IMPOT RES, V18, P559, DOI 10.1038/sj.ijir.3901479
   Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503
   Kwan P, 2007, EPILEPSY BEHAV, V11, P112, DOI 10.1016/j.yebeh.2007.04.013
   Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x
   Kwan P, 2009, PHARMACOGENOMICS, V10, P723, DOI [10.2217/pgs.09.32, 10.2217/PGS.09.32]
   Lakhan R, 2009, EPILEPSY BEHAV, V14, P78, DOI 10.1016/j.yebeh.2008.08.019
   Leschziner GD, 2007, PHARMACOGENET GENOM, V17, P217, DOI 10.1097/01.fpc.0000230408.23146.b1
   Li MZ, 2014, EPILEPSY RES, V108, P1052, DOI 10.1016/j.eplepsyres.2014.03.019
   Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x
   Loscher W, 2002, J PHARMACOL EXP THER, V301, P7, DOI 10.1124/jpet.301.1.7
   MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U
   Maleki Mehri, 2010, Iranian Biomedical Journal, V14, P89
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Meng HM, 2011, EPILEPSY BEHAV, V21, P27, DOI 10.1016/j.yebeh.2011.02.015
   Ebid AHI, 2007, THER DRUG MONIT, V29, P305
   Nadkarni S, 2005, NEUROLOGY, V64, pS2, DOI 10.1212/WNL.64.12_suppl_3.S2
   Nurmohamed L, 2010, EPILEPSIA, V51, P1882, DOI 10.1111/j.1528-1167.2010.02588.x
   Ozgon GO, 2008, EUR NEUROL, V59, P67, DOI 10.1159/000109264
   Potschka H, 2002, NEUROREPORT, V13, P167, DOI 10.1097/00001756-200201210-00038
   Qu J, 2012, CNS NEUROSCI THER, V18, P647, DOI 10.1111/j.1755-5949.2012.00336.x
   Regesta G, 1999, EPILEPSY RES, V34, P109, DOI 10.1016/S0920-1211(98)00106-5
   SANDER JWAS, 1993, EPILEPSIA, V34, P1007, DOI 10.1111/j.1528-1157.1993.tb02126.x
   Saygi S, 2014, BRAIN DEV-JPN, V36, P137, DOI 10.1016/j.braindev.2013.01.016
   Sayyah M, 2011, EPILEPTIC DISORD, V13, P155, DOI 10.1684/epd.2011.0443
   Seo T, 2006, PHARMACOGENOMICS, V7, P551, DOI 10.2217/14622416.7.4.551
   Seven M, 2014, MOL BIOL REP, V41, P331, DOI 10.1007/s11033-013-2866-y
   Shaheen U, 2014, EPILEPSY RES, V108, P251, DOI 10.1016/j.eplepsyres.2013.11.009
   Shahwan A, 2007, EPILEPSY RES, V73, P192, DOI 10.1016/j.eplepsyres.2006.10.004
   Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986
   Sills GJ, 2005, EPILEPSIA, V46, P643, DOI 10.1111/j.1528-1167.2005.46304.x
   Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002
   Soranzo N, 2004, GENOME RES, V14, P1333, DOI 10.1101/gr.1965304
   Sporis D, 2011, NEUROL CROATICA, V60, P63
   Sterjev Z, 2012, NEUROPSYCH DIS TREAT, V8, P191, DOI 10.2147/NDT.S28285
   Subenthiran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064827
   Szoeke C, 2009, EPILEPSIA, V50, P1689, DOI 10.1111/j.1528-1167.2009.02059.x
   Tan NCK, 2004, NEUROLOGY, V63, P1090, DOI 10.1212/01.WNL.0000137051.33486.C7
   Tang JL, 2000, J CLIN EPIDEMIOL, V53, P477, DOI 10.1016/S0895-4356(99)00204-8
   TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x
   Trikalinos TA, 2008, ADV GENET, V60, P311, DOI 10.1016/S0065-2660(07)00413-0
   Ufer M, 2009, PHARMACOGENET GENOM, V19, P353, DOI 10.1097/FPC.0b013e328329940b
   Vahab SA, 2009, DRUG METAB PHARMACOK, V24, P255, DOI 10.2133/dmpk.24.255
   von Stulpnagel C, 2009, EPILEPSIA, V50, P1835, DOI 10.1111/j.1528-1167.2009.02077.x
   Wang SY, 2008, ZHEJIANG MED J, V30, P1307
   Wang X., 2011, BIOMED, V11, P2717
   Yang M., 2012, CHIN J DIFFIC COMPL, V11, P594
   [郑兴珍 ZHENG Xing-zhen], 2009, [中风与神经疾病杂志, Journal of Apoplexy and Nervous Diseases], V26, P44
   Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048
   陆骏超, 2007, [中华神经科杂志, Chinese Journal of Neurology], V40, P584
NR 83
TC 0
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 27
PY 2015
VL 10
IS 3
AR e0122043
DI 10.1371/journal.pone.0122043
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE8ZT
UT WOS:000352133600139
PM 25816099
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Park, SK
   Choi, GJ
   Choi, YS
   Ahn, EJ
   Kang, H
AF Park, Sun Kyung
   Choi, Geun Joo
   Choi, Yun Suk
   Ahn, Eun Jin
   Kang, Hyun
TI Comparison of the I-Gel and the Laryngeal Mask Airway Proseal during
   General Anesthesia: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID SUPRAGLOTTIC AIRWAY; LMA; CROSSOVER; PRESSURE
AB Objectives
   Conflicting results have been reported for the i-gel and the laryngeal mask airway proseal (LMA-P) during general anesthesia. The objective of the current investigation was to compare the efficacy and safety of the i-gel vs. the LMA-P during general anesthesia.
   Methods
   Two authors performed searches of MEDLINE, EMBASE, CENTRAL, and Google Scholar to identify randomized clinical trials that compared the LMA-P with the i-gel during general anesthesia. A meta -analysis was performed using both random and fixed-effect models. Publication bias was evaluated using Begg's funnel plot and Egger's linear regression test.
   Results
   Twelve randomized clinical trials met the eligibility criteria. There were no significant differences in insertion success rate at the first attempt (risk ratio [RR] 1.01, 95% confidence interval [CI] 0.97, 1.06), ease of insertion (RR 1.14, 95% CI 0.93, 1.39), oropharyngeal leak pressure (OLP) (MD -1.98, 95% CI -5.41, 1.45), quality of fiberoptic view (RR 1.00, 95% CI 0.91, 1.10) and success rate of gastric tube insertion (RR 1.07, 95% CI 0.98, 1.18) between the i-gel and the LMA-P, respectively. The i-gel had a shorter insertion time than the LMA-P (MD -3.99, 95% CI -7.13, -0.84) and a lower incidence of blood staining on the device (RR 0.26, 95% CI 0.14, 0.49), sore throat (RR 0.28, 95% CI 0.15, 0.50) and dysphagia (RR 0.27, 95% CI 0.10, 0.74).
   Conclusions
   Both devices were comparable in ease of insertion to insert and both had sufficient OLP to provide a reliable airway. Only a few minor complications were reported. The i-gel was found to have fewer complications (blood staining, sore throat, dysphagia) than the LMA-P and offers certain advantages over the LMA-P in adults under general anesthesia.
C1 [Park, Sun Kyung; Choi, Yun Suk] Jeju Natl Univ, Dept Anesthesiol & Pain Med, Coll Med, Jeju, South Korea.
   [Choi, Geun Joo; Kang, Hyun] Chung Ang Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul 156756, South Korea.
   [Ahn, Eun Jin] SungKyunKwan Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.
RP Kang, H (reprint author), Chung Ang Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul 156756, South Korea.
EM roman00@naver.com
OI Ahn, EunJin/0000-0001-6321-5285
CR Brain AIJ, 2000, BRIT J ANAESTH, V84, P650, DOI 10.1093/bja/84.5.650
   Brimacombe J, 2000, ANESTHESIOLOGY, V93, P104, DOI 10.1097/00000542-200007000-00019
   Brimacombe J, 2001, ANESTH ANALG, V93, P1351, DOI 10.1097/00000539-200111000-00064
   Chauhan Gaurav, 2013, J Anaesthesiol Clin Pharmacol, V29, P56, DOI 10.4103/0970-9185.105798
   Cook T, 2011, BJA EDUC, V11, P56, DOI 10.1093/bjaceaccp/mkq058
   Cook TM, 2005, CAN J ANAESTH, V52, P739, DOI 10.1007/BF03016565
   Das A, 2014, J CLIN DIAGN RES, V8, P80, DOI 10.7860/JCDR/2014/7890.4113
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Gasteiger L, 2010, ANAESTHESIA, V65, P913, DOI 10.1111/j.1365-2044.2010.06422.x
   Goldmann K, 2006, ANASTH INTENSIV NOTF, V41, P228, DOI 10.1055/s-2005-921200
   Hayashi Kentaro, 2013, Masui, V62, P134
   Helmy AM, 2010, SAUDI J ANAESTH, V4, P131, DOI 10.4103/1658-354X.71250
   Higgins J. P. T., 2011, COCHRANE HDB SYSTEMA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Jeon WJ, 2012, KOREAN J ANESTHESIOL, V63, P510, DOI 10.4097/kjae.2012.63.6.510
   Kini Gurudas, 2014, J Anaesthesiol Clin Pharmacol, V30, P183, DOI 10.4103/0970-9185.130008
   Levitan RM, 2005, ANAESTHESIA, V60, P1022, DOI 10.1111/j.1365-2044.2005.04258.x
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Richez B, 2008, ANESTH ANALG, V106, P1137, DOI 10.1213/ane.0b013e318164f062
   Seet E, 2010, EUR J ANAESTH, V27, P602, DOI 10.1097/EJA.0b013e32833679e3
   Sharma Bimla, 2010, J Anaesthesiol Clin Pharmacol, V26, P451
   Shi Ying-bin, 2013, Zhonghua Yi Xue Za Zhi, V93, P1978
   Shin WJ, 2010, EUR J ANAESTH, V27, P598, DOI 10.1097/EJA.0b013e3283340a81
   Singh I, 2009, INDIAN J ANAESTH, V53, P302
   Timmermann A, 2011, ANAESTHESIA, V66, P45, DOI 10.1111/j.1365-2044.2011.06934.x
   Trivedi V, 2011, INTERNET J ANESTHESI, V27
   van Zundert TCRV, 2012, ACTA ANAESTH BELG, V63, P35
NR 27
TC 19
Z9 19
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2015
VL 10
IS 3
AR e0119469
DI 10.1371/journal.pone.0119469
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK6QW
UT WOS:000356353700017
PM 25812135
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, C
   Zhao, ZG
   Liao, YB
   Peng, Y
   Meng, QT
   Chai, H
   Li, Q
   Luo, XL
   Liu, W
   Zhang, C
   Chen, M
   Huang, DJ
AF Chen, Chi
   Zhao, Zhen-Gang
   Liao, Yan-Biao
   Peng, Yong
   Meng, Qing-Tao
   Chai, Hua
   Li, Qiao
   Luo, Xiao-Lin
   Liu, Wei
   Zhang, Chen
   Chen, Mao
   Huang, De-Jia
TI Impact of Renal Dysfunction on Mid-Term Outcome after Transcatheter
   Aortic Valve Implantation: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID ACUTE KIDNEY INJURY; HIGH-RISK PATIENTS; ACADEMIC RESEARCH CONSORTIUM;
   LONG-TERM OUTCOMES; OBSTRUCTIVE PULMONARY-DISEASE; FRANCE 2 REGISTRY;
   CLINICAL-OUTCOMES; PROGNOSTIC VALUE; 2-YEAR OUTCOMES; REPLACEMENT
AB Background
   There is conflicting evidence regarding the impact of preexisting renal dysfunction (RD) on mid-term outcomes after transcatheter aortic valve implantation (TAVI) in patients with symptomatic aortic stenosis (AS).
   Methods and results
   Forty-seven articles representing 32,131 patients with AS undergoing a TAVI procedure were included in this systematic review and meta-analysis. Pooled analyses were performed with both univariate and multivariate models, using a fixed or random effects method when appropriate. Compared with patients with normal renal function, mid-term mortality was significantly higher in patients with preexisting RD, as defined by the author (univariate hazard ratio [HR]: 1.69; 95% confidence interval [CI]: 1.50-1.90; multivariate HR: 1.47; 95% CI: 1.17-1.84), baseline estimated glomerular filtration rate (eGFR) (univariate HR: 1.65; 95% CI: 1.47-1.86; multivariate HR: 1.46; 95% CI: 1.24-1.71), and serum creatinine (univariate HR: 1.69; 95% CI: 1.48-1.92; multivariate HR: 1.65; 95% CI: 1.36-1.99). Advanced stage of chronic kidney disease (CKD stage 3-5) was strongly related to bleeding (univariate HR in CKD stage 3: 1.30, 95% CI: 1.13-1.49; in CKD stage 4: 1.30, 95% CI: 1.04-1.62), acute kidney injure (AKI) (univariate HR in CKD stage 3: 1.28, 95% CI: 1.03-1.59; in CKD stage 4: 2.27, 95% CI: 1.74-2.96), stroke (univariate HR in CKD stage 4: 3.37, 95% CI: 1.52-7.46), and mid-term mortality (univariate HR in CKD stage 3: 1.57, 95% CI: 1.26-1.95; in CKD stage 4: 2.77, 95% CI: 2.06-3.72; in CKD stage 5: 2.64, 95% CI: 1.91-3.65) compared with CKD stage 1+2. Patients with CKD stage 4 had a higher incidence of AKI (univariate HR: 1.70, 95% CI: 1.34-2.16) and all-cause death (univariate HR: 1.60, 95% CI: 1.28-.99) compared with those with CKD stage 3. A per unit decrease in serum creatinine was also associated with a higher mortality at mid-term follow-up (univariate HR: 1.24, 95% CI: 1.18-1.30; multivariate HR: 1.19, 95% CI: 1.08-1.30).
   Conclusions
   Preexisting RD was associated with increased mid-term mortality after TAVI. Patients with CKD stage 4 had significantly higher incidences of peri-procedural complications and a poorer prognosis, a finding that should be factored into the clinical decision-making process regarding these patients.
C1 [Chen, Chi; Zhao, Zhen-Gang; Liao, Yan-Biao; Peng, Yong; Meng, Qing-Tao; Chai, Hua; Li, Qiao; Luo, Xiao-Lin; Liu, Wei; Zhang, Chen; Chen, Mao; Huang, De-Jia] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China.
RP Chen, M (reprint author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China.
EM hmaochen@hotmail.com
CR Aregger F, 2009, NEPHROL DIAL TRANSPL, V24, P2175, DOI 10.1093/ndt/gfp036
   Barbanti M, 2014, CATHETER CARDIOVASC
   Ben-Dor I, 2012, AM J CARDIOL, V110, P1008, DOI 10.1016/j.amjcard.2012.05.034
   Chopard R, 2014, AM J CARDIOL, V113, P1543, DOI 10.1016/j.amjcard.2014.01.432
   Codner P, 2013, AM J CARDIOL, V111, P1330, DOI 10.1016/j.amjcard.2013.01.275
   Conrotto F, 2014, AM J CARDIOL, V113, P529, DOI 10.1016/j.amjcard.2013.10.025
   Cronin RE, 2010, PEDIATR NEPHROL, V25, P191, DOI 10.1007/s00467-009-1204-z
   D'Ascenzo F, 2013, INT J CARDIOL, V167, P1514, DOI 10.1016/j.ijcard.2012.04.161
   Drews T, 2013, ANN THORAC SURG, V95, P85, DOI 10.1016/j.athoracsur.2012.08.055
   Dumonteil N, 2013, AM HEART J, V165, P752, DOI 10.1016/j.ahj.2012.12.013
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Dvir D, 2014, J AM COLL CARDIOL, V63, P269, DOI 10.1016/j.jacc.2013.09.024
   Godino C, 2010, JACC-CARDIOVASC INTE, V3, P1110, DOI 10.1016/j.jcin.2010.09.012
   Gotzmann M, 2012, AM J CARDIOL, V110, P1500, DOI 10.1016/j.amjcard.2012.07.010
   Gummert JF, 2004, THORAC CARDIOV SURG, V52, P70, DOI 10.1055/s-2004-817806
   Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P1247, DOI 10.1016/j.jcin.2012.09.003
   Heinz A, 2014, J THORAC CARDIOV SUR, V147, P1021, DOI 10.1016/j.jtcvs.2013.11.011
   Houthuizen P, 2012, CIRCULATION, V126, P720, DOI 10.1161/CIRCULATIONAHA.112.101055
   Kamga M, 2013, ACTA CARDIOL, V68, P599, DOI 10.2143/AC.68.6.8000007
   Katsanos S, 2013, J AM SOC ECHOCARDIOG, V26, P691, DOI 10.1016/j.echo.2013.04.003
   Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384
   Lange R, 2012, J AM COLL CARDIOL, V59, P280, DOI 10.1016/j.jacc.2011.10.868
   Le Ven F, 2013, J AM COLL CARDIOL, V62, P782, DOI 10.1016/j.jacc.2013.05.044
   Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x
   Linke A, 2014, EUR HEART J
   London GM, 2000, J AM SOC NEPHROL, V11, P778
   Lucon A, 2014, CIRC-CARDIOVASC INTE, V7, P240, DOI 10.1161/CIRCINTERVENTIONS.113.000482
   Madershahian N, 2012, EUR J CARDIO-THORAC, V41, P1225, DOI 10.1093/ejcts/ezr199
   Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277
   McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035
   Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050
   Mok M, 2013, JACC-CARDIOVASC INTE, V6, P1072, DOI 10.1016/j.jcin.2013.06.008
   Moretti C, 2014, J INTERV CARDIOL, V27, P293, DOI 10.1111/joic.12115
   Munoz-Garcia AJ, 2013, INT J CARDIOL, V169, P359, DOI 10.1016/j.ijcard.2013.09.006
   Nguyen TC, 2013, J THORAC CARDIOV SUR, V146, P1399, DOI 10.1016/j.jtcvs.2013.07.065
   Nombela-Franco L, 2012, CIRCULATION, V126, P3041, DOI 10.1161/CIRCULATIONAHA.112.110981
   Nuis RJ, 2012, NETH HEART J, V20, P16, DOI 10.1007/s12471-011-0224-z
   Panico C, 2012, MINERVA CARDIOANGIOL, V60, P561
   Rau S, 2012, NEPHRON CLIN PRACT, V120, pC86, DOI 10.1159/000335781
   Rodes-Cabau J, 2012, J AM COLL CARDIOL, V60, P1864, DOI 10.1016/j.jacc.2012.08.960
   Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014
   Sabate M, 2013, REV ESP CARDIOL, V66, P949, DOI 10.1016/j.rec.2013.07.003
   Saia F, 2013, INT J CARDIOL, V168, P1034, DOI 10.1016/j.ijcard.2012.10.029
   Seiffert M, 2013, CATHETER CARDIO INTE, V82, P640, DOI 10.1002/ccd.24751
   Sinning JM, 2012, EUR HEART J, V33, P1459, DOI 10.1093/eurheartj/ehs002
   Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048
   Sinning JM, 2010, JACC-CARDIOVASC INTE, V3, P1141, DOI 10.1016/j.jcin.2010.09.009
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   SOSLAU G, 1990, AM J HEMATOL, V35, P171, DOI 10.1002/ajh.2830350306
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Tamburino C, 2012, AM J CARDIOL, V109, P1487, DOI 10.1016/j.amjcard.2012.01.364
   Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533
   Thourani VH, 2011, ANN THORAC SURG, V91, P1798, DOI 10.1016/j.athoracsur.2011.02.015
   Tzikas A, 2011, ANN THORAC SURG, V91, P685, DOI 10.1016/j.athoracsur.2010.09.037
   Unbehaun A, 2014, EUR J CARDIOTHORAC S
   Unbehaun A, 2011, ANN THORAC SURG, V92, P1315, DOI 10.1016/j.athoracsur.2011.05.077
   Urena M, 2014, CIRCULATION, V129, P1233, DOI 10.1161/CIRCULATIONAHA.113.005479
   Van Belle E, 2014, CIRCULATION, V129, P1415, DOI 10.1161/CIRCULATIONAHA.113.002677
   Van Linden A, 2011, EUR J CARDIO-THORAC, V39, P835, DOI 10.1016/j.ejcts.2010.11.034
   Vasa-Nicotera M, 2012, JACC-CARDIOVASC INTE, V5, P858, DOI 10.1016/j.jcin.2012.04.011
   Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807
   Wendler O, 2013, EUR J CARDIO-THORAC, V43, P505, DOI 10.1093/ejcts/ezs297
   Wessely M, 2012, NEPHROL DIAL TRANSPL, V27, P3502, DOI 10.1093/ndt/gfs102
   Yamamoto M, 2014, ANN THORAC SURG, V97, P29, DOI 10.1016/j.athoracsur.2013.07.100
   Yamamoto M, 2013, J AM COLL CARDIOL, V62, P869, DOI 10.1016/j.jacc.2013.04.057
   Yamamoto M, 2013, JACC-CARDIOVASC INTE, V6, P479, DOI 10.1016/j.jcin.2013.02.007
   Zahn R, 2013, AM J CARDIOL, V112, P272, DOI 10.1016/j.amjcard.2013.03.024
NR 69
TC 17
Z9 17
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2015
VL 10
IS 3
AR e0119817
DI 10.1371/journal.pone.0119817
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE8IA
UT WOS:000352084200118
PM 25793780
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ebert, DD
   Zarski, AC
   Christensen, H
   Stikkelbroek, Y
   Cuijpers, P
   Berking, M
   Riper, H
AF Ebert, David Daniel
   Zarski, Anna-Carlotta
   Christensen, Helen
   Stikkelbroek, Yvonne
   Cuijpers, Pim
   Berking, Matthias
   Riper, Heleen
TI Internet and Computer-Based Cognitive Behavioral Therapy for Anxiety and
   Depression in Youth: A Meta-Analysis of Randomized Controlled Outcome
   Trials
SO PLOS ONE
LA English
DT Article
ID TEENS-CD-ROM; MENTAL-HEALTH; ADOLESCENT DEPRESSION; YOUNG-PEOPLE;
   SERVICE USE; DISORDERS; CHILDREN; PSYCHOTHERAPY; COMORBIDITY; CHILDHOOD
AB Background
   Anxiety and depression in children and adolescents are undertreated. Computer-and Internet-based cognitive behavioral treatments (cCBT) may be an attractive treatment alternative to regular face-to-face treatment. This meta-analysis aims to evaluate whether cCBT is effective for treating symptoms of anxiety and depression in youth.
   Methods and Findings
   We conducted systematic searches in bibliographical databases (Pubmed, Cochrane controlled trial register, PsychInfo) up to December 4, 2013. Only randomized controlled trials in which a computer-, Internet-or mobile-based cognitive behavioral intervention targeting either depression, anxiety or both in children or adolescents up to the age of 25 were compared to a control condition were selected. We employed a random-effects pooling model in overall effect analyses and a mixed effect model for sub-group analyses. Searches resulted in identifying 13 randomized trials, including 796 children and adolescents that met inclusion criteria. Seven studies were directed at treating anxiety, four studies at depression, and two were of a transdiagnostic nature, targeting both anxiety and depression. The overall mean effect size (Hedges' g) of cCBT on symptoms of anxiety or depression at post-test was g=0.72 (95% CI: 0.55-0.90, numbers needed to be treated (NNT)=2.56). Heterogeneity was low (I-2=20.14%, 95% CI: 0-58%). The superiority of cCBT over controls was evident for interventions targeting anxiety (g=0.68; 95% CI: 0.45-0.92; p < .001; NNT=2.70) and for interventions targeting depression (g=0.76; 95% CI: 0.41-0.12; p < .001; NNT=2.44) as well as for transdiagnostic interventions (g=0.94; 95% CI: 0.23-2.66; p < .001; NNT=2.60).
   Conclusions
   Results provide evidence for the efficacy of cCBT in the treatment of anxiety and depressive symptoms in youth. Hence, such interventions may be a promising treatment alternative when evidence based face-to-face treatment is not feasible. Future studies should examine long-term effects of treatments and should focus on obtaining patient-level data from existing studies, to perform an individual patient data meta-analysis.
C1 [Ebert, David Daniel; Zarski, Anna-Carlotta; Cuijpers, Pim; Berking, Matthias; Riper, Heleen] Leuphana Univ, Innovat Incubator, Div Hlth Trainings Online, Luneburg, Germany.
   [Ebert, David Daniel; Berking, Matthias] Univ Erlangen Nurnberg, Dept Psychol Clin Psychol & Psychotherapy, D-91054 Erlangen, Germany.
   [Christensen, Helen] Black Dog Inst, Sydney, NSW, Australia.
   [Stikkelbroek, Yvonne] Univ Utrecht, Ctr Child & Adolescent Studies, NL-3508 TC Utrecht, Netherlands.
   [Cuijpers, Pim; Riper, Heleen] Vrije Univ Amsterdam Med Ctr, Reg Mental Hlth Serv Ctr, GGZ inGeest, Amsterdam, Netherlands.
   [Ebert, David Daniel; Cuijpers, Pim; Riper, Heleen] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Ebert, David Daniel; Cuijpers, Pim; Riper, Heleen] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
RP Ebert, DD (reprint author), Leuphana Univ, Innovat Incubator, Div Hlth Trainings Online, Luneburg, Germany.
EM ebert@inkubator.leuphana.de
RI Cuijpers, Pim/G-1703-2013; Christensen, Helen/O-2670-2019
OI Christensen, Helen/0000-0003-0435-2065; Ebert, David
   Daniel/0000-0001-6820-0146; Cuijpers, Pim/0000-0001-5497-2743
FU European Union [EFRE: ZW6-80119999, CCI 2007DE161PR001]
FX This study is funded by the European Union (EFRE: ZW6-80119999, CCI
   2007DE161PR001). The funders played no role in study design, collection,
   analysis, interpretation of data, writing of the report, or in the
   decision to submit the paper for publication.
CR Andersson G, WORLD PSYCH IN PRESS
   Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196
   Angold A, 1998, AM J PUBLIC HEALTH, V88, P75, DOI 10.2105/AJPH.88.1.75
   ANGOLD A, 1993, AM J PSYCHIAT, V150, P1779
   Axelson DA, 2001, DEPRESS ANXIETY, V14, P67, DOI 10.1002/da.1048
   Barrett PM, 1996, J CONSULT CLIN PSYCH, V64, P333, DOI 10.1037/0022-006X.64.2.333
   Bodden DHM, 2008, J ABNORM CHILD PSYCH, V36, P487, DOI 10.1007/s10802-007-9194-4
   Borenstein M., 2009, INTRO METAANALYSIS
   BRADY EU, 1992, PSYCHOL BULL, V111, P244, DOI 10.1037/0033-2909.111.2.244
   Buntrock C, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-25
   BURNS BJ, 1995, HEALTH AFFAIR, V14, P147, DOI 10.1377/hlthaff.14.3.147
   Calear AL, 2010, MED J AUSTRALIA, V192, pS12
   Calear AL, 2009, J CONSULT CLIN PSYCH, V77, P1021, DOI 10.1037/a0017391
   Compton SN, 2004, J AM ACAD CHILD PSY, V43, P930, DOI 10.1097/01.chi.0000127589.57468.bf
   Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837
   Cunningham MJ, 2009, EUR CHILD ADOLES PSY, V18, P125, DOI 10.1007/s00787-008-0703-y
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ehrenreich JT, 2009, CHILD FAM BEHAV THER, V31, P20, DOI 10.1080/07317100802701228
   Essau CA, 2005, DEPRESS ANXIETY, V22, P130, DOI 10.1002/da.20115
   Fleming T, 2012, BEHAV COGN PSYCHOTH, V40, P529, DOI 10.1017/S1352465811000695
   Ford T, 1999, AIRCR ENG AEROSP TEC, V71, P42, DOI 10.1108/00022669910252169
   Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113
   Haug T, 2012, CLIN PSYCHOL REV, V32, P425, DOI 10.1016/j.cpr.2012.04.002
   Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/ERP.12.67, 10.1586/erp.12.67]
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1002/9780470712184
   Hofstra MB, 2002, J AM ACAD CHILD PSY, V41, P182, DOI 10.1097/00004583-200202000-00012
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   James AC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004690.pub3
   Kataoka SH, 2002, AM J PSYCHIAT, V159, P1548, DOI 10.1176/appi.ajp.159.9.1548
   Kazdin AE, 2002, RES DESIGN CLIN PSYC, P1000
   Keller M., 2009, THESIS
   Khanna MS, 2010, J CONSULT CLIN PSYCH, V78, P737, DOI 10.1037/a0019739
   Klein JB, 2007, J AM ACAD CHILD PSY, V46, P1403, DOI 10.1097/chi.0b013e3180592aaa
   Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930
   Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014
   LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605
   Lin J, 2013, REHABILITATION, V52, P155, DOI 10.1055/s-0033-1343491
   Makarushka MM, 2011, THESIS U OREGON OREG
   March S, 2009, J PEDIATR PSYCHOL, V34, P474, DOI 10.1093/jpepsy/jsn099
   Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017
   Michael KD, 2002, CLIN PSYCHOL REV, V22, P247, DOI 10.1016/S0272-7358(01)00089-7
   Orsini N, 2013, HETEROGI STATA MODUL
   ORVASCHEL H, 1995, J AM ACAD CHILD PSY, V34, P1525, DOI 10.1097/00004583-199511000-00020
   Parker G, 2003, J AFFECT DISORDERS, V74, P131, DOI 10.1016/S0165-0327(02)00002-2
   RAO U, 1995, J AM ACAD CHILD PSY, V34, P566, DOI 10.1097/00004583-199505000-00009
   Reynolds S, 2012, CLIN PSYCHOL REV, V32, P251, DOI 10.1016/j.cpr.2012.01.005
   Rozental A, 2014, INTERNET INTERV, V1, P12, DOI [10.1016/j.invent.2014.02.001, DOI 10.1016/J.INVENT.2014.02.001]
   Sawyer MG, 2001, AUST NZ J PSYCHIAT, V35, P806, DOI 10.1046/j.1440-1614.2001.00964.x
   Sethi S, 2010, J TECHNOL HUMAN SERV, V28, P144, DOI 10.1080/15228835.2010.508317
   Spence SH, 2011, J CONSULT CLIN PSYCH, V79, P629, DOI 10.1037/a0024512
   Stallard P, 2011, BEHAV COGN PSYCHOTH, V39, P273, DOI 10.1017/S135246581000086X
   Stasiak K, 2012, BEHAV COGN PSYCHOTH, V20, P1
   Storch EA, 2011, PSYCHIAT RES, V189, P407, DOI 10.1016/j.psychres.2011.05.047
   Tillfors M, 2008, DEPRESS ANXIETY, V25, P708, DOI 10.1002/da.20416
   Tillfors Maria, 2011, Cognitive Behaviour Therapy, V40, P147, DOI 10.1080/16506073.2011.555486
   Trosper SE, 2009, CLIN CHILD FAM PSYCH, V12, P234, DOI 10.1007/s10567-009-0043-6
   van der Zanden R, 2012, J MED INTERNET RES, V14, P274, DOI 10.2196/jmir.2033
   van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175
   Weisz JR, 2013, JAMA PSYCHIAT, V70, P750, DOI 10.1001/jamapsychiatry.2013.1176
   Weisz JR, 2006, PSYCHOL BULL, V132, P132, DOI 10.1037/0033-2909.132.1.132
   WEISZ JR, 1995, PSYCHOL BULL, V117, P450, DOI 10.1037/0033-2909.117.3.450
   Woodward LJ, 2001, J AM ACAD CHILD PSY, V40, P1086, DOI 10.1097/00004583-200109000-00018
   Wuthrich VM, 2012, J AM ACAD CHILD PSY, V51, P261, DOI 10.1016/j.jaac.2011.12.002
   Zachrisson HD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-34
NR 66
TC 111
Z9 113
U1 3
U2 90
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2015
VL 10
IS 3
AR e0119895
DI 10.1371/journal.pone.0119895
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE9BN
UT WOS:000352138500142
PM 25786025
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhou, XF
   Zhang, G
   Tian, Y
AF Zhou, Xiaofeng
   Zhang, Guan
   Tian, Ye
TI p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive
   Bladder Cancers Treated with Bacillus Calmette-Guerin: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID PROGNOSTIC VALUE; ARG72PRO POLYMORPHISM; UROTHELIAL CARCINOMA; PROTEIN
   OVEREXPRESSION; PROLIFERATIVE ACTIVITY; MOLECULAR MARKERS; TUMOR
   RECURRENCE; PRB EXPRESSION; ASSOCIATION; SURVIVAL
AB Objective
   Published studies have yielded inconsistent results on the relationship between p53 status and the prognosis of non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) intravesical therapy. Therefore, we performed a meta-analysis to evaluate the prognostic value of p53 in NMIBC treated with BCG.
   Methods
   We systematically searched for relevant literature in PubMed, EMBASE, CNKI, and Chinese Wanfang databases. Hazard ratios (HRs) with 95% confidence intervals (CIs) were combined as the effect size (ES) across studies for recurrence-free survival (RFS) and progression-free survival (PFS).
   Results
   A total of 11 studies, consisting of 1,049 participants, met the criteria. Overall, there was no clear relationship between p53 status and RFS or PFS for NMIBC patients treated with BCG (HR: 1.40, 95% CI: 0.91-2.16; HR: 1.37, 95% CI: 0.90-2.09, respectively). Obvious heterogeneity was observed across the studies (I-2 = 69.5%, P = 0.001; I-2 = 44.7%, P = 0.081, respectively). In stratified analysis by region, p53 overexpression was a predictor of poor RFS in Asian populations (HR: 1.57, 95% CI: 1.08-2.27). In addition, after excluding the studies that possibly contributed to the heterogeneity by the Galbraith plot, the overall association for RFS became statistically significant (HR: 1.38 95% CI: 1.08-1.77) without evidence of heterogeneity (I-2 = 0.0%, P = 0.499).
   Conclusion
   This meta-analysis suggests that p53 overexpression in NMIBC patients treated with BCG may be associated with RFS, especially in Asian populations. Because of the heterogeneity and other limitations, further studies with rigid criteria and large populations are still warranted to confirm our findings.
C1 [Zhou, Xiaofeng; Tian, Ye] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing 100050, Peoples R China.
   [Zhang, Guan] China Japan Friendship Hosp, Dept Urol, Beijing 100029, Peoples R China.
RP Tian, Y (reprint author), Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Yongan Rd 95, Beijing 100050, Peoples R China.
EM dr_tianye@163.com
FU National Natural Science Foundation of China [81373637]; International
   S&T Cooperation Program of China (ISTCP) [2014DFE30010]
FX This study was supported by grants from the National Natural Science
   Foundation of China (Grant No. 81373637) and International S&T
   Cooperation Program of China (ISTCP) (Grant No. 2014DFE30010). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alkhateeb SS, 2011, UROL ANNALS, V3, P119, DOI 10.4103/0974-7796.84954
   Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003
   Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bernardini S, 1999, J UROLOGY, V162, P1496, DOI 10.1016/S0022-5347(05)68347-4
   Burger M, 2013, EUR UROL, V63, P36, DOI 10.1016/j.eururo.2012.08.061
   Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475
   Cormio L, 2009, ANTICANCER RES, V29, P4201
   da Silva GN, 2011, MOL BIOL REP, V38, P4159, DOI 10.1007/s11033-010-0536-x
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dolicanin Z, 2011, VOJNOSANIT PREGL, V68, P567, DOI 10.2298/VSP1107567D
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Esuvaranathan K, 2007, CANCER-AM CANCER SOC, V109, P1097, DOI 10.1002/cncr.22503
   Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116
   Gontero P, 2000, EUR UROL, V38, P287, DOI 10.1159/000020295
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Jiang DK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.04.044
   Jin M, 2013, ANN ONCOL, V24, P807, DOI 10.1093/annonc/mds508
   Lacombe L, 1996, J CLIN ONCOL, V14, P2646, DOI 10.1200/JCO.1996.14.10.2646
   LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406
   Lee E, 1997, Int J Urol, V4, P552, DOI 10.1111/j.1442-2042.1997.tb00307.x
   Li DB, 2010, GENET MOL RES, V9, P1599, DOI 10.4238/vol9-3gmr882
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Liu ZH, 2013, MOL BIOL REP, V40, P2389, DOI 10.1007/s11033-012-2319-z
   Lopez-Beltran A, 2004, EUR UROL, V45, P606, DOI 10.1016/j.eururo.2003.11.011
   Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566
   Malats W, 2005, LANCET ONCOL, V6, P678
   Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059
   Nakopoulou L, 1998, HUM PATHOL, V29, P146, DOI 10.1016/S0046-8177(98)90225-8
   Nepple Kenneth G, 2009, Can Urol Assoc J, V3, pS188
   Oderda M, 2013, UROL INT, V90, P184, DOI 10.1159/000343431
   Oh JJ, 2010, ONCOLOGY-BASEL, V79, P440, DOI 10.1159/000327214
   Park J, 2013, UROL ONCOL-SEMIN ORI, V31, P849, DOI 10.1016/j.urolonc.2011.06.004
   Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   Peyromaure M, 2002, UROLOGY, V59, P409, DOI 10.1016/S0090-4295(01)01551-5
   Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3
   Resnick MJ, 2013, CURR OPIN ONCOL, V25, P281, DOI 10.1097/CCO.0b013e32835eb583
   Saint F, 2004, EUR UROL, V45, P475, DOI 10.1016/j.eururo.2003.11.018
   Sylvester RJ, 2011, EUR UROL, V60, P431, DOI 10.1016/j.eururo.2011.06.001
   van Rhijn BWG, 2012, BJU INT, V110, P1169, DOI 10.1111/j.1464-410X.2012.10996.x
   van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028
   Xu T, 2012, ASIAN PAC J CANCER P, V13, P2349, DOI 10.7314/APJCP.2012.13.5.2349
   Xu X, 2014, EUR J NUTR, V53, P1615, DOI 10.1007/s00394-014-0667-2
   Xylinas E, 2013, BRIT J CANCER, V109, P1460, DOI 10.1038/bjc.2013.372
   Yang ZL, 2013, GENE, V512, P408, DOI 10.1016/j.gene.2012.09.085
NR 47
TC 7
Z9 8
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 5
PY 2015
VL 10
IS 3
AR e0119476
DI 10.1371/journal.pone.0119476
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9KG
UT WOS:000350688100114
PM 25742650
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, ZG
   Zhu, JY
   Huang, CY
   Lian, F
   Wu, GB
   Zhao, YN
AF Chen, Zhigang
   Zhu, Jiye
   Huang, Chaoyuan
   Lian, Fang
   Wu, Guobin
   Zhao, Yinnong
TI The Association between Three Cyclooxygenase-2 Polymorphisms and
   Hepatocellular Carcinoma Risk: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; PROMOTER POLYMORPHISM; FUNCTIONAL
   POLYMORPHISMS; GENETIC-VARIANTS; COX-2 GENE; CANCER; GROWTH;
   -765-G-GREATER-THAN-C; PTGS2
AB Background
   A quantity of case-control studies have been performed to address the association between three cyclooxygenase-2(COX-2) polymorphisms (-1195G/A, -765G/C and + 8473T/C) and the risk of hepatocellular carcinoma (HCC). However, previous research results are inconsistent. We conducted this meta-analysis to clarify the correlation between these COX-2 polymorphisms and HCC risk.
   Methods
   The authors searched in PubMed, EMBASE, Google Scholar, CNKI and WanFang database for relevant articles up to April 28, 2014. The data were extracted by two independent reviewers. Odds ratios (ORs) and 95% confidence intervals were calculated.
   Results
   A total of 8 studies consisting of 2182 cases and 3324 controls were included in this meta-analysis. For COX-2 polymorphism -1195G/A, an association with increased risk was observed under the heterogeneous, homozygous, dominant model. However, COX-2 polymorphisms (-765G/C and + 8473T/C) were not related to HCC risk in this study. We also found a similar result in the subgroup analysis of Chinese population that -1195G/A polymorphism, instead of -765G/C or + 8473T/C polymorphism, was correlated with the risk of HCC.
   Conclusions
   Polymorphism -1195G/A of COX-2 might be associated with susceptibility to HCC, but no similar correlations were observed between polymorphisms (-765G/C and + 8473T/C) and HCC risk. Further large and well-designed studies are required to validate this association.
C1 [Chen, Zhigang; Zhu, Jiye; Huang, Chaoyuan; Wu, Guobin; Zhao, Yinnong] Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China.
   [Lian, Fang] Guangxi Med Univ, Dept Physiol, Nanning, Peoples R China.
RP Wu, GB (reprint author), Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China.
EM gb.wu@139.com; mike106210mh@126.com
FU National Natural Science Foundation of China [81360315/H1603-]
FX This work was supported by National Natural Science Foundation of China
   (81360315/H1603-) and the funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. URL: http://www.nsfc.gov.cn/
CR Akkiz H, 2011, MOL CELL BIOCHEM, V347, P201, DOI 10.1007/s11010-010-0629-9
   Aubin F, 2010, J INVEST DERMATOL, V130, P2134, DOI 10.1038/jid.2010.116
   Ben Nasr H, 2009, MOL BIOL REP, V36, P193, DOI 10.1007/s11033-007-9166-3
   Bu XM, 2013, TUMOR BIOL, V34, P1479, DOI 10.1007/s13277-013-0672-8
   Chang WS, 2012, CHINESE J PHYSIOL, V55, P1, DOI 10.4077/CJP.2012.AMM056
   Cui W, 2005, CLIN CANCER RES, V11, P8213, DOI 10.1158/1078-0432
   Dong J, 2010, J GASTROEN HEPATOL, V25, P1042, DOI 10.1111/j.1440-1746.2010.06293.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fan X, 2011, CHIN J CANC PREV TRE, V18, P405
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gast.2004.09.014
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Gharib AF, 2014, GENE, V543, P234, DOI 10.1016/j.gene.2014.04.014
   He JH, 2012, MOL BIOL REP, V39, P4163, DOI 10.1007/s11033-011-1199-y
   Kim WH, 2012, GENE, V504, P92, DOI 10.1016/j.gene.2012.05.014
   Langsenlehner U, 2006, CLIN CANCER RES, V12, P1392, DOI 10.1158/1078-0432.CCR-05-2055
   Liu LF, 2010, CHIN J GASTROENTEROL, V19, P333
   Mohamed FZ, 2014, MOL BIOL REP, V41, P1461, DOI 10.1007/s11033-013-2991-7
   Pan F, 2011, ASIAN PAC J CANCER P, V12, P1941
   Pazhang Y, 2012, TUMOR BIOL, V33, P207, DOI 10.1007/s13277-011-0263-5
   Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799
   Santovito D, 2009, CURR OPIN LIPIDOL, V20, P402, DOI 10.1097/MOL.0b013e32832fa22c
   Sitarz R, 2008, MODERN PATHOL, V21, P685, DOI 10.1038/modpathol.2008.36
   Song X, 2011, PRACTICAL J CANC, P255
   Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54
   Upadhyay R, 2009, MUTAT RES-FUND MOL M, V663, P52, DOI 10.1016/j.mrfmmm.2009.01.007
   Wang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073213
   Xie HH, 2009, MOL CARCINOGEN, V48, P56, DOI 10.1002/mc.20455
   Xu D, 2008, CHIN J HEPATOBILIARY, V14, P840
   Yin JB, 2010, ONCOL RES, V19, P131, DOI 10.3727/096504011X12935427587803
   Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018
   Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003
   Zhu W, 2010, MOL BIOL REP, V37, P277, DOI 10.1007/s11033-009-9685-1
NR 32
TC 3
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 2
PY 2015
VL 10
IS 3
AR e0118251
DI 10.1371/journal.pone.0118251
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9JF
UT WOS:000350684900021
PM 25730260
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cheng, DS
   Fei, Y
   Liu, YM
   Li, JH
   Xue, Q
   Wang, XX
   Wang, NS
AF Cheng, Dongsheng
   Fei, Yang
   Liu, Yumei
   Li, Junhui
   Xue, Qin
   Wang, Xiaoxia
   Wang, Niansong
TI HbA1C Variability and the Risk of Renal Status Progression in Diabetes
   Mellitus: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID FASTING PLASMA-GLUCOSE; MICROVASCULAR COMPLICATIONS; HBA(1C)
   VARIABILITY; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; TYPE-2;
   NEPHROPATHY; PUBLICATION; ASSOCIATION; MORTALITY
AB Objective: To explore the association between glycated hemoglobin (A1C) variability and renal disease progression in patients with diabetes mellitus.
   Methods: A comprehensive search was performed using the PubMed and Embase databases (up to April 26, 2014). The hazard ratio (HR) was pooled per unit increase in the standard deviation of A1C (A1C-SD) to evaluate the dose-response relationship between A1C-SD and the risk of nephropathy.
   Results: Eight studies with a total of 17,758 subjects provided the HR for A1C-SD and were included in the final meta-analysis. The pooled HR results demonstrated that A1C-SD was significantly associated with the progression of renal status (HR for both T1DM and T2DM 1.43, 95% confidence interval [CI] 1.24-1.64; HR for T1DM 1.70, 95% CI 1.41-2.05; HR for T2DM 1.20, 95% CI 1.12-1.28). A1C-SD was significantly correlated with new-onset microalbuminuria (HR for T1DM 1.63, 95% CI 1.28-2.07; HR for T2DM 1.23, 95% CI 1.08-1.39). These outcomes were also supported in subgroup analyses. Furthermore, sensitivity analyses demonstrated that the results were robust.
   Conclusions: A1C variability is independently associated with the development of microalbuminuria and the progression of renal status in both type 1 and 2 diabetes patients. A standard method for measuring A1C variability is essential for further and deeper analyses. In addition, future studies should assess the effect of reducing A1C variability on nephropathy complication.
C1 [Cheng, Dongsheng; Fei, Yang; Liu, Yumei; Li, Junhui; Xue, Qin; Wang, Xiaoxia; Wang, Niansong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200233, Peoples R China.
RP Wang, NS (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200233, Peoples R China.
EM wangniansong2012@163.com
FU Project of National Nature Science Foundation of China [81270824];
   Shanghai Science and Technology Project [11DZ1921904, 11410708500]
FX This research is supported by grants from the Project of National Nature
   Science Foundation of China (81270824), Shanghai Science and Technology
   Project (11DZ1921904 and 11410708500). The funders played no role in the
   study design, data collection and analysis, decision to publish, and
   preparation of the manuscript.
CR Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615
   Cavalot F, 2013, DIABETES OBES METAB, V15, pS3
   Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414
   Ceriello A, 2008, DIABETES, V57, P1349, DOI [10.2337/db08-0063, 10.2337/dbO8-0063]
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hsu CC, 2012, DIABETOLOGIA, V55, P3163, DOI 10.1007/s00125-012-2700-4
   Kilpatrick ES, 2008, DIABETES CARE, V31, P2198, DOI 10.2337/dc08-0864
   Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.1337/dc06-0293
   Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]
   Lin CC, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.015
   Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404
   Marcovecchio ML, 2011, DIABETES CARE, V34, P1011, DOI 10.2337/dc10-2028
   Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681
   Muggeo M, 2000, DIABETES CARE, V23, P45, DOI 10.2337/diacare.23.1.45
   Muggeo M, 1997, CIRCULATION, V96, P1750, DOI 10.1161/01.CIR.96.6.1750
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264
   Raman S, 2011, AM DIAB ASS ADA 71 S
   Rodriguez-Segade S, 2012, DIABETIC MED, V29, P1562, DOI 10.1111/j.1464-5491.2012.03767.x
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Siegelaar SE, 2009, DIABETOLOGIA, V52, P2229, DOI 10.1007/s00125-009-1473-x
   Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Sugawara A, 2012, DIABETOLOGIA, V55, P2128, DOI 10.1007/s00125-012-2572-7
   Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55
   Waden J, 2009, DIABETES, V58, P2649, DOI 10.2337/db09-0693
   Wells GA, NEWCASTLE OTTAWA SCA
NR 30
TC 12
Z9 13
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 18
PY 2014
VL 9
IS 12
AR e115509
DI 10.1371/journal.pone.0115509
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA4AC
UT WOS:000348845600052
PM 25521346
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Angkurawaranon, C
   Jiraporncharoen, W
   Chenthanakij, B
   Doyle, P
   Nitsch, D
AF Angkurawaranon, Chaisiri
   Jiraporncharoen, Wichuda
   Chenthanakij, Boriboon
   Doyle, Pat
   Nitsch, Dorothea
TI Urban Environments and Obesity in Southeast Asia: A Systematic Review,
   Meta-Analysis and Meta-Regression
SO PLOS ONE
LA English
DT Article
ID BODY-MASS INDEX; RISK-FACTORS; NONCOMMUNICABLE DISEASES;
   NUTRITIONAL-STATUS; SOCIOECONOMIC-STATUS; METABOLIC SYNDROME; HEALTH;
   OVERWEIGHT; PREVALENCE; CHILDREN
AB Many environmental factors contribute to the rise in prevalence of obesity in populations but one key driver is urbanization. Countries in Southeast (SE) Asia have undergone rapid changes in urbanization in recent decades. The aim of this study is to provide a systematic review of studies exploring the relationship between living in an urban or rural environment (urbanicity) and obesity in Southeast Asia. In particular, the review will investigate whether the associations are uniform across countries and ages, and by sex. The literature search was conducted up to June 2014 using five databases: EMBASE, PubMed, GlobalHealth, DigitalJournal and Open Grey. Forty-five articles representing eight of the eleven countries in SE Asia were included in the review. The review found a consistent positive association between urbanicity and obesity in countries of Southeast Asia, in all age groups and both genders. Regional differences between the associations are partly explained by gross national income (GNI). In countries with lower GNI per capita, the association between urbanicity and obesity was greater. Such findings have implications for policy makers. They imply that population level interventions need to be country or region specific, tailored to suit the current stage of economic development. In addition, less developed countries might be more vulnerable to the negative health impact of urbanization than more developed countries.
C1 [Angkurawaranon, Chaisiri; Doyle, Pat; Nitsch, Dorothea] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England.
   [Angkurawaranon, Chaisiri; Jiraporncharoen, Wichuda] Chiang Mai Univ, Dept Family Med, Fac Med, Chiang Mai 50000, Thailand.
   [Chenthanakij, Boriboon] Chiang Mai Univ, Dept Emergency Med, Fac Med, Chiang Mai 50000, Thailand.
RP Angkurawaranon, C (reprint author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England.
EM chaisiri.angkurawaranon@lshtm.ac.uk
RI Angkurawaranon, Chaisiri/I-6140-2015
OI Angkurawaranon, Chaisiri/0000-0003-4206-9164; Jiraporncharoen,
   Wichuda/0000-0002-8131-6474
FU Faculty of Medicine, Chiang Mai University, Thailand
FX The authors received no specific funding for this work. CA is a PhD
   student funded by the Faculty of Medicine Development Scholarship
   (Faculty of Medicine, Chiang Mai University, Thailand). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aekplakorn W, 2011, BMC PUBLIC HLTH, V11
   Aekplakorn W, 2007, OBESITY, V15, P3113, DOI 10.1038/oby.2007.371
   Aekplakorn W, 2011, ASIA-PAC J PUBLIC HE, V23, P792, DOI 10.1177/1010539511424482
   Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4
   [Anonymous], GBD ARR DIAGR
   Azmi M Y Jr, 2009, Malays J Nutr, V15, P97
   Banwell C, 2009, J EPIDEMIOL COMMUN H, V63, P366, DOI 10.1136/jech.2008.080820
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Canoy D, 2007, OBES REV, V8, P1, DOI 10.1111/j.1467-789X.2007.00308.x
   Chinh VD, 2010, ASIA PAC J CLIN NUTR, V19, P209
   Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207
   Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1
   Davey TM, 2013, PUBLIC HEALTH, V127, P1057, DOI 10.1016/j.puhe.2013.09.008
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377
   Firestone R, 2011, SOC SCI MED, V72, P1420, DOI 10.1016/j.socscimed.2011.03.003
   Fuke Y, 2007, DIABETES RES CLIN PR, V77, pS224, DOI 10.1016/j.diabres.2007.01.062
   Gu DF, 2003, EUR J CARDIOV PREV R, V10, P249, DOI 10.1097/01.hjr.0000085254.65733.21
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017
   Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62
   Hanh TTM, 2001, J AM COLL NUTR, V20, P616, DOI 10.1080/07315724.2001.10719066
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1002/9780470712184
   Jinam TA, 2008, ETHNIC HEALTH, V13, P277, DOI 10.1080/13557850801930478
   Jitnarin N, 2010, NUTRIENTS, V2, P60, DOI [10.3390/nu2010060, 10.3390/nu20100060]
   Julia M., 2004, Food and Nutrition Bulletin, V25, P354
   Jurgensen Nanna, 2009, BMC Oral Health, V9, P29, DOI 10.1186/1472-6831-9-29
   Kinra S, 2004, INT J EPIDEMIOL, V33, P777, DOI 10.1093/ije/dyh161
   KOYAMA H, 1988, HUM BIOL, V60, P263
   Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI [10.1038/sj.ijo.0801938, 10.1038/sj/oji/0801938]
   Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702
   Le Nguyen BK, 2013, BRIT J NUTR, V110
   Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x
   Leowski J, 2009, HEALTH POLICY, V92, P43, DOI 10.1016/j.healthpol.2009.02.003
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Ly KA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-35
   Mai TTT, 2003, J NUTR SCI VITAMINOL, V49, P13
   Ghazali SM, 2006, TROP BIOMED, V23, P148
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716
   Myo Thet Htoon, 1992, Asia Pac J Public Health, V6, P188
   Naidu BM, 2013, ASIA PAC J CLIN NUTR, V22, P408, DOI 10.6133/apjcn.2013.22.3.18
   Nambooze J, 2014, ENVIRON HEALTH PREV, V19, P143, DOI 10.1007/s12199-013-0367-1
   Narain JP, 2011, NATL MED J INDIA, V24, P280
   Ng N, 2006, B WORLD HEALTH ORGAN, V84, P305
   Nguyen MD, 2007, PUBLIC HEALTH NUTR, V10, P115, DOI 10.1017/S1368980007224085
   Poh BK, 2013, BRIT J NUTR, V110, pS21, DOI 10.1017/S0007114513002092
   Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7
   Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272
   Ramke J, 2012, PUBLIC HEALTH NUTR, V15, P2118, DOI 10.1017/S1368980011003491
   Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561
   Rasiah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-886
   Rojroongwasinkul N, 2013, BRIT J NUTR, V110
   Sakamoto N, 2001, INT J OBESITY, V25, P389, DOI 10.1038/sj.ijo.0801477
   Sandjaja S, 2013, BRIT J NUTR, V110, pS11, DOI 10.1017/S0007114513002109
   Sartika Ratu Ayu Dewi, 2011, Malays J Nutr, V17, P337
   Shariff ZM, 2014, ASIA PAC J CLIN NUTR, V23, P138, DOI 10.6133/apjcn.2014.23.1.05
   Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2
   Suzana S, 2012, ASIA-PAC J PUBLIC HE, V24, P318, DOI 10.1177/1010539510380736
   Tang HK, 2007, ASIA PAC J CLIN NUTR, V16, P74
   Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187
   Toh CM, 2002, BRIT MED J, V324, P427
   Tran TMH, 2001, J NUTR SCI VITAMINOL, V47, P147
   Tuan NT, 2008, EUR J CLIN NUTR, V62, P78, DOI 10.1038/sj.ejcn.1602675
   United Nations Department of Economic and Social Affairs Population Division, 2012, WORLD URB PROSP 2011
   van Lierop A, 2008, ASIA PAC J CLIN NUTR, V17, P603
   Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3
   Hien VTT, 2013, PUBLIC HEALTH NUTR, V16, P922, DOI 10.1017/S1368980012003552
   Mohamud WNW, 2012, DIABETES RES CLIN PR, V96, P90, DOI 10.1016/j.diabres.2011.12.023
   WHO, 2003, WHO TECHN REP SER, V916
   WHO, 2000, WHO TECHNICAL REPORT, V894
   World Health Organization, 2013, OB OV
   Zaini M Z Anuar, 2005, Asia Pac J Public Health, V17, P71
   Zainuddin AA, 2013, MALAYSIAN J NUTR, V19, P149
   Zalilah M S, 2006, Med J Malaysia, V61, P48
NR 75
TC 14
Z9 14
U1 1
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 26
PY 2014
VL 9
IS 11
AR e113547
DI 10.1371/journal.pone.0113547
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA8CZ
UT WOS:000349145400062
PM 25426942
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Kvillemo, P
   Branstrom, R
AF Kvillemo, Pia
   Branstrom, Richard
TI Coping with Breast Cancer: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID CONTROLLED-TRIAL; HEALTH OUTCOMES; MINDFULNESS; STRESS; WOMEN;
   ADJUSTMENT; INTERVENTION; STRATEGIES; SURVIVORS; SYMPTOMS
AB Objective: The primary aim of this study was to examine the associations between different types of coping and psychological well-being and physical health among women with breast cancer. A second aim was to explore the potential moderating influences of situational and measurement factors on the associations between coping and psychological well-being and physical health.
   Methods: On 14 February 2011, a literature search was made for articles published in the PubMed and PsycINFO databases before January 2010. On 5 September 2013, a repeated literature search was made for articles published before May 2013. In the final analyses, 78 studies with 11 948 participants were included.
   Results: Efforts to facilitate adaptation to stress, such as Acceptance and Positive Reappraisal, were related to higher well-being and health. Disengagement and avoidance types of coping were associated with lower well-being and health. The analyses indicated that, in several circumstances, coping effectiveness was dependent on cancer stage, treatment, disease duration, and type of coping measure.
   Conclusions: Use of coping targeting adjustment and avoiding use of disengagement forms of coping were related to better psychological well-being and physical health. Adaptive strategies and avoiding disengagement forms of coping seemed particularly beneficial for women undergoing treatment.
C1 [Kvillemo, Pia] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Branstrom, Richard] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
RP Kvillemo, P (reprint author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
EM pia.kvillemo@ki.se
RI Branstrom, Richard/E-1647-2017
OI Branstrom, Richard/0000-0002-5889-2481
FU Swedish Council for Working Life and Social Research [2006-0069]; Center
   for Health Care Science at the Karolinska Institute, Sweden [2008-4737]
FX This work was supported by the Swedish Council for Working Life and
   Social Research under Grant nr: 2006-0069; Center for Health Care
   Science at the Karolinska Institute, Sweden under Grant nr: 2008-4737.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adler NE, 2008, CANC CARE WHOLE PATI
   [Anonymous], 2013, CAUS DEATH 2012
   Borenstein M., 2009, INTRO METAANALYSIS
   Bower JE, 2008, J CLIN ONCOL, V26, P768, DOI 10.1200/JCO.2007.14.3248
   Branstrom R, 2010, ANN BEHAV MED, V39, P151, DOI 10.1007/s12160-010-9168-6
   Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6
   CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Cohen J, 1988, STAT POWER ANAL BEHA
   Compas BE, 2006, PSYCHO-ONCOLOGY, V15, P1038, DOI 10.1002/pon.999
   Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080
   Danhauer SC, 2009, J BEHAV MED, V32, P371, DOI 10.1007/s10865-009-9211-x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Foley E, 2010, J CONSULT CLIN PSYCH, V78, P72, DOI 10.1037/a0017566
   FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992
   Hulbert-Williams NJ, 2012, PSYCHO-ONCOLOGY, V21, P792, DOI 10.1002/pon.1994
   IARC, 2013, GLOBOCAN 2012
   Lazarus R, 1984, STRESS APPRASISAL CO
   Lengacher CA, 2009, PSYCHO-ONCOLOGY, V18, P1261, DOI 10.1002/pon.1529
   McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002
   Monti DA, 2006, PSYCHO-ONCOL, V15, P363, DOI 10.1002/pon.988
   Moskowitz JT, 2009, PSYCHOL BULL, V135, P121, DOI 10.1037/a0014210
   Panagiotou OA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f707
   Papageorgiou C, 2003, COGNITIVE THER RES, V27, P243, DOI 10.1023/A:1023918331490
   Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589
   Roesch SC, 2005, J BEHAV MED, V28, P281, DOI 10.1007/s10865-005-4664-z
   Schreiber JA, 2012, J CANCER SURVIV, V6, P82, DOI 10.1007/s11764-011-0193-7
   Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216
   Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004
   Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521
   Stanton AL, 2000, J CONSULT CLIN PSYCH, V68, P875, DOI 10.1037/0022-006X.68.5.875
   WATSON M, 1988, PSYCHOL MED, V18, P203, DOI 10.1017/S0033291700002026
   World Health Organization, 1948, 2 WHO
NR 33
TC 30
Z9 31
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 25
PY 2014
VL 9
IS 11
AR e112733
DI 10.1371/journal.pone.0112733
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU9GL
UT WOS:000345899700014
PM 25423095
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Li, W
   Shi, Q
   Wang, WB
   Liu, JR
   Li, Q
   Hou, FG
AF Li, Wen
   Shi, Qi
   Wang, Weibing
   Liu, Jianrong
   Li, Qi
   Hou, Fenggang
TI RETRACTED: Calcium Channel Blockers and Risk of Breast Cancer: A
   Meta-Analysis of 17 Observational Studies (Retracted article. See vol.
   13, pg. 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID ANTIHYPERTENSIVE MEDICATIONS; PUBLICATION BIAS; IN-VITRO; WOMEN;
   MORTALITY; COHORT; ANTAGONISTS; STATISTICS; CARCINOMA; APOPTOSIS
AB Purpose: Studies on the association between the use of calcium channel blockers (CCBs) and breast cancer risk have reported inconsistent results. We quantitatively assessed this association by conducting a meta-analysis based on the evidence from observational studies.
   Methods: We searched PubMed, MEDLINE, EMBASE and the Cochrane Library for relevant studies published up to and including December 31, 2013. We calculated pooled risk ratios (RRs) for cancer risk.
   Results: A total of 17 studies (9 cohort studies, 8 case-control studies) were selected for further study. These studies included 149,607 female subjects, of which 53,812 were CCBs users, who were followed for 2-16 years. The risks of breast cancer among patients receiving CCBs were significantly different for the pooled RRs (95% confidence interval) of cohort studies 1.08 (0.95, 1.20) and case-control studies 0.98 (0.86, 1.09). Differences were also noted for cancer risk, for CCBs use of <5 years 0.96 (0.78, 1.15), and for >5 years 1.01 (0.74, 1.28), as well as for ever used 1.08 (0.95, 1.20), and for current use 1.13 (0.83, 1.42). The RR for studies longer than 10 years was 1.71 (1.01, 2.42), and for studies evaluating nifedipine was 1.10 (0.87, 1.33) and diltiazem was 0.75 (0.40, 1.10).
   Conclusions: The long-term use of CCBs appears to have a significant relationship with breast cancer. Well-designed clinical trials are needed to optimize the doses and types of these drugs needed to minimize their carcinogenic potential.
C1 [Li, Wen; Shi, Qi; Liu, Jianrong; Hou, Fenggang] Shanghai TCM Univ, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China.
   [Wang, Weibing] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.
   [Li, Qi] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Oncol, Shanghai, Peoples R China.
RP Hou, FG (reprint author), Shanghai TCM Univ, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China.
EM fghou555@126.com
FU Shanghai Municipal Education Commission [12YZ057, 10CG25]; Fundamental
   Research Funds for the Central Universities [78210021]
FX This work is supported by Innovation Project of Shanghai Municipal
   Education Commission (12YZ057), the Fundamental Research Funds for the
   Central Universities (78210021) and the Chenguang Program from Shanghai
   Municipal Education Commission (10CG25). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altamirano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081222
   Assimes TL, 2008, PHARMACOEPIDEM DR S, V17, P1039, DOI 10.1002/pds.1656
   Beiderbeck-Noll AB, 2003, EUR J CANCER, V39, P98, DOI 10.1016/S0959-8049(02)00157-0
   Braun S, 1998, J AM COLL CARDIOL, V31, P804, DOI 10.1016/S0735-1097(98)00008-4
   CARSON DA, 1993, LANCET, V341, P1251, DOI 10.1016/0140-6736(93)91154-E
   Chobanian AV, 1996, JAMA-J AM MED ASSOC, V276, P829, DOI 10.1001/jama.276.10.829
   Curry MC, 2013, BIOCH BIOPHYSICAL RE
   Das Arindam, 2013, Pigment Cell Melanoma Res, V26, P874, DOI 10.1111/pcmr.12155
   Davis S, 2007, EUR J EPIDEMIOL, V22, P319, DOI 10.1007/s10654-007-9135-0
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fitzpatrick AL, 1997, CANCER, V80, P1438, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6
   Fryzek JP, 2006, BREAST CANCER RES TR, V97, P231, DOI 10.1007/s10549-005-9091-x
   Gonzalez-Perez A, 2004, PHARMACOEPIDEM DR S, V13, P581, DOI 10.1002/pds.910
   Handayani S, 2013, INDONESIAN J PHARM, V23
   Hole DJ, 1998, J HYPERTENS, V16, P119, DOI 10.1097/00004872-199816010-00017
   Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001
   Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345
   Jang SJ, 2013, BIOORG MED CHEM LETT, V23, P6656, DOI 10.1016/j.bmcl.2013.10.049
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0
   Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001
   KONRADDALHOFF I, 1991, EUR J CLIN PHARMACOL, V41, P313, DOI 10.1007/BF00314958
   Li CI, 2013, JAMA INTERN MED, V173, P1629, DOI 10.1001/jamainternmed.2013.9071
   Li CI, 2003, CANCER, V98, P1504, DOI 10.1002/cncr.11663
   Lindberg G, 2002, PHARMACOEPIDEM DR S, V11, P493, DOI 10.1002/pds.737
   Meier CR, 2000, ARCH INTERN MED, V160, P349, DOI 10.1001/archinte.160.3.349
   Michels KB, 1998, CANCER, V83, P2003, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.3.CO;2-V
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Moon D, 2013, J SURG RES, V180, P208, DOI 10.1016/j.jss.2012.04.027
   Olsen JH, 1997, HYPERTENSION, V29, P1091, DOI 10.1161/01.HYP.29.5.1091
   Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8
   Pahor M, 1996, LANCET, V347, P1061, DOI 10.1016/S0140-6736(96)90276-7
   PAHOR M, 1994, J AM GERIATR SOC, V42, P50, DOI 10.1111/j.1532-5415.1994.tb06073.x
   Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889
   PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620
   QUINN M, 1995, BRIT MED J, V311, P1391, DOI 10.1136/bmj.311.7017.1391
   Rosenberg L, 1998, JAMA-J AM MED ASSOC, V279, P1000, DOI 10.1001/jama.279.13.1000
   Saltzman BS, 2013, CANCER CAUSE CONTROL, V24, P365, DOI 10.1007/s10552-012-0122-8
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Sorensen HT, 2000, CANCER-AM CANCER SOC, V89, P165, DOI 10.1002/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G
   STEIN G, 1990, ARCH TOXICOL, V64, P623, DOI 10.1007/BF01974690
   WAGENKNECHT LE, 1995, BRIT MED J, V310, P776, DOI 10.1136/bmj.310.6982.776
NR 43
TC 9
Z9 9
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 3
PY 2014
VL 9
IS 9
AR e105801
DI 10.1371/journal.pone.0105801
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO3TB
UT WOS:000341257700025
PM 25184210
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Li, YY
   Chen, Y
   Zhao, Y
AF Li, Yuanyuan
   Chen, Yu
   Zhao, Ying
TI The Diagnostic Value of the FIB-4 Index for Staging Hepatitis B-Related
   Fibrosis: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID CHRONIC VIRAL-HEPATITIS; HIV-INFECTED PATIENTS; TRANSIENT ELASTOGRAPHY
   FIBROSCAN; SIMPLE NONINVASIVE INDEXES; PREDICTING LIVER FIBROSIS; C
   VIRUS-INFECTION; SYSTEMATIC REVIEWS; TEST ACCURACY;
   HEPATOCELLULAR-CARCINOMA; ESOPHAGEAL-VARICES
AB Background: Liver fibrosis stage is an important factor in determining prognosis and need for treatment in patients infected with hepatitis B virus (HBV). Liver biopsies are typically used to assess liver fibrosis; however, noninvasive alternatives such as the FIB-4 index have also been developed.
   Aims: To quantify the accuracy of the FIB-4 index in the diagnosis of HBV related fibrosis and cirrhosis.
   Methods: A meta-analysis of studies comparing the diagnostic accuracy of the FIB-4 index vs. liver biopsy in HBV-infected patients was performed using studies retrieved from the following databases: PubMed, Ovid, EMBASE, the Cochrane Library, the Chinese National Knowledge Infrastructure and the Chinese Biology Medicine disc. A hierarchical summary receiver operating curves model and bivariate model were used to produce summary receiver operating characteristic curves and pooled estimates of sensitivity and specificity. The heterogeneity was explored with meta-regression analysis. Publication bias was detected using Egger's test and the trim and fill method.
   Results: 12 studies (N = 1,908) and 10 studies (N = 2,105) were included in the meta-analysis for significant fibrosis and cirrhosis, respectively. For significant fibrosis, the area under the hierarchical summary receiver operating curve (AUHSROC) was 0.78 (95% CI = 0.74-0.81). The recommended cutoff value was between 1.45 and 1.62, and the AUHSROC, summary sensitivity and specificity were 0.78 (95% CI = 0.74-0.81), 0.65 (95% CI = 0.56-0.73) and 0.77 (95% CI = 0.7-0.83), respectively. For cirrhosis, the AUHSROC was 0.89 (95% CI = 0.85-0.91). The recommended cutoff value was between 2.9 and 3.6, and the AUHSROC, summary sensitivity and specificity were 0.96 (95% CI = 0.92-1.00), 0.42 (95% CI = 0.36-0.48) and 0.96 (95% CI = 0.95-0.97), respectively. No publication bias was detected.
   Conclusions: The FIB-4 index is valuable for detecting significant fibrosis and cirrhosis in HBV-infected patients, but has suboptimal accuracy in excluding fibrosis and cirrhosis.
C1 [Li, Yuanyuan; Chen, Yu; Zhao, Ying] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Lab Med, Hangzhou 310003, Zhejiang, Peoples R China.
RP Chen, Y (reprint author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Lab Med, Hangzhou 310003, Zhejiang, Peoples R China.
EM yuchenyuchen666@126.com
CR ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188
   Basar O, 2013, CLIN RES HEPATOL GAS, V37, P152, DOI 10.1016/j.clinre.2012.07.003
   BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007
   Beckebaum S, 2010, TRANSPLANTATION, V89, P983, DOI 10.1097/TP.0b013e3181cc66ca
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022
   Bonnard P, 2010, AM J TROP MED HYG, V82, P454, DOI 10.4269/ajtmh.2010.09-0088
   Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706
   Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018
   Chen BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068780
   Cheong JY, 2011, DIGEST DIS SCI, V56, P555, DOI 10.1007/s10620-010-1305-3
   Chon YE, 2012, J CLIN GASTROENTEROL, V46, P518, DOI 10.1097/MCG.0b013e31825079f1
   Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005
   Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011
   de Franchis R, 2008, J HEPATOL, V49, P520, DOI 10.1016/j.jhep.2008.07.009
   de Ledinghen V, 2013, ALIMENT PHARM THER, V37, P979, DOI 10.1111/apt.12307
   Ding D, 2013, J HBUM, P245
   Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Erdogan S, 2013, SCAND J CLIN LAB INV, V73, P300, DOI 10.3109/00365513.2013.773592
   Friedman Lawrence S, 2004, Curr Gastroenterol Rep, V6, P30, DOI 10.1007/s11894-004-0023-4
   [巩海燕 Gong Haiyan], 2013, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V33, P131
   Gumusay O, 2013, HEPATOL RES, V43, P228, DOI 10.1111/j.1872-034X.2012.01057.x
   Huang YC, 2011, J GASTROEN HEPATOL, V26, P129, DOI 10.1111/j.1440-1746.2010.06476.x
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Jain MK, 2012, AIDS PATIENT CARE ST, V26, P73, DOI 10.1089/apc.2011.0191
   Ji D, 2011, MED J CLIN PLA, V36
   Jin WW, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-14
   Kim BK, 2010, DIGEST DIS SCI, V55, P2636, DOI 10.1007/s10620-009-1070-3
   Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x
   Lan X, 2012, CHINESE J HLTH LAB T, P2467
   Lee JH, 2009, J VIRAL HEPATITIS, V16, P444, DOI 10.1111/j.1365-2893.2009.01091.x
   Lee MH, 2010, DIGEST DIS SCI, V55, P3552, DOI 10.1007/s10620-010-1219-0
   Leeflang MMG, 2014, CLIN MICROBIOL INFEC, V20, P105, DOI 10.1111/1469-0691.12474
   Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032
   Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008
   Li X, 2012, J CLIN HEPATOL, V15, P472
   Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364
   Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185
   Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105
   Liu XD, 2012, WORLD J GASTROENTERO, V18, P2784, DOI 10.3748/wjg.v18.i22.2784
   Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513
   Lu XL, 2013, NEPHROL DIAL TRANSPL, V28, P122, DOI 10.1093/ndt/gfs339
   Ma J, 2013, EUR J GASTROEN HEPAT, V25, P428, DOI 10.1097/MEG.0b013e32835cb5dd
   Mallet V, 2009, ALIMENT PHARM THER, V29, P409, DOI 10.1111/j.1365-2036.2008.03895.x
   Molto J, 2009, J ANTIMICROB CHEMOTH, V63, P992, DOI 10.1093/jac/dkp070
   Nalpas B, 2009, J HEPATOL, V50, pS142, DOI 10.1016/S0168-8278(09)60376-7
   Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010
   Pissaia A, 2009, TRANSPL P, V41, P679, DOI 10.1016/j.transproceed.2008.12.014
   Regev A, 2002, AM J GASTROENTEROL, V97, P2614
   Salkic NN, 2014, AM J GASTROENTEROL, V109, P796, DOI 10.1038/ajg.2014.21
   SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O
   Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x
   Seto W-K, 2011, PLOS ONE, V6
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725
   Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842
   Ucar F, 2013, EUR J GASTROEN HEPAT, V25, P1076, DOI 10.1097/MEG.0b013e32835fd699
   Wang F, 2008, STAT MED, V27, P243, DOI 10.1002/sim.2828
   Wang H, 2013, J VIRAL HEPATITIS, V20, pe3, DOI 10.1111/jvh.12010
   Wang Y, 2013, HEPATOL RES, V43, P441, DOI 10.1111/j.1872-034X.2012.01094.x
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   Wong GLH, 2010, ALIMENT PHARM THER, V31, P1095, DOI 10.1111/j.1365-2036.2010.04276.x
   Wu SD, 2010, WORLD J GASTROENTERO, V16, P501, DOI 10.3748/wjg.v16.i4.501
   Xu MY, 2013, BIOMED PHARMACOTHER, V67, P561, DOI 10.1016/j.biopha.2013.03.021
   Xun YH, 2013, J GASTROEN HEPATOL, V28, P1746, DOI 10.1111/jgh.12304
   Zhang Y, 2009, CH J GASTROENTERO IH, V1, P213
   Zhang Y, 2012, CHIN J CLIN INFECT D, V5, P338
   Zhang Yu-feng, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P215
   Zhou J, 2013, INT J LAB MED, P409
   Zhu CL, 2012, J DIGEST DIS, V13, P558, DOI 10.1111/j.1751-2980.2012.00629.x
   Zhu X, 2011, DIGEST DIS SCI, V56, P2742, DOI 10.1007/s10620-011-1659-1
   ZWEIG MH, 1993, CLIN CHEM, V39, P561
NR 74
TC 19
Z9 21
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2014
VL 9
IS 8
AR e105728
DI 10.1371/journal.pone.0105728
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO4JP
UT WOS:000341303700039
PM 25165830
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, SY
   Shen, QY
   Tang, YM
   He, L
   Li, Y
   Li, H
   Li, M
   Peng, Y
AF Chen, Shuying
   Shen, Qingyu
   Tang, Yamei
   He, Lei
   Li, Yi
   Li, Hui
   Li, Mei
   Peng, Ying
TI Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke
   Prevention among High Vascular Risk Patients: A Meta-Analysis of
   Randomized Controlled Trials
SO PLOS ONE
LA English
DT Article
ID DUAL ANTIPLATELET THERAPY; TRANSIENT ISCHEMIC ATTACK;
   MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; RATIONALE; DESIGN; SURGERY
AB Objectives: Whether clopidogrel should be added to aspirin for stroke prevention remained controversial for the risk of hemorrhagic complications. This meta-analysis was aimed to assess the efficacy and safety of adding clopidogrel to aspirin on stroke prevention in high vascular risk patients, and to provide evidence for a suitable duration of dual antiplatelet therapy.
   Methods: We searched PubMed, EMBase, OVID and Cochrane Central Register of Controlled Trials (up to June, 2013) for randomized controlled trials evaluating the efficacy and safety of clopidogrel plus aspirin versus aspirin alone in high vascular risk patients. Comparisons of stroke and hemorrhagic complications between treatment groups were expressed by the pooled Relative Risks (RRs) with 95% Confidence Intervals (CIs).
   Results: Fifteen trials with a total of 97692 intention-to-treat participants were included with duration of follow-up ranging from 7 days to 3.6 years. Dual antiplatelet therapy reduced all stroke by 21% (RR: 0.79, 95% CI: 0.73-0.85) with no evidence of heterogeneity across the trials (P = 0.27, I-2 = 17%). The effects were consistent between short-term subgroup (<= 1 month, RR: 0.76, 95% CI: 0.67-0.85) and long-term subgroup (>= 3 months, RR: 0.81, 95% CI: 0.73-0.89). The risk of major bleeding was not significantly increased by dual antiplatelet therapy in short-term subgroup (RR: 1.11, 95% CI: 0.91-1.36), while significantly increased in long-term subgroup (RR: 1.52, 95% CI: 1.36-1.69). Long-term dual antiplatelet therapy substantially increased the risk of intracranial bleeding (RR: 1.76, 95% CI: 1.22-2.54).
   Conclusions: This meta-analysis demonstrates that short-term combination of clopidogrel and aspirin is effective and safe for stroke prevention in high vascular risk patients. Long-term combination therapy substantially increases the risk of major bleeding and intracranial bleeding.
C1 [Chen, Shuying; Tang, Yamei; He, Lei; Li, Yi; Li, Mei; Peng, Ying] Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.
   [Shen, Qingyu] Sun Yat Sen Univ, Dept Neurol, Affiliated Boji Hosp, Guangzhou 510275, Guangdong, Peoples R China.
   [Li, Hui] Guangdong Gen Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.
RP Peng, Y (reprint author), Sun Yat Sen Univ, Dept Neurol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.
EM 2353352460@qq.com
FU Sub-Program of National "12-5'' Science & Technology Plan Project of
   China [2011BAI08B11]; International Collaboration Program of
   Universities in Guangdong Province [2012gjhz001]; National Natural
   Science Key Program Foundation of China of Sun Yat-Sen University
   [10ykjc26]
FX This study was supported by the Sub-Program of National "12-5'' Science
   & Technology Plan Project of China (NO. 2011BAI08B11 to Ying Peng),
   International Collaboration Program of Universities in Guangdong
   Province (NO. 2012gjhz001 to Ying Peng), and the culture funds for
   National Natural Science Key Program Foundation of China of Sun Yat-Sen
   University (No. 10ykjc26 to Ying Peng). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Belch JJF, 2010, J VASC SURG, V52, P825, DOI 10.1016/j.jvs.2010.04.027
   Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133
   Benavente OR, 2011, INT J STROKE, V6, P164, DOI 10.1111/j.1747-4949.2010.00573.x
   Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989
   Bhatt DL, 2004, AM HEART J, V148, P263, DOI 10.1016/j.ahj.2004.03.028
   Chen ZM, 2005, LANCET, V366, P1607
   Connolly S, 2006, AM HEART J, V151, P1187, DOI 10.1016/j.ahj.2005.06.026
   Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Gent M, 1996, LANCET, V348, P1329
   Gouya G, 2014, STROKE, V45, P492, DOI 10.1161/STROKEAHA.113.002590
   Hankey GJ, 2011, INT J STROKE, V6, P3, DOI 10.1111/j.1747-4949.2010.00535.x
   Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8
   Kulik A, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-15
   Kulik A, 2010, CIRCULATION, V122, P2680, DOI 10.1161/CIRCULATIONAHA.110.978007
   Lee M, 2013, ANN INTERN MED, V159, P463, DOI [10.7326/00030003-4819-159-7-201310010-00006, 10.7326/0003-4819-159-7-201310010-00006]
   Liu LS, 2000, J CARDIOVASC RISK, V7, P435
   Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Palacio S, 2013, INT J STROKE
   Palacio S, 2012, STROKE, V43, P2157, DOI 10.1161/STROKEAHA.112.656173
   Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266
   Sabatine MS, 2005, AM HEART J, V149, P227, DOI 10.1016/j.ahj.2004.11.006
   Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522
   Sun JCJ, 2010, AM HEART J, V160, P1178, DOI 10.1016/j.ahj.2010.07.035
   Ussia GP, 2011, AM J CARDIOL, V108, P1772, DOI 10.1016/j.amjcard.2011.07.049
   Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340
   Wang YJ, 2010, AM HEART J, V160, P380, DOI 10.1016/j.ahj.2010.05.017
   Wong KSL, 2013, CIRCULATION, V128, P1656, DOI 10.1161/CIRCULATIONAHA.113.003187
   Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
   Yusuf S, 2000, EUR HEART J, V21, P2033
   Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031642
NR 33
TC 1
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 11
PY 2014
VL 9
IS 8
AR e104402
DI 10.1371/journal.pone.0104402
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO1WB
UT WOS:000341105100052
PM 25110930
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tie, RX
   Zhang, TS
   Fu, HR
   Wang, LM
   Wang, YB
   He, Y
   Wang, BS
   Zhu, N
   Fu, S
   Lai, XY
   Shi, JM
   Huang, H
AF Tie, Ruxiu
   Zhang, Tiansong
   Fu, Huarui
   Wang, Limengmeng
   Wang, Yebo
   He, Ying
   Wang, Binsheng
   Zhu, Ni
   Fu, Shan
   Lai, Xiaoyu
   Shi, Jimin
   Huang, He
TI Association between DNMT3A Mutations and Prognosis of Adults with De
   Novo Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID MICRORNA-EXPRESSION SIGNATURES; ACUTE MYELOGENOUS LEUKEMIA; GROUP-B;
   PUBLICATION BIAS; POOR-PROGNOSIS; CLINICAL-IMPLICATIONS; OLDER PATIENTS;
   FUNNEL PLOTS; GENE; IMPACT
AB Background: DNA methyltransferase 3A (DNMT3A) mutations were considered to be independently associated with unfavorable prognosis in adults with de novo acute myeloid leukemia (AML), however, there are still debates on this topic. Here, we aim to further investigate the association between DNMT3A mutations and prognosis of patients with AML.
   Methods: Eligible studies were identified from several data bases including PubMed, Embase, Web of Science, ClinicalTrials and the Cochrane Library (up to June 2013). The primary endpoint was overall survival (OS), while relapse-free survival (RFS) and event-free survival (EFS) were chosen as secondary endpoints. If possible, we would pool estimate effects (hazard ratio [HR] with 95% confidence interval[CI]) of outcomes in random and fixed effects models respectively.
   Results: That twelve cohort studies with 6377 patients exploring the potential significance of DNMT3A mutations on prognosis were included. Patients with DNMT3A mutations had slightly shorter OS (HR = 1.60; 95% CI, 1.31-1.95; P < 0.001), as compared to wild-type carriers. Among the patients younger than 60 years of age, DNMT3A mutations predicted a worse OS (HR = 1.84; 95% CI, 1.36-2.50; P < 0.001). In addition, mutant DNMT3A predicted inferior OS (HR = 2.30; 95% CI, 1.78-2.97; P = 0.862) in patients with unfavorable genotype abnormalities. Similar results were also found in some other subgroups. However, no significant prognostic value was found on OS (HR = 1.40; 95% CI, 0.98-1.99; P = 0.798) in the favorable genotype subgroup. Similar results were found on RFS and EFS under different conditions.
   Conclusions: DNMT3A mutations have slightly but significantly poor prognostic impact on OS, RFS and EFS of adults with de novo AML in total population and some specific subgroups.
C1 [Tie, Ruxiu; Fu, Huarui; Wang, Limengmeng; Wang, Yebo; He, Ying; Wang, Binsheng; Zhu, Ni; Fu, Shan; Lai, Xiaoyu; Shi, Jimin; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China.
   [Zhang, Tiansong] Jingan Dist Cent Hosp, Dept TCM, Shanghai, Peoples R China.
RP Huang, H (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China.
EM hehuang.zju@gmail.com
FU National Natural Science Foundation of China [81170526]; National
   Natural Science Foundation for Distinguished Young Scholars of China
   [81100364]; Zhejiang Province Natural Science Major Foundation
   [Z2100097]; Zhejiang Province Natural Science Foundation [Y2110152];
   Public Welfare Research Subproject from National Ministry of Health
   [201202017]
FX The research article was supported by the National Natural Science
   Foundation of China (No: 81170526), the National Natural Science
   Foundation for Distinguished Young Scholars of China (No: 81100364), the
   Zhejiang Province Natural Science Major Foundation (No: Z2100097), the
   Zhejiang Province Natural Science Foundation (No: Y2110152) and the
   Public Welfare Research Subproject from National Ministry of Health (No:
   201202017). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abdel-Wahab O, 2012, HEMATOLOGY, V17, pS39, DOI 10.1179/102453312X13336169155411
   Becker H, 2010, BLOOD, V116, P255
   Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772
   Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036
   Deeks J, 2011, COCHRANE HDB SYSTEMA
   Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974
   Gaidzik VI, 2013, BLOOD, V121, P4769, DOI 10.1182/blood-2012-10-461624
   Grimwade D, 1998, BLOOD, V92, P2322
   Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441
   Hou HA, 2012, BLOOD, V119, P559, DOI 10.1182/blood-2011-07-369934
   Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143
   Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554
   Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092
   Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730
   Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840
   Markova J, 2012, EUR J HAEMATOL, V88, P128, DOI 10.1111/j.1600-0609.2011.01716.x
   Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981
   Ostronoff F, 2013, LEUKEMIA, V27, P238, DOI 10.1038/leu.2012.168
   Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206
   Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304
   Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010
   Renneville A, 2012, LEUKEMIA, V26, P1247, DOI 10.1038/leu.2011.382
   Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961
   Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6
   Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988
   Shivarov V, 2013, LEUKEMIA RES, V37, P1445, DOI 10.1016/j.leukres.2013.07.032
   Slovak ML, 2000, BLOOD, V96, P4075
   Taskesen E, 2011, BLOOD, V117, P2469, DOI 10.1182/blood-2010-09-307280
   Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326
   Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Wells GA, 2012, NEWCASTLE OTTAWA SCA
   Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648
   Xu Y, 2012, BLOOD, P120
   Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117
   Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788
NR 44
TC 24
Z9 24
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 17
PY 2014
VL 9
IS 6
AR e93353
DI 10.1371/journal.pone.0093353
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK5YM
UT WOS:000338503400002
PM 24936645
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Riper, H
   Blankers, M
   Hadiwijaya, H
   Cunningham, J
   Clarke, S
   Wiers, R
   Ebert, D
   Cuijpers, P
AF Riper, Heleen
   Blankers, Matthijs
   Hadiwijaya, Hana
   Cunningham, John
   Clarke, Stella
   Wiers, Reinout
   Ebert, David
   Cuijpers, Pim
TI Effectiveness of Guided and Unguided Low-Intensity Internet
   Interventions for Adult Alcohol Misuse: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; COMPUTER-DELIVERED INTERVENTIONS; SERVICES
   TASK-FORCE; PROBLEM DRINKERS; PRIMARY-CARE; SELF-HELP; PROBLEM DRINKING;
   USE DISORDERS; HEALTH-CARE; COST-EFFECTIVENESS
AB Background: Alcohol misuse ranks within the top ten health conditions with the highest global burden of disease. Low-intensity, Internet interventions for curbing adult alcohol misuse have been shown effective. Few meta-analyses have been carried out, however, and they have involved small numbers of studies, lacked indicators of drinking within low risk guidelines, and examined the effectiveness of unguided self-help only. We therefore conducted a more thorough meta-analysis that included both guided and unguided interventions.
   Methods: Systematic literature searches were performed up to September 2013. Primary outcome was the mean level of alcohol consumption and drinking within low risk guidelines for alcohol consumption at post-treatment.
   Findings: We selected 16 randomised controlled trials (with 23 comparisons and 5,612 participants) for inclusion. Results, showed a small but significant overall effect size in favour of Internet interventions (g = 0.20, 95% CI: 0.13-0.27, p<.001). Participants in Internet interventions drunk on average 22 grams of ethanol less than controls and were significantly more likely to be adhering to low-risk drinking guidelines at post-treatment (RD 0.13, 95% CI: 0.09-0.17, p<.001). Subgroup analyses revealed no significant differences in potential moderators for the outcome of alcohol consumption, although there was a near-significant difference between comparisons with waitlist control and those with assessment-only or alcohol information control conditions (p = .056).
   Conclusions: Internet interventions are effective in reducing adult alcohol consumption and inducing alcohol users to adhere to guidelines for low-risk drinking. This effect is small but from a public health point of view this may warrant large scale implementation at low cost of Internet interventions for adult alcohol misuse. Moderator analyses with sufficient power are, however, needed in order to assess the robustness of these overall results and to assess whether these interventions may impact on subgroups with different levels of success.
C1 [Riper, Heleen; Hadiwijaya, Hana; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Riper, Heleen; Hadiwijaya, Hana; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst, Amsterdam, Netherlands.
   [Riper, Heleen; Ebert, David; Cuijpers, Pim] Leuphana Univ, EU Innovat Incubator, Div Hlth Trainings Online, Luneburg, Germany.
   [Blankers, Matthijs] Arkin Mental Hlth Care, Amsterdam, Netherlands.
   [Blankers, Matthijs] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands.
   [Blankers, Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam Inst Addict Res, NL-1012 WX Amsterdam, Netherlands.
   [Cunningham, John] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia.
   [Cunningham, John] Ctr Addict & Mental Hlth, Toronto, ON, Canada.
   [Clarke, Stella] NHS Fife, Edinburgh, Midlothian, Scotland.
   [Wiers, Reinout] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol ADAPT Lab, Amsterdam, Netherlands.
   [Ebert, David] Univ Marburg, Dept Psychol, Div Clin Psychol & Psychotherapy, D-35032 Marburg, Germany.
   [Hadiwijaya, Hana] Tilburg Univ, Dept Dev Psychol, TS Social & Behav Sci, NL-5000 LE Tilburg, Netherlands.
RP Riper, H (reprint author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
EM h.riper@vu.nl
RI Cuijpers, Pim/G-1703-2013
OI Wiers, Reinout/0000-0002-4312-9766; Cuijpers, Pim/0000-0001-5497-2743;
   Ebert, David Daniel/0000-0001-6820-0146
CR Apodaca TR, 2003, J CLIN PSYCHOL, V59, P289, DOI 10.1002/jclp.10130
   Bischof G, 2008, DRUG ALCOHOL DEPEN, V93, P244, DOI 10.1016/j.drugalcdep.2007.10.003
   Blankers M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2052
   Blankers M, 2011, J CONSULT CLIN PSYCH, V79, P330, DOI 10.1037/a0023498
   Boon B., 2006, GEZOND VERSTAND EVID
   Boon B, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1695
   Borenstein M, 2009, INTRO META ANAL
   Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843
   Chan KK, 2007, ADDICT BEHAV, V32, P967, DOI 10.1016/j.addbeh.2006.07.003
   Cohen J, 1997, STAT POWER ANAL BEHA
   Cuijpers P, 2004, ADDICTION, V99, P839, DOI 10.1111/j.1360-0443.2004.00778.x
   Cuijpers P., 2010, PSYCHOL MED, V21, P1
   Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776
   Cunningham JA, 2004, ADDICT BEHAV, V29, P221, DOI 10.1016/S0306-4603(03)00077-7
   Cunningham JA, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-150
   Cunningham JA, 2010, DRUG ALCOHOL REV, V29, P617, DOI 10.1111/j.1465-3362.2010.00201.x
   Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x
   Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5
   Donker T, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-59
   Doumas DM, 2008, J SUBST ABUSE TREAT, V34, P263, DOI 10.1016/j.jsat.2007.04.006
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11
   Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P763, DOI 10.1111/j.1530-0277.2008.00635.x
   Hansen ABG, 2012, J MED INTERNET RES, V14, P3, DOI 10.2196/jmir.1883
   Hester RK, 2013, J MED INTERNET RES, V15, P45, DOI 10.2196/jmir.2565
   HESTER RK, 1995, HDB ALCOHOLISM TREAT, P148
   Higgins JP, 2008, COCHRANE HDB SYSTEMA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hodgson R, 2002, ALCOHOL ALCOHOLISM, V37, P61, DOI 10.1093/alcalc/37.1.61
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544
   Jonas DE, 2012, 12EHC055EF AG HEALTH
   Kalden R, 1992, NIAAA PROJECT MATCH
   Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub3
   Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501
   Koski-Jannes A, 2001, ADDICT BEHAV, V26, P91, DOI 10.1016/S0306-4603(00)00092-7
   Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014
   Latimer N., 2009, PREVENTION EARLY IDE
   McCambridge J, 2013, DRUG ALCOHOL DEPEND
   McCambridge J, 2014, DRUG ALCOHOL DEPEN, V135, P156, DOI 10.1016/j.drugalcdep.2013.11.017
   Mdege ND, 2013, DRUG ALCOHOL DEPEN, V131, P1, DOI 10.1016/j.drugalcdep.2013.01.023
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x
   Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652
   Nilsen P, 2011, ADDICTION, V106, P1748, DOI 10.1111/j.1360-0443.2011.03476.x
   O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170
   Orsini N., 2006, HETEROGI STATA MODUL
   Osilla Karen Chan, 2012, Am J Manag Care, V18, pe68
   Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x
   Pedersen B, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-26
   Pemberton MR, 2011, J STUD ALCOHOL DRUGS, V72, P480, DOI 10.15288/jsad.2011.72.480
   Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014
   Postel MG, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1811
   Postel MG, 2010, J MED INTERNET RES, V12, P11, DOI 10.2196/jmir.1642
   Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38
   Purshouse RC, 2013, ALCOHOL ALCOHOLISM, V48, P180, DOI 10.1093/alcalc/ags103
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7
   Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004
   Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x
   Riper H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1691
   Riper H, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1102
   Riper H, 2009, ALCOHOL CLIN EXP RES, V33, P1401, DOI 10.1111/j.1530-0277.2009.00970.x
   Riper H, 2009, AM J PREV MED, V36, P247, DOI 10.1016/j.amepre.2008.10.016
   Robinson SM, 2014, ADDICT BEHAV, V39, P39, DOI 10.1016/j.addbeh.2013.09.029
   Roerecke M, 2013, J CLIN PSYCHIAT, V74, pE1181, DOI 10.4088/JCP.13r08379
   Rooke S, 2010, ADDICTION, V105, P1381, DOI 10.1111/j.1360-0443.2010.02975.x
   Saitz R, 2010, DRUG ALCOHOL REV, V29, P631, DOI 10.1111/j.1465-3362.2010.00217.x
   SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x
   Saunders JB, 2000, COMPR PSYCHIAT, V41, P95, DOI 10.1016/S0010-440X(00)80015-2
   Schulz DN, 2013, J MED INTERNET RES, V15, P53, DOI 10.2196/jmir.2568
   Smit F, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1694
   Suffoletto B, 2012, ALCOHOL CLIN EXP RES, V36, P552, DOI 10.1111/j.1530-0277.2011.01646.x
   Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318
   Tariq L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005696
   Vasilaki EI, 2006, ALCOHOL ALCOHOLISM, V41, P328, DOI 10.1093/alcalc/ag1016
   Vernon ML, 2010, J SUBST ABUSE TREAT, V38, P203, DOI 10.1016/j.jsat.2009.11.001
   Wallace P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014740
   Watson HE, 1999, J ADV NURS, V30, P513, DOI 10.1046/j.1365-2648.1999.01107.x
   Watson JM, 2013, DRUG ALCOHOL REV, V32, P356, DOI 10.1111/dar.12037
   White A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1479
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
   Wilson GB, 2011, CURR PSYCHIAT REP, V13, P422, DOI 10.1007/s11920-011-0219-x
   World Health Organization, 2000, INT GUID MON ALC CON
NR 85
TC 99
Z9 99
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 17
PY 2014
VL 9
IS 6
AR e99912
DI 10.1371/journal.pone.0099912
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK5YM
UT WOS:000338503400056
PM 24937483
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, HF
   Wang, F
   Ding, L
   Zhang, ZY
   Sun, DR
   Feng, XM
   An, JL
   Zhu, Y
AF Zhang, Haifei
   Wang, Feng
   Ding, Lin
   Zhang, Zhiyu
   Sun, Deri
   Feng, Xinmin
   An, Jiuli
   Zhu, Yue
TI A Meta Analysis of Lumbar Spinal Fusion Surgery Using Bone Morphogenetic
   Proteins and Autologous Iliac Crest Bone Graft
SO PLOS ONE
LA English
DT Article
ID PROTEIN-2/COMPRESSION RESISTANT MATRIX; INSTRUMENTED POSTEROLATERAL
   FUSIONS; RADIOGRAPHIC OUTCOMES; OSTEOGENIC PROTEIN-1; PUBLICATION BIAS;
   SITE MORBIDITY; RHBMP-2; SAFETY; METAANALYSIS; AUTOGRAFT
AB Background: Bone morphogenetic protein (BMPs) as a substitute for iliac crest bone graft (ICBG) has been increasingly widely used in lumbar fusion. The purpose of this study is to systematically compare the effectiveness and safety of fusion with BMPs for the treatment of lumbar disease.
   Methods: Cochrane review methods were used to analyze all relevant randomized controlled trials (RCTs) published up to nov 2013.
   Results: 19 RCTs (1,852 patients) met the inclusion criteria. BMPs group significantly increased fusion rate (RR: 1.13; 95% CI 1.05-1.23, P = 0.001), while there was no statistical difference in overall success of clinical outcomes (RR: 1.04; 95% CI 0.95-1.13, P = 0.38) and complications (RR: 0.96; 95% CI 0.85-1.09, p = 0.54). A significant reduction of the reoperation rate was found in BMPs group (RR: 0.57; 95% CI 0.42-0.77, p = 0.0002). Significant difference was found in the operating time (MD-0.32; 95% CI-0.55, -0.08; P = 0.009), but no significant difference was found in the blood loss, the hospital stay, patient satisfaction, and work status.
   Conclusion: Compared with ICBG, BMPs in lumbar fusion can increase the fusion rate, while reduce the reoperation rate and operating time. However, it doesn't increase the complication rate, the amount of blood loss and hospital stay. No significant difference was found in the overall success of clinical outcome of the two groups.
C1 [Zhang, Haifei; Wang, Feng; Zhang, Zhiyu; Sun, Deri; Feng, Xinmin; An, Jiuli] China Med Univ, Affiliated Hosp 4, Dept Orthoped, Shenyang, Peoples R China.
   [Ding, Lin] China Med Univ, Ctr Comp, Shenyang, Peoples R China.
   [Zhu, Yue] China Med Univ, Affiliated Hosp 1, Dept Orthoped, Shenyang, Peoples R China.
RP Zhu, Y (reprint author), China Med Univ, Affiliated Hosp 1, Dept Orthoped, Shenyang, Peoples R China.
EM zhuyuedr@163.com
CR Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   An H, 2003, SPINE, V28, pS24, DOI 10.1097/00007632-200308011-00005
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037
   Assiri I, 2004, CAN J SURG S, V47, P7
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   BLUMENTHAL SL, 1993, SPINE, V18, P1186, DOI 10.1097/00007632-199307000-00010
   Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532
   Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012
   Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337, DOI 10.1097/00024720-200210000-00001
   Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/01.BRS.0000030193.26290.DD
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Chen ZG, 2012, ARCH ORTHOP TRAUM SU, V132, P1725, DOI 10.1007/s00402-012-1607-3
   Dawson E, 2009, J BONE JOINT SURG AM, V91A, P1604, DOI 10.2106/JBJS.G.01157
   Delawi D, 2010, SPINE, V35, P1185, DOI 10.1097/BRS.0b013e3181d3cf28
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81
   Dimar JR, 2009, J BONE JOINT SURG AM, V91A, P1377, DOI 10.2106/JBJS.H.00200
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Donell S, 2011, BONE MORPHOGENETIC P
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f
   Glassman SD, 2005, SPINE, V30, P1694, DOI 10.1097/01.brs.0000172157.39513.80
   Glassman SD, 2008, SPINE, V33, P2843, DOI 10.1097/BRS.0b013e318190705d
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   HUTCHINSON MR, 1994, SPINE, V19, P62, DOI 10.1097/00007632-199401000-00013
   Johnsson R, 2002, SPINE, V27, P2654, DOI 10.1097/00007632-200212010-00004
   Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Michielsen J, 2013, J BONE JOINT SURG AM, V95A, P873, DOI 10.2106/JBJS.L.00137
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   Mussano F, 2007, SPINE, V32, P824, DOI 10.1097/01.brs.0000259227.51180.ca
   Papakostidis C, 2008, SPINE, V33, pE680, DOI 10.1097/BRS.0b013e3181844eca
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vaccaro AR, 2008, SPINE, V33, P2850, DOI 10.1097/BRS.0b013e31818a314d
   Vaccaro AR, 2005, SPINE, V30, P2709, DOI 10.1097/01.brs.0000190812.08447.ba
   Viera AJ, 2005, FAM MED, V37, P360
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 52
TC 8
Z9 8
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 2
PY 2014
VL 9
IS 6
AR e97049
DI 10.1371/journal.pone.0097049
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6CB
UT WOS:000336956300011
PM 24886911
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Arnberg, FK
   Linton, SJ
   Hultcrantz, M
   Heintz, E
   Jonsson, U
AF Arnberg, Filip K.
   Linton, Steven J.
   Hultcrantz, Monica
   Heintz, Emelie
   Jonsson, Ulf
TI Internet-Delivered Psychological Treatments for Mood and Anxiety
   Disorders: A Systematic Review of Their Efficacy, Safety, and
   Cost-Effectiveness
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; UNGUIDED
   SELF-HELP; SOCIAL PHOBIA; PANIC DISORDER; FOLLOW-UP; MENTAL-DISORDERS;
   CLINICAL-TRIALS; NON-INFERIORITY; PRIMARY-CARE
AB Background: Greater access to evidence-based psychological treatments is needed. This review aimed to evaluate whether internet-delivered psychological treatments for mood and anxiety disorders are efficacious, noninferior to established treatments, safe, and cost-effective for children, adolescents and adults.
   Methods: We searched the literature for studies published until March 2013. Randomized controlled trials (RCTs) were considered for the assessment of short-term efficacy and safety and were pooled in meta-analyses. Other designs were also considered for long-term effect and cost-effectiveness. Comparisons against established treatments were evaluated for noninferiority. Two reviewers independently assessed the relevant studies for risk of bias. The quality of the evidence was graded using an international grading system.
   Results: A total of 52 relevant RCTs were identified whereof 12 were excluded due to high risk of bias. Five cost-effectiveness studies were identified and three were excluded due to high risk of bias. The included trials mainly evaluated internet-delivered cognitive behavioral therapy (I-CBT) against a waiting list in adult volunteers and 88% were conducted in Sweden or Australia. One trial involved children. For adults, the quality of evidence was graded as moderate for the short-term efficacy of I-CBT vs. waiting list for mild/moderate depression (d = 0.83; 95% CI 0.59, 1.07) and social phobia (d = 0.85; 95% CI 0.66, 1.05), and moderate for no efficacy of internet-delivered attention bias modification vs. sham treatment for social phobia (d = 20.04; 95% CI 20.24, 0.35). The quality of evidence was graded as low/very low for other disorders, interventions, children/adolescents, noninferiority, adverse events, and cost-effectiveness.
   Conclusions: I-CBT is a viable treatment option for adults with depression and some anxiety disorders who request this treatment modality. Important questions remain before broad implementation can be supported. Future research would benefit from prioritizing adapting treatments to children/adolescents and using noninferiority designs with established forms of treatment.
C1 [Arnberg, Filip K.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden.
   [Linton, Steven J.] Univ Orebro, Dept Law Psychol & Social Work, Ctr Hlth & Med Psychol, SE-70182 Orebro, Sweden.
   [Hultcrantz, Monica; Heintz, Emelie; Jonsson, Ulf] Swedish Council Hlth Technol Assessment, Stockholm, Sweden.
   [Heintz, Emelie] Linkoping Univ, Dept Med & Hlth Sci, Ctr Med Technol Assessment CMT, Linkoping, Sweden.
   [Jonsson, Ulf] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.
RP Arnberg, FK (reprint author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.
EM filip.arnberg@neuro.uu.se
RI Arnberg, Filip/I-5756-2019
OI Arnberg, Filip/0000-0002-1317-2093; Heintz, Emelie/0000-0002-0715-7591
FU Swedish Council on Health Technology Assessment
FX This work was funded by the Swedish Council on Health Technology
   Assessment (www.sbu.se). The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Andersson E, 2012, PSYCHOL MED, V42, P2193, DOI 10.1017/S0033291712000244
   Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677
   Andersson G, 2013, J MENT HEALTH, V22, P155, DOI 10.3109/09638237.2011.608747
   Andersson G, 2012, PSYCHOTHER PSYCHOSOM, V81, P344, DOI 10.1159/000339371
   Andersson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037411
   Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960
   Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P55, DOI 10.1080/16506070902916400
   Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P114, DOI 10.1080/16506070902931326
   Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010
   Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196
   Arnberg FK, 2013, J PSYCHOSOM RES, V75, P401, DOI 10.1016/j.jpsychores.2013.08.019
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429
   Bell CJ, 2012, AUST NZ J PSYCHIAT, V46, P630, DOI 10.1177/0004867412437345
   Berger Thomas, 2011, Cognitive Behaviour Therapy, V40, P251, DOI 10.1080/16506073.2011.616531
   Berger T, 2009, J CLIN PSYCHOL, V65, P1021, DOI 10.1002/jclp.20603
   Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54
   Boettcher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071760
   Boettcher J, 2012, COGNITIVE THER RES, V36, P522, DOI 10.1007/s10608-011-9374-y
   Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003
   Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002
   Carlbring P, 2001, BEHAV THER, V32, P751, DOI 10.1016/S0005-7894(01)80019-8
   Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107
   Carlbring P, 2006, AM J PSYCHIAT, V163, P2119, DOI 10.1176/appi.ajp.163.12.2119
   Carlbring P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-66
   Carlbring P, 2013, J AFFECT DISORDERS, V148, P331, DOI 10.1016/j.jad.2012.12.020
   Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002
   Carlbring P, 2009, BEHAV RES THER, V47, P848, DOI 10.1016/j.brat.2009.06.012
   Chambless D. L., 1998, CLIN PSYCHOL, V51, P3, DOI DOI 10.1037//0022-006X.66.1.53
   Choi I, 2012, J AFFECT DISORDERS, V136, P459, DOI 10.1016/j.jad.2011.11.003
   Cohen J, 1988, STAT POWER ANAL BEHA
   Collaboration TC, 2014, COCHR ED PUBL POL RE
   Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6
   Cuijpers P, 2011, AM J PSYCHIAT, V168, P581, DOI 10.1176/appi.ajp.2010.10101411
   D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425
   Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996
   Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463
   Griffiths KM, 2010, MED J AUSTRALIA, V192, pS4
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017
   Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021
   Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/ERP.12.67, 10.1586/erp.12.67]
   Hedman E, 2011, BEHAV RES THER, V49, P729, DOI 10.1016/j.brat.2011.07.009
   Hedman E, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1776
   Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001
   Hey SP, 2013, PERSPECT BIOL MED, V56, P1, DOI 10.1353/pbm.2013.0002
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA
   Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621
   Hollinghurst S, 2010, BRIT J PSYCHIAT, V197, P297, DOI 10.1192/bjp.bp.109.073080
   International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 2000, E10 ICH
   James AC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004690.pub3
   Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ERN.12.63, 10.1586/ern.12.63]
   Johansson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038021
   Johansson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036905
   Johnston L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028079
   Jonsson U, 2014, CONTEMP CLIN TRIALS, V38, P1, DOI 10.1016/j.cct.2014.02.005
   Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527
   Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kessler RC, 2010, CURR TOP BEHAV NEURO, V2, P21, DOI 10.1007/7854_2009_9
   Kimmelman J, 2009, LANCET, V373, P13, DOI 10.1016/S0140-6736(08)61936-4
   Klein B, 2006, J BEHAV THER EXP PSY, V37, P213, DOI 10.1016/j.jbtep.2005.07.001
   Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617
   March S, 2009, J PEDIATR PSYCHOL, V34, P474, DOI 10.1093/jpepsy/jsn099
   McHugh RK, 2013, J CLIN PSYCHIAT, V74, P595, DOI 10.4088/JCP.12r07757
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   National Institute for Health and Care Excellence, 2013, SOC ANX DIS REC ASS
   Neubauer K, 2013, BEHAV RES THER, V51, P87, DOI 10.1016/j.brat.2012.10.006
   Newby JM, 2013, PSYCHOL MED, V18, P1
   Osenbach JE, 2013, DEPRESS ANXIETY, V30, P1058, DOI 10.1002/da.22165
   Palmqvist Bjorn, 2007, Expert Rev Pharmacoecon Outcomes Res, V7, P291, DOI 10.1586/14737167.7.3.291
   Paxling Bjorn, 2011, Cognitive Behaviour Therapy, V40, P159, DOI 10.1080/16506073.2011.576699
   Peterson AL, 2013, CONTEMP CLIN TRIALS, V34, P152, DOI 10.1016/j.cct.2012.10.009
   Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942
   Rothmann MD, 2011, DESIGN ANAL NONINFER
   Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106
   Shedler J, 2010, AM PSYCHOL, V65, P98, DOI 10.1037/a0018378
   Shemilt I, 2010, EVID POLICY, V6, P51, DOI 10.1332/174426410X482999
   Sloan Denise M., 2011, Cognitive Behaviour Therapy, V40, P111, DOI 10.1080/16506073.2010.550058
   Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944
   Spence J, 2011, DEPRESS ANXIETY, V28, P541, DOI 10.1002/da.20835
   Stein MB, 2004, AM J PSYCHIAT, V161, P2230, DOI 10.1176/appi.ajp.161.12.2230
   Swedish Council on Health Technology Assessment (SBU), 2013, UTV MET HALS SJUKVA
   Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820
   Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762
   Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007
   Titov N, 2010, BEHAV RES THER, V48, P890, DOI 10.1016/j.brat.2010.05.014
   Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939
   Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269
   Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107
   Tolin DF, 2010, CLIN PSYCHOL REV, V30, P710, DOI 10.1016/j.cpr.2010.05.003
   Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28
   Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005
   Wims E, 2010, AUST NZ J PSYCHIAT, V44, P599, DOI 10.3109/00048671003614171
   Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018
   World Health Organization, 1992, ICD 10 INT STAT CLAS
NR 98
TC 119
Z9 120
U1 0
U2 67
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 20
PY 2014
VL 9
IS 5
AR e98118
DI 10.1371/journal.pone.0098118
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM0UW
UT WOS:000339563400097
PM 24844847
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shao, JB
   Li, Y
   Zhao, PW
   Yue, X
   Jiang, J
   Liang, XH
   He, XL
AF Shao, Jianbo
   Li, Ying
   Zhao, Peiwei
   Yue, Xin
   Jiang, Jun
   Liang, Xiaohui
   He, Xuelian
TI Association of mTOR Polymorphisms with Cancer Risk and Clinical
   Outcomes: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ACTIVATED MAMMALIAN TARGET; SQUAMOUS-CELL CARCINOMA; PI3K/PTEN/AKT/MTOR
   PATHWAY; GENETIC-VARIATIONS; SIGNALING PATHWAY; PI3K-AKT-MTOR PATHWAY;
   CISPLATIN RESISTANCE; RAPAMYCIN; VARIANTS; EXPRESSION
AB Genetic polymorphisms in mTOR gene may be associated with cancer risk and clinical outcomes of cancer patients by affecting mTOR gene expression or its activation. However, inconsistent results have been reported. The aim of this study is to systematically evaluate the association between mTOR polymorphisms (rs2295080, rs2536 and rs11121704) and cancer risk as well as clinical outcome by a meta-analysis. We identified 10 eligible studies and extracted data by two investigators. Based on dominant and recessive models, odds ratio (ORs) and 95% confidence intervals (CIs) were calculated by using Stata, version 11 to evaluate the association strength. Our meta-analysis results showed that the wild genotype TT of rs2295080 polymorphism was associated with increased cancer risk under dominant model (OR = 1.24, 95% CI: 1.12-1.36, p < 0.0005) in Chinese but not with clinical outcome parameters, while the TT genotype of rs11121704 was associated with poor clinical outcome parameters (OR = 1.53, 95% CI: 1.01-2.32, p = 0.044), such as death, metastasis and resistance to chemotherapy. However, rs2536 may not influence cancer susceptibility. In conclusion, this meta-analysis indicated the common polymorphisms in mTOR gene might be genetic risk factors for the carcinogenesis and clinical outcomes of cancer patients. However, further investigation on large population and different ethnicities are warranted.
C1 [Shao, Jianbo] Wuhan Childrens Hosp, Dept CT MRI, Wuhan, Hubei, Peoples R China.
   [Li, Ying] Wuhan Childrens Hosp, Dept Radiol, Wuhan, Hubei, Peoples R China.
   [Zhao, Peiwei; Yue, Xin; He, Xuelian] Wuhan Childrens Hosp, Cent Lab, Wuhan, Hubei, Peoples R China.
   [Jiang, Jun] Wuhan Childrens Hosp, Dept Electrophysiol, Wuhan, Hubei, Peoples R China.
   [Liang, Xiaohui] Wuhan Univ, Sch Publ Hlth, Wuhan, Hubei, Peoples R China.
RP Liang, XH (reprint author), Wuhan Univ, Sch Publ Hlth, Wuhan, Hubei, Peoples R China.
EM xhliang@whu.edu.cn; hexuelian2013@hotmail.com
FU Ministry of Human Resource of China
FX This study was funded by the support program of the Ministry of Human
   Resource of China Overseas Returned scholars. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050302
   Chen JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040817
   Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062
   Faried LS, 2008, MOL CARCINOGEN, V47, P446, DOI 10.1002/mc.20402
   Faried LS, 2006, ONCOL REP, V16, P57
   He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hildebrandt MAT, 2012, CLIN CANCER RES, V18, P3705, DOI 10.1158/1078-0432.CCR-11-3271
   Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297
   Hou GQ, 2007, CANCER LETT, V253, P236, DOI 10.1016/j.canlet.2007.01.026
   Huang LZ, 2012, LEUKEMIA LYMPHOMA, V53, P947, DOI 10.3109/10428194.2011.628062
   Kim JG, 2010, ONCOLOGY-BASEL, V79, P278, DOI 10.1159/000320761
   Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410
   Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051
   Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093
   Li QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071968
   Lin J, 2010, CANCER PREV RES, V3, P505, DOI 10.1158/1940-6207.CAPR-09-0263
   Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1185/0008-5472.CAN-06-4261
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008
   Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001
   Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28
   Slattery ML, 2011, NUTR CANCER, V63, P1226, DOI 10.1080/01635581.2011.607545
   Slattery ML, 2010, CARCINOGENESIS, V31, P1604, DOI 10.1093/carcin/bgq142
   Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839
   Wang LE, 2012, J CANCER RES CLIN, V138, P377, DOI 10.1007/s00432-011-1103-0
   Xu JL, 2012, ASIAN PAC J CANCER P, V13, P2157, DOI 10.7314/APJCP.2012.13.5.2157
   Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060080
   Zhu ML, 2013, J THORAC ONCOL, V8, P788, DOI 10.1097/JTO.0b013e31828916c6
NR 35
TC 7
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2014
VL 9
IS 5
AR e97085
DI 10.1371/journal.pone.0097085
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI4LX
UT WOS:000336838000102
PM 24816861
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Niu, X
   Chen, X
   Xiao, Y
   Dong, JQ
   Zhang, R
   Lu, MX
   Kong, WJ
AF Niu, Xun
   Chen, Xiong
   Xiao, Ying
   Dong, Jiaqi
   Zhang, Rui
   Lu, Meixia
   Kong, Weijia
TI The Differences in Homocysteine Level between Obstructive Sleep Apnea
   Patients and Controls: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID PLASMA HOMOCYSTEINE; CARDIOVASCULAR-DISEASE; RISK-FACTOR; SERUM
   HOMOCYSTEINE; OXIDATIVE STRESS; FOLIC-ACID; ASSOCIATION;
   HYPERHOMOCYSTEINEMIA; MANAGEMENT; IMPACT
AB Background: Studies have reported inconsistent findings regarding the relationship between obstructive sleep apnea (OSA) and homocysteine (HCY) level. This study aimed to assess the difference in plasma HCY level between OSA patients and controls by conducting a meta-analysis of published studies.
   Methods: Database of PubMed, SCI, and China National Knowledge Internet (CNKI) were comprehensively searched. Eligible studies regarding plasma HCY level in OSA patients were identified by two independent reviewers. RevMan (version 5.2) and STATA (version 12.0) were employed for data synthesis.
   Results: A total of 10 studies involving 432 subjects were included. Meta-analysis showed that plasma HCY levels in OSA group were 3.11 mu mol/l higher than that in control group (95% confidence interval: 2.08 to 4.15, P<0.01). Subgroup analysis revealed a more significant differences between OSA patients and controls when average body mass index >= 30 (the total weighted mean difference (WMD) was 3.64), average age < 50 (the total WMD was 3.96) and average apnea hypopnea index >= 35 (the total WMD was 4.54).
   Conclusions: In this meta-analysis, plasma HCY levels were found to be higher in OSA patients compared to control subjects.
C1 [Niu, Xun; Chen, Xiong; Xiao, Ying; Dong, Jiaqi; Zhang, Rui; Kong, Weijia] Huazhong Univ Sci & Technol, Dept Otolaryngol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China.
   [Lu, Meixia] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.
   [Lu, Meixia] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China.
   [Kong, Weijia] Huazhong Univ Sci & Technol, Tongji Med Coll, Res Inst Otorhinolaryngol, Wuhan 430074, Hubei, Peoples R China.
RP Kong, WJ (reprint author), Huazhong Univ Sci & Technol, Dept Otolaryngol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China.
EM entwjkong@hust.edu.cn
OI Kong, Wei-Jia/0000-0001-5410-2297
FU Natural Science Foundation of Hubei Province in China [2011CDC072]
FX This study was supported by the Natural Science Foundation of Hubei
   Province in China (number 2011CDC072). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Basoglu OK, 2011, ANN THORAC MED, V6, P120, DOI 10.4103/1817-1737.82440
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049
   Brown DL, 2006, SEMIN NEUROL, V26, P117, DOI 10.1055/s-2006-933315
   Chen MG, 2011, J CLIN NEUROSCI, V18, P1454, DOI 10.1016/j.jocn.2011.01.037
   Cintra F, 2011, CHEST, V139, P246, DOI 10.1378/chest.10-0667
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008
   Ford AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033345
   Geisel J, 2003, CLIN CHEM LAB MED, V41, P1513, DOI 10.1515/CCLM.2003.232
   Girelli D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000083
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Kokturk O, 2006, RESP MED, V100, P536, DOI 10.1016/j.rmed.2005.05.025
   Labuz-Roszak Beata, 2004, Pol Merkur Lekarski, V16, P536
   Lavie L, 2001, CHEST, V120, P900, DOI 10.1378/chest.120.3.900
   Macey PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076631
   Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Martinez D, 2012, SLEEP BREATH, V16, P695, DOI 10.1007/s11325-011-0559-0
   McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406
   Monneret D, 2012, RESP PHYSIOL NEUROBI, V180, P298, DOI 10.1016/j.resp.2011.12.009
   Ozkan Y, 2008, SLEEP BREATH, V12, P149, DOI 10.1007/s11325-007-0148-4
   PEPPARD PE, 2013, AM J EPIDEMIOL
   Petrisor BA, 2006, INJURY, V37, P321, DOI 10.1016/j.injury.2006.02.001
   Ryan CM, 2005, J APPL PHYSIOL, V99, P2440, DOI 10.1152/japplphysiol.00772.2005
   Ryan S, 2007, THORAX, V62, P509, DOI 10.1136/thx.2006.066720
   Sales LV, 2013, CLINICS, V68, P449, DOI 10.6061/clinics/2013(04)03
   Silvestrini M, 2002, STROKE, V33, P1782, DOI 10.1161/01.STR.0000019123.47840.2D
   Stanger O, 2004, Z KARDIOL, V93, P439, DOI 10.1007/s00392-004-0075-3
   Svatikova A, 2004, EUR HEART J, V25, P1325, DOI 10.1016/j.ehj.2004.05.018
   Wang L, 2010, BIOMED ENVIRON SCI, V23, P42, DOI 10.1016/S0895-3988(10)60030-X
   Wang XH, 2008, CONCURRENT ENG-RES A, V16, P253, DOI 10.1177/1063293X08100025
   Wood D, 2001, AM HEART J, V141, pS49, DOI 10.1067/mhj.2001.109951
   Xiao Y, 2011, J HUAZHONG U SCI-MED, V31, P413, DOI 10.1007/s11596-011-0392-5
   Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025142
NR 38
TC 13
Z9 13
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 25
PY 2014
VL 9
IS 4
AR e95794
DI 10.1371/journal.pone.0095794
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI3CM
UT WOS:000336736600011
PM 24769854
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Peng, QL
   Yang, S
   Lao, XJ
   Tang, WZ
   Chen, ZP
   Lai, H
   Wang, J
   Sui, JZ
   Qin, X
   Li, S
AF Peng, Qiliu
   Yang, Shi
   Lao, Xianjun
   Tang, Weizhong
   Chen, Zhiping
   Lai, Hao
   Wang, Jian
   Sui, Jingzhe
   Qin, Xue
   Li, Shan
TI Meta-Analysis of the Association between COX-2 Polymorphisms and Risk of
   Colorectal Cancer Based on Case-Control Studies
SO PLOS ONE
LA English
DT Article
ID FUNCTIONAL POLYMORPHISMS; CYCLOOXYGENASE-2 GENE; EXPRESSION;
   INFLAMMATION; PROMOTER; DISEASE; VARIANT; BIAS
AB Objective: Cyclooxygenase-2 (COX-2) is an inducible enzyme converting arachidonic acid to prostaglandins and playing important roles in inflammatory diseases as well as tumor development. Previous studies investigating the association between COX-2 polymorphisms and colorectal cancer (CRC) risk reported conflicting results. We performed a meta-analysis of all available studies to explore this association.
   Methods: All studies published up to October 2013 on the association between COX-2 polymorphisms and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Cochrane library. The association between COX-2 polymorphisms and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs).
   Results: Ten studies with 6,774 cases and 9,772 controls were included for -1195A>G polymorphism, 13 studies including 6,807 cases and 10,052 controls were available for -765G>C polymorphism, and 8 studies containing 5,121 cases and 7,487 controls were included for 8473T>C polymorphism. With respect to -765G>C polymorphism, we did not find a significant association with CRC risk when all eligible studies were pooled into the meta-analysis. However, in subgroup analyses by ethnicity and cancer location, with a Bonferroni corrected alpha of 0.05/2, statistical significant increased CRC risk was found in the Asian populations (dominant model CC+CG vs. GG: OR = 1.399, 95% CI: 1.113-1.760, P = 0.004) and rectum cancer patients (CC vs. GG: OR = 2.270, 95% CI: 1.295-3.980, P = 0.004; Recessive model CC vs. CG+GG: OR = 2.269, 95% CI: 1.297-3.970, P = 0.004). In subgroup analysis according to source of control, no significant association was detected. With respect to -1195A>G and 8473T>C polymorphisms, no significant association with CRC risk was demonstrated in the overall and subgroup analyses.
   Conclusions: The present meta-analysis suggests that the COX-2 -765G>C polymorphism may be a risk factor for CRC in Asians and rectum cancer patients. Further large and well-designed studies are needed to confirm this association.
C1 [Peng, Qiliu; Yang, Shi; Lao, Xianjun; Wang, Jian; Sui, Jingzhe; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.
   [Tang, Weizhong] Guangxi Med Univ, Affiliated Hosp 1, Dept Anal & Colorectal Surg, Nanning, Guangxi, Peoples R China.
   [Chen, Zhiping] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China.
   [Lai, Hao] Guangxi Med Univ, Tumor Hosp, Dept Gastrointestinal Surg, Nanning, Guangxi, Peoples R China.
RP Qin, X (reprint author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.
EM qinxue919@126.com; lis8858@126.com
FU National Natural Science Foundation of China [81260302]
FX This research was supported by National Natural Science Foundation of
   China (No. 81260302). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156
   Akkiz H, 2011, MOL CELL BIOCHEM, V347, P201, DOI 10.1007/s11010-010-0629-9
   Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407
   Brosens LAA, 2005, CLIN CANCER RES, V11, P4090, DOI 10.1158/1078-0432.CCR-04-2379
   Burn John, 2013, Recent Results Cancer Res, V191, P157, DOI 10.1007/978-3-642-30331-9_9
   Cakmakoglu BA, 2011, MOL BIOL REP, V38, P3481, DOI 10.1007/s11033-010-0458-7
   Cao H, 2010, TOHOKU J EXP MED, V222, P15, DOI 10.1620/tjem.222.15
   Coskunpinar E, 2011, MED ONCOL, V28, P1436, DOI 10.1007/s12032-010-9627-8
   Cox DG, 2004, BRIT J CANCER, V91, P339, DOI 10.1038/sj.bjc.6601906
   Daraei A, 2012, MOL BIOL REP, V39, P5219, DOI 10.1007/s11033-011-1319-8
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dong J, 2010, J GASTROEN HEPATOL, V25, P1042, DOI 10.1111/j.1440-1746.2010.06293.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fujita H, 2002, PROSTATE, V53, P232, DOI 10.1002/pros.10152
   Gao J, 2007, J TOXICOL ENV HEAL A, V70, P908, DOI 10.1080/15287390701289966
   Goodman JE, 2004, CARCINOGENESIS, V25, P2467, DOI 10.1093/carcin/bgh260
   Hamajima Nobuyuki, 2001, Asian Pac J Cancer Prev, V2, P57
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hla T, 1999, INT J BIOCHEM CELL B, V31, P551, DOI 10.1016/S1357-2725(98)00152-6
   Hoff JH, 2009, WORLD J GASTROENTERO, V15, P4561, DOI 10.3748/wjg.15.4561
   Iglesias D, 2009, CANCER CAUSE CONTROL, V20, P1421, DOI 10.1007/s10552-009-9368-1
   Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Kirschenbaum A, 2001, UROLOGY, V58, P127, DOI 10.1016/S0090-4295(01)01255-9
   Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797
   Kwagyan J, 2012, CTS-CLIN TRANSL SCI, V5, P60, DOI 10.1111/j.1752-8062.2011.00373.x
   Li S, 2013, FAM CANC
   Makar KW, 2013, CANC CAUSES CONTROL
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Miyashita M, 2012, J VIRAL HEPATITIS, V19, P608, DOI 10.1111/j.1365-2893.2011.01580.x
   Muller-Decker K, 2011, CANCER METAST REV, V30, P343, DOI 10.1007/s10555-011-9306-z
   Nithipatikom K, 2002, CLIN EXP METASTAS, V19, P593, DOI 10.1023/A:1020915914376
   Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5
   Pereira C, 2010, EUR J GASTROEN HEPAT, V22, P607, DOI 10.1097/MEG.0b013e3283352cbb
   Ross J, 2013, EUR J HUM GENET
   Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799
   Siezen CLE, 2006, INT J CANCER, V119, P297, DOI 10.1002/ijc.21858
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030
   Tan W, 2007, CARCINOGENESIS, V28, P1197, DOI 10.1093/carcin/bgl242
   TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167
   Theodoratou E, 2012, JNCI-J NATL CANCER I, V104, P1433, DOI 10.1093/jnci/djs369
   Thompson CL, 2009, WORLD J GASTROENTERO, V15, P2240, DOI 10.3748/wjg.15.2240
   Wang J, 2012, INT J CANCER, V130, P1898, DOI 10.1002/ijc.26199
   Wang WZ, 2005, CLIN CANCER RES, V11, P3250, DOI 10.1158/1078-0432.CCR-04-2405
   Wang YX, 2012, TUMOR BIOL, V33, P957, DOI 10.1007/s13277-012-0324-4
   Xing LL, 2008, WORLD J GASTROENTERO, V14, P1785, DOI 10.3748/wjg.14.1785
NR 49
TC 13
Z9 14
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 14
PY 2014
VL 9
IS 4
AR e94790
DI 10.1371/journal.pone.0094790
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI6GP
UT WOS:000336970400102
PM 24733273
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chan, CS
   Rhodes, JE
AF Chan, Christian S.
   Rhodes, Jean E.
TI Measuring Exposure in Hurricane Katrina: A Meta-Analysis and an
   Integrative Data Analysis
SO PLOS ONE
LA English
DT Article
ID POSTTRAUMATIC-STRESS-DISORDER; SOCIAL SUPPORT; MENTAL-HEALTH;
   PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL IMPACT; SCREENING SCALES;
   UNITED-STATES; PET LOSS; DISASTER; PTSD
AB To date there is no consensus on the operationalization of exposure severity in the study of the impact of natural disasters. This is problematic because incomplete and inconsistent measurement of exposure limits the internal and external validity of disaster studies. The current paper examined the predictive validity of severity measures in two interrelated studies of Hurricane Katrina survivors. First, in a meta-analysis of eight studies that measured both exposure severity and posttraumatic stress, the effect size was estimated to be r = .266. The moderating effects of sample and study characteristics were examined and we found that minority status and number of stressors assessed were significant moderators. Second, in an integrative data analysis of five independent samples of Hurricane Katrina survivors, the impact of specific wdisaster-related stressors on mental health was compared. Threat to physical integrity of self and others were found to have the strongest association with posttraumatic stress (PTS) and general psychological distress (GPD). The lack of basic necessities, such as food, water, and medical care, and loss of pet were also found to be strongly associated with both PTS and GPD. The results from the two studies are integrated and their implication for disaster research and relief are discussed.
C1 [Chan, Christian S.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.
   [Rhodes, Jean E.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA.
RP Chan, CS (reprint author), Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.
EM shaunlyn@hku.hk
RI Chan, Christian/D-9637-2011
OI Chan, Christian/0000-0003-2616-5199
FU National PERISHIP award by the Natural Hazards Center; Bollinger
   Memorial Research Grant; Graduate Student Assembly at the University of
   Massachusetts Boston
FX This work was funded by a National PERISHIP award provided by the
   Natural Hazards Center and a Bollinger Memorial Research Grant awarded
   to Christian Chan by the Graduate Student Assembly at the University of
   Massachusetts Boston. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amaya-Jackson L, 1995, CHILD PTSD CHECKLIST
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Beaudoin CE, 2009, HEALTH COMMUN, V24, P515, DOI 10.1080/10410230903104905
   Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908
   Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748
   Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158
   Briere J, 2000, J TRAUMA STRESS, V13, P661, DOI 10.1023/A:1007814301369
   Cepeda A, 2010, COMMUNITY MENT HLT J, V46, P612, DOI 10.1007/s10597-009-9286-4
   Chen A. C.-C., 2007, J AM PSYCHIAT NURSES, V13, P257, DOI DOI 10.1177/1078390307307260
   Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5
   Cieslak R, 2009, ANXIETY STRESS COPIN, V22, P449, DOI 10.1080/10615800802403815
   Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678
   Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839
   Curran PJ, 2009, PSYCHOL METHODS, V14, P81, DOI 10.1037/a0015914
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elal G, 2005, J TRAUMA STRESS, V18, P213, DOI 10.1002/jts.20030
   Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062
   Elliott JR, 2006, SOC SCI RES, V35, P295, DOI 10.1016/j.ssresearch.2006.02.003
   FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405
   Fothergill A, 1999, DISASTERS, V23, P156, DOI 10.1111/1467-7717.00111
   Friedman MJ, 2006, METHODS DISASTER MEN, P289
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003
   Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427
   GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.1111/j.1467-8624.1984.tb00276.x
   GOENJIAN AK, 1994, AM J PSYCHIAT, V151, P895
   Green B. L., 1991, J CONSULT CLIN PSYCH, V3, P538, DOI DOI 10.1037/1040-3590.3.4.538
   GREEN BL, 1990, J APPL SOC PSYCHOL, V20, P1632, DOI 10.1111/j.1559-1816.1990.tb01498.x
   Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426
   Heir T, 2008, PSYCHIATRY, V71, P266, DOI 10.1521/psyc.2008.71.3.266
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hirschel MJ, 2009, PSYCHOL SERV, V6, P293, DOI 10.1037/a0017467
   Hunt M, 2008, ANTHROZOOS, V21, P109, DOI 10.2752/75303708X305765
   Kaplan RM, 2005, MED CARE, V43, P79
   Keane T. M., 2008, GUIDE ASSESSMENTS WO, P293
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kilpatrick D, 1989, NATL WOMENS STUDY PT
   LaJoie AS, 2010, DISASTERS, V34, P1031, DOI 10.1111/j.1467-7717.2010.01181.x
   Lawson EJ, 2007, J HEALTH CARE POOR U, V18, P341, DOI 10.1353/hpu.2007.0039
   LeClere FB, 1997, SOC FORCES, V76, P169, DOI 10.2307/2580322
   Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3
   Logan JR, 2006, WORKING PAPER
   Lowe SR, 2009, J TRAUMA STRESS, V22, P244, DOI 10.1002/jts.20403
   McLeish AC, 2008, DEPRESS ANXIETY, V25, P416, DOI 10.1002/da.20426
   Neria Y., 2009, MENTAL HLTH DISASTER
   Netland M, 2005, J TRAUMA STRESS, V18, P507, DOI 10.1002/jts.20059
   Netland M, 2001, J TRAUMA STRESS, V14, P311, DOI 10.1023/A:1011164901867
   Norris F, 2009, MENTAL HLTH DISASTER, P29, DOI DOI 10.1017/CBO9780511730030.003
   NORRIS FH, 1993, J APPL SOC PSYCHOL, V23, P1263, DOI 10.1111/j.1559-1816.1993.tb01032.x
   Norris FH, 2005, CNS SPECTRUMS, V10, P132, DOI 10.1017/S1092852900019477
   Norris FH, 2005, AM J COMMUN PSYCHOL, V36, P15, DOI 10.1007/s10464-005-6230-9
   Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173
   Norris FH, 2006, METHODS DISASTER MEN, P20
   Norris FH, 2009, J TRAUMA STRESS, V22, P91, DOI 10.1002/jts.20389
   Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52
   Pynoos R, 1998, UCLA PTSD INDEX DSM
   Reuther ET, 2010, J TRAUMA STRESS, V23, P519, DOI 10.1002/jts.20549
   Rhodes J, 2010, AM J ORTHOPSYCHIAT, V80, P237, DOI 10.1111/j.1939-0025.2010.01027.x
   Rosenthal R., 1994, HDB RES SYNTHESIS, P231
   RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384
   Shelby RA, 2005, J TRAUMA STRESS, V18, P347, DOI 10.1002/jts.20033
   Solomon S.D., 1992, PTSD RES Q, V3, P1
   SOLOMON SD, 1987, J APPL SOC PSYCHOL, V17, P1092, DOI 10.1111/j.1559-1816.1987.tb02349.x
   Spence PR, 2007, SOCIOL SPECTRUM, V27, P653, DOI 10.1080/02732170701533939
   Sprang G., 2009, TRAUMATOLOGY, V15, P10
   STEINGLASS P, 1990, J APPL SOC PSYCHOL, V20, P1746, DOI 10.1111/j.1559-1816.1990.tb01509.x
   Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P75, DOI 10.1002/0470870168.ch5
   Ticehurst S, 1996, INT J GERIATR PSYCH, V11, P943, DOI 10.1002/(SICI)1099-1166(199611)11:11<943::AID-GPS412>3.0.CO;2-B
   U.S. Census Bureau, 2011, STAT COUNT QUICK FAC
   *US CENS BUR, 2007, STAT COUNT QUICK FAC
   Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237
   Wadsworth ME, 2009, ANXIETY STRESS COPIN, V22, P413, DOI 10.1080/10615800902855781
   Wang PS, 2008, AM J PSYCHIAT, V165, P34, DOI 10.1176/appi.ajp.2007.07030502
   Weathers F, 1991, PTSD CHECKLIST CIVIL
   Weathers F., 1993, ANN CONV INT SOC TRA
   Weems CF, 2007, BEHAV RES THER, V45, P2295, DOI 10.1016/j.brat.2007.04.013
   Weiss D. S., 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000
   White IK, 2007, J BLACK STUD, V37, P523, DOI 10.1177/0021934706296191
   Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200
   Williams DR, 1997, RACIAL DIFFERENCES P
NR 84
TC 24
Z9 24
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2014
VL 9
IS 4
AR e92899
DI 10.1371/journal.pone.0092899
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE7FA
UT WOS:000334160900009
PM 24713851
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lu, X
   Yang, HB
   Shu, XM
   Chen, F
   Zhang, YL
   Zhang, SG
   Peng, QL
   Tian, XL
   Wang, GC
AF Lu, Xin
   Yang, Hanbo
   Shu, Xiaoming
   Chen, Fang
   Zhang, Yinli
   Zhang, Sigong
   Peng, Qinglin
   Tian, Xiaolan
   Wang, Guochun
TI Factors Predicting Malignancy in Patients with Polymyositis and
   Dermatomyostis: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID CANCER-ASSOCIATED MYOSITIS; ANTI-P155 AUTOANTIBODY; INFLAMMATORY
   MYOPATHY; RETROSPECTIVE COHORT; KOREAN PATIENTS; RISK; ASSOCIATIONS;
   VASCULITIS; FIBROSIS; DISEASE
AB Objective: To define potential factors that could predict concomitant neoplastic diseases in patients diagnosed with PM/DM, which could inform screening decisions.
   Methods: Two researchers independently reviewed articles from Pubmed (MEDLINE), EMBASE, Cochrane Plus Library and ISI Web of Knowledge with no restrictions on study design or language. Given that some of the studies combined PM and DM patients as research subjects while others included only DM patients, data were subjected to meta-analyses for all combined PM/DM studies and studies that included only DM patients to obtain informative results.
   Results: For PM/DM patients, the following factors are all associated with an increased risk of malignancy: older age, age greater than 45, male sex, dysphagia, cutaneous necrosis, cutaneous vasculitis, rapid onset of myostis (<4 weeks), elevated CK, higher ESR, higher CRP levels. Several factors were associated with lower-than-average risk, including the presence of ILD, arthritis/arthralgia, Raynaud's syndrome, or anti-Jo-1 antibody. For DM patients, results indicated an increased risk of malignancy with older age, male sex, the presence of cutaneous necrosis, elevated ESR (>35 mm/hr), higher CRP levels, or anti-p155 antibody. In addition, the presence of anti-ENA antibodies seem to be related to reduced risk of malignancy.
   Conclusion: Awareness and implementation of early-stage cancer screening in PM/DM patients who have these identified factors - such as being older than 45, male sex, cutaneous necrosis, cutaneous vasculitis - are of crucial importance from public health and clinical perspectives and provide insight into the etiopathogenesis of CAM.
C1 [Lu, Xin; Yang, Hanbo; Shu, Xiaoming; Chen, Fang; Zhang, Yinli; Zhang, Sigong; Peng, Qinglin; Tian, Xiaolan; Wang, Guochun] China Japan Friendship Hosp, Beijing, Peoples R China.
RP Wang, GC (reprint author), China Japan Friendship Hosp, Beijing, Peoples R China.
EM guochunwang@hotmail.com
FU Beijing Science and Technology Committee [Z111107058811084]
FX This work was supported by a Beijing Science and Technology Committee
   grant (No: Z111107058811084)
   (http://www.bjkw.gov.cn/n8785584/index.html). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aggarwal R, 2013, RHEUMATOLOGY
   Aggarwal R, 2011, RHEUM DIS CLIN N AM, V37, P607, DOI 10.1016/j.rdc.2011.09.007
   AIRIO A, 1995, J RHEUMATOL, V22, P1300
   Amerio P, 2002, EUR J DERMATOL, V12, P165
   Amoura Z, 2005, CANCER EPIDEM BIOMAR, V14, P1279, DOI 10.1158/1055-9965.EPI-04-0624
   Andras C, 2008, J RHEUMATOL, V35, P438
   Antiochos BB, 2009, J RHEUMATOL, V36, P2704, DOI 10.3899/jrheum.090549
   Anzures-Cabrera J, 2011, STAT MED, V30, P2967, DOI 10.1002/sim.4298
   Azuma K, 2011, MOD RHEUMATOL, V21, P178, DOI 10.1007/s10165-010-0362-y
   Buchbinder R, 2001, ANN INTERN MED, V134, P1087, DOI 10.7326/0003-4819-134-12-200106190-00008
   Buchbinder Rachelle, 2002, Curr Rheumatol Rep, V4, P415, DOI 10.1007/s11926-002-0087-9
   de Souza FHC, 2012, REV BRAS REUMATOL, V52, P717, DOI 10.1590/S0482-50042012000500006
   Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1016/jem.20041367
   Ceribelli A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3822
   Chen YJ, 2001, BRIT J DERMATOL, V144, P825, DOI 10.1046/j.1365-2133.2001.04140.x
   Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M
   Chinoy H, 2007, ANN RHEUM DIS, V66, P1345, DOI 10.1136/ard.2006.068502
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DUNCAN AG, 1991, ACTA DERM-VENEREOL, V71, P312
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fain O, 2007, ARTHRIT RHEUM-ARTHR, V57, P1473, DOI 10.1002/art.23085
   Fardet L, 2009, ARCH DERMATOL, V145, P889, DOI 10.1001/archdermatol.2009.152
   Fardet L, 2009, MEDICINE, V88, P91, DOI 10.1097/MD.0b013e31819da352
   FELDMAN D, 1983, J RHEUMATOL, V10, P85
   Fiorentino D, 2012, ARTHRITIS RHEUM-US, V64, P346, DOI 10.1002/art.33402
   FRAIRE AE, 1973, CANCER-AM CANCER SOC, V31, P1078, DOI 10.1002/1097-0142(197305)31:5<1078::AID-CNCR2820310507>3.0.CO;2-1
   Fujikawa K, 2009, SCAND J RHEUMATOL, V38, P263, DOI 10.1080/03009740802687455
   Gunawardena H, 2008, RHEUMATOLOGY, V47, P324, DOI 10.1093/rheumatology/kem359
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6
   HOGUE CJR, 1983, AM J EPIDEMIOL, V118, P396, DOI 10.1093/oxfordjournals.aje.a113646
   Hosono Y, 2012, ARTHRITIS RHEUMATI S
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062
   Hunger RE, 2001, DERMATOLOGY, V202, P123, DOI 10.1159/000051611
   Ikeda N, 2011, J DERMATOL, V38, P973, DOI 10.1111/j.1346-8138.2011.01262.x
   Kaji K, 2007, RHEUMATOLOGY, V46, P25, DOI 10.1093/rheumatology/kel161
   Kang EH, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-223
   Kannan MA, 2013, NEUROL INDIA, V61, P152, DOI 10.4103/0028-3886.111121
   KAWAI T, 1987, ACTA PATHOL JAPON, V37, P11
   Labrador-Horrillo M, 2012, ANN RHEUM DIS, V71, P993, DOI 10.1136/annrheumdis-2011-200871
   Lee SW, 2006, YONSEI MED J, V47, P519, DOI 10.3349/ymj.2006.47.4.519
   Liu WC, 2010, ANN ACAD MED SINGAP, V39, P843
   Marie I, 2012, AUTOIMMUN REV, V11, P739, DOI 10.1016/j.autrev.2012.01.006
   Morris P, 2010, J PEDIAT HEMATOL ONC, V32, P189, DOI 10.1097/MPH.0b013e3181bf29a2
   Ponyi A, 2005, ANN NY ACAD SCI, V1051, P64, DOI 10.1196/annals.1361.047
   Prohic A, 2009, J EUR ACAD DERMATOL, V23, P591, DOI 10.1111/j.1468-3083.2008.02971.x
   Rider LG, 2013, MEDICINE, V92, P223, DOI 10.1097/MD.0b013e31829d08f9
   ROSE C, 1994, REV MED INTERNE, V15, P19, DOI 10.1016/S0248-8663(05)82125-3
   Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001
   Selva-O'Callaghan A, 2002, ARTHRITIS RHEUM, V46, P2547, DOI 10.1002/art.10435
   So MW, 2011, J RHEUMATOL, V38, P2432, DOI 10.3899/jrheum.110320
   Sparsa A, 2002, ARCH DERMATOL, V138, P885, DOI 10.1001/archderm.138.7.885
   Stockton D, 2001, BRIT J CANCER, V85, P41, DOI 10.1054/bjoc.2001.1699
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Targoff IN, 2006, ARTHRITIS RHEUM, V54, P3682, DOI 10.1002/art.22164
   Trallero-Araguas E, 2012, ARTHRITIS RHEUM-US, V64, P523, DOI 10.1002/art.33379
   Trallero-Araguas E, 2010, MEDICINE, V89, P47, DOI 10.1097/MD.0b013e3181ca14ff
   Uchino M, 2013, CLIN NEUROL NEUROSUR, V115, P603, DOI 10.1016/j.clineuro.2012.07.019
   Volkert J, 2013, AGEING RES REV, V12, P339, DOI 10.1016/j.arr.2012.09.004
   Wakata N, 2002, INT J DERMATOL, V41, P729, DOI 10.1046/j.1365-4362.2002.01648.x
   Witchalls J, 2012, BRIT J SPORT MED, V46, P515, DOI 10.1136/bjsports-2011-090137
   Zampieri S, 2010, AUTOIMMUN REV, V9, P449, DOI 10.1016/j.autrev.2009.12.005
NR 63
TC 29
Z9 32
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2014
VL 9
IS 4
AR e94128
DI 10.1371/journal.pone.0094128
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE7FA
UT WOS:000334160900089
PM 24713868
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mei, ZB
   Zhang, ZJ
   Liu, CY
   Liu, Y
   Cui, A
   Liang, ZL
   Wang, GH
   Cui, L
AF Mei, Zu-Bing
   Zhang, Zhi-Jiang
   Liu, Chen-Ying
   Liu, Yun
   Cui, Ang
   Liang, Zhong-Lin
   Wang, Guang-Hui
   Cui, Long
TI Survival Benefits of Metformin for Colorectal Cancer Patients with
   Diabetes: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID EPIDEMIOLOGY STROBE STATEMENT; RISK; MELLITUS; COHORT;
   THIAZOLIDINEDIONES; GUIDELINES; MORTALITY; THERAPY
AB Background: Several studies suggest that metformin has the potential effect of reducing cancer risk. However, its survival benefit in patients with colorectal cancer (CRC) and diabetes is unknown. The aim of our study is to address the effect of metformin on outcomes for CRC based on a systematic review and meta-analysis.
   Methods and Findings: We searched EMBASE and MEDLINE databases from inception through August, 2013, using search terms related to metformin, diabetes, colorectal cancer, and prognostic outcome. The outcome measures were hazard ratios (HRs) with 95% CIs comparing CRC survival in diabetic patients using metformin and without using metformin. The primary end points were overall survival (OS) and CRC specific survival (CS). A total of six cohort studies including 2,461 patients met full eligibility criteria. The pooled HR favoring metformin users was 0.56 for OS (95% CI, 0.41 to 0.77) and 0.66 for CRC-specific survival (95% CI, 0.50 to 0.87). Thus metformin therapy reduced the risk of all cause of death by 44% and the risk of CRC specific death by 34% in CRC patients compared to those in non-users. However, evidence of heterogeneity and possible publication bias was noted for OS.
   Conclusions: Patients with CRC and diabetes treated with metformin appear to have an improved survival outcome. Prospective study should be warranted to examine the association between metformin exposure intensity as well as some other confounding variables and survival outcome in diabetic CRC patients.
C1 [Mei, Zu-Bing; Liu, Chen-Ying; Liu, Yun; Cui, Ang; Liang, Zhong-Lin; Wang, Guang-Hui; Cui, Long] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal Surg, Shanghai 200030, Peoples R China.
   [Zhang, Zhi-Jiang] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol, Wuhan 430072, Peoples R China.
RP Cui, L (reprint author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal Surg, Shanghai 200030, Peoples R China.
EM longcuidr@126.com
FU National Natural Science Foundation of China [81372636, 81302089];
   National High Technology Research and Development Program of China (863
   Program) [SQ2014SFOZD00314]
FX This research was supported by two National Natural Science Foundation
   of China (Grant No. 81372636 and No. 81302089) and the National High
   Technology Research and Development Program of China (863 Program)
   (Grant No. SQ2014SFOZD00314). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670
   Bansal M, 2011, ASCO M, V29, P2608
   Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824
   Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152
   Cossor FI, 2013, CANC EPIDEMIOL
   Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161
   Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6
   Del Barco S, 2011, ONCOTARGET, V2, P896
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Garrett CR, 2012, BRIT J CANCER, V106, P1374, DOI 10.1038/bjc.2012.71
   Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078
   He X, 2012, ANN ONCOL, V23, P1771, DOI 10.1093/annonc/mdr534
   He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HILL AB, 1965, P ROY SOC MED, V58, P295
   Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871
   Larsson SC, 2005, J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375
   LAVECCHIA C, 1994, BRIT J CANCER, V70, P950, DOI 10.1038/bjc.1994.427
   LEE GE, 2012, J CLIN ONCOL, V30
   Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421
   Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20
   Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175
   Rousseau MC, 2006, INT J CANCER, V118, P2105, DOI 10.1002/ijc.21600
   Sahra IB, 2010, MOL CANCER THER, V9, P1092
   Spillane SC, 2013, CANC EPIDEM BIOMAR
   von Elm E, 2007, PREV MED, V45, P247, DOI [10.1016/j.ypmed.2007.08.012, 10.7326/0003-4819-147-8-200710160-00010]
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Yang YX, 2005, CLIN GASTROENTEROL H, V3, P587, DOI 10.1053/S1542-3565(05)00152-7
   Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011
   Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512
NR 31
TC 46
Z9 55
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2014
VL 9
IS 3
AR e91818
DI 10.1371/journal.pone.0091818
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6ER
UT WOS:000333348500053
PM 24647047
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Mayo-Wilson, E
   Grant, S
   Burton, J
   Parsons, A
   Underhill, K
   Montgomery, P
AF Mayo-Wilson, Evan
   Grant, Sean
   Burton, Jennifer
   Parsons, Amanda
   Underhill, Kristen
   Montgomery, Paul
TI Preventive Home Visits for Mortality, Morbidity, and
   Institutionalization in Older Adults: A Systematic Review and
   Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; MULTIFACTORIAL FALL PREVENTION;
   HEALTH-PROMOTION PROGRAM; QUALITY-OF-LIFE; COMPREHENSIVE GERIATRIC
   ASSESSMENT; FRAIL ELDERLY-PEOPLE; PRIMARY-CARE; FUNCTIONAL DECLINE;
   ECONOMIC-EVALUATION; EXERCISE PROGRAM
AB Background: Home visits for older adults aim to prevent cognitive and functional impairment, thus reducing institutionalization and mortality. Visitors may provide information, investigate untreated problems, encourage medication compliance, and provide referrals to services.
   Methods and Findings: Data Sources: Ten databases including CENTRAL and Medline searched through December 2012. Study Selection: Randomized controlled trials enrolling community-dwelling persons without dementia aged over 65 years. Interventions included visits at home by a health or social care professional that were not related to hospital discharge. Data Extraction and Synthesis: Two authors independently extracted data. Outcomes were pooled using random effects. Main Outcomes and Measures: Mortality, institutionalization, hospitalization, falls, injuries, physical functioning, cognitive functioning, quality of life, and psychiatric illness.
   Results: Sixty-four studies with 28642 participants were included. Home visits were not associated with absolute reductions in mortality at longest follow-up, but some programs may have small relative effects (relative risk = 0.93 [0.87 to 0.99]; absolute risk = 0.00 [-0.01 to 0.00]). There was moderate quality evidence of no overall effect on the number of people institutionalized (RR = 1.02 [0.88 to 1.18]) or hospitalized (RR = 0.96 [0.91 to 1.01]). There was high quality evidence for number of people who fell, which is consistent with no effect or a small effect (odds ratio = 0.86 [0.73 to 1.01]), but there was no evidence that these interventions increased independent living. There was low and very low quality evidence of effects for quality of life (standardised mean difference = -0.06 [-0.11 to -0.01]) and physical functioning (SMD = -0.10 [-0.17 to -0.03]) respectively, but these may not be clinically important.
   Conclusions: Home visiting is not consistently associated with differences in mortality or independent living, and investigations of heterogeneity did not identify any programs that are associated with consistent benefits. Due to poor reporting of intervention components and delivery, we cannot exclude the possibility that some programs may be effective.
C1 [Mayo-Wilson, Evan] UCL, Ctr Outcomes Res & Effectiveness, Res Dept Clin Educ & Hlth Psychol, London, England.
   [Grant, Sean; Burton, Jennifer; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England.
   [Parsons, Amanda] Yale Univ, Sch Law, New Haven, CT 06520 USA.
   [Underhill, Kristen] Yale Univ, Sch Law, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.
RP Mayo-Wilson, E (reprint author), UCL, Ctr Outcomes Res & Effectiveness, Res Dept Clin Educ & Hlth Psychol, London, England.
EM e.mayo-wilson@ucl.ac.uk
RI Grant, Sean/L-9912-2016
OI Grant, Sean/0000-0002-7775-3022
FU Nordic Campbell Centre (Denmark); linked Clarendon Fund; Green Templeton
   College Annual Fund Scholarship
FX This work was sponsored by a grant from the Nordic Campbell Centre
   (Denmark). The authors received internal support from the Centre for
   Evidence Based Intervention, Department of Social Policy and
   Intervention, University of Oxford (UK). EMW received internal support
   from the Centre for Outcomes Research and Effectiveness (CORE), Research
   Department of Clinical, Educational & Health Psychology, University
   College London (UK). SG is supported by a linked Clarendon Fund & Green
   Templeton College Annual Fund Scholarship. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alessi CA, 1997, J AM GERIATR SOC, V45, P1044, DOI 10.1111/j.1532-5415.1997.tb05964.x
   Altman DG, 2013, AM J GASTROENTEROL, V108, P1231, DOI 10.1038/ajg.2012.457
   ARCHBOLD PG, 1995, RES NURS HEALTH, V18, P3, DOI 10.1002/nur.4770180103
   BALABAN DJ, 1988, J FAM PRACTICE, V26, P307
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348
   Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Bouman A, 2008, J GERONTOL A-BIOL, V63, P291, DOI 10.1093/gerona/63.3.291
   Bouman A, 2008, J AM GERIATR SOC, V56, P397, DOI 10.1111/j.1532-5415.2007.01565.x
   Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74
   BULA CJ, 1995, J AM GERIATR SOC, V43, P1016
   Burton J, 2009, CAMPBELL SYSTEMATIC, V5
   Byles JE, 2004, MED J AUSTRALIA, V181, P186
   Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55
   Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513
   Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065
   Caplan GA, 2004, J AM GERIATR SOC, V52, P1417, DOI 10.1111/j.1532-5415.2004.52401.x
   CARPENTER GI, 1990, BMJ-BRIT MED J, V300, P1253, DOI 10.1136/bmj.300.6734.1253
   Chandler JM, 1998, ARCH PHYS MED REHAB, V79, P24, DOI 10.1016/S0003-9993(98)90202-7
   Ciaschini PM, 2009, AGE AGEING, V38, P724, DOI 10.1093/ageing/afp176
   Ciaschini PM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-62
   Ciechanowski P, 2004, JAMA-J AM MED ASSOC, V291, P1569, DOI 10.1001/jama.291.13.1569
   Clark J, 2001, BRIT MED J, V323, P708, DOI 10.1136/bmj.323.7315.708
   CLARKE M, 1992, AM J EPIDEMIOL, V136, P1517, DOI 10.1093/oxfordjournals.aje.a116473
   Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9
   Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x
   Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4
   Comans TA, 2010, J GERONTOL A-BIOL, V65, P672, DOI 10.1093/gerona/glq054
   Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623
   Counsell SR, 2006, J AM GERIATR SOC, V54, P1136, DOI 10.1111/j.1532-5415.2006.00791.x
   Counsell SR, 2009, J AM GERIATR SOC, V57, P1420, DOI 10.1111/j.1532-5415.2009.02383.x
   Cutchin Malcolm P, 2009, BMC Geriatr, V9, P54, DOI 10.1186/1471-2318-9-54
   Dahlin-Ivanoff S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-27
   Dalby DM, 2000, CAN MED ASSOC J, V162, P497
   Dapp U, 2005, J PUBLIC HEALTH-HEID, V13, P122, DOI 10.1007/s10389-004-0097-3
   Dapp U, 2011, J GERONTOL A-BIOL, V66, P591, DOI 10.1093/gerona/glr021
   Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053
   Day L., 2002, BMJ-BRIT MED J, V325, P1
   de Vries OJ, 2010, ARCH INTERN MED, V170, P1110, DOI 10.1001/archinternmed.2010.169
   Department of Health, 2001, NAT SERV FRAM OLD PE
   DUNN RB, 1994, ARCH GERONTOL GERIAT, V18, P15, DOI 10.1016/0167-4943(94)90044-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eldridge Sandra, 2005, J Health Serv Res Policy, V10, P133, DOI 10.1258/1355819054338942
   Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719
   Elkan R, 2004, WHAT IS EFFECTIVENES
   Elley CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-185
   Elley CR, 2008, J AM GERIATR SOC, V56, P1383, DOI 10.1111/j.1532-5415.2008.01802.x
   Engelhardt JB, 1996, J AM GERIATR SOC, V44, P847, DOI 10.1111/j.1532-5415.1996.tb03747.x
   EPSTEIN AM, 1990, JAMA-J AM MED ASSOC, V263, P538, DOI 10.1001/jama.263.4.538
   Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25
   FABACHER D, 1994, J AM GERIATR SOC, V42, P630, DOI 10.1111/j.1532-5415.1994.tb06862.x
   Fairhall Nicola, 2008, BMC Geriatr, V8, P27, DOI 10.1186/1471-2318-8-27
   Ferrer Assumpta, 2010, Rev Esp Geriatr Gerontol, V45, P79, DOI 10.1016/j.regg.2009.10.013
   Fleischer S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-185
   Fletcher AE, 2004, LANCET, V364, P1667, DOI 10.1016/S0140-6736(04)17353-4
   Flood C, 2005, AGE AGEING, V34, P47, DOI 10.1093/ageing/afh232
   Fordyce M, 1997, J Am Board Fam Pract, V10, P398
   Fox PJ, 2010, HEALTH EDUC BEHAV, V37, P831, DOI 10.1177/1090198110366003
   Gallagher EM, 1996, CAN J AGING, V15, P84, DOI 10.1017/S0714980800013301
   GERMAN PS, 1995, AM J PUBLIC HEALTH, V85, P379, DOI 10.2105/AJPH.85.3.379
   Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423
   Gill TM, 2004, ARCH PHYS MED REHAB, V85, P1043, DOI 10.1016/j.apmr.2003.10.021
   Gillespie LD, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007146.pub2, 10.1002/14651858.CD007146.pub3]
   Gitlin LN, 2006, J AM GERIATR SOC, V54, P950, DOI 10.1111/j.1532-5415.2006.00733.x
   Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x
   Gitlin LN, 2009, J AM GERIATR SOC, V57, P476, DOI 10.1111/j.1532-5415.2008.02147.x
   Graham SA, 2006, EFFECTS HOME BASED P
   Grant SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065442
   Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3
   Gunner-Svensson F, 1984, Scand J Prim Health Care, V2, P49, DOI 10.3109/02813438409017704
   Guralnik JM, 2002, J AM GERIATR SOC, V50, P1599, DOI 10.1046/j.1532-5415.2002.50421.x
   Gustafsson S, 2012, J AM GERIATR SOC, V60, P447, DOI 10.1111/j.1532-5415.2011.03861.x
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011
   HALL N, 1992, CAN J AGING, V11, P72, DOI 10.1017/S0714980800014537
   HANSEN FR, 1992, AGE AGEING, V21, P445, DOI 10.1093/ageing/21.6.445
   Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202
   Hay WI, 1998, CAN FAM PHYSICIAN, V44, P2677
   Hebert R, 2001, AGE AGEING, V30, P265, DOI 10.1093/ageing/30.3.265
   Hendriks MRC, 2008, J AM GERIATR SOC, V56, P1390, DOI 10.1111/j.1532-5415.2008.01803.x
   HENDRIKSEN C, 1984, BMJ-BRIT MED J, V289, P1522, DOI 10.1136/bmj.289.6457.1522
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Hinrichs Timo, 2009, BMC Geriatr, V9, P37, DOI 10.1186/1471-2318-9-37
   Hogan DB, 2001, CAN MED ASSOC J, V165, P537
   HOLLAND R, 2006, INT J PHARM PRACT, V14, P71, DOI DOI 10.1211/ijpp.14.1.0009
   Holland R, 2005, BMJ-BRIT MED J, V330, P393
   HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16
   Huang TT, 2004, PUBLIC HEALTH NURS, V21, P247, DOI 10.1111/j.0737-1209.2004.21307.x
   Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298
   Jitapunkul Sutthichai, 1998, Journal of the Medical Association of Thailand, V81, P352
   June KJ, 2009, J KOREAN ACAD NURS, V39, P366, DOI 10.4040/jkan.2009.39.3.366
   Karatay G, 2012, WESTERN J NURS RES, V34, P883, DOI 10.1177/0193945911410329
   Kerse NM, 1999, BRIT MED J, V319, P683, DOI 10.1136/bmj.319.7211.683
   Kingston P, 2001, REV CLIN GERONTOLOGY, V11, P209
   Kono A, 2004, AGING CLIN EXP RES, V16, P293
   Kono A, 2012, J GERONTOL A-BIOL, V67, P302, DOI 10.1093/gerona/glr176
   Kono A, 2009, AGING CLIN EXP RES, V21, P167
   Krebs DE, 1998, ARCH PHYS MED REHAB, V79, P1489, DOI 10.1016/S0003-9993(98)90408-7
   Kronborg Christian, 2006, Eur J Health Econ, V7, P238, DOI 10.1007/s10198-006-0361-2
   La Grow SJ, 2006, INJURY PREV, V12, P296, DOI 10.1136/ip.2006.012252
   Legault C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-27
   Lenaghan E, 2007, AGE AGEING, V36, P292, DOI 10.1093/ageing/afm036
   Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x
   Lightbody E, 2002, AGE AGEING, V31, P203, DOI 10.1093/ageing/31.3.203
   Lin MR, 2007, J AM GERIATR SOC, V55, P499, DOI 10.1111/j.1532-5415.2007.01146.x
   Liu-Ambrose T, 2008, J AM GERIATR SOC, V56, P1821, DOI [10.1111/j.1532-5415.2008.01931.x, 10.1111/j.1532-5415.2008.01984.x]
   Luker KA, 1981, NURS TIMES, V77, P137
   Luukinen H, 2007, PREV MED, V44, P265, DOI 10.1016/j.ypmed.2006.09.011
   Luukinen H, 2006, SCAND J PRIM HEALTH, V24, P199, DOI 10.1080/02813430600958476
   Mahoney JE, 2007, J AM GERIATR SOC, V55, P489, DOI 10.1111/j.1532-5415.2007.01144.x
   Mann WC, 1999, ARCH FAM MED, V8, P210, DOI 10.1001/archfami.8.3.210
   Markle-Reid M, 2006, J ADV NURS, V54, P381, DOI 10.1111/j.1365-2648.2006.03817.x
   Markle-Reid M, 2006, MED CARE RES REV, V63, P531, DOI 10.1177/1077558706290941
   Markle-Reid M, 2010, CAN J AGING, V29, P139, DOI 10.1017/S0714980809990377
   Matzen Lars Erik, 2007, Ugeskr Laeger, V169, P2109
   Matzen Lars Erik, 2007, Ugeskr Laeger, V169, P2113
   Mayo-Wilson E, 2007, AM J PUBLIC HEALTH, V97, P630, DOI 10.2105/AJPH.2006.094169
   Mayo-Wilson E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-242
   MCEWAN RT, 1990, BRIT J GEN PRACT, V40, P94
   MCMURDO MET, 1995, AGE AGEING, V24, P425, DOI 10.1093/ageing/24.5.425
   MELIN AL, 1992, MED CARE, V30, P1004, DOI 10.1097/00005650-199211000-00004
   Melis RJF, 2008, J GERONTOL A-BIOL, V63, P283, DOI 10.1093/gerona/63.3.283
   Melis RJF, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-65
   Messier SP, 2000, J AM GERIATR SOC, V48, P131, DOI 10.1111/j.1532-5415.2000.tb03903.x
   Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008
   Miller DK, 1996, J AM GERIATR SOC, V44, P513, DOI 10.1111/j.1532-5415.1996.tb01435.x
   Montgomery P, 2013, J CLIN EPIDEMIOL, V66, P874, DOI 10.1016/j.jclinepi.2013.03.006
   Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2
   Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462
   Nelson ME, 2004, J GERONTOL A-BIOL, V59, P154
   Newbury J, 2001, 75 HLTH ASSESSMENTS
   Newbury JW, 2001, MED J AUSTRALIA, V175, P104
   Newcomer R, 2004, EVAL HEALTH PROF, V27, P323, DOI 10.1177/0163278704270011
   Nicolaides-Bouman A, 2004, BMC HEALTH SERV RES, V4, P1, DOI 10.1186/1472-6963-4-35
   Nicolaides-Bouman A, 2007, J ADV NURS, V58, P425, DOI 10.1111/j.1365-2648.2007.04235.x
   OKTAY JS, 1990, AM J PUBLIC HEALTH, V80, P39, DOI 10.2105/AJPH.80.1.39
   Pacini M, 2007, PHARMACOECONOMICS, V25, P171, DOI 10.2165/00019053-200725020-00008
   Parsons J, 2012, AGE AGEING, V41, P24, DOI 10.1093/ageing/afr118
   PATHY MSJ, 1992, LANCET, V340, P890, DOI 10.1016/0140-6736(92)93294-W
   Peeters Geeske M E E, 2007, BMC Geriatr, V7, P15, DOI 10.1186/1471-2318-7-15
   Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124
   Pighills AC, 2011, J AM GERIATR SOC, V59, P26, DOI 10.1111/j.1532-5415.2010.03221.x
   Ploeg J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1480
   Poulsen T, 2007, EUR J AGEING, V4, P115, DOI 10.1007/s10433-007-0057-1
   Poulstrup A, 2000, EUR J PUBLIC HEALTH, V10, P45, DOI 10.1093/eurpub/10.1.45
   Rejeski WJ, 1997, MED SCI SPORT EXER, V29, P977, DOI 10.1097/00005768-199708000-00001
   Robertson MC, 2001, J EPIDEMIOL COMMUN H, V55, P600, DOI 10.1136/jech.55.8.600
   Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697
   Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701
   Robichaud L, 2000, ARCH GERONTOL GERIAT, V30, P73, DOI 10.1016/S0167-4943(99)00053-9
   Rosie J, 2007, AGE AGEING, V36, P555, DOI 10.1093/ageing/afm093
   Rostgaard T, 1998, CARING CHILDREN OLDE
   RUBENSTEIN LZ, 1994, AGING-CLIN EXP RES, V6, P105, DOI 10.1007/BF03324224
   Sahlen KG, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-220
   Salminen M, 2008, AGING CLIN EXP RES, V20, P487
   Salminen M, 2009, ARCH GERONTOL GERIAT, V48, P22, DOI 10.1016/j.archger.2007.09.006
   Salminen MJ, 2009, J AM GERIATR SOC, V57, P612, DOI 10.1111/j.1532-5415.2009.02176.x
   Schraeder C, 2001, J GERONTOL A-BIOL, V56, pM106, DOI 10.1093/gerona/56.2.M106
   Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332
   Scogin F, 2007, PSYCHOL AGING, V22, P657, DOI 10.1037/0882-7974.22.4.657
   Sevick MA, 2000, MED SCI SPORT EXER, V32, P1534
   Shapiro A, 2002, GERONTOLOGIST, V42, P334, DOI 10.1093/geront/42.3.334
   Shearer NBC, 2010, NURS RES, V59, P203, DOI 10.1097/NNR.0b013e3181dbbd4a
   SILVERMAN M, 1995, J AM GERIATR SOC, V43, P733, DOI 10.1111/j.1532-5415.1995.tb07041.x
   Sjosten NM, 2007, EUR J PUBLIC HEALTH, V17, P464, DOI 10.1093/eurpub/ckl272
   Sjosten NM, 2007, PUBLIC HEALTH, V121, P308, DOI 10.1016/j.puhe.2006.09.018
   Sjosten NA, 2008, INT J GERIATR PSYCH, V23, P504, DOI 10.1002/gps.1927
   Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825
   Sorensen K H, 1988, Compr Gerontol B, V2, P85
   Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192
   StataCorp, 2009, STAT STAT SOFTW REL
   Steinberg M, 2000, J EPIDEMIOL COMMUN H, V54, P227, DOI 10.1136/jech.54.3.227
   Stevens M, 2001, J AM GERIATR SOC, V49, P1442, DOI 10.1046/j.1532-5415.2001.4911235.x
   Stevens M, 2001, J AM GERIATR SOC, V49, P1455
   Stewart S, 2005, AGE AGEING, V34, P41, DOI 10.1093/ageing/afh230
   Stuck AE, 2000, ARCH INTERN MED, V160, P977, DOI 10.1001/archinte.160.7.977
   Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022
   STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V
   STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805
   Stuck AE, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-2
   The Cochrane Collaboration, 2011, REV MAN REVMAN VERS
   Theander E, 2005, SCAND J PUBLIC HEALT, V33, P392, DOI 10.1080/14034940510005842
   Thomas R, 2007, CAN J AGING, V26, P379, DOI 10.3138/cia.26.4.379
   TINETTI ME, 1993, J AM GERIATR SOC, V41, P315, DOI 10.1111/j.1532-5415.1993.tb06710.x
   TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301
   Toseland RW, 1996, MED CARE, V34, P624, DOI 10.1097/00005650-199606000-00011
   TOWNSEND J, 1988, BMJ-BRIT MED J, V297, P544, DOI 10.1136/bmj.297.6647.544
   Tulloch A J, 1979, J R Coll Gen Pract, V29, P733
   Turner S, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003600.PUB3
   Underhill K, 2007, AIDS, V21, P266, DOI 10.1097/QAD.0b013e32801199fe
   United Nations, 2011, WORLD POP PROSP 2010
   Vaapio S, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-20
   van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994
   van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754
   van Hout HPJ, 2010, J GERONTOL A-BIOL, V65, P734, DOI 10.1093/gerona/glq037
   VANROSSUM E, 1993, BMJ-BRIT MED J, V307, P27, DOI 10.1136/bmj.307.6895.27
   Vass M, 2005, J AM GERIATR SOC, V53, P563, DOI 10.1111/j.1532-5415.2005.53201.x
   VETTER NJ, 1984, BRIT MED J, V288, P369, DOI 10.1136/bmj.288.6414.369
   VETTER NJ, 1992, BMJ-BRIT MED J, V304, P888, DOI 10.1136/bmj.304.6831.888
   von Renteln-Kruse W, 2003, Z GERONTOL GERIATR, V36, P378, DOI 10.1007/s00391-003-0179-9
   WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800
   Wallace JI, 1998, J GERONTOL A-BIOL, V53, pM301, DOI 10.1093/gerona/53A.4.M301
   Wasson J H, 1999, Eff Clin Pract, V2, P1
   Whitehead Craig, 2003, Aust Health Rev, V26, P88
   WILLIAMS EI, 1992, J PUBLIC HEALTH MED, V14, P138
   Williams K, 2002, ACTIVITIES ADAPTATIO, V27, P1, DOI DOI 10.1300/J016V27N02_01
   Wolf B, 2001, CLIN REHABIL, V15, P624, DOI 10.1191/0269215501cr456oa
   Wyman JF, 2007, J AM GERIATR SOC, V55, P1548, DOI 10.1111/j.1532-5415.2007.01315.x
   Yamada Y, 2003, GERIATR GERONTOL INT, V3, P236
   Yates SM, 2001, J GERONTOL A-BIOL, V56, pM226, DOI 10.1093/gerona/56.4.M226
   ZIMMER JG, 1985, AM J PUBLIC HEALTH, V75, P134, DOI 10.2105/AJPH.75.2.134
NR 211
TC 51
Z9 51
U1 0
U2 39
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 12
PY 2014
VL 9
IS 3
AR e89257
DI 10.1371/journal.pone.0089257
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC9HN
UT WOS:000332845300007
PM 24622676
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Galuschka, K
   Ise, E
   Krick, K
   Schulte-Korne, G
AF Galuschka, Katharina
   Ise, Elena
   Krick, Kathrin
   Schulte-Koerne, Gerd
TI Effectiveness of Treatment Approaches for Children and Adolescents with
   Reading Disabilities: A Meta-Analysis of Randomized Controlled Trials
SO PLOS ONE
LA English
DT Article
ID PUBLICATION BIAS; COLORED FILTERS; DEVELOPMENTAL DYSLEXIA;
   LEARNING-DISABILITIES; STRUGGLING READERS; PHONEMIC AWARENESS;
   DISABLED-CHILDREN; IRLEN-SYNDROME; INTERVENTIONS; INSTRUCTION
AB Children and adolescents with reading disabilities experience a significant impairment in the acquisition of reading and spelling skills. Given the emotional and academic consequences for children with persistent reading disorders, evidence-based interventions are critically needed. The present meta-analysis extracts the results of all available randomized controlled trials. The aims were to determine the effectiveness of different treatment approaches and the impact of various factors on the efficacy of interventions. The literature search for published randomized-controlled trials comprised an electronic search in the databases ERIC, PsycINFO, PubMed, and Cochrane, and an examination of bibliographical references. To check for unpublished trials, we searched the websites clinicaltrials.com and ProQuest, and contacted experts in the field. Twenty-two randomized controlled trials with a total of 49 comparisons of experimental and control groups could be included. The comparisons evaluated five reading fluency trainings, three phonemic awareness instructions, three reading comprehension trainings, 29 phonics instructions, three auditory trainings, two medical treatments, and four interventions with coloured overlays or lenses. One trial evaluated the effectiveness of sunflower therapy and another investigated the effectiveness of motor exercises. The results revealed that phonics instruction is not only the most frequently investigated treatment approach, but also the only approach whose efficacy on reading and spelling performance in children and adolescents with reading disabilities is statistically confirmed. The mean effect sizes of the remaining treatment approaches did not reach statistical significance. The present meta-analysis demonstrates that severe reading and spelling difficulties can be ameliorated with appropriate treatment. In order to be better able to provide evidence-based interventions to children and adolescent with reading disabilities, research should intensify the application of blinded randomized controlled trials.
C1 [Galuschka, Katharina; Krick, Kathrin; Schulte-Koerne, Gerd] Univ Munich, Dept Child & Adolescent Psychiat & Psychotherapy, Munich, Germany.
   [Ise, Elena] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, D-50931 Cologne, Germany.
RP Schulte-Korne, G (reprint author), Univ Munich, Dept Child & Adolescent Psychiat & Psychotherapy, Munich, Germany.
EM Gerd.Schulte-Koerne@med.uni-muenchen.de
FU Bundesverband fur Legasthenie und Dyskalkulie e.V. (BVL); Deutsche
   Gesellschaft fur Kinder- und Jugendpsychiatrie, Psychosomatik und
   Psychotherapie (DGKJP)
FX This research was supported by grants from the Bundesverband fur
   Legasthenie und Dyskalkulie e.V. (BVL) and Deutsche Gesellschaft fur
   Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973
   Berwanger D, 2004, Z KINDER JUG-PSYCH, V32, P77, DOI 10.1024/1422-4917.32.2.77
   Bhattacharya A, 2004, J LEARN DISABIL-US, V37, P331, DOI 10.1177/00222194040370040501
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Bull Leona, 2007, Complement Ther Clin Pract, V13, P15, DOI 10.1016/j.ctcp.2006.07.003
   Bus AG, 1999, J EDUC PSYCHOL, V91, P403, DOI 10.1037/0022-0663.91.3.403
   Carroll JM, 2005, J CHILD PSYCHOL PSYC, V46, P524, DOI 10.1111/j.1469-7610.2004.00366.x
   DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x
   DIIANNI M, 1985, J CLIN PSYCHOPHARM, V5, P272, DOI 10.1097/00004714-198510000-00004
   Dohnert M, 2003, Z KINDER JUG-PSYCH, V31, P305, DOI 10.1024//1422-4917.31.4.305
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ehri LC, 2001, REV EDUC RES, V71, P393, DOI 10.3102/00346543071003393
   Ehri LC, 2001, READ RES QUART, V36, P250, DOI 10.1598/RRQ.36.3.2
   Elbaum B, 2000, J EDUC PSYCHOL, V92, P605, DOI 10.1037/0022-0663.92.4.605
   Erickson K, 2010, AUGMENT ALTERN COMM, V26, P177, DOI 10.3109/07434618.2010.505606
   EVANS BJW, 1991, OPHTHAL PHYSL OPT, V11, P206, DOI 10.1016/0275-5408(91)90092-W
   Gonzalez MDO, 2002, J LEARN DISABIL-US, V35, P334, DOI 10.1177/00222194020350040401
   Goodwin AP, 2010, ANN DYSLEXIA, V60, P183, DOI 10.1007/s11881-010-0041-x
   Goswami U, 2011, DEVELOPMENTAL SCI, V14, P34, DOI 10.1111/j.1467-7687.2010.00955.x
   Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]
   HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490
   Heikkila R, 2013, SCI STUD READ, V17, P398, DOI 10.1080/10888438.2012.753452
   Ise E, 2012, KINDH ENTWICKL, V21, P122, DOI 10.1026/0942-5403/a000077
   Jimenez JE, 2007, SPAN J PSYCHOL, V10, P52, DOI 10.1017/S1138741600006314
   Kirk C, 2009, LANG SPEECH HEAR SER, V40, P341, DOI 10.1044/0161-1461(2008/08-0009)
   Landerl K, 2013, J CHILD PSYCHOL PSYC, V54, P686, DOI 10.1111/jcpp.12029
   Loo JHY, 2010, DEV MED CHILD NEUROL, V52, P708, DOI 10.1111/j.1469-8749.2010.03654.x
   Lovett MW, 1996, BRAIN LANG, V54, P447, DOI 10.1006/brln.1996.0085
   LOVETT MW, 1990, J EDUC PSYCHOL, V82, P769, DOI 10.1037/0022-0663.82.4.769
   LOVETT MW, 1989, BRAIN LANG, V37, P90, DOI 10.1016/0093-934X(89)90103-X
   Lovett MW, 2000, J EDUC PSYCHOL, V92, P263, DOI 10.1037/0022-0663.92.2.263
   Lovett MW, 1997, LEARN DISABILITY Q, V20, P189, DOI 10.2307/1511308
   Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9
   McArthur G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009115.pub2
   McPhillips M, 2000, LANCET, V355, P537, DOI 10.1016/S0140-6736(99)02179-0
   Mitchell C, 2008, PERCEPT MOTOR SKILL, V106, P517, DOI 10.2466/PMS.106.2.517-532
   Murphy CFB, 2011, FOLIA PHONIATR LOGO, V63, P147, DOI 10.1159/000316327
   National Institute of Child Health and Human Development, 2000, NIH PUBL
   O'Shaughnessy TE, 2000, J LEARN DISABIL-US, V33, P257, DOI 10.1177/002221940003300304
   Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087
   Robinson GL, 1999, PERCEPT MOTOR SKILL, V88, P35, DOI 10.2466/PMS.88.1.35-52
   Ryder JF, 2008, READ WRIT, V21, P349, DOI 10.1007/s11145-007-9080-z
   SANCHEZ E, 1991, READ WRIT, V3, P11, DOI 10.1007/BF00554561
   Scammacca N., 2007, INTERVENTIONS ADOLES
   Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0
   Schulte-Korne G, 2010, CLIN NEUROPHYSIOL, V121, P1794, DOI 10.1016/j.clinph.2010.04.028
   SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408
   Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859
   Suggate SP, 2010, DEV PSYCHOL, V46, P1556, DOI 10.1037/a0020612
   Swanson HL, 1999, J LEARN DISABIL, V32, P504, DOI 10.1177/002221949903200605
   Swanson HL, 2001, ELEM SCHOOL J, V101, P331, DOI 10.1086/499671
   Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4
   Tormanen MRK, 2009, SCAND J PSYCHOL, V50, P277, DOI 10.1111/j.1467-9450.2009.00708.x
   Tressoldi PE, 2000, J LEARN DISABIL-US, V33, P278, DOI 10.1177/002221940003300305
   Wanzek J, 2013, REV EDUC RES, V83, P163, DOI 10.3102/0034654313477212
   Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368
   Wilsher Colin R, 1994, Eur Child Adolesc Psychiatry, V3, P59, DOI 10.1007/BF01977668
   WILSHER CR, 1987, J CLIN PSYCHOPHARM, V7, P230
   Ziegler JC, 2010, DEVELOPMENTAL SCI, V13, pF8, DOI 10.1111/j.1467-7687.2010.00983.x
   Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406
NR 60
TC 65
Z9 65
U1 2
U2 110
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 26
PY 2014
VL 9
IS 2
AR e89900
DI 10.1371/journal.pone.0089900
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC3BC
UT WOS:000332389000107
PM 24587110
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Peng, QL
   Lao, XJ
   Tang, WZ
   Chen, ZP
   Li, RL
   Wang, J
   Deng, Y
   Li, TJ
   Qin, X
   Li, S
AF Peng, Qiliu
   Lao, Xianjun
   Tang, Weizhong
   Chen, Zhiping
   Li, Ruolin
   Wang, Jian
   Deng, Yan
   Li, Taijie
   Qin, Xue
   Li, Shan
TI CASP8-652 6N Del Polymorphism Contributes to Colorectal Cancer
   Susceptibility: Evidence from a Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID PATHWAY CONFER SUSCEPTIBILITY; GENETIC-VARIANTS; RISK; ASSOCIATION;
   HETEROGENEITY; PROGNOSIS; PROMOTER; DISEASE; BIAS
AB Objective: Caspase-8 (CASP8) plays a central role in the apoptotic pathway and aberrant regulation of this pathway may cause cancers. Previous studies investigating the association between CASP8 -652 6N ins/del polymorphism and colorectal cancer (CRC) risk showed inconclusive results. We performed a meta-analysis of all available studies to investigate this association.
   Methods: All studies published up to October 2013 on the association between CASP8 -652 6N ins/del polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Cochrane library. The association between CASP8 -652 6N ins/del polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs).
   Results: Six studies with 6,325 cases and 6,842 controls were included in the meta-analysis. We observed that the CASP8 652 6N ins/del polymorphism was significantly correlated with CRC risk when all studies were pooled into the meta-analysis (ins/del vs. ins/ins: OR = 0.890, 95% CI 0.821-0.964, P = 0.004; del/del + ins/del vs. ins/ins: OR = 0.899, 95% CI 0.833-0.970, P = 0.006). In stratified analyses by ethnicity, source of control, and quality score, significant association was observed in Asians (ins/del vs. ins/ins: OR = 0.862, 95% CI 0.761-0.977, P = 0.020; del/del + ins/del vs. ins/ins: OR = 0.845, 95% CI 0.749-0.953, P = 0.006), population-based studies (ins/del vs. ins/ins: OR = 0.890, 95% CI 0.813-0.975, P = 0.012; del/del + ins/del vs. ins/ins: OR = 0.901, 95% CI 0.827-0.982, P = 0.018), and high quality studies. However, in subgroup analysis according to cancer location, no significant association was detected.
   Conclusions: The present meta-analysis suggests that the CASP8 is a candidate gene for CRC susceptibility. The CASP8 -652 6N ins/del polymorphism may play a protective role in CRC development especially among Asians. Further large and well-designed studies are needed to confirm this association.
C1 [Peng, Qiliu; Lao, Xianjun; Wang, Jian; Deng, Yan; Li, Taijie; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.
   [Tang, Weizhong] Guangxi Med Univ, Affiliated Hosp 1, Dept Anal & Colorectal Surg, Nanning, Guangxi, Peoples R China.
   [Chen, Zhiping] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Sch Publ Hlth, Nanning, Guangxi, Peoples R China.
   [Li, Ruolin] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Res, Nanning, Guangxi, Peoples R China.
RP Qin, X (reprint author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.
EM qinxue919@126.com; lis8858@126.com
FU National Natural Science Foundation [81260302]
FX The work described in this paper was supported by the National Natural
   Science Foundation (No. 81260302). The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156
   Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Gangwar R, 2009, ANN SURG ONCOL, V16, P2028, DOI 10.1245/s10434-009-0488-3
   Goodman JE, 2006, INT J CANCER, V118, P1790, DOI 10.1002/ijc.21523
   Grenet J, 1999, GENE, V226, P225, DOI 10.1016/S0378-1119(98)00565-4
   Haiman CA, 2008, NAT GENET, V40, P259, DOI 10.1038/ng0308-259
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1
   Liu B, 2010, MOL CARCINOGEN, V49, P75, DOI 10.1002/mc.20579
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Pittman AM, 2008, BRIT J CANCER, V98, P1434, DOI 10.1038/sj.bjc.6604314
   Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030
   Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184
   Theodoropoulos GE, 2011, INT J COLORECTAL DIS, V26, P1113, DOI 10.1007/s00384-011-1217-5
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113
   Wu ZW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0565-0
   Xiao MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067577
   Ye YQ, 2008, CANCER-AM CANCER SOC, V112, P2467, DOI 10.1002/cncr.23472
NR 26
TC 6
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2014
VL 9
IS 2
AR e87925
DI 10.1371/journal.pone.0087925
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 302TD
UT WOS:000330626900149
PM 24498403
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cronin-Fenton, DP
   Christensen, M
   Lash, TL
   Ahern, TP
   Pedersen, L
   Garne, JP
   Ewertz, M
   Autrup, H
   Sorensen, HT
   Hamilton-Dutoit, S
AF Cronin-Fenton, Deirdre P.
   Christensen, Mariann
   Lash, Timothy L.
   Ahern, Thomas P.
   Pedersen, Lars
   Garne, Jens Peter
   Ewertz, Marianne
   Autrup, Herman
   Sorensen, Henrik T.
   Hamilton-Dutoit, Stephen
TI Manganese Superoxide Dismutase and Breast Cancer Recurrence: A Danish
   Clinical Registry-Based Case-Control Study, and a Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ANTIOXIDANT INTAKE; GENE POLYMORPHISM; SURVIVAL; MNSOD; RISK;
   HETEROZYGOSITY; ASSOCIATION; SEQUENCE; REGIONS; CAT
AB Background: Manganese superoxide dismutase (MnSOD) inhibits oxidative damage and cancer therapy effectiveness. A polymorphism in its encoding gene (SOD2: Val16Ala rs4880) may confer poorer breast cancer survival, but data are inconsistent. We examined the association of SOD2 genotype and breast cancer recurrence (BCR) among patients treated with cyclophosphamide-based chemotherapy (Cyclo). We compared our findings with published studies using meta-analyses.
   Methods: We conducted a population-based case-control study of BCR among women in Jutland, Denmark. Subjects were diagnosed with non-metastatic breast cancer from 1990-2001, received adjuvant Cyclo, and were registered in the Danish Breast Cancer Cooperative Group. We identified 118 patients with BCR and 213 matched breast cancer controls. We genotyped SOD2 and used conditional logistic regression to compute the odds ratio (OR) and associated 95% confidence intervals (95% CI) of BCR. We used random-effects meta-analytic models to evaluate the association of SOD2 polymorphisms and BCR.
   Results: The frequency of the SOD2-Ala allele was 70% in cases versus 71% in controls; 40% versus 44% were heterozygotes, and 30% versus 25% were homozygotes, respectively. Heterozygote and homozygote carriers of the Ala allele had no increased rate of BCR (OR = 1.1, 95% CI = 0.65, 2.0, and OR = 0.87, 95% CI = 0.47, 1.6, respectively). Five studies informed the meta-analytic models; summary estimates associating BCR for homozygote, or any inheritance of the variant Ala allele were 1.18 (95% CI = 0.74, 1.88), and 1.18, (95% CI = 0.91, 1.54), respectively.
   Conclusion: Our findings do not suggest that MnSOD enzymatic activity, as measured by SOD2 genotype, affects rates of BCR among patients treated with Cyclo.
C1 [Cronin-Fenton, Deirdre P.; Lash, Timothy L.; Pedersen, Lars; Sorensen, Henrik T.] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark.
   [Christensen, Mariann; Hamilton-Dutoit, Stephen] Aarhus Univ, Inst Pathol, DK-8000 Aarhus, Denmark.
   [Lash, Timothy L.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Ahern, Thomas P.] Univ Vermont, Dept Surg, Coll Med, Burlington, VT 05405 USA.
   [Garne, Jens Peter; Ewertz, Marianne] Danish Breast Canc Cooperat Grp, Copenhagen, Denmark.
   [Garne, Jens Peter] Aalborg Univ Hosp, Dept Breast Surg, Aalborg, Denmark.
   [Ewertz, Marianne] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Oncol, Odense, Denmark.
   [Autrup, Herman] Aarhus Univ, Inst Publ Hlth, Aarhus, Denmark.
RP Cronin-Fenton, DP (reprint author), Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark.
EM dc@dce.au.dk
OI Toft Sorensen, Henrik/0000-0003-4299-7040; Hamilton-Dutoit,
   Stephen/0000-0003-2158-3885
FU Danish Medical Research Council; US NCI; Karen Elise Jensen Foundation;
   US NIH [NIH 5 T32 CA 009001]; Department of Clinical Epidemiology,
   Aarhus University Hospital
FX This project was supported primarily by a research grant from the Danish
   Medical Research Council (to SHD), and secondarily by research grants
   from the US NCI (to TLL), the Danish Medical Research Council (to TLL),
   and the Karen Elise Jensen Foundation (to HTS). TPA was supported by a
   US NIH postdoctoral training award (NIH 5 T32 CA 009001). In addition,
   the Department of Clinical Epidemiology, Aarhus University Hospital,
   receives funding for other studies from companies in the form of
   research grants to (and administered by) Aarhus University. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ahern Thomas P, 2010, Clin Epidemiol, V2, P241, DOI 10.2147/CLEP.S13811
   Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039
   Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5
   Ambrosone CB, 2005, CANCER RES, V65, P1105
   Bewick MA, 2008, BREAST CANCER RES TR, V111, P93, DOI 10.1007/s10549-007-9764-8
   Bica CG, 2010, CANCER GENET CYTOGEN, V196, P153, DOI 10.1016/j.cancergencyto.2009.09.011
   Cai QY, 2004, BREAST CANCER RES, V6, pR647, DOI 10.1186/bcr929
   Chen PM, 2012, MOL CANC RES
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Erichsen Rune, 2010, Clin Epidemiol, V2, P51
   Fu TY, 2011, HEAD NECK-J SCI SPEC, V33, P1606, DOI 10.1002/hed.21653
   Funke S, 2009, J CANCER EPIDEMIOL, DOI 10.1155/2009/302047
   Glynn SA, 2009, CLIN CANCER RES, V15, P4165, DOI 10.1158/1078-0432.CCR-09-0119
   Hansen PS, 1997, ACTA ONCOL, V36, P711, DOI 10.3109/02841869709001342
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hubackova M, 2012, INT J CANCER, V130, P338, DOI 10.1002/ijc.26006
   Ji MH, 2012, CANCER BIOL THER, V13, P264, DOI [10.4161/cbt.13.5.18920, 10.4161/cbt.18920]
   Johnatty SE, 2007, GYNECOL ONCOL, V107, P388, DOI 10.1016/j.ygyno.2007.09.004
   Martin RCG, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1532
   Martin RCG, 2009, DNA CELL BIOL, V28, P3, DOI 10.1089/dna.2008.0788
   Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827
   Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259
   Noviello C, 1996, CLIN CANCER RES, V2, P1601
   Rae JM, 2013, JNCI-J NATL CANCER I, V105, P1332, DOI 10.1093/jnci/djt204
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P111
   Sgambato A, 2009, CANCER SCI, V100, P1026, DOI 10.1111/j.1349-7006.2009.01141.x
   Sheng ZM, 1996, BRIT J CANCER, V73, P144, DOI 10.1038/bjc.1996.27
   Slanger TE, 2006, CANCER CAUSE CONTROL, V17, P1025, DOI 10.1007/s10552-006-0043-5
   Sutton A, 2005, PHARMACOGENET GENOM, V15, P311, DOI 10.1097/01213011-200505000-00006
   Weir BS, 1996, GENETIC DATA ANAL, VII
   Yao S, 2010, BREAST CANCER RES TR, V124, P433, DOI 10.1007/s10549-010-0840-0
NR 32
TC 6
Z9 6
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 31
PY 2014
VL 9
IS 1
AR e87450
DI 10.1371/journal.pone.0087450
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 302RF
UT WOS:000330621900113
PM 24498107
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kaufmann, E
   Reips, UD
   Wittmann, WW
AF Kaufmann, Esther
   Reips, Ulf-Dietrich
   Wittmann, Werner W.
TI A Critical Meta-Analysis of Lens Model Studies in Human Judgment and
   Decision-Making
SO PLOS ONE
LA English
DT Article
ID CLINICAL JUDGMENT; CORRELATION-COEFFICIENTS; PREDICTIONS; RELIABILITY;
   ACCURACY; ACHIEVEMENT; STRATEGY; TASK
AB Achieving accurate judgment ('judgmental achievement') is of utmost importance in daily life across multiple domains. The lens model and the lens model equation provide useful frameworks for modeling components of judgmental achievement and for creating tools to help decision makers (e. g., physicians, teachers) reach better judgments (e. g., a correct diagnosis, an accurate estimation of intelligence). Previous meta-analyses of judgment and decision-making studies have attempted to evaluate overall judgmental achievement and have provided the basis for evaluating the success of bootstrapping (i.e., replacing judges by linear models that guide decision making). However, previous meta-analyses have failed to appropriately correct for a number of study design artifacts (e. g., measurement error, dichotomization), which may have potentially biased estimations (e. g., of the variability between studies) and led to erroneous interpretations (e. g., with regards to moderator variables). In the current study we therefore conduct the first psychometric meta-analysis of judgmental achievement studies that corrects for a number of study design artifacts. We identified 31 lens model studies (N = 1,151, k = 49) that met our inclusion criteria. We evaluated overall judgmental achievement as well as whether judgmental achievement depended on decision domain (e. g., medicine, education) and/or the level of expertise (expert vs. novice). We also evaluated whether using corrected estimates affected conclusions with regards to the success of bootstrapping with psychometrically-corrected models. Further, we introduce a new psychometric trim-and-fill method to estimate the effect sizes of potentially missing studies correct psychometric meta-analyses for effects of publication bias. Comparison of the results of the psychometric meta-analysis with the results of a traditional meta-analysis (which only corrected for sampling error) indicated that artifact correction leads to a) an increase in values of the lens model components, b) reduced heterogeneity between studies, and c) increases the success of bootstrapping. We argue that psychometric meta-analysis is useful for accurately evaluating human judgment and show the success of bootstrapping.
C1 [Kaufmann, Esther] Univ Zurich, Inst Educ, Zurich, Switzerland.
   [Kaufmann, Esther] Univ Konstanz, Dept Econ, Chair Business & Econ Educ 2, Constance, Germany.
   [Reips, Ulf-Dietrich] Univ Konstanz, Dept Psychol, Constance, Germany.
   [Wittmann, Werner W.] Univ Mannheim, Otto Selz Inst Appl Psychol, Mannheim, Germany.
RP Kaufmann, E (reprint author), Univ Zurich, Inst Educ, Zurich, Switzerland.
EM esther.kaufmann@gmx.ch
RI Reips, Ulf-Dietrich/A-5177-2012
OI Reips, Ulf-Dietrich/0000-0002-1566-4745; Kaufmann,
   Esther/0000-0003-1177-5146
FU Excellence Intitiative of the Deutsche Forschungsgemeinschaft
FX This work is funded by a fellowship for Esther Kaufmann to attend the
   Graduate School of Economics & Social Sciences in Mannheim (Germany)
   offered by the Excellence Intitiative of the Deutsche
   Forschungsgemeinschaft (see: http://www.dfg.de/en/index.jsp). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR AEgisdottir S, 2006, COUNS PSYCHOL, V34, P341, DOI 10.1177/0011000005285875
   Armstrong JS, 2001, INT SER OPER RES MAN, V30, P171
   ASHTON AH, 1982, J ACCOUNTING RES, V20, P440, DOI 10.2307/2490751
   Ashton RH, 2000, J BEHAV DECIS MAKING, V13, P277, DOI 10.1002/1099-0771(200007/09)13:3<277::AID-BDM350>3.0.CO;2-B
   BANGERTDROWNS RL, 1986, PSYCHOL BULL, V99, P388, DOI 10.1037/0033-2909.99.3.388
   Bernieri FJ, 1996, J PERS SOC PSYCHOL, V71, P110, DOI 10.1037/0022-3514.71.1.110
   Brunswik E., 1952, INT ENCY UNIFIED SCI
   CAMERER C, 1981, ORGAN BEHAV HUM PERF, V27, P411, DOI 10.1016/0030-5073(81)90031-3
   Cooksey RW, 2007, EDUC RES EVAL, V13, P401, DOI 10.1080/13803610701728311
   COOKSEY RW, 1986, AM EDUC RES J, V23, P41, DOI 10.2307/1163041
   Cooksey RW, 2001, J VOCATIONAL ED RES, V26, P1
   COOPER RP, 1990, CRIM JUSTICE BEHAV, V17, P431, DOI 10.1177/0093854890017004004
   DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   EINHORN HJ, 1974, ORGAN BEHAV HUM PERF, V12, P30, DOI 10.1016/0030-5073(74)90035-X
   EYSENCK HJ, 1952, J CONSULT PSYCHOL, V16, P319
   Field AP, 2005, PSYCHOL METHODS, V10, P444, DOI 10.1037/1082-989X.10.4.444
   Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037/1082-989X.6.2.161
   GOLDBERG LR, 1976, ORGAN BEHAV HUM PERF, V16, P13, DOI 10.1016/0030-5073(76)90003-9
   GORMAN CD, 1978, ORGAN BEHAV HUM PERF, V22, P165, DOI 10.1016/0030-5073(78)90011-9
   Grove WM, 2000, PSYCHOL ASSESSMENT, V12, P19, DOI 10.1037/1040-3590.12.1.19
   Hammond K. R, 2001, ESSENTIAL BRUNSWIK B
   HAMMOND KR, 1964, PSYCHOL REV, V71, P438, DOI 10.1037/h0040736
   Harvey N, 2004, INT J FORECASTING, V20, P391, DOI 10.1016/j.ijforecast.2003.09.012
   Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1
   Hedges L. V., 1985, STAT METHODS METAANA
   Herzog SM, 2009, PSYCHOL SCI, V20, P231, DOI 10.1111/j.1467-9280.2009.02271.x
   Hogarth RM, 2006, INFORMATION SAMPLING AND ADAPTIVE COGNITION, P456
   Hunter J. E, 2004, METHODS METAANALYSIS
   HURSCH CJ, 1964, PSYCHOL REV, V71, P42, DOI 10.1037/h0041729
   Ioannidisa JPA, 2010, RES SYNTH METHODS, V1, P169, DOI 10.1002/jrsm.19
   Jenny MA, 2013, J APPL RES MEM COGN, V2, P149, DOI 10.1016/j.jarmac.2013.06.001
   Karelaia N, 2008, PSYCHOL BULL, V134, P404, DOI 10.1037/0033-2909.134.3.404
   Kaufmann E, 2007, INT J IDIOGRAPHIC SC, P2
   Kaufmann E, 2009, DO WE UNDERRESTIMATE
   Kaufmann E, 2010, THESIS U MANNHEIM
   Kaufmann E, 2013, WORKING PAPER
   Kaufmann E, 2009, SWISS J PSYCHOL, V68, P99, DOI 10.1024/1421-0185.68.2.99
   Kim CN, 1997, DECIS SUPPORT SYST, V21, P83, DOI 10.1016/S0167-9236(97)00022-5
   LADUCA A, 1988, EVAL HEALTH PROF, V11, P178, DOI 10.1177/016327878801100203
   Lehman HA, 1992, THESIS CALIFORNIA CH
   Lichtenstein S, 1981, PTR1092816
   LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181
   MacGregor D., 1986, HUMAN COMPUTER INTER, V2, P179, DOI DOI 10.1207/S15327051HCI0203_
   MCCLELLAN PG, 1984, PERCEPT PSYCHOPHYS, V36, P234, DOI 10.3758/BF03206364
   MEAR R, 1987, ACCOUNT ORG SOC, V12, P331, DOI 10.1016/0361-3682(87)90022-5
   Meehl Paul E., 1954, CLIN VERSUS STAT PRE
   Mutz R, 2010, Z PSYCHOL, V218, P175, DOI 10.1027/0044-3409/a000027
   NYSTEDT L, 1975, PERCEPT MOTOR SKILL, V40, P343, DOI 10.2466/pms.1975.40.2.343
   Renkewitz F, 2011, JUDGM DECIS MAK, V6, P870
   Reynolds DJ, 2001, PERS SOC PSYCHOL B, V27, P187, DOI 10.1177/0146167201272005
   ROOSE JE, 1976, ORGAN BEHAV HUM PERF, V16, P231, DOI 10.1016/0030-5073(76)90015-5
   Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59
   Rosenthal R., 1991, METAANALYTIC PROCEDU
   Rothstein H. R., 2007, J EXPT CRIMINOLOGY, V4, P61, DOI [10.1007/s11292-007-9046-9, DOI 10.1007/S11292-007-9046-9]
   Shanteau J, 2002, WORKING PAPER
   Simpson RJS, 1904, BRIT MED J, V1904, P1243
   SINGH H, 1990, Q REV ECON BUS, V30, P64
   Smith L, 2003, APPL COGNITIVE PSYCH, V17, P51, DOI 10.1002/acp.844
   SMITH ML, 1977, AM PSYCHOL, V32, P752, DOI 10.1037/0003-066X.32.9.752
   SPEROFF T, 1989, MED DECIS MAKING, V9, P243, DOI 10.1177/0272989X8900900403
   STEINMANN DO, 1972, ORGAN BEHAV HUM PERF, V8, P450, DOI 10.1016/0030-5073(72)90062-1
   STEWART TR, 1990, WEATHER FORECAST, V5, P661, DOI 10.1175/1520-0434(1990)005<0661:ADOTCC>2.0.CO;2
   Stewart TR, 1997, ORGAN BEHAV HUM DEC, V69, P205, DOI 10.1006/obhd.1997.2682
   SZUCKO JJ, 1981, AM PSYCHOL, V36, P488, DOI 10.1037/0003-066X.36.5.488
   Trailer JW, 2004, J AM ACAD BUSINESS C, V3, P42
   TUCKER LR, 1964, PSYCHOL REV, V71, P528, DOI 10.1037/h0047061
   Vacha-Haase T, 1998, EDUC PSYCHOL MEAS, V58, P6, DOI 10.1177/0013164498058001002
   WERNER PD, 1983, J CONSULT CLIN PSYCH, V51, P815, DOI 10.1037/0022-006X.51.6.815
   WERNER PD, 1989, SOC WORK RES ABSTR, V25, P17, DOI 10.1093/swra/25.3.17
   WIGGINS N, 1971, J PERS SOC PSYCHOL, V19, P100, DOI 10.1037/h0031147
   Wittmann W. W., 1988, HDB MULTIVARIATE EXP, P505, DOI DOI 10.1007/978-1-4613-0893-5_16
   WITTMANN WW, 1986, PSYCHOL RUNDSCH, V37, P20
   Wittmann WW, 2009, EVALUATION, V1, P59
   Wittmann WW, 1985, EVALUATIONSFORSUNGE
   WRIGHT WF, 1979, ORGAN BEHAV HUM PERF, V23, P73, DOI 10.1016/0030-5073(79)90047-3
NR 76
TC 8
Z9 8
U1 0
U2 34
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2013
VL 8
IS 12
AR e83528
DI 10.1371/journal.pone.0083528
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 284NF
UT WOS:000329325200078
PM 24391781
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Wu, B
   Liu, K
   Huang, HX
   Yuan, J
   Yuan, WQ
   Wang, SQ
   Chen, TT
   Zhao, H
   Yin, CJ
AF Wu, Bin
   Liu, Kang
   Huang, Huaxing
   Yuan, Jun
   Yuan, Wanqing
   Wang, Shangqian
   Chen, Tingting
   Zhao, Hu
   Yin, Changjun
TI MspI and Ile462Val Polymorphisms in CYP1A1 and Overall Cancer Risk: A
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID METABOLIZING ENZYME POLYMORPHISMS; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE
   POLYMORPHISMS; SUSCEPTIBILITY; TOXICITY; GSTM1
AB Background: Cytochrome P450 1A1 (CYP1A1) is a member of the CYP1 family, which is a key enzyme in the metabolism of many endogenous substrates and exogenous carcinogens. To date, many studies have examined the association between CYP1A1 MspI and Ile462Val polymorphisms and cancer risk in various populations, but their results have been conflicting rather than consistent.
   Methods: To assess this relationship more precisely, a meta-analysis based on 198 publications was performed. Odds ratios (OR) and corresponding 95% confidence intervals (CIs) were used to assess the association. The statistical heterogeneity across studies was examined with a chi-square-based Q-test.
   Results: Overall, a significant elevated risk of cancer was associated with CYP1A1 MspI and Ile462Val polymorphisms for all genetic models studied. Further stratified analysis by cancer types revealed that the MspI polymorphism may increase the risk of lung cancer and cervical cancer whereas the Ile462Val polymorphism may contribute to a higher risk of lung cancer, leukemia, esophageal carcinoma, and prostate cancer. In the subgroup analysis by ethnicity, obvious associations were found in the Asian population for the MspI polymorphism while an increased risk of cancer was observed in Asians and Caucasians for the Ile462Val polymorphism.
   Conclusions: The results of this meta-analysis suggest that CYP1A1 MspI and Ile462Val polymorphisms contribute to increased cancer susceptibility among Asians. Additional comprehensive system analyses are required to validate this association and other related polymorphisms.
C1 [Wu, Bin; Yuan, Jun; Zhao, Hu] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Urol, Wuxi, Peoples R China.
   [Liu, Kang; Wang, Shangqian; Chen, Tingting; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.
   [Huang, Huaxing] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China.
   [Yuan, Wanqing] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Orthoped, Qingdao 266071, Peoples R China.
RP Zhao, H (reprint author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Urol, Wuxi, Peoples R China.
EM doctorzhao11@163.com
CR Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187
   Bozina N, 2009, ARH HIG RADA TOKSIKO, V60, P217, DOI 10.2478/10004-1254-60-2009-1885
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Gonzalez FJ, 1997, REPROD TOXICOL, V11, P397, DOI 10.1016/S0890-6238(96)00154-2
   GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001
   Gutman G, 2009, INT J GYNECOL CANCER, V19, P1300, DOI 10.1111/IGC.0b013e3181b9fa5d
   Jin JQ, 2011, WORLD J GASTROENTERO, V17, P260, DOI 10.3748/wjg.v17.i2.260
   Li M, 2008, CHINESE MED J-PEKING, V121, P305, DOI 10.1097/00029330-200802020-00005
   Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015
   Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7
   Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273
   Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377
   Rodriguez-Antona C, 2010, HUM GENET, V127, P1, DOI 10.1007/s00439-009-0748-0
   Sergentanis TN, 2012, MOL BIOL REP, V39, P6647, DOI 10.1007/s11033-012-1470-x
   Sugawara T, 2003, INT J GYNECOL CANCER, V13, P785, DOI 10.1136/ijgc-00009577-200311000-00009
   Varela-Lema L, 2008, GENET MED, V10, P369, DOI 10.1097/GIM.0b013e3181770196
   Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095
   Wideroff L, 2007, CANCER DETECT PREV, V31, P233, DOI 10.1016/j.cdp.2007.03.004
   Yu L, 2012, MOL BIOL REP, V39, P6641, DOI 10.1007/s11033-012-1469-3
   Zhan P, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-99
   Zheng Y, 2012, MOL BIOL REP, V39, P3533, DOI 10.1007/s11033-011-1126-2
   Zhuo WL, 2012, GENE, V510, P14, DOI 10.1016/j.gene.2012.08.042
   Zhuo XL, 2012, CANCER INVEST, V30, P552, DOI 10.3109/07357907.2012.716470
NR 23
TC 14
Z9 15
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2013
VL 8
IS 12
AR e85166
DI 10.1371/journal.pone.0085166
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 284MV
UT WOS:000329323900136
PM 24391993
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kicinski, M
AF Kicinski, Michal
TI Publication Bias in Recent Meta-Analyses
SO PLOS ONE
LA English
DT Article
ID ANTIDEPRESSANT TRIALS; SELECTION MODELS; FILL METHOD; TRIM; PERFORMANCE;
   DATABASE; IMPACT; TESTS; SIZE
AB Introduction: Positive results have a greater chance of being published and outcomes that are statistically significant have a greater chance of being fully reported. One consequence of research underreporting is that it may influence the sample of studies that is available for a meta-analysis. Smaller studies are often characterized by larger effects in published meta-analyses, which can be possibly explained by publication bias. We investigated the association between the statistical significance of the results and the probability of being included in recent meta-analyses.
   Methods: For meta-analyses of clinical trials, we defined the relative risk as the ratio of the probability of including statistically significant results favoring the treatment to the probability of including other results. For meta-analyses of other studies, we defined the relative risk as the ratio of the probability of including biologically plausible statistically significant results to the probability of including other results. We applied a Bayesian selection model for meta-analyses that included at least 30 studies and were published in four major general medical journals (BMJ, JAMA, Lancet, and PLOS Medicine) between 2008 and 2012.
   Results: We identified 49 meta-analyses. The estimate of the relative risk was greater than one in 42 meta-analyses, greater than two in 16 meta-analyses, greater than three in eight meta-analyses, and greater than five in four meta-analyses. In 10 out of 28 meta-analyses of clinical trials, there was strong evidence that statistically significant results favoring the treatment were more likely to be included. In 4 out of 19 meta-analyses of observational studies, there was strong evidence that plausible statistically significant outcomes had a higher probability of being included.
   Conclusions: Publication bias was present in a substantial proportion of large meta-analyses that were recently published in four major medical journals.
C1 Hasselt Univ, Dept Sci, Hasselt, Belgium.
RP Kicinski, M (reprint author), Hasselt Univ, Dept Sci, Hasselt, Belgium.
EM michal.kicinski@uhasselt.be
CR Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636
   CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208
   CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405
   Chavers S, 2011, PHARMACOEPIDEM DR S, V20, P1009, DOI 10.1002/pds.2221
   Copas JB, 2001, STAT METHODS MED RES, V10, P251, DOI 10.1191/096228001678227776
   Dear KB, 1992, STAT SCI, V7, P237, DOI DOI 10.1214/SS/1177011363
   Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Gelman A., 2003, BAYESIAN DATA ANAL
   Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A
   Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380
   Hedges LV, 1996, J EDUC BEHAV STAT, V21, P299, DOI 10.2307/1165338
   HEDGES LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364
   Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286
   Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441
   Iyengar Shanto, 1988, STAT SCI, V3, P109, DOI DOI 10.1214/SS/1177013012
   Jalota L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1110
   Jang J, 2009, J STAT COMPUT SIM, V79, P691, DOI 10.1080/00949650801891595
   Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365
   Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010
   Kromrey JD, 2006, EDUC PSYCHOL MEAS, V66, P357, DOI 10.1177/0013164405278585
   KULINSKAYA E, 2008, METAANALYSIS GUIDE C
   Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112
   Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597
   Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191
   Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698
   Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2
   Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981
   Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349
   Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515
   Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889
   Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x
   Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676
   Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671
   Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971
   Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046
   Rufibach K, 2011, BIOMETRICAL J, V53, P689, DOI 10.1002/bimj.201000240
   Silliman NP, 1997, J AM STAT ASSOC, V92, P926, DOI 10.2307/2965556
   Song FJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-79
   Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Sutton AJ, 2000, STAT METHODS MED RES, V9, P421, DOI 10.1191/096228000701555244
   Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461
   Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779
   Zhang ZH, 2013, CRIT CARE, V17, DOI 10.1186/cc11919
NR 52
TC 46
Z9 47
U1 1
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 27
PY 2013
VL 8
IS 11
AR UNSP e81823
DI 10.1371/journal.pone.0081823
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 261GG
UT WOS:000327652100101
PM 24363797
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, HJ
   Liu, H
   Jiang, GF
AF Zhang, Haijun
   Liu, Hang
   Jiang, Gaofeng
TI Genetic Polymorphisms of XRCC1 and Leukemia Risk: A Meta-Analysis of 19
   Case-Control Studies
SO PLOS ONE
LA English
DT Article
ID DNA-REPAIR POLYMORPHISMS; BASE EXCISION-REPAIR; CANCER-RISK; GENOTYPE
   DISTRIBUTION; POLYMERASE BETA; SUSCEPTIBILITY; ASSOCIATION; P14ARF;
   BIAS; XPD
AB Objective: Three common X-ray repair cross-complementing groups 1 (XRCC1) polymorphisms, Arg399Gln, Arg194Trp, and Arg280His, have been reported to be implicated in the development of leukemia. However, previous results from different studies were inconsistent. Consequently, we performed a meta-analysis in order to accurately evaluate the association between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and leukemia risk.
   Methods: Through computerized searching of PubMed, ISI Web of Knowledge, Cochrane, EBSCO, and OpenGrey databases, and manually searching relevant references, a total of 19 studies with 3387 cases and 6168 controls for Arg399Gln (G > A) polymorphism, 12 studies with 2043 cases and 4550 controls for Arg194Trp (C > T), and 6 studies with 1445 cases and 1905 controls for Arg280His (G > A) were collected to perform meta-analysis and stratified analysis to explore the associations between these variants and leukemia susceptibility. Based on three genetic models, the codominant model, dominant model and recessive model, odds ratios (ORs) as well as their 95% confidence intervals (CIs) were used to evaluate the association strength between XRCC1 genotypes and leukemia risk.
   Results: With respect to overall leukemia susceptibility, no association was detected. In stratified analyses by tumor type, Arg399Gln was associated with higher acute lymphoblastic leukemia (ALL) risk (AA vs. GG, OR = 1.50, 95% CI: 1.11-2.02; AA+GA vs. GG, OR = 1.35, 95% CI: 1.02-1.78). Additionally, Arg399Gln, Arg194Trp, and Arg280His may influence the susceptibilities of some leukemia type and race populations.
   Conclusion: This meta-analysis indicates these three polymorphisms of XRCC1 do not associate with overall leukemia risks but could be associated with the risks for some specific subgroups.
C1 [Zhang, Haijun] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10021 USA.
   [Liu, Hang] Columbia Univ, Sch Social Work, New York, NY USA.
   [Jiang, Gaofeng] Wuhan Univ Sci & Technol, Sch Publ Hlth, Coll Med, Wuhan, Hubei, Peoples R China.
RP Zhang, HJ (reprint author), Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10021 USA.
EM haz2004@med.cornell.edu; gaofeng.jiang@yahoo.com
FU National Natural Science Foundation of China [81172462]
FX This work was partly supported by the National Natural Science
   Foundation of China (No. 81172462). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. No additional external funding received
   for this study.
CR Abramenko I, 2012, J RADIAT RES, V53, P497, DOI 10.1269/jrr.11093
   Annamaneni S, 2012, HEMATOLOGY
   Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x
   Batar B, 2009, LEUKEMIA RES, V33, P759, DOI 10.1016/j.leukres.2008.11.005
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874
   Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387
   Canalle R, 2011, LEUKEMIA LYMPHOMA, V52, P1118, DOI 10.3109/10428194.2011.559672
   Celkan T, 2008, LEUKEMIA LYMPHOMA, V49, P1638, DOI 10.1080/10428190802140063
   Dai LP, 2012, MOL BIOL REP, V39, P9535, DOI 10.1007/s11033-012-1818-2
   Deligezer U, 2007, ANTICANCER RES, V27, P2453
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dianov GL, 1999, J BIOL CHEM, V274, P13741, DOI 10.1074/jbc.274.20.13741
   Duman N, 2012, GENET TEST MOL BIOMA, V16, P287, DOI 10.1089/gtmb.2011.0152
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   El-Din M. S., 2012, Comparative Clinical Pathology, V21, P505
   Ganster C, 2009, GENE CHROMOSOME CANC, V48, P760, DOI 10.1002/gcc.20680
   Ginsberg G, 2011, MUTAT RES-REV MUTAT, V727, P1, DOI 10.1016/j.mrrev.2011.02.001
   Howlader N, 2013, SEER CANC STAT REV 1
   Hu ZB, 2005, CANCER EPIDEM BIOMAR, V14, P1810, DOI 10.1158/1055-9965.EPI-04-0793
   Joseph T, 2005, CANCER LETT, V217, P17, DOI 10.1016/j.canlet.2004.06.055
   Kim HN, 2012, LEUKEMIA LYMPHOMA, V53, P681, DOI 10.3109/10428194.2011.625576
   Li WJ, 2009, CHEMOTHERAPY, V55, P335, DOI 10.1159/000230697
   Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280
   Meza-Espinoza J P, 2009, Genet Mol Res, V8, P1451, DOI 10.4238/vol8-4gmr687
   Ozcan A, 2011, AFR J BIOTECHNOL, V10, P8860
   Pakakasama S, 2007, PEDIATR BLOOD CANCER, V48, P16, DOI 10.1002/pbc.20742
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Seedhouse C, 2002, BLOOD, V100, P3761, DOI 10.1182/blood-2002-04-1152
   Shi JY, 2011, INT J CANCER, V128, P233, DOI 10.1002/ijc.25318
   Sorour A, 2013, GENET TEST MOL BIOMA, V17, P195, DOI 10.1089/gtmb.2012.0278
   Stanczyk M, 2011, MOL BIOL REP, V38, P445, DOI 10.1007/s11033-010-0127-x
   Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0
   Tumer TB, 2010, LEUKEMIA RES, V34, P1275, DOI 10.1016/j.leukres.2010.02.035
   Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067
   Zhang HJ, 2010, J CELL BIOCHEM, V109, P693, DOI 10.1002/jcb.22446
   Zhang HJ, 2009, J CELL BIOCHEM, V106, P464, DOI 10.1002/jcb.22033
   Zhang HJ, 2013, TUMOR BIOL, V34, P3003, DOI 10.1007/s13277-013-0865-1
   Zhang HJ, 2011, ANTICANCER RES, V31, P3945
   Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603
   Zhang H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00001
NR 42
TC 7
Z9 7
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 25
PY 2013
VL 8
IS 11
AR e80687
DI 10.1371/journal.pone.0080687
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259RH
UT WOS:000327543500053
PM 24363792
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, YB
   Chen, Q
   Wang, Z
   Zhou, J
AF Chen, Yan-bo
   Chen, Qi
   Wang, Zhong
   Zhou, Juan
TI Insulin Therapy and Risk of Prostate Cancer: a Systematic Review and
   Meta-Analysis of Observational Studies
SO PLOS ONE
LA English
DT Review
ID SMOOTH-MUSCLE-CELLS; PUBLICATION BIAS; ANALOG GLARGINE; CLINICAL-TRIALS;
   RECEPTOR; GLUCOSE; PROLIFERATION; EPIDEMIOLOGY; MALIGNANCIES; PREVALENCE
AB Background: Previous observational studies have shown that insulin therapy may modify the risk of prostate cancer (PCa). However, these studies yielded controversial results. Thus, we performed this meta-analysis to determine whether insulin use was associated with PCa risk in patients with diabetes mellitus (DM).
   Method: A literature search was carried out in PubMed, EMBASE, and Cochrane Library Central database between January 1966 and January 2013. Fixed-effect and random-effect models were used to estimate pooled relative risks (RR) and corresponding 95% confidence intervals (CIs). Subgroup analyses and sensitivity analyses were also performed.
   Result: A total of 11 (10 cohorts, and one case-control) studies published between 2007 and 2013 were included in the meta-analysis, representing data for 205,523 male subjects and 7,053 PCa cases. There were five studies investigating the influence of insulin and other glucose-lowering agents on the risk of PCa, and six studies investigating the influence of glargine and non-glargine insulin. Insulin use was not associated with PCa risk when compared with other glucose-lowering agents (RR=0.89, 95% CI, 0.72-1.09). Use of insulin glargine did not contribute to susceptibility to PCa as compared with use of non-glargine insulin (RR=1.26, 95% CI, 0.86-1.84). Sensitivity analysis confirmed the stability of present results, since no individual study affected the pooled result significantly.
   Conclusions: Our results suggest that, there may be no significant association between insulin use and risk of PCa as compared with other glucose-lowering agents in patients with DM, and there was no substantial evidence for increase risk of PCa among insulin glargine users as compared to non-glargine insulin users. Further studies are warranted to validate these conclusions.
C1 [Chen, Yan-bo; Chen, Qi; Wang, Zhong; Zhou, Juan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol & Androl, Shanghai 200030, Peoples R China.
RP Wang, Z (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol & Androl, Shanghai 200030, Peoples R China.
EM wz_wzz@126.com
RI Chen, Yanbo/K-8163-2019
CR BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074
   Blin P, 2012, DIABETOLOGIA, V55, P644, DOI 10.1007/s00125-011-2429-5
   Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4
   CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]
   Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1
   Colmers IN, 2012, DIABETES METAB, V38, P485, DOI 10.1016/j.diabet.2012.08.011
   Cox ME, 2009, PROSTATE, V69, P33, DOI 10.1002/pros.20852
   Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eckardt K, 2007, DIABETOLOGIA, V50, P2534, DOI 10.1007/s00125-007-0815-9
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]
   Gu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053411
   Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y
   Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3
   Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782
   Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891
   Janghorbani M, 2012, HORM CANCER-US, V3, P137, DOI 10.1007/s12672-012-0112-z
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Koro C, 2007, PHARMACOEPIDEM DR S, V16, P485, DOI 10.1002/pds.1352
   Li QA, 2010, CANCER CAUSE CONTROL, V21, P1025, DOI 10.1007/s10552-010-9530-9
   Ljung R, 2011, ACTA ONCOL, V50, P685, DOI 10.3109/0284186X.2011.558913
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699
   Ruiter R, 2012, DIABETOLOGIA, V55, P51, DOI 10.1007/s00125-011-2312-4
   Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240
   Staiger K, 2005, DIABETOLOGIA, V48, P1898, DOI 10.1007/s00125-005-1874-4
   Tseng CH, 2011, ANN MED, V43, P142, DOI 10.3109/07853890.2010.530683
   Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640
   Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x
   Wada T, 2008, DIABETES RES CLIN PR, V81, P269, DOI 10.1016/j.diabres.2008.05.007
   Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
   Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601
   Xu H, 2013, DIABETES RES CLIN PR
NR 43
TC 9
Z9 10
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 25
PY 2013
VL 8
IS 11
AR e81594
DI 10.1371/journal.pone.0081594
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259RH
UT WOS:000327543500116
PM 24282613
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Petti, S
   Masood, M
   Scully, C
AF Petti, Stefano
   Masood, Mohd
   Scully, Crispian
TI The Magnitude of Tobacco Smoking-Betel Quid Chewing-Alcohol Drinking
   Interaction Effect on Oral Cancer in South-East Asia. A Meta-Analysis of
   Observational Studies
SO PLOS ONE
LA English
DT Article
ID RISK-FACTORS; CIGARETTE-SMOKING; PUBLICATION BIAS; CAVITY CANCER; GLOBAL
   EPIDEMIOLOGY; NECK-CANCER; TAIWAN; INDIA; ASSOCIATION; CONSUMPTION
AB Tobacco smoking, betel quid chewing and alcohol drinking are oral cancer risk factors. Observational studies unanimously report that oral cancer risk in smoking-drinking-chewing exposed subjects is exceptionally high. However, none of them assessed the fractions of this risk attributable to the three individual risk factors and to the smoking-drinking-chewing interaction. The present study sought to assess the magnitude of the smoking-drinking-chewing interaction effect on oral cancer. A meta-analysis of observational South-East Asian studies which reported oral cancer odds ratios (ORs) stratified for smoking-drinking-chewing exposures was performed. The pooled ORs were estimated and controlled for quality, heterogeneity, publication bias and inclusion criteria. The smoking-drinking-chewing interaction effect was estimated through the pooled Relative Excess Risk due to Interaction (RERI, excess risk in smoking-drinking-chewing exposed individuals with respect to the risk expected from the addition of the three individual risks of smoking, drinking and chewing). Fourteen studies were included with low between-study heterogeneity. The pooled ORs for smoking, drinking, chewing, smoking-drinking-chewing, respectively were 3.6 (95% confidence interval 295% CI, 1.9-7.0), 2.2 (95% CI, 1.6-3.0), 7.9 (95% CI, 6.7-9.3), 40.1 (95% CI, 35.1-45.8). The pooled RERI was 28.4 (95% CI, 22.9-33.7). Among smoking-drinking-chewing subjects, the individual effects accounted for 6.7% (smoking), 3.1% (drinking), 17.7% (chewing) of the risk, while the interaction effect accounted for the remaining 72.6%. These data suggest that 44,200 oral cancer cases in South-East Asia annually occur among smoking-drinking-chewing exposed subjects and 40,400 of these are exclusively associated with the interaction effect. Effective oral cancer control policies must consider concurrent tobacco smoking, alcohol drinking, betel quid chewing usages as a unique unhealthy lifestyle.
C1 [Petti, Stefano] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Masood, Mohd] Univ Teknol Mara, Fac Dent, Ctr Studies Community Dent, Shah Alam, Malaysia.
   [Scully, Crispian] UCL, London, England.
RP Petti, S (reprint author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.
EM stefano.petti@uniroma1.it
OI Tringe, Susannah/0000-0001-6479-8427; Geib, Scott/0000-0002-9511-5139;
   Herr, Joshua/0000-0003-3425-292X; Petti, Stefano/0000-0001-9996-8860
CR Amarasinghe HK, 2010, COMMUNITY DENT ORAL, V38, P540, DOI 10.1111/j.1600-0528.2010.00566.x
   Anantharaman D, 2011, ORAL ONCOL, V47, P725, DOI 10.1016/j.oraloncology.2011.05.004
   Ariyawardana A, 2005, Asian Pac J Cancer Prev, V6, P58
   Aruna DS, 2011, ASIAN PAC J CANCER P, V12, P1561
   Assmann SF, 1996, EPIDEMIOLOGY, V7, P286, DOI 10.1097/00001648-199605000-00012
   Bekkering GE, 2008, AM J EPIDEMIOL, V167, P1017, DOI 10.1093/aje/kwn005
   BLAIR A, 1995, REGUL TOXICOL PHARM, V22, P189, DOI 10.1006/rtph.1995.1084
   Bloomfield K, 2003, ALCOHOL RES HEALTH, V27, P95
   Chang IH, 2011, J CHIN MED ASSOC, V74, P561, DOI 10.1016/j.jcma.2011.09.014
   Chen PCH, 2002, J ORAL PATHOL MED, V31, P317, DOI 10.1034/j.1600-0714.2002.00129.x
   Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x
   Cheong SC, 2009, ORAL ONCOL, V45, P712, DOI 10.1016/j.oraloncology.2008.11.002
   Chung CH, 2005, J ORAL PATHOL MED, V34, P460, DOI 10.1111/j.1600-0714.2005.00332.x
   de Mutsert R, 2009, KIDNEY INT, V75, P677, DOI 10.1038/ki.2008.645
   Desai NG, 2003, PREVENTION HARM ALCO
   Dos Santos Silva I., 1999, CANC EPIDEMIOLOGY PR
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Ferlay J., 2010, IARC CANC BASE
   Antunes JLF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068132
   GAJALAKSHMI CK, 2000, TOBACCO CONTROL DEV, P11
   Ghani WMN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-207
   Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X
   Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010
   Greenfield TK, 2008, ADDICTION, V103, P1082, DOI 10.1111/j.1360-0443.2008.02197.x
   Guo SE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-257
   Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31
   Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437
   Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V83, P1
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC MONOGR EVAL CAR, V96, P3
   Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157
   KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x
   Lee CH, 2012, INT J CANCER, V131, pE733, DOI 10.1002/ijc.27401
   Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809
   Lin WJ, 2011, J ONCOL, V2011, DOI DOI 10.1155/2011/525976
   Lohe VK, 2010, J ORAL PATHOL MED, V39, P141, DOI 10.1111/j.1600-0714.2009.00828.x
   Metcalfe C, 2008, SCAND J PUBLIC HEALT, V36, P442, DOI 10.1177/1403494807088451
   MORRIS RD, 1994, ENVIRON HEALTH PERSP, V102, P61, DOI 10.1289/ehp.94102s861
   Muwonge R, 2008, ORAL ONCOL, V44, P446, DOI 10.1016/j.oraloncology.2007.06.002
   NOTANI PN, 1988, J EPIDEMIOL COMMUN H, V42, P187, DOI 10.1136/jech.42.2.187
   Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889
   Petti S, 2012, CANCER EPIDEMIOL, V36, pE1, DOI 10.1016/j.canep.2011.09.009
   Petti S, 2009, ORAL ONCOL, V45, P340, DOI 10.1016/j.oraloncology.2008.05.018
   RAO DN, 1994, INT J CANCER, V58, P469, DOI 10.1002/ijc.2910580402
   Rowe AK, 2004, AM J PREV MED, V26, P243, DOI 10.1016/j.amepre.2003.12.007
   Saini Rajan, 2006, Singapore Dent J, V28, P34
   SANKARANARAYANAN R, 1989, BRIT J CANCER, V60, P638, DOI 10.1038/bjc.1989.330
   SANKARANARAYANAN R, 1990, J EPIDEMIOL COMMUN H, V44, P286, DOI 10.1136/jech.44.4.286
   Schoenbach VJ, 2000, UNDERSTANDING FUNDAM, P381
   Scully C, 2011, MED ORAL PATOL ORAL, V16, pE306, DOI 10.4317/medoral.16.e306
   Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Subapriya R, 2007, EUR J CANCER PREV, V16, P251, DOI 10.1097/01.cej.0000228402.53106.9e
   Sutton AJ, 2000, BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574
   Sutton AJ, 2000, METHODS METAANALYSIS
   Thomas SJ, 2008, INT J CANCER, V123, P1871, DOI 10.1002/ijc.23739
   Bich TH, 2009, GLOBAL HEALTH ACTION, V2, P28, DOI 10.3402/gha.v2i0.2017
   Tsai KY, 2009, COMMUNITY DENT ORAL, V37, P555, DOI 10.1111/j.1600-0528.2009.00504.x
   Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002
   Wen CP, 2005, TOB CONTROL, V14, pI16, DOI 10.1136/tc.2004.008003
   Yang KY, 2007, LARYNGOSCOPE, V117, P92, DOI 10.1097/01.mlg.0000245012.83011.50
   Yen TT, 2008, EUR ARCH OTO-RHINO-L, V265, P1403, DOI 10.1007/s00405-008-0659-z
   Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114
   Zou GY, 2008, AM J EPIDEMIOL, V168, P212, DOI 10.1093/aje/kwn104
NR 66
TC 101
Z9 102
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 18
PY 2013
VL 8
IS 11
AR e78999
DI 10.1371/journal.pone.0078999
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 256KH
UT WOS:000327308500018
PM 24260143
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zeng, XT
   Luo, W
   Huang, W
   Wang, Q
   Guo, Y
   Leng, WD
AF Zeng, Xian-Tao
   Luo, Wei
   Huang, Wei
   Wang, Quan
   Guo, Yi
   Leng, Wei-Dong
TI Tooth Loss and Head and Neck Cancer: A Meta-Analysis of Observational
   Studies
SO PLOS ONE
LA English
DT Article
ID SQUAMOUS-CELL CARCINOMA; ORAL HYGIENE; RISK-FACTORS; DENTITION; HEALTH;
   EPIDEMIOLOGY; SMOKING; CAVITY; LIFE; BIAS
AB Backgroud: Epidemiological studies have shown that tooth loss is associated with risk of head and neck cancer (HNC); however, the results were inconsistent. Therefore, we conducted a meta-analysis to ascertain the relationship between tooth loss and HNC.
   Methods: We searched for relevant observational studies that tested the association between tooth loss and risk of HNC from PubMed and were conducted up to January 30, 2013. Data from the eligible studies were independently extracted by two authors. The meta-analysis was performed using the Comprehensive Meta-Analysis 2.2 software. Sensitivity and subgroup analyses were conducted to evaluate the influence of various inclusions. Publication bias was also detected.
   Results: Ten articles involving one cohort and ten case-control studies were yielded. Based on random-effects meta-analysis, an association between tooth loss and HNC risk was identified [increased risk of 29% for 1 to 6 teeth loss (OR = 1.29, 95% CI = 0.52-3.20, p = 0.59), 58% for 6 to 15 teeth loss (OR = 1.58, 95% CI = 1.08-2.32, p = 0.02), 63% for 11+ teeth loss (OR = 1.63, 95% CI = 1.23-2.14, p<0.001), 72% for 15+ teeth loss (OR = 1.72, 95% CI = 1.26-2.36, p<0.001), and 89% for 20+ teeth loss (OR = 1.89, 95% CI = 1.27-2.80, p<0.001)]. The sensitivity analysis shows that the result was robust, and publication bias was not detected.
   Conclusions: Based on the current evidence, tooth loss is probably a significant and dependent risk factor of HNC, which may have a dose-response effect. People who lost six or more teeth should pay attention to symptoms of HNC, and losing 11 teeth or 15 teeth may be the threshold.
C1 [Zeng, Xian-Tao; Huang, Wei; Wang, Quan; Leng, Wei-Dong] Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Peoples R China.
   [Luo, Wei] Gen Hosp Chinese Peoples Liberat Army, Inst Stomatol, Beijing, Peoples R China.
   [Guo, Yi] Wuhan Univ, Dept Epidemil, Sch Publ Hlth, Wuhan 430072, Peoples R China.
RP Leng, WD (reprint author), Hubei Univ Med, Taihe Hosp, Dept Stomatol, Shiyan, Peoples R China.
EM lengtaihe@163.com
OI Zeng, Xian-Tao/0000-0003-1262-725X
FU Nature Science Foundation of Hubei Province [2012FFB03902]; Natural
   Science Foundation of Hubei Ministry of Education [D20122405];
   Foundation of Education and Science Planning Project of Hubei Province
   [2012A050]; Intramural Research Program of the Hubei University of
   Medcine [2011CZX01]
FX This research was supported (in part) by the Nature Science Foundation
   of Hubei Province (2012FFB03902), the Natural Science Foundation of
   Hubei Ministry of Education (D20122405), the Foundation of Education and
   Science Planning Project of Hubei Province (2012A050), and the
   Intramural Research Program of the Hubei University of Medcine
   (2011CZX01), without commercial, or not-for-profit sectors. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adegboye ARA, 2012, NUTRITION, V28, P779, DOI 10.1016/j.nut.2011.11.011
   Anand PS, 2012, ORAL HLTH PREV DENT, V10, P243
   Borenstein M, 2005, COMPREHENSIVE METAAN
   BUNDGAARD T, 1995, CANCER CAUSE CONTROL, V6, P57, DOI 10.1007/BF00051681
   Conway DI, 2009, ORAL ONCOL, V45, P743, DOI 10.1016/j.oraloncology.2009.02.007
   Cronin M, 2009, GERODONTOLOGY, V26, P137, DOI 10.1111/j.1741-2358.2008.00239.x
   Divaris K, 2010, CANCER CAUSE CONTROL, V21, P567, DOI 10.1007/s10552-009-9486-9
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825
   Gerritsen AE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-126
   Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221
   Guha N, 2007, AM J EPIDEMIOL, V166, P1159, DOI 10.1093/aje/kwm193
   Heegaard K, 2011, J PUBLIC HEALTH DENT, V71, P318, DOI 10.1111/j.1752-7325.2011.00276.x
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hiraki A, 2008, CANCER EPIDEM BIOMAR, V17, P1222, DOI 10.1158/1055-9965.EPI-07-2761
   Lissowska J, 2003, EUR J CANCER PREV, V12, P25, DOI 10.1097/01.cej.0000043735.13672.78
   MARSHALL JR, 1992, ORAL ONCOL, V28B, P9, DOI 10.1016/0964-1955(92)90005-L
   Matthews JC, 2011, J AM DENT ASSOC, V142, P379, DOI 10.14219/jada.archive.2011.0192
   Mehanna H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4684
   Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Talamini R, 2000, BRIT J CANCER, V83, P1238, DOI 10.1054/bjoc.2000.1398
   Taylor George W, 2004, Compend Contin Educ Dent, V25, P179
   Wang RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071122
   Wozniak Anna, 2012, Przegl Lek, V69, P1079
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
   ZHENG TZ, 1990, CANCER CAUSE CONTROL, V1, P235, DOI 10.1007/BF00117475
NR 31
TC 24
Z9 27
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 15
PY 2013
VL 8
IS 11
AR e79074
DI 10.1371/journal.pone.0079074
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255RX
UT WOS:000327258600017
PM 24260154
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wersebe, H
   Sijbrandij, M
   Cuijpers, P
AF Wersebe, Hanna
   Sijbrandij, Marit
   Cuijpers, Pim
TI Psychological Group-Treatments of Social Anxiety Disorder: A
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID BEHAVIORAL GROUP-THERAPY; COGNITIVE THERAPY; PHOBIA; COMORBIDITY;
   PREVALENCE; PHENELZINE; PLACEBO; HELP; BIAS
AB Background: A few meta-analyses have examined psychological treatments for a social anxiety disorder (SAD). This is the first meta-analysis that examines the effects of cognitive behavioural group therapies (CBGT) for SAD compared to control on symptoms of anxiety.
   Method: After a systematic literature search in PubMed, Cochrane, PsychINFO and Embase was conducted; eleven studies were identified that met the inclusion criteria. The studies had to be randomized controlled studies in which individuals with a diagnosed SAD were treated with cognitive-behavioural group therapy (CBGT) and compared with a control group. The overall quality of the studies was moderate.
   Results: The pooled effect size indicated that the difference between intervention and control conditions was 0.53 (96% CI: 0.33-0.73), in favour of the intervention. This corresponds to a NNT 3.24. Heterogeneity was low to moderately high in all analyses. There was some indication of publication bias.
   Conclusions: It was found that psychological group-treatments CBGT are more effective than control conditions in patients with SAD. Since heterogeneity between studies was high, more research comparing group psychotherapies for SAD to control is needed.
C1 [Wersebe, Hanna; Sijbrandij, Marit; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Sijbrandij, Marit; Cuijpers, Pim] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Cuijpers, Pim] Univ Luneburg, Luneburg, Germany.
RP Cuijpers, P (reprint author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
EM p.cuipers@vu.nl
RI Sijbrandij, Marit/N-6131-2018; Cuijpers, Pim/G-1703-2013
OI Sijbrandij, Marit/0000-0001-5430-9810; Cuijpers, Pim/0000-0001-5497-2743
CR Acarturk C, 2008, SOC PSYCH PSYCH EPID, V43, P273, DOI 10.1007/s00127-008-0309-1
   Acarturk C, 2009, PSYCHOL MED, V39, P241, DOI 10.1017/S0033291708003590
   Andlin-Sobocki P, 2011, EUR NEUROPSYCHOPHARM, V21, P718
   Andrews G, 2011, AUST NZ J PSYCHIAT, V45, P337, DOI 10.3109/00048674.2010.538840
   APA, 1987, DIAGN STAT MAN MENT
   APA, 1994, DIAGN STAT MAN MENT
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bjornsson AS, 2011, DEPRESS ANXIETY, V28, P1034, DOI 10.1002/da.20877
   Blanco C, 2010, ARCH GEN PSYCHIAT, V67, P286, DOI 10.1001/archgenpsychiatry.2010.11
   Brunello N, 2000, J AFFECT DISORDERS, V60, P61, DOI 10.1016/S0165-0327(99)00140-8
   Davidson JRT, 2004, ARCH GEN PSYCHIAT, V61, P1005, DOI 10.1001/archpsyc.61.10.1005
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fedoroff IC, 2001, J CLIN PSYCHOPHARM, V21, P311, DOI 10.1097/00004714-200106000-00011
   Ferrari J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000964.pub3
   FESKE U, 1995, BEHAV THER, V26, P695, DOI 10.1016/S0005-7894(05)80040-1
   Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163
   Furmark T, 2002, ACTA PSYCHIAT SCAND, V105, P84, DOI 10.1034/j.1600-0447.2002.1r103.x
   Gould RA, 1997, CLIN PSYCHOL-SCI PR, V4, P291, DOI 10.1111/j.1468-2850.1997.tb00123.x
   Gruber K, 2001, BEHAV THER, V32, P155, DOI 10.1016/S0005-7894(01)80050-2
   Heimberg RG, 1998, ARCH GEN PSYCHIAT, V55, P1133, DOI 10.1001/archpsyc.55.12.1133
   Herbert JD, 2005, BEHAV THER, V36, P125, DOI 10.1016/S0005-7894(05)80061-9
   Higgins JP, 2008, COCHRANE HDB SYSTEMA, P51, DOI DOI 10.1002/9780470712184.CH4
   Hofmann SG, 2004, J CONSULT CLIN PSYCH, V72, P588, DOI 10.1037/0022-0006X.72.4.588
   Hofmann SG, 2006, J ANXIETY DISORD, V20, P961, DOI 10.1016/j.janxdis.2006.03.005
   HOPE DA, 1995, BEHAV RES THER, V33, P637, DOI 10.1016/0005-7967(95)00013-N
   Kasper S, 1998, J AFFECT DISORD S, V50, P3
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014
   Magee WJ, 1996, ARCH GEN PSYCHIAT, V53, P159
   Mortberg E, 2007, ACTA PSYCHIAT SCAND, V115, P142, DOI 10.1111/j.1600-0447.2006.00839.x
   Mortberg E, 2006, J ANXIETY DISORD, V20, P646, DOI 10.1016/j.janxdis.2005.07.005
   Piet J, 2010, SCAND J PSYCHOL, V51, P403, DOI 10.1111/j.1467-9450.2009.00801.x
   Pishyar R, 2008, COGNITION EMOTION, V22, P1209, DOI 10.1080/02699930701686008
   Rapee RM, 2007, BRIT J PSYCHIAT, V191, P246, DOI 10.1192/bjp.bp.106.028167
   Rodebaugh TL, 2004, CLIN PSYCHOL REV, V24, P883, DOI 10.1016/j.cpr.2004.07.007
   Schunemann HJ, 2008, COCHRANE HDB SYSTEMA, P359, DOI DOI 10.1002/9780470712184.CH12
   Silverman WK, 1999, J CONSULT CLIN PSYCH, V67, P995, DOI 10.1037/0022-006X.67.6.995
   Stangier U, 2003, BEHAV RES THER, V41, P991, DOI 10.1016/S0005-7967(02)00176-6
   Taylor S, 1996, J BEHAV THER EXP PSY, V27, P1, DOI 10.1016/0005-7916(95)00058-5
   Weiller E., 1996, British Journal of Psychiatry, V168, P169, DOI 10.1192/bjp.168.2.169
   Wong DFK, 2006, HK J PSYCHIAT, V16, P1650
NR 41
TC 15
Z9 15
U1 1
U2 34
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 15
PY 2013
VL 8
IS 11
AR e79034
DI 10.1371/journal.pone.0079034
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255RX
UT WOS:000327258600016
PM 24260148
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Marcolino, MS
   Maia, JX
   Alkmim, MBM
   Boersma, E
   Ribeiro, AL
AF Marcolino, Milena Soriano
   Maia, Junia Xavier
   Moreira Alkmim, Maria Beatriz
   Boersma, Eric
   Ribeiro, Antonio Luiz
TI Telemedicine Application in the Care of Diabetes Patients: Systematic
   Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID NURSE FOLLOW-UP; GLYCEMIC CONTROL; HOME TELEHEALTH; AUTOMATED CALLS;
   BLOOD-GLUCOSE; HEALTH-CARE; MANAGEMENT; INTERVENTIONS; IMPACT; OLDER
AB Background: The impact of telemedicine application on the management of diabetes patients is unclear, as the results are not consistent among different studies. The objective of this study is to conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) assessing the impact of telemedicine interventions on change in hemoglobin A1c (HbA1c), blood pressure, LDL cholesterol (LDL-c) and body mass index (BMI) in diabetes patients.
   Methods: Electronic databases MEDLINE, Cochrane Central Register of Controlled Trials and LILACS were searched to identify relevant studies published until April 2012, supplemented by references from the selected articles. Study search and selection were performed by independent reviewers. Of the 6.258 articles retrieved, 13 RCTs (4207 patients) were included. Random effects model was applied to estimate the pooled results.
   Results: Telemedicine was associated with a statistically significant and clinically relevant absolute decline in HbA1c level compared to control (mean difference -0.44% [-4.8 mmol/mol] and 95% confidence interval [CI] -0.61 to -0.26% [-6.7 to -2.8 mmol/mol]; p<0.001). LDL-c was reduced in 6.6 mg/dL (95% CI -8.3 to -4.9; p<0.001), but the clinical relevance of this effect can be questioned. No effects of telemedicine strategies were seen on systolic (-1.6 mmHg and 95% CI -7.2 to 4.1) and diastolic blood pressure (-1.1 mmHg and 95% CI -3.0 to 0.8). The 2 studies that assessed the effect on BMI demonstrated a tendency of BMI reduction in favor of telemedicine.
   Conclusions: Telemedicine strategies combined to the usual care were associated with improved glycemic control in diabetic patients. No clinical relevant impact was observed on LDL-c and blood pressure, and there was a tendency of BMI reduction in diabetes patients who used telemedicine, but these outcomes should be further explored in future trials.
C1 [Marcolino, Milena Soriano; Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil.
   [Marcolino, Milena Soriano; Maia, Junia Xavier; Moreira Alkmim, Maria Beatriz; Ribeiro, Antonio Luiz] Univ Fed Minas Gerais, Univ Hosp, Belo Horizonte, MG, Brazil.
   [Boersma, Eric] Erasmus MC, Rotterdam, Netherlands.
RP Marcolino, MS (reprint author), Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil.
EM milenamarc@gmail.com
RI Ribeiro, Antonio/C-2707-2009
OI Ribeiro, Antonio/0000-0002-2740-0042
FU Brazilian research agency Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico [563893/2010-9]; Brazilian research agency
   Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais;
   Brazilian research agency Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais [PPM 328-08]
FX This study was funded by Brazilian research agencies Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (563893/2010-9),
   Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais and
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (PPM 328-08).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ajay Vamadevan S, 2011, J Diabetes Sci Technol, V5, P778
   Alkmim MB, 2012, B WORLD HEALTH ORGAN, V90, P373, DOI 10.2471/BLT.11.099408
   Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011
   [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011]
   Azar M, 2009, DIABETES RES CLIN PR, V83, P9, DOI 10.1016/j.diabres.2008.09.055
   Bond GE, 2007, DIABETES TECHNOL THE, V9, P52, DOI 10.1089/dia.2006.0057
   Borenstein M, 2009, INTRO METAANALYSIS, P421, DOI DOI 10.1002/9780470743386
   Bujnowska-Fedak MM, 2011, TELEMED E-HEALTH, V17, P153, DOI 10.1089/tmj.2010.0113
   Costa BM, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-72
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   European's Information Society, 2012, UR INF SOC THEM PORT
   Farmer A, 2005, DIABETIC MED, V22, P1372, DOI 10.1111/j.1464-5491.2005.01627.x
   Farmer A, 2007, BMJ-BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE
   Guariguata L, 2011, DIABETES RES CLIN PR, V94, P322, DOI 10.1016/j.diabres.2011.10.040
   Izquierdo R, 2010, DIABETES TECHNOL THE, V12, P213, DOI 10.1089/dia.2009.0102
   Klonoff David C, 2009, J Diabetes Sci Technol, V3, P624
   Kuenen JC, 2011, DIABETES CARE, V34, P1843, DOI 10.2337/dc10-2217
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Little RR, 2001, CLIN CHEM, V47, P1985
   Marcolino M, 2012, TELEDIABETES CARE DI
   McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Montori VM, 2004, DIABETES CARE, V27, P1088, DOI 10.2337/diacare.27.5.1088
   Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3
   Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202
   Polisena J, 2009, DIABETES OBES METAB, V11, P913, DOI 10.1111/j.1463-1326.2009.01057.x
   Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220
   Rodriguez-Idigoras MI, 2009, DIABETES TECHNOL THE, V11, P431, DOI 10.1089/dia.2008.0114
   Russell-Minda Elizabeth, 2009, J Diabetes Sci Technol, V3, P1460
   Sacks DB, 2011, DIABETES CARE, V34, P1419, DOI 10.2337/dc11-9997
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shea S, 2006, J AM MED INFORM ASSN, V13, P40, DOI 10.1197/jamia.M1917
   Siriwardena LSAN, 2012, J TELEMED TELECARE, V18, P164, DOI 10.1258/jtt.2012.SFT110
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Stone RA, 2010, DIABETES CARE, V33, P478, DOI 10.2337/dc09-1012
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   van den Berg N, 2012, MATURITAS, V73, P94, DOI 10.1016/j.maturitas.2012.06.010
   Verhoeven Fenne, 2010, J Diabetes Sci Technol, V4, P666
   Wakefield BJ, 2011, TELEMED E-HEALTH, V17, P254, DOI 10.1089/tmj.2010.0176
NR 39
TC 60
Z9 64
U1 0
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2013
VL 8
IS 11
AR e79246
DI 10.1371/journal.pone.0079246
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255CG
UT WOS:000327216200059
PM 24250826
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lu, XZ
   Ke, JT
   Luo, X
   Zhu, YW
   Zou, L
   Li, HJ
   Zhu, BB
   Xiong, ZG
   Chen, W
   Deng, LY
   Lou, J
   Wang, XX
   Zhang, Y
   Wang, ZL
   Miao, XP
   Cheng, LM
AF Lu, Xuzai
   Ke, Juntao
   Luo, Xia
   Zhu, Yaowu
   Zou, Li
   Li, Huijun
   Zhu, Beibei
   Xiong, Zhigang
   Chen, Wei
   Deng, Lingyan
   Lou, Jiao
   Wang, Xianxiu
   Zhang, Yu
   Wang, Zhenling
   Miao, Xiaoping
   Cheng, Liming
TI The SNP rs402710 in 5p15.33 Is Associated with Lung Cancer Risk: A
   Replication Study in Chinese Population and a Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; GENETIC-VARIANTS;
   POLYMORPHISMS; BIAS; TERT
AB Background: Lung cancer is the most commonly diagnosed cancer and leading cause of cancer mortality in the world. A single nucleotide polymorphism (SNP), rs402710, located in 5p15.33, was firstly identified to be associated with the lung cancer risk in a genome-wide association study. However, some following replication studies yielded inconsistent results.
   Methodology and Findings: A case-control study of 611 cases and 1062 controls in a Chinese population was conducted, and then a meta-analysis integrating the current and previously published studies with a total 31811 cases and 36333 controls was performed to explore the real effect of rs402710 on lung cancer susceptibility. Significant associations between the SNP rs402710 and lung cancer risk were observed in both case-control study and meta-analysis, with ORs equal to 0.77 (95% CI = 0.63-0.95) and 0.83 (95% CI = 0.81-0.86) in dominant model, respectively. By stratified analysis of our case-control study, the associations were also observed in never smoker group and non-small cell lung cancer(NSCLC) group with ORs equal to 0.71 (95% CI = 0.53-0.95) and 0.69 (95% CI = 0.55-0.87), which was remarkable that larger effect of the minor allele T was seen in the two groups than that in overall lung cancer. Besides, the sensitive and cumulative analysis indicated the robust stability of the current results of meta-analysis.
   Conclusion: The results from our replication study and the meta-analysis provided firm evidence that rs402710 T allele significantly contributed to decreased lung cancer risk, and the case-control study implied that the variant may yield stronger effect on NSCLC and never smokers. However, the mechanism underlying the polymorphism conferring susceptibility to lung cancer is warranted to clarify in the follow-up studies.
C1 [Lu, Xuzai; Ke, Juntao; Zou, Li; Zhu, Beibei; Chen, Wei; Lou, Jiao; Zhang, Yu; Wang, Zhenling; Miao, Xiaoping] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, Key Lab Environm & Hlth,Minist Environm Protect, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Wuhan 430074, Peoples R China.
   [Lu, Xuzai; Ke, Juntao; Zou, Li; Zhu, Beibei; Chen, Wei; Lou, Jiao; Zhang, Yu; Wang, Zhenling; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.
   [Luo, Xia; Zhu, Yaowu; Li, Huijun; Xiong, Zhigang; Deng, Lingyan; Wang, Xianxiu; Cheng, Liming] Huazhong Univ Sci & Technol, Dept Lab Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.
   [Lu, Xuzai] Guangdong Maternal & Child Hlth Care Hosp, Guangzhou, Guangdong, Peoples R China.
RP Miao, XP (reprint author), Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat, Key Lab Environm & Hlth,Minist Environm Protect, MOE Minist Educ,Key Lab Environm & Hlth Wuhan, Wuhan 430074, Peoples R China.
EM miaoxp@mail.hust.edu.cn; chengliming@tjh.tjmu.edu.cn
RI miao, xiaoping/C-4336-2011
OI miao, xiaoping/0000-0002-6818-9722
CR Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109
   Bae EY, 2012, RESPIROLOGY, V17, P699, DOI 10.1111/j.1440-1843.2012.02165.x
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1
   Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680
   Chen XF, 2012, GENET MOL RES, V11, P370, DOI 10.4238/2012.February.16.2
   Chung CC, 2010, CARCINOGENESIS, V31, P111, DOI 10.1093/carcin/bgp273
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051
   Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885
   Ito H, 2012, J THORAC ONCOL, V7, P790, DOI 10.1097/JTO.0b013e3182475028
   James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116
   Jaworowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025057
   Jin GF, 2009, CARCINOGENESIS, V30, P987, DOI 10.1093/carcin/bgp090
   Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004
   Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001
   Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012
   Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254
   Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222
   Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006
   Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33
   Pande M, 2011, CARCINOGENESIS, V32, P1493, DOI 10.1093/carcin/bgr136
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010
   Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846
   Truong T, 2010, J NATL CANCER I, V102, P959, DOI 10.1093/jnci/djq178
   Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608
   Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273
   Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020
   Xun WW, 2011, MUTAGENESIS, V26, P657, DOI 10.1093/mutage/ger030
   Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250
   Yang P, 2010, CANCER EPIDEM BIOMAR, V19, P240, DOI 10.1158/1055-9965.EPI-09-0710
   Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421
   Young RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016476
   Zhong H, 2009, GENETIC EPIDEMIOLOGY
   Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131
NR 43
TC 7
Z9 7
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 23
PY 2013
VL 8
IS 10
AR e76252
DI 10.1371/journal.pone.0076252
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 239PE
UT WOS:000326037000010
PM 24194831
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Soeters, HM
   Poole, C
   Patel, MR
   Van Rie, A
AF Soeters, Heidi M.
   Poole, Charles
   Patel, Monita R.
   Van Rie, Annelies
TI The Effect of Tuberculosis Treatment at Combination Antiretroviral
   Therapy Initiation on Subsequent Mortality: A Systematic Review and
   Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID HIV-INFECTED PATIENTS; FOLLOW-UP; TREATMENT OUTCOMES; TREATMENT
   PROGRAMS; RISK-FACTORS; 1ST YEAR; ADULTS; HAART; COINFECTION; PREDICTORS
AB Objective: We aimed to perform a systematic review and meta-analysis examining the impact of TB treatment at the time of combination antiretroviral therapy (cART) initiation on subsequent mortality.
   Methods: We searched PubMed, EMBASE, and selected conference proceedings for studies that report adult mortality on cART, stratified by TB treatment status at cART initiation. Stratified random-effects and meta-regression analyses were used to examine the influence of study and population characteristics.
   Results: 22 eligible cohort studies reported data on 98,350 (range 74-15,225) adults, of whom 14,779 (15%) were receiving TB treatment at cART initiation. Studies of those receiving vs. not receiving TB treatment had an average mortality relative risk of 1.10 (95% confidence interval 0.87-1.40) at 1-3 months (based upon 8 estimates), 1.15 (0.94-1.41) at 6-12 months (11 estimates), and 1.33 (1.02-1.75) at 18-98 months (10 estimates) following cART initiation. However, there was a wide range of estimates and those at later time points were markedly heterogeneous. Meta-regression identified factors associated with elevated average risk estimates: lower median baseline CD4 counts and adjustment for baseline hemoglobin at 1-3 months; longer length of follow-up and women-only studies at 6-12 months; and not adjusting for BMI/weight at 18-98 months.
   Conclusions: Patients receiving TB treatment at cART initiation did not have a statistically significant estimated increase in short-term risk of all-cause mortality as compared to those not receiving TB treatment. TB treatment was significantly associated with increased mortality after about a year of cART, suggesting that patients with concurrent TB treatment at cART initiation may benefit from continued support after TB treatment completion.
C1 [Soeters, Heidi M.; Poole, Charles; Patel, Monita R.; Van Rie, Annelies] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.
RP Soeters, HM (reprint author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.
EM hsoeters@email.unc.edu
RI Soeters, Heidi/H-3271-2019; Van Rie, Annelies/C-2082-2017
OI Soeters, Heidi/0000-0002-9415-9340; Van Rie,
   Annelies/0000-0001-7666-3263
FU National Institutes of Health [2T32AI070114]
FX HMS and MRP were partially supported by National Institutes of Health
   training grant 2T32AI070114. No additional external funding was received
   for this study. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2010, GLOB PLAN STOP TB 20
   Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba
   BASSETT IV, 2010, VIENN AUSTR 18 INT A
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bera E, 2009, SAJOG-S AFR J OBSTET, V15, P26
   Bhowmik A, 2012, ASIAN PAC J TROP MED, V5, P986, DOI 10.1016/S1995-7645(12)60187-4
   Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911
   Borenstein M., 2009, INTRO METAANALYSIS
   Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530
   Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7
   Braitstein P, 2006, LANCET, V367, P817
   Breton G, 2012, INT J TUBERC LUNG D, V16, P1365, DOI 10.5588/ijtld.11.0693
   Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790
   Chu R, 2011, AM J EPIDEMIOL, V173, pS73
   Curran A, 2012, AIDS REV, V14, P231
   Dao CN, 2011, AIDS RES HUM RETROV, V27, P1149, DOI [10.1089/aid.2010.0345, 10.1089/AID.2010.0345]
   Desilva MB, 2009, AIDS CARE, V21, P70, DOI 10.1080/09540120802017636
   Dronda F, 2011, CURR HIV RES, V9, P229, DOI 10.2174/157016211796320324
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Egger M, 2001, SYSTEMATIC REV HLTH
   Greenland S, 2008, MODERN EPIDEMIOLOGY, V3, P652
   Greig J, 2012, JAIDS-J ACQ IMM DEF, V59, pE92, DOI 10.1097/QAI.0b013e31824206c7
   Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055824
   Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607
   Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x
   Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181
   Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848
   Lartey M, 2011, CLIN INFECT DIS, V52, P547, DOI 10.1093/cid/ciq196
   Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd
   Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd
   Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1
   Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f
   Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x
   LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005
   Makombe SD, 2007, INT J TUBERC LUNG D, V11, P412
   Manosuthi W, 2010, INT J INFECT DIS, V14, pE1013, DOI 10.1016/j.ijid.2010.06.016
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716
   Mugusi SF, 2012, ANTIVIR THER, V17, P265, DOI 10.3851/IMP1956
   Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24
   Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795
   Nguyen VTT, 2011, ANTIVIR THER, V16, pA51
   Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23
   RODGERS A, 1995, THROMB HAEMOSTASIS, V73, P167
   Siika AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053022
   Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241
   Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782
   Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V
   Volberding PA, 2008, GLOBAL HIV AIDS MED
   Walker AS, 2012, CLIN INFECT DIS, V55, P1707, DOI 10.1093/cid/cis797
   Westreich D, 2012, AIDS, V26, P770, DOI 10.1097/QAD.0b013e328351f6b8
   Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542
   World Health Organization, 2010, ANT THER HIV INF AD
   Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0
   Zachariah R, 2009, TROP MED INT HEALTH, V14, P713, DOI 10.1111/j.1365-3156.2009.02291.x
   Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55
NR 59
TC 3
Z9 4
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 15
PY 2013
VL 8
IS 10
AR UNSP e78073
DI 10.1371/journal.pone.0078073
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 237TP
UT WOS:000325894100099
PM 24143260
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhu, ML
   Wang, MY
   Shi, TY
   Li, QX
   Xi, P
   Xia, KQ
   Zheng, LZ
   Wei, QY
AF Zhu, Mei-Ling
   Wang, MengYun
   Shi, Ting-Yan
   Li, Qiao-Xin
   Xi, Pan
   Xia, Kai-Qin
   Zheng, Leizhen
   Wei, Qing-Yi
TI No Association between TGFB1 Polymorphisms and Late Radiotherapy
   Toxicity: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID SINGLE NUCLEOTIDE POLYMORPHISMS; NORMAL TISSUE RADIOSENSITIVITY; CANCER
   PATIENTS; TGF-BETA-1; BREAST; FIBROSIS; XRCC1; RISK; GENE; DNA
AB Background: Transforming growth factor-beta 1 (TGF-beta 1) protein may be multifunctional and related to the development of fibrosis, induction of apoptosis, extracellular signaling and inhibition of proliferation in response to radiation-induced DNA damage. Several studies have investigated associations between single nucleotide polymorphisms (SNPs) in the TGFB1 gene and risk of late radiation-induced injury of normal tissue, but the conclusions remain controversial.
   Methods: We searched three electronic databases (i.e., MEDLINE, EMBASE and EBSCO) for eligible publications and performed a meta-analysis assessing the association of three commonly studied SNPs in TGFB1 (i.e., rs1800469, rs1800470 and rs1800471) with risk of late radiation-induced injury of normal tissue.
   Results: We finally included 28 case-only studies from 16 publications on aforementioned SNPs in TGFB1. However, we did not find statistical evidence of any significant association with overall risk of late radiotherapy toxicity in the pooled analysis or in further stratified analysis by cancer type, endpoint, ethnicity and sample size.
   Conclusions: This meta-analysis did not find statistical evidence for an association between SNPs in TGFB1 and risk of late radiation-induced injury of normal tissue, but this finding needs further confirmation by a single large study.
C1 [Zhu, Mei-Ling; Xi, Pan; Zheng, Leizhen] Shanghai Jiao Tong Univ, Dept Oncol, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China.
   [Wang, MengYun; Shi, Ting-Yan; Li, Qiao-Xin; Wei, Qing-Yi] Fudan Univ, Inst Canc, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
   [Xia, Kai-Qin] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
   [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.
RP Zheng, LZ (reprint author), Shanghai Jiao Tong Univ, Dept Oncol, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China.
EM zhengleizhen2006@126.com; weiqingyi@yahoo.com
FU "China's Thousand Talents Program" Recruitment at Fudan University
FX This study was supported by the funds from "China's Thousand Talents
   Program" Recruitment at Fudan University. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1
   Alsner J, 2008, SEMIN RADIAT ONCOL, V18, P126, DOI 10.1016/j.semradonc.2007.10.004
   Andreassen CN, 2006, INT J RADIAT BIOL, V82, P577, DOI 10.1080/09553000600876637
   Andreassen CN, 2010, RADIOTHER ONCOL, V97, P1, DOI 10.1016/j.radonc.2010.07.018
   Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010
   Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012
   Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101
   ANSCHER MS, 1990, RADIAT RES, V122, P77, DOI 10.2307/3577586
   Azria D, 2008, CLIN CANCER RES, V14, P6284, DOI 10.1158/1078-0432.CCR-08-0700
   Barnett GC, 2012, RADIOTHER ONCOL, V105, P289, DOI 10.1016/j.radonc.2012.10.017
   Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3
   Barnett GC, 2010, RADIOTHER ONCOL, V97, P9, DOI 10.1016/j.radonc.2009.12.006
   Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950
   Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703
   De Ruyck K, 2006, INT J RADIAT ONCOL, V65, P1240, DOI 10.1016/j.ijrobp.2006.03.047
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dunning AM, 2003, CANCER RES, V63, P2610
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ehrhart EJ, 1997, FASEB J, V11, P991
   El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P517, DOI 10.1016/S1053-2498(98)00024-2
   Evans ES, 2006, CYTOKINE, V35, P186, DOI 10.1016/j.cyto.2006.07.021
   Ewan KB, 2002, CANCER RES, V62, P5627
   Fachal L, 2012, RADIOTHER ONCOL, V103, P206, DOI 10.1016/j.radonc.2012.01.015
   FINKELSTEIN JN, 1994, INT J RADIAT ONCOL, V28, P621, DOI 10.1016/0360-3016(94)90187-2
   Giotopoulos G, 2007, BRIT J CANCER, V96, P1001, DOI 10.1038/sj.bjc.6603637
   Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93
   Lyons AJ, 2011, OSTEORADIONECROSIS T
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1
   Martin SI, 2010, CONTEMP HEMATOL, P15, DOI 10.1007/978-1-59745-415-5_2
   Peters CA, 2008, INT J RADIAT ONCOL, V70, P752, DOI 10.1016/j.ijrobp.2007.05.023
   Quarmby S, 2003, INT J RADIAT BIOL, V79, P137, DOI 10.1080/0955300021000045673
   Suga T, 2008, INT J RADIAT ONCOL, V72, P808, DOI 10.1016/j.ijrobp.2008.01.029
   Terrazzino S, 2012, INT J RADIAT ONCOL, V83, P504, DOI 10.1016/j.ijrobp.2011.06.2012
   Thurner EM, 2012, GENETIC VARIANTS TGF
   WEST CML, 1995, BRIT J RADIOL, V68, P827, DOI 10.1259/0007-1285-68-812-827
   Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783
   Yuan SH, 2013, J THORAC ONCOL, V8, P208, DOI 10.1097/JTO.0b013e318274592e
   Zhang G, 2010, ASS POLYMORPHISMS DN
   Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016
NR 41
TC 4
Z9 4
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 9
PY 2013
VL 8
IS 10
AR e76964
DI 10.1371/journal.pone.0076964
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 236PJ
UT WOS:000325810900112
PM 24130819
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Qin, X
   Peng, QL
   Tang, WZ
   Lao, XJ
   Chen, ZP
   Lai, H
   Deng, Y
   Mo, CJ
   Sui, JZ
   Wu, JR
   Zhai, LM
   Yang, S
   Li, S
   Zhao, JM
AF Qin, Xue
   Peng, Qiliu
   Tang, Weizhong
   Lao, Xianjun
   Chen, Zhiping
   Lai, Hao
   Deng, Yan
   Mo, Cuiju
   Sui, Jingzhe
   Wu, Junrong
   Zhai, Limin
   Yang, Shi
   Li, Shan
   Zhao, Jinmin
TI An Updated Meta-Analysis on the Association of MDM2 SNP309 Polymorphism
   with Colorectal Cancer Risk
SO PLOS ONE
LA English
DT Article
ID SINGLE NUCLEOTIDE POLYMORPHISM; HARDY-WEINBERG EQUILIBRIUM; ACCELERATES
   TUMOR-FORMATION; PROMOTER POLYMORPHISM; P53-INDEPENDENT ROLE; GENOTYPING
   ERRORS; TP53 R72P; P53; GENE; AGE
AB Background: The mouse double minute 2 (MDM2) gene encodes a phosphoprotein that interacts with P53 and negatively regulates its activity. The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 polymorphism and colorectal cancer (CRC) risk reported conflicting results. We performed a meta-analysis of all available studies to explore the association of this polymorphism with CRC risk.
   Methods: All studies published up to July 2013 on the association between MDM2 SNP309 polymorphism and CRC risk were identified by searching electronic databases PubMed, EMBASE, and Chinese Biomedical Literature database (CBM) databases. The association between the MDM2 SNP309 polymorphism and CRC risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs).
   Results: A total of 14 case-control studies including 4460 CRC cases and 4828 controls were identified. We did not find a significant association between the MDM2 SNP309 polymorphism and CRC risk in all genetic models in overall population. However, in subgroup analysis by ethnicity, significant associations were found in Asians (TG vs. TT: OR = 1.197, 95% CI = 1.055-1.358, P=0.005; GG+TG vs. TT: OR = 1.246, 95% CI = 1.106-1.404, P=0.000) and Africans. When stratified by HWE in controls, significantly increased risk was also found among the studies consistent with HWE (TG vs. TT: OR = 1.166, 95% CI = 1.037-1.311, P=0.010). In subgroup analysis according to p53 mutation status, and gender, no any significant association was detected.
   Conclusions: The present meta-analysis suggests that the MDM2 is a candidate gene for CRC susceptibility. The MDM2 SNP309 polymorphism may be a risk factor for CRC in Asians.
C1 [Qin, Xue; Peng, Qiliu; Lao, Xianjun; Deng, Yan; Mo, Cuiju; Sui, Jingzhe; Wu, Junrong; Zhai, Limin; Yang, Shi; Li, Shan] Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
   [Tang, Weizhong] Guangxi Med Univ, Dept Anal & Colorectal Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
   [Chen, Zhiping] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Sch Publ Hlth, Nanning, Guangxi, Peoples R China.
   [Lai, Hao] Guangxi Med Univ, Dept Gastrointestinal Surg, Tumor Hosp, Nanning, Guangxi, Peoples R China.
   [Zhao, Jinmin] Guangxi Med Univ, Dept Orthoped Trauma Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
RP Li, S (reprint author), Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
EM lis8858@126.com; zhaojinmin@126.com
OI Zhao, Jinmin/0000-0002-1047-8820
FU National Natural Science Foundation of China [81260302]
FX This research was supported by National Natural Science Foundation of
   China (No. 81260302). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alazzouzi H, 2007, J MED GENET, V44, P75, DOI 10.1136/jmg.2006.042572
   Alhopuro P, 2005, J MED GENET, V42, P694, DOI 10.1136/jmg.2005.031260
   Bogush TA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1421, DOI 10.1134/S0006297910120011
   Bond GL, 2006, J MED GENET, V43, P950, DOI 10.1136/jmg.2006.043539
   Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180
   Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022
   Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.0379532
   Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804
   Cao XM, 2012, DNA CELL BIOL, V31, P354, DOI 10.1089/dna.2011.1338
   Chaar I, 2013, APPL IMMUNOHISTO M M, V21, P228, DOI 10.1097/PAI.0b013e31825f4e20
   Chaar I, 2012, EUR J GASTROEN HEPAT, V24, P320, DOI 10.1097/MEG.0b013e32834bdf84
   Chen YL, 2009, ANAL BIOANAL CHEM, V394, P1291, DOI 10.1007/s00216-008-2416-y
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fang F, 2011, MED ONCOL, V28, P981, DOI 10.1007/s12032-010-9577-1
   Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014
   Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164
   Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656
   Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]
   Jin M, 2013, CHIN J DIG, V32, P703
   Joshi AM, 2011, JPN J CLIN ONCOL, V41, P232, DOI 10.1093/jjco/hyq200
   Khan SA, 2008, J SURG ONCOL, V97, P621, DOI 10.1002/jso.20996
   Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236
   Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P1019
   Levav-Cohen Y, 2005, GROWTH FACTORS, V23, P183, DOI 10.1080/08977190500196218
   Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872
   Liu Jun-niao, 2008, Zhonghua Zhongliu Zazhi, V30, P335
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Menin C, 2006, J NATL CANCER I, V98, P285, DOI 10.1093/jnci/djj054
   Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203
   Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1469
   Olivier Magali, 2004, IARC Sci Publ, P247
   Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008
   Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872
   Ruijs MWG, 2007, EUR J HUM GENET, V15, P110, DOI 10.1038/sj.ejhg.5201715
   Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410
   Sotamaa K, 2005, CLIN CANCER RES, V11, P6840, DOI 10.1158/1078-0432.CCR-05-1139
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sugano N, 2010, GENE CHROMOSOME CANC, V49, P620, DOI 10.1002/gcc.20774
   Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8
   Talseth BA, 2007, INT J CANCER, V120, P563, DOI 10.1002/ijc.22339
   Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184
   Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046
   Tuna G, 2013, DNA CELL BIOL, V32, P400, DOI 10.1089/dna.2012.1933
   Verma MK, 2011, J STEROID BIOCHEM, V127, P216, DOI 10.1016/j.jsbmb.2011.07.013
   Wu H, 2011, CELL CYCLE, V10, P1912, DOI 10.4161/cc.10.12.15882
   Zhang YX, 2012, MOL BIOL REP, V39, P9661, DOI 10.1007/s11033-012-1831-5
   Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187
NR 53
TC 16
Z9 17
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 30
PY 2013
VL 8
IS 9
AR e76031
DI 10.1371/journal.pone.0076031
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 231NL
UT WOS:000325423500130
PM 24098760
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ziakas, PD
   Thapa, R
   Rice, LB
   Mylonakis, E
AF Ziakas, Panayiotis D.
   Thapa, Rachana
   Rice, Louis B.
   Mylonakis, Eleftherios
TI Trends and Significance of VRE Colonization in the ICU: A Meta-Analysis
   of Published Studies
SO PLOS ONE
LA English
DT Article
ID VANCOMYCIN-RESISTANT ENTEROCOCCI; INTENSIVE-CARE-UNIT; BLOOD-STREAM
   INFECTION; GRAM-NEGATIVE BACILLI; STAPHYLOCOCCUS-AUREUS; RISK-FACTORS;
   SECULAR TRENDS; ACQUISITION; CARRIAGE; SURVEILLANCE
AB Background: The burden and significance of vancomycin-resistant enterococci (VRE) colonization in the ICU is not clearly understood.
   Methods: We searched PubMed and EMBASE up to May 2013 for studies reporting the prevalence of VRE upon admission to the ICU and performed a meta-analysis to assess rates and trends of VRE colonization. We calculated the prevalence of VRE on admission and the acquisition (colonization and/or infection) rates to estimate time trends and the impact of colonization on ensuing VRE infections.
   Findings: Across 37 studies (62,959 patients at risk), the estimated prevalence of VRE on admission to the ICU was 8.8% (7.1-10.6). Estimates were more consistent when cultures were obtained within 24 hours from admission. The VRE acquisition rate was 8.8% (95% CI 6.9-11.0) across 26 evaluable studies (35,364 patients at risk). Across US studies, VRE acquisition rate was 10.2% (95% CI 7.7-13.0) and demonstrated significant decline in annual trends. We used the US estimate of colonization on admission [12.3% (10.5-14.3)] to evaluate the impact of VRE colonization on admission in overall VRE prevalence. We demonstrated that VRE colonization on admission is a major determinant of the overall VRE burden in the ICU. Importantly, among colonized patients (including admitted and/or acquired cases) the VRE infection rates vary widely from 0-45% (with the risk of VRE bacteremia being reported from 0-16%) and <2% among those without a proven colonization.
   Conclusion: In summary, up to 10.6% of patients admitted in the ICU are colonized with VRE on admission and a similar percentage will acquire VRE during their ICU stay. Importantly, colonization on admission is a major determinant of VRE dynamics in the ICU and the risk of VRE-related infections is close related to colonization.
C1 [Ziakas, Panayiotis D.; Thapa, Rachana; Mylonakis, Eleftherios] Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA.
   [Ziakas, Panayiotis D.; Thapa, Rachana; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
   [Rice, Louis B.] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA.
RP Mylonakis, E (reprint author), Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA.
EM emylonakis@lifespan.org
CR Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908
   Baden LR, 2001, CLIN INFECT DIS, V33, P1654, DOI 10.1086/323762
   Bonten MJM, 1998, CRIT CARE MED, V26, P2001, DOI 10.1097/00003246-199812000-00029
   Bonten MJM, 1996, LANCET, V348, P1615, DOI 10.1016/S0140-6736(96)02331-8
   Borg MA, 2012, J HOSP INFECT, V81, P251, DOI 10.1016/j.jhin.2012.05.001
   Bourdon N, 2011, J ANTIMICROB CHEMOTH, V66, P713, DOI 10.1093/jac/dkq524
   Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849
   Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d
   Batistao DWD, 2012, MEM I OSWALDO CRUZ, V107, P57, DOI 10.1590/S0074-02762012000100008
   Dan M, 1999, J HOSP INFECT, V43, P231, DOI 10.1053/jhin.1998.0641
   de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1
   DEKRAKER ME, 2012, CLIN MICROBIOL INFEC
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Doyle JS, 2011, SEMIN RESP CRIT CARE, V32, P115, DOI 10.1055/s-0031-1275525
   Drees M, 2008, INFECT CONT HOSP EP, V29, P709, DOI 10.1086/589582
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225
   Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003
   Furuno JP, 2005, EMERG INFECT DIS, V11, P1539, DOI 10.3201/eid1110.050508
   Gardiner D, 2002, INFECT CONT HOSP EP, V23, P466, DOI 10.1086/502087
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   Grabsch EA, 2012, J HOSP INFECT, V82, P234, DOI 10.1016/j.jhin.2012.08.010
   Grayson ML, 1999, MED J AUSTRALIA, V171, P133, DOI 10.5694/j.1326-5377.1999.tb123564.x
   Harris AD, 2004, INFECT CONT HOSP EP, V25, P105, DOI 10.1086/502358
   Hendrix CW, 2001, ANN SURG, V233, P259, DOI 10.1097/00000658-200102000-00016
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Ho PL, 2003, CRIT CARE MED, V31, P1175, DOI 10.1097/01.CCM.0000059437.01924.97
   Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002
   Huang SS, 2011, CRIT CARE, V15, DOI 10.1186/cc10445
   Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373
   Kim YJ, 2012, AM J INFECT CONTROL, V40, P1018, DOI 10.1016/j.ajic.2012.01.009
   Lambiase A, 2007, INFECTION, V35, P428, DOI 10.1007/s15010-007-6288-4
   Lin MY, 2010, CRIT CARE MED, V38, pS335, DOI 10.1097/CCM.0b013e3181e6ab12
   Littvik A. M., 2006, Rev. argent. microbiol., V38, P28
   Marin ME, 2001, INFECT CONT HOSP EP, V22, P332, DOI 10.1086/503402
   Martinez JA, 2003, ARCH INTERN MED, V163, P1905, DOI 10.1001/archinte.163.16.1905
   Mascini EM, 2003, J CLIN MICROBIOL, V41, P5377, DOI 10.1128/JCM.41.12.5377-5383.2003
   Matar MJ, 2006, AM J INFECT CONTROL, V34, P534, DOI 10.1016/j.ajic.2006.04.205
   Meyer E, 2010, CRIT CARE, V14, DOI 10.1186/cc9062
   Minhas P, 2011, CRIT CARE MED, V39, P2322, DOI 10.1097/CCM.0b013e3182227222
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Olivier CN, 2008, INFECT CONT HOSP EP, V29, P404, DOI 10.1086/587647
   Ostrowsky BE, 1999, ARCH INTERN MED, V159, P1467, DOI 10.1001/archinte.159.13.1467
   Padiglione AA, 2000, EMERG INFECT DIS, V6, P534, DOI 10.3201/eid0605.000514
   Padiglione AA, 2003, ANTIMICROB AGENTS CH, V47, P2492, DOI 10.1128/AAC.47.8.2492-2498.2003
   Pan SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047297
   Patel R, 2001, LIVER TRANSPLANT, V7, P27, DOI 10.1053/jlts.2001.20784
   Peta M, 2006, CLIN MICROBIOL INFEC, V12, P163, DOI 10.1111/j.1469-0691.2005.01331.x
   Pogorzelska M, 2012, AM J INFECT CONTROL, V40, P96, DOI 10.1016/j.ajic.2011.10.002
   Puzniak LA, 2002, CLIN INFECT DIS, V35, P18, DOI 10.1086/340739
   Ramsey AM, 2009, INFECT CONT HOSP EP, V30, P184, DOI 10.1086/593956
   Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79
   Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013
   Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141
   SALGADO CD, 2008, AM J INFECT CONTROL, V36, pE178
   Sandiumenge A, 2012, CURR OPIN PULM MED, V18, P187, DOI 10.1097/MCP.0b013e328351f974
   Shadel BN, 2006, INFECT CONT HOSP EP, V27, P1068, DOI 10.1086/507960
   Slaughter S, 1996, ANN INTERN MED, V125, P448, DOI 10.7326/0003-4819-125-6-199609150-00004
   Song Joon Young, 2005, Korean Journal of Internal Medicine, V20, P55
   Song JY, 2009, AM J INFECT CONTROL, V37, P734, DOI 10.1016/j.ajic.2008.09.025
   Sutter ST, 2010, CLIN INFECT DIS, V51, P678, DOI 10.1086/655824
   Top J, 2008, FEMS IMMUNOL MED MIC, V52, P297, DOI 10.1111/j.1574-695X.2008.00383.x
   Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306
   Warren DK, 2003, INFECT CONT HOSP EP, V24, P257, DOI 10.1086/502199
   Weinstock DM, 2007, BIOL BLOOD MARROW TR, V13, P615, DOI 10.1016/j.bbmt.2007.01.078
   Werner G., 2008, Eurosurveillance, V13, P19046
   Wibbenmeyer L, 2009, J BURN CARE RES, V30, P648, DOI 10.1097/BCR.0b013e3181abff7e
   Winston LG, 2004, AM J INFECT CONTROL, V32, P462, DOI 10.1016/j.ajic.2004.07.004
   Yeh KM, 2004, MICROB DRUG RESIST, V10, P177, DOI 10.1089/1076629041310091
   Yoon YK, 2012, J ANTIMICROB CHEMOTH, V67, P2963, DOI 10.1093/jac/dks303
   Zuckerman RA, 1999, INFECT CONT HOSP EP, V20, P685, DOI 10.1086/501565
NR 72
TC 38
Z9 38
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 27
PY 2013
VL 8
IS 9
AR UNSP e75658
DI 10.1371/journal.pone.0075658
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 228WY
UT WOS:000325223900055
PM 24086603
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yin, AA
   Zhang, LH
   Cheng, JX
   Dong, Y
   Liu, BL
   Han, N
   Zhang, X
AF Yin, An-an
   Zhang, Lu-hua
   Cheng, Jin-xiang
   Dong, Yu
   Liu, Bo-lin
   Han, Ning
   Zhang, Xiang
TI Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma
   in the Elderly: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID HYPOFRACTIONATED RADIOTHERAPY; CONCOMITANT TEMOZOLOMIDE; ADJUVANT
   TEMOZOLOMIDE; PATIENTS OLDER; PHASE-II; MULTIFORME; RADIATION; SURVIVAL;
   AGE; CHEMOTHERAPY
AB Background: Many physicians are reluctant to treat elderly glioblastoma (GBM) patients as aggressively as younger patients, which is not evidence based due to the absence of validated data from primary studies. We conducted a meta-analysis to provide valid evidence for the use of the aggressive combination of radiotherapy (RT) and temozolomide (TMZ) in elderly GBM patients.
   Methods: A systematic literature search was conducted using the PubMed, EMBASE and Cochrane databases. Studies comparing combined RT/TMZ with RT alone in elderly patients (>= 65 years) with newly diagnosed GBM were eligible for inclusion.
   Results: No eligible randomized trials were identified. Alternatively, a meta-analysis of nonrandomized studies (NRSs) was performed, with 16 studies eligible for overall survival (OS) analysis and nine for progression-free survival (PFS) analysis. Combined RT/TMZ was shown to reduce the risk of death and progression in elderly GBM patients compared with RT alone (OS hazard ratio [HR] 0.59, 95% confidence interval [CI] 0.48-0.72; PFS: HR 0.58, 95% CI 0.41-0.84). Evaluable patients were reported to tolerate combined treatment but certain toxicities, and especially hematological toxicities, were more frequently observed. Limited data on O6-methylguanine-DNA methyltransferase (MGMT) promoter status and quality of life were reported.
   Conclusion: The meta-analysis of NRSs provided level 2a evidence (Oxford Centre for Evidence-Based Medicine) that combined RT/TMZ conferred a clear survival benefit on a selection of elderly GBM patients who had a favorable prognosis (e. g., extensive resection, favorable KPS). Toxicities were more frequent but acceptable. Future randomized trials are warranted to justify a definitive conclusion.
C1 [Yin, An-an; Zhang, Lu-hua; Cheng, Jin-xiang; Liu, Bo-lin; Han, Ning; Zhang, Xiang] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xijing Inst Clin Neurosci, Xian 710032, Shaanxi Provinc, Peoples R China.
   [Dong, Yu] Fourth Mil Med Univ, Dept Prosthodont, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China.
RP Zhang, X (reprint author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xijing Inst Clin Neurosci, Xian 710032, Shaanxi Provinc, Peoples R China.
EM xzhang@fmmu.edu.cn
OI Yin, An-An/0000-0002-1888-5551
FU National Natural Science Foundation of China [81171087]
FX This work was financially supported by National Natural Science
   Foundation of China (No: 81171087). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdel Karim K, 2012, NEURO ONCOL S3, V14, pi22
   Abhinav K, 2013, CLIN NEUROL NEUROSUR, V115, P1375, DOI 10.1016/j.clineuro.2012.12.023
   Ackerl MS, 2012, NEURO-ONCOLOGY, V14, P46
   Balducci M, 2012, MED ONCOL, V29, P3478, DOI 10.1007/s12032-012-0263-3
   Barker CA, 2012, J NEURO-ONCOL, V109, P391, DOI 10.1007/s11060-012-0906-4
   Brandes AA, 2003, CANCER, V97, P657, DOI 10.1002/cncr.11097
   Brandes AA, 2009, CANCER-AM CANCER SOC, V115, P3512, DOI 10.1002/cncr.24406
   Cao JQ, 2012, J NEURO-ONCOL, V107, P395, DOI 10.1007/s11060-011-0766-3
   Caroli M, 2011, EUR J CANCER, V47, pS581, DOI 10.1016/S0959-8049(11)72272-9
   Cheng JX, 2009, NEURO-ONCOLOGY, V11, P41, DOI 10.1215/15228517-2008-050
   Combs SE, 2008, INT J RADIAT ONCOL, V70, P987, DOI 10.1016/j.ijrobp.2007.07.2368
   Dirier A, 2010, NEURO-ONCOLOGY, V12, P42
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ewelt C, 2011, J NEURO-ONCOL, V103, P611, DOI 10.1007/s11060-010-0429-9
   Fiorentino A, 2013, AM J CLIN ONCOL
   Fiorentino A, 2013, INT J NEUROSCI, V123, P133, DOI 10.3109/00207454.2012.744309
   Fiorica F, 2010, ARCH GERONTOL GERIAT, V51, P31, DOI 10.1016/j.archger.2009.06.011
   Floyd SR, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00122
   Gerstein J, 2010, RADIOTHER ONCOL, V97, P382, DOI 10.1016/j.radonc.2010.06.014
   Gerstner ER, 2009, NEUROLOGY, V73, P1509, DOI 10.1212/WNL.0b013e3181bf9907
   Hashem SA, 2012, J MED IMAG RADIAT ON, V56, P204, DOI 10.1111/j.1754-9485.2011.02325.x
   Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331
   Higgins JP, COCHRANE HDB SYSTEMA
   Iwamoto FM, 2008, ANN NEUROL, V64, P628, DOI 10.1002/ana.21521
   Kimple RJ, 2010, AM J CLIN ONCOL-CANC, V33, P265, DOI 10.1097/COC.0b013e3181a76a24
   Kita D, 2009, NEUROEPIDEMIOLOGY, V33, P17, DOI 10.1159/000210017
   Kushnir I, 2011, ISR MED ASSOC J, V13, P290
   Laperriere N, 2010, RADIOTHER ONCOL, V96, pS34
   Laperriere N, 2013, CANCER TREAT REV, V39, P350, DOI 10.1016/j.ctrv.2012.05.008
   Lee JH, 2013, J CLIN NEUROSCI, V20, P503, DOI 10.1016/j.jocn.2012.03.044
   MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277
   Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6
   Mangiola A, 2006, J NEURO-ONCOL, V76, P159, DOI 10.1007/s11060-005-4711-1
   Minniti G, 2008, J NEURO-ONCOL, V88, P97, DOI 10.1007/s11060-008-9538-0
   Minniti G, 2012, INT J RADIAT ONCOL, V83, P93, DOI 10.1016/j.ijrobp.2011.06.1992
   Minniti G, 2011, J NEURO-ONCOL, V102, P311, DOI 10.1007/s11060-010-0324-4
   Minniti G, 2009, J NEURO-ONCOL, V91, P95, DOI 10.1007/s11060-008-9689-z
   Mishima K, 2010, NEURO-ONCOLOGY, V12, P46
   Muni R, 2010, TUMORI J, V96, P60
   Niyazi M, 2012, STRAHLENTHER ONKOL, V188, P154, DOI 10.1007/s00066-011-0026-7
   Perry JR, 2012, J CLIN ONCOL S, V30, pS2104
   Petretta M, 2011, AM J CARDIOL, V108, P1171, DOI 10.1016/j.amjcard.2011.06.022
   Piccirilli M, 2006, TUMORI J, V92, P98
   Pichlmeier U, 2008, NEURO-ONCOLOGY, V10, P1025, DOI 10.1215/15228517-2008-052
   Reifenberger G, 2012, INT J CANCER, V131, P1342, DOI 10.1002/ijc.27385
   Reyngold M, 2012, J NEURO-ONCOL, V110, P369, DOI 10.1007/s11060-012-0972-7
   Saito K, 2011, NEURO-ONCOLOGY, V13, P44
   Sharp HJ, 2011, INT J RADIAT ONCOL, V81, pS278, DOI 10.1016/j.ijrobp.2011.06.482
   Sijben AE, 2008, J NEURO-ONCOL, V89, P97, DOI 10.1007/s11060-008-9593-6
   Siu LL, 2007, NEW ENGL J MED, V356, P1575, DOI 10.1056/NEJMe078023
   Smith S, 2011, ASIA PACIFIC J CL S4, V7, P76
   Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]
   Stummer W, 2011, J NEURO-ONCOL, V103, P361, DOI 10.1007/s11060-010-0400-9
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Tanaka S, 2013, J NEUROSURG, V118, P786, DOI 10.3171/2012.10.JNS112268
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   van den Bent MJ, 2005, EJC SUPPL, V3, P134
   Weiss SE, 2010, INT J RADIAT ONCOL, V78, pS271, DOI 10.1016/j.ijrobp.2010.07.645
   Wells GA, NEWCASTLE OTTAWA SCA
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X
   Zachenhofer I, 2011, WIEN KLIN WOCHENSCHR, V123, P364, DOI 10.1007/s00508-011-1577-4
NR 63
TC 37
Z9 37
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 24
PY 2013
VL 8
IS 9
AR e74242
DI 10.1371/journal.pone.0074242
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 226HG
UT WOS:000325025200011
PM 24086323
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bacon, AP
   Carter, RE
   Ogle, EA
   Joyner, MJ
AF Bacon, Andrew P.
   Carter, Rickey E.
   Ogle, Eric A.
   Joyner, Michael J.
TI VO(2)max Trainability and High Intensity Interval Training in Humans: A
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID BETA-ALANINE SUPPLEMENTATION; AEROBIC POWER; SKELETAL-MUSCLE; ENDURANCE
   PERFORMANCE; METABOLIC RESPONSES; CARDIAC GROWTH; OXYGEN-UPTAKE;
   BLOOD-FLOW; O-2 UPTAKE; EXERCISE
AB Endurance exercise training studies frequently show modest changes in VO(2)max with training and very limited responses in some subjects. By contrast, studies using interval training (IT) or combined IT and continuous training (CT) have reported mean increases in VO(2)max of up to similar to 1.0 L . min(-1). This raises questions about the role of exercise intensity and the trainability of VO(2)max. To address this topic we analyzed IT and IT/CT studies published in English from 1965-2012. Inclusion criteria were: 1)>= 3 healthy sedentary/3recreationally active humans <45 yrs old, 2) training duration 6-13 weeks, 3) >= 3 days/3week, 4) >= 10 minutes of high intensity work, 5) >= 1:1 work/rest ratio, and 6) results reported as mean +/- SD or SE, ranges of change, or individual data. Due to heterogeneity (I-2 value of 70), statistical synthesis of the data used a random effects model. The summary statistic of interest was the change in VO2max. A total of 334 subjects (120 women) from 37 studies were identified. Participants were grouped into 40 distinct training groups, so the unit of analysis was 40 rather than 37. An increase in VO(2)max of 0.51 L . min(-1) (95% CI: 0.43 to 0.60 L . min(-1)) was observed. A subset of 9 studies, with 72 subjects, that featured longer intervals showed even larger (similar to 0.8-0.9 L . min(-1)) changes in VO(2)max with evidence of a marked response in all subjects. These results suggest that ideas about trainability and VO(2)max should be further evaluated with standardized IT or IT/CT training programs.
C1 [Bacon, Andrew P.; Joyner, Michael J.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.
   [Carter, Rickey E.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA.
   [Ogle, Eric A.] Creighton Univ, Sch Med, Omaha, NE USA.
RP Joyner, MJ (reprint author), Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA.
EM joyner.michael@mayo.edu
FU National Center for Advancing Translational Sciences (NCATS) [UL1
   TR000135]; Mayo Foundation; Caywood Professorship
FX This publication was partially supported by Grant Number UL1 TR000135
   from the National Center for Advancing Translational Sciences (NCATS),
   the Mayo Foundation, and Caywood Professorship to MJJ. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Berger NJA, 2006, MED SCI SPORT EXER, V38, P504, DOI 10.1249/01.mss.0000191418.37709.81
   Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019
   Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   BURKE J, 1994, BRIT J SPORT MED, V28, P18, DOI 10.1136/bjsm.28.1.18
   CLAUSEN JP, 1977, PHYSIOL REV, V57, P779
   COGGAN AR, 1993, J APPL PHYSIOL, V75, P70
   COGGAN AR, 1990, J APPL PHYSIOL, V68, P990
   COGGAN AR, 1993, AM J PHYSIOL, V264, pE215
   COX ML, 1986, J APPL PHYSIOL, V61, P926
   CUNNINGHAM DA, 1979, EUR J APPL PHYSIOL O, V41, P187, DOI 10.1007/BF00430011
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duffield R, 2006, J SCI MED SPORT, V9, P249, DOI 10.1016/j.jsams.2006.03.014
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Edge J, 2006, J APPL PHYSIOL, V101, P918, DOI 10.1152/japplphysiol.01534.2005
   FOX EL, 1977, MED SCI SPORT EXER, V9, P191
   GAESSER GA, 1988, INT J SPORTS MED, V9, P417, DOI 10.1055/s-2007-1025043
   Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725
   Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030
   GYNTELBERG F, 1977, J APPL PHYSIOL, V43, P302
   HICKSON RC, 1985, J APPL PHYSIOL, V58, P492
   HICKSON RC, 1981, MED SCI SPORT EXER, V13, P13
   HICKSON RC, 1982, J APPL PHYSIOL, V53, P225
   HICKSON RC, 1981, MED SCI SPORT EXER, V13, P17
   HICKSON RC, 1977, J APPL PHYSIOL, V42, P372
   HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831
   HURLEY BF, 1986, J APPL PHYSIOL, V60, P562
   Joyner MJ, 2009, J PHYSIOL-LONDON, V587, P5551, DOI 10.1113/jphysiol.2009.179432
   Kemi OJ, 2010, J CARDIOPULM REHABIL, V30, P2, DOI 10.1097/HCR.0b013e3181c56b89
   KNUTTGEN HG, 1973, MED SCI SPORT EXER, V5, P220
   Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71
   Laursen PB, 2002, SPORTS MED, V32, P53, DOI 10.2165/00007256-200232010-00003
   Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057
   Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629
   Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335
   OVEREND TJ, 1992, CAN J SPORT SCI, V17, P129
   POOLE DC, 1990, EUR J APPL PHYSIOL, V59, P421, DOI 10.1007/BF02388623
   POOLE DC, 1985, J APPL PHYSIOL, V58, P1115
   Proctor DN, 2001, J APPL PHYSIOL, V91, P2619
   RAY CA, 1991, J APPL PHYSIOL, V71, P596
   ROCA J, 1992, J APPL PHYSIOL, V73, P1067
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   SIEGEL W, 1970, CIRCULATION, V41, P19, DOI 10.1161/01.CIR.41.1.19
   Skinner JS, 2001, J APPL PHYSIOL, V90, P1770
   Slordahl SA, 2004, MED SCI SPORT EXER, V36, P1871, DOI 10.1249/01.MSS.0000145444.01292.3D
   Smith AE, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-5
   SPINA RJ, 1992, J APPL PHYSIOL, V72, P307
   Walter AA, 2010, J STRENGTH COND RES, V24, P1199, DOI 10.1519/JSC.0b013e3181d82f8b
   Warburton DER, 2004, MED SCI SPORT EXER, V36, P991, DOI 10.1249/01.MSS.0000128163.88298.CB
   Weltman A, 1997, MED SCI SPORT EXER, V29, P669, DOI 10.1097/00005768-199705000-00013
   WINDER WW, 1979, J APPL PHYSIOL, V46, P766
   WOMACK CJ, 1995, J APPL PHYSIOL, V79, P838
NR 53
TC 89
Z9 91
U1 2
U2 61
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 16
PY 2013
VL 8
IS 9
AR e73182
DI 10.1371/journal.pone.0073182
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 219GJ
UT WOS:000324494000017
PM 24066036
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, XF
   Huang, MZ
   Zhang, XW
   Hua, RX
   Guo, WJ
AF Wang, Xiao-feng
   Huang, Ming-zhu
   Zhang, Xiao-wei
   Hua, Rui-xi
   Guo, Wei-jian
TI COX-2-765G > C Polymorphism Increases the Risk of Cancer: A
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SINGLE-NUCLEOTIDE POLYMORPHISMS;
   ACUTE MYELOID-LEUKEMIA; CELL LUNG-CANCER; COLORECTAL-CANCER;
   PROSTATE-CANCER; CYCLOOXYGENASE-2 GENE; GASTRIC-CANCER; COX-2 GENE;
   HEPATOCELLULAR-CARCINOMA
AB Background: Chronic inflammation has been regarded as an important mechanism in carcinogenesis. Inflammation-associated genetic variants have been highly associated with cancer risk. Polymorphisms in the gene cyclooxygenase-2 (COX-2), a pro-inflammation factor, have been suggested to alter the risk of multiple tumors, but the findings of various studies are not consistent.
   Methods: A literature search through February 2013 was performed using PubMed, EMBASE, and CNKI databases. We used odds ratios (ORs) with confidence intervals (CIs) of 95% to assess the strength of the association between the COX-2-765G>C polymorphism and cancer risk in a random-effect model. We also assessed heterogeneity and publication bias.
   Results: In total, 65 articles with 29,487 cancer cases and 39,212 non-cancer controls were included in this meta-analysis. The pooled OR (95% CIs) in the co-dominant model (GC vs. GG) was 1.11 (1.02-1.22), and in the dominant model ((CC+GC) vs. GG), the pooled OR was 1.12 (1.02-1.23). In the subgroup analysis, stratified by cancer type and race, significant associations were found between the-765 C allele and higher risk for gastric cancer, leukemia, pancreatic cancer, and cancer in the Asian population.
   Conclusion: In summary, the COX-2-765 C allele was related to increased cancer susceptibility, especially gastric cancer and cancer in the Asian population.
C1 [Wang, Xiao-feng; Huang, Ming-zhu; Zhang, Xiao-wei; Guo, Wei-jian] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
   [Wang, Xiao-feng; Huang, Ming-zhu; Zhang, Xiao-wei; Guo, Wei-jian] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China.
   [Hua, Rui-xi] Sun Yat Sen Univ, Dept Med Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.
RP Guo, WJ (reprint author), Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
EM guoweijian0001@163.com
OI Hua, Rui-Xi/0000-0001-5319-656X
FU National Natural Scientific Funding [81171909]
FX This work was supported by grants from the National Natural Scientific
   Funding (81171909). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407
   Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449
   Balistreri CR, 2010, CURR PHARM DESIGN, V16, P718, DOI 10.2174/138161210790883877
   Ben Nasr H, 2009, MOL BIOL REP, V36, P193, DOI 10.1007/s11033-007-9166-3
   Berlau J, 2004, ANAL BIOANAL CHEM, V378, P737, DOI 10.1007/s00216-003-2284-4
   Bi N, 2010, CLIN CANCER RES, V16, P2383, DOI 10.1158/1078-0432.CCR-09-2793
   Biramijamal F, 2010, BIOCHEM GENET, V48, P915, DOI 10.1007/s10528-010-9372-x
   Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211
   Cakmakoglu BA, 2011, MOL BIOL REP, V38, P3481, DOI 10.1007/s11033-010-0458-7
   Campa D, 2004, CARCINOGENESIS, V25, P229, DOI 10.1093/carcin/bgh008
   Cao H, 2010, TOHOKU J EXP MED, V222, P15, DOI 10.1620/tjem.222.15
   Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068
   Catsburg C, 2012, CARCINOGENESIS, V33, P1352, DOI 10.1093/carcin/bgs175
   Chang ET, 2009, CANCER EPIDEM BIOMAR, V18, P976, DOI 10.1158/1055-9965.EPI-08-1130
   Chang WS, 2012, CHINESE J PHYSIOL, V55, P1, DOI 10.4077/CJP.2012.AMM056
   Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9
   Cheng I, 2007, BRIT J CANCER, V97, P557, DOI 10.1038/sj.bjc.6603874
   Chiang SL, 2008, CANCER RES, V68, P8489, DOI 10.1158/0008-5472.CAN-08-0823
   Cocos R, 2012, ARCH DERMATOL RES, V304, P335, DOI 10.1007/s00403-011-1194-0
   Coskunpinar E, 2011, MED ONCOL, V28, P1436, DOI 10.1007/s12032-010-9627-8
   Cox DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1635
   Cox DG, 2004, BRIT J CANCER, V91, P339, DOI 10.1038/sj.bjc.6601906
   Daraei A, 2012, MOL BIOL REP, V39, P5219, DOI 10.1007/s11033-011-1319-8
   Dong J, 2010, J GASTROEN HEPATOL, V25, P1042, DOI 10.1111/j.1440-1746.2010.06293.x
   Dossus L, 2010, CARCINOGENESIS, V31, P455, DOI 10.1093/carcin/bgp307
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802
   Gong ZH, 2009, INT J COLORECTAL DIS, V24, P647, DOI 10.1007/s00384-009-0656-8
   Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042
   Haghshenas M, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-20
   Hamajima Nobuyuki, 2001, Asian Pac J Cancer Prev, V2, P57
   Hardbower DM, 2013, GUT MICROBES, P4
   He JH, 2012, MOL BIOL REP, V39, P4163, DOI 10.1007/s11033-011-1199-y
   Hoeft B, 2008, CANCER CAUSE CONTROL, V19, P163, DOI 10.1007/s10552-007-9082-9
   Hoff JH, 2009, WORLD J GASTROENTERO, V15, P4561, DOI 10.3748/wjg.15.4561
   Hou L, 2007, ANTICANCER RES, V27, P4243
   Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/ncr1046
   Iglesias D, 2009, CANCER CAUSE CONTROL, V20, P1421, DOI 10.1007/s10552-009-9368-1
   Joshi AD, 2012, CARCINOGENESIS, V33, P2108, DOI 10.1093/carcin/bgs242
   Ke JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062485
   Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797
   Li YC, 2012, ONCOL LETT, V3, P107, DOI 10.3892/ol.2011.426
   Liang YA, 2011, TOHOKU J EXP MED, V223, P137, DOI 10.1620/tjem.223.137
   Lira MG, 2007, BRIT J DERMATOL, V157, P49, DOI 10.1111/j.1365-2133.2007.07921.x
   Liu CJ, 2010, ANTICANCER RES, V30, P1195
   Liu F, 2006, GASTROENTEROLOGY, V130, P1975, DOI 10.1053/j.gastro.2006.03.021
   Liu JL, 2010, WORLD J GASTROENTERO, V16, P5510, DOI 10.3748/wjg.v16.i43.5510
   Liu L, 2011, CANCER-AM CANCER SOC, V117, P5172, DOI 10.1002/cncr.26154
   Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z
   Ma Y, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-11
   Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a
   Mittal M, 2010, ORAL ONCOL, V46, P622, DOI 10.1016/j.oraloncology.2010.06.002
   Monroy CM, 2011, MOL CARCINOGEN, V50, P36, DOI 10.1002/mc.20688
   Moons LMG, 2007, AM J GASTROENTEROL, V102, P2373, DOI 10.1111/j.1572-0241.2007.01373.x
   Murad A, 2009, PROSTATE CANCER P D, V12, P296, DOI 10.1038/pcan.2009.18
   O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943
   Pandey S, 2010, INT J GYNECOL CANCER, V20, P625, DOI 10.1111/IGC.0b013e3181c63f79
   Panguluri RCK, 2004, CARCINOGENESIS, V25, P961, DOI 10.1093/carcin/bgh100
   Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5
   Pereira C, 2006, WORLD J GASTROENTERO, V12, P5473, DOI 10.3748/wjg.v12.i34.5473
   Pereira C, 2010, EUR J GASTROEN HEPAT, V22, P607, DOI 10.1097/MEG.0b013e3283352cbb
   Pereira C, 2009, EUR J GASTROEN HEPAT, V21, P76, DOI 10.1097/MEG.0b013e32830ce7ba
   Peters WHM, 2009, HEAD NECK-J SCI SPEC, V31, P938, DOI 10.1002/hed.21058
   Pinheiro SP, 2010, INT J MOL EPIDEMIOL, V1, P320
   Piranda DN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-613
   Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107
   Saxena A, 2008, WORLD J GASTROENTERO, V14, P1498, DOI 10.3748/wjg.14.1498
   Schwartzbaum J, 2005, CANCER RES, V65, P6459, DOI 10.1158/0008-5472.CAN-04-3728
   Sethi G, 2012, BIOSCIENCE REP, V32, P1, DOI 10.1042/BSR20100136
   Shin WG, 2012, GUT LIVER, V6, P321, DOI 10.5009/gnl.2012.6.3.321
   Sitarz R, 2008, MODERN PATHOL, V21, P685, DOI 10.1038/modpathol.2008.36
   Song QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033318
   Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030
   Tan W, 2007, CARCINOGENESIS, V28, P1197, DOI 10.1093/carcin/bgl242
   Thompson CL, 2009, WORLD J GASTROENTERO, V15, P2240, DOI 10.3748/wjg.15.2240
   Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6
   Ueda N, 2008, CANCER SCI, V99, P576, DOI 10.1111/j.1349-7006.2007.00711.x
   Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P616, DOI 10.1158/1055-9965.EPI-04-0510
   Upadhyay R, 2009, MUTAT RES-FUND MOL M, V663, P52, DOI 10.1016/j.mrfmmm.2009.01.007
   Vogel U, 2007, MUTAT RES-FUND MOL M, V617, P138, DOI 10.1016/j.mrfmmm.2007.01.005
   Wang CH, 2010, ANTICANCER RES, V30, P3649
   Wang J, 2012, INT J CANCER, V130, P1898, DOI 10.1002/ijc.26199
   Wang MT, 2007, CANCER METAST REV, V26, P525, DOI 10.1007/s10555-007-9096-5
   Wei GQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-46
   Wu HC, 2011, ANTICANCER RES, V31, P221
   Xing LL, 2008, WORLD J GASTROENTERO, V14, P1785, DOI 10.3748/wjg.14.1785
   Xu Dong-kui, 2008, Zhonghua Yi Xue Za Zhi, V88, P1961
   Yaghoobi M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-28
   Yu KD, 2010, BREAST CANCER RES TR, V122, P251, DOI 10.1007/s10549-009-0688-3
   Zhang HT, 2012, GENET MOL RES, V11, P1642, DOI 10.4238/2012.June.15.13
   Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003
   Zhang XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021894
   Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071
   Zheng J, 2011, EUR J HAEMATOL, V87, P486, DOI 10.1111/j.1600-0609.2011.01691.x
   Zhu W, 2010, MOL BIOL REP, V37, P277, DOI 10.1007/s11033-009-9685-1
NR 96
TC 17
Z9 18
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 4
PY 2013
VL 8
IS 9
AR e73213
DI 10.1371/journal.pone.0073213
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 219OE
UT WOS:000324515600077
PM 24023834
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sgolastra, F
   Petrucci, A
   Severino, M
   Gatto, R
   Monaco, A
AF Sgolastra, Fabrizio
   Petrucci, Ambra
   Severino, Marco
   Gatto, Roberto
   Monaco, Annalisa
TI Relationship between Periodontitis and Pre-Eclampsia: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID ADVERSE PREGNANCY OUTCOMES; RISK-FACTOR; MATERNAL PERIODONTITIS;
   SYSTEMIC AMOXICILLIN/METRONIDAZOLE; ADJUNCTIVE THERAPY; PRETERM BIRTH;
   ORAL-HEALTH; DISEASE; WOMEN; ASSOCIATION
AB Background: Studies have suggested controversial results regarding a possible association between pre-eclampsia (PE) and periodontal disease (PD) and no meta-analysis has been performed to clarify this issue.
   Methods: A literature search of electronic databases was performed for articles published through March 24, 2013, followed by a manual search of several dental and medical journals. The meta-analysis was conducted according to the recommendations of the Cochrane Collaboration and PRISMA. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Heterogeneity was assessed with the chi(2)-based Cochran Q test and I-2 statistic. The level of significance was set at P<0.05.
   Results: Fifteen studies were included, including three cohort and 12 case-control studies. A positive association was found between PE and PD (OR 2.17, 95% CI 1.38-3.41, P = 0.0008). However, a high and significant heterogeneity was found (chi(2) = 62.42, P<0.00001, I-2 = 75%). In most cases, subgroup analysis had low power to detect significant differences between PE and non-PE groups.
   Conclusion: Based on the findings of the meta-analysis, PD appears to be a possible risk factor for PE. However, given the important differences in the definitions and diagnoses of PD and PE among the studies, as well as their lack of good methodological quality, future trials are needed to confirm the results of the present meta-analysis.
C1 [Sgolastra, Fabrizio; Petrucci, Ambra; Severino, Marco; Gatto, Roberto; Monaco, Annalisa] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy.
RP Sgolastra, F (reprint author), Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy.
EM fabrizio.sgolastra@gmail.com
OI Monaco, Annalisa/0000-0002-9567-4459; Sgolastra,
   Fabrizio/0000-0002-0527-388X; Gatto, Roberto/0000-0002-1965-6080
CR Abati S, 2012, J MATERN FE IN PRESS
   Abenhaim Haim A., 2007, Archives of Gynecology and Obstetrics, V275, P39, DOI 10.1007/s00404-006-0219-y
   Boggess KA, 2006, AM J OBSTET GYNECOL, V194, P1316, DOI 10.1016/j.ajog.2005.11.059
   Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1
   Boggess KA, 2012, J PERIODONT IN PRESS
   Canakci V, 2004, AUST NZ J OBSTET GYN, V44, P568, DOI 10.1111/j.1479-828X.2004.00323.x
   Canakci V, 2007, J PERIODONTOL, V78, P1602, DOI 10.1902/jop.2007.060469
   Canakci V, 2007, J CLIN PERIODONTOL, V34, P639, DOI 10.1111/j.1600-051X.2007.01105.x
   Castaldi JL, 2006, REV PANAM SALUD PUBL, V19, P253, DOI 10.1590/S1020-49892006000400005
   Cetin I, 2012, REPROD SCI, V19, P633, DOI 10.1177/1933719111432871
   Chaparro A, 2012, J PERIODONT IN PRESS
   Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040
   Contreras A, 2006, J PERIODONTOL, V77, P182, DOI 10.1902/jop.2006.050020
   da Silva GM, 2012, J PERIODONTOL, V83, P1388, DOI 10.1902/jop.2012.110256
   Darmochwal-Kolarz D, 2002, AM J REPROD IMMUNOL, V48, P381, DOI 10.1034/j.1600-0897.2002.01089.x
   Dasanayake Ananda P, 2007, J Evid Based Dent Pract, V7, P176, DOI 10.1016/j.jebdp.2007.09.008
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Gibbs R S, 2001, Ann Periodontol, V6, P153, DOI 10.1902/annals.2001.6.1.153
   GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N
   Gilbert WM, 2007, J REPROD MED, V52, P1046
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Ha JE, 2011, J PERIODONTOL, V82, P1685, DOI 10.1902/jop.2011.110035
   Hirano E, 2012, J CLIN PERIODONTOL, V39, P229, DOI 10.1111/j.1600-051X.2011.01845.x
   Horton AL, 2010, J PERIODONTOL, V81, P199, DOI 10.1902/jop.2009.090437
   Khader YS, 2006, J PERIODONTOL, V77, P1681, DOI 10.1902/jop.2006.050463
   Kumar A, 2012, J OBSTET GY IN PRESS
   Kunnen A, 2007, J CLIN PERIODONTOL, V34, P202, DOI 10.1111/j.1600-051X.2006.01036.x
   Kunnen A, 2010, J CLIN PERIODONTOL, V37, P1075, DOI 10.1111/j.1600-051X.2010.01636.x
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786
   Lohsoonthorn V, 2009, AM J HYPERTENS, V22, P457, DOI 10.1038/ajh.2008.365
   Lopez-Jaramillo P, 2011, J HYPERTENS, V29, P1020, DOI 10.1097/HJH.0b013e328344b6e8
   Matevosyan NR, 2011, ARCH GYNECOL OBSTET, V283, P675, DOI 10.1007/s00404-010-1774-9
   Meurman JH, 2006, CLIN ORAL INVEST, V10, P96, DOI 10.1007/s00784-006-0037-4
   Cota LOM, 2006, J PERIODONTOL, V77, P2063, DOI 10.1902/jop.2006.060061
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Nabet C, 2010, J CLIN PERIODONTOL, V37, P37, DOI 10.1111/j.1600-051X.2009.01503.x
   Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552
   Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035
   Oettinger-Barak O, 2005, J PERIODONTOL, V76, P134, DOI 10.1902/jop.2005.76.1.134
   Offenbacher S, 2006, OBSTET GYNECOL, V107, P29, DOI 10.1097/01.AOG.0000190212.87012.96
   Offenbacher S, 2001, Ann Periodontol, V6, P164, DOI 10.1902/annals.2001.6.1.164
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Piscoya MDBV, 2012, PEDIATR INT, V54, P68, DOI 10.1111/j.1442-200X.2011.03502.x
   Politano GT, 2011, J PERIODONTAL RES, V46, P505, DOI 10.1111/j.1600-0765.2011.01368.x
   ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0
   Ruma M, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.002
   Sayar F, 2011, IRAN J PUBLIC HEALTH, V40, P122
   Sgolastra F, 2013, LASERS MED SCI
   Sgolastra F, 2013, J PERIODONTAL RES
   Sgolastra F, 2013, J CLIN PERIODONTOL, V40, P514, DOI 10.1111/jcpe.12094
   Sgolastra F, 2012, J PERIODONTOL, V83, P1257, DOI 10.1902/jop.2012.110625
   Sgolastra F, 2012, J PERIODONTOL, V83, P731, DOI 10.1902/jop.2011.110432
   Sgolastra F, 2011, J PERIODONTOL, V82, P1570, DOI 10.1902/jop.2011.110026
   Shetty M, 2010, ACTA OBSTET GYN SCAN, V89, P718, DOI 10.3109/00016341003623738
   Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2
   Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8
   Siqueira FM, 2008, J PERIODONTOL, V79, P207, DOI [10.1902/jop.2008.070174, 10.1902/jop.2008.070174 ]
   Srinivas SK, 2009, AM J OBSTET GYNECOL, V200
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Sun Y, 2008, INT J GYNECOL OBSTET, V101, P74, DOI 10.1016/j.ijgo.2007.10.008
   Swati P, 2012, ARCH GYNECOL OBSTET, V285, P613, DOI 10.1007/s00404-011-2012-9
   Swati P, 2012, J PERIODONT IN PRESS
   Taghzouti N, 2012, J PERIODONTOL, V83, P871, DOI 10.1902/jop.2011.110342
   Trogstad LIS, 2001, ACTA OBSTET GYN SCAN, V80, P1036, DOI 10.1034/j.1600-0412.2001.801112.x
   Vergnes Jean-Noel, 2008, Evid Based Dent, V9, P46, DOI 10.1038/sj.ebd.6400580
   von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x
   Wang Y, 2012, INT J IMMUNOGENET, V39, P492, DOI 10.1111/j.1744-313X.2012.01124.x
   Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x
NR 70
TC 15
Z9 15
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2013
VL 8
IS 8
AR e71387
DI 10.1371/journal.pone.0071387
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 205ER
UT WOS:000323425700043
PM 23990948
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ye, XH
   Fu, JJ
   Yang, Y
   Gao, YH
   Liu, L
   Chen, SD
AF Ye, Xiaohua
   Fu, Jinjian
   Yang, Yi
   Gao, Yanhui
   Liu, Li
   Chen, Sidong
TI Frequency-Risk and Duration-Risk Relationships between Aspirin Use and
   Gastric Cancer: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Review
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; ESOPHAGEAL;
   ADENOCARCINOMAS; PROGNOSIS; FEATURES; NSAIDS; TRIAL
AB Background: Although previous meta-analyses have suggested an association between aspirin use and risk of gastric cancer, current evidence is inconsistent. Additionally, it remains unclear whether there are frequency-risk and duration-risk relationships and if a threshold of effect exists.
   Methods: We identified studies by searching MEDLINE and PUBMED databases and reviewing relevant articles. We derived the summary risk estimates using fixed-effects or random-effects model based on homogeneity analysis. The dose-response meta-analysis was performed by linear trend regression and restricted cubic spline regression. Potential heterogeneity was tested using the Q statistic and quantified with the I 2 statistic. Subgroup analyses and Galbraith plots were used to explore the potential sources of heterogeneity. Publication bias was evaluated with funnel plots and quantified by the Begg's and Egger's test.
   Results: Fifteen studies were included in this meta-analysis. There was an overall 29% reduced risk of gastric cancer corresponding to aspirin use (RR = 0.71, 95% CI 0.60-0.82). We found there are nonlinear frequency-risk and linear duration-risk relations between aspirin use and gastric cancer. A monotonically decreasing relation was observed only for low-frequency (<= 4.5 times/week) aspirin intake (10% decreased risk for once/week, 19% for twice/week and 29% for 4.5 times/week), and the frequency threshold of aspirin use is 4.5 times per week. Regarding those with duration of aspirin use, there was a tendency towards stronger risk reduction of gastric cancer for longer aspirin use (10% decreased risk for 4 years, 19% for 8 years and 28% for 12 years), and no duration threshold was observed.
   Conclusion: Our findings suggest that long-term (>= 4 years) and low-frequency (1-4.5 times per week) aspirin use is associated with a statistically significant, dose-dependent reduction in the risk of gastric cancer.
C1 [Ye, Xiaohua] Guangdong Pharmaceut Univ, Guangdong Key Lab Mol Epidemiol, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Ye, Xiaohua; Yang, Yi; Gao, Yanhui; Liu, Li; Chen, Sidong] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.
   [Fu, Jinjian] Liuzhou Municipal Matern & Child Healthcare Hosp, Liuzhou, Guangxi, Peoples R China.
RP Chen, SD (reprint author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.
EM chensidong1@126.com
FU Guangzhou Science and Technology Bureau [2011J5200017]
FX This work was supported by funds from International cooperation project
   of the Guangzhou Science and Technology Bureau (No. 2011J5200017). The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abnet CC, 2009, BRIT J CANCER, V100, P551, DOI 10.1038/sj.bjc.6604880
   Akre K, 2001, BRIT J CANCER, V84, P965, DOI 10.1054/bjoc.2001.1702
   Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2
   Bai Y, 2011, J GASTROEN HEPATOL, V26, P1626, DOI 10.1111/j.1440-1746.2011.06759.x
   Baigent C, 2002, BMJ-BRIT MED J, V324, P71
   Bertuccio P, 2010, EUR J CANCER PREV, V19, P426, DOI 10.1097/CEJ.0b013e32833ecbdc
   Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290
   Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113
   Choi AL, 2008, CRIT REV TOXICOL, V38, P877, DOI 10.1080/10408440802273164 
   Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47
   Duan L, 2008, CANCER EPIDEM BIOMAR, V17, P126, DOI 10.1158/1055-9965.EPI-07-0664
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9
   Epplein M, 2009, AM J EPIDEMIOL, V170, P507, DOI 10.1093/aje/kwp162
   FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044
   Farrow DC, 1998, CANCER EPIDEM BIOMAR, V7, P97
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Figueroa JD, 2009, CANCER CAUSE CONTROL, V20, P361, DOI 10.1007/s10552-008-9250-6
   Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x
   Fortuny J, 2007, CLIN GASTROENTEROL H, V5, P1154, DOI 10.1016/j.cgh.2007.05.022
   GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807
   Gillies M, 1968, Med J Aust, V2, P1132
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Huang ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015721
   Ishikawa S, 2008, ACTA MED OKAYAMA, V62, P29
   Jana NR, 2008, CELL MOL LIFE SCI, V65, P1295, DOI 10.1007/s00018-008-7511-x
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289
   Lee J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-596
   Lindblad M, 2005, CANCER EPIDEM BIOMAR, V14, P444, DOI 10.1158/1055-9965.EPI-04-0467
   Marrelli D, 2009, ANN SURG, V250, P43, DOI 10.1097/SLA.0b013e3181ad6487
   Meade TW, 1998, LANCET, V351, P233
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313
   Ratnasinghe LD, 2004, ANTICANCER RES, V24, P3177
   Rota M, 2010, STAT MED, V29, P2679, DOI 10.1002/sim.4041
   Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1
   Sadeghi S, 2008, CANCER EPIDEM BIOMAR, V17, P1169, DOI 10.1158/1055-9965.EPI-07-2852
   Sample DA, 2002, CANCER EPIDEM BIOMAR, V11, P281
   SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538
   THUN MJ, 1993, CANCER RES, V53, P1322
   Tian WJ, 2010, EUR J CANCER PREV, V19, P288, DOI 10.1097/CEJ.0b013e328339648c
   Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106
   Yang P, 2010, DIGEST DIS SCI, V55, P1533, DOI 10.1007/s10620-009-0915-0
   Ye XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057578
   Zaridze D, 1999, INT J CANCER, V82, P473, DOI 10.1002/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K
   Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014
NR 51
TC 24
Z9 25
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 30
PY 2013
VL 8
IS 7
AR e71522
DI 10.1371/journal.pone.0071522
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 201AX
UT WOS:000323114200119
PM 23936269
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, Y
   Ji, J
   Liu, YJ
   Deng, X
   He, QQ
AF Wang, Ying
   Ji, Jie
   Liu, Yu-jian
   Deng, Xuan
   He, Qi-qiang
TI Passive Smoking and Risk of Type 2 Diabetes: A Meta-Analysis of
   Prospective Cohort Studies
SO PLOS ONE
LA English
DT Article
ID CIGARETTE-SMOKING; ACTIVE SMOKING; EXPOSURE; ASSOCIATION; POPULATION;
   DISEASE; RATIO; BIAS
AB Backgrounds/Objective: The prevalence of diabetes is increasing rapidly all over the world. However, studies on passive smoking and type 2 diabetes have not been systematically assessed. Therefore, we conducted a meta-analysis to explore whether an association exists between passive smoking and risk of type 2 diabetes.
   Methods: We searched PubMed, EMBASE, Cochrane library and Web of Science up to April 9th, 2013, to identify prospective cohort studies that assessed passive smoking and risk of type 2 diabetes. The fixed-effect model was used to calculate the overall relative risk (RR).
   Result: 4 prospective cohort studies were included for analysis, with a total of 112,351 participants involved. The pooled RR was 1.28 (95% confidence interval (CI) 1.14 to 1.44) comparing those who were exposed to passive smoking with those who were not. Subgroup, sensitivity analysis and publication bias test suggested the overall result of this analysis was robust.
   Conclusions: Passive smoking is associated with a significantly increased risk of type 2 diabetes. Further well-designed studies are warranted to confirm this association.
C1 [Wang, Ying; Ji, Jie; Liu, Yu-jian; Deng, Xuan; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.
   [Wang, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China.
   [He, Qi-qiang] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Peoples R China.
RP He, QQ (reprint author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.
EM heqiqiang@gmail.com
RI He, Qiqiang/A-7990-2012
CR Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI [10.2337/dc10-S062, 10.2337/dc11-S062, 10.2337/dc10-s062]
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Brownson RC, 2002, ONCOGENE, V21, P7341, DOI 10.1038/sj.onc.1205809
   Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371
   Chuang SC, 2011, CANCER CAUSE CONTROL, V22, P487, DOI 10.1007/s10552-010-9723-2
   de Lemos ML, 2002, LANCET, V360, P954, DOI 10.1016/S0140-6736(02)11063-4
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   ERIKSEN MP, 1988, ANNU REV PUBL HEALTH, V9, P47, DOI 10.1146/annurev.pu.09.050188.000403
   Hayashino Y, 2008, DIABETES CARE, V31, P732, DOI 10.2337/dc07-1905
   He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Houston TK, 2006, BRIT MED J, V332, P1064, DOI 10.1136/bmj.38779.584028.55
   Ko KP, 2011, ANN EPIDEMIOL, V21, P42, DOI 10.1016/j.annepidem.2010.10.006
   Kowall B, 2010, EUR J EPIDEMIOL, V25, P393, DOI 10.1007/s10654-010-9452-6
   McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2
   MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220
   Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8
   Oono IP, 2011, J PUBLIC HEALTH-UK, V33, P496, DOI 10.1093/pubmed/fdr025
   Sasaki S, 2011, SCI TOTAL ENVIRON, V412, P114, DOI 10.1016/j.scitotenv.2011.10.019
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789
   Sikorska-Jaroszynska MHJ, 2012, ANN AGR ENV MED, V19, P547
   Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004
   Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Vrieling A, 2010, INT J CANCER, V126, P2394, DOI 10.1002/ijc.24907
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   Xie XT, 2009, ACTA PHARMACOL SIN, V30, P784, DOI 10.1038/aps.2009.49
   Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
   Zhang LX, 2011, DIABETES CARE, V34, P892, DOI 10.2337/dc10-2087
NR 34
TC 17
Z9 18
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2013
VL 8
IS 7
AR e69915
DI 10.1371/journal.pone.0069915
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 197GU
UT WOS:000322838900113
PM 23922856
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Braun, SR
   Gregor, B
   Tran, US
AF Braun, Sarah R.
   Gregor, Bettina
   Tran, Ulrich S.
TI Comparing Bona Fide Psychotherapies of Depression in Adults with Two
   Meta-Analytical Approaches
SO PLOS ONE
LA English
DT Article
ID COGNITIVE-BEHAVIORAL THERAPY; MIXED TREATMENT COMPARISONS; LATE-LIFE
   DEPRESSION; 2ND-GENERATION ANTIDEPRESSANTS; PSYCHOLOGICAL TREATMENTS;
   UNIPOLAR DEPRESSION; ANXIETY DISORDERS; OUTCOME RESEARCH; METAANALYSIS;
   EFFICACY
AB Objective: Despite numerous investigations, the question whether all bona fide treatments of depression are equally efficacious in adults has not been sufficiently answered.
   Method: We applied two different meta-analytical techniques (conventional meta-analysis and mixed treatment comparisons). Overall, 53 studies with 3,965 patients, which directly compared two or more bona fide psychotherapies in a randomized trial, were included. Meta-analyses were conducted regarding five different types of outcome measures. Additionally, the influence of possible moderators was examined.
   Results: Direct comparisons of cognitive behavior therapy, behavior activation therapy, psychodynamic therapy, interpersonal therapy, and supportive therapies versus all other respective treatments indicated that at the end of treatment all treatments but supportive therapies were equally efficacious whereas there was some evidence that supportive therapies were somewhat less efficacious than all other treatments according to patient self-ratings and clinical significance. At follow-up no significant differences were present. Age, gender, comorbid mental disorders, and length of therapy session were found to moderate efficacy. Cognitive behavior therapy was superior in studies where therapy sessions lasted 90 minutes or longer, behavior activation therapy was more efficacious when therapy sessions lasted less than 90 minutes. Mixed treatment comparisons indicated no statistically significant differences in treatment efficacy but some interesting trends.
   Conclusions: This study suggests that there might be differential effects of bona fide psychotherapies which should be examined in detail.
C1 [Braun, Sarah R.; Gregor, Bettina; Tran, Ulrich S.] Univ Vienna, Vienna, Austria.
RP Tran, US (reprint author), Univ Vienna, Vienna, Austria.
EM ulrich.tran@univie.ac.at
CR Aderka IM, 2012, J CONSULT CLIN PSYCH, V80, P93, DOI 10.1037/a0026455
   American Psychological Association, 2006, AM PSYCHOL, V61, P271, DOI DOI 10.1037/0003-066X.61.4.271
   Baardseth TP, 2013, CLIN PSYCHOL REV, V33, P395, DOI 10.1016/j.cpr.2013.01.004
   Barbui C, 2004, J CLIN PSYCHOPHARM, V24, P126, DOI 10.1097/01.jcp.0000115665.45074.0d
   Beck A. T., 1979, COGNITIVE THERAPY DE
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Berkeljon A, 2009, PSYCHOTHER RES, V19, P511, DOI 10.1080/10503300802621172
   Berman JS, 2010, EUR J PSYCHOTHER COU, V12, P11, DOI 10.1080/13642531003637775
   Borenstein M., 2009, INTRO METAANALYSIS
   Caldwell DM, 2005, BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897
   Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5
   Cuijpers P, 2008, PSYCHOTHER RES, V18, P225, DOI 10.1080/10503300701442027
   Cuijpers P, 2010, CLIN PSYCHOL REV, V30, P768, DOI 10.1016/j.cpr.2010.06.001
   Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075
   Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36
   de Mello MF, 2005, EUR ARCH PSY CLIN N, V255, P75, DOI 10.1007/s00406-004-0542-x
   DERUBEIS RJ, 1990, COGNITIVE THER RES, V14, P469, DOI 10.1007/BF01172968
   Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724
   DOBSON KS, 1989, J CONSULT CLIN PSYCH, V57, P414, DOI 10.1037/0022-006X.57.3.414
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Enns MW, 2000, J AFFECT DISORDERS, V60, P33, DOI 10.1016/S0165-0327(99)00156-1
   Feng CY, 2012, WORLDV EVID-BASED NU, V9, P2, DOI 10.1111/j.1741-6787.2011.00229.x
   Forand NR, 2011, COGNITIVE THER RES, V35, P151, DOI 10.1007/s10608-010-9348-5
   GAFFAN EA, 1995, J CONSULT CLIN PSYCH, V63, P966, DOI 10.1037/0022-006X.63.6.966
   Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009
   Gloaguen V, 1998, J AFFECT DISORDERS, V49, P59, DOI 10.1016/S0165-0327(97)00199-7
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Hollon SD, 2010, DEPRESS ANXIETY, V27, P891, DOI 10.1002/da.20741
   Imel ZE, 2008, J AFFECT DISORDERS, V110, P197, DOI 10.1016/j.jad.2008.03.018
   Imel ZE, 2008, PSYCHOL ADDICT BEHAV, V22, P533, DOI 10.1037/a0013171
   Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x
   Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432
   Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875
   LUBORSKY L, 1975, ARCH GEN PSYCHIAT, V32, P995
   Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005
   Miller S, 2008, PSYCHOTHER RES, V18, P5, DOI 10.1080/10503300701472131
   Olatunji BO, 2010, CLIN PSYCHOL REV, V30, P642, DOI 10.1016/j.cpr.2010.04.008
   Olatunji BO, 2010, PSYCHIAT CLIN N AM, V33, P557, DOI 10.1016/j.psc.2010.04.002
   Porter JF, 2004, PROF PSYCHOL-RES PR, V35, P297, DOI 10.1037/0735-7028.35.3.297
   Raffin AL, 2009, EUR PSYCHIAT, V24, P297, DOI 10.1016/j.eurpsy.2008.12.001
   Riebe G, 2010, J INVEST MED, V58, P240
   ROBINSON LA, 1990, PSYCHOL BULL, V108, P30, DOI 10.1037/0033-2909.108.1.30
   Saito H, 2008, PSYCHOGERIATRICS, V8, P12, DOI 10.1111/j.1479-8301.2007.00216.x
   Schneider D, 2008, PSYCHOTHER PSYCH MED, V58, P23, DOI 10.1055/s-2007-970946
   Segrin C, 2000, CLIN PSYCHOL REV, V20, P379, DOI 10.1016/S0272-7358(98)00104-4
   SHADISH WR, 1991, J CONSULT CLIN PSYCH, V59, P883, DOI 10.1037/0022-006X.59.6.883
   Spielmans GI, 2011, J NERV MENT DIS, V199, P142, DOI 10.1097/NMD.0b013e31820caefb
   STEINBRUECK SM, 1983, J CONSULT CLIN PSYCH, V51, P856, DOI 10.1037/0022-006X.51.6.856
   Sutton AJ, 2000, METHODS METAANALYSIS
   Tolin DF, 2010, CLIN PSYCHOL REV, V30, P710, DOI 10.1016/j.cpr.2010.05.003
   Trinquart L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035219
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1
   Wampold B. E., 2001, GREAT PSYCHOTHERAPY
   Wampold BE, 2002, J AFFECT DISORDERS, V68, P159, DOI 10.1016/S0165-0327(00)00287-1
   Welton NJ, 2009, AM J EPIDEMIOL, V169, P1158, DOI 10.1093/aje/kwp014
NR 55
TC 18
Z9 18
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 28
PY 2013
VL 8
IS 6
AR e68135
DI 10.1371/journal.pone.0068135
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 174IH
UT WOS:000321148400167
PM 23840824
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Navarro-Mateu, F
   Escamez, T
   Koenen, KC
   Alonso, J
   Sanchez-Meca, J
AF Navarro-Mateu, Fernando
   Escamez, Teresa
   Koenen, Karestan C.
   Alonso, Jordi
   Sanchez-Meca, Julio
TI Meta-Analyses of the 5-HTTLPR Polymorphisms and Post-Traumatic Stress
   Disorder
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; EMOTIONAL REGULATION; CHILDHOOD ADVERSITY;
   SYSTEMATIC REVIEWS; OEF/OIF VETERANS; PROMOTER REGION; SOCIAL SUPPORT;
   LIFE EVENTS; ASSOCIATION; GENOTYPE
AB Objective: To conduct a meta-analysis of all published genetic association studies of 5-HTTLPR polymorphisms performed in PTSD cases
   Methods Data Sources: Potential studies were identified through PubMed/MEDLINE, EMBASE, Web of Science databases (Web of Knowledge, WoK), PsychINFO, PsychArticles and HuGeNet (Human Genome Epidemiology Network) up until December 2011. Study Selection: Published observational studies reporting genotype or allele frequencies of this genetic factor in PTSD cases and in non-PTSD controls were all considered eligible for inclusion in this systematic review. Data Extraction: Two reviewers selected studies for possible inclusion and extracted data independently following a standardized protocol. Statistical analysis: A biallelic and a triallelic meta-analysis, including the total S and S' frequencies, the dominant (S+/LL and S'+/L'L') and the recessive model (SS/L+ and S'S'/L'+), was performed with a random-effect model to calculate the pooled OR and its corresponding 95% CI. Forest plots and Cochran's Q-Statistic and I-2 index were calculated to check for heterogeneity. Subgroup analyses and meta-regression were carried out to analyze potential moderators. Publication bias and quality of reporting were also analyzed.
   Results: 13 studies met our inclusion criteria, providing a total sample of 1874 patients with PTSD and 7785 controls in the biallelic meta-analyses and 627 and 3524, respectively, in the triallelic. None of the meta-analyses showed evidence of an association between 5-HTTLPR and PTSD but several characteristics (exposure to the same principal stressor for PTSD cases and controls, adjustment for potential confounding variables, blind assessment, study design, type of PTSD, ethnic distribution and Total Quality Score) influenced the results in subgroup analyses and meta-regression. There was no evidence of potential publication bias.
   Conclusions: Current evidence does not support a direct effect of 5-HTTLPR polymorphisms on PTSD. Further analyses of gene-environment interactions, epigenetic modulation and new studies with large samples and/or meta-analyses are required.
C1 [Navarro-Mateu, Fernando] Serv Murciano Salud, Subdirecc Gen Salud Mental & Asistencia Psiquiatr, Unidad Docencia Invest & Formac Salud Mental UDIF, Murcia, Spain.
   [Navarro-Mateu, Fernando] CIBER Epidemiol & Salud Publ CIBERESP, Murcia, Spain.
   [Escamez, Teresa] Fdn Formac & Invest Sanitarias FFIS Reg Murcia, IMIB BIOBANC MUR, Biobanco HUVA AECC FFIS, Murcia, Spain.
   [Koenen, Karestan C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [Alonso, Jordi] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain.
   [Alonso, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.
   [Sanchez-Meca, Julio] Univ Murcia, Fac Psicol, Dept Psicol Basica & Metodol, Murcia, Spain.
RP Navarro-Mateu, F (reprint author), Serv Murciano Salud, Subdirecc Gen Salud Mental & Asistencia Psiquiatr, Unidad Docencia Invest & Formac Salud Mental UDIF, Murcia, Spain.
EM fernando.navarro@carm.es
RI Alonso, Jordi/A-5514-2010; Navarro-Mateu, Fernando/H-9055-2017
OI Alonso, Jordi/0000-0001-8627-9636; Navarro-Mateu,
   Fernando/0000-0002-3228-623X
FU Regional Health Authorities of Murcia (Consejeria de Sanidad y Politica
   Social and Servicio Murciano de Salud); Fundacion para la Formacion e
   Investigacion Sanitaria (FFIS) of the Murcia Region
FX This work has been financed by the Regional Health Authorities of Murcia
   (Consejeria de Sanidad y Politica Social and Servicio Murciano de Salud)
   and the Fundacion para la Formacion e Investigacion Sanitaria (FFIS) of
   the Murcia Region. The funding agencies had no role in study design,
   data collection and analysis, decision to publish or preparation of the
   manuscript. Jim van Os
CR Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Bray M, 2006, HUGENET HUGE REV HDB
   Brugha TS, 2012, BRIT J PSYCHIAT, V200, P446, DOI 10.1192/bjp.bp.111.098103
   Bryant RA, 2010, BIOL PSYCHIAT, V67, P1217, DOI 10.1016/j.biopsych.2010.03.016
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663
   Clarke H, 2010, PSYCHOL MED, V40, P1767, DOI 10.1017/S0033291710000516
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Esteller M, 2006, CARCINOGENESIS, V27, P1121, DOI 10.1093/carcin/bgl033
   Feinn R, 2005, AM J MED GENET B, V133B, P79, DOI 10.1002/ajmg.b.30132
   Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069
   Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542
   GREEN BL, 1994, J TRAUMA STRESS, V7, P341, DOI 10.1007/BF02102782
   Handwerger K L., 2010, THESIS PROQUEST INFO
   Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002
   Holman EA, 2011, J TRAUMA STRESS, V24, P497, DOI 10.1002/jts.20671
   Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62
   Huedo-Medina T, 2006, 19 CHIP
   Kaufman J, 2009, BIOL PSYCHIAT, V65, p106S
   Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4
   Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007
   King AP, 2011, BIOL PSYCHIAT, V69, p74S
   King AP, 2010, BIOL PSYCHIAT, V67, p209S
   King AP, 2009, BIOL PSYCHIAT, V65, p6S
   Koenen KC, 2008, EUR ARCH PSY CLIN N, V258, P82, DOI 10.1007/s00406-007-0787-2
   Koenen K, 2006, AM J MED GENET B, V141B, P742
   Koenen KC, 2007, J TRAUMA STRESS, V20, P737, DOI 10.1002/jts.20205
   Koenen KC, 2011, DEPRESS ANXIETY, V28, P639, DOI 10.1002/da.20825
   Koenen KC, 2009, J TRAUMA STRESS, V22, P416, DOI 10.1002/jts.20435
   Koenen KC, 2009, AM J EPIDEMIOL, V169, P704, DOI 10.1093/aje/kwn397
   Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu
   Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Li D, 2007, MOL PSYCHIATR, V12, P47, DOI 10.1038/sj.mp.4001890
   Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/aje/kwf054
   Little J, 2009, ANN INTERN MED, V150, P206, DOI 10.7326/0003-4819-150-3-200902030-00011
   Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001
   Valente NLM, 2011, J MOL NEUROSCI, V44, P59, DOI 10.1007/s12031-011-9513-7
   Mellman TA, 2009, PSYCHOSOM MED, V71, P627, DOI 10.1097/PSY.0b013e3181a54341
   Mercer KB, 2012, ARCH GEN PSYCHIAT, V69, P89, DOI 10.1001/archgenpsychiatry.2011.109
   Morey RA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-76
   Munafo MR, 2006, NEUROPSYCHOBIOLOGY, V53, P1, DOI 10.1159/000089915
   Mushtaq D, 2012, J AFFECT DISORDERS, V136, P955, DOI 10.1016/j.jad.2011.08.033
   Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698
   Nugent NR, 2008, AM J MED GENET C, V148C, P127, DOI 10.1002/ajmg.c.30169
   Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48
   Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185
   Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028
   Sanchez-Meca J, 2008, PSYCHOL METHODS, V13, P31, DOI 10.1037/1082-989X.13.1.31
   Sayin A, 2010, DNA CELL BIOL, V29, P71, DOI 10.1089/dna.2009.0936
   Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P99
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Takano A, 2007, BIOL PSYCHIAT, V62, P588, DOI 10.1016/j.biopsych.2006.11.007
   Terracciano A, 2010, NEUROPSYCHOPHARMACOL, V35, P1083, DOI 10.1038/npp.2009.213
   Thakur GA, 2009, J TRAUMA STRESS, V22, P240, DOI 10.1002/jts.20405
   Toyokawa S, 2012, SOC SCI MED, V74, P67, DOI 10.1016/j.socscimed.2011.09.036
   Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872
   Wang ZW, 2009, BIOL PSYCHIAT, V65, p119S
   Xie PX, 2012, AM J MED GENET B, V159B, P644, DOI 10.1002/ajmg.b.32068
   Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153
   Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588
NR 65
TC 25
Z9 25
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 25
PY 2013
VL 8
IS 6
AR e66227
DI 10.1371/journal.pone.0066227
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 175IB
UT WOS:000321223000010
PM 23825531
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, YL
   Li, CL
   Chen, PZ
   Li, XG
   Li, M
   Guo, H
   Li, JQ
   Chu, RA
   Wang, H
AF Liu, Yanling
   Li, Chenglin
   Chen, Peizhan
   Li, Xiaoguang
   Li, Mian
   Guo, He
   Li, Jingquan
   Chu, Ruiai
   Wang, Hui
TI Polymorphisms in the Vitamin D Receptor (VDR) and the Risk of Ovarian
   Cancer: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID GENE POLYMORPHISMS; PROSTATE-CANCER; 1,25-DIHYDROXYVITAMIN D-3;
   PUBLICATION BIAS; GROWTH; INHIBITION; EXPRESSION; EXPOSURE; BIOLOGY;
   CELLS
AB The vitamin D receptor (VDR) principally mediates the anticancer activities of vitamin D. Various epidemiological studies have investigated the associations of VDR gene polymorphisms with ovarian cancer; however, the results have been inconclusive. In the current study, we evaluated, in a meta-analysis, the association of five common single nucleotide polymorphisms (SNPs) in the VDR gene (ApaI, BsmI, Cdx-2, FokI, and TaqI) with the risk of ovarian cancer. Six eligible studies, with a total of 4,107 cases and 6,661 controls, which evaluated the association of these variants and ovarian cancer risk, were identified from the MEDLINE and PubMed databases. The meta-analysis indicated that FokI was associated with an increased ovarian cancer risk, with a pooled odds ratio (OR) of 1.10 [95% confidence intervals (95% CI) = 1.00-1.20] for CT heterozygotes and 1.16 (95% CI = 1.02-1.30) for TT homozygotes relative to common CC carriers. Carriers of the T allele (also known as the f allele) showed an 11% (pooled OR = 1.11, 95% CI = 1.02-1.21; TT/CT vs. CC) increased risk of ovarian cancer relative to CC carriers. For FokI, no significant heterogeneity between the studies was found (I-2 = 0%, P = 0.62 for the Q test). There was no statistically significant association between the other four variants (ApaI, BsmI, Cdx-2 and TaqI) and risk of ovarian cancer. These data indicate that the polymorphism FokI on the VDR is a susceptibility factor for ovarian cancer. Nevertheless, more studies are warranted to elucidate the underlying mechanisms of the VDR in development of ovarian cancer.
C1 [Liu, Yanling; Li, Chenglin; Chen, Peizhan; Li, Xiaoguang; Li, Mian; Guo, He; Li, Jingquan; Chu, Ruiai; Wang, Hui] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Food Safety Res,Inst Nutr Sci, Shanghai, Peoples R China.
   [Li, Jingquan; Chu, Ruiai; Wang, Hui] Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.
RP Wang, H (reprint author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Food Safety Res,Inst Nutr Sci, Shanghai, Peoples R China.
EM huiwang@sibs.ac.cn
FU One Hundred Talents Program and Knowledge Innovation Program of the
   Chinese Academy of Sciences [KSCX2-EW-R 10]; National Nature Science
   Foundation [81125020, 91029715, 31070680, 31101261, 81242002, 31200569];
   Ministry of Science and Technology of China [2012BAK01B00, 2011BAK10B00,
   2009CB919000]; Science and Technology Commission of Shanghai
   Municipality [12XD1407000, 12431900500, 10391902100]; Xuhui Central
   Hospital [CRC2011001, CRC2011004]; Director Foundation; Food Safety
   Research Center; Key Laboratory of Nutrition and Metabolism of INS,
   SIBS, CAS; SA-SIBS scholarship program
FX This study was supported by grants from One Hundred Talents Program and
   Knowledge Innovation Program (KSCX2-EW-R 10) of the Chinese Academy of
   Sciences; the National Nature Science Foundation (81125020, 91029715,
   31070680, 31101261, 81242002, and 31200569); the Ministry of Science and
   Technology of China (2012BAK01B00, 2011BAK10B00, and 2009CB919000); the
   Science and Technology Commission of Shanghai Municipality (12XD1407000,
   12431900500, and 10391902100); Xuhui Central Hospital (CRC2011001 and
   CRC2011004), and Director Foundation and the Food Safety Research Center
   and Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS.
   Peizhan Chen gratefully acknowledges the support of SA-SIBS scholarship
   program. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ahonen MH, 2000, INT J CANCER, V86, P40, DOI 10.1002/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO;2-E
   Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915
   Bai YH, 2012, WORLD J GASTROENTERO, V18, P1672, DOI 10.3748/wjg.v18.i14.1672
   BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294
   Brekelmans CTM, 2003, CURR OPIN OBSTET GYN, V15, P63, DOI 10.1097/01.gco.0000051560.77832.3b
   Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9
   Cheteri MBK, 2004, PROSTATE, V59, P409, DOI 10.1002/pros.20001
   Clendenen TV, 2008, CANCER LETT, V260, P209, DOI 10.1016/j.canlet.2007.11.002
   Colin EM, 2000, CLIN ENDOCRINOL, V52, P211, DOI 10.1046/j.1365-2265.2000.00909.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260
   Grant DJ, 2012, GYNECOL ONCOL
   Grant WB, 2012, ANTICANCER RES, V32, P223
   Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200
   John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134
   Jurutka P W, 2001, Rev Endocr Metab Disord, V2, P203, DOI 10.1023/A:1010062929140
   Kostner K, 2009, ANTICANCER RES, V29, P3511
   Lurie G, 2007, CANCER EPIDEM BIOMAR, V16, P2566, DOI 10.1158/1055-9965.EPI-07-0753
   Lurie G, 2011, INT J CANCER, V128, P936, DOI 10.1002/ijc.25403
   MANOLAGAS SC, 1994, SEMIN NEPHROL, V14, P129
   Mikhak B, 2007, PROSTATE, V67, P911, DOI 10.1002/pros.20570
   Mocellin S, 2008, CANCER-AM CANCER SOC, V113, P2398, DOI 10.1002/cncr.23867
   Mostowska A, 2013, GENET TEST MOL BIOMA, V17, P183, DOI 10.1089/gtmb.2012.0332
   Orlow I, 2012, INT J CANCER, V130, P405, DOI 10.1002/ijc.26023
   Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889
   Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103
   Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123
   Rukin NJ, 2007, CANCER LETT, V247, P328, DOI 10.1016/j.canlet.2006.05.012
   Spina CS, 2007, J STEROID BIOCHEM, V103, P757, DOI 10.1016/j.jsbmb.2006.12.040
   Tamez S, 2009, BRIT J CANCER, V101, P1957, DOI 10.1038/sj.bjc.6605414
   Tworoger SS, 2009, CANCER RES, V69, P1885, DOI 10.1158/0008-5472.CAN-08-3515
   Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014
   van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043
   Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5
   Yamamoto H, 1999, J BONE MINER RES, V14, P240, DOI 10.1359/jbmr.1999.14.2.240
   Yin M, 2009, INT J CLIN EXP MED, V2, P159
NR 39
TC 2
Z9 2
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 24
PY 2013
VL 8
IS 6
AR e66716
DI 10.1371/journal.pone.0066716
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 182JP
UT WOS:000321738400036
PM 23826116
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xu, YQ
   Gu, L
   Pan, YQ
   Li, R
   Gao, TY
   Song, GQ
   Nie, ZL
   Chen, LP
   Wang, SK
   He, BS
AF Xu, Yeqiong
   Gu, Ling
   Pan, Yuqin
   Li, Rui
   Gao, Tianyi
   Song, Guoqi
   Nie, Zhenlin
   Chen, Liping
   Wang, Shukui
   He, Bangshun
TI Different Effects of Three Polymorphisms in MicroRNAs on Cancer Risk in
   Asian Population: Evidence from Published Literatures
SO PLOS ONE
LA English
DT Article
ID NORTH INDIAN POPULATION; COMMON GENETIC-VARIANTS; CHINESE POPULATION;
   HEPATOCELLULAR-CARCINOMA; FUNCTIONAL POLYMORPHISM; GASTRIC-CANCER;
   PRE-MICRORNAS; COLORECTAL-CANCER; LUNG-CANCER; STEM-CELL
AB MicroRNAs (miRNAs) are a class of small non-protein-coding RNAs, which have emerged as integrated and important post-transcriptional regulators of gene expression. It has been demonstrated that single nucleotide polymorphisms (SNPs) exist in protein-coding genes. Accumulated studies have evaluated the association of miRNA SNPs with cancer risk, especially in Asian population, which included a series of related studies. However, the results remain controversial for the different genetic backgrounds, living habits and environment exposed. To evaluate the relationship between SNPs in miRNAs and cancer risk, 21 studies focused on Asian population were enrolled for the pooled analysis for three polymorphisms rs2910164, rs11614913, rs3746444 in three miRNAs miR-146aG>C, miR-196a2C>T, miR-499A>G using odds ratios (ORs) with 95% confidence intervals (CIs). For rs2910164 polymorphism, C allele was observed association with decreased overall cancer risk. In addition, subgroup analysis revealed of rs2910164 C allele decreased hepatocellular carcinoma (HCC), cervical cancer and prostate cancer risk among Chinese population. For rs11614913 polymorphism, TT genotype was observed to be associated with decreased cancer risk, especially for cancer type of colorectal cancer (CRC), lung cancer and country of Korea, North India. Whereas, rs3746444 G allele was an increased cancer risk factor in Chinese population, especially for breast cancer. In conclusion, this meta-analysis indicated that rs2910164 C allele was associated with decreased cancer risk in Chinese population. However, the association varied from different cancer types. Furthermore, TT genotype of rs11614913 was associated with decreased cancer risk. While different cancer types and countries contributed to different effects. Whereas, rs3746444 G allele was a risk factor in Chinese population, and the association varied from different cancer types.
C1 [Xu, Yeqiong; Pan, Yuqin; Gao, Tianyi; Song, Guoqi; Nie, Zhenlin; Wang, Shukui; He, Bangshun] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.
   [Gu, Ling; Li, Rui; Chen, Liping] Nanjing Normal Univ, Dept Life Sci, Nanjing, Jiangsu, Peoples R China.
RP Wang, SK (reprint author), Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.
EM shukwang@163.com; hebangshun@163.com
FU National Nature Science Foundation of China [81172141, 81200401];
   Jiangsu Provincial Key Medical Talents; Program of Healthy Talents'
   Cultivation for Nanjing City; Medical Science and technology development
   Foundation; Nanjing Department of Health [QYK11175]
FX This project was supported by grants from The National Nature Science
   Foundation of China (81172141, 81200401), Jiangsu Provincial Key Medical
   Talents to SK Wang, Program of Healthy Talents' Cultivation for Nanjing
   City to BS He, and Medical Science and technology development
   Foundation, Nanjing Department of Health (QYK11175) to BS He. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030049
   Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1174
   Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9
   Chen H, 2012, INTERN MED J, V42, pE115, DOI 10.1111/j.1445-5994.2011.02434.x
   Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725
   Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777
   Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102
   Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4
   Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816
   Hong Young-Seoub, 2011, J Prev Med Public Health, V44, P125, DOI 10.3961/jpmph.2011.44.3.125
   Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934
   Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837
   JAKOBOVITS A, 1986, P NATL ACAD SCI USA, V83, P7806, DOI 10.1073/pnas.83.20.7806
   Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105
   Kim WH, 2012, GENE, V504, P92, DOI 10.1016/j.gene.2012.05.014
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175
   Lung RW, 2012, MOL CARCINOG
   Min KT, 2012, MOL CARCINOGEN, V51, pE65, DOI 10.1002/mc.21849
   Murakami A, 2001, NUCLEIC ACIDS RES, V29, P3347, DOI 10.1093/nar/29.16.3347
   Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x
   Punj V, 2010, ONCOGENE, V29, P1835, DOI 10.1038/onc.2009.460
   Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434
   Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54
   Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103
   Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814
   Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070
   Wynter CVA, 2006, MED HYPOTHESES, V66, P612, DOI 10.1016/j.mehy.2005.10.024
   Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080
   Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195
   Yang YC, 2009, EUR J GASTROEN HEPAT, V21, P1016, DOI 10.1097/MEG.0b013e32831d7b9c
   Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578
   Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001
   Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x
   Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740
   Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596
   Zhou J, 2012, DNA CELL BIOL, V31, P524, DOI 10.1089/dna.2011.1340
   Zhu LJ, 2012, DNA CELL BIOL, V31, P349, DOI 10.1089/dna.2011.1348
NR 42
TC 26
Z9 27
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 4
PY 2013
VL 8
IS 6
AR e65123
DI 10.1371/journal.pone.0065123
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 158IE
UT WOS:000319961900038
PM 23750236
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Carey, RN
   McDermott, DT
   Sarma, KM
AF Carey, Rachel N.
   McDermott, Daragh T.
   Sarma, Kiran M.
TI The Impact of Threat Appeals on Fear Arousal and Driver Behavior: A
   Meta-Analysis of Experimental Research 1990-2011
SO PLOS ONE
LA English
DT Article
ID TERROR MANAGEMENT THEORY; RISK-TAKING; HEALTH-RISK; ANTICIPATION;
   VALIDATION; INTENTIONS; FEEDBACK
AB The existing empirical research exploring the impact of threat appeals on driver behavior has reported inconsistent findings. In an effort to provide an up-to-date synthesis of the experimental findings, meta-analytic techniques were employed to examine the impact of threat-based messages on fear arousal and on lab-based indices of driving behavior. Experimental studies (k = 13, N = 3044), conducted between 1990 and 2011, were included in the analyses. The aims of the current analysis were (a) to examine whether or not the experimental manipulations had a significant impact on evoked fear, (b) to examine the impact of threat appeals on three distinct indices of driving, and (c) to identify moderators and mediators of the relationship between fear and driving outcomes. Large effects emerged for the level of fear evoked, with experimental groups reporting increased fear arousal in comparison to control groups (r = .64, n = 619, p < .01). The effect of threat appeals on driving outcomes, however, was not significant (r = .03, p = .17). This analysis of the experimental literature indicates that threat appeals can lead to increased fear arousal, but do not appear to have the desired impact on driving behavior. We discuss these findings in the context of threat-based road safety campaigns and future directions for experimental research in this area.
C1 [Carey, Rachel N.; Sarma, Kiran M.] Natl Univ Ireland, Sch Psychol, Galway, Ireland.
   [McDermott, Daragh T.] Anglia Ruskin Univ, Dept Psychol, Cambridge, England.
RP Sarma, KM (reprint author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.
EM kiran.sarma@nuigalway.ie
FU bursary from the Road Safety Authority of Ireland
FX This research is supported by a bursary from the Road Safety Authority
   of Ireland. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR af Wahlberg AE, 2010, J SAFETY RES, V41, P99, DOI 10.1016/j.jsr.2010.02.005
   Algie J, 2010, J PREV INTERV COMMUN, V38, P264, DOI 10.1080/10852352.2010.509019
   Baumeister RF, 2007, PERS SOC PSYCHOL REV, V11, P167, DOI 10.1177/1088868307301033
   Baumeister RF, 2011, J FORENSIC PSYCHI PS, V22, P635, DOI 10.1080/14789949.2011.617535
   Ben-Ari OT, 1999, J PERS SOC PSYCHOL, V76, P35, DOI 10.1037/0022-3514.76.1.35
   Ben-Ari OT, 2000, ACCIDENT ANAL PREV, V32, P1
   Borenstein M., 2009, INTRO METAANALYSIS
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321
   Carey RN, 2011, J AUSTRALAS COLL ROA, V22, P51
   Cauberghe V, 2009, ACCIDENT ANAL PREV, V41, P276, DOI 10.1016/j.aap.2008.11.006
   Chen M, 2011, EXAMINING EFFECTIVEN
   Clarke S, 2005, J OCCUP ORGAN PSYCH, V78, P355, DOI 10.1348/096317905X26183
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   de Hoog N, 2007, REV GEN PSYCHOL, V11, P258, DOI 10.1037/1089-2680.11.3.258
   de Hoog N, 2008, SOC INFLUENCE, V3, P84, DOI 10.1080/15534510802185836
   De Pelsmacker P, 2011, J SOC MARKET, V1, P171, DOI 10.1108/20426761111170696
   Dillard JP, 2006, J COMMUN, V56, pS123, DOI 10.1111/j.1460-2466.2006.00286.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fern EF, 1996, J CONSUM RES, V23, P89, DOI 10.1086/209469
   Gerber J, 2009, PERSPECT PSYCHOL SCI, V4, P468, DOI 10.1111/j.1745-6924.2009.01158.x
   Goldenbeld C, 2008, TRANSPORT RES F-TRAF, V11, P207, DOI 10.1016/j.trf.2007.11.001
   Good A, 2007, HLTH PSYCHOL REV, V1, P208, DOI DOI 10.1080/17437190802280889
   Greenberg J, 1986, PUBLIC SELF PRIVATE, V189, P212
   HIGBEE KL, 1969, PSYCHOL BULL, V72, P426, DOI 10.1037/h0028430
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Horswill MS, 2008, PERCEPTION, V37, P1269, DOI 10.1068/p5821
   Horswill MS, 1999, J APPL PSYCHOL, V84, P977
   Horswill MS, 1999, J APPL SOC PSYCHOL, V29, P377, DOI 10.1111/j.1559-1816.1999.tb01392.x
   Hovland Carl I., 1953, COMMUNICATION PERSUA
   Jessop DC, 2008, PERS SOC PSYCHOL B, V34, P951, DOI 10.1177/0146167208316790
   JOB RFS, 1988, AM J PUBLIC HEALTH, V78, P163, DOI 10.2105/AJPH.78.2.163
   LaTour MS, 1997, J ADVERTISING, V26, P45, DOI 10.1080/00913367.1997.10673528
   Lennon Ron, 2010, ACAD MARKETING STUDI, V14, P95
   Leshner G, 2010, J BROADCAST ELECTRON, V54, P485, DOI 10.1080/08838151.2010.498850
   Leshner G, 2009, HEALTH COMMUN, V24, P447, DOI 10.1080/10410230903023493
   Leventhal H, 1970, ADV EXPT SOCIAL PSYC, V5, P119, DOI DOI 10.1016/S0065-2601(08)60091-X
   Lewis IM, 2010, ACCIDENT ANAL PREV, V42, P459, DOI 10.1016/j.aap.2009.09.008
   Lewis IM, 2007, INT J BEHAV CONSULTA, V3, P203, DOI DOI 10.1037/H0100799
   Lewis Watson BC, 2009, AUSTR ROAD SAF RES P, P733
   Light RJ, 1984, SUMMING SCI REV RES
   Maloney EK, 2011, SOC PERSONAL PSYCHOL, V5, P206, DOI 10.1111/j.1751-9004.2011.00341.x
   Masten SV, 2004, J SAFETY RES, V35, P403, DOI 10.1016/j.jsr.2004.06.002
   Matsumoto David, 2011, Acta de investigación psicol, V1, P441
   McKenna FP, 2006, J EXP PSYCHOL-APPL, V12, P1, DOI 10.1037/1076-898X.12.1.1
   MURRY JP, 1993, J AM STAT ASSOC, V88, P50, DOI 10.2307/2290691
   Nielsen J, 2009, J EXP PSYCHOL-APPL, V15, P258, DOI 10.1037/a0017018
   Ordonana JR, 2009, HUM COMMUN RES, V35, P195, DOI 10.1111/j.1468-2958.2009.01344.x
   Peters GJY, 2013, HEALTH PSYCHOL REV, V7, pS8, DOI 10.1080/17437199.2012.703527
   Phillips RO, 2011, ACCIDENT ANAL PREV, V43, P1204, DOI 10.1016/j.aap.2011.01.002
   Popova L, 2012, HEALTH EDUC BEHAV, V39, P455, DOI 10.1177/1090198111418108
   RAY ML, 1970, J MARKETING, V34, P54, DOI 10.2307/1250296
   ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803
   Rosenbloom T, 2003, PERS INDIV DIFFER, V35, P1809, DOI 10.1016/S0191-8869(03)00031-X
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Rotfeld HJ, 1988, CURRENT ISSUES RES A, V11, P21
   Sarma KM, 2013, ACCIDENT ANAL PREV, V50, P1226, DOI 10.1016/j.aap.2012.09.020
   Schwarz N, 1996, SOCIAL PSYCHOL HDB B, P385
   Shehryar O, 2011, INV EFF MORT SAL RES
   Shehryar O, 2011, ASS CONS RES C
   Strong JT, 1993, J MANAGERIAL ISSUES, V5, P532
   Sutton SR, 1982, SOCIAL PSYCHOL BEHAV, P303
   Taubman-Ben-Ari O, 2003, DEATH STUD, V27, P603, DOI 10.1080/07481180390220799
   Tay R, 2005, EVID BASED HEALTHC P, V9, P26
   Thornton J, 2003, AUSTR ROAD SAF RES P
   Thornton JA, 2005, SCH MANAGEMENT MARKE
   Toledo T, 2008, TRANSPORT RES C-EMER, V16, P320, DOI 10.1016/j.trc.2008.01.001
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249
   WEST R, 1993, BRIT J PSYCHOL, V84, P207, DOI 10.1111/j.2044-8295.1993.tb02474.x
   Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328
   Xu Yaoshan, 2011, Business Management and Electronic Information. Proceedings of the 2011 International Conference on Business Management and Electronic Information (BMEI 2011), P255, DOI 10.1109/ICBMEI.2011.5916920
   Yartz AR, 2002, BIOL PSYCHOL, V59, P55, DOI 10.1016/S0301-0511(01)00121-1
NR 75
TC 22
Z9 22
U1 0
U2 44
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2013
VL 8
IS 5
AR e62821
DI 10.1371/journal.pone.0062821
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 146RJ
UT WOS:000319107900012
PM 23690955
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gao, TY
   He, BS
   Pan, YQ
   Li, R
   Xu, YQ
   Chen, LP
   Nie, ZL
   Gu, L
   Wang, SK
AF Gao, Tianyi
   He, Bangshun
   Pan, Yuqin
   Li, Rui
   Xu, Yeqiong
   Chen, Liping
   Nie, Zhenling
   Gu, Ling
   Wang, Shukui
TI The Association of Retinoic Acid Receptor Beta2(RAR beta 2) Methylation
   Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID PROMOTER METHYLATION; BREAST-CANCER; MOLECULAR-DETECTION; BETA GENE;
   CELLS; HYPERMETHYLATION; EXPRESSION; DISEASE; MEN; CARCINOGENESIS
AB The retinoic acid receptor beta2(RAR beta 2) is a type of nuclear receptor that is activated by both all-trans retinoic acid and 9-cis retinoic acid, which has been shown to function as a tumor suppressor gene in different types of human tumors. Previous reports demonstrated that the frequency of RAR beta 2 methylation was significantly higher in prostate cancer patients compared with controls, but the relationship between RAR beta 2 promoter methylation and pathological stage or Gleason score of prostate cancer remained controversial. Therefore, a meta-analysis of published studies investigating the effects of RAR beta 2 methylation status in prostate cancer occurrence and association with both pathological stage and Gleason score in prostate cancer was performed in the study. A total of 12 eligible studies involving 777 cases and 404 controls were included in the pooled analyses. Under the random-effects model, the pooled OR of RAR beta 2 methylation in prostate cancer patients, compared to non-cancer controls, was 17.62 with 95%CI = 6.30-49.28. The pooled OR with the fixed-effects model of pathological stage in RASSF1A methylated patients, compared to unmethylated patients, was 0.67 (95%CI = 0.40-1.09) and the pooled OR of low-GS in RAR beta 2 methylated patients by the random-effect model, compared to high-GS RAR beta 2 methylated patients, was 0.54 (95% CI = 0.28-1.04). This study showed that RAR beta 2 might be a potential biomarker in prostate cancer prevention and diagnosis. The detection of RAR beta 2 methylation in urine or serum is a potential non-invasive diagnostic tool in prostate cancer. The present findings also require confirmation through adequately designed prospective studies.
C1 [Gao, Tianyi; He, Bangshun; Pan, Yuqin; Li, Rui; Xu, Yeqiong; Chen, Liping; Nie, Zhenling; Gu, Ling; Wang, Shukui] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.
   [Li, Rui; Chen, Liping; Gu, Ling] Nanjing Normal Univ, Dept Life Sci, Nanjing, Jiangsu, Peoples R China.
RP Wang, SK (reprint author), Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.
EM sk_wang@njmu.edu.cn
FU National Natural Science Foundation of China [NSFC:C0606]
FX This work was supported by National Natural Science Foundation of China
   (http://www.nsfc.gov.cn/Portal0/default152.htm) NSFC:C0606. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30
   Baden J, 2009, J UROLOGY, V182, P1186, DOI 10.1016/j.juro.2009.05.003
   Bastian PJ, 2007, EUR UROL, V51, P665, DOI 10.1016/j.eururo.2006.08.008
   Bastian PJ, 2007, EUR UROL, V51, P674
   Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452
   Chambon P, 1996, FASEB J, V10, P940
   Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10
   Collin SM, 2008, LANCET ONCOL, V9, P407
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dumache R, 2012, CHIRURGIA-BUCHAREST, V107, P780
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Esteller M, 2002, CANCER RES, V62, P5902
   FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827
   Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332
   GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9
   GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61
   Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7
   Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4
   Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006
   Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051
   Henrique R, 2006, MOL CANCER RES, V4, P1, DOI 10.1158/1541-7786.MCR-05-0113
   Henrique R, 2004, EUR UROL, V46, P660, DOI 10.1016/j.eururo.2004.06.014
   Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075
   Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009
   HOULE B, 1993, P NATL ACAD SCI USA, V90, P985, DOI 10.1073/pnas.90.3.985
   Jeronimo C, 2004, CLIN CANCER RES, V10, P4010, DOI 10.1158/1078-0432.CCR-03-0643
   Karray-Chouayekh S, 2000, JNCI-J NATL CANCER I, V92, P826
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Maruyama R, 2002, CLIN CANCER RES, V8, P514
   Mian BM, 2002, UROLOGY, V60, P836, DOI 10.1016/S0090-4295(02)01950-7
   Moinpour CM, 1998, J NATL CANCER I, V90, P1537, DOI 10.1093/jnci/90.20.1537
   Nakayama T, 2001, LAB INVEST, V81, P1049, DOI 10.1038/labinvest.3780316
   ROMAN SD, 1992, CANCER RES, V52, P2236
   Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467
   Sabichi AL, 1998, J NATL CANCER I, V90, P597, DOI 10.1093/jnci/90.8.597
   SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077
   Sirchia SM, 2002, CANCER RES, V62, P2455
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   SWISSHELM K, 1994, CELL GROWTH DIFFER, V5, P133
   Toulouse A, 1996, BBA-GENE STRUCT EXPR, V1309, P1, DOI 10.1016/S0167-4781(96)00126-1
   Virmani AK, 2000, J NATL CANCER I, V92, P1303, DOI 10.1093/jnci/92.16.1303
   Woodson K, 2004, PROSTATE, V60, P25, DOI 10.1002/pros.20013
   Woodson K, 2004, CANCER LETT, V205, P181, DOI 10.1016/j.canlet.2003.11.027
   Yamanaka M, 2003, INT J CANCER, V106, P382, DOI 10.1002/ijc.11227
   Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209
   Zagars GK, 1997, CANCER, V79, P1370, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.3.CO;2-P
   Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328
NR 48
TC 9
Z9 12
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 13
PY 2013
VL 8
IS 5
AR e62950
DI 10.1371/journal.pone.0062950
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 145RZ
UT WOS:000319036100025
PM 23675444
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Li, X
   Yao, XP
   Wang, YB
   Hu, FL
   Wang, F
   Jiang, LY
   Liu, YP
   Wang, D
   Sun, GZ
   Zhao, YS
AF Li, Xia
   Yao, Xiaoping
   Wang, Yibaina
   Hu, Fulan
   Wang, Fan
   Jiang, Liying
   Liu, Yupeng
   Wang, Da
   Sun, Guizhi
   Zhao, Yashuang
TI MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and
   Related Clinicopathological and Molecular Features
SO PLOS ONE
LA English
DT Article
ID REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; HMLH1 PROMOTER;
   LYNCH-SYNDROME; COLON-CANCER; INSTITUTE WORKSHOP; GENE METHYLATION; BRAF
   MUTATION; HEREDITARY; HYPERMETHYLATION
AB Purpose: To describe the frequency of MLH1 promoter methylation in colorectal cancer (CRC); to explore the associations between MLH1 promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis.
   Methods: A literature search of the PubMed and Embase databases was conducted to identify relevant articles published up to September 7, 2012 that described the frequency of MLH1 promoter methylation or its associations with clinicopathological and molecular factors in CRC. The pooled frequency, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated.
   Results: The pooled frequency of MLH1 promoter methylation in unselected CRC was 20.3% (95% CI: 16.8-24.1%). They were 18.7% (95% CI: 14.7-23.6%) and 16.4% (95% CI: 11.9-22.0%) in sporadic and Lynch syndrome (LS) CRC, respectively. Significant associations were observed between MLH1 promoter methylation and gender (pooled OR = 1.641, 95% CI: 1.215-2.215; P = 0.001), tumor location (pooled OR = 3.804, 95% CI: 2.715-5.329; P<0.001), tumor differentiation (pooled OR = 2.131, 95% CI: 1.464-3.102; P<0.001), MSI (OR: 27.096, 95% CI: 13.717-53.526; P<0.001). Significant associations were also observed between MLH1 promoter methylation and MLH1 protein expression, BRAF mutation (OR = 14.919 (95% CI: 6.427-34.631; P<0.001) and 9.419 (95% CI: 2.613-33.953; P = 0.001), respectively).
   Conclusion: The frequency of MLH1 promoter methylation in unselected CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively. MLH1 promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, MLH1 protein expression, and BRAF mutation.
C1 [Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.
   [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China.
   [Sun, Guizhi] Harbin Med Univ, Canc Hosp, Dept Surg, Harbin, Heilongjiang Pr, Peoples R China.
RP Zhao, YS (reprint author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.
EM zhao_yashuang@263.net
RI Zhao, Yashuang/I-6145-2019; Wang, Fan/I-6099-2019
OI Wang, Fan/0000-0002-9869-9504
FU National Natural Science Foundation of China for Priority Areas [NSFC
   30972538]; Education Bureau of Heilongjiang Province [11531100];
   Graduate Foundation; Scientific Research of Heilongjiang Province
   [YJSCX2009-224HLJ]; Harbin Medical University [HCXB2009009]
FX This study was supported by grants from National Natural Science
   Foundation of China for Priority Areas (NSFC 30972538), Education Bureau
   of Heilongjiang Province (11531100), and the Graduate Foundation,
   supported by the Scientific Research of Heilongjiang Province
   (YJSCX2009-224HLJ) and Harbin Medical University (HCXB2009009). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121
   Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010
   Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94
   Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502
   Arnold CN, 2004, CANCER BIOL THER, V3, P73, DOI 10.4161/cbt.3.1.590
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495
   Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064
   BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I
   Boland CR, 1998, CANCER RES, V58, P5248
   Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058
   Cunningham JM, 1998, CANCER RES, V58, P3455
   de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782
   Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3
   Deng GR, 1999, CANCER RES, V59, P2029
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084
   Garagnani P, 2012, CURR PHARM DES
   Gay LJ, 2011, NUTR CANCER, V63, P1000, DOI 10.1080/01635581.2011.596987
   Gazzoli I, 2002, CANCER RES, V62, P3925
   GLOBOCAN, 2008, CANC FACT SHEET
   Grady WM, 2001, CANCER RES, V61, P900
   Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146
   Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Huang Q, 2012, DIAGN MOL PATHOL, V21, P24, DOI 10.1097/PDM.0b013e318230effd
   Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237
   IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0
   Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507
   Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0
   Jass JR, 2002, EUR J CANCER, V38, P858, DOI 10.1016/S0959-8049(02)00041-2
   Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x
   Kane MF, 1997, CANCER RES, V57, P808
   Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782
   Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661
   Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029
   Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708
   Lee KH, 2011, LANGENBECK ARCH SURG, V396, P1017, DOI 10.1007/s00423-011-0812-9
   Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0
   Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x
   Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28
   Mathers JC, ADV GENET, V71, P3
   Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444
   Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154
   Mirchev M, 2007, J IMAB ANN P SCI PAP, P95
   Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1053/S1542-3565(03)00314-8
   Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154
   Nakagawa H, 2001, CANCER RES, V61, P6991
   Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238
   Park IJ, 2007, J KOREAN MED SCI, V22, pS91, DOI 10.3346/jkms.2007.22.S.S91
   Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509
   Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X
   Potocnik U, 2001, CANCER GENET CYTOGEN, V126, P85, DOI 10.1016/S0165-4608(00)00399-X
   Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512
   Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007
   RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758
   Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020
   Shannon BA, 2001, CANCER LETT, V167, P91, DOI 10.1016/S0304-3835(01)00431-1
   Shi XZ, 2006, BIOMED CHROMATOGR, V20, P815, DOI 10.1002/bmc.606
   Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9
   Strazzullo M, 2003, CANCER, V98, P1540, DOI 10.1002/cncr.11651
   Tannergard P, 1997, HUM GENET, V101, P51, DOI 10.1007/s004390050585
   THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122
   Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034
   Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X
   VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699
   Velayos FS, 2005, J GASTROINTEST SURG, V9, P329, DOI 10.1016/j.gassur.204.05.007
   Vilkin A, 2009, CANCER-AM CANCER SOC, V115, P760, DOI 10.1002/cncr.24019
   Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264
   Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821
   Ward RL, 2005, J PATHOL, V207, P377, DOI 10.1002/path.1851
   Yamamoto H, 2002, GENE CHROMOSOME CANC, V33, P322, DOI 10.1002/gcc.10010
   Yiu R, 2005, DIS COLON RECTUM, V48, P2061, DOI 10.1007/s10350-005-0171-0
   Zhou HH, 2008, WORLD J GASTROENTERO, V14, P7329, DOI 10.3748/wjg.14.7329
NR 78
TC 23
Z9 24
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 29
PY 2013
VL 8
IS 3
AR e59064
DI 10.1371/journal.pone.0059064
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 121SG
UT WOS:000317263900009
PM 23555617
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Li, DD
   Hu, FL
   Wang, F
   Cui, BB
   Dong, XS
   Zhang, WC
   Lin, CQ
   Li, X
   Wang, D
   Zhao, YS
AF Li, Dandan
   Hu, Fulan
   Wang, Fan
   Cui, Binbin
   Dong, Xinshu
   Zhang, Wencui
   Lin, Chunqing
   Li, Xia
   Wang, Da
   Zhao, Yashuang
TI Prevalence of Pathological Germline Mutations of hMLH1 and hMSH2 Genes
   in Colorectal Cancer
SO PLOS ONE
LA English
DT Article
ID MISMATCH-REPAIR GENES; NONPOLYPOSIS COLON-CANCER; TUMOR MICROSATELLITE
   INSTABILITY; REVISED BETHESDA GUIDELINES; LYNCH-SYNDROME; HNPCC
   FAMILIES; AMSTERDAM CRITERIA; PUBLICATION BIAS; MSH2 MUTATIONS; MLH1
   MUTATIONS
AB The prevalence of pathological germline mutations in colorectal cancer has been widely studied, as germline mutations in the DNA mismatch repair genes hMLH1 and hMSH2 confer a high risk of colorectal cancer. However, because the sample size and population of previous studies are very different from each other, the conclusions still remain controversial. In this paper, Databases such as PubMed were applied to search for related papers. The data were imported into Comprehensive Meta-Analysis V2, which was used to estimate the weighted prevalence of hMLH1 and hMSH2 pathological mutations and compare the differences of prevalence among different family histories, ethnicities and related factors. This study collected and utilized data from 102 papers. In the Amsterdam-criteria positive group, the prevalence of pathological germline mutations of the hMLH1 and hMSH2 genes was 28.55% (95% CI 26.04%-31.19%) and 19.41% (95% CI 15.88%-23.51%), respectively, and the prevalence of germline mutations in hMLH1/hMSH2 was 15.44%/10.02%, 20.43%/13.26% and 15.43%/11.70% in Asian, American multiethnic and European/Australian populations, respectively. Substitution mutations accounted for the largest proportion of germline mutations (hMLH1: 52.34%, hMSH2: 43.25%). The total prevalence of mutations of hMLH1 and hMSH2 in Amsterdam-criteria positive, Amsterdam-criteria negative and sporadic colorectal cancers was around 45%, 25% and 15%, respectively, and there were no obvious differences in the prevalence of germline mutations among different ethnicities.
C1 [Li, Dandan; Hu, Fulan; Wang, Fan; Zhang, Wencui; Lin, Chunqing; Li, Xia; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.
   [Cui, Binbin; Dong, Xinshu] Harbin Med Univ, Tumor Hosp, Dept Abdominal Surg, Harbin, Heilongjiang Pr, Peoples R China.
   [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China.
RP Zhao, YS (reprint author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.
EM zhao_yashuang@263.net
RI Zhao, Yashuang/I-6145-2019; Wang, Fan/I-6099-2019
OI Wang, Fan/0000-0002-9869-9504
FU National Natural Science Foundation of China [30671801]; Harbin
   Foundation for the Returned Scholars [2005AFLXJ017]; Health Bureau of
   Heilongjiang Province [2005-103]
FX This work was supported by grants from the National Natural Science
   Foundation of China (Grant number 30671801), the Harbin Foundation for
   the Returned Scholars (Grant number 2005AFLXJ017), and the Health Bureau
   of Heilongjiang Province (Grant number 2005-103). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101
   AALTONEN LA, 1994, ANTICANCER RES, V14, P1657
   Abe Y, 2000, J SURG ONCOL, V74, P249, DOI 10.1002/1096-9098(200008)74:4<249::AID-JSO2>3.0.CO;2-S
   [Anonymous], 1997, IARC SCI PUBL, VVII, p[i, 1]
   Apessos A, 2005, BRIT J CANCER, V92, P396, DOI 10.1038/sj.bjc.6602260
   Bai YQ, 1999, INT J CANCER, V82, P512, DOI 10.1002/(SICI)1097-0215(19990812)82:4<512::AID-IJC7>3.0.CO;2-8
   Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469
   Bapat BV, 1999, HUM GENET, V104, P167, DOI 10.1007/s004390050931
   Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493
   Bartosova Z, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9127
   Beck NE, 1997, BRIT J SURG, V84, P233, DOI 10.1002/bjs.1800840228
   Beck NE, 1997, HUM GENET, V99, P219, DOI 10.1007/s004390050343
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Boland CR, 1998, CANCER RES, V58, P5248
   BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0
   BUERSTEDDE JM, 1995, J MED GENET, V32, P909, DOI 10.1136/jmg.32.11.909
   Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240
   Calistri D, 2000, INT J CANCER, V89, P87, DOI 10.1002/(SICI)1097-0215(20000120)89:1<87::AID-IJC14>3.0.CO;2-9
   Canard G, 2011, ANN SURG ONCOL
   Casey G, 2005, JAMA-J AM MED ASSOC, V293, P799, DOI 10.1001/jama.293.7.799
   Cederquist K, 2004, INT J CANCER, V109, P370, DOI 10.1002/ijc.11718
   Cederquist K, 2001, INT J CANCER, V91, P486, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1093>3.0.CO;2-P
   Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012
   Coggins RP, 2005, GUT, V54, P636, DOI 10.1136/gut.2003.017517
   Coleman MG, 2001, BRIT J CANCER, V85, P1486, DOI 10.1054/bjoc.2001.2058
   Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M
   Cravo M, 1999, J PATHOL, V188, P252, DOI 10.1002/(SICI)1096-9896(199907)188:3<252::AID-PATH354>3.0.CO;2-3
   Cui L, 2004, WORLD J GASTROENTERO, V10, P209
   Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658
   Curia MC, 1999, CANCER RES, V59, P3570
   de Leon MP, 1999, GUT, V45, P32, DOI 10.1136/gut.45.1.32
   Dietmaier W, 1997, CANCER RES, V57, P4749
   Dieumegard B, 2000, BRIT J CANCER, V82, P871, DOI 10.1054/bjoc.1999.1014
   Dunlop MG, 2000, BRIT J CANCER, V83, P1643, DOI 10.1054/bjoc.2000.1520
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996
   Fidalgo P, 2000, EUR J HUM GENET, V8, P49, DOI 10.1038/sj.ejhg.5200393
   FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3
   Froggatt NJ, 1996, J MED GENET, V33, P726, DOI 10.1136/jmg.33.9.726
   Genuardi M, 1998, INT J CANCER, V75, P835, DOI 10.1002/(SICI)1097-0215(19980316)75:6<835::AID-IJC4>3.0.CO;2-W
   Ghimenti C, 1999, BRIT J CANCER, V80, P11, DOI 10.1038/sj.bjc.6690314
   Giraldo A, 2005, FAM CANCER, V4, P285, DOI 10.1007/s10689-005-4523-7
   Goldberg Y, 2008, FAM CANCER, V7, P309, DOI 10.1007/s10689-008-9191-y
   Green SE, 1998, INT J COLORECTAL DIS, V13, P3, DOI 10.1007/s003840050123
   HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302
   Heinimann K, 1999, CANCER, V85, P2512, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2512::AID-CNCR4>3.0.CO;2-G
   Herfarth KKF, 1997, GENE CHROMOSOME CANC, V18, P42, DOI 10.1002/(SICI)1098-2264(199701)18:1<42::AID-GCC5>3.0.CO;2-1
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hutter P, 1998, INT J CANCER, V78, P680, DOI 10.1002/(SICI)1097-0215(19981209)78:6<680::AID-IJC3>3.0.CO;2-U
   Jeong SY, 2003, DIS COLON RECTUM, V46, P1069, DOI 10.1097/01.DCR.0000074689-32015.C1
   Jin HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-44
   Katballe N, 2002, GUT, V50, P43, DOI 10.1136/gut.50.1.43
   KohonenCorish M, 1996, AM J HUM GENET, V59, P818
   Kouraklis G, 2005, DIGEST DIS SCI, V50, P336, DOI 10.1007/s10620-005-1607-z
   Kurzawski G, 2006, CLIN GENET, V69, P40, DOI 10.1111/j.1399-0004.2006.00550.x
   Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839
   Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169
   LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348
   Liu SR, 2004, WORLD J GASTROENTERO, V10, P2647, DOI 10.3748/wjg.v10.i18.2647
   Liu T, 1998, CLIN GENET, V53, P131
   Liu T, 2001, CANCER RES, V61, P7798
   Luo DC, 2005, WORLD J GASTROENTERO, V11, P1673
   Lynch HT, 1999, J MED GENET, V36, P801
   Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5
   Maliaka YK, 1996, HUM GENET, V97, P251, DOI 10.1007/BF02265276
   Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863
   Mauillon JL, 1996, CANCER RES, V56, P5728
   Millar AL, 1999, HUM MOL GENET, V8, P823, DOI 10.1093/hmg/8.5.823
   MIYAKI M, 1995, J MOL MED-JMM, V73, P515
   MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305
   Montera M, 2000, J Med Genet, V37, pE7, DOI 10.1136/jmg.37.7.e7
   Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245
   Nilbert M, 2009, FAM CANCER, V8, P75, DOI 10.1007/s10689-008-9199-3
   Nomura S, 2000, BIOCHEM BIOPH RES CO, V271, P120, DOI 10.1006/bbrc.2000.2547
   NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763
   Palicio M, 2002, J Med Genet, V39, pE29, DOI 10.1136/jmg.39.6.e29
   PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251
   Papp J, 2007, WORLD J GASTROENTERO, V13, P2727, DOI 10.3748/wjg.v13.i19.2727
   Park JG, 1999, INT J CANCER, V82, P516, DOI 10.1002/(SICI)1097-0215(19990812)82:4<516::AID-IJC8>3.0.CO;2-U
   Peel DJ, 2000, J NATL CANCER I, V92, P1517, DOI 10.1093/jnci/92.18.1517
   Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509
   Pensotti V, 1997, GENE CHROMOSOME CANC, V19, P135
   Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944
   Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676
   Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986
   Pistorius SR, 2000, INT J COLORECTAL DIS, V15, P255
   Planck M, 1999, INT J CANCER, V83, P197, DOI 10.1002/(SICI)1097-0215(19991008)83:2<197::AID-IJC9>3.0.CO;2-X
   Pucciarelli S, 2003, DIS COLON RECTUM, V46, P305, DOI 10.1097/01.DCR.0000054881.56204.F3
   Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Ravnik-Glavac M, 2000, J MED GENET, V37, P533, DOI 10.1136/jmg.37.7.533
   Robinson KL, 2007, J NATL CANCER I, V99, P291, DOI 10.1093/jnci/djk051
   Roh SA, 2003, J KOREAN MED SCI, V18, P387, DOI 10.3346/jkms.2003.18.3.387
   Rossi BM, 2002, ANN SURG ONCOL, V9, P555, DOI 10.1245/aso.2002.9.6.555
   Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193
   Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996
   Sarroca C, 2000, DIS COLON RECTUM, V43, P353, DOI 10.1007/BF02258301
   Scartozzi M, 2002, J CLIN ONCOL, V20, P1203, DOI 10.1200/JCO.20.5.1203
   Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056
   Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942
   Sheng J Q, 2008, Cytogenet Genome Res, V122, P22, DOI 10.1159/000151312
   Sheng Jian Qiu, 2006, Chin J Dig Dis, V7, P197, DOI 10.1111/j.1443-9573.2006.00269.x
   Shin Young-Kyoung, 2004, Hum Mutat, V24, P351, DOI 10.1002/humu.9277
   Southey MC, 2005, J CLIN ONCOL, V23, P6524, DOI 10.1200/JCO.2005.04.671
   Spaepen M, 2006, FAM CANCER, V5, P179, DOI 10.1007/s10689-005-5958-6
   Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247
   TANNERGARD P, 1995, CANCER RES, V55, P6092
   Taylor CE, 2003, HUM MUTAT, V22, P428, DOI 10.1002/humu.10291
   Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874
   Tomlinson IPM, 1997, J MED GENET, V34, P39, DOI 10.1136/jmg.34.1.39
   Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034
   Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X
   Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074
   Viel A, 1997, GENE CHROMOSOME CANC, V18, P8, DOI 10.1002/(SICI)1098-2264(199701)18:1<8::AID-GCC2>3.0.CO;2-7
   Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963
   Wahlberg SS, 1997, INT J CANCER, V74, P134, DOI 10.1002/(SICI)1097-0215(19970220)74:1<134::AID-IJC22>3.3.CO;2-1
   Wang CF, 2007, WORLD J GASTROENTERO, V13, P6254, DOI 10.3748/wjg.13.6254
   Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067
   Wang Q, 1997, INT J CANCER, V73, P831, DOI 10.1002/(SICI)1097-0215(19971210)73:6<831::AID-IJC11>3.0.CO;2-7
   Wang XL, 2006, WORLD J GASTROENTERO, V12, P4074, DOI 10.3748/wjg.v12.i25.4074
   Weber TK, 1999, JAMA-J AM MED ASSOC, V281, P2316, DOI 10.1001/jama.281.24.2316
   Weber TK, 1997, CANCER RES, V57, P3798
   Wehner M, 1997, HUM MUTAT, V10, P241
   Wei SC, 2003, CLIN GENET, V64, P243, DOI 10.1034/j.1399-0004.2003.00123.x
   Wei WQ, 2010, J BIOINFORM COMPUT B, V8, P111, DOI 10.1142/S0219720010005154
   Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X
   Wijnen J, 1998, NAT GENET, V20, P326
   Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847
   Wolf B, 2005, WIEN KLIN WOCHENSCHR, V117, P269, DOI 10.1007/s00508-005-0337-8
   Wu Y, 1997, GENE CHROMOSOME CANC, V18, P269, DOI 10.1002/(SICI)1098-2264(199704)18:4<269::AID-GCC4>3.0.CO;2-Z
   Yan HL, 2008, CANCER SCI, V99, P770, DOI 10.1111/j.1349-7006.2008.00737.x
   Yuan Y, 2004, CHINESE MED J-PEKING, V117, P748
   Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968
   Zhang CH, 2008, WORLD J GASTROENTERO, V14, P298, DOI 10.3748/wjg.14.298
   Zhao YS, 2009, J TOXICOL ENV HEAL A, V72, P690, DOI 10.1080/15287390902841003
NR 137
TC 5
Z9 5
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2013
VL 8
IS 3
AR e51240
DI 10.1371/journal.pone.0051240
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 125SR
UT WOS:000317562100002
PM 23526924
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liu, X
   Cheng, DX
   Kuang, Q
   Liu, G
   Xu, W
AF Liu, Xiang
   Cheng, Dangxiao
   Kuang, Qin
   Liu, Geoffrey
   Xu, Wei
TI Association between UGT1A1*28 Polymorphisms and Clinical Outcomes of
   Irinotecan-Based Chemotherapies in Colorectal Cancer: A Meta-Analysis in
   Caucasians
SO PLOS ONE
LA English
DT Article
ID DIPHOSPHATE GLUCURONOSYLTRANSFERASE 1A1; GENOTYPING REDUCE MORBIDITY;
   GENETIC POLYMORPHISMS; PHASE-I; PROMOTER POLYMORPHISM;
   COST-EFFECTIVENESS; PREDICT TOXICITY; UGT1A1 PROMOTER; SOLID TUMORS;
   PHARMACOKINETICS
AB Background: Whether UGT1A1*28 genotype is associated with clinical outcomes of irinotecan (IRI)-based chemotherapy in Colorectal cancer (CRC) is an important gap in existing knowledge to inform clinical utility. Published data on the association between UGT1A1*28 gene polymorphisms and clinical outcomes of IRI-based chemotherapy in CRC were inconsistent.
   Methodology/Principal Findings: Literature retrieval, trials selection and assessment, data collection, and statistical analysis were performed according to the PRISMA guidelines. Primary outcomes included therapeutic response (TR), progression-free survival (PFS) and overall survival (OS). We calculated odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI). Twelve clinical trials were included. No statistical heterogeneity was detected in analyses of all studies and for each subgroup. Differences in TR, PFS and OS for any genotype comparison, UGT1A1*28/*28 versus (vs) UGT1A1*1/*1 (homozygous model), UGT1A1*1/*28 vs UGT1A1*1/*1 (heterozygous model), and UGT1A1*28/*28 vs all others (recessive model, only for TR) were not statistically significant. IRI dose also did not impact upon TR and PFS differences between UGT1A1 genotype groups. A statistically significant increase in the hazard of death was found in Low IRI subgroup of the homozygous model (HR = 1.48, 95% CI = 1.06-2.07; P = 0.02). The UGT1A1* 28 allele was associated with a trend of increase in the hazard of death in two models (homozygous model: HR = 1.22, 95% CI = 0.99-1.51; heterozygous model: HR = 1.13, 95% CI = 0.96-1.32). These latter findings were driven primarily by one single large study (Shulman et al. 2011).
   Conclusions/Significance: UGT1A1* 28 polymorphism cannot be considered as a reliable predictor of TR and PFS in CRC patients treated with IRI-based chemotherapy. The OS relationship with UGT1A1* 28 in the patients with lower-dose IRI chemotherapy requires further validation.
C1 [Liu, Xiang; Cheng, Dangxiao; Kuang, Qin; Liu, Geoffrey; Xu, Wei] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada.
   [Liu, Xiang] Hubei Univ Chinese Med, Sch Lab Med, Wuhan, Peoples R China.
   [Liu, Geoffrey] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada.
   [Liu, Geoffrey; Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Xu, Wei] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Biostat, Toronto, ON, Canada.
RP Liu, G (reprint author), Ontario Canc Inst, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.
EM Geoffrey.Liu@uhn.on.ca; wxu@uhnres.utoronto.ca
RI Liu, Geoffrey/N-4421-2016
OI Liu, Geoffrey/0000-0002-2603-7296
FU Alan B. Brown Chair in Molecular Genomics; CCO Chair in Experimental
   Therapeutics and Population Studies; Scholarship Fund Award for Young
   Teachers Studying Abroad from the Department of Education of Hubei
   Province; Hubei University of Chinese Medicine; Posluns Family
   Foundation
FX This work was sponsored in part by the Alan B. Brown Chair in Molecular
   Genomics, CCO Chair in Experimental Therapeutics and Population Studies
   and Posluns Family Foundation
   (https://www.cancercare.on.ca/research/fundedresearch/2009recipients/).
   This work was also supported by the Scholarship Fund Award for Young
   Teachers Studying Abroad from the Department of Education of Hubei
   Province and Hubei University of Chinese Medicine
   (http://rsc.hbtcm.edu.cn/daohang/shizijianshe/2012-03-26/155.html). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Berg AO, 2009, GENET MED, V11, P15, DOI 10.1097/GIM.0b013e31818efd9d
   Berman Nancy G, 2002, BMC Med Res Methodol, V2, P10, DOI 10.1186/1471-2288-2-10
   Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170
   Boige V, 2010, J CLIN ONCOL, V28, P2556, DOI 10.1200/JCO.2009.25.2106
   Carlini LE, 2005, CLIN CANCER RES, V11, P1226
   Choi YH, 2012, ONCOLOGY-BASEL, V82, P290, DOI 10.1159/000337989
   Cote JF, 2007, CLIN CANCER RES, V13, P3269, DOI 10.1158/1078-0432.CCR-06-2290
   Dias MM, 2012, PHARMACOGENOMICS, V13, P889, DOI [10.2217/PGS.12.68, 10.2217/pgs.12.68]
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Freyer G, 2011, ANTICANCER RES, V31, P359
   Garcia-Carbonero R, 2002, CLIN CANCER RES, V8, P641
   Glimelius B, 2011, PHARMACOGENOMICS J, V11, P61, DOI 10.1038/tpj.2010.10
   Gold HT, 2009, CANCER-AM CANCER SOC, V115, P3858, DOI 10.1002/cncr.24428
   Hall D, 1999, PHARMACOGENETICS, V9, P591, DOI 10.1097/00008571-199910000-00006
   Han JY, 2006, J CLIN ONCOL, V24, P2237, DOI 10.1200/JCO.2005.03.0239
   Hazama S, 2010, CANCER SCI, V101, P722, DOI 10.1111/j.1349-7006.2009.01428.x
   Hoskins JM, 2007, J NATL CANCER I, V99, P1290, DOI 10.1093/jnci/djm115
   Hoskins JM, 2009, J CLIN ONCOL, V27, P2419, DOI 10.1200/JCO.2008.20.9478
   Hu ZY, 2010, EUR J CANCER, V46, P1856, DOI 10.1016/j.ejca.2010.02.049
   Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173
   Iyer L, 1999, CLIN PHARMACOL THER, V65, P576, DOI 10.1016/S0009-9236(99)70078-0
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Jorgensen AL, 2008, STAT MED, V27, P6547, DOI 10.1002/sim.3420
   Kim TW, 2007, THER DRUG MONIT, V29, P265, DOI 10.1097/FTD.0b013e318068623b
   Kweekel DM, 2008, BRIT J CANCER, V99, P275, DOI 10.1038/sj.bjc.6604461
   Lamas MJ, 2012, CANCER CHEMOTH PHARM, V69, P1591, DOI 10.1007/s00280-012-1866-2
   Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061
   Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001
   Liu CY, 2008, CANCER-AM CANCER SOC, V112, P1932, DOI 10.1002/cncr.23370
   Marcuello E, 2004, BRIT J CANCER, V91, P678, DOI 10.1038/sj.bjc.6602042
   Martinez-Balibrea E, 2010, BRIT J CANCER, V103, P581, DOI 10.1038/sj.bjc.6605776
   Martinez-Balibrea E, 2007, ONCOL REP, V17, P637
   Massacesi C, 2006, CANCER, V106, P1007, DOI 10.1002/cncr.21722
   Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182
   McLeod HL, 2010, J CLIN ONCOL, V28, P3227, DOI 10.1200/JCO.2009.21.7943
   MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
   Miners JO, 2002, TOXICOLOGY, V181, P453, DOI 10.1016/S0300-483X(02)00449-3
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   O'Dwyer PJ, 2006, J CLIN ONCOL, V24, P4534, DOI 10.1200/JCO.2006.07.3031
   Obradovic M, 2008, PHARMACOGENOMICS, V9, P539, DOI 10.2217/14622416.9.5.539
   Okuyama Y, 2011, JPN J CLIN ONCOL, V41, P477, DOI 10.1093/jjco/hyr001
   OYE RK, 1984, JAMA-J AM MED ASSOC, V252, P2722, DOI 10.1001/jama.252.19.2722
   Palomaki GE, 2009, GENET MED, V11, P21, DOI 10.1097/GIM.0b013e31818efd77
   Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8
   Rhodes Katrin E, 2007, Drug Metab Lett, V1, P23, DOI 10.2174/187231207779814328
   Rouits E, 2008, BRIT J CANCER, V99, P1239, DOI 10.1038/sj.bjc.6604673
   Ruzzo A, 2008, PHARMACOGENOMICS J, V8, P278, DOI 10.1038/sj.tpj.6500463
   Schulz C, 2009, WORLD J GASTROENTERO, V15, P5058, DOI 10.3748/wjg.15.5058
   Shulman K, 2011, CANCER-AM CANCER SOC, V117, P3156, DOI 10.1002/cncr.25735
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Sunakawa Y, 2012, ONCOLOGY-BASEL, V82, P242, DOI 10.1159/000337225
   Sunakawa Y, 2011, CANCER CHEMOTH PHARM, V68, P279, DOI 10.1007/s00280-010-1485-8
   Temple RJ, 1995, CLIN MEASURMENT DRUG
   Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Toffoli G., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P225, DOI 10.2174/1568011033482477
   Toffoli G, 2006, J CLIN ONCOL, V24, P3061, DOI 10.1200/JCO.2005.05.5400
   Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004
   Wright MA, 2005, CLIN CANCER RES, V11, P4144, DOI 10.1158/1078-0432.CCR-04-2439
   Wu XC, 2006, CANCER-AM CANCER SOC, V107, P1121, DOI 10.1002/cncr.22009
   Yong WP, 2006, BRIT J CLIN PHARMACO, V62, P35, DOI 10.1111/j.1365-2125.2006.02591.x
   Zhe-Yi H, 2010, CLIN CANCER RES, V16, P3832
NR 63
TC 17
Z9 19
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2013
VL 8
IS 3
AR e58489
DI 10.1371/journal.pone.0058489
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 109YM
UT WOS:000316407400033
PM 23516488
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xu, CX
   Bai, RP
   Zhang, DD
   Li, ZL
   Zhu, HH
   Lai, MD
   Zhu, YM
AF Xu, Chunxiao
   Bai, Rongpan
   Zhang, Dandan
   Li, Zhenli
   Zhu, Honghong
   Lai, Maode
   Zhu, Yimin
TI Effects of APOA5-1131T > C (rs662799) on Fasting Plasma Lipids and Risk
   of Metabolic Syndrome: Evidence from a Case-Control Study in China and a
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID APOLIPOPROTEIN A5 GENE; CORONARY-ARTERY-DISEASE; APOA-V GENE;
   TRIGLYCERIDE LEVELS; HEART-DISEASE; VITAMIN-E; POLYMORPHISM;
   ASSOCIATION; VARIANTS; SUSCEPTIBILITY
AB The apolipoprotein A5 (APOA5) gene -1131T>C (rs662799) has been suggested to be involved in the pathway of lipid homeostasis and the development of metabolic syndrome (MetS). However, the findings are not consistent. To systematically evaluate the associations between -1131T>C polymorphism and fasting lipid parameters and the risk of MetS, we conducted a case-control study in a Chinese population and a meta-analysis. The findings from 1840 Chinese participants indicated that the C allele carriers had significantly higher fasting total cholesterol (TC), triglycerides (TG) and lower HDL-cholesterol (HDL-C) than the TT homozygotes carriers. The -1131C allele was also found to be significantly associated with increased risk of MetS (OR = 1.40, 95% confidence interval (CI) = 1.15, 1.69) compared to the TT homozygotes. In the meta-analysis of 51,868 participants from 46 East Asian studies, 26 European studies and 19 studies of other ethnic groups, the -1131C allele was associated with higher fasting TC (weighted mean difference (WMD) = 0.08 mmol/L, 95% CI = 0.05, 0.10, P = 1.74 x 10(-9)), TG (WMD = 0.30 mmol/L, 95% CI = 0.26, 0.33, P = 1.87 x 10(-55)), LDL-cholesterol (LDL-C) (WMD = 0.04 mmol/L, 95% CI = 0.02, 0.07, P = 0.002), and lower HDL-C (WMD = -0.05 mmol/L, 95% CI = -0.06, -0.04, P = 1.88 x 10(-21)), respectively. Based on 12 studies with 5,573 MetS cases and 8,290 controls from 5 East Asian studies, 5 European studies and 2 studies of other ethnic groups, the -1131C allele was associated with increased risk of MetS with an OR (95% CI) = 1.33 (1.16, 1.53) in the overall population, 1.43 (1.29, 1.58) in East Asian and 1.30 (0.94, 1.78) in European populations. In conclusion, the -1131C allele may be associated with elevated levels of fasting TG, TC, LDL-C and decreased HDL-C, and increased risk of MetS, especially in East Asians.
C1 [Xu, Chunxiao; Zhu, Yimin] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China.
   [Bai, Rongpan] Zhejiang Univ, Sch Publ Hlth, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China.
   [Zhang, Dandan; Li, Zhenli; Lai, Maode] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310003, Zhejiang, Peoples R China.
   [Zhu, Honghong] Western Kentucky Univ, Coll Hlth & Human Serv, Dept Publ Hlth, Bowling Green, KY 42101 USA.
RP Zhu, YM (reprint author), Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hangzhou 310003, Zhejiang, Peoples R China.
EM zhuym@zju.edu.cn
RI Zhu, Yimin/D-6387-2017
OI Zhu, Yimin/0000-0001-8409-7636; zhang, dandan/0000-0001-5305-9856
FU National Natural Science Foundation of China [81172755]; National Key
   Technology R&D Program of China [2012BAI02B03, 2009BAI80B02]; Zhejiang
   Provincial Program for the Cultivation of High-Level Innovative Health
   Talents; Fundamental Research Funds for the Central Universities;
   Program for Zhejiang Leading Team of Science and Technology Innovation
   [2010R50050]
FX Supported by the National Natural Science Foundation of China
   (81172755), National Key Technology R&D Program of China (2012BAI02B03,
   2009BAI80B02), Zhejiang Provincial Program for the Cultivation of
   High-Level Innovative Health Talents, Fundamental Research Funds for the
   Central Universities, Program for Zhejiang Leading Team of Science and
   Technology Innovation (2010R50050). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Aouizerat BE, 2003, J LIPID RES, V44, P1167, DOI 10.1194/jlr.M200480-JLR200
   Baum L, 2003, CLIN GENET, V63, P377, DOI 10.1034/j.1399-0004.2003.00063.x
   Baum L, 2007, J DIABETES COMPLICAT, V21, P158, DOI 10.1016/j.jdiacomp.2006.02.003
   Beecham GW, 2010, ANN HUM GENET, V74, P189, DOI 10.1111/j.1469-1809.2010.00573.x
   Bi N, 2004, MOL GENET METAB, V83, P280, DOI 10.1016/j.ymgme.2004.06.017
   Chaaba Raja, 2005, Lipids Health Dis, V4, P1, DOI 10.1186/1476-511X-4-1
   Chandak GR, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-76
   Charriere S, 2008, CLIN CHIM ACTA, V394, P99, DOI 10.1016/j.cca.2008.04.013
   Cheng YQ, 2007, MOL CARDIOLOGY CHINA, V7
   Chien KL, 2008, CLIN CHIM ACTA, V390, P56, DOI 10.1016/j.cca.2007.12.014
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Dai HY, 2011, J CHINESE PHYS, V13, P754
   Dallongeville J, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-84
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Elosua R, 2006, J LIPID RES, V47, P990, DOI 10.1194/jlr.M500446-JLR200
   Gao LB, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-117
   Girona J, 2008, CLIN CHEM LAB MED, V46, P453, DOI 10.1515/CCLM.2008.110
   Grallert H, 2007, J LIPID RES, V48, P2614, DOI 10.1194/jlr.M700011-JLR200
   Hahne P, 2008, J INTERN MED, V264, P452, DOI 10.1111/j.1365-2796.2008.01987.x
   Hodoglugil U, 2006, J LIPID RES, V47, P144, DOI 10.1194/jlr.M500343-JLR200
   Hsu LA, 2006, ATHEROSCLEROSIS, V185, P143, DOI 10.1016/j.atherosclerosis.2005.05.031
   Hsu LA, 2008, CLIN CHEM LAB MED, V46, P1714, DOI 10.1515/CCLM.2008.352
   Huang MC, 2008, KAOHSIUNG J MED SCI, V24, P171, DOI 10.1016/S1607-551X(08)70114-1
   Hubacek Jaroslav A, 2008, Exp Clin Cardiol, V13, P129
   Jang Y, 2004, AM J CLIN NUTR, V80, P832
   Jang Y, 2010, ATHEROSCLEROSIS, V211, P512, DOI 10.1016/j.atherosclerosis.2010.03.014
   Jang Y, 2009, CLIN CHIM ACTA, V402, P83, DOI 10.1016/j.cca.2008.12.024
   Jaromi L, 2010, J MOL NEUROSCI, V41, P121, DOI 10.1007/s12031-009-9301-9
   Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75
   Ken-Dror G, 2010, J HUM GENET, V55, P300, DOI 10.1038/jhg.2010.27
   Kisfali P, 2010, NUTR METAB CARDIOVAS, V20, P505, DOI 10.1016/j.numecd.2009.05.001
   Komurcu-Bayrak E, 2008, CLIN CHEM LAB MED, V46, P778, DOI 10.1515/CCLM.2008.161
   Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011
   Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482
   Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200
   Lee KWJ, 2004, ATHEROSCLEROSIS, V176, P165, DOI 10.1016/j.atherosclerosis.2004.04.024
   Li GP, 2004, CLIN GENET, V65, P470, DOI 10.1111/j.1399-0004.2004.00251.x
   Li XQ, 2011, EUR J INTERN MED, V22, P99, DOI 10.1016/j.ejim.2010.07.012
   Li XP, 2007, CHINESE CIRCULATION, V22
   Li XF, 2008, J HUAZHONG U SCI-MED, V28, P653, DOI 10.1007/s11596-008-0608-5
   Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533
   Lin J, 2011, ANN NUTR METAB, V58, P150, DOI 10.1159/000327913
   Liu HK, 2005, METABOLISM, V54, P568, DOI 10.1016/j.metabol.2004.11.009
   Liu ZK, 2010, ATHEROSCLEROSIS, V208, P427, DOI 10.1016/j.atherosclerosis.2009.08.013
   Maasz A, 2008, CIRC J, V72, P1065, DOI 10.1253/circj.72.1065
   Maasz A, 2007, PATHOL ONCOL RES, V13, P243, DOI 10.1007/BF02893505
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Martinelli N, 2007, ATHEROSCLEROSIS, V191, P409, DOI 10.1016/atherosclerosis.2006.04.009
   Mattei J, 2009, J NUTR, V139, P2301, DOI 10.3945/jn.109.109900
   Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234
   Niculescu LS, 2010, BIOCHEM BIOPH RES CO, V391, P587, DOI 10.1016/j.bbrc.2009.11.103
   Olano-Martin E, 2008, J LIPID RES, V49, P945, DOI 10.1194/jlr.M700112-JLR200
   Ong KL, 2011, CLIN ENDOCRINOL, V74, P206, DOI 10.1111/j.1365-2265.2010.03899.x
   Palmen J, 2008, BBA-MOL BASIS DIS, V1782, P447, DOI 10.1016/j.bbadis.2008.03.003
   Pennacchio LA, 2003, ARTERIOSCL THROM VAS, V23, P529, DOI 10.1161/01.ATV.0000054194.78240.45
   Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031
   Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852
   Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Qiao Y, 2008, J SICHUAN U MED SCI, V39
   Qiu F, 2007, CHIN J ANERIOSCLER, V15
   Saleheen D, 2010, CIRC-CARDIOVASC GENE, V3, P348, DOI 10.1161/CIRCGENETICS.109.906180
   Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4
   Song KH, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/598394
   Sundl I, 2007, J LIPID RES, V48, P2506, DOI 10.1194/jlr.M700285-JLR200
   Szalai C, 2004, ATHEROSCLEROSIS, V173, P109, DOI 10.1016/j.atherosclerosis.2003.12.003
   Talmud PJ, 2004, J LIPID RES, V45, P750, DOI 10.1194/jlr.M300458-JLR200
   Tang YB, 2005, CHIN J ARTERIOSCLER, V13
   Vasilopoulos Y, 2011, GENET TEST MOL BIOMA, V15, P613, DOI 10.1089/gtmb.2010.0256
   Wang Q, 2010, ANHUI MED J, V31
   Yamada Y, 2007, GENOMICS, V90, P551, DOI 10.1016/j.ygeuo.2007.08.001
   Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035
   Yan SK, 2005, CLIN CHEM LAB MED, V43, P607, DOI 10.1515/CCLM.2005.105
   Yang F, 2007, SHANDONG MED J, V47, P1
   Yin RX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017954
   Zhu M, 2007, CHIN J DIABETES, V15
   Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295
NR 81
TC 21
Z9 21
U1 0
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2013
VL 8
IS 2
AR e56216
DI 10.1371/journal.pone.0056216
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 098DA
UT WOS:000315524900020
PM 23468858
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ye, XH
   Fu, JJ
   Yang, Y
   Chen, SD
AF Ye, Xiaohua
   Fu, Jinjian
   Yang, Yi
   Chen, Sidong
TI Dose-Risk and Duration-Risk Relationships between Aspirin and Colorectal
   Cancer: A Meta-Analysis of Published Cohort Studies
SO PLOS ONE
LA English
DT Article
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DAILY SOLUBLE ASPIRIN; ADENOMA
   RECURRENCE; PRIMARY PREVENTION; COLON-CANCER; NSAIDS; BIAS; SEX
AB Background: In previous meta-analyses, aspirin use has been associated with reduced risk of colorectal cancer. However, uncertainty remains on the exact dose-risk and duration-risk relationships.
   Methods: We identified studies by searching several English and Chinese electronic databases and reviewing relevant articles. The dose-response meta-analysis was performed by linear trend regression and restricted cubic spline regression. Subgroup analyses were conducted to explore possible heterogeneity among studies. Potential heterogeneity was calculated as Q statistic and I-2 value. Publication bias was evaluated using funnel plots and quantified by the Begg's and Egger's test.
   Results: Twelve studies were included in this meta-analysis. An inverse association between aspirin use and colorectal cancer was observed in both the overall group (RR = 0.74, 95% CI 0.64-0.83 for aspirin dose; RR = 0.80, 95% CI 0.75-0.85 for frequency of aspirin use; RR = 0.75, 95% CI 0.68-0.81 for years of aspirin use) and subgroups stratified by sex and cancer site. The dose-response meta-analysis showed that there was a 20% statistically significant decreased risk of colorectal cancer for 325 mg aspirin per day increment, 18% decreased risk for 7 times aspirin per week increment and 18% decreased risk for 10 years aspirin increment.
   Conclusion: Long-term (>5 years), low-dose (75-325 mg per day) and regular aspirin use (2-7 times per week) can effectively reduce the risk of colorectal cancer.
C1 [Ye, Xiaohua; Fu, Jinjian] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.
   [Ye, Xiaohua; Fu, Jinjian; Yang, Yi; Chen, Sidong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.
   [Fu, Jinjian] Liuzhou Municipal Matern & Child Healthcare Hosp, Liuzhou, Guangxi, Peoples R China.
RP Chen, SD (reprint author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.
EM chensidong1@126.com
FU International cooperation project of the Guangzhou Science and
   Technology Bureau [2011J5200017]
FX This work was supported by fund from International cooperation project
   of the Guangzhou Science and Technology Bureau (No. 2011J5200017). The
   funders had no role in study design, data collection and analysis, and
   interpretation of the data.
CR Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2
   Allison M, 2006, AM J EPIDEMIOL, V164, P567, DOI 10.1093/aje/kwj250
   Baigent C, 2002, BMJ-BRIT MED J, V324, P71
   Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4
   Benamouzig R, 2012, GUT, V61, P255, DOI 10.1136/gutjnl-2011-300113
   Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306
   BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005
   Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848
   Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113
   Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7
   Brasky TM, 2012, CANCER CAUSE CONTROL, V23, P431, DOI 10.1007/s10552-011-9891-8
   Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0
   Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035
   Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914
   Chu Huei-An, 2006, Int J Environ Res Public Health, V3, P316, DOI 10.3390/ijerph2006030039
   Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485
   Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
   Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47
   Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8
   Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7
   GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001
   Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   Harris RE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-237
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Irving HM, 2009, J PANCREAS, V10, P387
   Jacobs EJ, 2007, J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132
   Jana NR, 2008, CELL MOL LIFE SCI, V65, P1295, DOI 10.1007/s00018-008-7511-x
   Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289
   Larsson SC, 2006, BRIT J CANCER, V95, P1277, DOI 10.1038/sj.bjc.6603442
   Leopoldo S, 2008, ANN SURG ONCOL, V15, P1429, DOI 10.1245/s10434-007-9757-1
   Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014
   Mahipal A, 2006, CANCER EPIDEM BIOMAR, V15, P1785, DOI 10.1158/1055-9965.EPI-05-0674
   Meade TW, 1998, LANCET, V351, P233
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015
   Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1
   Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7
   Ruder EH, 2011, AM J GASTROENTEROL, V106, P1340, DOI 10.1038/ajg.2011.38
   Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538
   Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218
   Vinogradova Y, 2007, GASTROENTEROLOGY, V133, P393, DOI 10.1053/j.gastro.2007.05.023
   Wu XC, 2004, CANCER EPIDEM BIOMAR, V13, P1215
   Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014
NR 53
TC 28
Z9 31
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 25
PY 2013
VL 8
IS 2
AR e57578
DI 10.1371/journal.pone.0057578
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 115ZB
UT WOS:000316849500116
PM 23451245
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, SQ
   Cao, Q
   Wang, XX
   Li, BJ
   Tang, M
   Yuan, WQ
   Fang, JZ
   Qian, J
   Qin, C
   Zhang, W
AF Wang, Shangqian
   Cao, Qiang
   Wang, Xiaoxiang
   Li, Bingjie
   Tang, Min
   Yuan, Wanqing
   Fang, Jianzheng
   Qian, Jian
   Qin, Chao
   Zhang, Wei
TI PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence
   from Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; DEEP-VEIN THROMBOSIS; BREAST-CANCER;
   COLORECTAL-CANCER; GENE POLYMORPHISMS; MATRIX-METALLOPROTEINASE;
   OVARIAN-CANCER; SYSTEM; RISK; PROMOTER
AB Background: The plasminogen activator inhibitor-1 (PAI-1) is expressed in many cancer cell types and allows the modulation of cancer growth, invasion and angiogenesis. To date, studies investigated the association between a functional polymorphism in PAI-1 (4G/5G) and risk of cancer have shown inclusive results.
   Methods: A meta-analysis based on 25 case-control studies was performed to address this issue. Odds ratios (OR) with corresponding 95% confidence intervals (CIs) were used to assess the association. The statistical heterogeneity across studies was examined with I-2 test.
   Results: Overall, a significant increased risk of cancer was associated with the PAI-1 4G/4G polymorphism for the allele contrast (4G vs. 5G: OR = 1.10, CI = 1.03-1.18, I-2 = 49.5%), the additive genetic model (4G/4G vs. 5G/5G: OR = 1.21, CI = 1.06-1.39, I-2 = 51.9%), the recessive genetic model (4G/4G vs. 4G/5G+5G/5G: OR = 1.11, CI = 1.04-1.18, I-2 = 20.8%). In the subgroup analysis by ethnicity, the results indicated that individuals with 4G/4G genotype had a significantly higher cancer risk among Caucasians (4G/4G vs. 5G/5G: OR = 1.31, 95% CI = 1.09-1.59, I-2 = 59.6%; 4G/4G vs. 4G/5G: OR = 1.12, 95% CI = 1.04-1.21, I-2 = 3.6%; recessive model: OR = 1.12, 95% CI = 1.05-1.21, I-2 = 25.3%).
   Conclusions: The results of the present meta-analysis support an association between the PAI-1 4G/5G polymorphism and increasing cancer risk, especially among Caucasians, and those with 4G allele have a high risk to develop colorectal cancer and endometrial cancer.
C1 [Wang, Shangqian; Cao, Qiang; Tang, Min; Fang, Jianzheng; Qian, Jian; Qin, Chao; Zhang, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.
   [Wang, Xiaoxiang] Yangzhou 1 Peoples Hosp, Dept Urol, Yangzhou, Peoples R China.
   [Li, Bingjie] Univ Texas Hlth Sci Ctr, Div Epidemiol, Houston, TX USA.
   [Yuan, Wanqing] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Orthoped, Qingdao 266071, Peoples R China.
RP Qin, C (reprint author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.
EM qinchao@njmu.edu.cn; zhangweinjmu@gmail.com
RI Cao, Qiang/K-2349-2019
FU Program for Development of Innovative Research Team in the First
   Affiliated Hospital of Nanjing Medical University; Provincial Initiative
   Program for Excellency Disciplines of Jiangsu Province; National Natural
   Science Foundation of China [81201571]
FX This work was supported by the Program for Development of Innovative
   Research Team in the First Affiliated Hospital of Nanjing Medical
   University, Provincial Initiative Program for Excellency Disciplines of
   Jiangsu Province, by the National Natural Science Foundation of China
   (grant numbers 81201571). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z
   Bentov Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005918
   Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977
   Blasiak J, 2000, ACTA BIOCHIM POL, V47, P191
   Burzotta F, 1998, THROMB HAEMOSTASIS, V79, P354
   Castello R, 2006, THROMB RES, V117, P487, DOI 10.1016/j.thromres.2005.03.025
   Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd
   DAWSON S, 1991, ARTERIOSCLER THROMB, V11, P183, DOI 10.1161/01.ATV.11.1.183
   Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033
   Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851
   Eroglu A, 2006, J BUON, V11, P481
   Eroglu A, 2007, J BUON, V12, P135
   Fersching DMI, 2012, ANTICANCER RES, V32, P2047
   Forsti A, 2007, ANN ONCOL, V18, P1990, DOI 10.1093/annonc/mdm361
   Gilabert-Estelles J, 2012, THROMB RES, V130, P242, DOI 10.1016/j.thromres.2011.10.007
   Grubic N, 1996, THROMB RES, V84, P431, DOI 10.1016/S0049-3848(96)00211-3
   Han B, 2005, ONCOL REP, V14, P105
   Huang J, 2012, BLOOD, V120, P4873, DOI 10.1182/blood-2012-06-436188
   Jorgenson E, 2007, PROSTATE, V67, P172, DOI 10.1002/pros.20512
   Ju HS, 2010, CANCER-AM CANCER SOC, V116, P4248, DOI 10.1002/cncr.25213
   Lei H, 2008, BREAST CANCER RES TR, V109, P165, DOI 10.1007/s10549-007-9635-3
   Loktionov A, 2003, CANCER LETT, V189, P189, DOI 10.1016/S0304-3835(02)00556-6
   McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156
   Minisini AM, 2007, AM J CLIN PATHOL, V128, P112, DOI 10.1309/M0GXVXAB9BVLJ5C9
   Morgan H, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-1
   Onur E, 2012, MED PRIN PRACT, V21, P160, DOI 10.1159/000333394
   Palmirotta R, 2009, THROMB RES, V124, P403, DOI 10.1016/j.thromres.2009.02.014
   Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685
   Romanowicz-Makowska H, 1999, MED SCI MONITOR, V5, P833
   Sartori MT, 2003, CLIN APPL THROMB-HEM, V9, P299, DOI 10.1177/107602960300900405
   Sartori MT, 2001, THROMB HAEMOSTASIS, V86, P1161
   Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940
   Stegnar M, 1998, THROMB HAEMOSTASIS, V79, P975
   Sternlicht MD, 2006, CANCER EPIDEM BIOMAR, V15, P2107, DOI 10.1158/1055-9965.EPI-06-0351
   Su CK, 2011, J SURG ONCOL, V104, P755, DOI 10.1002/jso.22035
   Tee YT, 2012, J SURG ONCOL, V106, P204, DOI 10.1002/jso.23072
   Turkmen B, 1997, ELECTROPHORESIS, V18, P686, DOI 10.1002/elps.1150180505
   Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002
   Vairaktaris E, 2009, ORAL ONCOL, V45, P247, DOI 10.1016/j.oraloncology.2008.05.003
   Vossen CY, 2011, J CLIN ONCOL, V29, P1722, DOI 10.1200/JCO.2010.31.8873
   Weng CJ, 2011, ANN SURG ONCOL, V18, P805, DOI 10.1245/s10434-010-1432-2
   Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y
   Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2007.04424.x
   Zorio E, 2008, CURR MED CHEM, V15, P923, DOI 10.2174/092986708783955455
NR 46
TC 15
Z9 15
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 20
PY 2013
VL 8
IS 2
AR e56797
DI 10.1371/journal.pone.0056797
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 093IE
UT WOS:000315184200164
PM 23437240
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Qin, X
   Peng, QL
   Chen, ZP
   Deng, Y
   Huang, S
   Xu, JJ
   Li, HW
   Li, S
   Zhao, JM
AF Qin, Xue
   Peng, Qiliu
   Chen, Zhiping
   Deng, Yan
   Huang, Shan
   Xu, Juanjuan
   Li, Haiwei
   Li, Shan
   Zhao, Jinmin
TI The Association between MTHFR Gene Polymorphisms and Hepatocellular
   Carcinoma Risk: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; COMMON MUTATION; C677T
   POLYMORPHISM; A1298C POLYMORPHISMS; POOLED ANALYSES; CANCER; DISEASE;
   POPULATION; CIRRHOSIS; ALCOHOL
AB Background: The association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and hepatocellular carcinoma (HCC) risk was inconsistent and underpowered. To clarify the effects of MTHFR gene polymorphisms on the risk of HCC, a meta-analysis of all available studies relating C677T and/or A1298C polymorphisms of MTHFR gene to the risk of HCC was conducted.
   Methods: The authors searched PubMed, EMBASE, Cochrane Library, Web of Science, and Chinese Biomedical Literature database (CBM) for the period up to July 2012. Data were extracted by two independent authors and pooled odds ratio (OR) with 95% confidence interval (CI) was calculated. Metaregression and subgroup analyses were performed to identify the source of heterogeneity.
   Results: Finally, 12 studies with 2,351 cases and 4,091 controls were included for C677T polymorphism and 6 studies with 1,333 cases and 1,878 controls were included for A1298C polymorphism. With respect to A1298C polymorphism, significantly decreased HCC risk was found in the overall population (CC vs. AA: OR = 0.660, 95% CI 0.460-0.946, P = 0.024; recessive model: OR = 0.667, 95% CI = 0.470-0.948, P = 0.024). In subgroup analyses, significantly decreased HCC risk was found in Asian population (CC vs. AA: OR = 0.647, 95% CI = 0.435-0.963; P = 0.032) and population-based studies (CC vs. AA: OR = 0.519, 95% CI = 0.327-0.823; P = 0.005). With respect to C677T polymorphism, no significant association with HCC risk was demonstrated in overall and stratified analyses.
   Conclusions: We concluded that MTHFR A1298C polymorphism may play a protective role in the carcinogenesis of HCC. Further large and well-designed studies are needed to confirm this association.
C1 [Qin, Xue; Peng, Qiliu; Deng, Yan; Huang, Shan; Xu, Juanjuan; Li, Haiwei; Li, Shan] Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
   [Chen, Zhiping] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Sch Publ Hlth, Nanning, Guangxi, Peoples R China.
   [Zhao, Jinmin] Guangxi Med Univ, Dept Orthoped Trauma Surg, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
   [Peng, Qiliu] Baise City Peoples Hosp, Dept Clin Lab, Baise, Guangxi, Peoples R China.
RP Li, S (reprint author), Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.
EM lis8858@126.com; zhaojinmin@126.com
OI Zhao, Jinmin/0000-0002-1047-8820
FU National Natural Science Fundation [81060199]
FX The work described in this paper was supported by the National Natural
   Science Fundation (No. 81060199). The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217
   Boccia S, 2008, AM J EPIDEMIOL, V167, P505, DOI 10.1093/aje/kwm344
   Botto LD, 2000, AM J EPIDEMIOL, V151, P862
   Cui LH, 2011, MED ONCOL
   D'Amico M, 2009, J THROMB THROMBOLYS, V28, P70, DOI 10.1007/s11239-008-0246-6
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fabris C, 2009, ALCOHOL CLIN EXP RES, V33, P102, DOI 10.1111/j.1530-0277.2008.00816.x
   Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299
   FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111
   Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838
   Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594
   Heijmans BT, 2003, CANCER RES, V63, P1249
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jin F, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-39
   Kamen B, 1997, SEMIN ONCOL, V24, P30
   Kim YI, 2005, NUTR REV, V63, P398, DOI 10.1301/nr.2005.nov.398-407
   Kwak SY, 2008, ANTICANCER RES, V28, P2807
   Liu JJ, 2010, SHI JIE HUA REN XIAO, V18, P1555
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Mu LN, 2007, CANCER CAUSE CONTROL, V18, P665, DOI 10.1007/s10552-007-9012-x
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731
   Pereira AC, 2004, CLIN CHIM ACTA, V340, P99, DOI 10.1016/j.cccn.2003.09.016
   Rosenblatt DS, 2001, CLIN INVEST MED, V24, P56
   Saffroy R, 2004, CARCINOGENESIS, V25, P1443, DOI 10.1093/carcin/bgh147
   Samonakis DN, 2004, DIGEST DIS SCI, V49, P854, DOI 10.1023/B:DDAS.0000030099.13397.28
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Taioli E, 2009, AM J EPIDEMIOL, V170, P1207, DOI 10.1093/aje/kwp275
   Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184
   van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825
   Ventura P, 2005, LIVER INT, V25, P49, DOI 10.1111/j.1478-3231.2005.01042.x
   Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714
   Yang H., 2007, GENETIC ASS CANDIDAT
   Yu MC, 2008, J GASTROEN HEPATOL, V23, pS92, DOI 10.1111/j.1440-1746.2007.05293.x
   Yuan JM, 2007, HEPATOLOGY, V46, P749, DOI 10.1002/hep.21735
   Zhu Zhong-zheng, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P196
   Zintzaras E, 2006, CLIN GENET, V69, P327, DOI 10.1111/j.1399-0004.2006.00605.x
NR 40
TC 25
Z9 25
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 14
PY 2013
VL 8
IS 2
AR e56070
DI 10.1371/journal.pone.0056070
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 099EJ
UT WOS:000315602700040
PM 23457501
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gao, TY
   Wang, SK
   He, BS
   Pan, YQ
   Song, GQ
   Gu, L
   Chen, LP
   Nie, ZL
   Xu, YQ
   Li, R
AF Gao, Tianyi
   Wang, Shukui
   He, Bangshun
   Pan, Yuqin
   Song, Guoqi
   Gu, Ling
   Chen, Liping
   Nie, Zhenling
   Xu, Yeqiong
   Li, Rui
TI The Association of RAS Association Domain Family Protein1A (RASSF1A)
   Methylation States and Bladder Cancer Risk: A Systematic Review and
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID TUMOR-SUPPRESSOR GENE; PROMOTER HYPERMETHYLATION; EPIGENETIC
   INACTIVATION; CELL CARCINOMA; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE;
   VOIDED URINE; LUNG; DNA; PHENOTYPE
AB RAS association domain family protein 1a (RASSF1A) is a putative tumor suppressor gene located on 3p21, has been regarded playing important roles in the regulation of different types of human tumors. Previous reports demonstrated that the frequency of RASSF1A methylation was significantly higher in patients group compared with controls, but the relationship between RASSF1A promoter methylation and pathological features or the tumor grade of bladder cancer remains controversial. Therefore, A meta-analysis of published studies investigating the effects of RASSF1A methylation status in bladder cancer occurrence and association with both pTNM (p, pathologic stage; T, tumor size; N, node status; M, metastatic status) and tumor grade in bladder cancer was performed in the study. A total of 10 eligible studies involving 543 cases and 217 controls were included in the pooled analyses. Under the fixed-effects model, the OR of RASSF1A methylation in bladder cancer patients, compared to non-cancer controls, was 8.40 with 95% CI = 4.96-14.23. The pooled OR with the random-effects model of pTNM and tumor grade in RASSF1A methylated patients, compared to unmethylated patients, was 0.75 (95% CI = 0.28-1.99) and 0.39 (95% CI = 0.14-1.09). This study showed that RASSF1A methylation appears to be an independent prognostic factor for bladder cancer. The present findings also require confirmation through adequately designed prospective studies.
C1 [Gao, Tianyi; Wang, Shukui; He, Bangshun; Pan, Yuqin; Song, Guoqi; Gu, Ling; Chen, Liping; Nie, Zhenling; Xu, Yeqiong; Li, Rui] Nanjing Univ, Nanjing Hosp 1, Cent Lab, Nanjing 210008, Jiangsu, Peoples R China.
   [Gu, Ling; Chen, Liping; Li, Rui] Nanjing Normal Univ, Dept Life Sci, Nanjing, Jiangsu, Peoples R China.
RP Wang, SK (reprint author), Nanjing Univ, Nanjing Hosp 1, Cent Lab, Nanjing 210008, Jiangsu, Peoples R China.
EM sk_wang@njmu.edu.cn
FU National nature science foundation of China [81172141/H1611]
FX The study was supported by National nature science foundation of China
   (81172141/H1611; http://isisn.nsfc.gov.cn/egrantweb/). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agathanggelou A, 2003, CANCER RES, V63, P5344
   Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175
   Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440
   BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6
   Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691
   Cairns P, 2007, NAT REV CANCER, V7, P531, DOI 10.1038/nrc2170
   Catto JWF, 2005, J CLIN ONCOL, V23, P2903, DOI 10.1200/JCO.2005.03.163
   Chan MWY, 2003, INT J CANCER, V104, P611, DOI 10.1002/ijc.10971
   Chen PC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-45
   Chen WT, 2007, HISTOPATHOLOGY, V51, P785, DOI 10.1111/j.1365-2559.2007.02871.x
   Cho YH, 2012, BREAST CANCER RES TR, V131, P197, DOI 10.1007/s10549-011-1712-y
   Dammann R, 2000, NAT GENET, V25, P315
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dulaimi E, 2004, CLIN CANCER RES, V10, P1887, DOI 10.1158/1078-0432.CCR-03-0127
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fleshner NE, 1996, AIDCNGR19 3 0 CO, P2
   Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006
   Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538
   Jarmalaite S, 2008, ONCOLOGY-BASEL, V75, P145, DOI 10.1159/000158665
   Jo H, 2006, ONCOL RES, V16, P205
   KANTOR AF, 1988, CANCER RES, V48, P3853
   Kawai Y, 2010, ANN ONCOL, V21, P1612, DOI 10.1093/annonc/mdp577
   Kioulafa M, 2009, CLIN BIOCHEM, V42, P970, DOI 10.1016/j.clinbiochem.2009.04.003
   Lee MG, 2001, CANCER RES, V61, P6688
   Lin HH, 2010, UROL ONCOL-SEMIN ORI, V28, P597, DOI 10.1016/j.urolonc.2008.12.008
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Marsit CJ, 2006, CANCER RES, V66, P10621, DOI 10.1158/0008-5472.CAN-06-1687
   Martins AT, 2011, BREAST CANCER RES TR, V129, P1, DOI 10.1007/s10549-010-1160-0
   Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812
   Misawa A, 2009, BRIT J CANCER, V100, P399, DOI 10.1038/sj.bjc.6604887
   Negraes PD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-238
   Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3
   Serizawa RR, 2011, INT J CANCER, V129, P78, DOI 10.1002/ijc.25651
   Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755
   Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361
   Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200
   Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266
   Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209
   Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861
NR 40
TC 15
Z9 18
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 6
PY 2012
VL 7
IS 11
AR e48300
DI 10.1371/journal.pone.0048300
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 040IE
UT WOS:000311315300024
PM 23139773
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Guo, SJ
   Gao, M
   Li, XB
   Li, YQ
   Chu, SL
   Zhu, DL
   Niu, WQ
AF Guo, Shujie
   Gao, Min
   Li, Xiaobo
   Li, Yuqiong
   Chu, Shaoli
   Zhu, Dingliang
   Niu, Wenquan
TI Lack of Association between NADPH Quinone Oxidoreductase 1 (NQO1) Gene
   C609T Polymorphism and Lung Cancer: A Case-Control Study and a
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID DT-DIAPHORASE ACTIVITY; NAD(P)H-QUINONE OXIDOREDUCTASE; RISK; SMOKING;
   NAD(P)H; SUSCEPTIBILITY; GSTM1; GSTT1; GSTP1; POPULATION
AB Background: The association between NAD(P) H:quinone oxidoreductase 1 (NQO1) gene C609T polymorphism (rs1800566) and lung cancer has been widely evaluated, and a definitive answer so far is lacking. We first conducted a case-control study to assess this association in northeastern Han Chinese, and then performed a meta-analysis to further address this issue.
   Methodology/Principal Findings: This case-control study involved 684 patients clinically diagnosed as lung cancer and 602 age-matched cancer-free controls from Harbin city, Heilongjiang province, China. Genotyping was conducted using the PCR-LDR (ligase detection reactions) method. Meta-analysis was managed by STATA software. Data and study quality were assessed in duplicate. Our case-control association study indicated no significant difference in the genotype and allele distributions of C609T polymorphism between lung cancer patients and controls, consistent with the results of the further meta-analysis involving 7286 patients and 9167 controls under both allelic (odds ratio (OR) = 0.99; 95% confidence interval (CI): 0.92-1.06; P = 0.692) and dominant (OR = 0.98; 95% CI: 0.89-1.08; P = 0.637) models. However, there was moderate evidence of between-study heterogeneity and low probability of publication bias. Further subgroup analyses by ethnicity, source of controls and sample size detected no positive associations in this meta-analysis.
   Conclusions: Our study in northeastern Han Chinese, along with the meta-analysis, failed to confirm the association of NQO1 gene C609T polymorphism with lung cancer risk, even across different ethnic populations.
C1 [Guo, Shujie; Li, Xiaobo; Li, Yuqiong; Zhu, Dingliang; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.
   [Gao, Min] Harbin Med Univ, Affiliated Hosp 4, Dept Resp, Harbin, Heilongjiang, Peoples R China.
   [Chu, Shaoli] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China.
RP Niu, WQ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.
EM niuwenquan@yahoo.cn
FU Shanghai Rising Star Program [11QA1405500]; National Natural Science
   Foundation of China [30900808]; Science Fund of Shanghai Jiao Tong
   University School of Medicine [11XJ21034]
FX This work was supported by the Shanghai Rising Star Program
   (11QA1405500), the National Natural Science Foundation of China
   (30900808) and Science Fund of Shanghai Jiao Tong University School of
   Medicine (11XJ21034). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alexandrie AK, 2004, CANCER EPIDEM BIOMAR, V13, P908
   Bock CH, 2005, CARCINOGENESIS, V26, P381, DOI 10.1093/carcin/bgh314
   Chan EC, 2005, CANCER GENET CYTOGEN, V162, P10, DOI 10.1016/j.cancergencyto.2005.03.008
   Chao C, 2006, CANCER EPIDEM BIOMAR, V15, P979, DOI 10.1158/1055-9965.EPI-05-0899
   Chen HW, 1999, CANCER RES, V59, P3045
   Cote ML, 2009, CARCINOGENESIS, V30, P626, DOI 10.1093/carcin/bgp033
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Eom SY, 2009, CANCER CAUSE CONTROL, V20, P137, DOI 10.1007/s10552-008-9225-7
   Guo SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039814
   Hamajima Nobuyuki, 2002, Int J Clin Oncol, V7, P103
   Heller G, 2010, CANCER METAST REV, V29, P95, DOI 10.1007/s10555-010-9203-x
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x
   JOSEPH P, 1994, P NATL ACAD SCI USA, V91, P8413, DOI 10.1073/pnas.91.18.8413
   KUEHL BL, 1995, BRIT J CANCER, V72, P555, DOI 10.1038/bjc.1995.373
   Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240
   Lawson KA, 2005, CANCER EPIDEM BIOMAR, V14, P2275, DOI 10.1158/1055-9965.EPI-05-0375
   Lewis SJ, 2001, LUNG CANCER-J IASLC, V34, P177, DOI 10.1016/S0169-5002(01)00243-4
   Liang Ge-Yu, 2004, Yichuan, V26, P584
   Lin PP, 2003, LUNG CANCER-J IASLC, V40, P123, DOI 10.1016/S0169-5002(03)00027-8
   Lin Y, 2000, J THORAC ONCOL, V6, P1826
   MALKINSON AM, 1992, CANCER RES, V52, P4752
   Marin A, 1997, BRIT J CANCER, V76, P923, DOI 10.1038/bjc.1997.485
   Misra V, 2000, BRIT J CANCER, V83, P998, DOI 10.1054/bjoc.2000.1359
   Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135
   Niu WQ, 2010, CLIN CHIM ACTA, V411, P1491, DOI 10.1016/j.cca.2010.06.004
   ROSVOLD EA, 1995, PHARMACOGENETICS, V5, P199, DOI 10.1097/00008571-199508000-00003
   Saldivar SJ, 2005, MUTAT RES-GEN TOX EN, V582, P71, DOI 10.1016/j.mrgentox.2004.12.010
   SCHLAGER JJ, 1990, INT J CANCER, V45, P403, DOI 10.1002/ijc.2910450304
   Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37
   Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015
   Skuladottir H, 2005, LUNG CANCER, V48, P187, DOI 10.1016/j.lungcan.2004.10.013
   SMITSKAMPWILMS E, 1995, BRIT J CANCER, V72, P917, DOI 10.1038/bjc.1995.433
   Sorensen M, 2005, CANCER LETT, V221, P185, DOI 10.1016/j.canlet.2004.11.012
   SPECTOR TD, 1991, J EPIDEMIOL COMMUN H, V45, P89, DOI 10.1136/jech.45.2.89
   Sunaga N, 2002, CANCER EPIDEM BIOMAR, V11, P730
   Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184
   Timofeeva M, 2010, INT J CANCER, V127, P1547, DOI 10.1002/ijc.25175
   Wiencke JK, 1997, CANCER EPIDEM BIOMAR, V6, P87
   Xu LL, 2001, CANCER EPIDEM BIOMAR, V10, P303
   Yang M, 2007, LUNG CANCER, V57, P135, DOI 10.1016/j.lungcan.2007.03.005
   Yin L, 2001, LUNG CANCER-J IASLC, V33, P133, DOI 10.1016/S0169-5002(01)00182-9
NR 42
TC 10
Z9 10
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 24
PY 2012
VL 7
IS 10
AR e47939
DI 10.1371/journal.pone.0047939
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 026VC
UT WOS:000310310200114
PM 23110137
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zeng, XT
   Tu, ML
   Liu, DY
   Zheng, D
   Zhang, J
   Leng, WD
AF Zeng, Xian-Tao
   Tu, Ming-Li
   Liu, Dong-Yan
   Zheng, Dong
   Zhang, Jing
   Leng, WeiDong
TI Periodontal Disease and Risk of Chronic Obstructive Pulmonary Disease: A
   Meta-Analysis of Observational Studies
SO PLOS ONE
LA English
DT Article
ID GLOBAL BURDEN; ORAL-HEALTH; ASSOCIATION; DISABILITY; MORTALITY; OLDER;
   BIAS
AB Background: Many epidemiological studies have found a positive association between periodontal disease (PD) and risk of chronic obstructive pulmonary disease (COPD), but this association is varied and even contradictory among studies. We performed a meta-analysis to ascertain the relationship between PD and COPD.
   Methods: PubMed and Embase database were searched up to January 10, 2012, for relevant observational studies on the association between PD and risk of COPD. Data from the studies selected were extracted and analyzed independently by two authors. The meta-analysis was performed using the Comprehensive Meta-Analysis software.
   Results: Fourteen observational studies (one nested case-control, eight case-control, and five cross-sectional) involving 3,988 COPD patients were yielded. Based on random-effects meta-analysis, a significant association between PD and COPD was identified (odds ratio = 2.08, 95% confidence interval = 1.48-2.91; P<0.001), with sensitivity analysis showing that the result was robust. Subgroups analyses according to study design, ethnicity, assessment of PD/COPD, and adjusted/unadjusted odds ratios also revealed a significant association. Publication bias was detected.
   Conclusions: Based on current evidence, PD is a significant and independent risk factor of COPD. However, whether a causal relationships exists remains unclear. Morever, we suggest performing randomized controlled trails to explore whether periodontal interventions are beneficial in regulating COPD pathogenesis and progression.
C1 [Zeng, Xian-Tao; Liu, Dong-Yan; Leng, WeiDong] Hubei Univ Medicne, Dept Stomatol, Taihe Hosp, Shiyan, Hubei Province, Peoples R China.
   [Tu, Ming-Li; Zhang, Jing] Hubei Univ Medicne, Dept Resp Med, Taihe Hosp, Shiyan, Hubei Province, Peoples R China.
   [Zheng, Dong; Leng, WeiDong] Hubei Univ Medicne, Sch Stomatol, Shiyan, Hubei Province, Peoples R China.
RP Leng, WD (reprint author), Hubei Univ Medicne, Dept Stomatol, Taihe Hosp, Shiyan, Hubei Province, Peoples R China.
EM lengtaihe@163.com
OI Zeng, Xian-Tao/0000-0003-1262-725X
FU Hubei University of Medcine [2011 CZX01]
FX This research was supported (in part) by the Intramural Research Program
   of the Hubei University of Medcine (2011 CZX01), without commercial, or
   not-for-profit sectors. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. No additional external funding was received for this study.
CR Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13
   Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010
   Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13
   Borenstein M, 2005, COMPREHENSIVE METAAN
   Corbridge S, 2012, AM J NURS, V112, P46, DOI 10.1097/01.NAJ.0000412639.08764.21
   Coulthwaite L, 2007, BRIT J BIOMED SCI, V64, P180, DOI 10.1080/09674845.2007.11732784
   CROXSON LJ, 1984, INT DENT J, V34, P28
   Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x
   Deo Vikas, 2009, Indian J Dent Res, V20, P466, DOI 10.4103/0970-9290.59456
   Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fatemi K, 2009, J MASH DENT SCH, V33, P214
   Garcia R I, 2001, Ann Periodontol, V6, P71, DOI 10.1902/annals.2001.6.1.71
   Gomes-Filho IS, 2010, J ORAL MICROBIOL, P2
   Hayes C, 1998, Ann Periodontol, V3, P257, DOI 10.1902/annals.1998.3.1.257
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784
   Hyman JJ, 2004, J PERIODONTOL, V75, P9, DOI 10.1902/jop.2004.75.1.9
   Katancik JA, 2005, J PERIODONTOL, V76, P2161, DOI 10.1902/jop.2005.76.11-S.2161
   Kowalski Marcin, 2005, Pol Merkur Lekarski, V19, P537
   Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001
   Liu ZQ, 2012, J CLIN PERIODONTOL, V39, P45, DOI 10.1111/j.1600-051X.2011.01808.x
   MCKUSICK KA, 1974, SCAND J RESPIR DIS, P51
   Megson E, 2010, INT J EVID-BASED HEA, V8, P129, DOI 10.1111/j.1744-1609.2010.00171.x
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Mojon Philippe, 2002, J Can Dent Assoc, V68, P340
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Prasanna Surya J, 2011, J Indian Soc Periodontol, V15, P359, DOI 10.4103/0972-124X.92570
   Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y
   Russell S L, 1999, Spec Care Dentist, V19, P128, DOI 10.1111/j.1754-4505.1999.tb01413.x
   Scannapieco F A, 1998, Ann Periodontol, V3, P251, DOI 10.1902/annals.1998.3.1.251
   Scannapieco FA, 1999, J PERIODONTOL, V70, P793, DOI 10.1902/jop.1999.70.7.793
   Scannapieco FA, 2001, J PERIODONTOL, V72, P50, DOI 10.1902/jop.2001.72.1.50
   Scannapieco Frank A, 2003, Ann Periodontol, V8, P54, DOI 10.1902/annals.2003.8.1.54
   Sharma N, 2011, J PERIODONTOL, V82, P1155, DOI 10.1902/jop.2011.100582
   Si Y, 2012, J PERIODONTOL
   Terpenning M S, 2001, Ann Periodontol, V6, P66, DOI 10.1902/annals.2001.6.1.66
   Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x
   Wang ZM, 2009, J CLIN PERIODONTOL, V36, P750, DOI 10.1111/j.1600-051X.2009.01448.x
   Xiong X, 2007, OBSTET GYNECOL SURV, V62, P605, DOI 10.1097/01.ogx.0000279292.63435.40
   Zhou X, 2012, J CLIN PERIODONTOL, V39, P350, DOI 10.1111/j.1600-051X.2012.01852.x
NR 45
TC 53
Z9 58
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 19
PY 2012
VL 7
IS 10
AR e46508
DI 10.1371/journal.pone.0046508
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 023QT
UT WOS:000310050200009
PM 23094025
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Dykiert, D
   Der, G
   Starr, JM
   Deary, IJ
AF Dykiert, Dominika
   Der, Geoff
   Starr, John M.
   Deary, Ian J.
TI Age Differences in Intra-Individual Variability in Simple and Choice
   Reaction Time: Systematic Review and Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID LIFE-STYLE; PERFORMANCE VARIABILITY; COGNITIVE IMPAIRMENT; PUBLICATION
   BIAS; SEX-DIFFERENCES; HIGH-ALTITUDE; INCONSISTENCY; ATTENTION; HEALTH;
   SPEED
AB Background: Intra-individual variability in reaction time (RT IIV) is considered to be an index of central nervous system functioning. Such variability is elevated in neurodegenerative diseases or following traumatic brain injury. It has also been suggested to increase with age in healthy ageing.
   Objectives: To investigate and quantify age differences in RT IIV in healthy ageing; to examine the effect of different tasks and procedures; to compare raw and mean-adjusted measures of RT IIV.
   Data Sources: Four electronic databases: PsycINFO, Medline, Web of Science and EMBASE, and hand searching of reference lists of relevant studies.
   Study Eligibility: English language journal articles, books or book chapters, containing quantitative empirical data on simple and/or choice RT IIV. Samples had to include younger (under 60 years) and older (60 years and above) human adults.
   Study Appraisal and Synthesis: Studies were evaluated in terms of sample representativeness and data treatment. Relevant data were extracted, using a specially-designed form, from the published report or obtained directly from the study authors. Age-group differences in raw and RT-mean-adjusted measures of simple and choice RT IIV were quantified using random effects meta-analyses.
   Results: Older adults (60+ years) had greater RT IIV than younger (20-39) and middle-aged (40-59) adults. Age effects were larger in choice RT tasks than in simple RT tasks. For all measures of RT IIV, effect sizes were larger for the comparisons between older and younger adults than between older and middle-aged adults, indicating that the age-related increases in RT IIV are not limited to old age. Effect sizes were also larger for raw than for RT-mean-adjusted RT IIV measures.
   Conclusions: RT IIV is greater among older adults. Some (but not all) of the age-related increases in RT IIV are accounted for by the increased RT means.
C1 [Dykiert, Dominika; Der, Geoff; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.
   [Der, Geoff] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.
   [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.
RP Dykiert, D (reprint author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.
EM ddykiert@staffmail.ed.ac.uk
RI Deary, Ian/C-6297-2009
OI Deary, Ian/0000-0002-1733-263X; Dykiert, Dominika/0000-0002-6050-8223;
   Der, Geoff/0000-0002-8677-073X
FU UK Medical Research Council PhD studentship; The University of Edinburgh
   Centre for Cognitive Ageing and Cognitive Epidemiology, part of the
   cross council Lifelong Health and Wellbeing Initiative [G0700704/84698];
   Biotechnology and Biological Sciences Research Council (BBSRC);
   Engineering and Physical Sciences Research Council (EPSRC); Economic and
   Social Research Council (ESRC); Medical Research Council (MRC); Chief
   Scientist Office [SPHSU2]; Medical Research Council [G0700704B,
   G0700704, MC_U130059823, MC_UP_A540_1021]
FX Dominika Dykiert was supported by a UK Medical Research Council PhD
   studentship. The work was undertaken by The University of Edinburgh
   Centre for Cognitive Ageing and Cognitive Epidemiology, part of the
   cross council Lifelong Health and Wellbeing Initiative (G0700704/84698).
   Funding from the Biotechnology and Biological Sciences Research Council
   (BBSRC), Engineering and Physical Sciences Research Council (EPSRC),
   Economic and Social Research Council (ESRC) and Medical Research Council
   (MRC) is gratefully acknowledged. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adam M, 2006, SLEEP, V29, P55, DOI 10.1093/sleep/29.1.55
   Anstey KJ, 1999, AGING NEUROPSYCHOL C, V6, P84, DOI 10.1076/anec.6.2.84.786
   Anstey KJ, 2005, Q J EXP PSYCHOL-A, V58, P5, DOI 10.1080/02724980443000232
   Bherer L, 2006, ACTA PSYCHOL, V123, P261, DOI 10.1016/j.actpsy.2006.01.005
   Borenstein M., 2009, INTRO METAANALYSIS
   Brebner J., 1980, REACTION TIMES, P1
   Bunce D, 2004, BRAIN COGNITION, V56, P320, DOI 10.1016/j.bandc.2004.08.006
   Bunce D, 2008, J GERONTOL B-PSYCHOL, V63, pP67, DOI 10.1093/geronb/63.2.P67
   Bunce D, 2012, ACCIDENT ANAL PREV, V49, P293, DOI 10.1016/j.aap.2012.01.001
   Bunce D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013567
   Bunce D, 2008, PSYCHOL AGING, V23, P848, DOI 10.1037/a0013678
   Burton CL, 2006, J CLIN EXP NEUROPSYC, V28, P67, DOI 10.1080/13803390490918318
   Cherbuin N, 2010, AM J GERIAT PSYCHIAT, V18, P723, DOI 10.1097/JGP.0b013e3181cdecf1
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1
   Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/138255805990969235
   Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62
   Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381
   Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583
   Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Dykiert D, 2012, DEV PSYCHOL, V48, P1262, DOI 10.1037/a0027550
   Finkel D, 2007, EXP AGING RES, V33, P13, DOI 10.1080/03610730601006222
   Fontani G, 2004, EUR J APPL PHYSIOL, V92, P452, DOI 10.1007/s00421-004-1108-3
   FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179
   FOZARD JL, 1976, J GERONTOL, V31, P556, DOI 10.1093/geronj/31.5.556
   Gooch CM, 2009, AGING NEUROPSYCHOL C, V16, P285, DOI 10.1080/13825580802592771
   Gorus E, 2006, AGING CLIN EXP RES, V18, P407, DOI 10.1007/BF03324837
   Hendrickson AE, 1982, MODEL INTELLIGENCE, P151
   Hogan MJ, 2003, IRISH J PSYCHOL, V24, P161
   Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101
   Hultsch DF, 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10
   Jackson JD, 2012, NEUROPSYCHOLOGIA, V50, P357, DOI 10.1016/j.neuropsychologia.2011.11.024
   LAHTELA K, 1985, SCAND J PSYCHOL, V26, P357, DOI 10.1111/j.1467-9450.1985.tb01175.x
   Li SC, 2009, PSYCHOL RES-PSYCH FO, V73, P777, DOI 10.1007/s00426-008-0190-2
   MacDonald SWS, 2012, J NEUROSCI, V32, P8186, DOI 10.1523/JNEUROSCI.5474-11.2012
   MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510
   Martin DM, 2009, NEUROPSYCHOLOGY, V23, P158, DOI 10.1037/a0014182
   Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x
   McAuley T, 2006, DEV NEUROPSYCHOL, V29, P447, DOI 10.1207/s15326942dn2903_4
   McFarland RA, 1937, J COMP PSYCHOL, V23, P227, DOI 10.1037/h0056332
   McFarland RA, 1937, J COMP PSYCHOL, V23, P191, DOI 10.1037/h0058262
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Obrist WD, 1953, J PSYCHOL, V35, P259, DOI 10.1080/00223980.1953.9712860
   PIERSON WR, 1958, J GERONTOL, V13, P418, DOI 10.1093/geronj/13.4.418
   Rakitin BC, 2006, J COGNITIVE NEUROSCI, V18, P376, DOI 10.1162/089892906775990615
   ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638
   Shammi P, 1998, AGING NEUROPSYCHOL C, V5, P1, DOI 10.1076/anec.5.1.1.23
   Shipley BA, 2006, PSYCHOSOM MED, V68, P17, DOI 10.1097/01.psy.0000195867.66643.0f
   Smulders FTY, 1997, BIOL PSYCHOL, V45, P217, DOI 10.1016/S0301-0511(96)05229-5
   Sparrow WA, 2006, MOTOR CONTROL, V10, P201, DOI 10.1123/mcj.10.3.201
   SPIRDUSO WW, 1978, J GERONTOL, V33, P26, DOI 10.1093/geronj/33.1.26
   Stuss D, 1994, NEUROPSYCHOLOGY, V8, P316, DOI [10.1037//0894-4105.8.3.316, DOI 10.1037//0894-4105.8.3.316]
   STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742
   SURWILLO WW, 1963, ELECTROEN CLIN NEURO, V15, P1029, DOI 10.1016/0013-4694(63)90146-9
   WAUGH NC, 1973, J GERONTOL, V28, P466, DOI 10.1093/geronj/28.4.466
   West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507
   WILKINSON RT, 1989, J GERONTOL, V44, pP29, DOI 10.1093/geronj/44.2.P29
   Williams BR, 2007, AGING NEUROPSYCHOL C, V14, P417, DOI 10.1080/13825580600584590
   Williams BR, 2005, NEUROPSYCHOLOGY, V19, P88, DOI 10.1037/0894-4105.19.1.88
   Wolf FM, 1986, METAANALYSIS QUANTIT
   Yan JH, 1998, EXP AGING RES, V24, P155
NR 62
TC 61
Z9 61
U1 0
U2 41
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 11
PY 2012
VL 7
IS 10
AR e45759
DI 10.1371/journal.pone.0045759
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 020KP
UT WOS:000309807700013
PM 23071524
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zhang, ZZ
   Xu, GL
   Liu, DZ
   Fan, XY
   Zhu, WS
   Liu, XF
AF Zhang, Zhizhong
   Xu, Gelin
   Liu, Dezhi
   Fan, Xinying
   Zhu, Wusheng
   Liu, Xinfeng
TI Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism
   Contributes to Ischemic Stroke Risk: A Meta-Analysis of 50 Case-Control
   Studies
SO PLOS ONE
LA English
DT Article
ID ACE I/D POLYMORPHISM; SILENT BRAIN INFARCTION; GENE POLYMORPHISM;
   DELETION POLYMORPHISM; CEREBROVASCULAR-DISEASE; CEREBRAL INFARCTION;
   ALDOSTERONE SYSTEM; VESSEL DISEASE; IN-VIVO; ASSOCIATION
AB Background: Many studies have investigated the association between the angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and risk of ischemic stroke. However, the evidence is inadequate to draw robust conclusions because most studies were generally small and conducted in heterogeneous populations. To shed light on these inconclusive findings, we conducted a large meta-analysis of studies relating the ACE I/D polymorphism to the risk of ischemic stroke.
   Methods: Relevant studies were identified by searching PubMed and Embase through February 2012 and by reviewing the references of retrieved articles. We included studies that reported odds ratio (OR) with 95% confidence interval (CI) for the association between this polymorphism and ischemic stroke risk.
   Results: Fifty independent publications, with 10 070 stroke cases and 22 103 controls, were included. The results indicated that the DD homozygote carriers had a 37% higher risk of ischemic stroke when compared with the homozygotes II and heterozygote ID [odds ratio (OR) = 1.37, 95% confidence interval (CI): 1.22-1.53]. Subgroup analyses indicated that this higher risk was more pronounced among Asians, hospital-based studies, and small vessel disease (SVD). Potential publication bias may exist, but correction for this bias using a formal statistical method did not materially alter the combined risk estimate.
   Conclusion: The results of our meta-analysis indicate that the D allele of ACE I/D polymorphism is a low-penetrance susceptibility marker of ischemic stroke.
C1 [Zhang, Zhizhong; Xu, Gelin; Liu, Dezhi; Fan, Xinying; Zhu, Wusheng; Liu, Xinfeng] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.
RP Liu, XF (reprint author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.
EM xfliu2@yahoo.com.cn
OI Xu, Gelin/0000-0002-6194-0341
FU National Natural Science Foundation of China [31200938, 31171016,
   81070922, 81171099]; Natural Science Foundation of Jiangsu Province
   [BK2011021]; Natural Science Foundation of Jinling Hospital [2012009]
FX This study was supported by National Natural Science Foundation of China
   (31200938, 31171016, 81070922, 81171099), Natural Science Foundation of
   Jiangsu Province (BK2011021), and Natural Science Foundation of Jinling
   Hospital (2012009). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AgerholmLarsen B, 1997, ANN INTERN MED, V127, P346, DOI 10.7326/0003-4819-127-5-199709010-00002
   Ariyaratnam R, 2007, PLOS MED, V4, P728, DOI 10.1371/journal.pmed.0040131
   Banerjee I, 2007, J HUM GENET, V52, P205, DOI 10.1007/s10038-006-0098-x
   Bentley P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009136
   Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2
   Brenner D, 2005, ANN NEUROL, V58, P131, DOI 10.1002/ana.20537
   Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652
   Catto A, 1996, STROKE, V27, P435, DOI 10.1161/01.STR.27.3.435
   Celiker G, 2009, CLIN APPL THROMB-HEM, V15, P415, DOI 10.1177/1076029608315163
   Chutinet A, 2011, J STROKE CEREBROVASC
   DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450
   DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387
   Dikmen M, 2006, ARQ NEURO-PSIQUIAT, V64, P211
   Doi Y, 1997, ATHEROSCLEROSIS, V132, P145, DOI 10.1016/S0021-9150(97)00080-4
   Domingues-Montanari S, 2010, EUR J NEUROL, V17, P1390, DOI 10.1111/j.1468-1331.2010.03022.x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Gao XG, 2006, NEUROSCI LETT, V398, P172, DOI 10.1016/j.neulet.2005.12.078
   Gawel B, 2007, UDAR MOZGU PROBLEMY, V9, P8
   Gormley K, 2007, CEREBROVASC DIS, V23, P148, DOI 10.1159/000097052
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hong SH, 2008, ACTA NEUROL SCAND, V117, P244, DOI 10.1111/j.1600-0404.2007.00932.x
   Indrajaya Taufik, 2011, Acta Med Indones, V43, P152
   Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998
   Jiang X, 2009, J HUM HYPERTENS, V23, P176, DOI 10.1038/jhh.2008.123
   Juo SHH, 2009, FRONT BIOSCI-LANDMRK, V14, P4525, DOI 10.2741/3545
   Kalita J, 2011, CLIN CHIM ACTA, V412, P642, DOI 10.1016/j.cca.2010.12.022
   Karagiannis A, 2004, EUR NEUROL, V51, P148, DOI 10.1159/000077203
   Kario K, 1996, CIRCULATION, V93, P1630, DOI 10.1161/01.CIR.93.9.1630
   Kim S, 2000, PHARMACOL REV, V52, P11
   Kostulas K, 1999, EUR J CLIN INVEST, V29, P478, DOI 10.1046/j.1365-2362.1999.00476.x
   Lalouschek W, 2007, CLIN CHEM, V53, P600, DOI 10.1373/clinchem.2006.073494
   LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406
   Li Cai-ming, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P359
   Li Y, 2010, PHARMACOGENET GENOM, V20, P298, DOI 10.1097/FPC.0b013e328338f54f
   Lin JJ, 2000, J FORMOS MED ASSOC, V99, P895
   Margaglione M, 1996, ARTERIOSCL THROM VAS, V16, P304, DOI 10.1161/01.ATV.16.2.304
   Markoula S, 2011, J RENIN-ANGIO-ALDO S, V12, P510, DOI 10.1177/1470320310391333
   Moellsten A, 2008, J HYPERTENS, V26, P1367, DOI 10.1097/HJH.0b013e3282fe1d55
   MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464
   Munshi A, 2008, J NEUROL SCI, V272, P132, DOI 10.1016/j.jns.2008.05.017
   Nakata Y, 1997, AM J HYPERTENS, V10, P1391, DOI 10.1016/S0895-7061(97)90510-0
   Notsu Y, 1999, STROKE, V30, P1881, DOI 10.1161/01.STR.30.9.1881
   Ohkubo R, 2002, J NEUROL SCI, V198, P31, DOI 10.1016/S0022-510X(02)00055-2
   Pera J, 2006, ACTA NEUROL SCAND, V114, P320, DOI 10.1111/j.1600-0404.2006.00672.x
   Pfohl M, 1998, ATHEROSCLEROSIS, V140, P161, DOI 10.1016/S0021-9150(98)00100-2
   PITT B, 1994, AM HEART J, V128, P1328, DOI 10.1016/0002-8703(94)90255-0
   Polupanov A, 2007, TURK KARDIYOL DERN A, V35, P347
   Rao R, 2009, EUR NEUROL, V61, P76, DOI 10.1159/000177939
   RAYNOLDS MV, 1993, LANCET, V342, P1073, DOI 10.1016/0140-6736(93)92061-W
   RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969
   RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844
   Rubattu S, 2004, J HYPERTENS, V22, P2129, DOI 10.1097/00004872-200411000-00015
   Saidi S, 2009, J THROMB THROMBOLYS, V27, P68, DOI 10.1007/s11239-007-0165-y
   Seino Y, 1998, J THROMB THROMBOLYS, V5, P263, DOI 10.1023/A:1008804211738
   Sharma P, 1996, J HYPERTENS, V14, P277, DOI 10.1097/00004872-199603000-00002
   SHARMA P, 1994, J HUM HYPERTENS, V8, P645
   Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227
   Shen D, 1998, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V15, P136
   Szolnoki Z, 2003, J NEUROL NEUROSUR PS, V74, P1615, DOI 10.1136/jnnp.74.12.1615
   Tascilar N, 2009, J NEUROL SCI, V285, P137, DOI 10.1016/j.jns.2009.06.016
   Tseng CH, 2007, EUR J CLIN INVEST, V37, P483, DOI 10.1111/j.1365-2362.2007.01813.x
   Tuncer N, 2006, J CLIN NEUROSCI, V13, P224, DOI 10.1016/j.jocn.2005.08.005
   Ueda S, 1995, J HYPERTENS, V13, P1597
   Um JY, 2003, HEREDITAS, V138, P166, DOI 10.1034/j.1601-5223.2003.01605.x
   Wang Yi-ming, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P156
   Wei X, 2000, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V17, P256
   Xu XW, 2008, CEREBROVASC DIS, V26, P48, DOI 10.1159/000135653
   XU Y, 1998, CHIN J NEUROL, V31, P152
   Yuan Xiao-dong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P822
   Zee RYL, 1999, CIRCULATION, V99, P340, DOI 10.1161/01.CIR.99.3.340
   Zhang JH, 2004, CEREBROVASC DIS, V17, P273, DOI 10.1159/000077337
   Zhang X, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P462
   Zhang X, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P435
NR 73
TC 29
Z9 30
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 1
PY 2012
VL 7
IS 10
AR e46495
DI 10.1371/journal.pone.0046495
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 014PQ
UT WOS:000309388500032
PM 23049705
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU ter Riet, G
   Korevaar, DA
   Leenaars, M
   Sterk, PJ
   Van Noorden, CJF
   Bouter, LM
   Lutter, R
   Elferink, RPO
   Hooft, L
AF ter Riet, Gerben
   Korevaar, Daniel A.
   Leenaars, Marlies
   Sterk, Peter J.
   Van Noorden, Cornelis J. F.
   Bouter, Lex M.
   Lutter, Rene
   Elferink, Ronald P. Oude
   Hooft, Lotty
TI Publication Bias in Laboratory Animal Research: A Survey on Magnitude,
   Drivers, Consequences and Potential Solutions
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIALS; ANTIDEPRESSANT TRIALS; MEDICAL STATISTICS;
   PRIMARY OUTCOMES; METAANALYSIS; REVIEWS
AB Context: Publication bias jeopardizes evidence-based medicine, mainly through biased literature syntheses. Publication bias may also affect laboratory animal research, but evidence is scarce.
   Objectives: To assess the opinion of laboratory animal researchers on the magnitude, drivers, consequences and potential solutions for publication bias. And to explore the impact of size of the animals used, seniority of the respondent, working in a for-profit organization and type of research (fundamental, pre-clinical, or both) on those opinions.
   Design: Internet-based survey.
   Setting: All animal laboratories in The Netherlands.
   Participants: Laboratory animal researchers.
   Main Outcome Measure(s): Median (interquartile ranges) strengths of beliefs on 5 and 10-point scales (1: totally unimportant to 5 or 10: extremely important).
   Results: Overall, 454 researchers participated. They considered publication bias a problem in animal research (7 (5 to 8)) and thought that about 50% (32-70) of animal experiments are published. Employees (n = 21) of for-profit organizations estimated that 10% (5 to 50) are published. Lack of statistical significance (4 (4 to 5)), technical problems (4 (3 to 4)), supervisors (4 (3 to 5)) and peer reviewers (4 (3 to 5)) were considered important reasons for non-publication (all on 5-point scales). Respondents thought that mandatory publication of study protocols and results, or the reasons why no results were obtained, may increase scientific progress but expected increased bureaucracy. These opinions did not depend on size of the animal used, seniority of the respondent or type of research.
   Conclusions: Non-publication of "negative" results appears to be prevalent in laboratory animal research. If statistical significance is indeed a main driver of publication, the collective literature on animal experimentation will be biased. This will impede the performance of valid literature syntheses. Effective, yet efficient systems should be explored to counteract selective reporting of laboratory animal research.
C1 [ter Riet, Gerben; Korevaar, Daniel A.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands.
   [Leenaars, Marlies] Radboud Univ Nijmegen, Med Ctr, Cent Anim Lab, Res Ctr 3R, NL-6525 ED Nijmegen, Netherlands.
   [Sterk, Peter J.; Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands.
   [Van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands.
   [Bouter, Lex M.] Vrije Univ Amsterdam, Execut Board, Amsterdam, Netherlands.
   [Elferink, Ronald P. Oude] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands.
   [Hooft, Lotty] Univ Amsterdam, Acad Med Ctr, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands.
RP ter Riet, G (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM g.terriet@amc.nl
RI Leenaars, P.P.A.M./L-4478-2015; Korevaar, Daniel A./O-5809-2019
OI Leenaars, P.P.A.M./0000-0002-9855-708X; Bouter, Lex/0000-0002-2659-5482;
   ter Riet, Gerben/0000-0002-2231-7637
CR Bennett DA, 2004, J CLIN EPIDEMIOL, V57, P349, DOI 10.1016/j.jclinepi.2003.09.015
   Bernard C, 1865, INTRO ETUDE MED EXPT
   Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651
   Bracken MB, 2009, J ROY SOC MED, V102, P120, DOI 10.1258/jrsm.2008.08k033
   Bracken MB, 2009, ANN EPIDEMIOL, V19, P220, DOI 10.1016/j.annepidem.2008.11.006
   De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109
   de Jong JP, 2010, J CLIN EPIDEMIOL, V63, P1342, DOI 10.1016/j.jclinepi.2010.01.018
   Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Goodman SN, 1999, ANN INTERN MED, V130, P1005, DOI 10.7326/0003-4819-130-12-199906150-00019
   Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008
   Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003
   Greenland S, 2007, INT J EPIDEMIOL, V36, P944, DOI 10.1093/ije/dym174
   Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731
   Knight J, 2003, NATURE, V422, P554, DOI 10.1038/422554a
   Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121
   Lemon R, 2005, BRIT MED J, V330, P977, DOI 10.1136/bmj.330.7498.977
   Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20
   Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242
   Mignini Luciano E, 2006, BMC Med Res Methodol, V6, P10, DOI 10.1186/1471-2288-6-10
   Ministerie van Economische Zaken Landbouw en Innovatie, 2010, RAPP NVWA ZO DOEND 2
   Moreno SG, 2012, STAT MED, V31, P1407, DOI 10.1002/sim.4488
   Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2
   Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981
   Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1
   Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344
   Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779
   Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126
NR 30
TC 37
Z9 39
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 5
PY 2012
VL 7
IS 9
AR e43404
DI 10.1371/journal.pone.0043404
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 001MC
UT WOS:000308463800020
PM 22957028
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yamada, T
   Hara, K
   Umematsu, H
   Suzuki, R
   Kadowaki, T
AF Yamada, Tomohide
   Hara, Kazuo
   Umematsu, Hitomi
   Suzuki, Ryo
   Kadowaki, Takashi
TI Erectile Dysfunction and Cardiovascular Events in Diabetic Men: A
   Meta-analysis of Observational Studies
SO PLOS ONE
LA English
DT Article
ID SILENT-MYOCARDIAL-ISCHEMIA; CORONARY-ARTERY-DISEASE; ENDOTHELIAL
   DYSFUNCTION; HEART-DISEASE; TYPE-2; RISK; PREVALENCE; ASSOCIATION;
   GUIDELINES; STATEMENT
AB Background: Several studies have shown that erectile dysfunction (ED) influences the risk of cardiovascular events (CV events). However, a meta-analysis of the overall risk of CV events associated with ED in patients with diabetes has not been performed.
   Methodology/Principal Findings: We searched MEDLINE and the Cochrane Library for pertinent articles (including references) published between 1951 and April 22, 2012. English language reports of original observational cohort studies and cross-sectional studies were included. Pooled effect estimates were obtained by random effects meta-analysis. A total of 3,791 CV events were reported in 3 cohort studies and 9 cross-sectional studies (covering 22,586 subjects). Across the cohort studies, the overall odds ratio (OR) of diabetic men with ED versus those without ED was 1.74 (95% confidence interval [CI]: 1.34-2.27; P<0.001) for CV events and 1.72 (95% CI: 1.5-1.98; P<0.001) for coronary heart disease (CHD). The funnel plot, Begg's test, and Egger's test did not show evidence of publication bias (all P>0.05). Moreover, meta-regression analysis found no relationship between the method used to assess ED (questionnaire or interview), mean age, mean hemoglobin A(1c), mean body mass index, or mean duration of diabetes and the risk of CV events or CHD. In the cross-sectional studies, the OR of diabetic men with ED versus those without ED was 3.39 (95% CI: 2.58-4.44; P<0.001) for CV events (N = 9), 3.43 (95% CI: 2.46-4.77; P<0.001) for CHD (N = 7), and 2.63 (95% CI: 1.41-4.91; P = 0.002) for peripheral vascular disease (N = 5).
   Conclusion/Significance: ED was associated with an increased risk of CV events in diabetic patients. Prevention and early detection of cardiovascular disease are important in the management of diabetes, especially in view of the rapid increase in its prevalence.
C1 [Yamada, Tomohide; Hara, Kazuo; Umematsu, Hitomi; Suzuki, Ryo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan.
RP Yamada, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan.
EM thara-tky@umin.ac.jp
CR ANDERSSON KE, 1995, PHYSIOL REV, V75, P191
   Batty GD, 2010, J AM COLL CARDIOL, V56, P1908, DOI 10.1016/j.jacc.2010.04.067
   Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322
   Cho NH, 2006, DIABETIC MED, V23, P198, DOI 10.1111/j.1464-5491.2005.01789.x
   De Berardis G, 2005, DIABETES CARE, V28, P2637, DOI 10.2337/diacare.28.11.2637
   Dong JY, 2011, J AM COLL CARDIOL, V58, P1378, DOI 10.1016/j.jacc.2011.06.024
   DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fedele D, 2000, INT J EPIDEMIOL, V29, P524, DOI 10.1093/ije/29.3.524
   Frantzen J, 2006, ANN EPIDEMIOL, V16, P85, DOI 10.1016/j.annepidem.2005.06.047
   Garcia-Malpartida K, 2011, J SEX MED, V8, P2606, DOI 10.1111/j.1743-6109.2011.02365.x
   Gazzaruso C, 2004, CIRCULATION, V110, P22, DOI 10.1161/01.CIR.0000133278.81226.C9
   Gazzaruso C, 2006, INT J IMPOT RES, V18, P311, DOI 10.1038/sj.ijir.3901403
   Gazzaruso C, 2008, J AM COLL CARDIOL, V51, P2040, DOI 10.1016/j.jacc.2007.10.069
   Gazzaruso C, 2011, ENDOCRINE, V40, P273, DOI 10.1007/s12020-011-9523-9
   Giuliano FA, 2004, UROLOGY, V64, P1196, DOI 10.1016/j.urology.2004.08.059
   Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291
   Guo WB, 2010, J SEX MED, V7, P2805, DOI 10.1111/j.1743-6109.2010.01792.x
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042
   Kalter-Leibovici O, 2005, DIABETES CARE, V28, P1739, DOI 10.2337/diacare.28.7.1739
   Kirby M, 2005, INT J CLIN PRACT, V59, P225, DOI 10.1111/j.1368-5031.2004.00453.x
   Klein R, 1996, DIABETES CARE, V19, P135, DOI 10.2337/diacare.19.2.135
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136
   Ma RCW, 2008, J AM COLL CARDIOL, V51, P2045, DOI 10.1016/j.jacc.2008.02.051
   McEvoy JW, 2011, ARCH INTERN MED, V171, P1260, DOI 10.1001/archinternmed.2011.204
   Montorsi P, 2005, AM J CARDIOL, V96, p19M
   Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002
   Romeo JH, 2000, J UROLOGY, V163, P788, DOI 10.1016/S0022-5347(05)67805-6
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   Sasaki H, 2005, DIABETES RES CLIN PR, V70, P81, DOI 10.1016/j.diabres.2005.02.018
   Shiri R, 2006, INT J IMPOT RES, V18, P348, DOI 10.1038/sj.ijir.3901432
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996
   Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553
   Vlachopoulos C, 2008, CURR PHARM DESIGN, V14, P3700, DOI 10.2174/138161208786898716
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008
   Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954
   Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476
   Yu LW, 2010, INT J ANDROL, V33, P853, DOI 10.1111/j.1365-2605.2009.01026.x
NR 40
TC 38
Z9 38
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 4
PY 2012
VL 7
IS 9
AR e43673
DI 10.1371/journal.pone.0043673
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 002ZJ
UT WOS:000308577600014
PM 22962586
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Shi, TY
   He, J
   Qiu, LX
   Zhu, ML
   Wang, MY
   Zhou, XY
   Han, JL
   Yu, HP
   Zang, RY
   Wei, QY
AF Shi, Ting-Yan
   He, Jing
   Qiu, Li-Xin
   Zhu, Mei-Ling
   Wang, Meng-Yun
   Zhou, Xiao-Yan
   Han, Jiali
   Yu, Hongpin
   Zang, Rong-Yu
   Wei, Qingyi
TI Association between XPF Polymorphisms and Cancer Risk: A Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; BREAST-CANCER; GENETIC
   POLYMORPHISMS; LUNG-CANCER; XERODERMA-PIGMENTOSUM; ENDOMETRIAL CANCER;
   COLORECTAL-CANCER; BLADDER-CANCER; MOLECULAR EPIDEMIOLOGY
AB Background: Xeroderma pigmentosum complementation group F (XPF or ERCC4) plays a key role in DNA repair that protects against genetic instability and carcinogenesis. A series of epidemiological studies have examined associations between XPF polymorphisms and cancer risk, but the findings remain inconclusive.
   Methodology/Principal Findings: In this meta-analysis of 47,639 cancer cases and 51,915 controls, by searching three electronic databases (i.e., MEDLINE, EMBASE and CNKI), we summarized 43 case-control studies from 29 publications on four commonly studied polymorphisms of XPF (i.e., rs1800067, rs1799801, rs2020955 and rs744154), and we did not find statistical evidence of any significant association with overall cancer risk. However, in stratification analyses, we found a significant association of XPF-rs1799801 with a reduced cancer risk in Caucasian populations (4,845 cases and 5,556 controls; recessive model: OR = 0.87, 95% CI = 0.76-1.00, P = 0.049, P = 0.723 for heterogeneity test, I-2 = 0). Further genotype-phenotype correlation analysis showed that the homozygous variant CC genotype carriers had higher XPF expression levels than that of the TT genotype carriers (Student's t test for a recessive model: P = 0.046). No publication bias was found by using the funnel plot and Egger's test.
   Conclusion: This meta-analysis suggests a lack of statistical evidence for the association between the four XPF SNPs and overall risk of cancers. However, XPF-rs1799801 may be associated with cancer risk in Caucasian populations, which needs to be further validated in single large, well-designed prospective studies.
C1 [Shi, Ting-Yan; He, Jing; Zhu, Mei-Ling; Wang, Meng-Yun; Zhou, Xiao-Yan; Wei, Qingyi] Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
   [Shi, Ting-Yan; He, Jing; Qiu, Li-Xin; Zhu, Mei-Ling; Wang, Meng-Yun; Zhou, Xiao-Yan; Zang, Rong-Yu] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China.
   [Qiu, Li-Xin] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
   [Zang, Rong-Yu] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
   [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Dept Dermatol, Sch Med, Boston, MA 02115 USA.
   [Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.
   [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Yu, Hongpin; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.
RP Shi, TY (reprint author), Fudan Univ, Canc Res Lab, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.
EM fudanGOG@gmail.com; weiqingyi@yahoo.com
RI He, Jing/M-5774-2015; He, Jing/Q-8740-2019
OI He, Jing/0000-0002-1954-2892; He, Jing/0000-0002-1954-2892
FU China's Thousand Talents Program at Fudan University
FX This study was supported by the funds from China's Thousand Talents
   Program at Fudan University. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442
   Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5
   Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08
   Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0
   Chang JS, 2008, INT J CANCER, V123, P2095, DOI 10.1002/ijc.23801
   Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663
   Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Ding DP, 2011, BREAST CANCER RES TR, V129, P203, DOI 10.1007/s10549-011-1447-9
   Doherty JA, 2011, CANCER EPIDEM BIOMAR, V20, P1873, DOI 10.1158/1055-9965.EPI-11-0119
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000
   Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014
   Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749
   Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5
   Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600
   Hooker S, 2008, PROSTATE CANCER P D, V11, P349, DOI 10.1038/sj.pcan.4501027
   Hsu MS, 2010, ANN SURG ONCOL, V17, P760, DOI 10.1245/s10434-009-0802-0
   Huang WY, 2006, CANCER EPIDEM BIOMAR, V15, P306, DOI 10.1158/1055-9965.EPI-05-0751
   Hung RJ, 2008, CANCER EPIDEM BIOMAR, V17, P3081, DOI 10.1158/1055-9965.EPI-08-0411
   Jorgensen TJ, 2007, BREAST CANCER RES TR, V101, P65, DOI 10.1007/s10549-006-9263-3
   Joshi AD, 2009, CARCINOGENESIS, V30, P472, DOI 10.1093/carcin/bgn260
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kovacs MS, 1999, BRIT J CANCER, V80, P1245, DOI 10.1038/sj.bjc.6690492
   KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018
   Krupa R., 2011, Experimental Oncology, V33, P55
   Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008
   Lee SA, 2005, EXP MOL MED, V37, P86, DOI 10.1038/emm.2005.12
   Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010
   Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x
   LIU P, 1993, MUTAGENESIS, V8, P199, DOI 10.1093/mutage/8.3.199
   Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Manuguerra M, 2006, AM J EPIDEMIOL, V164, P297, DOI 10.1093/aje/kwj189
   Matullo G, 2005, CANCER EPIDEM BIOMAR, V14, P2569, DOI 10.1158/1055-9965.EPI-05-0189
   McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539
   Mechanic LE, 2006, CARCINOGENESIS, V27, P1377, DOI 10.1093/carcin/bgi330
   Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252
   Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418
   Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363
   Mort R, 2003, BRIT J CANCER, V89, P333, DOI 10.1038/sj.bjc.6601061
   Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004
   Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7
   Oliveira C, 2011, EUR J CANCER, V47, pS654, DOI 10.1016/S0959-8049(11)72517-5
   Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257
   Rajaraman P, 2008, INT J CANCER, V123, P2713, DOI 10.1002/ijc.23779
   Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012
   Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096
   Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117
   Shen MR, 1998, CANCER RES, V58, P604
   SHIELDS PG, 1991, JAMA-J AM MED ASSOC, V266, P681, DOI 10.1001/jama.266.5.681
   Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193
   Smith TR, 2011, CARCINOGENESIS, V32, P1354, DOI 10.1093/carcin/bgr117
   Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200
   Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678
   Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105
   Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014
   Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012
   Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102
   Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075
   Wang M, 2010, ONCOGENE, V29, P1920, DOI 10.1038/onc.2009.484
   Weiss JM, 2005, CANCER EPIDEM BIOMAR, V14, P2524, DOI 10.1158/1055-9965.EPI-05-0414
   Weiss JM, 2006, GYNECOL ONCOL, V103, P891, DOI 10.1016/j.ygyno.2006.05.020
   Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154
   Yu H, 2011, ASS SINGLE NUCLEOTID
   Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232
NR 71
TC 22
Z9 22
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 2
PY 2012
VL 7
IS 7
AR e38606
DI 10.1371/journal.pone.0038606
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 968GX
UT WOS:000305966500006
PM 22768293
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Zheng, XW
   Wang, L
   Zhu, YW
   Guan, Q
   Li, HJ
   Xiong, ZG
   Deng, LY
   Lu, J
   Miao, XP
   Cheng, LM
AF Zheng, Xiawen
   Wang, Li
   Zhu, Yaowu
   Guan, Qing
   Li, Huijun
   Xiong, Zhigang
   Deng, Lingyan
   Lu, Jie
   Miao, Xiaoping
   Cheng, Liming
TI The SNP rs961253 in 20p12.3 Is Associated with Colorectal Cancer Risk: A
   Case-Control Study and a Meta-Analysis of the Published Literature
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS;
   PUBLICATION BIAS; SCAN; POLYMORPHISMS; SUPPRESSION; COLON; 8Q24
AB Background: Colorectal cancer (CRC) is the third common cancer and the fourth leading cause of cancer death worldwide. A single nucleotide polymorphism (SNP), rs961253 located in 20p12, was firstly described to be associated with the increased risk of CRC in a genome-wide association study; however, more recent replication studies yielded controversial results.
   Methodology/Principal Findings: A hospital-based case-control study in a Chinese population was firstly performed, and then a meta-analysis combining the current and previously published studies were conducted to explore the real effect of rs961253 in CRC susceptibility. In the Chinese population including 641 cases and 1037 controls, per-A-allele conferred an OR of 1.60 (95% CI = 1.26-2.02) under additive model. In the meta-analysis including 29859 cases and 29696 controls, per-A-allele have an OR of 1.13 (95% CI = 1.09-1.18) under a random-effects model due to heterogeneity (P = 0.019). Nevertheless, the heterogeneity can be totally explained by ethnicity, with the tau(2)reduced to 0 after including ethnicity in meta-regression model. In stratified analysis by ethnicity, per-A-allele had ORs of 1.34 (95% CI = 1.20-1.50) and 1.11 (95% CI = 1.08-1.14) for Asian and European, respectively, without heterogeneity. Modest influence of each study was observed on overall estimate in sensitive analysis, and evident tendency to significant association was seen in cumulative analysis over time, together indicating the robust stability of the current results.
   Conclusions/Significance: The results from our study and the meta-analysis provided firm evidence that rs961253 significantly contributed to CRC risk in both Asian and European population.
C1 [Zheng, Xiawen; Zhu, Yaowu; Guan, Qing; Li, Huijun; Xiong, Zhigang; Deng, Lingyan; Lu, Jie; Cheng, Liming] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430074, Peoples R China.
   [Zheng, Xiawen; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth,Dept Epidemiol & Biostat, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China.
   [Wang, Li] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing, Peoples R China.
   [Wang, Li] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China.
RP Cheng, LM (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430074, Peoples R China.
EM chengliming@tjh.tjmu.edu.cn
RI miao, xiaoping/C-4336-2011
OI miao, xiaoping/0000-0002-6818-9722
FU Natural Science Foundation of China [NSFC-81001275, 81171878]; Fok Ying
   Tung Foundation for Young Teachers in the Higher Education Institutions
   of China [131038]
FX This work was supported by the National Natural Science Foundation of
   China [NSFC-81001275 and 81171878 to X.M.] and the Fok Ying Tung
   Foundation for Young Teachers in the Higher Education Institutions of
   China (131038) to X.M. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Beck SE, 2006, AM J PHYSIOL-GASTR L, V291, pG135, DOI 10.1152/ajpgi.00482.2005
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18
   de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098
   Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067
   He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892
   He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977
   Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670
   Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262
   Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919
   Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006
   Niittymaki I, 2010, CANCER EPIDEM BIOMAR, V19, P1478, DOI 10.1158/1055-9965.EPI-09-1320
   Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33
   Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108
   Qiu L, 2008, EUR J CANCER, V44, P2241, DOI 10.1016/j.ejca.2008.06.024
   Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133
   Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574
   Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184
   Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010
   Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187
   Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085
   Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111
   Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105
   von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774
   Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210
   Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089
   Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437
NR 38
TC 7
Z9 8
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2012
VL 7
IS 4
AR e34625
DI 10.1371/journal.pone.0034625
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959TP
UT WOS:000305336600042
PM 22509336
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Yang, WS
   Va, P
   Bray, F
   Gao, S
   Gao, J
   Li, HL
   Xiang, YB
AF Yang, Wan-Shui
   Va, Puthiery
   Bray, Freddie
   Gao, Shan
   Gao, Jing
   Li, Hong-Lan
   Xiang, Yong-Bing
TI The Role of Pre-Existing Diabetes Mellitus on Hepatocellular Carcinoma
   Occurrence and Prognosis: A Meta-Analysis of Prospective Cohort Studies
SO PLOS ONE
LA English
DT Article
ID CHRONIC HEPATITIS-C; POPULATION-BASED COHORT; CANCER-MORTALITY;
   UNITED-STATES; VIRAL-HEPATITIS; VIRUS-INFECTION; BREAST-CANCER;
   METABOLIC SYNDROME; PUBLICATION BIAS; LIVER-DISEASE
AB Background: The impact of pre-existing diabetes mellitus (DM) on hepatocellular carcinoma (HCC) occurrence and prognosis is complex and unclear. The aim of this meta-analysis is to evaluate the association between pre-existing diabetes mellitus and hepatocellular carcinoma occurrence and prognosis.
   Methods: We searched PubMed, Embase and the Cochrane Library from their inception to January, 2011 for prospective epidemiological studies assessing the effect of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence, mortality outcomes, cancer recurrence, and treatment-related complications. Study-specific risk estimates were combined by using fixed effect or random effect models.
   Results: The database search generated a total of 28 prospective studies that met the inclusion criteria. Among these studies, 14 reported the risk of HCC incidence and 6 studies reported risk of HCC specific mortality. Six studies provided a total of 8 results for all-cause mortality in HCC patients. Four studies documented HCC recurrence risks and 2 studies reported risks for hepatic decomposition occurrence in HCC patients. Meta-analysis indicated that pre-existing diabetes mellitus (DM) was significantly associated with increased risk of HCC incidence [meta-relative risk (RR) = 1.87, 95% confidence interval (CI): 1.15-2.27] and HCC-specific mortality (meta-RR = 1.88, 95% CI: 1.39-2.55) compared with their non-DM counterparts. HCC patients with pre-existing DM had a 38% increased (95% CI: 1.13-1.48) risk of death from all-causes and 91% increased (95% CI: 1.41-2.57) risk of hepatic decomposition occurrence compared to those without DM. In DM patients, the meta-RR for HCC recurrence-free survival was 1.93(95% CI: 1.12-3.33) compared with non-diabetic patients.
   Conclusion: The findings from the current meta-analysis suggest that DM may be both associated with elevated risks of both HCC incidence and mortality. Furthermore, HCC patients with pre-existing diabetes have a poorer prognosis relative to their non-diabetic counterparts.
C1 [Yang, Wan-Shui] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.
   [Yang, Wan-Shui; Gao, Shan; Gao, Jing; Li, Hong-Lan; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogene & Related Genes,Renji Hosp, Shanghai 200030, Peoples R China.
   [Yang, Wan-Shui; Gao, Shan; Gao, Jing; Li, Hong-Lan; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, Dept Epidemiol,Renji Hosp, Shanghai 200030, Peoples R China.
   [Va, Puthiery] Univ New England, Coll Osteopath Med, Biddeford, ME USA.
   [Bray, Freddie] Int Agcy Res Canc, Sect Canc Informat, F-69372 Lyon, France.
RP Yang, WS (reprint author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.
EM ybxiang@shsci.org
FU State Key Project Specialized for Infectious Diseases of China
   [2008ZX10002-015]; Fogarty International Clinical Research Scholars;
   Fogarty International Center, National Institutes of Health
   [R24TW007988]
FX This study is supported by the fund of the State Key Project Specialized
   for Infectious Diseases of China (No. 2008ZX10002-015). W-SY and PV are
   also supported by the Fogarty International Clinical Research Scholars
   and Fellows Support Center at the Vanderbilt Institute for Global
   Health, funded by the Fogarty International Center, National Institutes
   of Health, through an R24 Training Grant (Grant number: R24TW007988).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753
   Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824
   Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Chen Jian-guo, 2005, Zhonghua Yi Xue Za Zhi, V85, P3052
   Cheruvattath R, 2007, J CLIN GASTROENTEROL, V41, P403, DOI 10.1097/01.mcg.0000248018.08515.f9
   Chodick G, 2010, CANCER CAUSE CONTROL, V21, P879, DOI 10.1007/s10552-010-9515-8
   Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004
   Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161
   Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296
   Cucchetti A, 2011, ANN SURG ONCOL, V18, P1630, DOI 10.1245/s10434-010-1463-8
   Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6
   Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167
   Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020
   Denley A, 2007, MOL CELL BIOL, V27, P3569, DOI 10.1128/MCB.01447-06
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Di Costanzo GG, 2008, EUR J GASTROEN HEPAT, V20, P674, DOI 10.1097/MEG.0b013e3282f762e1
   Donadon Valter, 2009, Expert Rev Gastroenterol Hepatol, V3, P465, DOI 10.1586/egh.09.41
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
   El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x
   Feng YH, 2011, MED ONCOL, V28, P1080, DOI 10.1007/s12032-010-9650-9
   Ferlay J., 2010, IARC CANC BASE
   Fujino Y, 2001, DIABETES METAB RES, V17, P374, DOI 10.1002/dmrr.214
   FULLER JH, 1983, DIABETOLOGIA, V24, P336
   Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S
   Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666
   Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/01.MCG.0000024617.97388.72
   Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1.572
   Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585
   Huo TI, 2010, LIVER INT, V30, P198, DOI 10.1111/j.1478-3231.2009.02143.x
   Huo TI, 2004, AM J GASTROENTEROL, V99, P1479, DOI 10.1111/j.1572-0241.2004.30024.x
   Huo TI, 2003, EUR J GASTROEN HEPAT, V15, P1203, DOI 10.1097/01.meg.0000085498.01212.6a
   Huo TI, 2003, AM J GASTROENTEROL, V98, P2293, DOI 10.1016/S0002-9270(03)00694-4
   Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615
   Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871
   Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039
   Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194
   Jin F, 1999, INT J CANCER, V83, P435, DOI 10.1002/(SICI)1097-0215(19991112)83:4<435::AID-IJC1>3.3.CO;2-A
   Jonsson JR, 2005, J HEPATOL, V43, P929, DOI 10.1016/j.jhep.2005.05.030
   Kawamura Y, 2008, J GASTROEN HEPATOL, V23, P1739, DOI 10.1111/j.1440-1746.2008.05436.x
   Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253
   Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x
   Lai MS, 2006, HEPATOLOGY, V43, P1295, DOI 10.1002/hep.21208
   Lam EKK, 2011, ANN ONCOL, V22, P730, DOI 10.1093/annonc/mdq405
   Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380
   Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237
   LaVecchia C, 1997, INT J CANCER, V73, P204, DOI 10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#
   Lee CL, 2003, CANCER EPIDEM BIOMAR, V12, P57
   Lipscombe LL, 2006, BREAST CANCER RES TR, V98, P349, DOI 10.1007/s10549-006-9172-5
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14
   Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0
   Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125
   Monami M, 2008, EXP CLIN ENDOCR DIAB, V116, P184, DOI 10.1055/s-2007-992157
   Morss AS, 2007, J BIOL CHEM, V282, P14635, DOI 10.1074/jbc.M608565200
   Oba S, 2008, J EPIDEMIOL, V18, P197, DOI 10.2188/jea.JE2008004
   Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Park SM, 2006, J CLIN ONCOL, V24, P5017, DOI 10.1200/JCO.2006.07.0243
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   PAYNE JE, 1995, AUST NZ J SURG, V65, P398, DOI 10.1111/j.1445-2197.1995.tb01767.x
   Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536
   Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5
   Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200
   Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006
   Richardson LC, 2005, NAT CLIN PRACT ONCOL, V2, P48, DOI 10.1038/ncponc0062
   Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190
   Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019
   Rousseau MC, 2006, INT J CANCER, V118, P2105, DOI 10.1002/ijc.21600
   Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14
   Sanz C, 2010, DIABETES METAB, V36, P346, DOI 10.1016/j.diabet.2010.06.001
   Shi M, 2004, WORLD J SURG, V28, P376, DOI 10.1007/s00268-003-7308-x
   Snyder CF, 2010, PROSTATE CANCER P D, V13, P58, DOI 10.1038/pcan.2009.39
   Takiya L, 2002, AM J MANAG CARE, V8, P1009
   Tazawa J, 2002, DIGEST DIS SCI, V47, P710, DOI 10.1023/A:1014715327729
   Torisu Y, 2007, HEPATOL RES, V37, P517, DOI 10.1111/j.1872-034X.2007.00077.x
   van de Poll-Franse LV, 2007, INT J CANCER, V120, P1986, DOI 10.1002/ijc.22532
   Veldt BJ, 2008, HEPATOLOGY, V47, P1856, DOI 10.1002/hep.22251
   Wang CS, 2009, CANCER EPIDEM BIOMAR, V18, P2054, DOI 10.1158/1055-9965.EPI-08-1131
   Weiser MA, 2004, CANCER, V100, P1179, DOI 10.1002/cncr.20071
   Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x
   Wong IHN, 2001, CANCER LETT, V167, P183, DOI 10.1016/S0304-3835(01)00455-4
   Wu SC, 2000, PUBLIC HEALTH, V114, P137, DOI 10.1016/S0033-3506(00)00323-1
   Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734
   YU MC, 1991, JNCI-J NATL CANCER I, V83, P1820, DOI 10.1093/jnci/83.24.1820
   Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229
   Zhang H, 2007, CANCER RES, V67, P391, DOI 10.1158/0008-5472.CAN-06-1712
   Zhu AX, 2010, ONCOLOGIST, V15, P1, DOI 10.1634/theoncologist.2010-S4-01
NR 93
TC 54
Z9 57
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 21
PY 2011
VL 6
IS 12
AR e27326
DI 10.1371/journal.pone.0027326
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 876NF
UT WOS:000299113600002
PM 22205924
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Cuijpers, P
   Donker, T
   Johansson, R
   Mohr, DC
   van Straten, A
   Andersson, G
AF Cuijpers, Pim
   Donker, Tara
   Johansson, Robert
   Mohr, David C.
   van Straten, Annemieke
   Andersson, Gerhard
TI Self-Guided Psychological Treatment for Depressive Symptoms: A
   Meta-Analysis
SO PLOS ONE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; PRIMARY-CARE;
   STEPPED-CARE; OVERCOMING DEPRESSION; HELP INTERVENTIONS; ANXIETY
   DISORDERS; INTERNET ODIN; HEALTH-CARE; PROGRAM
AB Background: A number of trials have examined the effects of self-guided psychological intervention, without any contact between the participants and a therapist or coach. The results and sizes of these trials have been mixed. This is the first quantitative meta-analysis, aimed at organizing and evaluating the literature, and estimating effect size.
   Method: We conducted systematic literature searches in PubMed, PsycINFO and Embase up to January 2010, and identified additional studies through earlier meta-analyses, and the references of included studies. We identified seven randomized controlled trials that met our inclusion criteria, with a total of 1,362 respondents. The overall quality of the studies was high. A post-hoc power calculation showed that the studies had sufficient statistical power to detect an effect size of d = 0.19.
   Results: The overall mean effect size indicating the difference between self-guided psychological treatment and control groups at post-test was d = 0.28 (p<0.001), which corresponds to a NNT of 6.41. At 4 to 12 months follow-up the effect size was d = 0.23. There was no indication for significant publication bias.
   Conclusions: We found evidence that self-guided psychological treatment has a small but significant effect on participants with increased levels of depressive symptomatology.
C1 [Cuijpers, Pim; Donker, Tara; van Straten, Annemieke] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Johansson, Robert; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Swedish Inst Disabil Res, Linkoping, Sweden.
   [Mohr, David C.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA.
   [Andersson, Gerhard] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden.
RP Cuijpers, P (reprint author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
EM p.cuijpers@psy.vu.nl
RI Andersson, Gerhard/J-8529-2012; Cuijpers, Pim/G-1703-2013; van Straten,
   Annemieke/P-8495-2019
OI Andersson, Gerhard/0000-0003-4753-6745; van Straten,
   Annemieke/0000-0001-6875-2215; Johansson, Robert/0000-0001-5547-3866;
   Donker, Tara/0000-0002-7470-8234; Cuijpers, Pim/0000-0001-5497-2743;
   Mohr, David/0000-0002-5443-7596
FU NCRR NIH HHS [UL1 RR025741]; NICHD NIH HHS [RL1 HD058295]
CR Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960
   Borenstein M., 2009, INTRO METAANALYSIS
   Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695
   Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE
   Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16
   Clarke G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.3.e14
   Clarke Greg, 2009, Cognitive Behaviour Therapy, V38, P222, DOI 10.1080/16506070802675353
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cuijpers P, 1997, J BEHAV THER EXP PSY, V28, P139, DOI 10.1016/S0005-7916(97)00005-0
   Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772
   Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114
   Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36
   de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Fletcher J, 2005, BEHAV COGN PSYCHOTH, V33, P319, DOI 10.1017/S1352465805002079
   Gellatly J, 2007, PSYCHOL MED, V37, P1217, DOI 10.1017/S0033291707000062
   Gregory RJ, 2004, PROF PSYCHOL-RES PR, V35, P275, DOI 10.1037/0735-7028.35.3.275
   Grime PR, 2004, OCCUP MED-OXFORD, V54, P353, DOI 10.1093/occmed/kqh077
   Haddock CK, 1997, CEPHALALGIA, V17, P113, DOI 10.1046/j.1468-2982.1997.1702113.x
   Higgins JP, 2008, COCHRANE HDB SYSTEMA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hirai M, 2006, BEHAV THER, V37, P99, DOI 10.1016/j.beth.2005.05.002
   Holdsworth N, 1996, J MENTAL HLTH, V5, P195
   Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014
   LITTLE P, BMJ, V328, P441
   Marrs RW, 1995, AM J COMMUN PSYCHOL, V23, P843, DOI 10.1007/BF02507018
   Menchola M, 2007, PROF PSYCHOL-RES PR, V38, P421, DOI 10.1037/0735-7028.38.4.421
   Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151
   Patten SB, 2003, PSYCHIAT SERV, V54, P396, DOI 10.1176/appi.ps.54.3.396
   Rahe RH, 2002, PSYCHOSOM MED, V64, P278, DOI 10.1097/00006842-200203000-00011
   Sackett DL, 2000, EVIDENCE BASED MED P
   Salkovskis P, 2006, PSYCHOL MED, V36, P325, DOI 10.1017/S0033291705006422
   SCOGIN F, 1996, J CONSULT CLIN PSYCH, V64, P1068
   Seekles W, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-90
   Spek V, 2007, PSYCHOL MED, V37, P1797, DOI 10.1017/S0033291707000542
   Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944
   van Straten A, 2010, MED J AUSTRALIA, V192, pS36
   van Straten A, 2009, SLEEP MED REV, V13, P61, DOI 10.1016/j.smrv.2008.04.006
   van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555
   Webster J, 2003, BJOG-INT J OBSTET GY, V110, P842, DOI 10.1111/j.1471-0528.2003.02377.x
   Zetterqvist Kristofer, 2003, Cognitive Behaviour Therapy, V32, P151, DOI 10.1080/16506070302316
NR 41
TC 134
Z9 137
U1 0
U2 36
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2011
VL 6
IS 6
AR e21274
DI 10.1371/journal.pone.0021274
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 782CL
UT WOS:000291985100023
PM 21712998
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Demenescu, LR
   Kortekaas, R
   den Boer, JA
   Aleman, A
AF Demenescu, Liliana R.
   Kortekaas, Rudie
   den Boer, Johan A.
   Aleman, Andre
TI Impaired Attribution of Emotion to Facial Expressions in Anxiety and
   Major Depression
SO PLOS ONE
LA English
DT Article
ID OBSESSIVE-COMPULSIVE DISORDER; SOCIAL PHOBIA; ATTENTIONAL BIAS; MOOD
   DISORDERS; TRAIT ANXIETY; RECOGNITION; CHILDREN; ADOLESCENTS; DEFICITS;
   FACE
AB Background: Recognition of others' emotions is an important aspect of interpersonal communication. In major depression, a significant emotion recognition impairment has been reported. It remains unclear whether the ability to recognize emotion from facial expressions is also impaired in anxiety disorders. There is a need to review and integrate the published literature on emotional expression recognition in anxiety disorders and major depression.
   Methodology/Principal Findings: A detailed literature search was used to identify studies on explicit emotion recognition in patients with anxiety disorders and major depression compared to healthy participants. Eighteen studies provided sufficient information to be included. The differences on emotion recognition impairment between patients and controls (Cohen's d) with corresponding confidence intervals were computed for each study. Over all studies, adults with anxiety disorders had a significant impairment in emotion recognition (d = -0.35). In children with anxiety disorders no significant impairment of emotion recognition was found (d = -0.03). Major depression was associated with an even larger impairment in recognition of facial expressions of emotion (d = -0.58).
   Conclusions/Significance: Results from the current analysis support the hypothesis that adults with anxiety disorders or major depression both have a deficit in recognizing facial expression of emotions, and that this deficit is more pronounced in major depression than in anxiety.
C1 [Demenescu, Liliana R.; Kortekaas, Rudie; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, Groningen, Netherlands.
   [Demenescu, Liliana R.] Rhein Westfal TH Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany.
   [den Boer, Johan A.] Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands.
RP Demenescu, LR (reprint author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, Groningen, Netherlands.
EM ldemenescu@ukaachen.de
RI Aleman, Andre/E-1341-2012; Demenescu, Liliana Ramona/C-4884-2014
OI Demenescu, Liliana Ramona/0000-0002-8770-0725
FU University of Groningen, The Netherlands
FX The present study was funded by University of Groningen, The
   Netherlands. The founders had no role in the study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056
   Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003
   Allen JL, 2006, BEHAV CHANGE, V23, P239, DOI 10.1375/bech.23.4.239
   ARCHER J, 1992, BRIT J CLIN PSYCHOL, V31, P45, DOI 10.1111/j.2044-8260.1992.tb00967.x
   Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200
   Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022
   Bennett MR, 2005, PROG NEUROBIOL, V75, P29, DOI 10.1016/j.pneurobio.2004.11.002
   Bouhuys AL, 1997, J AFFECT DISORDERS, V43, P213, DOI 10.1016/S0165-0327(97)01432-8
   Bourke C, 2010, AUST NZ J PSYCHIAT, V44, P681, DOI 10.3109/00048674.2010.496359
   Bradley BP, 1999, BRIT J CLIN PSYCHOL, V38, P267, DOI 10.1348/014466599162845
   Campbell DW, 2009, DEPRESS ANXIETY, V26, P419, DOI 10.1002/da.20474
   Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cooper RM, 2008, J ANXIETY DISORD, V22, P1120, DOI 10.1016/j.janxdis.2007.11.010
   Corcoran KM, 2008, J ANXIETY DISORD, V22, P56, DOI 10.1016/j.janxdis.2007.01.003
   Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Easter J, 2005, J CHILD ADOL PSYCHOP, V15, P563, DOI 10.1089/cap.2005.15.563
   EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377
   Ellis C. R., 1997, J CHILD FAM STUD, V6, P453
   Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504
   FEINBERG TE, 1986, ARCH GEN PSYCHIAT, V43, P276
   Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294
   Gotlib Ian H, 2004, J Abnorm Psychol, V113, P121
   GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K
   Guyer AE, 2007, J CHILD PSYCHOL PSYC, V48, P863, DOI 10.1111/j.1469-7610.2007.01758.x
   Hale WW, 1998, PSYCHIAT RES, V80, P265, DOI 10.1016/S0165-1781(98)00070-5
   Harmer CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P148, DOI 10.1038/sj.npp.1300004
   Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HIRSCH RC, 2004, CLIN PSYCHOL REV, V24, P799
   Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705
   Kan Y, 2004, J NEUROL NEUROSUR PS, V75, P1667, DOI 10.1136/jnnp.2004.036079
   Keightley ML, 2003, NEUROPSYCHOLOGIA, V41, P585, DOI 10.1016/S0028-3932(02)00199-9
   Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [DOI 10.1037/1089-2680.2.3.320, 10.1037/1089-2680.2.3.320]
   Kessler H, 2007, DEPRESS ANXIETY, V24, P223, DOI 10.1002/da.20223
   Lang AJ, 2004, DEPRESS ANXIETY, V20, P190, DOI 10.1002/da.20030
   LeMoult J, 2009, J ABNORM PSYCHOL, V118, P828, DOI 10.1037/a0016944
   Lenti C, 2000, PERCEPT MOTOR SKILL, V91, P227, DOI 10.2466/PMS.91.5.227-236
   Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020
   MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15
   Manassis K, 2000, DEPRESS ANXIETY, V12, P209, DOI 10.1002/1520-6394(2000)12:4<209::AID-DA4>3.0.CO;2-A
   MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3
   McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424
   McClure EB, 2003, AM J PSYCHIAT, V160, P1172, DOI 10.1176/appi.ajp.160.6.1172
   Melfsen S, 2002, J NONVERBAL BEHAV, V26, P109, DOI 10.1023/A:1015665521371
   Mendlewicz L, 2005, J AFFECT DISORDERS, V89, P195, DOI 10.1016/j.jad.2005.07.010
   Mennin DS, 2005, BEHAV RES THER, V43, P1281, DOI 10.1016/j.brat.2004.08.008
   Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7
   Mohlman J, 2007, BEHAV RES THER, V45, P591, DOI 10.1016/j.brat.2006.03.007
   Mullins DT, 2004, J NONVERBAL BEHAV, V28, P3
   PERSAD SM, 1993, J ABNORM PSYCHOL, V102, P358, DOI 10.1037/0021-843X.102.3.358
   RUBINOW DR, 1992, BIOL PSYCHIAT, V31, P947, DOI 10.1016/0006-3223(92)90120-O
   Simonian SJ, 2001, CHILD PSYCHIAT HUM D, V32, P137, DOI 10.1023/A:1012298707253
   Surcinelli P, 2006, J ANXIETY DISORD, V20, P110, DOI 10.1016/j.janxdis.2004.11.010
   Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212
   Tse WS, 2004, J NERV MENT DIS, V192, P260, DOI 10.1097/01.nmd.0000120884.60002.2b
   Venn HR, 2006, INT J NEUROPSYCHOPH, V9, P229, DOI 10.1017/S1461145705006012
   WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42
   WINTON EC, 1995, BEHAV RES THER, V33, P193, DOI 10.1016/0005-7967(94)E0019-F
   ZUROFF DC, 1986, J CLIN PSYCHOL, V42, P411, DOI 10.1002/1097-4679(198605)42:3<411::AID-JCLP2270420302>3.0.CO;2-T
NR 62
TC 83
Z9 84
U1 3
U2 43
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 1
PY 2010
VL 5
IS 12
AR e15058
DI 10.1371/journal.pone.0015058
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 688AU
UT WOS:000284821300015
PM 21152015
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Peng, XN
   Zeng, XM
   Peng, SH
   Deng, DF
   Zhang, J
AF Peng, Xiaoning
   Zeng, Xiaomin
   Peng, Sihua
   Deng, Defeng
   Zhang, Jian
TI The Association Risk of Male Subfertility and Testicular Cancer: A
   Systematic Review
SO PLOS ONE
LA English
DT Review
AB Background: An association between male subfertility and an increased risk of testicular cancer has been proposed, but conflicting results of research on this topic have rendered this theory equivocal. To more precisely assess the association between subfertility and the risk of testicular cancer, we performed a systematic review of international epidemiologic evidence.
   Principal Findings: We searched the Medline database for records from January 1966 to March 2008 complemented with manual searches of the literature and then identified studies that met our inclusion criteria. Study design, sample size, exposure to subfertility and risk estimates of testicular cancer incidence were abstracted. Summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using the DerSimonian and Laird model. All statistical tests were two-sided. We identified seven case-control studies and two cohort studies published between 1987 and 2005. Analysis of the seven case-control studies that included 4,954 participants revealed an overall statistically significant association between subfertility and increased risk of testicular cancer (summary RR = 1.68, 95% CI: 1.22 to 2.31), without heterogeneity between studies (Q = 8.46, P heterogeneity = 0.21, I(2) statistics = 0.29). The association between subfertility and testicular cancer was somewhat stronger in the United States (summary RR = 1.75, 95% CI: 1.01 to 3.02) than it was in Europe (summary RR = 1.53, 95% CI: 1.22 to 1.92). The source of the control subjects had a statistically significant effect on the magnitude of the association (population-based summary-RR = 2.15, 95% CI: 1.11 to 4.17; hospital-based summary-RR = 1.56, 95% CI: 0.93 to 2.61). After excluding possible cryptorchidism, an important confounding factor, we also found a positive association between subfertility and increased risk of testicular cancer (summary RR = 1.59, 95% CI: 1.28 to 1.98). These results were consistent between studies conducted in the United States and in Europe (Q = 0.20, P heterogeneity = 0.66). Of the two cohort studies that reported standardized incidence ratios, both reported a statistically significant positive association between subfertility and increased risk of testicular cancer.
   Conclusions: Our findings support a relationship between subfertility and increased risk of testicular cancer and apply to the management of men with subfertility, and prevention and diagnosis of testicular cancer.
RP Peng, XN (reprint author), Hunan Normal Univ, Dept Internal Med, Coll Med, Changsha, Hunan, Peoples R China.
EM pxiaoning@hunnu.edu.cn; zhangjian@hunnu.edu.cn
CR Baker JA, 2005, CANCER CAUSE CONTROL, V16, P295, DOI 10.1007/s10552-004-4024-2
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   BROWN LM, 1987, J EPIDEMIOL COMMUN H, V41, P349, DOI 10.1136/jech.41.4.349
   Chow V, 2006, J REPROD MED, V51, P149
   de Kretser DM, 2000, BRIT MED J, V321, P781, DOI 10.1136/bmj.321.7264.781
   DEPUE RH, 1983, J NATL CANCER I, V71, P1151
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8
   Doria-Rose VP, 2005, CANCER CAUSE CONTROL, V16, P651, DOI 10.1007/s10552-005-0169-x
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5
   FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393
   Fossa SD, 2000, BRIT J CANCER, V82, P737, DOI 10.1054/bjoc.1999.0989
   Garner MJ, 2005, INT J CANCER, V116, P331, DOI 10.1002/ijc.21032
   Giwercman A, 2007, REPROD BIOMED ONLINE, V15, P633, DOI 10.1016/S1472-6483(10)60530-5
   GREENLAND S, 1987, EPIDEMIOL REV, V9, P1
   HAUGHEY BP, 1989, AM J EPIDEMIOL, V130, P25, DOI 10.1093/oxfordjournals.aje.a115319
   Heimdal K, 1996, BRIT J CANCER, V73, P970, DOI 10.1038/bjc.1996.174
   HENDERSON BE, 1979, INT J CANCER, V23, P598, DOI 10.1002/ijc.2910230503
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hoei-Hansen CE, 2005, ANN ONCOL, V16, P863, DOI 10.1093/annonc/mdi175
   HORWITZ RI, 1979, AM J MED, V66, P556, DOI 10.1016/0002-9343(79)91164-1
   Huyghe E, 2003, J UROLOGY, V170, P5, DOI 10.1097/01.ju.0000053866.68623.da
   Jacobsen R, 2000, BMJ-BRIT MED J, V321, P789, DOI 10.1136/bmj.321.7264.789
   Jacobsen R, 2000, HUM REPROD, V15, P1958, DOI 10.1093/humrep/15.9.1958
   KAHN HA, 1989, EPIDEMIOLOGY BIOSTAT, V12, pE3
   Mancini M, 2007, HUM REPROD, V22, P1042, DOI 10.1093/humrep/del500
   Moller H, 1999, BMJ-BRIT MED J, V318, P559, DOI 10.1136/bmj.318.7183.559
   Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455
   Olesen IA, 2007, INT J ANDROL, V30, P406, DOI 10.1111/j.1365-2605.2007.00798.x
   Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568
   Raman JD, 2005, J UROLOGY, V174, P1819, DOI 10.1097/01.ju.0000177491.98461.aa
   Richiardi L, 2004, J NATL CANCER I, V96, P145, DOI 10.1093/jnci/djh012
   Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x
   Snick HKA, 1997, HUM REPROD, V12, P1582, DOI 10.1093/humrep/12.7.1582
   SWERDLOW AJ, 1989, INT J CANCER, V43, P549, DOI 10.1002/ijc.2910430403
   Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.1289/ehp.96104s4741
   Walschaerts M, 2008, CANCER CAUSE CONTROL, V19, P155, DOI 10.1007/s10552-007-9081-x
   Weir HK, 2000, INT J CANCER, V87, P438, DOI 10.1002/1097-0215(20000801)87:3<438::AID-IJC20>3.0.CO;2-1
   Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595
NR 41
TC 34
Z9 35
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2009
VL 4
IS 5
AR e5591
DI 10.1371/journal.pone.0005591
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 446FZ
UT WOS:000266107500019
PM 19440348
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

EF